#1.3
35616	2	19	1
id	hmsDatasetID	smCenterCompoundID	smSalt	smCenterSampleID	smLincsID	smName	clName	clCenterSpecificID	ppName	ppLincsID	recordedPlate	recordedWell	controlType	smallMolConcentration	smallMolConcUnit	stimulusConcentration	stimulusConcUnit	expPlate	measuredProtein	measuredProteinMFI(a.u.)	beadCount
datapointUnit	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na	na		
339136	20233																	0	MIP-1B	73	36
339137	20233						RA2159	51112.0										1	MIP-1B	70	66
339138	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MIP-1B	66	60
339139	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MIP-1B	70	74
339140	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MIP-1B	68	67
339141	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MIP-1B	64.5	94
339142	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MIP-1B	66	54
339143	20233						RA2159	51112.0										1	MIP-1B	71	59
339144	20233						N2586	51107.0										1	MIP-1B	69	66
339145	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MIP-1B	67	64
339146	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MIP-1B	74	56
339147	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MIP-1B	71	64
339148	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MIP-1B	70	91
339149	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MIP-1B	62	37
339150	20233						N2586	51107.0										1	MIP-1B	72	42
339151	20233																	0	MIP-1B	66	71
339152	20233																	0	MIP-1B	64	42
339153	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	MIP-1B	90	61
339154	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	MIP-1B	77	69
339155	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIP-1B	77	59
339156	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIP-1B	71	89
339157	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIP-1B	83	73
339158	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	MIP-1B	77	65
339159	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	MIP-1B	69	83
339160	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	MIP-1B	89.5	66
339161	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	MIP-1B	96.5	62
339162	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIP-1B	85	61
339163	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIP-1B	90.5	56
339164	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIP-1B	93	45
339165	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	MIP-1B	78	53
339166	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	MIP-1B	78.5	38
339167	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	MIP-1B	160	79
339168	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	MIP-1B	88	67
339169	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIP-1B	65	70
339170	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIP-1B	166	71
339171	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIP-1B	99.5	82
339172	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	MIP-1B	63.5	78
339173	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	MIP-1B	66	69
339174	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	MIP-1B	128	68
339175	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	MIP-1B	171.5	52
339176	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIP-1B	80	73
339177	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIP-1B	167	47
339178	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIP-1B	180	73
339179	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	MIP-1B	76	55
339180	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	MIP-1B	71	63
339181	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	MIP-1B	77	51
339182	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	MIP-1B	64.5	78
339183	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIP-1B	66	87
339184	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIP-1B	76	89
339185	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIP-1B	67	74
339186	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	MIP-1B	73	67
339187	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	MIP-1B	68	65
339188	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	MIP-1B	75.5	76
339189	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	MIP-1B	60.5	60
339190	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIP-1B	73	65
339191	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIP-1B	70	55
339192	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIP-1B	62	65
339193	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	MIP-1B	75.5	74
339194	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	MIP-1B	71	60
339195	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	MIP-1B	70	65
339196	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	MIP-1B	67	63
339197	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIP-1B	77	95
339198	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIP-1B	79	59
339199	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIP-1B	78	61
339200	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	MIP-1B	72	82
339201	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	MIP-1B	80	80
339202	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	MIP-1B	76	61
339203	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIP-1B	68	61
339204	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIP-1B	73	81
339205	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIP-1B	78	64
339206	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	MIP-1B	72	66
339207	20233						RA2159	51112.0										1	MIP-1B	78	64
339208	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MIP-1B	68	67
339209	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MIP-1B	65	83
339210	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MIP-1B	71	78
339211	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MIP-1B	75	69
339212	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MIP-1B	65	69
339213	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	MIP-1B	69	50
339214	20233						N2586	51107.0										1	MIP-1B	68.5	44
339215	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MIP-1B	62.5	58
339216	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MIP-1B	68.5	48
339217	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MIP-1B	69	55
339218	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MIP-1B	77	56
339219	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MIP-1B	77	59
339220	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	MIP-1B	75	74
339221	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	MIP-1B	65	68
339222	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	MIP-1B	70.5	58
339223	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIP-1B	64.5	74
339224	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIP-1B	70	73
339225	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIP-1B	67	81
339226	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	MIP-1B	66	57
339227	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	MIP-1B	69	75
339228	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	MIP-1B	61	80
339229	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	MIP-1B	65	70
339230	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIP-1B	62	51
339231	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIP-1B	74	45
339232	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIP-1B	66	68
339233	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	MIP-1B	67	57
339234	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	MIP-1B	74.5	100
339235	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	MIP-1B	61	68
339236	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	MIP-1B	58.5	74
339237	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIP-1B	59	53
339238	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIP-1B	62	61
339239	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIP-1B	61	84
339240	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	MIP-1B	67	82
339241	20233						RA2159	51112.0										1	MIP-1B	63	60
339242	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	MIP-1B	63	63
339243	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	MIP-1B	60	74
339244	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIP-1B	66	75
339245	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIP-1B	63	55
339246	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIP-1B	62	73
339247	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	MIP-1B	62	63
339248	20233						N2586	51107.0										1	MIP-1B	78	85
339249	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	MIP-1B	62	79
339250	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	MIP-1B	61	71
339251	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIP-1B	65	75
339252	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIP-1B	59	58
339253	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIP-1B	68	62
339254	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	MIP-1B	55	81
339255	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	MIP-1B	63	64
339256	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	MIP-1B	62	47
339257	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIP-1B	60	65
339258	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIP-1B	61	47
339259	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIP-1B	67.5	66
339260	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	MIP-1B	59	51
339261	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	MIP-1B	69	79
339262	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	MIP-1B	69	61
339263	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIP-1B	64	67
339264	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIP-1B	64	59
339265	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIP-1B	60	61
339266	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	MIP-1B	72	59
339267	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	MIP-1B	62	49
339268	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	MIP-1B	63	40
339269	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIP-1B	61	88
339270	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIP-1B	61.5	70
339271	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIP-1B	59	49
339272	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	MIP-1B	63	48
339273	20233						RA2159	51112.0										1	MIP-1B	59.5	66
339274	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MIP-1B	67	71
339275	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MIP-1B	67	73
339276	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MIP-1B	68.5	72
339277	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MIP-1B	64	97
339278	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MIP-1B	61	71
339279	20233						RA2159	51112.0										1	MIP-1B	57.5	96
339280	20233						N2586	51107.0										1	MIP-1B	61	82
339281	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MIP-1B	61	71
339282	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MIP-1B	66	69
339283	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MIP-1B	62	72
339284	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MIP-1B	64	73
339285	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MIP-1B	66	77
339286	20233						N2586	51107.0										1	MIP-1B	62	67
339287	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	MIP-1B	67.5	68
339288	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	MIP-1B	64	69
339289	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIP-1B	74.5	70
339290	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIP-1B	64.5	74
339291	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIP-1B	63	43
339292	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	MIP-1B	62.5	78
339293	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	MIP-1B	58	76
339294	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	MIP-1B	64	59
339295	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIP-1B	61	71
339296	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIP-1B	60	57
339297	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIP-1B	61.5	72
339298	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	MIP-1B	58	33
339299	20233																	0	MIP-1B	68	59
339300	20233						RA2159	51112.0								2	ug/mL	1	MIP-1B	100	57
339301	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	MIP-1B	82	55
339302	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MIP-1B	69	71
339303	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MIP-1B	72.5	52
339304	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MIP-1B	81	69
339305	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	MIP-1B	69	68
339306	20233						N2586	51107.0								2	ug/mL	1	MIP-1B	75	46
339307	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	MIP-1B	68	72
339308	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MIP-1B	64	57
339309	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MIP-1B	66	35
339310	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MIP-1B	78.5	52
339311	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	MIP-1B	67	60
339312	20233																	0	MIP-1B	69	60
339313	20233						RA2159	51112.0										2	MIP-1B	63	65
339314	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MIP-1B	66.5	76
339315	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MIP-1B	73.5	70
339316	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MIP-1B	65	63
339317	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MIP-1B	66.5	70
339318	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MIP-1B	69	69
339319	20233						RA2159	51112.0										2	MIP-1B	64	51
339320	20233						N2586	51107.0										2	MIP-1B	66	47
339321	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MIP-1B	62	61
339322	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MIP-1B	68	50
339323	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MIP-1B	63.5	50
339324	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MIP-1B	75	45
339325	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MIP-1B	68	46
339326	20233						N2586	51107.0										2	MIP-1B	70	41
339327	20233																	0	MIP-1B	72	65
339328	20233																	0	MIP-1B	76	42
339329	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	MIP-1B	78	69
339330	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	MIP-1B	94	89
339331	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	MIP-1B	77	73
339332	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIP-1B	74.5	56
339333	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIP-1B	65	67
339334	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	MIP-1B	70	63
339335	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	MIP-1B	63	77
339336	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	MIP-1B	81	77
339337	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	MIP-1B	84	69
339338	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	MIP-1B	87.5	54
339339	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIP-1B	82	61
339340	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIP-1B	83	43
339341	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	MIP-1B	86	59
339342	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	MIP-1B	70	56
339343	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	MIP-1B	132.5	68
339344	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	MIP-1B	107	67
339345	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	MIP-1B	90	61
339346	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIP-1B	188.5	62
339347	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIP-1B	98	64
339348	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	MIP-1B	96	58
339349	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	MIP-1B	66.5	56
339350	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	MIP-1B	120.5	50
339351	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	MIP-1B	121	73
339352	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	MIP-1B	201	67
339353	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIP-1B	376.5	60
339354	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIP-1B	97	54
339355	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	MIP-1B	168	57
339356	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	MIP-1B	66	46
339357	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	MIP-1B	66.5	82
339358	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	MIP-1B	63	50
339359	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	MIP-1B	67.5	70
339360	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIP-1B	61.5	68
339361	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIP-1B	63	81
339362	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	MIP-1B	66	58
339363	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	MIP-1B	63.5	56
339364	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	MIP-1B	63	77
339365	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	MIP-1B	58	88
339366	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	MIP-1B	63.5	56
339367	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIP-1B	63.5	46
339368	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIP-1B	64	55
339369	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	MIP-1B	67	69
339370	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	MIP-1B	63	64
339371	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	MIP-1B	69.5	56
339372	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	MIP-1B	70	75
339373	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	MIP-1B	68	75
339374	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIP-1B	68	73
339375	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIP-1B	68	61
339376	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	MIP-1B	64	67
339377	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	MIP-1B	62	78
339378	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	MIP-1B	70	55
339379	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	MIP-1B	66	50
339380	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	MIP-1B	65	57
339381	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIP-1B	70	75
339382	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIP-1B	66.5	52
339383	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	MIP-1B	72	69
339384	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	MIP-1B	69	45
339385	20233						RA2159	51112.0										2	MIP-1B	64	74
339386	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MIP-1B	62	74
339387	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MIP-1B	65.5	66
339388	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MIP-1B	57	56
339389	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MIP-1B	61	71
339390	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MIP-1B	64	67
339391	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	MIP-1B	63	45
339392	20233						N2586	51107.0										2	MIP-1B	68	67
339393	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MIP-1B	61	60
339394	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MIP-1B	63	82
339395	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MIP-1B	61	59
339396	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MIP-1B	69	66
339397	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MIP-1B	64	52
339398	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	MIP-1B	70	55
339399	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	MIP-1B	64	79
339400	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	MIP-1B	62	74
339401	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	MIP-1B	52	68
339402	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	MIP-1B	62	77
339403	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	MIP-1B	63	88
339404	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	MIP-1B	64	85
339405	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	MIP-1B	61	81
339406	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	MIP-1B	69	78
339407	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	MIP-1B	57	59
339408	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	MIP-1B	62	65
339409	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	MIP-1B	51	47
339410	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	MIP-1B	42	67
339411	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	MIP-1B	59.5	100
339412	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	MIP-1B	66	53
339413	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	MIP-1B	61	97
339414	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIP-1B	66	62
339415	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIP-1B	64	67
339416	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	MIP-1B	61	63
339417	20233						RA2159	51112.0										2	MIP-1B	61	87
339418	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	MIP-1B	60.5	70
339419	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	MIP-1B	64.5	74
339420	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	MIP-1B	65	61
339421	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIP-1B	60.5	54
339422	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIP-1B	69	60
339423	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	MIP-1B	66.5	74
339424	20233						N2586	51107.0										2	MIP-1B	44	65
339425	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	MIP-1B	59	73
339426	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	MIP-1B	58	59
339427	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	MIP-1B	61	76
339428	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIP-1B	68	73
339429	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIP-1B	61	59
339430	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	MIP-1B	67.5	62
339431	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	MIP-1B	56	65
339432	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	MIP-1B	61	50
339433	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	MIP-1B	55.5	52
339434	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIP-1B	61	53
339435	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIP-1B	61	51
339436	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	MIP-1B	64	54
339437	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	MIP-1B	60	82
339438	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	MIP-1B	60	63
339439	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	MIP-1B	61	74
339440	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIP-1B	63	56
339441	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIP-1B	60	79
339442	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	MIP-1B	63	74
339443	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	MIP-1B	58.5	90
339444	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	MIP-1B	57	63
339445	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	MIP-1B	59	68
339446	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIP-1B	56	45
339447	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIP-1B	60	34
339448	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	MIP-1B	61	80
339449	20233						RA2159	51112.0										2	MIP-1B	69	96
339450	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MIP-1B	64	65
339451	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MIP-1B	64	81
339452	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MIP-1B	63.5	92
339453	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MIP-1B	63	78
339454	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MIP-1B	61.5	54
339455	20233						RA2159	51112.0										2	MIP-1B	66.5	58
339456	20233						N2586	51107.0										2	MIP-1B	60	40
339457	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MIP-1B	55	51
339458	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MIP-1B	65.5	62
339459	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MIP-1B	65.5	58
339460	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MIP-1B	63	64
339461	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MIP-1B	68	45
339462	20233						N2586	51107.0										2	MIP-1B	63	54
339463	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	MIP-1B	63	62
339464	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	MIP-1B	61.5	62
339465	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	MIP-1B	61.5	86
339466	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIP-1B	62.5	46
339467	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIP-1B	64	37
339468	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	MIP-1B	64.5	56
339469	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	MIP-1B	57	59
339470	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	MIP-1B	66	57
339471	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	MIP-1B	60	43
339472	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIP-1B	64	35
339473	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIP-1B	65	46
339474	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	MIP-1B	62	36
339475	20233																	0	MIP-1B	62	49
339476	20233						RA2159	51112.0								2	ug/mL	2	MIP-1B	94	60
339477	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	MIP-1B	80	56
339478	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	MIP-1B	76.5	70
339479	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	MIP-1B	111	71
339480	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	MIP-1B	57	25
339481	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	MIP-1B	188.5	48
339482	20233						N2586	51107.0								2	ug/mL	2	MIP-1B	65	31
339483	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	MIP-1B	66	43
339484	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	MIP-1B	73	46
339485	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	MIP-1B	82	35
339486	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	MIP-1B	63	39
339487	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	MIP-1B	73	58
339488	20233																	0	MIP-1B	67.5	78
339489	20233						RA2159	51112.0								2	ug/mL	3	MIP-1B	81.5	68
339490	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	MIP-1B	103	39
339491	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MIP-1B	60.5	70
339492	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MIP-1B	85	68
339493	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MIP-1B	81	61
339494	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	MIP-1B	67	61
339495	20233						N2586	51107.0								2	ug/mL	3	MIP-1B	99	74
339496	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	MIP-1B	84.5	62
339497	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MIP-1B	91.5	70
339498	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MIP-1B	91.5	68
339499	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MIP-1B	62	59
339500	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	MIP-1B	65	72
339501	20233						RA2159	51112.0										3	MIP-1B	55	77
339502	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MIP-1B	62	84
339503	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MIP-1B	60	57
339504	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MIP-1B	57	67
339505	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MIP-1B	63.5	82
339506	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MIP-1B	61	67
339507	20233						RA2159	51112.0										3	MIP-1B	63	69
339508	20233						N2586	51107.0										3	MIP-1B	54	56
339509	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MIP-1B	63	78
339510	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MIP-1B	63	51
339511	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MIP-1B	66	61
339512	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MIP-1B	63	81
339513	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MIP-1B	63	75
339514	20233						N2586	51107.0										3	MIP-1B	60.5	54
339515	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	MIP-1B	64.5	74
339516	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	MIP-1B	60.5	56
339517	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIP-1B	63.5	62
339518	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIP-1B	60	59
339519	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIP-1B	60	91
339520	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	MIP-1B	67	72
339521	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	MIP-1B	61	57
339522	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	MIP-1B	59	49
339523	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIP-1B	60	89
339524	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIP-1B	67	49
339525	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIP-1B	50.5	56
339526	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	MIP-1B	63	62
339527	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	MIP-1B	64.5	82
339528	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	MIP-1B	60	81
339529	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIP-1B	45.5	68
339530	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIP-1B	60	77
339531	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIP-1B	58	81
339532	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	MIP-1B	60	83
339533	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	MIP-1B	61.5	90
339534	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	MIP-1B	62	76
339535	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIP-1B	59	77
339536	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIP-1B	60	63
339537	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIP-1B	55.5	76
339538	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	MIP-1B	65	67
339539	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	MIP-1B	60	77
339540	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	MIP-1B	60	70
339541	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIP-1B	61	69
339542	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIP-1B	62.5	64
339543	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIP-1B	61	84
339544	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	MIP-1B	61	87
339545	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	MIP-1B	64.5	70
339546	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	MIP-1B	57.5	82
339547	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIP-1B	59.5	72
339548	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIP-1B	60	72
339549	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIP-1B	61	57
339550	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	MIP-1B	61.5	70
339551	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	MIP-1B	58	72
339552	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	MIP-1B	59.5	70
339553	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIP-1B	59	76
339554	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIP-1B	58.5	68
339555	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIP-1B	59	80
339556	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	MIP-1B	61	64
339557	20233						RA2159	51112.0										3	MIP-1B	59	62
339558	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	MIP-1B	58	81
339559	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	MIP-1B	60	49
339560	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIP-1B	58	68
339561	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIP-1B	65	83
339562	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIP-1B	59	77
339563	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	MIP-1B	59	73
339564	20233						N2586	51107.0										3	MIP-1B	69.5	68
339565	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	MIP-1B	59	67
339566	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	MIP-1B	57.5	58
339567	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIP-1B	64	67
339568	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIP-1B	59.5	46
339569	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIP-1B	56.5	78
339570	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	MIP-1B	61	55
339571	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	MIP-1B	54	67
339572	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	MIP-1B	65	72
339573	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	MIP-1B	54.5	86
339574	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIP-1B	61.5	62
339575	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIP-1B	59	73
339576	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIP-1B	59	52
339577	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	MIP-1B	43	67
339578	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	MIP-1B	61	59
339579	20233						RA2159	51112.0										3	MIP-1B	58	69
339580	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MIP-1B	59	47
339581	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MIP-1B	55	73
339582	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MIP-1B	62.5	60
339583	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MIP-1B	63	84
339584	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MIP-1B	56	73
339585	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	MIP-1B	58.5	68
339586	20233						N2586	51107.0										3	MIP-1B	56.5	86
339587	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MIP-1B	56	92
339588	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MIP-1B	57	81
339589	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MIP-1B	61	82
339590	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MIP-1B	54	63
339591	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MIP-1B	61	69
339592	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	MIP-1B	61	63
339593	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	MIP-1B	64	53
339594	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	MIP-1B	71.5	66
339595	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIP-1B	71	77
339596	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIP-1B	66	70
339597	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIP-1B	64	69
339598	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	MIP-1B	67	64
339599	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	MIP-1B	65.5	64
339600	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	MIP-1B	62	67
339601	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIP-1B	65.5	66
339602	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIP-1B	65	75
339603	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIP-1B	64	61
339604	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	MIP-1B	58	61
339605	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	MIP-1B	62	79
339606	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	MIP-1B	67.5	76
339607	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIP-1B	64	62
339608	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIP-1B	59	75
339609	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIP-1B	60	72
339610	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	MIP-1B	70.5	70
339611	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	MIP-1B	61.5	70
339612	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	MIP-1B	64	67
339613	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	MIP-1B	60	69
339614	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIP-1B	57	79
339615	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIP-1B	66	75
339616	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIP-1B	57.5	66
339617	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	MIP-1B	62.5	68
339618	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	MIP-1B	63	85
339619	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	MIP-1B	134	64
339620	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	MIP-1B	79.5	66
339621	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIP-1B	63.5	62
339622	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIP-1B	160	59
339623	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIP-1B	117.5	74
339624	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	MIP-1B	64	67
339625	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	MIP-1B	59	64
339626	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	MIP-1B	158	83
339627	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	MIP-1B	134	65
339628	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIP-1B	214	74
339629	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIP-1B	466.5	78
339630	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIP-1B	60	63
339631	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	MIP-1B	76	73
339632	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	MIP-1B	61	73
339633	20233																	0	MIP-1B	64	69
339634	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	MIP-1B	77	47
339635	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	MIP-1B	86	45
339636	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIP-1B	72	76
339637	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIP-1B	76	63
339638	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIP-1B	76	62
339639	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	MIP-1B	65.5	74
339640	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	MIP-1B	58	65
339641	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	MIP-1B	87	83
339642	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	MIP-1B	73	52
339643	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIP-1B	80.5	70
339644	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIP-1B	64	76
339645	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIP-1B	61	73
339646	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	MIP-1B	74	65
339647	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	MIP-1B	59	81
339648	20233																	0	MIP-1B	57.5	62
339649	20233						RA2159	51112.0										3	MIP-1B	58	74
339650	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MIP-1B	60	63
339651	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MIP-1B	56	63
339652	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MIP-1B	58	55
339653	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MIP-1B	65	43
339654	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MIP-1B	56	73
339655	20233						RA2159	51112.0										3	MIP-1B	61.5	64
339656	20233						N2586	51107.0										3	MIP-1B	59.5	58
339657	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MIP-1B	56	77
339658	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MIP-1B	62	67
339659	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MIP-1B	59	39
339660	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MIP-1B	58.5	42
339661	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MIP-1B	57	67
339662	20233						N2586	51107.0										3	MIP-1B	57.5	42
339663	20233																	0	MIP-1B	64	63
339664	20233						RA2159	51112.0								2	ug/mL	4	MIP-1B	152	62
339665	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	MIP-1B	128.5	76
339666	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	MIP-1B	81.5	68
339667	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	MIP-1B	138	71
339668	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	MIP-1B	74.5	60
339669	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	MIP-1B	172	67
339670	20233						N2586	51107.0								2	ug/mL	4	MIP-1B	91.5	78
339671	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	MIP-1B	87	85
339672	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	MIP-1B	62	64
339673	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	MIP-1B	66	77
339674	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	MIP-1B	65	89
339675	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	MIP-1B	62	55
339676	20233						RA2159	51112.0										4	MIP-1B	63.5	64
339677	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MIP-1B	64	65
339678	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MIP-1B	60	76
339679	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MIP-1B	61	77
339680	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MIP-1B	60	65
339681	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MIP-1B	63	83
339682	20233						RA2159	51112.0										4	MIP-1B	63	73
339683	20233						N2586	51107.0										4	MIP-1B	59	69
339684	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MIP-1B	59	63
339685	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MIP-1B	58	42
339686	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MIP-1B	60	69
339687	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MIP-1B	63	68
339688	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MIP-1B	61	81
339689	20233						N2586	51107.0										4	MIP-1B	60.5	68
339690	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	MIP-1B	60	62
339691	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	MIP-1B	74	52
339692	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	MIP-1B	56	73
339693	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIP-1B	62	64
339694	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIP-1B	59	75
339695	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	MIP-1B	62.5	64
339696	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	MIP-1B	58	75
339697	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	MIP-1B	57	60
339698	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	MIP-1B	61	69
339699	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIP-1B	57	60
339700	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIP-1B	57	77
339701	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	MIP-1B	59	67
339702	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	MIP-1B	56	69
339703	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	MIP-1B	56	75
339704	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	MIP-1B	57	71
339705	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIP-1B	57	67
339706	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIP-1B	60	74
339707	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	MIP-1B	60	68
339708	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	MIP-1B	57.5	52
339709	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	MIP-1B	57.5	54
339710	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	MIP-1B	59	69
339711	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIP-1B	59	88
339712	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIP-1B	64.5	72
339713	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	MIP-1B	59	73
339714	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	MIP-1B	63.5	82
339715	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	MIP-1B	61.5	70
339716	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	MIP-1B	57	55
339717	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIP-1B	60.5	80
339718	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIP-1B	60	65
339719	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	MIP-1B	61	42
339720	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	MIP-1B	58.5	62
339721	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	MIP-1B	65	61
339722	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	MIP-1B	58	47
339723	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIP-1B	59.5	74
339724	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIP-1B	60.5	70
339725	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	MIP-1B	58	66
339726	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	MIP-1B	63	60
339727	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	MIP-1B	60	49
339728	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	MIP-1B	62	74
339729	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIP-1B	64	94
339730	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIP-1B	57	66
339731	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	MIP-1B	61	58
339732	20233						RA2159	51112.0										4	MIP-1B	55	43
339733	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	MIP-1B	63	57
339734	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	MIP-1B	58	79
339735	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	MIP-1B	57	61
339736	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIP-1B	61	57
339737	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIP-1B	63	47
339738	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	MIP-1B	62	63
339739	20233						N2586	51107.0										4	MIP-1B	60	71
339740	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	MIP-1B	61	81
339741	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	MIP-1B	61	83
339742	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	MIP-1B	61.5	82
339743	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	MIP-1B	62	54
339744	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	MIP-1B	59	51
339745	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	MIP-1B	54	54
339746	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	MIP-1B	58	72
339747	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	MIP-1B	59	73
339748	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	MIP-1B	64	59
339749	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	MIP-1B	60	67
339750	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	MIP-1B	59.5	50
339751	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	MIP-1B	60	87
339752	20233						RA2159	51112.0										4	MIP-1B	62	80
339753	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MIP-1B	61	69
339754	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MIP-1B	57	78
339755	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MIP-1B	58	56
339756	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MIP-1B	59.5	52
339757	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MIP-1B	59	62
339758	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	MIP-1B	56	75
339759	20233						N2586	51107.0										4	MIP-1B	58	80
339760	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MIP-1B	56	65
339761	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MIP-1B	59	63
339762	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MIP-1B	55.5	66
339763	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MIP-1B	59	69
339764	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MIP-1B	59	75
339765	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	MIP-1B	60	58
339766	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	MIP-1B	64	60
339767	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	MIP-1B	58	62
339768	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	MIP-1B	64.5	62
339769	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIP-1B	65	52
339770	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIP-1B	59	64
339771	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	MIP-1B	59	71
339772	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	MIP-1B	58	70
339773	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	MIP-1B	62	61
339774	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	MIP-1B	62	61
339775	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	MIP-1B	64	64
339776	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIP-1B	67	71
339777	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIP-1B	63	67
339778	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	MIP-1B	65	67
339779	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	MIP-1B	62	55
339780	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	MIP-1B	63.5	48
339781	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	MIP-1B	57	74
339782	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	MIP-1B	54	53
339783	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIP-1B	60	51
339784	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIP-1B	57	74
339785	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	MIP-1B	65	68
339786	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	MIP-1B	53	43
339787	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	MIP-1B	59	43
339788	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	MIP-1B	61	65
339789	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	MIP-1B	56	71
339790	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIP-1B	57	49
339791	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIP-1B	64	68
339792	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	MIP-1B	60	65
339793	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	MIP-1B	65	55
339794	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	MIP-1B	126	42
339795	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	MIP-1B	104	68
339796	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	MIP-1B	106	56
339797	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIP-1B	136	83
339798	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIP-1B	75	46
339799	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	MIP-1B	190	64
339800	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	MIP-1B	57	57
339801	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	MIP-1B	126.5	74
339802	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	MIP-1B	148	61
339803	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	MIP-1B	65	57
339804	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIP-1B	166	58
339805	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIP-1B	78	47
339806	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	MIP-1B	55	55
339807	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	MIP-1B	60	53
339808	20233																	0	MIP-1B	62.5	44
339809	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	MIP-1B	73	82
339810	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	MIP-1B	68	50
339811	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	MIP-1B	72.5	68
339812	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIP-1B	72.5	76
339813	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIP-1B	60	53
339814	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	MIP-1B	70.5	54
339815	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	MIP-1B	54	47
339816	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	MIP-1B	93.5	52
339817	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	MIP-1B	80	71
339818	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	MIP-1B	70	57
339819	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIP-1B	84	58
339820	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIP-1B	63	53
339821	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	MIP-1B	56.5	52
339822	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	MIP-1B	57	71
339823	20233																	0	MIP-1B	64.5	76
339824	20233						RA2159	51112.0										4	MIP-1B	58	76
339825	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MIP-1B	60	66
339826	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MIP-1B	60	65
339827	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MIP-1B	55	57
339828	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MIP-1B	59	85
339829	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MIP-1B	56	47
339830	20233						RA2159	51112.0										4	MIP-1B	61.5	48
339831	20233						N2586	51107.0										4	MIP-1B	57	65
339832	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MIP-1B	60	53
339833	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MIP-1B	52	71
339834	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MIP-1B	56.5	46
339835	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MIP-1B	59	60
339836	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MIP-1B	62	70
339837	20233						N2586	51107.0										4	MIP-1B	54	70
339838	20233								TNF-a	201285.0						100	ng/mL	0	MIP-1B	100.5	82
339839	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIP-1B	67	86
339840	20233								IL-6	201287.0						100	ug/mL	0	MIP-1B	89	73
339841	20233								IL-17A	201288.0						100	ng/mL	0	MIP-1B	104	61
339842	20233								EGF	201289.0						100	ng/mL	0	MIP-1B	70.5	76
339843	20233								IGF-I	201290.0						100	ug/mL	0	MIP-1B	67	68
339844	20233								Adiponectin	201291.0						5	ng/mL	0	MIP-1B	62	78
339845	20233								Leptin	201292.0						1	ng/mL	0	MIP-1B	68	83
339846	20233								Visfatin	201293.0						1	ng/mL	0	MIP-1B	66.5	46
339847	20233															2	ug/mL	0	MIP-1B	71	73
339848	20233								TNF-a	201285.0						100	ng/mL	0	MIP-1B	85	63
339849	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIP-1B	68.5	50
339850	20233								IL-6	201287.0						100	ug/mL	0	MIP-1B	81	57
339851	20233								IL-17A	201288.0						100	ng/mL	0	MIP-1B	94.5	64
339852	20233								EGF	201289.0						100	ng/mL	0	MIP-1B	70	57
339853	20233								IGF-I	201290.0						100	ug/mL	0	MIP-1B	67	56
339854	20233								Adiponectin	201291.0						5	ng/mL	0	MIP-1B	68.5	46
339855	20233								Leptin	201292.0						1	ng/mL	0	MIP-1B	71	51
339856	20233								Visfatin	201293.0						1	ng/mL	0	MIP-1B	64	52
339857	20233															2	ug/mL	0	MIP-1B	74	49
339858	20233								TNF-a	201285.0						100	ng/mL	0	MIP-1B	96	57
339859	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIP-1B	61	57
339860	20233								IL-6	201287.0						100	ug/mL	0	MIP-1B	74	51
339861	20233								IL-17A	201288.0						100	ng/mL	0	MIP-1B	102.5	50
339862	20233								EGF	201289.0						100	ng/mL	0	MIP-1B	60.5	62
339863	20233								IGF-I	201290.0						100	ug/mL	0	MIP-1B	58.5	68
339864	20233								Adiponectin	201291.0						5	ng/mL	0	MIP-1B	49.5	64
339865	20233								Leptin	201292.0						1	ng/mL	0	MIP-1B	63	52
339866	20233								Visfatin	201293.0						1	ng/mL	0	MIP-1B	62	88
339867	20233															2	ug/mL	0	MIP-1B	59	73
339868	20233								TNF-a	201285.0						100	ng/mL	0	MIP-1B	88.5	78
339869	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIP-1B	53	58
339870	20233								IL-6	201287.0						100	ug/mL	0	MIP-1B	71	62
339871	20233								IL-17A	201288.0						100	ng/mL	0	MIP-1B	91	62
339872	20233								EGF	201289.0						100	ng/mL	0	MIP-1B	57	55
339873	20233								IGF-I	201290.0						100	ug/mL	0	MIP-1B	60	71
339874	20233								Adiponectin	201291.0						5	ng/mL	0	MIP-1B	54	53
339875	20233								Leptin	201292.0						1	ng/mL	0	MIP-1B	59	55
339876	20233								Visfatin	201293.0						1	ng/mL	0	MIP-1B	63.5	56
339877	20233															2	ug/mL	0	MIP-1B	63	49
339878	20233																	0	IL-6	22.5	50
339879	20233						RA2159	51112.0										1	IL-6	6151.5	58
339880	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-6	6103	66
339881	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-6	6141	75
339882	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-6	6825.5	64
339883	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-6	7005	75
339884	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-6	6696.5	68
339885	20233						RA2159	51112.0										1	IL-6	7570	53
339886	20233						N2586	51107.0										1	IL-6	6331	66
339887	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-6	5865	50
339888	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-6	5608	64
339889	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-6	5553	75
339890	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-6	3486	63
339891	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-6	5341.5	50
339892	20233						N2586	51107.0										1	IL-6	6720.5	34
339893	20233																	0	IL-6	24	72
339894	20233																	0	IL-6	19	41
339895	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-6	23023	59
339896	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-6	15395.5	66
339897	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-6	10121	56
339898	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-6	8976.5	84
339899	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-6	13678	57
339900	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-6	12146	63
339901	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-6	4021.5	72
339902	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-6	22841	74
339903	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-6	21795	61
339904	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-6	16608	77
339905	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-6	17563	66
339906	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-6	19724.5	44
339907	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-6	15929	57
339908	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-6	5876	37
339909	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-6	29712	75
339910	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-6	22454.5	88
339911	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-6	13639.5	64
339912	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-6	31145	72
339913	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-6	29507	76
339914	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-6	7497	66
339915	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-6	6146	79
339916	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-6	32328	63
339917	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-6	28210	67
339918	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-6	24911	79
339919	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-6	31782	49
339920	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-6	31713.5	68
339921	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-6	14575	49
339922	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-6	5266	68
339923	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-6	20611.5	66
339924	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-6	16937.5	56
339925	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-6	14230.5	50
339926	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-6	16471	81
339927	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-6	16433	79
339928	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-6	18473	70
339929	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-6	4752.5	58
339930	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-6	16903	82
339931	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-6	14037.5	72
339932	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-6	16593	53
339933	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-6	26527	57
339934	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-6	13380	73
339935	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-6	17938.5	72
339936	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-6	6681	63
339937	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-6	8258	79
339938	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-6	5090.5	54
339939	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-6	5944.5	78
339940	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-6	8602	78
339941	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-6	8037	63
339942	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-6	5548.5	66
339943	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-6	11164	75
339944	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-6	9195	55
339945	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-6	8173	61
339946	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-6	6074	75
339947	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-6	6790	59
339948	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-6	7008	57
339949	20233						RA2159	51112.0										1	IL-6	6651.5	84
339950	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-6	4422	73
339951	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-6	4914	67
339952	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-6	5171	65
339953	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-6	6499	61
339954	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-6	5246.5	66
339955	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-6	4821	61
339956	20233						N2586	51107.0										1	IL-6	5080	69
339957	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-6	4703	53
339958	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-6	5590	44
339959	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-6	3676	52
339960	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-6	6329.5	44
339961	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-6	4393	61
339962	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-6	2856	63
339963	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-6	9235	57
339964	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-6	6679	55
339965	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-6	4644	60
339966	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-6	4786	61
339967	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-6	7599	52
339968	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-6	5572	48
339969	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-6	3970	106
339970	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-6	7018	57
339971	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-6	5973.5	70
339972	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-6	3216.5	72
339973	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-6	5776	45
339974	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-6	4323	66
339975	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-6	5872	40
339976	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-6	5031.5	66
339977	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-6	6411.5	68
339978	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-6	4386	71
339979	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-6	4715.5	66
339980	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-6	5956	81
339981	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-6	4873	89
339982	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-6	4777	94
339983	20233						RA2159	51112.0										1	IL-6	6513	74
339984	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-6	5108	63
339985	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-6	4484	68
339986	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-6	3542	75
339987	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-6	4321.5	38
339988	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-6	4527.5	60
339989	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-6	4055.5	62
339990	20233						N2586	51107.0										1	IL-6	5486	71
339991	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-6	6922	71
339992	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-6	2414.5	60
339993	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-6	2255	71
339994	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-6	6312	49
339995	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-6	5302.5	84
339996	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-6	4638	78
339997	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-6	4267.5	60
339998	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-6	5898.5	46
339999	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-6	3859	59
340000	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-6	3755	43
340001	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-6	2774	39
340002	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-6	4844.5	46
340003	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-6	5824.5	66
340004	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-6	4688	53
340005	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-6	4258	75
340006	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-6	5135	61
340007	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-6	5233	70
340008	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-6	3856	46
340009	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-6	5693.5	40
340010	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-6	4258	59
340011	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-6	2519	68
340012	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-6	2935.5	62
340013	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-6	4171.5	62
340014	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-6	4357	42
340015	20233						RA2159	51112.0										1	IL-6	7892	52
340016	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-6	7134.5	72
340017	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-6	6955	75
340018	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-6	5882	62
340019	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-6	6236	73
340020	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-6	5105.5	60
340021	20233						RA2159	51112.0										1	IL-6	5701	69
340022	20233						N2586	51107.0										1	IL-6	6681	79
340023	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-6	6229.5	70
340024	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-6	6516	57
340025	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-6	5045	66
340026	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-6	5847	67
340027	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-6	5489	61
340028	20233						N2586	51107.0										1	IL-6	6995.5	52
340029	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-6	6639	61
340030	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-6	5442	71
340031	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-6	4785	70
340032	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-6	6376	90
340033	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-6	5185.5	48
340034	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-6	3724.5	64
340035	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-6	4011.5	58
340036	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-6	4529	58
340037	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-6	4001.5	68
340038	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-6	3144.5	68
340039	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-6	3520	65
340040	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-6	4636.5	34
340041	20233																	0	IL-6	21	61
340042	20233						RA2159	51112.0								2	ug/mL	1	IL-6	16926	61
340043	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-6	12197	63
340044	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-6	5586	51
340045	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-6	11660	37
340046	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-6	13768	67
340047	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-6	9211.5	66
340048	20233						N2586	51107.0								2	ug/mL	1	IL-6	20600	50
340049	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-6	16994	63
340050	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-6	3452	71
340051	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-6	10394	56
340052	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-6	14549.5	50
340053	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-6	12428	56
340054	20233																	0	IL-6	21	50
340055	20233						RA2159	51112.0										2	IL-6	3542.5	72
340056	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-6	2904	76
340057	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-6	6552	70
340058	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-6	5819	62
340059	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-6	4584	49
340060	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-6	5670	81
340061	20233						RA2159	51112.0										2	IL-6	5183	49
340062	20233						N2586	51107.0										2	IL-6	5033	50
340063	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-6	3652.5	66
340064	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-6	7246	49
340065	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-6	4164	38
340066	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-6	5951	51
340067	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-6	5566	46
340068	20233						N2586	51107.0										2	IL-6	6828	43
340069	20233																	0	IL-6	25	57
340070	20233																	0	IL-6	29	33
340071	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-6	18359	69
340072	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-6	10476	82
340073	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-6	19292	77
340074	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-6	18052.5	70
340075	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-6	12414	53
340076	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-6	13670	58
340077	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-6	4855	64
340078	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-6	20703	53
340079	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-6	12333.5	68
340080	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-6	22659	73
340081	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-6	21886	67
340082	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-6	21681	40
340083	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-6	22363	51
340084	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-6	4155	47
340085	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-6	27232	57
340086	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-6	21362.5	70
340087	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-6	24138	53
340088	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-6	31372.5	56
340089	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-6	30075.5	52
340090	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-6	26777	73
340091	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-6	4408	55
340092	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-6	29097	47
340093	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-6	14678	61
340094	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-6	31645	73
340095	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-6	33374	63
340096	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-6	29530	49
340097	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-6	28392	53
340098	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-6	4120	49
340099	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-6	14651	65
340100	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-6	15797.5	58
340101	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-6	14070	86
340102	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-6	11738	65
340103	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-6	10335	85
340104	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-6	10931	69
340105	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-6	4970	52
340106	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-6	13730	69
340107	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-6	9890	71
340108	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-6	15140	56
340109	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-6	15248	54
340110	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-6	11721	55
340111	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-6	13262.5	52
340112	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-6	5211	61
340113	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-6	9577	55
340114	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-6	8532	77
340115	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-6	8249.5	68
340116	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-6	9902	55
340117	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-6	4933.5	62
340118	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-6	8862	45
340119	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-6	5535	71
340120	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-6	9818.5	48
340121	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-6	5679	67
340122	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-6	8184	66
340123	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-6	9874.5	60
340124	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-6	5486.5	70
340125	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-6	8600.5	70
340126	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-6	3925.5	62
340127	20233						RA2159	51112.0										2	IL-6	6130.5	54
340128	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-6	5871.5	64
340129	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-6	5892.5	68
340130	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-6	6703.5	44
340131	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-6	2779	83
340132	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-6	4324	64
340133	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-6	4040	51
340134	20233						N2586	51107.0										2	IL-6	4126	71
340135	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-6	4485.5	54
340136	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-6	3653	61
340137	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-6	5326.5	68
340138	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-6	3271.5	64
340139	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-6	3843	39
340140	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-6	4314	62
340141	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-6	5620	64
340142	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-6	6115	67
340143	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-6	4218.5	70
340144	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-6	6473	60
340145	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-6	2880	62
340146	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-6	4355.5	74
340147	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-6	2371	73
340148	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-6	3078	71
340149	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-6	6229	74
340150	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-6	6336	79
340151	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-6	4346.5	34
340152	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-6	21.5	60
340153	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-6	4423.5	72
340154	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-6	4370	50
340155	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-6	4686.5	78
340156	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-6	5658.5	88
340157	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-6	3245	60
340158	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-6	4205	77
340159	20233						RA2159	51112.0										2	IL-6	5425	54
340160	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-6	4569	87
340161	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-6	3534	79
340162	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-6	4984.5	66
340163	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-6	4854	46
340164	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-6	3706	46
340165	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-6	2612.5	50
340166	20233						N2586	51107.0										2	IL-6	9	52
340167	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-6	6409.5	70
340168	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-6	6304	66
340169	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-6	4406.5	68
340170	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-6	5740	67
340171	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-6	2611	62
340172	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-6	3812	66
340173	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-6	4966	67
340174	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-6	1797	64
340175	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-6	3665	68
340176	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-6	3810	59
340177	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-6	2947	49
340178	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-6	5099.5	54
340179	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-6	7141	64
340180	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-6	4978	49
340181	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-6	5217.5	74
340182	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-6	5847	73
340183	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-6	3247.5	82
340184	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-6	4081	74
340185	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-6	4056	61
340186	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-6	2861	52
340187	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-6	4637	81
340188	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-6	4464	50
340189	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-6	3395	41
340190	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-6	5413	69
340191	20233						RA2159	51112.0										2	IL-6	6266	79
340192	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-6	6108	59
340193	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-6	5717	55
340194	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-6	6213	74
340195	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-6	3872.5	76
340196	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-6	4083.5	68
340197	20233						RA2159	51112.0										2	IL-6	4695.5	56
340198	20233						N2586	51107.0										2	IL-6	4788.5	42
340199	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-6	4452.5	48
340200	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-6	6098.5	56
340201	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-6	6393.5	48
340202	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-6	2911	51
340203	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-6	4423.5	56
340204	20233						N2586	51107.0										2	IL-6	6784	60
340205	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-6	6810	53
340206	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-6	4753	52
340207	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-6	5315	67
340208	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-6	4202.5	44
340209	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-6	3328	40
340210	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-6	5036	40
340211	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-6	3798	64
340212	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-6	4550	38
340213	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-6	3608.5	44
340214	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-6	4248	35
340215	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-6	3279.5	50
340216	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-6	5853	30
340217	20233																	0	IL-6	20	48
340218	20233						RA2159	51112.0								2	ug/mL	2	IL-6	16489	39
340219	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-6	9614	65
340220	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-6	14200	76
340221	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-6	11913	73
340222	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-6	6670.5	48
340223	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-6	12615.5	64
340224	20233						N2586	51107.0								2	ug/mL	2	IL-6	20088	39
340225	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-6	13684	44
340226	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-6	15176	33
340227	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-6	16479	35
340228	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-6	7976	35
340229	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-6	17210.5	48
340230	20233																	0	IL-6	17	85
340231	20233						RA2159	51112.0								2	ug/mL	3	IL-6	17187.5	58
340232	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-6	15485	84
340233	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-6	7017	63
340234	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-6	14347.5	86
340235	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-6	12123	70
340236	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-6	8015	76
340237	20233						N2586	51107.0								2	ug/mL	3	IL-6	23540	75
340238	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-6	16097	60
340239	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-6	21008	71
340240	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-6	22924	71
340241	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-6	6941	67
340242	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-6	16788	70
340243	20233						RA2159	51112.0										3	IL-6	5827.5	62
340244	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-6	5807	62
340245	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-6	6439	59
340246	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-6	7494	75
340247	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-6	6786	59
340248	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-6	6327	83
340249	20233						RA2159	51112.0										3	IL-6	8331	86
340250	20233						N2586	51107.0										3	IL-6	7723.5	68
340251	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-6	5605.5	76
340252	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-6	5757.5	70
340253	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-6	7250.5	78
340254	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-6	6324.5	72
340255	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-6	6815.5	74
340256	20233						N2586	51107.0										3	IL-6	7883	43
340257	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-6	7416	79
340258	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-6	6009	54
340259	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-6	6120	63
340260	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-6	6571	61
340261	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-6	5500.5	82
340262	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-6	5111	67
340263	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-6	6950.5	70
340264	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-6	5715	63
340265	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-6	5501	80
340266	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-6	6296.5	56
340267	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-6	5599	54
340268	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-6	6009	71
340269	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-6	7253	70
340270	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-6	5142	65
340271	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-6	5670.5	68
340272	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-6	6947	71
340273	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-6	5675	83
340274	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-6	5613	67
340275	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-6	6926	85
340276	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-6	5821	72
340277	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-6	5723	75
340278	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-6	6234	67
340279	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-6	6349.5	60
340280	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-6	5891.5	80
340281	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-6	6845	65
340282	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-6	5705.5	72
340283	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-6	6431.5	74
340284	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-6	6935	55
340285	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-6	6692.5	86
340286	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-6	5632.5	78
340287	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-6	8673	79
340288	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-6	6152.5	72
340289	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-6	7159	69
340290	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-6	8079	67
340291	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-6	5529	76
340292	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-6	6064	68
340293	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-6	6068.5	58
340294	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-6	5293.5	70
340295	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-6	5788	87
340296	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-6	6816	63
340297	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-6	6090.5	70
340298	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-6	4822	55
340299	20233						RA2159	51112.0										3	IL-6	7724	74
340300	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-6	6666	57
340301	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-6	6371.5	50
340302	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-6	5349	77
340303	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-6	8053	80
340304	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-6	5224	86
340305	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-6	5757	77
340306	20233						N2586	51107.0										3	IL-6	7601	80
340307	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-6	7018	71
340308	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-6	5755.5	62
340309	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-6	6990	68
340310	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-6	7781	64
340311	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-6	6070	77
340312	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-6	5726	50
340313	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-6	4455	71
340314	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-6	8999	57
340315	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-6	7099	73
340316	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-6	7002.5	38
340317	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-6	8295	52
340318	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-6	5226	67
340319	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-6	5325.5	52
340320	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-6	2906	39
340321	20233						RA2159	51112.0										3	IL-6	6290.5	66
340322	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-6	6450.5	46
340323	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-6	5763.5	54
340324	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-6	7075	67
340325	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-6	5921	70
340326	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-6	5109	55
340327	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-6	4343	64
340328	20233						N2586	51107.0										3	IL-6	6461	77
340329	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-6	6015	79
340330	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-6	5554	52
340331	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-6	7248	70
340332	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-6	4879	76
340333	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-6	5413	48
340334	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-6	7003	79
340335	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-6	10521.5	52
340336	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-6	6521	69
340337	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-6	8354.5	74
340338	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-6	9343	66
340339	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-6	8930	71
340340	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-6	6132	51
340341	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-6	11079.5	60
340342	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-6	7674.5	78
340343	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-6	3782.5	84
340344	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-6	10961	61
340345	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-6	8925	61
340346	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-6	7042	52
340347	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-6	19890	73
340348	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-6	20278	67
340349	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-6	17929	55
340350	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-6	19366	63
340351	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-6	20027	83
340352	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-6	19320	62
340353	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-6	7416.5	90
340354	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-6	16559	85
340355	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-6	16674	57
340356	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-6	14649	61
340357	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-6	15542	77
340358	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-6	12692	67
340359	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-6	14165.5	58
340360	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-6	6103	61
340361	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-6	31911	61
340362	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-6	25273	59
340363	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-6	16489	71
340364	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-6	31329.5	78
340365	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-6	31957	69
340366	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-6	7018	69
340367	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-6	7082.5	62
340368	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-6	31911	79
340369	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-6	21555	65
340370	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-6	32595.5	74
340371	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-6	31181	56
340372	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-6	12525	59
340373	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-6	29391	58
340374	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-6	5807.5	80
340375	20233																	0	IL-6	15	57
340376	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-6	20506	57
340377	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-6	18134	42
340378	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-6	11209	61
340379	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-6	18339.5	92
340380	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-6	17997	60
340381	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-6	10959.5	60
340382	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-6	7427	69
340383	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-6	24874.5	78
340384	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-6	15591	52
340385	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-6	26482	51
340386	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-6	8779	62
340387	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-6	8762	53
340388	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-6	25570	61
340389	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-6	7482	70
340390	20233																	0	IL-6	15	61
340391	20233						RA2159	51112.0										3	IL-6	5299.5	70
340392	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-6	5832	68
340393	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-6	5872.5	76
340394	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-6	7035	64
340395	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-6	6403	39
340396	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-6	6044.5	64
340397	20233						RA2159	51112.0										3	IL-6	7711	54
340398	20233						N2586	51107.0										3	IL-6	8040.5	70
340399	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-6	6570	84
340400	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-6	5634	58
340401	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-6	6867	43
340402	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-6	6044.5	54
340403	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-6	6351	63
340404	20233						N2586	51107.0										3	IL-6	8603	37
340405	20233																	0	IL-6	17	55
340406	20233						RA2159	51112.0								2	ug/mL	4	IL-6	23882	55
340407	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-6	15474.5	42
340408	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-6	21578	65
340409	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-6	21190.5	74
340410	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-6	11003	69
340411	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-6	14970	69
340412	20233						N2586	51107.0								2	ug/mL	4	IL-6	23221	65
340413	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-6	19160	73
340414	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-6	6456	64
340415	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-6	14544.5	52
340416	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-6	9970	65
340417	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-6	4348	67
340418	20233						RA2159	51112.0										4	IL-6	6558	63
340419	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-6	6984.5	74
340420	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-6	7633	66
340421	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-6	8606	90
340422	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-6	7435	75
340423	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-6	6507	72
340424	20233						RA2159	51112.0										4	IL-6	9063	63
340425	20233						N2586	51107.0										4	IL-6	7132.5	78
340426	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-6	7181	58
340427	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-6	5863	49
340428	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-6	6738	47
340429	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-6	6370	79
340430	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-6	5915	89
340431	20233						N2586	51107.0										4	IL-6	8959.5	64
340432	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-6	9460.5	58
340433	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-6	8469	72
340434	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-6	9180	72
340435	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-6	9529	89
340436	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-6	6878.5	74
340437	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-6	7865	67
340438	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-6	7205	80
340439	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-6	5752	67
340440	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-6	4494	59
340441	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-6	5071	57
340442	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-6	5579	71
340443	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-6	4162.5	72
340444	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-6	8732	76
340445	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-6	8420.5	64
340446	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-6	10505	79
340447	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-6	9964	63
340448	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-6	6306	68
340449	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-6	7750	77
340450	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-6	6262.5	64
340451	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-6	6004	47
340452	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-6	3516	56
340453	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-6	4992	77
340454	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-6	5571	75
340455	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-6	4049	79
340456	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-6	10672.5	84
340457	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-6	9688	66
340458	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-6	11261	61
340459	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-6	10674.5	62
340460	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-6	7122.5	58
340461	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-6	9353	54
340462	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-6	6618	74
340463	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-6	6618	56
340464	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-6	4136	55
340465	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-6	5787	61
340466	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-6	5606	64
340467	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-6	4527.5	72
340468	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-6	9045	71
340469	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-6	9253	57
340470	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-6	9954.5	58
340471	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-6	10097	67
340472	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-6	6773	61
340473	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-6	8248	55
340474	20233						RA2159	51112.0										4	IL-6	9453	70
340475	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-6	6634.5	72
340476	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-6	5380.5	60
340477	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-6	4353	55
340478	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-6	5745	50
340479	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-6	5040.5	50
340480	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-6	3863	57
340481	20233						N2586	51107.0										4	IL-6	7573	78
340482	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-6	9815	75
340483	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-6	9613	63
340484	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-6	9478	61
340485	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-6	10851	36
340486	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-6	6732	39
340487	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-6	8493.5	46
340488	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-6	9296	69
340489	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-6	6875	59
340490	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-6	5430	65
340491	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-6	5905	41
340492	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-6	5550	62
340493	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-6	3815	95
340494	20233						RA2159	51112.0										4	IL-6	7707	59
340495	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-6	6802.5	72
340496	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-6	7756	69
340497	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-6	8265	59
340498	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-6	6401	51
340499	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-6	6519	60
340500	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-6	7200	57
340501	20233						N2586	51107.0										4	IL-6	6828.5	92
340502	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-6	6057.5	70
340503	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-6	4443	51
340504	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-6	5808	76
340505	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-6	6134	67
340506	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-6	3703	71
340507	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-6	4627	65
340508	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-6	8836	65
340509	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-6	8650.5	60
340510	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-6	10012.5	62
340511	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-6	12070	52
340512	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-6	7641	54
340513	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-6	8880	65
340514	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-6	7638.5	64
340515	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-6	9597	43
340516	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-6	9271	74
340517	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-6	8823.5	46
340518	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-6	7735	64
340519	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-6	7589	64
340520	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-6	4092	66
340521	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-6	4603	75
340522	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-6	14350	56
340523	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-6	14612.5	70
340524	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-6	12645	49
340525	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-6	15057	50
340526	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-6	14675	54
340527	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-6	14192	55
340528	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-6	6953.5	34
340529	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-6	17222	39
340530	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-6	16708.5	48
340531	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-6	17313	62
340532	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-6	21099	51
340533	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-6	17484	64
340534	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-6	12350.5	50
340535	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-6	7523	51
340536	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-6	31181	33
340537	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-6	20563	66
340538	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-6	30953	52
340539	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-6	31808.5	64
340540	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-6	30885	49
340541	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-6	28558	65
340542	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-6	4247.5	66
340543	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-6	32527	72
340544	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-6	29961	52
340545	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-6	22559	63
340546	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-6	30200	47
340547	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-6	16913.5	54
340548	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-6	4207	46
340549	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-6	7473	59
340550	20233																	0	IL-6	17	43
340551	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-6	21350	73
340552	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-6	14794.5	58
340553	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-6	21920	65
340554	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-6	19092	72
340555	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-6	13307	51
340556	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-6	16492	51
340557	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-6	7053	57
340558	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-6	24977	53
340559	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-6	23220.5	58
340560	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-6	14192	52
340561	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-6	19708	55
340562	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-6	16406.5	50
340563	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-6	4409.5	44
340564	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-6	6895.5	82
340565	20233																	0	IL-6	15	85
340566	20233						RA2159	51112.0										4	IL-6	6436.5	68
340567	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-6	5964	61
340568	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-6	7490	78
340569	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-6	7333	73
340570	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-6	7553	77
340571	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-6	5890.5	48
340572	20233						RA2159	51112.0										4	IL-6	8943	48
340573	20233						N2586	51107.0										4	IL-6	7789	57
340574	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-6	6799	47
340575	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-6	5624	57
340576	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-6	6300.5	60
340577	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-6	6280	59
340578	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-6	5545	65
340579	20233						N2586	51107.0										4	IL-6	8385	65
340580	20233								TNF-a	201285.0						100	ng/mL	0	IL-6	68	73
340581	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-6	34	76
340582	20233								IL-6	201287.0						100	ug/mL	0	IL-6	35706.5	88
340583	20233								IL-17A	201288.0						100	ng/mL	0	IL-6	29	63
340584	20233								EGF	201289.0						100	ng/mL	0	IL-6	22	80
340585	20233								IGF-I	201290.0						100	ug/mL	0	IL-6	19	76
340586	20233								Adiponectin	201291.0						5	ng/mL	0	IL-6	33	71
340587	20233								Leptin	201292.0						1	ng/mL	0	IL-6	24	78
340588	20233								Visfatin	201293.0						1	ng/mL	0	IL-6	23.5	54
340589	20233															2	ug/mL	0	IL-6	21	71
340590	20233								TNF-a	201285.0						100	ng/mL	0	IL-6	59	73
340591	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-6	24	35
340592	20233								IL-6	201287.0						100	ug/mL	0	IL-6	35342	66
340593	20233								IL-17A	201288.0						100	ng/mL	0	IL-6	31	74
340594	20233								EGF	201289.0						100	ng/mL	0	IL-6	20	31
340595	20233								IGF-I	201290.0						100	ug/mL	0	IL-6	23	61
340596	20233								Adiponectin	201291.0						5	ng/mL	0	IL-6	33.5	46
340597	20233								Leptin	201292.0						1	ng/mL	0	IL-6	26.5	38
340598	20233								Visfatin	201293.0						1	ng/mL	0	IL-6	22	58
340599	20233															2	ug/mL	0	IL-6	20.5	28
340600	20233								TNF-a	201285.0						100	ng/mL	0	IL-6	67.5	74
340601	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-6	17	61
340602	20233								IL-6	201287.0						100	ug/mL	0	IL-6	36245	57
340603	20233								IL-17A	201288.0						100	ng/mL	0	IL-6	26	67
340604	20233								EGF	201289.0						100	ng/mL	0	IL-6	18	60
340605	20233								IGF-I	201290.0						100	ug/mL	0	IL-6	17	43
340606	20233								Adiponectin	201291.0						5	ng/mL	0	IL-6	24	79
340607	20233								Leptin	201292.0						1	ng/mL	0	IL-6	17	60
340608	20233								Visfatin	201293.0						1	ng/mL	0	IL-6	17	62
340609	20233															2	ug/mL	0	IL-6	20	57
340610	20233								TNF-a	201285.0						100	ng/mL	0	IL-6	65.5	70
340611	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-6	16	59
340612	20233								IL-6	201287.0						100	ug/mL	0	IL-6	35720	55
340613	20233								IL-17A	201288.0						100	ng/mL	0	IL-6	23	65
340614	20233								EGF	201289.0						100	ng/mL	0	IL-6	19	69
340615	20233								IGF-I	201290.0						100	ug/mL	0	IL-6	16	71
340616	20233								Adiponectin	201291.0						5	ng/mL	0	IL-6	26	51
340617	20233								Leptin	201292.0						1	ng/mL	0	IL-6	22	63
340618	20233								Visfatin	201293.0						1	ng/mL	0	IL-6	17	43
340619	20233															2	ug/mL	0	IL-6	17	56
340620	20233																	0	IFN-g	16	39
340621	20233						RA2159	51112.0										1	IFN-g	22	56
340622	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IFN-g	24.5	54
340623	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IFN-g	20	68
340624	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IFN-g	23	65
340625	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IFN-g	23	67
340626	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IFN-g	19	63
340627	20233						RA2159	51112.0										1	IFN-g	23	55
340628	20233						N2586	51107.0										1	IFN-g	24	64
340629	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IFN-g	21	50
340630	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IFN-g	24	45
340631	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IFN-g	24	63
340632	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IFN-g	23.5	62
340633	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IFN-g	23.5	50
340634	20233						N2586	51107.0										1	IFN-g	24	26
340635	20233																	0	IFN-g	17	43
340636	20233																	0	IFN-g	21	39
340637	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IFN-g	48	42
340638	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IFN-g	32	68
340639	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IFN-g	41.5	56
340640	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IFN-g	34.5	66
340641	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IFN-g	36	61
340642	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IFN-g	27	36
340643	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IFN-g	22.5	66
340644	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IFN-g	41.5	54
340645	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IFN-g	44.5	44
340646	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IFN-g	40	60
340647	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IFN-g	43	39
340648	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IFN-g	43	38
340649	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IFN-g	35	54
340650	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IFN-g	35.5	32
340651	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IFN-g	48	49
340652	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IFN-g	36	68
340653	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IFN-g	23.5	58
340654	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IFN-g	45	57
340655	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IFN-g	45	50
340656	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IFN-g	23	54
340657	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IFN-g	22	66
340658	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IFN-g	44	45
340659	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IFN-g	41	61
340660	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IFN-g	39	59
340661	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IFN-g	51	57
340662	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IFN-g	44.5	48
340663	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IFN-g	30	42
340664	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IFN-g	23	67
340665	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IFN-g	26.5	50
340666	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IFN-g	27	62
340667	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IFN-g	25	63
340668	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IFN-g	32	47
340669	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IFN-g	24	52
340670	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IFN-g	28	61
340671	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IFN-g	24	49
340672	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IFN-g	28	71
340673	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IFN-g	26	48
340674	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IFN-g	29	38
340675	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IFN-g	37	47
340676	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IFN-g	24.5	54
340677	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IFN-g	28	50
340678	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IFN-g	22	51
340679	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IFN-g	24	50
340680	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IFN-g	20	50
340681	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IFN-g	24	73
340682	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IFN-g	23	46
340683	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IFN-g	22	51
340684	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IFN-g	21.5	64
340685	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IFN-g	24	72
340686	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IFN-g	24	57
340687	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IFN-g	23	54
340688	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IFN-g	21.5	84
340689	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IFN-g	24.5	62
340690	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IFN-g	22	77
340691	20233						RA2159	51112.0										1	IFN-g	23	64
340692	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IFN-g	21	61
340693	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IFN-g	22.5	68
340694	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IFN-g	21	57
340695	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IFN-g	22	37
340696	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IFN-g	19	62
340697	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IFN-g	22	64
340698	20233						N2586	51107.0										1	IFN-g	24	49
340699	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IFN-g	16.5	56
340700	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IFN-g	19	32
340701	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IFN-g	20	40
340702	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IFN-g	21.5	38
340703	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IFN-g	25	53
340704	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IFN-g	21.5	56
340705	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IFN-g	22	47
340706	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IFN-g	18	48
340707	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IFN-g	22	34
340708	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IFN-g	28	53
340709	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IFN-g	21	41
340710	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IFN-g	21	57
340711	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IFN-g	23.5	58
340712	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IFN-g	20	67
340713	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IFN-g	17	47
340714	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IFN-g	20.5	42
340715	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IFN-g	22	37
340716	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IFN-g	19	43
340717	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IFN-g	15	37
340718	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IFN-g	21	51
340719	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IFN-g	18	37
340720	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IFN-g	18	63
340721	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IFN-g	15	54
340722	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IFN-g	21	61
340723	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IFN-g	21	57
340724	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IFN-g	22	61
340725	20233						RA2159	51112.0										1	IFN-g	22	62
340726	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IFN-g	19	51
340727	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IFN-g	18	53
340728	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IFN-g	22	49
340729	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IFN-g	21	43
340730	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IFN-g	22	39
340731	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IFN-g	17	62
340732	20233						N2586	51107.0										1	IFN-g	23	50
340733	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IFN-g	20.5	68
340734	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IFN-g	17	51
340735	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IFN-g	18.5	54
340736	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IFN-g	18	44
340737	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IFN-g	21	47
340738	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IFN-g	17	71
340739	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IFN-g	19.5	54
340740	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IFN-g	21.5	48
340741	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IFN-g	20	46
340742	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IFN-g	18	29
340743	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IFN-g	19	41
340744	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IFN-g	24	49
340745	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IFN-g	19	61
340746	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IFN-g	19.5	48
340747	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IFN-g	20	42
340748	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IFN-g	23	43
340749	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IFN-g	18.5	54
340750	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IFN-g	21.5	48
340751	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IFN-g	16.5	40
340752	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IFN-g	20	43
340753	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IFN-g	17	59
340754	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IFN-g	19.5	60
340755	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IFN-g	18	54
340756	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IFN-g	19	43
340757	20233						RA2159	51112.0										1	IFN-g	19	56
340758	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IFN-g	24	50
340759	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IFN-g	23	59
340760	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IFN-g	20	42
340761	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IFN-g	21	55
340762	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IFN-g	19	51
340763	20233						RA2159	51112.0										1	IFN-g	18.5	70
340764	20233						N2586	51107.0										1	IFN-g	19	75
340765	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IFN-g	21	65
340766	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IFN-g	23	51
340767	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IFN-g	21	64
340768	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IFN-g	20.5	50
340769	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IFN-g	19	55
340770	20233						N2586	51107.0										1	IFN-g	20	49
340771	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IFN-g	21	49
340772	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IFN-g	19	65
340773	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IFN-g	20	47
340774	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IFN-g	22	58
340775	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IFN-g	18	35
340776	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IFN-g	20.5	48
340777	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IFN-g	18	58
340778	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IFN-g	20	54
340779	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IFN-g	23	42
340780	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IFN-g	19.5	46
340781	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IFN-g	19	53
340782	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IFN-g	22	37
340783	20233																	0	IFN-g	17	56
340784	20233						RA2159	51112.0								2	ug/mL	1	IFN-g	28	48
340785	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IFN-g	28	50
340786	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IFN-g	21	35
340787	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IFN-g	23	31
340788	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IFN-g	24	43
340789	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IFN-g	24.5	60
340790	20233						N2586	51107.0								2	ug/mL	1	IFN-g	30.5	42
340791	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IFN-g	28	65
340792	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IFN-g	22	50
340793	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IFN-g	21	23
340794	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IFN-g	29	46
340795	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IFN-g	20.5	42
340796	20233																	0	IFN-g	19	41
340797	20233						RA2159	51112.0										2	IFN-g	22	66
340798	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IFN-g	18	50
340799	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IFN-g	24.5	62
340800	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IFN-g	21	61
340801	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IFN-g	21	41
340802	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IFN-g	21	42
340803	20233						RA2159	51112.0										2	IFN-g	22	39
340804	20233						N2586	51107.0										2	IFN-g	23	46
340805	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IFN-g	21	38
340806	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IFN-g	20.5	60
340807	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IFN-g	20	39
340808	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IFN-g	19.5	48
340809	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IFN-g	21	47
340810	20233						N2586	51107.0										2	IFN-g	21	32
340811	20233																	0	IFN-g	20	49
340812	20233																	0	IFN-g	21	28
340813	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IFN-g	38	57
340814	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IFN-g	37	68
340815	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IFN-g	38	62
340816	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IFN-g	35.5	48
340817	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IFN-g	29	36
340818	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IFN-g	28.5	40
340819	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IFN-g	20.5	64
340820	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IFN-g	33	46
340821	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IFN-g	33	60
340822	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IFN-g	41.5	46
340823	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IFN-g	39	59
340824	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IFN-g	35	29
340825	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IFN-g	41	44
340826	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IFN-g	22	49
340827	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IFN-g	39	50
340828	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IFN-g	34	51
340829	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IFN-g	34	58
340830	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IFN-g	40.5	66
340831	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IFN-g	45	54
340832	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IFN-g	38	51
340833	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IFN-g	18	52
340834	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IFN-g	39	43
340835	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IFN-g	33	55
340836	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IFN-g	41	59
340837	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IFN-g	36.5	64
340838	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IFN-g	41.5	42
340839	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IFN-g	40	45
340840	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IFN-g	23	42
340841	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IFN-g	27.5	50
340842	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IFN-g	21	48
340843	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IFN-g	26	71
340844	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IFN-g	25	54
340845	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IFN-g	20	50
340846	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IFN-g	20	50
340847	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IFN-g	18	58
340848	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IFN-g	23	50
340849	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IFN-g	23	57
340850	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IFN-g	23.5	48
340851	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IFN-g	23	45
340852	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IFN-g	21	49
340853	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IFN-g	23	41
340854	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IFN-g	19	48
340855	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IFN-g	20.5	50
340856	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IFN-g	22	63
340857	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IFN-g	20	53
340858	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IFN-g	24	51
340859	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IFN-g	20.5	60
340860	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IFN-g	23	40
340861	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IFN-g	18.5	62
340862	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IFN-g	24	49
340863	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IFN-g	22.5	56
340864	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IFN-g	17	50
340865	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IFN-g	21	51
340866	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IFN-g	21	51
340867	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IFN-g	23	57
340868	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IFN-g	21	32
340869	20233						RA2159	51112.0										2	IFN-g	24	51
340870	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IFN-g	17	49
340871	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IFN-g	20	57
340872	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IFN-g	22.5	30
340873	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IFN-g	18	59
340874	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IFN-g	18	53
340875	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IFN-g	21.5	48
340876	20233						N2586	51107.0										2	IFN-g	21	53
340877	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IFN-g	18	47
340878	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IFN-g	17	55
340879	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IFN-g	19	60
340880	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IFN-g	20.5	52
340881	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IFN-g	19.5	40
340882	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IFN-g	20.5	44
340883	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IFN-g	20	69
340884	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IFN-g	18	50
340885	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IFN-g	21	65
340886	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IFN-g	21	80
340887	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IFN-g	21	50
340888	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IFN-g	20.5	64
340889	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IFN-g	20	59
340890	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IFN-g	16	54
340891	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IFN-g	19	60
340892	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IFN-g	18	45
340893	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IFN-g	18.5	46
340894	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IFN-g	9	59
340895	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IFN-g	18	50
340896	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IFN-g	19.5	42
340897	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IFN-g	19	73
340898	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IFN-g	19	57
340899	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IFN-g	18	68
340900	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IFN-g	20.5	54
340901	20233						RA2159	51112.0										2	IFN-g	19	79
340902	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IFN-g	22	49
340903	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IFN-g	18	58
340904	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IFN-g	19	59
340905	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IFN-g	19	63
340906	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IFN-g	18	54
340907	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IFN-g	21	39
340908	20233						N2586	51107.0										2	IFN-g	8.5	40
340909	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IFN-g	17	43
340910	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IFN-g	21	53
340911	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IFN-g	18.5	54
340912	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IFN-g	15	64
340913	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IFN-g	18	49
340914	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IFN-g	19	32
340915	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IFN-g	19	50
340916	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IFN-g	18	52
340917	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IFN-g	17.5	50
340918	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IFN-g	19	47
340919	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IFN-g	16	47
340920	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IFN-g	19.5	42
340921	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IFN-g	19	57
340922	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IFN-g	18	46
340923	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IFN-g	21	61
340924	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IFN-g	18	59
340925	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IFN-g	18	67
340926	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IFN-g	19.5	58
340927	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IFN-g	18	43
340928	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IFN-g	17	39
340929	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IFN-g	18	45
340930	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IFN-g	21	55
340931	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IFN-g	18	34
340932	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IFN-g	20	57
340933	20233						RA2159	51112.0										2	IFN-g	16.5	52
340934	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IFN-g	18	59
340935	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IFN-g	21	63
340936	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IFN-g	17	70
340937	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IFN-g	18.5	56
340938	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IFN-g	16	35
340939	20233						RA2159	51112.0										2	IFN-g	20.5	48
340940	20233						N2586	51107.0										2	IFN-g	18	50
340941	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IFN-g	14	33
340942	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IFN-g	19	62
340943	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IFN-g	22	43
340944	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IFN-g	18	33
340945	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IFN-g	21.5	46
340946	20233						N2586	51107.0										2	IFN-g	16.5	36
340947	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IFN-g	19	57
340948	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IFN-g	20	42
340949	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IFN-g	19	66
340950	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IFN-g	18	41
340951	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IFN-g	19	37
340952	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IFN-g	25.5	36
340953	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IFN-g	21	43
340954	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IFN-g	19	36
340955	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IFN-g	20	25
340956	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IFN-g	17	29
340957	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IFN-g	19.5	26
340958	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IFN-g	16	29
340959	20233																	0	IFN-g	17.5	38
340960	20233						RA2159	51112.0								2	ug/mL	2	IFN-g	31	39
340961	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IFN-g	25	43
340962	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IFN-g	25	66
340963	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IFN-g	25	46
340964	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IFN-g	21	41
340965	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IFN-g	21	47
340966	20233						N2586	51107.0								2	ug/mL	2	IFN-g	31	48
340967	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IFN-g	26	33
340968	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IFN-g	28	28
340969	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IFN-g	28	33
340970	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IFN-g	20	33
340971	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IFN-g	24	41
340972	20233																	0	IFN-g	15	50
340973	20233						RA2159	51112.0								2	ug/mL	3	IFN-g	27	50
340974	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IFN-g	33	57
340975	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IFN-g	19	60
340976	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IFN-g	25	49
340977	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IFN-g	22.5	52
340978	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IFN-g	18	67
340979	20233						N2586	51107.0								2	ug/mL	3	IFN-g	36.5	50
340980	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IFN-g	35	52
340981	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IFN-g	33	48
340982	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IFN-g	40	52
340983	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IFN-g	18	57
340984	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IFN-g	31	57
340985	20233						RA2159	51112.0										3	IFN-g	18.5	64
340986	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IFN-g	19	51
340987	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IFN-g	17	47
340988	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IFN-g	19	48
340989	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IFN-g	17	49
340990	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IFN-g	17	51
340991	20233						RA2159	51112.0										3	IFN-g	20	87
340992	20233						N2586	51107.0										3	IFN-g	19	61
340993	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IFN-g	17	60
340994	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IFN-g	20	47
340995	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IFN-g	17	50
340996	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IFN-g	17	69
340997	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IFN-g	19.5	52
340998	20233						N2586	51107.0										3	IFN-g	25	37
340999	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IFN-g	19	59
341000	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IFN-g	17	42
341001	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IFN-g	21	55
341002	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IFN-g	20	37
341003	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IFN-g	17	52
341004	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IFN-g	20	62
341005	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IFN-g	21	55
341006	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IFN-g	17.5	50
341007	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IFN-g	16.5	40
341008	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IFN-g	17	39
341009	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IFN-g	15.5	54
341010	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IFN-g	18	76
341011	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IFN-g	16	57
341012	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IFN-g	20	59
341013	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IFN-g	15	52
341014	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IFN-g	16.5	50
341015	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IFN-g	19.5	50
341016	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IFN-g	20	63
341017	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IFN-g	19.5	50
341018	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IFN-g	16.5	50
341019	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IFN-g	17	63
341020	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IFN-g	18	54
341021	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IFN-g	17	56
341022	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IFN-g	19	63
341023	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IFN-g	14.5	50
341024	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IFN-g	19	52
341025	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IFN-g	19	58
341026	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IFN-g	18.5	66
341027	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IFN-g	18	57
341028	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IFN-g	19	50
341029	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IFN-g	23	63
341030	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IFN-g	17	57
341031	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IFN-g	20	59
341032	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IFN-g	19	51
341033	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IFN-g	18	64
341034	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IFN-g	19	65
341035	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IFN-g	16.5	52
341036	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IFN-g	17.5	70
341037	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IFN-g	20	50
341038	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IFN-g	17.5	52
341039	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IFN-g	18	48
341040	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IFN-g	16	37
341041	20233						RA2159	51112.0										3	IFN-g	22	49
341042	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IFN-g	18	55
341043	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IFN-g	19	61
341044	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IFN-g	17	55
341045	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IFN-g	17	77
341046	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IFN-g	18	68
341047	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IFN-g	17.5	56
341048	20233						N2586	51107.0										3	IFN-g	19	57
341049	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IFN-g	17	50
341050	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IFN-g	19	43
341051	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IFN-g	18	67
341052	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IFN-g	20	45
341053	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IFN-g	13.5	40
341054	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IFN-g	12	47
341055	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IFN-g	13.5	46
341056	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IFN-g	21	51
341057	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IFN-g	18	56
341058	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IFN-g	19	62
341059	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IFN-g	16	33
341060	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IFN-g	17	59
341061	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IFN-g	10.5	50
341062	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IFN-g	15	35
341063	20233						RA2159	51112.0										3	IFN-g	20	47
341064	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IFN-g	17.5	46
341065	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IFN-g	15	45
341066	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IFN-g	19	42
341067	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IFN-g	14	67
341068	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IFN-g	17	58
341069	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IFN-g	15	53
341070	20233						N2586	51107.0										3	IFN-g	17	55
341071	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IFN-g	16	73
341072	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IFN-g	14	49
341073	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IFN-g	16	61
341074	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IFN-g	17	40
341075	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IFN-g	21	46
341076	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IFN-g	18	60
341077	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IFN-g	20	61
341078	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IFN-g	21	58
341079	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IFN-g	16	54
341080	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IFN-g	21	53
341081	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IFN-g	19	49
341082	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IFN-g	18	44
341083	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IFN-g	21	50
341084	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IFN-g	16	61
341085	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IFN-g	16	61
341086	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IFN-g	22	49
341087	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IFN-g	17.5	50
341088	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IFN-g	15	38
341089	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IFN-g	24	67
341090	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IFN-g	25	51
341091	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IFN-g	22	65
341092	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IFN-g	20.5	58
341093	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IFN-g	21.5	50
341094	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IFN-g	25	57
341095	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IFN-g	15	61
341096	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IFN-g	24	57
341097	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IFN-g	20.5	74
341098	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IFN-g	20	56
341099	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IFN-g	21	63
341100	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IFN-g	22	70
341101	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IFN-g	18	47
341102	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IFN-g	17	60
341103	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IFN-g	43	56
341104	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IFN-g	33	50
341105	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IFN-g	25	53
341106	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IFN-g	42	59
341107	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IFN-g	35	52
341108	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IFN-g	17	52
341109	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IFN-g	14.5	46
341110	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IFN-g	45	63
341111	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IFN-g	31	54
341112	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IFN-g	42	50
341113	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IFN-g	44.5	46
341114	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IFN-g	21	39
341115	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IFN-g	36.5	56
341116	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IFN-g	15.5	50
341117	20233																	0	IFN-g	12	43
341118	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IFN-g	36	35
341119	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IFN-g	37.5	30
341120	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IFN-g	28.5	60
341121	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IFN-g	35	69
341122	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IFN-g	33.5	50
341123	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IFN-g	21	51
341124	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IFN-g	20	59
341125	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IFN-g	36	65
341126	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IFN-g	34	38
341127	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IFN-g	41	53
341128	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IFN-g	15.5	48
341129	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IFN-g	22.5	46
341130	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IFN-g	35.5	66
341131	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IFN-g	21	40
341132	20233																	0	IFN-g	18	38
341133	20233						RA2159	51112.0										3	IFN-g	18	62
341134	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IFN-g	16	61
341135	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IFN-g	18	61
341136	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IFN-g	15.5	50
341137	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IFN-g	18	34
341138	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IFN-g	18	41
341139	20233						RA2159	51112.0										3	IFN-g	18	56
341140	20233						N2586	51107.0										3	IFN-g	18	50
341141	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IFN-g	18	59
341142	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IFN-g	15	40
341143	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IFN-g	15	40
341144	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IFN-g	15	24
341145	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IFN-g	18	46
341146	20233						N2586	51107.0										3	IFN-g	17.5	24
341147	20233																	0	IFN-g	16	52
341148	20233						RA2159	51112.0								2	ug/mL	4	IFN-g	40	41
341149	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IFN-g	30.5	52
341150	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IFN-g	37.5	56
341151	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IFN-g	32	63
341152	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IFN-g	25	47
341153	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IFN-g	32	51
341154	20233						N2586	51107.0								2	ug/mL	4	IFN-g	34	50
341155	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IFN-g	32	66
341156	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IFN-g	17	55
341157	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IFN-g	31	47
341158	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IFN-g	20.5	46
341159	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IFN-g	18.5	66
341160	20233						RA2159	51112.0										4	IFN-g	15	48
341161	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IFN-g	16	61
341162	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IFN-g	18.5	56
341163	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IFN-g	20	61
341164	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IFN-g	17	58
341165	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IFN-g	16	60
341166	20233						RA2159	51112.0										4	IFN-g	18	53
341167	20233						N2586	51107.0										4	IFN-g	18.5	68
341168	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IFN-g	15.5	50
341169	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IFN-g	16.5	34
341170	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IFN-g	18	53
341171	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IFN-g	20	45
341172	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IFN-g	18	59
341173	20233						N2586	51107.0										4	IFN-g	18	50
341174	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IFN-g	20	50
341175	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IFN-g	16	39
341176	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IFN-g	21	53
341177	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IFN-g	22	70
341178	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IFN-g	19	57
341179	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IFN-g	16	58
341180	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IFN-g	20	78
341181	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IFN-g	17	51
341182	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IFN-g	17.5	44
341183	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IFN-g	18.5	52
341184	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IFN-g	17	59
341185	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IFN-g	16	50
341186	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IFN-g	18	55
341187	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IFN-g	15	56
341188	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IFN-g	21	60
341189	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IFN-g	18.5	54
341190	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IFN-g	21	56
341191	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IFN-g	19	52
341192	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IFN-g	17	47
341193	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IFN-g	21	34
341194	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IFN-g	17	48
341195	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IFN-g	18	47
341196	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IFN-g	17	47
341197	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IFN-g	17	66
341198	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IFN-g	20	61
341199	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IFN-g	24	51
341200	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IFN-g	24	53
341201	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IFN-g	21.5	64
341202	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IFN-g	16	40
341203	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IFN-g	20	36
341204	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IFN-g	16	54
341205	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IFN-g	18	43
341206	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IFN-g	18	47
341207	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IFN-g	18	60
341208	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IFN-g	19	51
341209	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IFN-g	17	52
341210	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IFN-g	19.5	60
341211	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IFN-g	21.5	46
341212	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IFN-g	22	52
341213	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IFN-g	18	63
341214	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IFN-g	15	49
341215	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IFN-g	16	33
341216	20233						RA2159	51112.0										4	IFN-g	21	49
341217	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IFN-g	18	58
341218	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IFN-g	16.5	50
341219	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IFN-g	17	51
341220	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IFN-g	19.5	48
341221	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IFN-g	17.5	36
341222	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IFN-g	17	40
341223	20233						N2586	51107.0										4	IFN-g	18	48
341224	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IFN-g	22	59
341225	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IFN-g	19	56
341226	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IFN-g	19	47
341227	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IFN-g	19	31
341228	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IFN-g	19.5	32
341229	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IFN-g	17.5	46
341230	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IFN-g	19.5	72
341231	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IFN-g	17	52
341232	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IFN-g	16	59
341233	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IFN-g	14	42
341234	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IFN-g	18	40
341235	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IFN-g	18	75
341236	20233						RA2159	51112.0										4	IFN-g	19.5	38
341237	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IFN-g	20	57
341238	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IFN-g	17	59
341239	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IFN-g	18	56
341240	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IFN-g	16	39
341241	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IFN-g	18	41
341242	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IFN-g	17	53
341243	20233						N2586	51107.0										4	IFN-g	17	69
341244	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IFN-g	20	49
341245	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IFN-g	16.5	58
341246	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IFN-g	19	55
341247	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IFN-g	18.5	42
341248	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IFN-g	16	61
341249	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IFN-g	17	56
341250	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IFN-g	17.5	58
341251	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IFN-g	17	67
341252	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IFN-g	21	64
341253	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IFN-g	24	51
341254	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IFN-g	17.5	50
341255	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IFN-g	18	57
341256	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IFN-g	18	55
341257	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IFN-g	22.5	40
341258	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IFN-g	21	43
341259	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IFN-g	18	35
341260	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IFN-g	18	57
341261	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IFN-g	21	47
341262	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IFN-g	17	50
341263	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IFN-g	16	59
341264	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IFN-g	22	37
341265	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IFN-g	21.5	42
341266	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IFN-g	16	31
341267	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IFN-g	18	39
341268	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IFN-g	18.5	38
341269	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IFN-g	20.5	60
341270	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IFN-g	17	27
341271	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IFN-g	23	41
341272	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IFN-g	22	43
341273	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IFN-g	21	43
341274	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IFN-g	23	29
341275	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IFN-g	20	43
341276	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IFN-g	17	41
341277	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IFN-g	18	45
341278	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IFN-g	43	33
341279	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IFN-g	31	50
341280	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IFN-g	45	63
341281	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IFN-g	43	51
341282	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IFN-g	33	33
341283	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IFN-g	39.5	38
341284	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IFN-g	17	59
341285	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IFN-g	41	56
341286	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IFN-g	37	51
341287	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IFN-g	31	38
341288	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IFN-g	34	33
341289	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IFN-g	27.5	36
341290	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IFN-g	18	49
341291	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IFN-g	20	27
341292	20233																	0	IFN-g	14.5	36
341293	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IFN-g	36	48
341294	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IFN-g	25.5	32
341295	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IFN-g	38	43
341296	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IFN-g	32	57
341297	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IFN-g	27	39
341298	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IFN-g	27	54
341299	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IFN-g	17	43
341300	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IFN-g	42	54
341301	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IFN-g	38	37
341302	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IFN-g	32	39
341303	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IFN-g	35	45
341304	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IFN-g	24	33
341305	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IFN-g	18	37
341306	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IFN-g	16	66
341307	20233																	0	IFN-g	13	66
341308	20233						RA2159	51112.0										4	IFN-g	17	58
341309	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IFN-g	16.5	50
341310	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IFN-g	16	71
341311	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IFN-g	16	64
341312	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IFN-g	19	51
341313	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IFN-g	18	37
341314	20233						RA2159	51112.0										4	IFN-g	15	52
341315	20233						N2586	51107.0										4	IFN-g	18	53
341316	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IFN-g	16	31
341317	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IFN-g	14.5	46
341318	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IFN-g	17	53
341319	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IFN-g	15	59
341320	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IFN-g	18	60
341321	20233						N2586	51107.0										4	IFN-g	15	49
341322	20233								TNF-a	201285.0						100	ng/mL	0	IFN-g	71	66
341323	20233								IL-1 alpha	201286.0						100	ng/mL	0	IFN-g	17	75
341324	20233								IL-6	201287.0						100	ug/mL	0	IFN-g	42.5	68
341325	20233								IL-17A	201288.0						100	ng/mL	0	IFN-g	26	77
341326	20233								EGF	201289.0						100	ng/mL	0	IFN-g	19.5	70
341327	20233								IGF-I	201290.0						100	ug/mL	0	IFN-g	19	57
341328	20233								Adiponectin	201291.0						5	ng/mL	0	IFN-g	28.5	50
341329	20233								Leptin	201292.0						1	ng/mL	0	IFN-g	16	59
341330	20233								Visfatin	201293.0						1	ng/mL	0	IFN-g	18	40
341331	20233															2	ug/mL	0	IFN-g	21	54
341332	20233								TNF-a	201285.0						100	ng/mL	0	IFN-g	67	65
341333	20233								IL-1 alpha	201286.0						100	ng/mL	0	IFN-g	22.5	32
341334	20233								IL-6	201287.0						100	ug/mL	0	IFN-g	43	45
341335	20233								IL-17A	201288.0						100	ng/mL	0	IFN-g	23	57
341336	20233								EGF	201289.0						100	ng/mL	0	IFN-g	19	51
341337	20233								IGF-I	201290.0						100	ug/mL	0	IFN-g	18	49
341338	20233								Adiponectin	201291.0						5	ng/mL	0	IFN-g	30	30
341339	20233								Leptin	201292.0						1	ng/mL	0	IFN-g	22.5	28
341340	20233								Visfatin	201293.0						1	ng/mL	0	IFN-g	21	38
341341	20233															2	ug/mL	0	IFN-g	17	45
341342	20233								TNF-a	201285.0						100	ng/mL	0	IFN-g	72	62
341343	20233								IL-1 alpha	201286.0						100	ng/mL	0	IFN-g	14	52
341344	20233								IL-6	201287.0						100	ug/mL	0	IFN-g	35	47
341345	20233								IL-17A	201288.0						100	ng/mL	0	IFN-g	19	71
341346	20233								EGF	201289.0						100	ng/mL	0	IFN-g	14	61
341347	20233								IGF-I	201290.0						100	ug/mL	0	IFN-g	15	47
341348	20233								Adiponectin	201291.0						5	ng/mL	0	IFN-g	14	61
341349	20233								Leptin	201292.0						1	ng/mL	0	IFN-g	15.5	32
341350	20233								Visfatin	201293.0						1	ng/mL	0	IFN-g	13	62
341351	20233															2	ug/mL	0	IFN-g	14	46
341352	20233								TNF-a	201285.0						100	ng/mL	0	IFN-g	65	47
341353	20233								IL-1 alpha	201286.0						100	ng/mL	0	IFN-g	16	50
341354	20233								IL-6	201287.0						100	ug/mL	0	IFN-g	37	48
341355	20233								IL-17A	201288.0						100	ng/mL	0	IFN-g	17	35
341356	20233								EGF	201289.0						100	ng/mL	0	IFN-g	13.5	44
341357	20233								IGF-I	201290.0						100	ug/mL	0	IFN-g	13.5	66
341358	20233								Adiponectin	201291.0						5	ng/mL	0	IFN-g	22	43
341359	20233								Leptin	201292.0						1	ng/mL	0	IFN-g	14	47
341360	20233								Visfatin	201293.0						1	ng/mL	0	IFN-g	14	32
341361	20233															2	ug/mL	0	IFN-g	13	32
341362	20233																	0	IL-1RA	21	52
341363	20233						RA2159	51112.0										1	IL-1RA	28	66
341364	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-1RA	24	53
341365	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-1RA	26	69
341366	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-1RA	27	60
341367	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-1RA	24	69
341368	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-1RA	28	50
341369	20233						RA2159	51112.0										1	IL-1RA	26	55
341370	20233						N2586	51107.0										1	IL-1RA	24	65
341371	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-1RA	24	55
341372	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-1RA	24	49
341373	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-1RA	27	72
341374	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-1RA	25	63
341375	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-1RA	23.5	56
341376	20233						N2586	51107.0										1	IL-1RA	24	31
341377	20233																	0	IL-1RA	20	72
341378	20233																	0	IL-1RA	22	35
341379	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-1RA	43.5	46
341380	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-1RA	43	66
341381	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-1RA	46.5	54
341382	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-1RA	36	65
341383	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-1RA	49	47
341384	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-1RA	36	72
341385	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-1RA	27	60
341386	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-1RA	51	54
341387	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-1RA	54	59
341388	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-1RA	52	63
341389	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-1RA	53	61
341390	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-1RA	48	48
341391	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-1RA	39	47
341392	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-1RA	25.5	30
341393	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-1RA	41	71
341394	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-1RA	37.5	50
341395	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-1RA	27	57
341396	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-1RA	46	50
341397	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-1RA	46	65
341398	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-1RA	25	73
341399	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-1RA	26	63
341400	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-1RA	53	65
341401	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-1RA	43	63
341402	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-1RA	44	64
341403	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-1RA	53.5	54
341404	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-1RA	53	59
341405	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-1RA	35	39
341406	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-1RA	24	49
341407	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-1RA	33	55
341408	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-1RA	25	78
341409	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-1RA	23	85
341410	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-1RA	32.5	68
341411	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-1RA	32.5	50
341412	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-1RA	32	63
341413	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-1RA	18	53
341414	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-1RA	29	90
341415	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-1RA	24.5	54
341416	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-1RA	28	58
341417	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-1RA	37	41
341418	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-1RA	25	64
341419	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-1RA	32.5	68
341420	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-1RA	28	44
341421	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-1RA	24	67
341422	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-1RA	26	57
341423	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-1RA	26	53
341424	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-1RA	25	50
341425	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-1RA	27.5	56
341426	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-1RA	24	78
341427	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-1RA	31	67
341428	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-1RA	27	57
341429	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-1RA	30	67
341430	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-1RA	22	69
341431	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-1RA	25	69
341432	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-1RA	24	59
341433	20233						RA2159	51112.0										1	IL-1RA	27.5	64
341434	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-1RA	25.5	68
341435	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-1RA	23	64
341436	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-1RA	26	50
341437	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-1RA	26	49
341438	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-1RA	24	53
341439	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-1RA	25	40
341440	20233						N2586	51107.0										1	IL-1RA	22.5	60
341441	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-1RA	23	51
341442	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-1RA	29	45
341443	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-1RA	25.5	56
341444	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-1RA	23	39
341445	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-1RA	29.5	52
341446	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-1RA	24.5	66
341447	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-1RA	22	72
341448	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-1RA	23	55
341449	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-1RA	24	53
341450	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-1RA	25	59
341451	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-1RA	23	66
341452	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-1RA	25	52
341453	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-1RA	25	67
341454	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-1RA	24	71
341455	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-1RA	25	68
341456	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-1RA	24	59
341457	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-1RA	20	45
341458	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-1RA	22	71
341459	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-1RA	18.5	42
341460	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-1RA	23	50
341461	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-1RA	26	56
341462	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-1RA	22.5	52
341463	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-1RA	22	55
341464	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-1RA	23	65
341465	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-1RA	21	87
341466	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-1RA	21	63
341467	20233						RA2159	51112.0										1	IL-1RA	23	52
341468	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-1RA	17	44
341469	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-1RA	23	54
341470	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-1RA	21	61
341471	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-1RA	19.5	50
341472	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-1RA	25	65
341473	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-1RA	20.5	52
341474	20233						N2586	51107.0										1	IL-1RA	28	70
341475	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-1RA	22	67
341476	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-1RA	24.5	50
341477	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-1RA	20	52
341478	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-1RA	24	52
341479	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-1RA	26	61
341480	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-1RA	21.5	74
341481	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-1RA	19	57
341482	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-1RA	21.5	52
341483	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-1RA	22.5	54
341484	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-1RA	23	48
341485	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-1RA	22	71
341486	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-1RA	25	47
341487	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-1RA	22	55
341488	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-1RA	21	48
341489	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-1RA	22	60
341490	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-1RA	20	59
341491	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-1RA	18	56
341492	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-1RA	17	62
341493	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-1RA	20	45
341494	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-1RA	21	42
341495	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-1RA	20	63
341496	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-1RA	24	63
341497	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-1RA	22	45
341498	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-1RA	22	30
341499	20233						RA2159	51112.0										1	IL-1RA	19	49
341500	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-1RA	26	85
341501	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-1RA	25	78
341502	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-1RA	23	55
341503	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-1RA	22	87
341504	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-1RA	22	66
341505	20233						RA2159	51112.0										1	IL-1RA	23	78
341506	20233						N2586	51107.0										1	IL-1RA	24	90
341507	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-1RA	24	56
341508	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-1RA	21	55
341509	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-1RA	24	72
341510	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-1RA	28	43
341511	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-1RA	21	45
341512	20233						N2586	51107.0										1	IL-1RA	24	51
341513	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-1RA	21	51
341514	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-1RA	21	69
341515	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-1RA	22	59
341516	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-1RA	25	63
341517	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-1RA	19	49
341518	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-1RA	19	47
341519	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-1RA	18	59
341520	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-1RA	24	50
341521	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-1RA	23	70
341522	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-1RA	23	49
341523	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-1RA	21	64
341524	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-1RA	25	29
341525	20233																	0	IL-1RA	19	61
341526	20233						RA2159	51112.0								2	ug/mL	1	IL-1RA	36	60
341527	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-1RA	27	43
341528	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-1RA	22	62
341529	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-1RA	27	45
341530	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-1RA	31.5	54
341531	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-1RA	25.5	64
341532	20233						N2586	51107.0								2	ug/mL	1	IL-1RA	32	30
341533	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-1RA	33	51
341534	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-1RA	18.5	62
341535	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-1RA	26.5	36
341536	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-1RA	31.5	44
341537	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-1RA	25	38
341538	20233																	0	IL-1RA	23	39
341539	20233						RA2159	51112.0										2	IL-1RA	24	65
341540	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-1RA	26	75
341541	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-1RA	27	62
341542	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-1RA	24	54
341543	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-1RA	26	46
341544	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-1RA	22.5	60
341545	20233						RA2159	51112.0										2	IL-1RA	23	44
341546	20233						N2586	51107.0										2	IL-1RA	26	45
341547	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-1RA	26	47
341548	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-1RA	28	51
341549	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-1RA	25.5	36
341550	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-1RA	24	59
341551	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-1RA	25	53
341552	20233						N2586	51107.0										2	IL-1RA	25	35
341553	20233																	0	IL-1RA	20	52
341554	20233																	0	IL-1RA	24	50
341555	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-1RA	45	67
341556	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-1RA	46.5	58
341557	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-1RA	44	56
341558	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-1RA	40	61
341559	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-1RA	33	59
341560	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-1RA	35	51
341561	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-1RA	22	57
341562	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-1RA	43	55
341563	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-1RA	34.5	52
341564	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-1RA	52	45
341565	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-1RA	39	74
341566	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-1RA	48	41
341567	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-1RA	37.5	48
341568	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-1RA	22	43
341569	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-1RA	47	56
341570	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-1RA	40	61
341571	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-1RA	36	51
341572	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-1RA	41.5	62
341573	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-1RA	39.5	64
341574	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-1RA	45	55
341575	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-1RA	21	51
341576	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-1RA	38.5	44
341577	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-1RA	37	85
341578	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-1RA	44	43
341579	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-1RA	47.5	50
341580	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-1RA	46	43
341581	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-1RA	51	47
341582	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-1RA	25	44
341583	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-1RA	23	64
341584	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-1RA	25.5	38
341585	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-1RA	25.5	68
341586	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-1RA	29	62
341587	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-1RA	24	61
341588	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-1RA	25	70
341589	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-1RA	22	54
341590	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-1RA	23	63
341591	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-1RA	24.5	64
341592	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-1RA	26	57
341593	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-1RA	25	59
341594	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-1RA	22	62
341595	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-1RA	26	63
341596	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-1RA	24.5	50
341597	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-1RA	24	58
341598	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-1RA	28	63
341599	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-1RA	25	71
341600	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-1RA	25	53
341601	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-1RA	22	78
341602	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-1RA	23.5	42
341603	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-1RA	21.5	54
341604	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-1RA	24.5	40
341605	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-1RA	27.5	50
341606	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-1RA	22	61
341607	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-1RA	26	64
341608	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-1RA	20	54
341609	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-1RA	26	81
341610	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-1RA	26	47
341611	20233						RA2159	51112.0										2	IL-1RA	22	51
341612	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-1RA	20.5	52
341613	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-1RA	24	43
341614	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-1RA	23	48
341615	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-1RA	21	53
341616	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-1RA	24	68
341617	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-1RA	25	37
341618	20233						N2586	51107.0										2	IL-1RA	22.5	54
341619	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-1RA	24.5	64
341620	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-1RA	21	52
341621	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-1RA	23.5	50
341622	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-1RA	22	47
341623	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-1RA	19	40
341624	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-1RA	23	45
341625	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-1RA	23	60
341626	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-1RA	21	73
341627	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-1RA	18	64
341628	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-1RA	23	60
341629	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-1RA	21	71
341630	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-1RA	22	90
341631	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-1RA	19.5	72
341632	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-1RA	24	65
341633	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-1RA	23	59
341634	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-1RA	24	60
341635	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-1RA	22	51
341636	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-1RA	11	70
341637	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-1RA	20	75
341638	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-1RA	18	51
341639	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-1RA	19	65
341640	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-1RA	22	61
341641	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-1RA	20	62
341642	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-1RA	20	74
341643	20233						RA2159	51112.0										2	IL-1RA	19	53
341644	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-1RA	20.5	64
341645	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-1RA	22	69
341646	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-1RA	17	48
341647	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-1RA	21	59
341648	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-1RA	24	68
341649	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-1RA	20	49
341650	20233						N2586	51107.0										2	IL-1RA	11	41
341651	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-1RA	23	73
341652	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-1RA	19	69
341653	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-1RA	21	61
341654	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-1RA	22	66
341655	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-1RA	19	50
341656	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-1RA	24	53
341657	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-1RA	22	66
341658	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-1RA	22.5	50
341659	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-1RA	25	44
341660	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-1RA	23	50
341661	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-1RA	21.5	36
341662	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-1RA	22	47
341663	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-1RA	18	44
341664	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-1RA	22	50
341665	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-1RA	21	81
341666	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-1RA	20.5	50
341667	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-1RA	20	65
341668	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-1RA	22	55
341669	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-1RA	20	86
341670	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-1RA	17	49
341671	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-1RA	23.5	64
341672	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-1RA	20	48
341673	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-1RA	23	31
341674	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-1RA	21	61
341675	20233						RA2159	51112.0										2	IL-1RA	24.5	70
341676	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-1RA	22	69
341677	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-1RA	23	57
341678	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-1RA	23	84
341679	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-1RA	20	58
341680	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-1RA	22	46
341681	20233						RA2159	51112.0										2	IL-1RA	26	42
341682	20233						N2586	51107.0										2	IL-1RA	19	51
341683	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-1RA	23.5	52
341684	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-1RA	23	60
341685	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-1RA	22	43
341686	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-1RA	22	53
341687	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-1RA	20	44
341688	20233						N2586	51107.0										2	IL-1RA	27	34
341689	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-1RA	18.5	68
341690	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-1RA	21	49
341691	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-1RA	24	61
341692	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-1RA	23	46
341693	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-1RA	17.5	44
341694	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-1RA	19	43
341695	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-1RA	20	35
341696	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-1RA	20	46
341697	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-1RA	18	35
341698	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-1RA	21	39
341699	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-1RA	18	30
341700	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-1RA	19.5	34
341701	20233																	0	IL-1RA	14	38
341702	20233						RA2159	51112.0								2	ug/mL	2	IL-1RA	29	54
341703	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-1RA	28.5	48
341704	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-1RA	25.5	90
341705	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-1RA	26	63
341706	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-1RA	23	42
341707	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-1RA	28	40
341708	20233						N2586	51107.0								2	ug/mL	2	IL-1RA	28	37
341709	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-1RA	27	38
341710	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-1RA	33	44
341711	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-1RA	31	28
341712	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-1RA	21	29
341713	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-1RA	26	47
341714	20233																	0	IL-1RA	18	62
341715	20233						RA2159	51112.0								2	ug/mL	3	IL-1RA	36	55
341716	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-1RA	35	57
341717	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-1RA	22	57
341718	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-1RA	33.5	66
341719	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-1RA	33	63
341720	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-1RA	28	64
341721	20233						N2586	51107.0								2	ug/mL	3	IL-1RA	43	63
341722	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-1RA	38	52
341723	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-1RA	47	64
341724	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-1RA	41	52
341725	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-1RA	25	64
341726	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-1RA	42	73
341727	20233						RA2159	51112.0										3	IL-1RA	24	50
341728	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-1RA	22	61
341729	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-1RA	27	53
341730	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-1RA	26.5	72
341731	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-1RA	23	64
341732	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-1RA	26	66
341733	20233						RA2159	51112.0										3	IL-1RA	24	71
341734	20233						N2586	51107.0										3	IL-1RA	27	66
341735	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-1RA	20	74
341736	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-1RA	25.5	64
341737	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-1RA	24.5	48
341738	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-1RA	26	61
341739	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-1RA	19	56
341740	20233						N2586	51107.0										3	IL-1RA	23	52
341741	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-1RA	23	59
341742	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-1RA	25	47
341743	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-1RA	23	77
341744	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-1RA	23	47
341745	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-1RA	22.5	60
341746	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-1RA	27	65
341747	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-1RA	25	60
341748	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-1RA	22.5	80
341749	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-1RA	23	57
341750	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-1RA	26.5	32
341751	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-1RA	18	57
341752	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-1RA	25	65
341753	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-1RA	23	66
341754	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-1RA	23	79
341755	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-1RA	14.5	64
341756	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-1RA	24	60
341757	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-1RA	21	71
341758	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-1RA	21	67
341759	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-1RA	25	78
341760	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-1RA	25	64
341761	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-1RA	23	77
341762	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-1RA	20	77
341763	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-1RA	25	50
341764	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-1RA	25	61
341765	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-1RA	22	66
341766	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-1RA	22	70
341767	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-1RA	23	74
341768	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-1RA	21	67
341769	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-1RA	23	77
341770	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-1RA	22	77
341771	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-1RA	21	64
341772	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-1RA	24	50
341773	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-1RA	22	50
341774	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-1RA	21	59
341775	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-1RA	26	61
341776	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-1RA	25	57
341777	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-1RA	22	69
341778	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-1RA	21.5	56
341779	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-1RA	22	66
341780	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-1RA	24.5	52
341781	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-1RA	22	71
341782	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-1RA	19	63
341783	20233						RA2159	51112.0										3	IL-1RA	21.5	72
341784	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-1RA	24	47
341785	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-1RA	22	67
341786	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-1RA	22	59
341787	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-1RA	23	65
341788	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-1RA	25	73
341789	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-1RA	21	67
341790	20233						N2586	51107.0										3	IL-1RA	21	55
341791	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-1RA	20	54
341792	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-1RA	19	58
341793	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-1RA	21	57
341794	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-1RA	24	47
341795	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-1RA	15	71
341796	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-1RA	18.5	48
341797	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-1RA	20	76
341798	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-1RA	24	68
341799	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-1RA	20.5	72
341800	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-1RA	20	49
341801	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-1RA	28	53
341802	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-1RA	24	73
341803	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-1RA	18	63
341804	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-1RA	21	47
341805	20233						RA2159	51112.0										3	IL-1RA	23	66
341806	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-1RA	21	59
341807	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-1RA	22	48
341808	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-1RA	26	54
341809	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-1RA	21.5	62
341810	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-1RA	19	54
341811	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-1RA	20	67
341812	20233						N2586	51107.0										3	IL-1RA	25	64
341813	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-1RA	19	68
341814	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-1RA	22	61
341815	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-1RA	23	73
341816	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-1RA	25	41
341817	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-1RA	22.5	56
341818	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-1RA	22	63
341819	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-1RA	24.5	62
341820	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-1RA	23	53
341821	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-1RA	22	69
341822	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-1RA	27	60
341823	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-1RA	25	59
341824	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-1RA	25	46
341825	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-1RA	25.5	52
341826	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-1RA	25	67
341827	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-1RA	17	75
341828	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-1RA	22	53
341829	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-1RA	22	51
341830	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-1RA	27	42
341831	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-1RA	28	61
341832	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-1RA	27	48
341833	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-1RA	24	48
341834	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-1RA	26	76
341835	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-1RA	27	63
341836	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-1RA	28	74
341837	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-1RA	20	63
341838	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-1RA	27	70
341839	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-1RA	23.5	50
341840	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-1RA	24	56
341841	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-1RA	28	65
341842	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-1RA	25	59
341843	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-1RA	30	59
341844	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-1RA	25	68
341845	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-1RA	44	57
341846	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-1RA	42	60
341847	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-1RA	29	59
341848	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-1RA	46	59
341849	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-1RA	41	55
341850	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-1RA	22	60
341851	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-1RA	25	41
341852	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-1RA	50	60
341853	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-1RA	40	65
341854	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-1RA	48	59
341855	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-1RA	54	52
341856	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-1RA	26	41
341857	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-1RA	41	46
341858	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-1RA	22	76
341859	20233																	0	IL-1RA	15	63
341860	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-1RA	45	37
341861	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-1RA	48	43
341862	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-1RA	39	73
341863	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-1RA	45	76
341864	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-1RA	36	54
341865	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-1RA	27	58
341866	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-1RA	19	70
341867	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-1RA	42	73
341868	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-1RA	39	53
341869	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-1RA	44	67
341870	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-1RA	22	53
341871	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-1RA	31.5	52
341872	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-1RA	45	55
341873	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-1RA	21	61
341874	20233																	0	IL-1RA	17	53
341875	20233						RA2159	51112.0										3	IL-1RA	16	63
341876	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-1RA	23.5	54
341877	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-1RA	18.5	42
341878	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-1RA	20	60
341879	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-1RA	17	43
341880	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-1RA	19	64
341881	20233						RA2159	51112.0										3	IL-1RA	21	63
341882	20233						N2586	51107.0										3	IL-1RA	29.5	62
341883	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-1RA	22	72
341884	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-1RA	21	47
341885	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-1RA	22	40
341886	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-1RA	23	50
341887	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-1RA	21.5	56
341888	20233						N2586	51107.0										3	IL-1RA	19	41
341889	20233																	0	IL-1RA	21	48
341890	20233						RA2159	51112.0								2	ug/mL	4	IL-1RA	40	60
341891	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-1RA	35.5	50
341892	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-1RA	39	50
341893	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-1RA	37	72
341894	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-1RA	28	53
341895	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-1RA	37	67
341896	20233						N2586	51107.0								2	ug/mL	4	IL-1RA	45	67
341897	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-1RA	38	61
341898	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-1RA	30	67
341899	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-1RA	34	59
341900	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-1RA	26.5	60
341901	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-1RA	19	51
341902	20233						RA2159	51112.0										4	IL-1RA	23	53
341903	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-1RA	25	67
341904	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-1RA	23	59
341905	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-1RA	24	67
341906	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-1RA	23	52
341907	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-1RA	23	61
341908	20233						RA2159	51112.0										4	IL-1RA	22	63
341909	20233						N2586	51107.0										4	IL-1RA	21.5	58
341910	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-1RA	19	67
341911	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-1RA	24	49
341912	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-1RA	25.5	52
341913	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-1RA	25	57
341914	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-1RA	24	68
341915	20233						N2586	51107.0										4	IL-1RA	23	59
341916	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-1RA	24	45
341917	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-1RA	26	53
341918	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-1RA	23.5	78
341919	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-1RA	25	79
341920	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-1RA	23	77
341921	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-1RA	18	57
341922	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-1RA	23	65
341923	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-1RA	20	60
341924	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-1RA	20.5	50
341925	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-1RA	27	51
341926	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-1RA	28	61
341927	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-1RA	22	70
341928	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-1RA	24	73
341929	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-1RA	20	68
341930	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-1RA	26.5	64
341931	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-1RA	26.5	62
341932	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-1RA	27.5	52
341933	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-1RA	25	55
341934	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-1RA	20	51
341935	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-1RA	23.5	44
341936	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-1RA	19	66
341937	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-1RA	23	59
341938	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-1RA	24	49
341939	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-1RA	21	61
341940	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-1RA	25	74
341941	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-1RA	26	54
341942	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-1RA	24	62
341943	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-1RA	28	69
341944	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-1RA	22	49
341945	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-1RA	22.5	46
341946	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-1RA	23	57
341947	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-1RA	21	65
341948	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-1RA	25	67
341949	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-1RA	21.5	78
341950	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-1RA	19.5	60
341951	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-1RA	23	66
341952	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-1RA	21	57
341953	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-1RA	25	49
341954	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-1RA	25	75
341955	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-1RA	23	63
341956	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-1RA	21.5	54
341957	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-1RA	23	37
341958	20233						RA2159	51112.0										4	IL-1RA	24	61
341959	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-1RA	21	50
341960	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-1RA	24	64
341961	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-1RA	23.5	56
341962	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-1RA	24	48
341963	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-1RA	23.5	56
341964	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-1RA	20.5	54
341965	20233						N2586	51107.0										4	IL-1RA	24.5	74
341966	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-1RA	24	49
341967	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-1RA	24.5	52
341968	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-1RA	18	66
341969	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-1RA	24	51
341970	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-1RA	23	51
341971	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-1RA	23	49
341972	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-1RA	24.5	52
341973	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-1RA	28	51
341974	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-1RA	22.5	56
341975	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-1RA	29	49
341976	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-1RA	23	58
341977	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-1RA	21	87
341978	20233						RA2159	51112.0										4	IL-1RA	23	43
341979	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-1RA	18	53
341980	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-1RA	21	45
341981	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-1RA	20	55
341982	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-1RA	21	43
341983	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-1RA	23	45
341984	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-1RA	22	58
341985	20233						N2586	51107.0										4	IL-1RA	21	75
341986	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-1RA	20	55
341987	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-1RA	22	68
341988	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-1RA	22	54
341989	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-1RA	22	74
341990	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-1RA	19	73
341991	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-1RA	18.5	62
341992	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-1RA	23.5	50
341993	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-1RA	23	45
341994	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-1RA	21	61
341995	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-1RA	22.5	54
341996	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-1RA	21	45
341997	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-1RA	21	52
341998	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-1RA	20	45
341999	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-1RA	23.5	46
342000	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-1RA	25.5	60
342001	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-1RA	22	55
342002	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-1RA	22	45
342003	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-1RA	25	54
342004	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-1RA	21	54
342005	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-1RA	19	65
342006	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-1RA	25	46
342007	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-1RA	25	55
342008	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-1RA	21.5	44
342009	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-1RA	23	47
342010	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-1RA	21	47
342011	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-1RA	23	64
342012	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-1RA	19	37
342013	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-1RA	23	37
342014	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-1RA	29	56
342015	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-1RA	24	62
342016	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-1RA	30	40
342017	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-1RA	28	53
342018	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-1RA	25	57
342019	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-1RA	21	45
342020	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-1RA	49	37
342021	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-1RA	40	53
342022	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-1RA	40.5	54
342023	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-1RA	44	65
342024	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-1RA	42	36
342025	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-1RA	45.5	48
342026	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-1RA	21	46
342027	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-1RA	47	81
342028	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-1RA	43	39
342029	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-1RA	34	42
342030	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-1RA	60	33
342031	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-1RA	33	46
342032	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-1RA	21.5	44
342033	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-1RA	23	47
342034	20233																	0	IL-1RA	17	39
342035	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-1RA	47	65
342036	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-1RA	41	57
342037	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-1RA	43	56
342038	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-1RA	38	63
342039	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-1RA	37	57
342040	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-1RA	34.5	64
342041	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-1RA	22	51
342042	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-1RA	47	38
342043	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-1RA	52	49
342044	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-1RA	35	37
342045	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-1RA	45	38
342046	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-1RA	35	49
342047	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-1RA	23	54
342048	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-1RA	21	83
342049	20233																	0	IL-1RA	16	64
342050	20233						RA2159	51112.0										4	IL-1RA	21	53
342051	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-1RA	17	53
342052	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-1RA	22	57
342053	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-1RA	22	80
342054	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-1RA	23	74
342055	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-1RA	21	45
342056	20233						RA2159	51112.0										4	IL-1RA	24	40
342057	20233						N2586	51107.0										4	IL-1RA	21	58
342058	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-1RA	20.5	40
342059	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-1RA	23	51
342060	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-1RA	21.5	46
342061	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-1RA	19.5	50
342062	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-1RA	22	77
342063	20233						N2586	51107.0										4	IL-1RA	19	55
342064	20233								TNF-a	201285.0						100	ng/mL	0	IL-1RA	76	55
342065	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-1RA	20.5	66
342066	20233								IL-6	201287.0						100	ug/mL	0	IL-1RA	42	72
342067	20233								IL-17A	201288.0						100	ng/mL	0	IL-1RA	28	56
342068	20233								EGF	201289.0						100	ng/mL	0	IL-1RA	26	53
342069	20233								IGF-I	201290.0						100	ug/mL	0	IL-1RA	21	67
342070	20233								Adiponectin	201291.0						5	ng/mL	0	IL-1RA	23	74
342071	20233								Leptin	201292.0						1	ng/mL	0	IL-1RA	24	52
342072	20233								Visfatin	201293.0						1	ng/mL	0	IL-1RA	24	51
342073	20233															2	ug/mL	0	IL-1RA	23	65
342074	20233								TNF-a	201285.0						100	ng/mL	0	IL-1RA	67	60
342075	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-1RA	20	34
342076	20233								IL-6	201287.0						100	ug/mL	0	IL-1RA	38	55
342077	20233								IL-17A	201288.0						100	ng/mL	0	IL-1RA	28.5	64
342078	20233								EGF	201289.0						100	ng/mL	0	IL-1RA	20	56
342079	20233								IGF-I	201290.0						100	ug/mL	0	IL-1RA	26	42
342080	20233								Adiponectin	201291.0						5	ng/mL	0	IL-1RA	24	35
342081	20233								Leptin	201292.0						1	ng/mL	0	IL-1RA	18	37
342082	20233								Visfatin	201293.0						1	ng/mL	0	IL-1RA	22	47
342083	20233															2	ug/mL	0	IL-1RA	22	52
342084	20233								TNF-a	201285.0						100	ng/mL	0	IL-1RA	82	70
342085	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-1RA	19	81
342086	20233								IL-6	201287.0						100	ug/mL	0	IL-1RA	38	59
342087	20233								IL-17A	201288.0						100	ng/mL	0	IL-1RA	26	56
342088	20233								EGF	201289.0						100	ng/mL	0	IL-1RA	18	50
342089	20233								IGF-I	201290.0						100	ug/mL	0	IL-1RA	17	41
342090	20233								Adiponectin	201291.0						5	ng/mL	0	IL-1RA	20	55
342091	20233								Leptin	201292.0						1	ng/mL	0	IL-1RA	21.5	36
342092	20233								Visfatin	201293.0						1	ng/mL	0	IL-1RA	19	60
342093	20233															2	ug/mL	0	IL-1RA	19.5	70
342094	20233								TNF-a	201285.0						100	ng/mL	0	IL-1RA	75.5	68
342095	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-1RA	15.5	54
342096	20233								IL-6	201287.0						100	ug/mL	0	IL-1RA	37.5	52
342097	20233								IL-17A	201288.0						100	ng/mL	0	IL-1RA	24	50
342098	20233								EGF	201289.0						100	ng/mL	0	IL-1RA	15	55
342099	20233								IGF-I	201290.0						100	ug/mL	0	IL-1RA	19	65
342100	20233								Adiponectin	201291.0						5	ng/mL	0	IL-1RA	18	54
342101	20233								Leptin	201292.0						1	ng/mL	0	IL-1RA	17	51
342102	20233								Visfatin	201293.0						1	ng/mL	0	IL-1RA	19	35
342103	20233															2	ug/mL	0	IL-1RA	17.5	50
342104	20233																	0	IL-5	9	60
342105	20233						RA2159	51112.0										1	IL-5	18	50
342106	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-5	14	59
342107	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-5	13	60
342108	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-5	10	64
342109	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-5	12	85
342110	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-5	12	63
342111	20233						RA2159	51112.0										1	IL-5	11	61
342112	20233						N2586	51107.0										1	IL-5	11	73
342113	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-5	10.5	56
342114	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-5	12	68
342115	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-5	12	59
342116	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-5	12	58
342117	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-5	12	49
342118	20233						N2586	51107.0										1	IL-5	14	36
342119	20233																	0	IL-5	12	67
342120	20233																	0	IL-5	11	36
342121	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-5	15	55
342122	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-5	13	81
342123	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-5	12	63
342124	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-5	13	70
342125	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-5	12	61
342126	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-5	13	59
342127	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-5	12	67
342128	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-5	13	55
342129	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-5	13.5	54
342130	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-5	13	60
342131	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-5	14.5	54
342132	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-5	12	55
342133	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-5	12	63
342134	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-5	12	35
342135	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-5	10	64
342136	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-5	12	57
342137	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-5	11	71
342138	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-5	12	58
342139	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-5	14	67
342140	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-5	10	78
342141	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-5	10	77
342142	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-5	15.5	58
342143	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-5	10.5	60
342144	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-5	14	65
342145	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-5	13.5	68
342146	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-5	12.5	58
342147	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-5	12	42
342148	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-5	11	69
342149	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-5	12	73
342150	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-5	10	65
342151	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-5	10	83
342152	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-5	12	93
342153	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-5	10	72
342154	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-5	11.5	70
342155	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-5	12	65
342156	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-5	9.5	68
342157	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-5	10	70
342158	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-5	12.5	54
342159	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-5	11	63
342160	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-5	12	59
342161	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-5	18	76
342162	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-5	11	39
342163	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-5	10.5	70
342164	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-5	10.5	68
342165	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-5	8	75
342166	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-5	12	69
342167	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-5	11.5	60
342168	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-5	11	82
342169	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-5	11	71
342170	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-5	12	70
342171	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-5	11	57
342172	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-5	10	78
342173	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-5	12	82
342174	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-5	10	69
342175	20233						RA2159	51112.0										1	IL-5	12	69
342176	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-5	10	87
342177	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-5	10.5	80
342178	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-5	10	80
342179	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-5	10.5	56
342180	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-5	11	70
342181	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-5	9.5	56
342182	20233						N2586	51107.0										1	IL-5	9	69
342183	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-5	9	51
342184	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-5	12	51
342185	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-5	9	53
342186	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-5	11	43
342187	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-5	10	66
342188	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-5	13.5	66
342189	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-5	12	59
342190	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-5	11	56
342191	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-5	11	57
342192	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-5	10	73
342193	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-5	10	61
342194	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-5	10	67
342195	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-5	12	94
342196	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-5	12	64
342197	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-5	13	62
342198	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-5	14	55
342199	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-5	10	41
342200	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-5	10	62
342201	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-5	10.5	44
342202	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-5	12	66
342203	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-5	9	60
342204	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-5	10	68
342205	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-5	9	43
342206	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-5	8	71
342207	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-5	11	99
342208	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-5	10	78
342209	20233						RA2159	51112.0										1	IL-5	10	65
342210	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-5	11	52
342211	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-5	10	56
342212	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-5	11	72
342213	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-5	9	61
342214	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-5	10	47
342215	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-5	10	80
342216	20233						N2586	51107.0										1	IL-5	12	74
342217	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-5	11	65
342218	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-5	10.5	62
342219	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-5	11	67
342220	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-5	11	64
342221	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-5	13	57
342222	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-5	10.5	80
342223	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-5	11	65
342224	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-5	13	50
342225	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-5	12.5	54
342226	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-5	11	45
342227	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-5	10	55
342228	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-5	12	48
342229	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-5	10	56
342230	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-5	9	54
342231	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-5	9	58
342232	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-5	11	59
342233	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-5	11	55
342234	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-5	10	60
342235	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-5	11	54
342236	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-5	10	55
342237	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-5	9	71
342238	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-5	8	65
342239	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-5	10	78
342240	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-5	12	40
342241	20233						RA2159	51112.0										1	IL-5	11	55
342242	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-5	10	72
342243	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-5	12	67
342244	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-5	8	60
342245	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-5	8.5	80
342246	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-5	10	94
342247	20233						RA2159	51112.0										1	IL-5	10	74
342248	20233						N2586	51107.0										1	IL-5	11	60
342249	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-5	9	67
342250	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-5	10	62
342251	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-5	11	88
342252	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-5	10	67
342253	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-5	10	69
342254	20233						N2586	51107.0										1	IL-5	11	61
342255	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-5	12	68
342256	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-5	10	88
342257	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-5	12	62
342258	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-5	11	80
342259	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-5	11	54
342260	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-5	10	65
342261	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-5	11	64
342262	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-5	12	55
342263	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-5	9	61
342264	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-5	9	51
342265	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-5	10	55
342266	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-5	13	37
342267	20233																	0	IL-5	10	60
342268	20233						RA2159	51112.0								2	ug/mL	1	IL-5	12	55
342269	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-5	17.5	52
342270	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-5	16	56
342271	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-5	10	60
342272	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-5	11.5	56
342273	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-5	9	88
342274	20233						N2586	51107.0								2	ug/mL	1	IL-5	9.5	42
342275	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-5	11	82
342276	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-5	9	64
342277	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-5	10	33
342278	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-5	12	44
342279	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-5	10	47
342280	20233																	0	IL-5	11	51
342281	20233						RA2159	51112.0										2	IL-5	12	64
342282	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-5	15	65
342283	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-5	13	68
342284	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-5	14	59
342285	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-5	12	49
342286	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-5	11	84
342287	20233						RA2159	51112.0										2	IL-5	10	50
342288	20233						N2586	51107.0										2	IL-5	12	41
342289	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-5	12	49
342290	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-5	12	56
342291	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-5	12	55
342292	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-5	12	55
342293	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-5	8	46
342294	20233						N2586	51107.0										2	IL-5	12	53
342295	20233																	0	IL-5	8	59
342296	20233																	0	IL-5	10	44
342297	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-5	12	68
342298	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-5	15	55
342299	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-5	12	83
342300	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-5	12	44
342301	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-5	9	55
342302	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-5	12	55
342303	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-5	10	63
342304	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-5	15	47
342305	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-5	13	60
342306	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-5	14	69
342307	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-5	12	61
342308	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-5	11	54
342309	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-5	13	71
342310	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-5	10	50
342311	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-5	12	58
342312	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-5	14	64
342313	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-5	12	66
342314	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-5	11.5	64
342315	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-5	13	64
342316	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-5	13	80
342317	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-5	11	46
342318	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-5	12	39
342319	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-5	12	65
342320	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-5	12.5	64
342321	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-5	11.5	70
342322	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-5	13	71
342323	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-5	13	61
342324	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-5	12	43
342325	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-5	9	83
342326	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-5	9	60
342327	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-5	9	76
342328	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-5	11	55
342329	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-5	11	53
342330	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-5	11	62
342331	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-5	10	51
342332	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-5	11	67
342333	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-5	8.5	86
342334	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-5	11	55
342335	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-5	9	58
342336	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-5	9	54
342337	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-5	10	60
342338	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-5	10	42
342339	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-5	12	65
342340	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-5	12	85
342341	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-5	11	75
342342	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-5	13	77
342343	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-5	12	63
342344	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-5	9	61
342345	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-5	9	66
342346	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-5	10	50
342347	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-5	10	73
342348	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-5	11	54
342349	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-5	12.5	66
342350	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-5	12	47
342351	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-5	9.5	68
342352	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-5	11	57
342353	20233						RA2159	51112.0										2	IL-5	9	55
342354	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-5	9	65
342355	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-5	9.5	60
342356	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-5	9.5	60
342357	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-5	11	68
342358	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-5	10.5	68
342359	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-5	9	49
342360	20233						N2586	51107.0										2	IL-5	10	59
342361	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-5	12	63
342362	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-5	12	56
342363	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-5	10	61
342364	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-5	9	59
342365	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-5	8.5	52
342366	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-5	9	57
342367	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-5	10	66
342368	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-5	10	84
342369	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-5	10.5	76
342370	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-5	9	79
342371	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-5	12	69
342372	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-5	11	70
342373	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-5	8	83
342374	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-5	8	62
342375	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-5	10	79
342376	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-5	10	70
342377	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-5	11	50
342378	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-5	8	71
342379	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-5	12	69
342380	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-5	9.5	66
342381	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-5	10	67
342382	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-5	10	76
342383	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-5	10.5	78
342384	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-5	9	74
342385	20233						RA2159	51112.0										2	IL-5	12	53
342386	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-5	12	78
342387	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-5	11	67
342388	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-5	10	67
342389	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-5	11	66
342390	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-5	11	70
342391	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-5	9	57
342392	20233						N2586	51107.0										2	IL-5	6	56
342393	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-5	11.5	58
342394	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-5	12	68
342395	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-5	9.5	70
342396	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-5	11	61
342397	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-5	10	62
342398	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-5	13	61
342399	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-5	12.5	62
342400	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-5	11	73
342401	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-5	12	70
342402	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-5	9	51
342403	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-5	10	64
342404	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-5	12	45
342405	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-5	10	61
342406	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-5	10.5	64
342407	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-5	10	72
342408	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-5	11.5	66
342409	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-5	10.5	80
342410	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-5	9	77
342411	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-5	11	75
342412	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-5	8	59
342413	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-5	11	64
342414	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-5	12	56
342415	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-5	11	37
342416	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-5	9	64
342417	20233						RA2159	51112.0										2	IL-5	12	69
342418	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-5	8	70
342419	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-5	11	70
342420	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-5	9	81
342421	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-5	8	75
342422	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-5	11	63
342423	20233						RA2159	51112.0										2	IL-5	10	43
342424	20233						N2586	51107.0										2	IL-5	14	47
342425	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-5	9	63
342426	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-5	9.5	60
342427	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-5	10	45
342428	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-5	9	53
342429	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-5	9	54
342430	20233						N2586	51107.0										2	IL-5	9.5	62
342431	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-5	9	64
342432	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-5	10	67
342433	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-5	10	75
342434	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-5	8.5	52
342435	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-5	10.5	32
342436	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-5	9	52
342437	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-5	8	61
342438	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-5	8	40
342439	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-5	10	43
342440	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-5	13	34
342441	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-5	11	36
342442	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-5	8	30
342443	20233																	0	IL-5	7	59
342444	20233						RA2159	51112.0								2	ug/mL	2	IL-5	13	53
342445	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-5	10	58
342446	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-5	12	68
342447	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-5	11	69
342448	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-5	10	32
342449	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-5	10	40
342450	20233						N2586	51107.0								2	ug/mL	2	IL-5	12	39
342451	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-5	9	51
342452	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-5	13	46
342453	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-5	10	31
342454	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-5	6	29
342455	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-5	9	36
342456	20233																	0	IL-5	12	69
342457	20233						RA2159	51112.0								2	ug/mL	3	IL-5	14	79
342458	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-5	15	82
342459	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-5	12.5	82
342460	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-5	11	78
342461	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-5	14.5	66
342462	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-5	13	54
342463	20233						N2586	51107.0								2	ug/mL	3	IL-5	13	65
342464	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-5	15	69
342465	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-5	15	61
342466	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-5	12	53
342467	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-5	10	70
342468	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-5	15	75
342469	20233						RA2159	51112.0										3	IL-5	11	63
342470	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-5	11	55
342471	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-5	8.5	60
342472	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-5	10.5	62
342473	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-5	11	79
342474	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-5	11	71
342475	20233						RA2159	51112.0										3	IL-5	12	93
342476	20233						N2586	51107.0										3	IL-5	11	63
342477	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-5	12	81
342478	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-5	11	76
342479	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-5	12	71
342480	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-5	12	76
342481	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-5	12	72
342482	20233						N2586	51107.0										3	IL-5	10	52
342483	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-5	9	58
342484	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-5	11	63
342485	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-5	13	68
342486	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-5	14	63
342487	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-5	10	63
342488	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-5	11	70
342489	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-5	9	72
342490	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-5	9.5	68
342491	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-5	9.5	72
342492	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-5	13	51
342493	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-5	11	62
342494	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-5	9.5	62
342495	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-5	12	96
342496	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-5	13	66
342497	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-5	10.5	72
342498	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-5	9	69
342499	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-5	9	75
342500	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-5	12	57
342501	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-5	10	87
342502	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-5	11	81
342503	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-5	10.5	76
342504	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-5	12	83
342505	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-5	11	69
342506	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-5	11.5	72
342507	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-5	9.5	72
342508	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-5	11	63
342509	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-5	10	59
342510	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-5	10	61
342511	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-5	12	74
342512	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-5	13	77
342513	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-5	13	81
342514	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-5	12.5	56
342515	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-5	14	71
342516	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-5	12.5	66
342517	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-5	11	84
342518	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-5	14	77
342519	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-5	10	51
342520	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-5	11	70
342521	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-5	12	73
342522	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-5	11	64
342523	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-5	11	73
342524	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-5	8.5	70
342525	20233						RA2159	51112.0										3	IL-5	9	61
342526	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-5	8	68
342527	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-5	14	49
342528	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-5	11	67
342529	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-5	12	73
342530	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-5	9	72
342531	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-5	11	71
342532	20233						N2586	51107.0										3	IL-5	11	68
342533	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-5	12	61
342534	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-5	10	61
342535	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-5	10	88
342536	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-5	10	55
342537	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-5	9	66
342538	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-5	14	66
342539	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-5	11	83
342540	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-5	9	59
342541	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-5	13	77
342542	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-5	10	57
342543	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-5	10	65
342544	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-5	11	68
342545	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-5	9	64
342546	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-5	9	48
342547	20233						RA2159	51112.0										3	IL-5	10	54
342548	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-5	13	65
342549	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-5	10	66
342550	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-5	10	63
342551	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-5	11.5	74
342552	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-5	11	60
342553	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-5	11	75
342554	20233						N2586	51107.0										3	IL-5	10	81
342555	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-5	8	69
342556	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-5	11	70
342557	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-5	11	71
342558	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-5	9	64
342559	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-5	10	59
342560	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-5	13.5	70
342561	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-5	8	67
342562	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-5	9.5	72
342563	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-5	11.5	56
342564	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-5	10	54
342565	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-5	10	63
342566	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-5	10	80
342567	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-5	11	73
342568	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-5	11	74
342569	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-5	11	73
342570	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-5	10	73
342571	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-5	12	53
342572	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-5	8	45
342573	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-5	10.5	76
342574	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-5	12	81
342575	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-5	11	64
342576	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-5	11	63
342577	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-5	9	71
342578	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-5	12	62
342579	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-5	9	75
342580	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-5	10	59
342581	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-5	11	69
342582	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-5	8	51
342583	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-5	10.5	76
342584	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-5	11	77
342585	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-5	11	70
342586	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-5	9	71
342587	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-5	10	58
342588	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-5	14	80
342589	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-5	12	90
342590	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-5	14	73
342591	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-5	11	52
342592	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-5	12	67
342593	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-5	10	55
342594	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-5	13	69
342595	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-5	14	72
342596	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-5	14	63
342597	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-5	12	64
342598	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-5	9	55
342599	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-5	12	63
342600	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-5	12	83
342601	20233																	0	IL-5	10	42
342602	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-5	30	61
342603	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-5	32.5	72
342604	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-5	18	75
342605	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-5	15.5	78
342606	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-5	13	59
342607	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-5	10	68
342608	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-5	10	71
342609	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-5	12	80
342610	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-5	13	60
342611	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-5	13	59
342612	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-5	11	59
342613	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-5	11.5	60
342614	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-5	14.5	56
342615	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-5	11	60
342616	20233																	0	IL-5	9	58
342617	20233						RA2159	51112.0										3	IL-5	8	60
342618	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-5	28	63
342619	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-5	13	84
342620	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-5	15.5	70
342621	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-5	12.5	48
342622	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-5	9	67
342623	20233						RA2159	51112.0										3	IL-5	10	63
342624	20233						N2586	51107.0										3	IL-5	9	69
342625	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-5	11	75
342626	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-5	12	57
342627	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-5	11	49
342628	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-5	9	39
342629	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-5	12	59
342630	20233						N2586	51107.0										3	IL-5	11	41
342631	20233																	0	IL-5	9	50
342632	20233						RA2159	51112.0								2	ug/mL	4	IL-5	16	51
342633	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-5	13	64
342634	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-5	13.5	54
342635	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-5	11.5	68
342636	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-5	11	70
342637	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-5	12	66
342638	20233						N2586	51107.0								2	ug/mL	4	IL-5	14	76
342639	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-5	14	66
342640	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-5	13	56
342641	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-5	12	58
342642	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-5	11	64
342643	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-5	12	68
342644	20233						RA2159	51112.0										4	IL-5	11.5	56
342645	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-5	14	76
342646	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-5	9	69
342647	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-5	10	72
342648	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-5	11	65
342649	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-5	10	69
342650	20233						RA2159	51112.0										4	IL-5	11	78
342651	20233						N2586	51107.0										4	IL-5	11	97
342652	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-5	11	61
342653	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-5	11	51
342654	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-5	10	54
342655	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-5	12	57
342656	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-5	9	69
342657	20233						N2586	51107.0										4	IL-5	13.5	54
342658	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-5	12	55
342659	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-5	9.5	52
342660	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-5	11	65
342661	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-5	10	49
342662	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-5	12.5	60
342663	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-5	10.5	52
342664	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-5	9	50
342665	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-5	13	53
342666	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-5	13	59
342667	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-5	10	49
342668	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-5	10.5	50
342669	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-5	13	73
342670	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-5	11	81
342671	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-5	10.5	60
342672	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-5	14	70
342673	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-5	13	75
342674	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-5	12	73
342675	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-5	11	70
342676	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-5	12	57
342677	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-5	10	53
342678	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-5	10	70
342679	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-5	9	61
342680	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-5	11.5	56
342681	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-5	11	75
342682	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-5	14	73
342683	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-5	11	66
342684	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-5	10	61
342685	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-5	14	71
342686	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-5	10.5	56
342687	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-5	9	58
342688	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-5	9	58
342689	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-5	9.5	50
342690	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-5	11	61
342691	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-5	11	73
342692	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-5	8	40
342693	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-5	12	89
342694	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-5	12	59
342695	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-5	12	64
342696	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-5	10	79
342697	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-5	12	71
342698	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-5	11	67
342699	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-5	11	50
342700	20233						RA2159	51112.0										4	IL-5	14	58
342701	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-5	9	67
342702	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-5	11	61
342703	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-5	12	61
342704	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-5	12	38
342705	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-5	13	56
342706	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-5	11.5	58
342707	20233						N2586	51107.0										4	IL-5	9.5	74
342708	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-5	11	77
342709	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-5	11	75
342710	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-5	13	65
342711	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-5	12	37
342712	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-5	13	39
342713	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-5	11	64
342714	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-5	10.5	68
342715	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-5	10	60
342716	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-5	10.5	52
342717	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-5	11	61
342718	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-5	10	55
342719	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-5	11	96
342720	20233						RA2159	51112.0										4	IL-5	9	61
342721	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-5	11	97
342722	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-5	11	81
342723	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-5	8	51
342724	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-5	11	53
342725	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-5	11	48
342726	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-5	11	62
342727	20233						N2586	51107.0										4	IL-5	10	57
342728	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-5	13	55
342729	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-5	10	69
342730	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-5	12	66
342731	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-5	10	55
342732	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-5	10	63
342733	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-5	10	75
342734	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-5	11	75
342735	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-5	10	73
342736	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-5	12	61
342737	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-5	12	50
342738	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-5	8	72
342739	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-5	12.5	58
342740	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-5	10	59
342741	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-5	9	44
342742	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-5	11	75
342743	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-5	12	67
342744	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-5	14.5	56
342745	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-5	9	63
342746	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-5	9.5	68
342747	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-5	10	53
342748	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-5	11	52
342749	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-5	11	65
342750	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-5	12	54
342751	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-5	14	46
342752	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-5	12	60
342753	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-5	10	87
342754	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-5	9	55
342755	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-5	9	53
342756	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-5	11	63
342757	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-5	13	61
342758	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-5	12	41
342759	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-5	11	64
342760	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-5	10	74
342761	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-5	10	60
342762	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-5	12	45
342763	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-5	12	59
342764	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-5	13	69
342765	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-5	13	72
342766	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-5	14	45
342767	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-5	14	65
342768	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-5	9	59
342769	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-5	12	68
342770	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-5	13	57
342771	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-5	10.5	48
342772	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-5	12	54
342773	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-5	11	54
342774	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-5	11	57
342775	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-5	9	50
342776	20233																	0	IL-5	10.5	38
342777	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-5	12	83
342778	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-5	11	64
342779	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-5	13.5	66
342780	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-5	13	70
342781	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-5	11	51
342782	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-5	13	47
342783	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-5	10	71
342784	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-5	13	69
342785	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-5	13.5	64
342786	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-5	13	40
342787	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-5	15	47
342788	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-5	13	42
342789	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-5	8	40
342790	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-5	10	83
342791	20233																	0	IL-5	10	77
342792	20233						RA2159	51112.0										4	IL-5	11	50
342793	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-5	22	62
342794	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-5	19.5	76
342795	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-5	23	66
342796	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-5	9	55
342797	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-5	11	55
342798	20233						RA2159	51112.0										4	IL-5	11	58
342799	20233						N2586	51107.0										4	IL-5	12	66
342800	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-5	8	51
342801	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-5	8	66
342802	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-5	10.5	54
342803	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-5	11.5	54
342804	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-5	8.5	64
342805	20233						N2586	51107.0										4	IL-5	9.5	52
342806	20233								TNF-a	201285.0						100	ng/mL	0	IL-5	12.5	86
342807	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-5	10.5	68
342808	20233								IL-6	201287.0						100	ug/mL	0	IL-5	15	74
342809	20233								IL-17A	201288.0						100	ng/mL	0	IL-5	12.5	72
342810	20233								EGF	201289.0						100	ng/mL	0	IL-5	8	71
342811	20233								IGF-I	201290.0						100	ug/mL	0	IL-5	11	77
342812	20233								Adiponectin	201291.0						5	ng/mL	0	IL-5	17	64
342813	20233								Leptin	201292.0						1	ng/mL	0	IL-5	10	71
342814	20233								Visfatin	201293.0						1	ng/mL	0	IL-5	10	41
342815	20233															2	ug/mL	0	IL-5	10	64
342816	20233								TNF-a	201285.0						100	ng/mL	0	IL-5	12.5	68
342817	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-5	9	50
342818	20233								IL-6	201287.0						100	ug/mL	0	IL-5	14	53
342819	20233								IL-17A	201288.0						100	ng/mL	0	IL-5	13	77
342820	20233								EGF	201289.0						100	ng/mL	0	IL-5	11	54
342821	20233								IGF-I	201290.0						100	ug/mL	0	IL-5	11	73
342822	20233								Adiponectin	201291.0						5	ng/mL	0	IL-5	21.5	44
342823	20233								Leptin	201292.0						1	ng/mL	0	IL-5	11	39
342824	20233								Visfatin	201293.0						1	ng/mL	0	IL-5	11.5	54
342825	20233															2	ug/mL	0	IL-5	10	57
342826	20233								TNF-a	201285.0						100	ng/mL	0	IL-5	12	64
342827	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-5	11	70
342828	20233								IL-6	201287.0						100	ug/mL	0	IL-5	16	59
342829	20233								IL-17A	201288.0						100	ng/mL	0	IL-5	10	65
342830	20233								EGF	201289.0						100	ng/mL	0	IL-5	7	50
342831	20233								IGF-I	201290.0						100	ug/mL	0	IL-5	9	69
342832	20233								Adiponectin	201291.0						5	ng/mL	0	IL-5	15	80
342833	20233								Leptin	201292.0						1	ng/mL	0	IL-5	11	54
342834	20233								Visfatin	201293.0						1	ng/mL	0	IL-5	10	98
342835	20233															2	ug/mL	0	IL-5	11	53
342836	20233								TNF-a	201285.0						100	ng/mL	0	IL-5	13	64
342837	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-5	11	58
342838	20233								IL-6	201287.0						100	ug/mL	0	IL-5	10	51
342839	20233								IL-17A	201288.0						100	ng/mL	0	IL-5	8	51
342840	20233								EGF	201289.0						100	ng/mL	0	IL-5	10	57
342841	20233								IGF-I	201290.0						100	ug/mL	0	IL-5	10.5	56
342842	20233								Adiponectin	201291.0						5	ng/mL	0	IL-5	14	54
342843	20233								Leptin	201292.0						1	ng/mL	0	IL-5	10	51
342844	20233								Visfatin	201293.0						1	ng/mL	0	IL-5	8	49
342845	20233															2	ug/mL	0	IL-5	9	55
342846	20233																	0	GM-CSF	274.5	56
342847	20233						RA2159	51112.0										1	GM-CSF	292	65
342848	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	GM-CSF	268	55
342849	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	GM-CSF	285.5	60
342850	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	GM-CSF	279	57
342851	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	GM-CSF	273.5	62
342852	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	GM-CSF	268.5	52
342853	20233						RA2159	51112.0										1	GM-CSF	284	63
342854	20233						N2586	51107.0										1	GM-CSF	257.5	60
342855	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	GM-CSF	275	61
342856	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	GM-CSF	277	33
342857	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	GM-CSF	289	67
342858	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	GM-CSF	284	56
342859	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	GM-CSF	241.5	54
342860	20233						N2586	51107.0										1	GM-CSF	311	39
342861	20233																	0	GM-CSF	267	57
342862	20233																	0	GM-CSF	283	35
342863	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	GM-CSF	313.5	46
342864	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	GM-CSF	294	55
342865	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	GM-CSF	303.5	58
342866	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	GM-CSF	298	61
342867	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	GM-CSF	316	68
342868	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	GM-CSF	318	69
342869	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	GM-CSF	304	63
342870	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	GM-CSF	311.5	58
342871	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	GM-CSF	397	50
342872	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	GM-CSF	356	46
342873	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	GM-CSF	350	49
342874	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	GM-CSF	296	47
342875	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	GM-CSF	273	53
342876	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	GM-CSF	403	31
342877	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	GM-CSF	341	73
342878	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	GM-CSF	288.5	56
342879	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	GM-CSF	269	64
342880	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	GM-CSF	344	74
342881	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	GM-CSF	332	55
342882	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	GM-CSF	267	50
342883	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	GM-CSF	218	75
342884	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	GM-CSF	324.5	58
342885	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	GM-CSF	316	75
342886	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	GM-CSF	298	53
342887	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	GM-CSF	317	50
342888	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	GM-CSF	325.5	56
342889	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	GM-CSF	300	36
342890	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	GM-CSF	263.5	64
342891	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	GM-CSF	363	65
342892	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	GM-CSF	275	57
342893	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	GM-CSF	291	75
342894	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	GM-CSF	229	75
342895	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	GM-CSF	330	68
342896	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	GM-CSF	314	50
342897	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	GM-CSF	259	58
342898	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	GM-CSF	344	82
342899	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	GM-CSF	230	58
342900	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	GM-CSF	278	45
342901	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	GM-CSF	313	45
342902	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	GM-CSF	261	58
342903	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	GM-CSF	315	59
342904	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	GM-CSF	274.5	40
342905	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	GM-CSF	286	79
342906	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	GM-CSF	264	70
342907	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	GM-CSF	311	64
342908	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	GM-CSF	317.5	52
342909	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	GM-CSF	315	65
342910	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	GM-CSF	271	53
342911	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	GM-CSF	280	66
342912	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	GM-CSF	276.5	42
342913	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	GM-CSF	293.5	52
342914	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	GM-CSF	245.5	64
342915	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	GM-CSF	318	61
342916	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	GM-CSF	264	61
342917	20233						RA2159	51112.0										1	GM-CSF	337.5	64
342918	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	GM-CSF	273.5	64
342919	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	GM-CSF	232	50
342920	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	GM-CSF	304.5	68
342921	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	GM-CSF	300	73
342922	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	GM-CSF	270	63
342923	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	GM-CSF	314	55
342924	20233						N2586	51107.0										1	GM-CSF	272	58
342925	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	GM-CSF	230	39
342926	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	GM-CSF	284	53
342927	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	GM-CSF	271	47
342928	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	GM-CSF	302.5	42
342929	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	GM-CSF	273	53
342930	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	GM-CSF	242	68
342931	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	GM-CSF	251.5	72
342932	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	GM-CSF	275	47
342933	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	GM-CSF	244.5	54
342934	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	GM-CSF	268	61
342935	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	GM-CSF	281	59
342936	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	GM-CSF	232	61
342937	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	GM-CSF	318	70
342938	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	GM-CSF	230	73
342939	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	GM-CSF	232.5	64
342940	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	GM-CSF	250.5	50
342941	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	GM-CSF	285	49
342942	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	GM-CSF	277	45
342943	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	GM-CSF	248	31
342944	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	GM-CSF	263.5	80
342945	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	GM-CSF	256	63
342946	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	GM-CSF	197	61
342947	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	GM-CSF	276	63
342948	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	GM-CSF	251	58
342949	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	GM-CSF	257	97
342950	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	GM-CSF	227	61
342951	20233						RA2159	51112.0										1	GM-CSF	254	64
342952	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	GM-CSF	235	52
342953	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	GM-CSF	225	49
342954	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	GM-CSF	253.5	70
342955	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	GM-CSF	212	40
342956	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	GM-CSF	227	35
342957	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	GM-CSF	217	64
342958	20233						N2586	51107.0										1	GM-CSF	283	71
342959	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	GM-CSF	97	72
342960	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	GM-CSF	136	62
342961	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	GM-CSF	160.5	62
342962	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	GM-CSF	102	47
342963	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	GM-CSF	131.5	70
342964	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	GM-CSF	117	77
342965	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	GM-CSF	120.5	56
342966	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	GM-CSF	138	39
342967	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	GM-CSF	124	55
342968	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	GM-CSF	130	37
342969	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	GM-CSF	119	49
342970	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	GM-CSF	186	47
342971	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	GM-CSF	259.5	64
342972	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	GM-CSF	281	54
342973	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	GM-CSF	239	59
342974	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	GM-CSF	238	57
342975	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	GM-CSF	240	57
342976	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	GM-CSF	234	56
342977	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	GM-CSF	229.5	36
342978	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	GM-CSF	215.5	46
342979	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	GM-CSF	234	77
342980	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	GM-CSF	215	69
342981	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	GM-CSF	223.5	34
342982	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	GM-CSF	231.5	32
342983	20233						RA2159	51112.0										1	GM-CSF	243	64
342984	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	GM-CSF	275	71
342985	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	GM-CSF	256	69
342986	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	GM-CSF	279	51
342987	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	GM-CSF	214.5	74
342988	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	GM-CSF	242	63
342989	20233						RA2159	51112.0										1	GM-CSF	207	59
342990	20233						N2586	51107.0										1	GM-CSF	233.5	64
342991	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	GM-CSF	263	60
342992	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	GM-CSF	285	57
342993	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	GM-CSF	211.5	50
342994	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	GM-CSF	273	56
342995	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	GM-CSF	258.5	72
342996	20233						N2586	51107.0										1	GM-CSF	215	57
342997	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	GM-CSF	239	49
342998	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	GM-CSF	309.5	72
342999	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	GM-CSF	294.5	66
343000	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	GM-CSF	273	70
343001	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	GM-CSF	225.5	46
343002	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	GM-CSF	224.5	40
343003	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	GM-CSF	214	60
343004	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	GM-CSF	321	52
343005	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	GM-CSF	261	59
343006	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	GM-CSF	251	55
343007	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	GM-CSF	234.5	60
343008	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	GM-CSF	226	38
343009	20233																	0	GM-CSF	220	46
343010	20233						RA2159	51112.0								2	ug/mL	1	GM-CSF	274	51
343011	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	GM-CSF	249	39
343012	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	GM-CSF	245	50
343013	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	GM-CSF	265.5	40
343014	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	GM-CSF	268	45
343015	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	GM-CSF	236.5	64
343016	20233						N2586	51107.0								2	ug/mL	1	GM-CSF	242.5	40
343017	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	GM-CSF	236	64
343018	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	GM-CSF	207	49
343019	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	GM-CSF	236	31
343020	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	GM-CSF	271	70
343021	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	GM-CSF	228	47
343022	20233																	0	GM-CSF	306	47
343023	20233						RA2159	51112.0										2	GM-CSF	308	53
343024	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	GM-CSF	260	87
343025	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	GM-CSF	275	61
343026	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	GM-CSF	256	57
343027	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	GM-CSF	285	45
343028	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	GM-CSF	257.5	64
343029	20233						RA2159	51112.0										2	GM-CSF	265.5	48
343030	20233						N2586	51107.0										2	GM-CSF	308	45
343031	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	GM-CSF	281	46
343032	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	GM-CSF	270	60
343033	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	GM-CSF	230	38
343034	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	GM-CSF	263	45
343035	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	GM-CSF	265	44
343036	20233						N2586	51107.0										2	GM-CSF	259.5	46
343037	20233																	0	GM-CSF	304	51
343038	20233																	0	GM-CSF	279	34
343039	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	GM-CSF	333	63
343040	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	GM-CSF	316	59
343041	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	GM-CSF	364	51
343042	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	GM-CSF	325	51
343043	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	GM-CSF	269	48
343044	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	GM-CSF	288	65
343045	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	GM-CSF	253	54
343046	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	GM-CSF	363	42
343047	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	GM-CSF	329.5	54
343048	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	GM-CSF	341.5	66
343049	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	GM-CSF	312	63
343050	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	GM-CSF	261.5	40
343051	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	GM-CSF	303	44
343052	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	GM-CSF	230	44
343053	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	GM-CSF	384.5	50
343054	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	GM-CSF	318	64
343055	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	GM-CSF	306.5	60
343056	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	GM-CSF	342.5	54
343057	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	GM-CSF	317	64
343058	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	GM-CSF	277.5	62
343059	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	GM-CSF	277.5	46
343060	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	GM-CSF	362.5	36
343061	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	GM-CSF	310	57
343062	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	GM-CSF	302	60
343063	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	GM-CSF	339	59
343064	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	GM-CSF	288	60
343065	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	GM-CSF	342	38
343066	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	GM-CSF	224	43
343067	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	GM-CSF	294	67
343068	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	GM-CSF	267	57
343069	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	GM-CSF	265	50
343070	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	GM-CSF	264	51
343071	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	GM-CSF	272	65
343072	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	GM-CSF	261	70
343073	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	GM-CSF	281.5	50
343074	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	GM-CSF	243	63
343075	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	GM-CSF	279	79
343076	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	GM-CSF	250	59
343077	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	GM-CSF	245.5	52
343078	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	GM-CSF	240	69
343079	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	GM-CSF	277	49
343080	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	GM-CSF	258.5	52
343081	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	GM-CSF	259	58
343082	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	GM-CSF	295.5	64
343083	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	GM-CSF	291.5	70
343084	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	GM-CSF	276	63
343085	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	GM-CSF	255	69
343086	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	GM-CSF	270	44
343087	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	GM-CSF	230	69
343088	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	GM-CSF	274.5	46
343089	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	GM-CSF	253.5	60
343090	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	GM-CSF	230.5	54
343091	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	GM-CSF	282	77
343092	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	GM-CSF	296	52
343093	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	GM-CSF	236	63
343094	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	GM-CSF	244	49
343095	20233						RA2159	51112.0										2	GM-CSF	232	54
343096	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	GM-CSF	247	59
343097	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	GM-CSF	267	59
343098	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	GM-CSF	237	34
343099	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	GM-CSF	244	69
343100	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	GM-CSF	274	59
343101	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	GM-CSF	245	36
343102	20233						N2586	51107.0										2	GM-CSF	244	47
343103	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	GM-CSF	245	61
343104	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	GM-CSF	214	48
343105	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	GM-CSF	265	53
343106	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	GM-CSF	228	73
343107	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	GM-CSF	192.5	36
343108	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	GM-CSF	248.5	52
343109	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	GM-CSF	235	77
343110	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	GM-CSF	236.5	66
343111	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	GM-CSF	243	59
343112	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	GM-CSF	226	53
343113	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	GM-CSF	238	69
343114	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	GM-CSF	231	56
343115	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	GM-CSF	230	55
343116	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	GM-CSF	252.5	76
343117	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	GM-CSF	248.5	62
343118	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	GM-CSF	219.5	62
343119	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	GM-CSF	224	37
343120	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	GM-CSF	10	73
343121	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	GM-CSF	243.5	82
343122	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	GM-CSF	247	53
343123	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	GM-CSF	243	88
343124	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	GM-CSF	260	71
343125	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	GM-CSF	252	68
343126	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	GM-CSF	264.5	72
343127	20233						RA2159	51112.0										2	GM-CSF	259.5	60
343128	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	GM-CSF	236	75
343129	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	GM-CSF	226	71
343130	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	GM-CSF	229	56
343131	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	GM-CSF	208	73
343132	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	GM-CSF	284	51
343133	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	GM-CSF	200	43
343134	20233						N2586	51107.0										2	GM-CSF	8	54
343135	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	GM-CSF	92	71
343136	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	GM-CSF	126	70
343137	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	GM-CSF	146	69
343138	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	GM-CSF	105	58
343139	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	GM-CSF	116	80
343140	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	GM-CSF	134	48
343141	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	GM-CSF	96	53
343142	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	GM-CSF	112.5	56
343143	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	GM-CSF	76	55
343144	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	GM-CSF	110.5	48
343145	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	GM-CSF	107	38
343146	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	GM-CSF	129.5	52
343147	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	GM-CSF	246	53
343148	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	GM-CSF	251	62
343149	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	GM-CSF	234	71
343150	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	GM-CSF	267	70
343151	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	GM-CSF	219.5	58
343152	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	GM-CSF	236.5	66
343153	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	GM-CSF	230	66
343154	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	GM-CSF	207	39
343155	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	GM-CSF	212	58
343156	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	GM-CSF	234	53
343157	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	GM-CSF	246.5	44
343158	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	GM-CSF	231.5	72
343159	20233						RA2159	51112.0										2	GM-CSF	260	65
343160	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	GM-CSF	236.5	62
343161	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	GM-CSF	229.5	62
343162	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	GM-CSF	224	70
343163	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	GM-CSF	255	60
343164	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	GM-CSF	215	39
343165	20233						RA2159	51112.0										2	GM-CSF	236	51
343166	20233						N2586	51107.0										2	GM-CSF	207	47
343167	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	GM-CSF	197	46
343168	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	GM-CSF	224.5	58
343169	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	GM-CSF	219	48
343170	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	GM-CSF	211	51
343171	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	GM-CSF	235	53
343172	20233						N2586	51107.0										2	GM-CSF	227	51
343173	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	GM-CSF	220	69
343174	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	GM-CSF	235	49
343175	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	GM-CSF	241.5	60
343176	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	GM-CSF	224	47
343177	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	GM-CSF	220	41
343178	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	GM-CSF	254	31
343179	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	GM-CSF	196	44
343180	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	GM-CSF	247	41
343181	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	GM-CSF	233	27
343182	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	GM-CSF	242	29
343183	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	GM-CSF	208	35
343184	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	GM-CSF	247	37
343185	20233																	0	GM-CSF	195	45
343186	20233						RA2159	51112.0								2	ug/mL	2	GM-CSF	262.5	40
343187	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	GM-CSF	237	61
343188	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	GM-CSF	247	61
343189	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	GM-CSF	258	61
343190	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	GM-CSF	228	21
343191	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	GM-CSF	283	59
343192	20233						N2586	51107.0								2	ug/mL	2	GM-CSF	272	31
343193	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	GM-CSF	232	51
343194	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	GM-CSF	243	33
343195	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	GM-CSF	215	19
343196	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	GM-CSF	218	24
343197	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	GM-CSF	232	46
343198	20233																	0	GM-CSF	206	58
343199	20233						RA2159	51112.0								2	ug/mL	3	GM-CSF	244	47
343200	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	GM-CSF	220.5	62
343201	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	GM-CSF	192.5	72
343202	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	GM-CSF	214	63
343203	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	GM-CSF	229	60
343204	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	GM-CSF	199	51
343205	20233						N2586	51107.0								2	ug/mL	3	GM-CSF	246	52
343206	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	GM-CSF	213	57
343207	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	GM-CSF	269	65
343208	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	GM-CSF	266	56
343209	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	GM-CSF	181.5	64
343210	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	GM-CSF	201.5	56
343211	20233						RA2159	51112.0										3	GM-CSF	209.5	58
343212	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	GM-CSF	204	61
343213	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	GM-CSF	203	61
343214	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	GM-CSF	206	77
343215	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	GM-CSF	229	58
343216	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	GM-CSF	191	63
343217	20233						RA2159	51112.0										3	GM-CSF	215	83
343218	20233						N2586	51107.0										3	GM-CSF	193	64
343219	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	GM-CSF	197	80
343220	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	GM-CSF	192	51
343221	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	GM-CSF	198	71
343222	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	GM-CSF	185.5	86
343223	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	GM-CSF	172	61
343224	20233						N2586	51107.0										3	GM-CSF	156	54
343225	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	GM-CSF	194	57
343226	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	GM-CSF	204	63
343227	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	GM-CSF	211	71
343228	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	GM-CSF	197	65
343229	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	GM-CSF	186	58
343230	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	GM-CSF	197	69
343231	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	GM-CSF	185	63
343232	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	GM-CSF	197	64
343233	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	GM-CSF	184	60
343234	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	GM-CSF	196	35
343235	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	GM-CSF	117	61
343236	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	GM-CSF	196	63
343237	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	GM-CSF	210	61
343238	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	GM-CSF	199	50
343239	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	GM-CSF	169.5	50
343240	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	GM-CSF	205	69
343241	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	GM-CSF	193	78
343242	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	GM-CSF	189	80
343243	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	GM-CSF	197.5	60
343244	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	GM-CSF	205	60
343245	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	GM-CSF	200	77
343246	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	GM-CSF	174.5	50
343247	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	GM-CSF	169	70
343248	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	GM-CSF	197	77
343249	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	GM-CSF	89.5	68
343250	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	GM-CSF	101	78
343251	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	GM-CSF	93	63
343252	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	GM-CSF	100.5	48
343253	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	GM-CSF	95	50
343254	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	GM-CSF	100	67
343255	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	GM-CSF	103	65
343256	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	GM-CSF	95	67
343257	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	GM-CSF	88	61
343258	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	GM-CSF	93	55
343259	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	GM-CSF	87	72
343260	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	GM-CSF	96	61
343261	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	GM-CSF	177	57
343262	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	GM-CSF	198	68
343263	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	GM-CSF	173	47
343264	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	GM-CSF	191	52
343265	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	GM-CSF	208	78
343266	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	GM-CSF	193	48
343267	20233						RA2159	51112.0										3	GM-CSF	181	65
343268	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	GM-CSF	185	67
343269	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	GM-CSF	169	46
343270	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	GM-CSF	195.5	50
343271	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	GM-CSF	178	82
343272	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	GM-CSF	179	80
343273	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	GM-CSF	185.5	76
343274	20233						N2586	51107.0										3	GM-CSF	182	70
343275	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	GM-CSF	192.5	60
343276	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	GM-CSF	181	48
343277	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	GM-CSF	168	45
343278	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	GM-CSF	184	49
343279	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	GM-CSF	147.5	62
343280	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	GM-CSF	153	39
343281	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	GM-CSF	180	69
343282	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	GM-CSF	194	57
343283	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	GM-CSF	193	53
343284	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	GM-CSF	181.5	58
343285	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	GM-CSF	188	73
343286	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	GM-CSF	165	55
343287	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	GM-CSF	100	69
343288	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	GM-CSF	175	27
343289	20233						RA2159	51112.0										3	GM-CSF	183.5	54
343290	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	GM-CSF	192	55
343291	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	GM-CSF	159	61
343292	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	GM-CSF	196	71
343293	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	GM-CSF	195.5	72
343294	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	GM-CSF	147.5	58
343295	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	GM-CSF	165	51
343296	20233						N2586	51107.0										3	GM-CSF	191	80
343297	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	GM-CSF	171	58
343298	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	GM-CSF	156	55
343299	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	GM-CSF	168	57
343300	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	GM-CSF	182	51
343301	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	GM-CSF	187	54
343302	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	GM-CSF	157	56
343303	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	GM-CSF	209	64
343304	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	GM-CSF	216	42
343305	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	GM-CSF	180	64
343306	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	GM-CSF	216	52
343307	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	GM-CSF	213.5	62
343308	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	GM-CSF	188	68
343309	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	GM-CSF	214	57
343310	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	GM-CSF	204.5	64
343311	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	GM-CSF	135	71
343312	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	GM-CSF	209	62
343313	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	GM-CSF	206	59
343314	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	GM-CSF	171	60
343315	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	GM-CSF	206	70
343316	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	GM-CSF	210	56
343317	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	GM-CSF	215.5	46
343318	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	GM-CSF	196.5	60
343319	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	GM-CSF	200.5	62
343320	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	GM-CSF	203	58
343321	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	GM-CSF	183	74
343322	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	GM-CSF	200.5	74
343323	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	GM-CSF	193	74
343324	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	GM-CSF	182	65
343325	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	GM-CSF	181	77
343326	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	GM-CSF	198	67
343327	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	GM-CSF	216	74
343328	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	GM-CSF	167	60
343329	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	GM-CSF	254	58
343330	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	GM-CSF	264	61
343331	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	GM-CSF	206	63
343332	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	GM-CSF	249	75
343333	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	GM-CSF	225	60
343334	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	GM-CSF	190	42
343335	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	GM-CSF	214	43
343336	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	GM-CSF	243	63
343337	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	GM-CSF	220	54
343338	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	GM-CSF	240	64
343339	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	GM-CSF	239	56
343340	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	GM-CSF	190	46
343341	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	GM-CSF	216	59
343342	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	GM-CSF	176	68
343343	20233																	0	GM-CSF	195	64
343344	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	GM-CSF	244	67
343345	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	GM-CSF	242.5	44
343346	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	GM-CSF	219	65
343347	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	GM-CSF	232	73
343348	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	GM-CSF	215	53
343349	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	GM-CSF	167.5	56
343350	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	GM-CSF	173.5	60
343351	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	GM-CSF	226.5	66
343352	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	GM-CSF	210.5	54
343353	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	GM-CSF	218	63
343354	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	GM-CSF	182	62
343355	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	GM-CSF	176	53
343356	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	GM-CSF	210.5	70
343357	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	GM-CSF	172	65
343358	20233																	0	GM-CSF	202	51
343359	20233						RA2159	51112.0										3	GM-CSF	154	43
343360	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	GM-CSF	196	54
343361	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	GM-CSF	177	39
343362	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	GM-CSF	193	57
343363	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	GM-CSF	182.5	32
343364	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	GM-CSF	179	56
343365	20233						RA2159	51112.0										3	GM-CSF	170.5	60
343366	20233						N2586	51107.0										3	GM-CSF	172	59
343367	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	GM-CSF	181	71
343368	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	GM-CSF	165	71
343369	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	GM-CSF	161.5	34
343370	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	GM-CSF	172	49
343371	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	GM-CSF	163	62
343372	20233						N2586	51107.0										3	GM-CSF	142.5	40
343373	20233																	0	GM-CSF	207	53
343374	20233						RA2159	51112.0								2	ug/mL	4	GM-CSF	278.5	50
343375	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	GM-CSF	262	41
343376	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	GM-CSF	233	57
343377	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	GM-CSF	245	69
343378	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	GM-CSF	232	63
343379	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	GM-CSF	217	61
343380	20233						N2586	51107.0								2	ug/mL	4	GM-CSF	245.5	62
343381	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	GM-CSF	234	74
343382	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	GM-CSF	204.5	58
343383	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	GM-CSF	214	59
343384	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	GM-CSF	202	61
343385	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	GM-CSF	173	47
343386	20233						RA2159	51112.0										4	GM-CSF	208.5	56
343387	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	GM-CSF	224	55
343388	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	GM-CSF	193.5	58
343389	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	GM-CSF	196	65
343390	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	GM-CSF	192	53
343391	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	GM-CSF	201	55
343392	20233						RA2159	51112.0										4	GM-CSF	201	61
343393	20233						N2586	51107.0										4	GM-CSF	178	67
343394	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	GM-CSF	101	63
343395	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	GM-CSF	174	59
343396	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	GM-CSF	186	50
343397	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	GM-CSF	197	61
343398	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	GM-CSF	212.5	68
343399	20233						N2586	51107.0										4	GM-CSF	207	61
343400	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	GM-CSF	198	47
343401	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	GM-CSF	238	49
343402	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	GM-CSF	210	50
343403	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	GM-CSF	215	75
343404	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	GM-CSF	208	63
343405	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	GM-CSF	199	57
343406	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	GM-CSF	181	68
343407	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	GM-CSF	193	60
343408	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	GM-CSF	187	55
343409	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	GM-CSF	195.5	52
343410	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	GM-CSF	191	55
343411	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	GM-CSF	166.5	62
343412	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	GM-CSF	197	68
343413	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	GM-CSF	192	64
343414	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	GM-CSF	225.5	74
343415	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	GM-CSF	194	51
343416	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	GM-CSF	186	72
343417	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	GM-CSF	194	49
343418	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	GM-CSF	185.5	56
343419	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	GM-CSF	171.5	46
343420	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	GM-CSF	161	65
343421	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	GM-CSF	182	49
343422	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	GM-CSF	197	56
343423	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	GM-CSF	183.5	60
343424	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	GM-CSF	88	83
343425	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	GM-CSF	119.5	54
343426	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	GM-CSF	97	59
343427	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	GM-CSF	105.5	50
343428	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	GM-CSF	100.5	38
343429	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	GM-CSF	98	46
343430	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	GM-CSF	88	72
343431	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	GM-CSF	90.5	50
343432	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	GM-CSF	102	53
343433	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	GM-CSF	88	67
343434	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	GM-CSF	91	43
343435	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	GM-CSF	99.5	72
343436	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	GM-CSF	207	58
343437	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	GM-CSF	212	51
343438	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	GM-CSF	170	77
343439	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	GM-CSF	199	61
343440	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	GM-CSF	181	44
343441	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	GM-CSF	239	46
343442	20233						RA2159	51112.0										4	GM-CSF	197	48
343443	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	GM-CSF	181.5	60
343444	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	GM-CSF	181	62
343445	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	GM-CSF	185	53
343446	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	GM-CSF	178	43
343447	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	GM-CSF	174.5	42
343448	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	GM-CSF	163	53
343449	20233						N2586	51107.0										4	GM-CSF	190	57
343450	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	GM-CSF	203	55
343451	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	GM-CSF	203	56
343452	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	GM-CSF	176	62
343453	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	GM-CSF	179	42
343454	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	GM-CSF	186	41
343455	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	GM-CSF	181	40
343456	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	GM-CSF	183	67
343457	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	GM-CSF	196.5	60
343458	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	GM-CSF	172	68
343459	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	GM-CSF	177	58
343460	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	GM-CSF	171.5	44
343461	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	GM-CSF	184	77
343462	20233						RA2159	51112.0										4	GM-CSF	182.5	52
343463	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	GM-CSF	198	61
343464	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	GM-CSF	189.5	54
343465	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	GM-CSF	170	61
343466	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	GM-CSF	188	45
343467	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	GM-CSF	164.5	48
343468	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	GM-CSF	182	42
343469	20233						N2586	51107.0										4	GM-CSF	192	57
343470	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	GM-CSF	175	54
343471	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	GM-CSF	164	62
343472	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	GM-CSF	178	69
343473	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	GM-CSF	161	64
343474	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	GM-CSF	166	60
343475	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	GM-CSF	173.5	50
343476	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	GM-CSF	195.5	58
343477	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	GM-CSF	229.5	64
343478	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	GM-CSF	199	63
343479	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	GM-CSF	212	47
343480	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	GM-CSF	191.5	54
343481	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	GM-CSF	180	69
343482	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	GM-CSF	183	64
343483	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	GM-CSF	205.5	60
343484	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	GM-CSF	200	55
343485	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	GM-CSF	194.5	64
343486	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	GM-CSF	207	60
343487	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	GM-CSF	157	55
343488	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	GM-CSF	176.5	62
343489	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	GM-CSF	159	59
343490	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	GM-CSF	212.5	54
343491	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	GM-CSF	192	54
343492	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	GM-CSF	166	45
343493	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	GM-CSF	173	49
343494	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	GM-CSF	160	46
343495	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	GM-CSF	175	63
343496	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	GM-CSF	164.5	36
343497	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	GM-CSF	176	55
343498	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	GM-CSF	196	52
343499	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	GM-CSF	169	47
343500	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	GM-CSF	178	44
343501	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	GM-CSF	179	53
343502	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	GM-CSF	164	47
343503	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	GM-CSF	167	52
343504	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	GM-CSF	242	45
343505	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	GM-CSF	230	51
343506	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	GM-CSF	231	50
343507	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	GM-CSF	247	59
343508	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	GM-CSF	221.5	46
343509	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	GM-CSF	220.5	44
343510	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	GM-CSF	181.5	52
343511	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	GM-CSF	242	52
343512	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	GM-CSF	260	35
343513	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	GM-CSF	191.5	52
343514	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	GM-CSF	239	33
343515	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	GM-CSF	185.5	56
343516	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	GM-CSF	157	43
343517	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	GM-CSF	180	37
343518	20233																	0	GM-CSF	208	34
343519	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	GM-CSF	223	57
343520	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	GM-CSF	213	45
343521	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	GM-CSF	203	50
343522	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	GM-CSF	216.5	80
343523	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	GM-CSF	199	33
343524	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	GM-CSF	204	53
343525	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	GM-CSF	167	52
343526	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	GM-CSF	252	60
343527	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	GM-CSF	231	47
343528	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	GM-CSF	196	39
343529	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	GM-CSF	218	53
343530	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	GM-CSF	216.5	64
343531	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	GM-CSF	168	60
343532	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	GM-CSF	160	72
343533	20233																	0	GM-CSF	185	54
343534	20233						RA2159	51112.0										4	GM-CSF	164	65
343535	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	GM-CSF	187	54
343536	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	GM-CSF	199.5	56
343537	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	GM-CSF	164.5	50
343538	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	GM-CSF	151	57
343539	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	GM-CSF	155	46
343540	20233						RA2159	51112.0										4	GM-CSF	169	56
343541	20233						N2586	51107.0										4	GM-CSF	192.5	54
343542	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	GM-CSF	190	50
343543	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	GM-CSF	158	58
343544	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	GM-CSF	171	51
343545	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	GM-CSF	182.5	66
343546	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	GM-CSF	170	59
343547	20233						N2586	51107.0										4	GM-CSF	143	46
343548	20233								TNF-a	201285.0						100	ng/mL	0	GM-CSF	348	59
343549	20233								IL-1 alpha	201286.0						100	ng/mL	0	GM-CSF	297	56
343550	20233								IL-6	201287.0						100	ug/mL	0	GM-CSF	408.5	60
343551	20233								IL-17A	201288.0						100	ng/mL	0	GM-CSF	398	77
343552	20233								EGF	201289.0						100	ng/mL	0	GM-CSF	268	67
343553	20233								IGF-I	201290.0						100	ug/mL	0	GM-CSF	262.5	50
343554	20233								Adiponectin	201291.0						5	ng/mL	0	GM-CSF	119	70
343555	20233								Leptin	201292.0						1	ng/mL	0	GM-CSF	275	61
343556	20233								Visfatin	201293.0						1	ng/mL	0	GM-CSF	277	55
343557	20233															2	ug/mL	0	GM-CSF	275	58
343558	20233								TNF-a	201285.0						100	ng/mL	0	GM-CSF	331.5	78
343559	20233								IL-1 alpha	201286.0						100	ng/mL	0	GM-CSF	298	41
343560	20233								IL-6	201287.0						100	ug/mL	0	GM-CSF	409	45
343561	20233								IL-17A	201288.0						100	ng/mL	0	GM-CSF	377	63
343562	20233								EGF	201289.0						100	ng/mL	0	GM-CSF	311.5	52
343563	20233								IGF-I	201290.0						100	ug/mL	0	GM-CSF	312	59
343564	20233								Adiponectin	201291.0						5	ng/mL	0	GM-CSF	113	33
343565	20233								Leptin	201292.0						1	ng/mL	0	GM-CSF	317	41
343566	20233								Visfatin	201293.0						1	ng/mL	0	GM-CSF	311.5	54
343567	20233															2	ug/mL	0	GM-CSF	307	36
343568	20233								TNF-a	201285.0						100	ng/mL	0	GM-CSF	258	73
343569	20233								IL-1 alpha	201286.0						100	ng/mL	0	GM-CSF	209	56
343570	20233								IL-6	201287.0						100	ug/mL	0	GM-CSF	268	61
343571	20233								IL-17A	201288.0						100	ng/mL	0	GM-CSF	284	61
343572	20233								EGF	201289.0						100	ng/mL	0	GM-CSF	184	61
343573	20233								IGF-I	201290.0						100	ug/mL	0	GM-CSF	177	43
343574	20233								Adiponectin	201291.0						5	ng/mL	0	GM-CSF	76	61
343575	20233								Leptin	201292.0						1	ng/mL	0	GM-CSF	194	45
343576	20233								Visfatin	201293.0						1	ng/mL	0	GM-CSF	213	77
343577	20233															2	ug/mL	0	GM-CSF	189	55
343578	20233								TNF-a	201285.0						100	ng/mL	0	GM-CSF	238	75
343579	20233								IL-1 alpha	201286.0						100	ng/mL	0	GM-CSF	167	58
343580	20233								IL-6	201287.0						100	ug/mL	0	GM-CSF	234	58
343581	20233								IL-17A	201288.0						100	ng/mL	0	GM-CSF	268	65
343582	20233								EGF	201289.0						100	ng/mL	0	GM-CSF	158	57
343583	20233								IGF-I	201290.0						100	ug/mL	0	GM-CSF	180	60
343584	20233								Adiponectin	201291.0						5	ng/mL	0	GM-CSF	71	55
343585	20233								Leptin	201292.0						1	ng/mL	0	GM-CSF	171	29
343586	20233								Visfatin	201293.0						1	ng/mL	0	GM-CSF	172.5	38
343587	20233															2	ug/mL	0	GM-CSF	177	49
343588	20233																	0	TNF-a	17.5	64
343589	20233						RA2159	51112.0										1	TNF-a	23	69
343590	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	TNF-a	20	72
343591	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	TNF-a	19	85
343592	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	TNF-a	23	74
343593	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	TNF-a	22	80
343594	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	TNF-a	21	58
343595	20233						RA2159	51112.0										1	TNF-a	23	62
343596	20233						N2586	51107.0										1	TNF-a	20	77
343597	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	TNF-a	19	51
343598	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	TNF-a	22	79
343599	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	TNF-a	23	83
343600	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	TNF-a	19	76
343601	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	TNF-a	25	56
343602	20233						N2586	51107.0										1	TNF-a	23	28
343603	20233																	0	TNF-a	17	81
343604	20233																	0	TNF-a	20	42
343605	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	TNF-a	4120	49
343606	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	TNF-a	3552	75
343607	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TNF-a	8092	72
343608	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TNF-a	3640	84
343609	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TNF-a	3615.5	54
343610	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	TNF-a	4610	84
343611	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	TNF-a	23	75
343612	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	TNF-a	4439	72
343613	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	TNF-a	5286	66
343614	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TNF-a	5989	72
343615	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TNF-a	5546	68
343616	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TNF-a	5974.5	46
343617	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	TNF-a	4756.5	56
343618	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	TNF-a	23.5	40
343619	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	TNF-a	38	78
343620	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	TNF-a	32.5	64
343621	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TNF-a	24.5	78
343622	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TNF-a	39.5	54
343623	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TNF-a	42	64
343624	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	TNF-a	19.5	80
343625	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	TNF-a	20	72
343626	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	TNF-a	39	79
343627	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	TNF-a	32.5	62
343628	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TNF-a	35.5	76
343629	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TNF-a	41.5	66
343630	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TNF-a	41	73
343631	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	TNF-a	27	59
343632	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	TNF-a	20	72
343633	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	TNF-a	28	58
343634	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	TNF-a	24	87
343635	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TNF-a	22.5	82
343636	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TNF-a	28	85
343637	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TNF-a	25.5	94
343638	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	TNF-a	24	77
343639	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	TNF-a	25	65
343640	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	TNF-a	27	94
343641	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	TNF-a	21	81
343642	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TNF-a	26	69
343643	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TNF-a	32	61
343644	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TNF-a	23	75
343645	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	TNF-a	29	75
343646	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	TNF-a	19	60
343647	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	TNF-a	22	80
343648	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	TNF-a	20	65
343649	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TNF-a	20	75
343650	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TNF-a	21	65
343651	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TNF-a	24	72
343652	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	TNF-a	19	65
343653	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	TNF-a	27	73
343654	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	TNF-a	22	70
343655	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TNF-a	20	66
343656	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TNF-a	20	90
343657	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TNF-a	23	76
343658	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	TNF-a	23	83
343659	20233						RA2159	51112.0										1	TNF-a	23	63
343660	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	TNF-a	20	71
343661	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	TNF-a	20	81
343662	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	TNF-a	21	64
343663	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	TNF-a	21.5	68
343664	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	TNF-a	20	65
343665	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	TNF-a	21	65
343666	20233						N2586	51107.0										1	TNF-a	19	78
343667	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	TNF-a	16	66
343668	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	TNF-a	18	50
343669	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	TNF-a	20.5	60
343670	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	TNF-a	21.5	58
343671	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	TNF-a	13.5	54
343672	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	TNF-a	20	68
343673	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	TNF-a	21	77
343674	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	TNF-a	22.5	50
343675	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TNF-a	18	62
343676	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TNF-a	22	80
343677	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TNF-a	21	83
343678	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	TNF-a	18	77
343679	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	TNF-a	22	90
343680	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	TNF-a	21	87
343681	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	TNF-a	19	77
343682	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TNF-a	18	60
343683	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TNF-a	20	49
343684	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TNF-a	21	58
343685	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	TNF-a	20	51
343686	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	TNF-a	21	88
343687	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	TNF-a	17	55
343688	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	TNF-a	19	83
343689	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TNF-a	20	69
343690	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TNF-a	20	102
343691	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TNF-a	20	92
343692	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	TNF-a	20.5	86
343693	20233						RA2159	51112.0										1	TNF-a	18	67
343694	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	TNF-a	16.5	72
343695	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	TNF-a	17	81
343696	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TNF-a	19	94
343697	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TNF-a	20	47
343698	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TNF-a	21	59
343699	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	TNF-a	17	80
343700	20233						N2586	51107.0										1	TNF-a	21	92
343701	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	TNF-a	21	79
343702	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	TNF-a	19	64
343703	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TNF-a	19	88
343704	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TNF-a	18	62
343705	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TNF-a	21	75
343706	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	TNF-a	19	95
343707	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	TNF-a	20	62
343708	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	TNF-a	16	60
343709	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TNF-a	17	59
343710	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TNF-a	17	51
343711	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TNF-a	19	73
343712	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	TNF-a	20	55
343713	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	TNF-a	18	74
343714	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	TNF-a	20	53
343715	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TNF-a	18	68
343716	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TNF-a	17.5	66
343717	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TNF-a	19	62
343718	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	TNF-a	21	67
343719	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	TNF-a	20	65
343720	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	TNF-a	19	58
343721	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TNF-a	20	75
343722	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TNF-a	20	55
343723	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TNF-a	17	63
343724	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	TNF-a	18.5	36
343725	20233						RA2159	51112.0										1	TNF-a	19	63
343726	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	TNF-a	21	81
343727	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	TNF-a	20	70
343728	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	TNF-a	20	70
343729	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	TNF-a	19	86
343730	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	TNF-a	18	79
343731	20233						RA2159	51112.0										1	TNF-a	19	91
343732	20233						N2586	51107.0										1	TNF-a	19.5	66
343733	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	TNF-a	23	83
343734	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	TNF-a	20	68
343735	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	TNF-a	20	67
343736	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	TNF-a	21	59
343737	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	TNF-a	20	69
343738	20233						N2586	51107.0										1	TNF-a	20	71
343739	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	TNF-a	20	71
343740	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	TNF-a	16.5	74
343741	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TNF-a	19.5	70
343742	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TNF-a	24.5	78
343743	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TNF-a	17	57
343744	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	TNF-a	22	66
343745	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	TNF-a	16	58
343746	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	TNF-a	21	70
343747	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TNF-a	23.5	60
343748	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TNF-a	18	59
343749	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TNF-a	18	66
343750	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	TNF-a	20	43
343751	20233																	0	TNF-a	17	65
343752	20233						RA2159	51112.0								2	ug/mL	1	TNF-a	32	67
343753	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	TNF-a	25.5	52
343754	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	TNF-a	20	56
343755	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	TNF-a	25	61
343756	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	TNF-a	25	66
343757	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	TNF-a	20	75
343758	20233						N2586	51107.0								2	ug/mL	1	TNF-a	33	45
343759	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	TNF-a	24	61
343760	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	TNF-a	19	61
343761	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	TNF-a	20	46
343762	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	TNF-a	27.5	52
343763	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	TNF-a	25	55
343764	20233																	0	TNF-a	20	60
343765	20233						RA2159	51112.0										2	TNF-a	21.5	84
343766	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	TNF-a	15	76
343767	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	TNF-a	23	67
343768	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	TNF-a	19	57
343769	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	TNF-a	20	52
343770	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	TNF-a	21	77
343771	20233						RA2159	51112.0										2	TNF-a	22.5	52
343772	20233						N2586	51107.0										2	TNF-a	17	47
343773	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	TNF-a	18	71
343774	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	TNF-a	20.5	60
343775	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	TNF-a	21	55
343776	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	TNF-a	19	56
343777	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	TNF-a	21.5	60
343778	20233						N2586	51107.0										2	TNF-a	21	57
343779	20233																	0	TNF-a	19	74
343780	20233																	0	TNF-a	17	50
343781	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	TNF-a	3192	67
343782	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	TNF-a	3527	69
343783	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	TNF-a	2846.5	52
343784	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	TNF-a	2374.5	62
343785	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	TNF-a	1686	61
343786	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	TNF-a	722	59
343787	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	TNF-a	18	67
343788	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	TNF-a	1173	53
343789	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	TNF-a	1936.5	58
343790	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	TNF-a	2808	75
343791	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	TNF-a	1827	63
343792	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	TNF-a	1985.5	38
343793	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	TNF-a	2027	55
343794	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	TNF-a	24	54
343795	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	TNF-a	37	54
343796	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	TNF-a	39	79
343797	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	TNF-a	31	78
343798	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	TNF-a	40	69
343799	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	TNF-a	36	64
343800	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	TNF-a	30	64
343801	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	TNF-a	18	57
343802	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	TNF-a	31	47
343803	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	TNF-a	29	82
343804	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	TNF-a	36	73
343805	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	TNF-a	36	73
343806	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	TNF-a	43.5	66
343807	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	TNF-a	38	70
343808	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	TNF-a	19	62
343809	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	TNF-a	23	93
343810	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	TNF-a	21	48
343811	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	TNF-a	24	86
343812	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	TNF-a	20.5	52
343813	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	TNF-a	19	65
343814	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	TNF-a	21	84
343815	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	TNF-a	21	55
343816	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	TNF-a	21	65
343817	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	TNF-a	21	103
343818	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	TNF-a	21	61
343819	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	TNF-a	20.5	64
343820	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	TNF-a	20	72
343821	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	TNF-a	24	58
343822	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	TNF-a	22.5	62
343823	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	TNF-a	20.5	54
343824	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	TNF-a	21	92
343825	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	TNF-a	20.5	76
343826	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	TNF-a	25	57
343827	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	TNF-a	18	57
343828	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	TNF-a	22	50
343829	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	TNF-a	19	73
343830	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	TNF-a	20.5	60
343831	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	TNF-a	22	58
343832	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	TNF-a	19	73
343833	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	TNF-a	22	75
343834	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	TNF-a	20.5	64
343835	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	TNF-a	21.5	76
343836	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	TNF-a	17.5	56
343837	20233						RA2159	51112.0										2	TNF-a	19	62
343838	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	TNF-a	18	79
343839	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	TNF-a	20	77
343840	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	TNF-a	17	55
343841	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	TNF-a	20	66
343842	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	TNF-a	19	63
343843	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	TNF-a	16	42
343844	20233						N2586	51107.0										2	TNF-a	20.5	74
343845	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	TNF-a	18.5	74
343846	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	TNF-a	19	64
343847	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	TNF-a	17.5	80
343848	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	TNF-a	17	74
343849	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	TNF-a	19	52
343850	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	TNF-a	23	47
343851	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	TNF-a	19	72
343852	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	TNF-a	20.5	72
343853	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	TNF-a	18	70
343854	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	TNF-a	20	75
343855	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	TNF-a	17	75
343856	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	TNF-a	18	86
343857	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	TNF-a	13	72
343858	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	TNF-a	17	64
343859	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	TNF-a	18	70
343860	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	TNF-a	18.5	72
343861	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	TNF-a	17	45
343862	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	TNF-a	9	68
343863	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	TNF-a	19	86
343864	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	TNF-a	19	46
343865	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	TNF-a	17	69
343866	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	TNF-a	20	78
343867	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	TNF-a	19	79
343868	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	TNF-a	17	80
343869	20233						RA2159	51112.0										2	TNF-a	17.5	70
343870	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	TNF-a	16	100
343871	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	TNF-a	19	83
343872	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	TNF-a	20	72
343873	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	TNF-a	17	68
343874	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	TNF-a	20	68
343875	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	TNF-a	17.5	68
343876	20233						N2586	51107.0										2	TNF-a	8	65
343877	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	TNF-a	20	86
343878	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	TNF-a	17.5	78
343879	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	TNF-a	20	71
343880	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	TNF-a	18	73
343881	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	TNF-a	19	58
343882	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	TNF-a	18.5	66
343883	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	TNF-a	19	91
343884	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	TNF-a	16	65
343885	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	TNF-a	18	78
343886	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	TNF-a	17	65
343887	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	TNF-a	17	77
343888	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	TNF-a	18	62
343889	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	TNF-a	19	64
343890	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	TNF-a	19	73
343891	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	TNF-a	16.5	72
343892	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	TNF-a	19	77
343893	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	TNF-a	19	79
343894	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	TNF-a	17	69
343895	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	TNF-a	17.5	72
343896	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	TNF-a	19	49
343897	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	TNF-a	18	62
343898	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	TNF-a	16	56
343899	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	TNF-a	18.5	32
343900	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	TNF-a	18	75
343901	20233						RA2159	51112.0										2	TNF-a	18.5	78
343902	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	TNF-a	19.5	68
343903	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	TNF-a	19	65
343904	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	TNF-a	20	85
343905	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	TNF-a	18	81
343906	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	TNF-a	15	61
343907	20233						RA2159	51112.0										2	TNF-a	22	56
343908	20233						N2586	51107.0										2	TNF-a	17	48
343909	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	TNF-a	21	60
343910	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	TNF-a	18	62
343911	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	TNF-a	19	50
343912	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	TNF-a	19	64
343913	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	TNF-a	19	59
343914	20233						N2586	51107.0										2	TNF-a	19.5	54
343915	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	TNF-a	18	69
343916	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	TNF-a	20.5	60
343917	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	TNF-a	17	61
343918	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	TNF-a	18	50
343919	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	TNF-a	17	36
343920	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	TNF-a	23	39
343921	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	TNF-a	16	66
343922	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	TNF-a	20	43
343923	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	TNF-a	15.5	34
343924	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	TNF-a	19	39
343925	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	TNF-a	14	31
343926	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	TNF-a	20	39
343927	20233																	0	TNF-a	16	41
343928	20233						RA2159	51112.0								2	ug/mL	2	TNF-a	33	56
343929	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	TNF-a	25	71
343930	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	TNF-a	23	86
343931	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	TNF-a	23	75
343932	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	TNF-a	20	40
343933	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	TNF-a	27	62
343934	20233						N2586	51107.0								2	ug/mL	2	TNF-a	30	51
343935	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	TNF-a	25	63
343936	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	TNF-a	21.5	34
343937	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	TNF-a	26	31
343938	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	TNF-a	25	32
343939	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	TNF-a	28	43
343940	20233																	0	TNF-a	16	84
343941	20233						RA2159	51112.0								2	ug/mL	3	TNF-a	28	69
343942	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	TNF-a	30	59
343943	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	TNF-a	18	62
343944	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	TNF-a	24	79
343945	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	TNF-a	21	69
343946	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	TNF-a	20	62
343947	20233						N2586	51107.0								2	ug/mL	3	TNF-a	33	75
343948	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	TNF-a	30.5	58
343949	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	TNF-a	33	73
343950	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	TNF-a	33	58
343951	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	TNF-a	19	63
343952	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	TNF-a	29	70
343953	20233						RA2159	51112.0										3	TNF-a	18	79
343954	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	TNF-a	18	82
343955	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	TNF-a	16.5	64
343956	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	TNF-a	19	67
343957	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	TNF-a	15	82
343958	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	TNF-a	15	71
343959	20233						RA2159	51112.0										3	TNF-a	20	92
343960	20233						N2586	51107.0										3	TNF-a	20	81
343961	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	TNF-a	19	63
343962	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	TNF-a	18.5	70
343963	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	TNF-a	20	78
343964	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	TNF-a	17.5	92
343965	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	TNF-a	17	82
343966	20233						N2586	51107.0										3	TNF-a	20	61
343967	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	TNF-a	18	77
343968	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	TNF-a	18	63
343969	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TNF-a	19	68
343970	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TNF-a	17	77
343971	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TNF-a	19.5	88
343972	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	TNF-a	19	70
343973	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	TNF-a	16	68
343974	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	TNF-a	20	66
343975	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TNF-a	17.5	64
343976	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TNF-a	17.5	62
343977	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TNF-a	19.5	66
343978	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	TNF-a	20	73
343979	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	TNF-a	19	68
343980	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	TNF-a	19	69
343981	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TNF-a	15	66
343982	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TNF-a	18.5	82
343983	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TNF-a	16	92
343984	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	TNF-a	17	77
343985	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	TNF-a	18	101
343986	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	TNF-a	15.5	60
343987	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TNF-a	16	86
343988	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TNF-a	18	81
343989	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TNF-a	16.5	64
343990	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	TNF-a	19	57
343991	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	TNF-a	19	71
343992	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	TNF-a	17	88
343993	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TNF-a	20	79
343994	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TNF-a	17	56
343995	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TNF-a	19	88
343996	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	TNF-a	19	81
343997	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	TNF-a	20	71
343998	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	TNF-a	18	67
343999	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TNF-a	20	73
344000	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TNF-a	18	81
344001	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TNF-a	19	93
344002	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	TNF-a	18	72
344003	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	TNF-a	16	62
344004	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	TNF-a	17	75
344005	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TNF-a	17.5	72
344006	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TNF-a	17	69
344007	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TNF-a	16.5	70
344008	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	TNF-a	18	56
344009	20233						RA2159	51112.0										3	TNF-a	19	63
344010	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	TNF-a	19	69
344011	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	TNF-a	16	65
344012	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TNF-a	17	79
344013	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TNF-a	21	91
344014	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TNF-a	17	77
344015	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	TNF-a	15.5	96
344016	20233						N2586	51107.0										3	TNF-a	22	64
344017	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	TNF-a	20	88
344018	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	TNF-a	19	51
344019	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TNF-a	16.5	66
344020	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TNF-a	21	58
344021	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TNF-a	14.5	66
344022	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	TNF-a	21.5	60
344023	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	TNF-a	17	73
344024	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	TNF-a	20	69
344025	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	TNF-a	20	75
344026	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TNF-a	15	64
344027	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TNF-a	20	51
344028	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TNF-a	14.5	54
344029	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	TNF-a	13	69
344030	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	TNF-a	15	44
344031	20233						RA2159	51112.0										3	TNF-a	19	78
344032	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	TNF-a	17	67
344033	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	TNF-a	16	66
344034	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	TNF-a	19	78
344035	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	TNF-a	15	73
344036	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	TNF-a	17	85
344037	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	TNF-a	18	61
344038	20233						N2586	51107.0										3	TNF-a	17	69
344039	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	TNF-a	15	72
344040	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	TNF-a	16	50
344041	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	TNF-a	18	73
344042	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	TNF-a	17	67
344043	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	TNF-a	19	70
344044	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	TNF-a	17.5	74
344045	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	TNF-a	21	59
344046	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	TNF-a	20	65
344047	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TNF-a	17	74
344048	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TNF-a	20	79
344049	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TNF-a	16	60
344050	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	TNF-a	20	62
344051	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	TNF-a	22	68
344052	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	TNF-a	18	89
344053	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TNF-a	16	62
344054	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TNF-a	22	65
344055	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TNF-a	18	51
344056	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	TNF-a	17	57
344057	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	TNF-a	27	57
344058	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	TNF-a	22	70
344059	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TNF-a	23	65
344060	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TNF-a	22.5	90
344061	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TNF-a	24	72
344062	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	TNF-a	24	73
344063	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	TNF-a	16	84
344064	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	TNF-a	20	90
344065	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	TNF-a	22	77
344066	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TNF-a	17	86
344067	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TNF-a	18	71
344068	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TNF-a	21	64
344069	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	TNF-a	19	74
344070	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	TNF-a	19	87
344071	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	TNF-a	40.5	66
344072	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	TNF-a	31	79
344073	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TNF-a	24.5	74
344074	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TNF-a	38	85
344075	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TNF-a	39	67
344076	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	TNF-a	19.5	74
344077	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	TNF-a	16.5	56
344078	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	TNF-a	46	78
344079	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	TNF-a	34.5	72
344080	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TNF-a	36	68
344081	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TNF-a	38	55
344082	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TNF-a	18.5	54
344083	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	TNF-a	33	91
344084	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	TNF-a	17	93
344085	20233																	0	TNF-a	14	74
344086	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	TNF-a	4346	67
344087	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	TNF-a	4716	61
344088	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TNF-a	9879	79
344089	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TNF-a	5192	85
344090	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TNF-a	4104	61
344091	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	TNF-a	4616	72
344092	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	TNF-a	19	64
344093	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	TNF-a	2338	83
344094	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	TNF-a	3154.5	68
344095	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TNF-a	3482	59
344096	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TNF-a	2568.5	56
344097	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TNF-a	3423	85
344098	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	TNF-a	2061	89
344099	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	TNF-a	18	82
344100	20233																	0	TNF-a	13	54
344101	20233						RA2159	51112.0										3	TNF-a	17	67
344102	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	TNF-a	21	79
344103	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	TNF-a	19	72
344104	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	TNF-a	19	73
344105	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	TNF-a	16.5	46
344106	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	TNF-a	18	88
344107	20233						RA2159	51112.0										3	TNF-a	15	71
344108	20233						N2586	51107.0										3	TNF-a	18	77
344109	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	TNF-a	16.5	92
344110	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	TNF-a	18.5	76
344111	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	TNF-a	17	42
344112	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	TNF-a	17	51
344113	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	TNF-a	17	68
344114	20233						N2586	51107.0										3	TNF-a	16	39
344115	20233																	0	TNF-a	18	64
344116	20233						RA2159	51112.0								2	ug/mL	4	TNF-a	39	63
344117	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	TNF-a	30	60
344118	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	TNF-a	38	62
344119	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	TNF-a	32	70
344120	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	TNF-a	25	72
344121	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	TNF-a	28	64
344122	20233						N2586	51107.0								2	ug/mL	4	TNF-a	32.5	68
344123	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	TNF-a	30	79
344124	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	TNF-a	18	66
344125	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	TNF-a	24	57
344126	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	TNF-a	19	62
344127	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	TNF-a	17	70
344128	20233						RA2159	51112.0										4	TNF-a	16	53
344129	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	TNF-a	19.5	60
344130	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	TNF-a	16.5	70
344131	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	TNF-a	18.5	92
344132	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	TNF-a	20	79
344133	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	TNF-a	17	63
344134	20233						RA2159	51112.0										4	TNF-a	19	77
344135	20233						N2586	51107.0										4	TNF-a	21	82
344136	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	TNF-a	15	73
344137	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	TNF-a	17	60
344138	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	TNF-a	18	65
344139	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	TNF-a	19	69
344140	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	TNF-a	16	86
344141	20233						N2586	51107.0										4	TNF-a	16	70
344142	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	TNF-a	20	59
344143	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	TNF-a	19	42
344144	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	TNF-a	20.5	82
344145	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	TNF-a	20	73
344146	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	TNF-a	20	78
344147	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	TNF-a	20	71
344148	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	TNF-a	17	65
344149	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	TNF-a	16.5	64
344150	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	TNF-a	16	70
344151	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	TNF-a	18	73
344152	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	TNF-a	14.5	52
344153	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	TNF-a	18	69
344154	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	TNF-a	20.5	82
344155	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	TNF-a	19	74
344156	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	TNF-a	18	78
344157	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	TNF-a	20	77
344158	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	TNF-a	17	84
344159	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	TNF-a	19	69
344160	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	TNF-a	17	63
344161	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	TNF-a	18.5	64
344162	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	TNF-a	15	74
344163	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	TNF-a	16	65
344164	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	TNF-a	17.5	64
344165	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	TNF-a	16	80
344166	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	TNF-a	23	72
344167	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	TNF-a	20.5	72
344168	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	TNF-a	23	68
344169	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	TNF-a	21.5	80
344170	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	TNF-a	20	61
344171	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	TNF-a	18	57
344172	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	TNF-a	17	64
344173	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	TNF-a	20	67
344174	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	TNF-a	17	54
344175	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	TNF-a	16	70
344176	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	TNF-a	15.5	48
344177	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	TNF-a	15	78
344178	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	TNF-a	20	90
344179	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	TNF-a	18	50
344180	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	TNF-a	19.5	70
344181	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	TNF-a	19	79
344182	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	TNF-a	19	57
344183	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	TNF-a	16	60
344184	20233						RA2159	51112.0										4	TNF-a	19	66
344185	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	TNF-a	18	51
344186	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	TNF-a	19	56
344187	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	TNF-a	14.5	56
344188	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	TNF-a	19	68
344189	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	TNF-a	16.5	64
344190	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	TNF-a	16	75
344191	20233						N2586	51107.0										4	TNF-a	19.5	86
344192	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	TNF-a	19	82
344193	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	TNF-a	19	82
344194	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	TNF-a	19	52
344195	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	TNF-a	20	57
344196	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	TNF-a	15	47
344197	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	TNF-a	18	43
344198	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	TNF-a	19	73
344199	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	TNF-a	17	93
344200	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	TNF-a	17.5	52
344201	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	TNF-a	18.5	58
344202	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	TNF-a	16	46
344203	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	TNF-a	16	81
344204	20233						RA2159	51112.0										4	TNF-a	17	61
344205	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	TNF-a	18	75
344206	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	TNF-a	19	61
344207	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	TNF-a	17	71
344208	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	TNF-a	19	51
344209	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	TNF-a	18.5	44
344210	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	TNF-a	15	63
344211	20233						N2586	51107.0										4	TNF-a	18	74
344212	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	TNF-a	16	72
344213	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	TNF-a	18	68
344214	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	TNF-a	16	85
344215	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	TNF-a	17	76
344216	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	TNF-a	17	69
344217	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	TNF-a	15.5	76
344218	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	TNF-a	19	91
344219	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	TNF-a	21	81
344220	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	TNF-a	18	84
344221	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	TNF-a	23	51
344222	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	TNF-a	18	68
344223	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	TNF-a	20.5	58
344224	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	TNF-a	19	67
344225	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	TNF-a	21	60
344226	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	TNF-a	19	89
344227	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	TNF-a	18.5	64
344228	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	TNF-a	19	62
344229	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	TNF-a	20	75
344230	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	TNF-a	16	74
344231	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	TNF-a	13.5	72
344232	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	TNF-a	23	59
344233	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	TNF-a	22	69
344234	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	TNF-a	18	32
344235	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	TNF-a	18	56
344236	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	TNF-a	21	54
344237	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	TNF-a	20	62
344238	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	TNF-a	14.5	34
344239	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	TNF-a	18	43
344240	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	TNF-a	24	71
344241	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	TNF-a	20	85
344242	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	TNF-a	27	51
344243	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	TNF-a	24	63
344244	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	TNF-a	17	79
344245	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	TNF-a	18	69
344246	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	TNF-a	35	58
344247	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	TNF-a	31	61
344248	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	TNF-a	37	57
344249	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	TNF-a	37	71
344250	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	TNF-a	36.5	40
344251	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	TNF-a	39	54
344252	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	TNF-a	18	69
344253	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	TNF-a	40	77
344254	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	TNF-a	37	57
344255	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	TNF-a	31	57
344256	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	TNF-a	38	51
344257	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	TNF-a	21	48
344258	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	TNF-a	14	75
344259	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	TNF-a	20.5	42
344260	20233																	0	TNF-a	16	50
344261	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	TNF-a	4367.5	82
344262	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	TNF-a	3483.5	68
344263	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	TNF-a	3052	62
344264	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	TNF-a	2683.5	80
344265	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	TNF-a	2177.5	64
344266	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	TNF-a	1174.5	72
344267	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	TNF-a	18	66
344268	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	TNF-a	4703	66
344269	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	TNF-a	5452	67
344270	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	TNF-a	4505	54
344271	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	TNF-a	5789	71
344272	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	TNF-a	4214	70
344273	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	TNF-a	3344	57
344274	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	TNF-a	15	67
344275	20233																	0	TNF-a	14	79
344276	20233						RA2159	51112.0										4	TNF-a	17	77
344277	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	TNF-a	19	79
344278	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	TNF-a	17	83
344279	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	TNF-a	18.5	74
344280	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	TNF-a	20	83
344281	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	TNF-a	18	64
344282	20233						RA2159	51112.0										4	TNF-a	17.5	56
344283	20233						N2586	51107.0										4	TNF-a	15	73
344284	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	TNF-a	15.5	50
344285	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	TNF-a	15	69
344286	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	TNF-a	17	64
344287	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	TNF-a	16	54
344288	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	TNF-a	18	65
344289	20233						N2586	51107.0										4	TNF-a	18	55
344290	20233								TNF-a	201285.0						100	ng/mL	0	TNF-a	22978	95
344291	20233								IL-1 alpha	201286.0						100	ng/mL	0	TNF-a	18	78
344292	20233								IL-6	201287.0						100	ug/mL	0	TNF-a	41	91
344293	20233								IL-17A	201288.0						100	ng/mL	0	TNF-a	24	59
344294	20233								EGF	201289.0						100	ng/mL	0	TNF-a	18	86
344295	20233								IGF-I	201290.0						100	ug/mL	0	TNF-a	18	79
344296	20233								Adiponectin	201291.0						5	ng/mL	0	TNF-a	24	78
344297	20233								Leptin	201292.0						1	ng/mL	0	TNF-a	21	74
344298	20233								Visfatin	201293.0						1	ng/mL	0	TNF-a	22	71
344299	20233															2	ug/mL	0	TNF-a	19	78
344300	20233								TNF-a	201285.0						100	ng/mL	0	TNF-a	23182.5	72
344301	20233								IL-1 alpha	201286.0						100	ng/mL	0	TNF-a	16	39
344302	20233								IL-6	201287.0						100	ug/mL	0	TNF-a	38	67
344303	20233								IL-17A	201288.0						100	ng/mL	0	TNF-a	24	50
344304	20233								EGF	201289.0						100	ng/mL	0	TNF-a	20	48
344305	20233								IGF-I	201290.0						100	ug/mL	0	TNF-a	19	64
344306	20233								Adiponectin	201291.0						5	ng/mL	0	TNF-a	24.5	46
344307	20233								Leptin	201292.0						1	ng/mL	0	TNF-a	18	50
344308	20233								Visfatin	201293.0						1	ng/mL	0	TNF-a	22	54
344309	20233															2	ug/mL	0	TNF-a	19	52
344310	20233								TNF-a	201285.0						100	ng/mL	0	TNF-a	23175	79
344311	20233								IL-1 alpha	201286.0						100	ng/mL	0	TNF-a	18	64
344312	20233								IL-6	201287.0						100	ug/mL	0	TNF-a	33	42
344313	20233								IL-17A	201288.0						100	ng/mL	0	TNF-a	21	81
344314	20233								EGF	201289.0						100	ng/mL	0	TNF-a	15	82
344315	20233								IGF-I	201290.0						100	ug/mL	0	TNF-a	15.5	64
344316	20233								Adiponectin	201291.0						5	ng/mL	0	TNF-a	18	71
344317	20233								Leptin	201292.0						1	ng/mL	0	TNF-a	16	54
344318	20233								Visfatin	201293.0						1	ng/mL	0	TNF-a	13	65
344319	20233															2	ug/mL	0	TNF-a	14	75
344320	20233								TNF-a	201285.0						100	ng/mL	0	TNF-a	22536	71
344321	20233								IL-1 alpha	201286.0						100	ng/mL	0	TNF-a	15	53
344322	20233								IL-6	201287.0						100	ug/mL	0	TNF-a	30	55
344323	20233								IL-17A	201288.0						100	ng/mL	0	TNF-a	19.5	58
344324	20233								EGF	201289.0						100	ng/mL	0	TNF-a	15	68
344325	20233								IGF-I	201290.0						100	ug/mL	0	TNF-a	14.5	58
344326	20233								Adiponectin	201291.0						5	ng/mL	0	TNF-a	22.5	70
344327	20233								Leptin	201292.0						1	ng/mL	0	TNF-a	15	51
344328	20233								Visfatin	201293.0						1	ng/mL	0	TNF-a	13	41
344329	20233															2	ug/mL	0	TNF-a	15	61
344330	20233																	0	RANTES	37.5	48
344331	20233						RA2159	51112.0										1	RANTES	207.5	74
344332	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	RANTES	216	57
344333	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	RANTES	125.5	76
344334	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	RANTES	73	65
344335	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	RANTES	66.5	80
344336	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	RANTES	80	61
344337	20233						RA2159	51112.0										1	RANTES	61	51
344338	20233						N2586	51107.0										1	RANTES	49	56
344339	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	RANTES	88	71
344340	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	RANTES	88	51
344341	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	RANTES	56	50
344342	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	RANTES	183	67
344343	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	RANTES	45	47
344344	20233						N2586	51107.0										1	RANTES	79	37
344345	20233																	0	RANTES	35.5	68
344346	20233																	0	RANTES	26	38
344347	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	RANTES	19872	56
344348	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	RANTES	12210	63
344349	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	RANTES	17358	59
344350	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	RANTES	9153	71
344351	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	RANTES	12290	51
344352	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	RANTES	1142.5	66
344353	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	RANTES	86	71
344354	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	RANTES	20850.5	60
344355	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	RANTES	21067	51
344356	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	RANTES	20509.5	66
344357	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	RANTES	18018	71
344358	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	RANTES	18428	63
344359	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	RANTES	10786	65
344360	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	RANTES	153.5	38
344361	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	RANTES	7177	76
344362	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	RANTES	6752.5	80
344363	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	RANTES	3077	51
344364	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	RANTES	8935.5	54
344365	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	RANTES	6895	54
344366	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	RANTES	158	68
344367	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	RANTES	81	63
344368	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	RANTES	11037	47
344369	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	RANTES	12141.5	70
344370	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	RANTES	8186.5	42
344371	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	RANTES	14344	53
344372	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	RANTES	13673.5	58
344373	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	RANTES	1967.5	42
344374	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	RANTES	93	82
344375	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	RANTES	178	66
344376	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	RANTES	110	69
344377	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	RANTES	69	63
344378	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	RANTES	78	81
344379	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	RANTES	83.5	60
344380	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	RANTES	78	55
344381	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	RANTES	64	53
344382	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	RANTES	60	71
344383	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	RANTES	56.5	62
344384	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	RANTES	49	42
344385	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	RANTES	99	48
344386	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	RANTES	61.5	62
344387	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	RANTES	120	67
344388	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	RANTES	74	40
344389	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	RANTES	100	76
344390	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	RANTES	107	56
344391	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	RANTES	109	67
344392	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	RANTES	71	55
344393	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	RANTES	166	50
344394	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	RANTES	136	71
344395	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	RANTES	138	57
344396	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	RANTES	117	49
344397	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	RANTES	70	69
344398	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	RANTES	149.5	84
344399	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	RANTES	150	58
344400	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	RANTES	92.5	60
344401	20233						RA2159	51112.0										1	RANTES	247	55
344402	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	RANTES	106	74
344403	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	RANTES	77	61
344404	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	RANTES	215	60
344405	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	RANTES	74	57
344406	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	RANTES	83	63
344407	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	RANTES	110	61
344408	20233						N2586	51107.0										1	RANTES	72	54
344409	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	RANTES	112.5	44
344410	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	RANTES	81	49
344411	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	RANTES	69.5	66
344412	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	RANTES	131	53
344413	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	RANTES	88.5	50
344414	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	RANTES	72	64
344415	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	RANTES	257	63
344416	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	RANTES	141	51
344417	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	RANTES	109	53
344418	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	RANTES	92	67
344419	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	RANTES	175	70
344420	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	RANTES	92	55
344421	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	RANTES	155	62
344422	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	RANTES	78	68
344423	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	RANTES	115	64
344424	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	RANTES	50	55
344425	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	RANTES	104	35
344426	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	RANTES	97.5	74
344427	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	RANTES	259	46
344428	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	RANTES	206	52
344429	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	RANTES	145.5	54
344430	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	RANTES	98	54
344431	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	RANTES	101.5	62
344432	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	RANTES	96	50
344433	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	RANTES	127.5	88
344434	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	RANTES	151.5	74
344435	20233						RA2159	51112.0										1	RANTES	97	73
344436	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	RANTES	113	60
344437	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	RANTES	80	53
344438	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	RANTES	59	66
344439	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	RANTES	95	46
344440	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	RANTES	77.5	44
344441	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	RANTES	129	51
344442	20233						N2586	51107.0										1	RANTES	115	68
344443	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	RANTES	114.5	66
344444	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	RANTES	67.5	66
344445	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	RANTES	74	60
344446	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	RANTES	158	60
344447	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	RANTES	123.5	54
344448	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	RANTES	60	75
344449	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	RANTES	92.5	64
344450	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	RANTES	92	49
344451	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	RANTES	65	65
344452	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	RANTES	74.5	48
344453	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	RANTES	87	51
344454	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	RANTES	93.5	46
344455	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	RANTES	73	50
344456	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	RANTES	135	53
344457	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	RANTES	67.5	60
344458	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	RANTES	106.5	56
344459	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	RANTES	147	68
344460	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	RANTES	70	57
344461	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	RANTES	74	55
344462	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	RANTES	99.5	42
344463	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	RANTES	51	70
344464	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	RANTES	94	48
344465	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	RANTES	74	49
344466	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	RANTES	64.5	20
344467	20233						RA2159	51112.0										1	RANTES	235	61
344468	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	RANTES	285.5	70
344469	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	RANTES	106	53
344470	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	RANTES	72	54
344471	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	RANTES	70	81
344472	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	RANTES	65	78
344473	20233						RA2159	51112.0										1	RANTES	46.5	72
344474	20233						N2586	51107.0										1	RANTES	45	51
344475	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	RANTES	76.5	72
344476	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	RANTES	102	51
344477	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	RANTES	45	64
344478	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	RANTES	215	58
344479	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	RANTES	42	62
344480	20233						N2586	51107.0										1	RANTES	79.5	56
344481	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	RANTES	101	52
344482	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	RANTES	67.5	80
344483	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	RANTES	85	49
344484	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	RANTES	121	74
344485	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	RANTES	81.5	42
344486	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	RANTES	87	61
344487	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	RANTES	89.5	66
344488	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	RANTES	116	61
344489	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	RANTES	53.5	62
344490	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	RANTES	149	52
344491	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	RANTES	60	48
344492	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	RANTES	98	33
344493	20233																	0	RANTES	27	61
344494	20233						RA2159	51112.0								2	ug/mL	1	RANTES	15867	77
344495	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	RANTES	15070	45
344496	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	RANTES	450	48
344497	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	RANTES	10041.5	38
344498	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	RANTES	12680.5	48
344499	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	RANTES	1696	60
344500	20233						N2586	51107.0								2	ug/mL	1	RANTES	14076	36
344501	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	RANTES	15352	62
344502	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	RANTES	149.5	50
344503	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	RANTES	9469	42
344504	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	RANTES	13212	57
344505	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	RANTES	4471	47
344506	20233																	0	RANTES	29	56
344507	20233						RA2159	51112.0										2	RANTES	48.5	62
344508	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	RANTES	67	54
344509	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	RANTES	70.5	62
344510	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	RANTES	49	57
344511	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	RANTES	57	58
344512	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	RANTES	77	75
344513	20233						RA2159	51112.0										2	RANTES	117	38
344514	20233						N2586	51107.0										2	RANTES	49	48
344515	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	RANTES	102	52
344516	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	RANTES	50	57
344517	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	RANTES	38	39
344518	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	RANTES	50.5	52
344519	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	RANTES	68	49
344520	20233						N2586	51107.0										2	RANTES	145	21
344521	20233																	0	RANTES	36.5	48
344522	20233																	0	RANTES	32	43
344523	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	RANTES	19224	61
344524	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	RANTES	22056	68
344525	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	RANTES	18587	55
344526	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	RANTES	12287	59
344527	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	RANTES	8299	52
344528	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	RANTES	12843	55
344529	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	RANTES	61	51
344530	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	RANTES	16721.5	50
344531	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	RANTES	23182	73
344532	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	RANTES	21317	59
344533	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	RANTES	19451	71
344534	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	RANTES	15625.5	34
344535	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	RANTES	19929	55
344536	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	RANTES	68	40
344537	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	RANTES	7679	52
344538	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	RANTES	10820	49
344539	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	RANTES	2808.5	70
344540	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	RANTES	9930.5	64
344541	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	RANTES	6099	64
344542	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	RANTES	8601	69
344543	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	RANTES	76	32
344544	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	RANTES	9140	37
344545	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	RANTES	11695	53
344546	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	RANTES	13296.5	50
344547	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	RANTES	18359	53
344548	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	RANTES	12480	55
344549	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	RANTES	15374	49
344550	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	RANTES	47	36
344551	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	RANTES	122	67
344552	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	RANTES	177	51
344553	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	RANTES	73	69
344554	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	RANTES	107	52
344555	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	RANTES	59	59
344556	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	RANTES	72	69
344557	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	RANTES	72.5	36
344558	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	RANTES	70	58
344559	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	RANTES	66	59
344560	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	RANTES	61	51
344561	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	RANTES	48	51
344562	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	RANTES	40	46
344563	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	RANTES	56	57
344564	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	RANTES	77	40
344565	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	RANTES	148.5	58
344566	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	RANTES	199	57
344567	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	RANTES	73	65
344568	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	RANTES	121	64
344569	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	RANTES	102	61
344570	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	RANTES	131.5	36
344571	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	RANTES	90.5	58
344572	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	RANTES	84	45
344573	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	RANTES	266	66
344574	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	RANTES	66.5	68
344575	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	RANTES	116	64
344576	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	RANTES	59.5	60
344577	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	RANTES	134	59
344578	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	RANTES	182.5	40
344579	20233						RA2159	51112.0										2	RANTES	79	70
344580	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	RANTES	191.5	52
344581	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	RANTES	75	59
344582	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	RANTES	59	43
344583	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	RANTES	89	50
344584	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	RANTES	73	69
344585	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	RANTES	86	37
344586	20233						N2586	51107.0										2	RANTES	60	60
344587	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	RANTES	142	73
344588	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	RANTES	130	53
344589	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	RANTES	81	65
344590	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	RANTES	92	71
344591	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	RANTES	72	36
344592	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	RANTES	117	46
344593	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	RANTES	83	61
344594	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	RANTES	124	63
344595	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	RANTES	55.5	86
344596	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	RANTES	60.5	54
344597	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	RANTES	83	56
344598	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	RANTES	64	49
344599	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	RANTES	69.5	72
344600	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	RANTES	233	69
344601	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	RANTES	74.5	52
344602	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	RANTES	207.5	66
344603	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	RANTES	55	50
344604	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	RANTES	11.5	44
344605	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	RANTES	96	69
344606	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	RANTES	109	45
344607	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	RANTES	47	65
344608	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	RANTES	122	55
344609	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	RANTES	59.5	50
344610	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	RANTES	97	50
344611	20233						RA2159	51112.0										2	RANTES	78	61
344612	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	RANTES	111.5	72
344613	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	RANTES	119	68
344614	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	RANTES	74	55
344615	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	RANTES	62.5	70
344616	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	RANTES	82	45
344617	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	RANTES	103	43
344618	20233						N2586	51107.0										2	RANTES	10	43
344619	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	RANTES	217	63
344620	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	RANTES	163	57
344621	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	RANTES	52.5	64
344622	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	RANTES	55	69
344623	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	RANTES	76.5	64
344624	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	RANTES	81.5	50
344625	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	RANTES	93	51
344626	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	RANTES	74	53
344627	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	RANTES	46	64
344628	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	RANTES	65.5	58
344629	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	RANTES	30.5	44
344630	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	RANTES	61	60
344631	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	RANTES	205	61
344632	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	RANTES	135	56
344633	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	RANTES	142	68
344634	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	RANTES	70.5	58
344635	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	RANTES	64	59
344636	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	RANTES	144	62
344637	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	RANTES	73	59
344638	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	RANTES	240	45
344639	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	RANTES	65.5	48
344640	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	RANTES	52.5	48
344641	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	RANTES	163	41
344642	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	RANTES	67.5	56
344643	20233						RA2159	51112.0										2	RANTES	69	59
344644	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	RANTES	93	50
344645	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	RANTES	41	61
344646	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	RANTES	50	82
344647	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	RANTES	51	65
344648	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	RANTES	68	55
344649	20233						RA2159	51112.0										2	RANTES	80	47
344650	20233						N2586	51107.0										2	RANTES	37.5	44
344651	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	RANTES	99	43
344652	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	RANTES	54	50
344653	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	RANTES	48	45
344654	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	RANTES	38	57
344655	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	RANTES	53	47
344656	20233						N2586	51107.0										2	RANTES	130	41
344657	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	RANTES	161	58
344658	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	RANTES	215.5	48
344659	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	RANTES	57	57
344660	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	RANTES	118.5	42
344661	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	RANTES	79	43
344662	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	RANTES	88	43
344663	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	RANTES	86.5	44
344664	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	RANTES	95.5	52
344665	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	RANTES	64	28
344666	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	RANTES	70.5	42
344667	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	RANTES	39	45
344668	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	RANTES	133	35
344669	20233																	0	RANTES	21	52
344670	20233						RA2159	51112.0								2	ug/mL	2	RANTES	18029.5	58
344671	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	RANTES	12355	51
344672	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	RANTES	8001	77
344673	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	RANTES	9644	55
344674	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	RANTES	8234	35
344675	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	RANTES	13077	51
344676	20233						N2586	51107.0								2	ug/mL	2	RANTES	9133.5	40
344677	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	RANTES	16356	43
344678	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	RANTES	13790	36
344679	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	RANTES	10677	27
344680	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	RANTES	3849	39
344681	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	RANTES	7361.5	40
344682	20233																	0	RANTES	31.5	58
344683	20233						RA2159	51112.0								2	ug/mL	3	RANTES	13150	59
344684	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	RANTES	16102	69
344685	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	RANTES	160	81
344686	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	RANTES	10454	65
344687	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	RANTES	9138	63
344688	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	RANTES	1165	69
344689	20233						N2586	51107.0								2	ug/mL	3	RANTES	12531	63
344690	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	RANTES	14007	59
344691	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	RANTES	13851.5	64
344692	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	RANTES	15680	55
344693	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	RANTES	297.5	50
344694	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	RANTES	10412	63
344695	20233						RA2159	51112.0										3	RANTES	96	73
344696	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	RANTES	69.5	38
344697	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	RANTES	69	53
344698	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	RANTES	68	53
344699	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	RANTES	82.5	58
344700	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	RANTES	49.5	62
344701	20233						RA2159	51112.0										3	RANTES	71	79
344702	20233						N2586	51107.0										3	RANTES	143	50
344703	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	RANTES	75.5	56
344704	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	RANTES	55.5	58
344705	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	RANTES	63	62
344706	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	RANTES	55	67
344707	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	RANTES	100	55
344708	20233						N2586	51107.0										3	RANTES	112	43
344709	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	RANTES	127	55
344710	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	RANTES	76	56
344711	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	RANTES	111.5	58
344712	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	RANTES	107	63
344713	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	RANTES	217.5	66
344714	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	RANTES	115	58
344715	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	RANTES	110	60
344716	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	RANTES	332.5	70
344717	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	RANTES	80	55
344718	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	RANTES	117	49
344719	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	RANTES	198	68
344720	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	RANTES	202.5	68
344721	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	RANTES	170	61
344722	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	RANTES	126	72
344723	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	RANTES	45.5	70
344724	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	RANTES	119	57
344725	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	RANTES	70.5	68
344726	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	RANTES	128	65
344727	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	RANTES	109	85
344728	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	RANTES	148	65
344729	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	RANTES	182	63
344730	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	RANTES	66.5	72
344731	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	RANTES	84	65
344732	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	RANTES	96.5	64
344733	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	RANTES	91	65
344734	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	RANTES	80	87
344735	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	RANTES	150	81
344736	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	RANTES	63	61
344737	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	RANTES	148	73
344738	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	RANTES	121	74
344739	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	RANTES	156	63
344740	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	RANTES	133	76
344741	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	RANTES	99.5	52
344742	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	RANTES	136.5	50
344743	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	RANTES	199	71
344744	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	RANTES	211	57
344745	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	RANTES	126	53
344746	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	RANTES	65	61
344747	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	RANTES	69	69
344748	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	RANTES	84	55
344749	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	RANTES	126	64
344750	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	RANTES	89.5	50
344751	20233						RA2159	51112.0										3	RANTES	76	69
344752	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	RANTES	254	49
344753	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	RANTES	294	67
344754	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	RANTES	106	63
344755	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	RANTES	135.5	58
344756	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	RANTES	70.5	84
344757	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	RANTES	95	53
344758	20233						N2586	51107.0										3	RANTES	328	71
344759	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	RANTES	118	67
344760	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	RANTES	75.5	52
344761	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	RANTES	64	60
344762	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	RANTES	78	48
344763	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	RANTES	101.5	68
344764	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	RANTES	52	54
344765	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	RANTES	102.5	66
344766	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	RANTES	103	52
344767	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	RANTES	166	63
344768	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	RANTES	167	43
344769	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	RANTES	177.5	32
344770	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	RANTES	75	50
344771	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	RANTES	136	55
344772	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	RANTES	171	45
344773	20233						RA2159	51112.0										3	RANTES	152	68
344774	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	RANTES	215	55
344775	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	RANTES	119	49
344776	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	RANTES	111.5	58
344777	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	RANTES	105.5	68
344778	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	RANTES	69	68
344779	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	RANTES	90	59
344780	20233						N2586	51107.0										3	RANTES	97.5	62
344781	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	RANTES	183	71
344782	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	RANTES	90	66
344783	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	RANTES	84	63
344784	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	RANTES	86.5	52
344785	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	RANTES	162	55
344786	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	RANTES	187.5	56
344787	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	RANTES	150.5	60
344788	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	RANTES	97	53
344789	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	RANTES	82	63
344790	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	RANTES	133	48
344791	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	RANTES	85	56
344792	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	RANTES	72	65
344793	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	RANTES	103	70
344794	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	RANTES	226.5	80
344795	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	RANTES	81.5	50
344796	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	RANTES	759	69
344797	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	RANTES	52.5	72
344798	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	RANTES	83	55
344799	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	RANTES	102	64
344800	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	RANTES	60	56
344801	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	RANTES	63	45
344802	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	RANTES	80	74
344803	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	RANTES	89	67
344804	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	RANTES	74	68
344805	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	RANTES	74	71
344806	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	RANTES	76.5	70
344807	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	RANTES	216.5	62
344808	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	RANTES	49	75
344809	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	RANTES	88	57
344810	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	RANTES	50	68
344811	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	RANTES	123	56
344812	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	RANTES	77	69
344813	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	RANTES	11575	64
344814	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	RANTES	8423.5	64
344815	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	RANTES	4412.5	60
344816	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	RANTES	10696	68
344817	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	RANTES	8313	60
344818	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	RANTES	77	56
344819	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	RANTES	113	59
344820	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	RANTES	16383	50
344821	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	RANTES	18088	70
344822	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	RANTES	19286	60
344823	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	RANTES	20267	70
344824	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	RANTES	387.5	54
344825	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	RANTES	9808.5	78
344826	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	RANTES	55.5	78
344827	20233																	0	RANTES	38.5	48
344828	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	RANTES	20768.5	54
344829	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	RANTES	17815	41
344830	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	RANTES	17450	68
344831	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	RANTES	18658.5	70
344832	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	RANTES	17837	59
344833	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	RANTES	1793	68
344834	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	RANTES	140.5	70
344835	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	RANTES	21898	68
344836	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	RANTES	24304	48
344837	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	RANTES	23220.5	50
344838	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	RANTES	2905.5	44
344839	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	RANTES	899	45
344840	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	RANTES	19217.5	58
344841	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	RANTES	164	59
344842	20233																	0	RANTES	26.5	54
344843	20233						RA2159	51112.0										3	RANTES	79	53
344844	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	RANTES	79.5	60
344845	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	RANTES	65	66
344846	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	RANTES	59	63
344847	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	RANTES	75	35
344848	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	RANTES	48	69
344849	20233						RA2159	51112.0										3	RANTES	59	70
344850	20233						N2586	51107.0										3	RANTES	117.5	54
344851	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	RANTES	78	66
344852	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	RANTES	45.5	58
344853	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	RANTES	57.5	42
344854	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	RANTES	47.5	48
344855	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	RANTES	96	68
344856	20233						N2586	51107.0										3	RANTES	92	40
344857	20233																	0	RANTES	33	57
344858	20233						RA2159	51112.0								2	ug/mL	4	RANTES	19913	36
344859	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	RANTES	16857	33
344860	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	RANTES	13486	57
344861	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	RANTES	15362.5	50
344862	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	RANTES	10315	65
344863	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	RANTES	13593.5	78
344864	20233						N2586	51107.0								2	ug/mL	4	RANTES	16127	61
344865	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	RANTES	14223.5	50
344866	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	RANTES	124	50
344867	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	RANTES	9831	53
344868	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	RANTES	1624	57
344869	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	RANTES	105	55
344870	20233						RA2159	51112.0										4	RANTES	80	58
344871	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	RANTES	181	69
344872	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	RANTES	51.5	58
344873	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	RANTES	386	79
344874	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	RANTES	340	65
344875	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	RANTES	88	61
344876	20233						RA2159	51112.0										4	RANTES	234.5	66
344877	20233						N2586	51107.0										4	RANTES	101	60
344878	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	RANTES	67	61
344879	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	RANTES	46.5	54
344880	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	RANTES	59	57
344881	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	RANTES	67	53
344882	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	RANTES	79.5	68
344883	20233						N2586	51107.0										4	RANTES	113	66
344884	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	RANTES	300.5	54
344885	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	RANTES	346	47
344886	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	RANTES	198	79
344887	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	RANTES	318	69
344888	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	RANTES	395	63
344889	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	RANTES	240.5	62
344890	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	RANTES	109	68
344891	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	RANTES	62	49
344892	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	RANTES	52.5	52
344893	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	RANTES	122	63
344894	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	RANTES	161	60
344895	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	RANTES	37	59
344896	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	RANTES	315	63
344897	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	RANTES	246	57
344898	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	RANTES	111	62
344899	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	RANTES	173.5	58
344900	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	RANTES	150	61
344901	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	RANTES	333	63
344902	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	RANTES	76	57
344903	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	RANTES	74	48
344904	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	RANTES	37	67
344905	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	RANTES	122	63
344906	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	RANTES	99	49
344907	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	RANTES	59	50
344908	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	RANTES	407	62
344909	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	RANTES	346.5	54
344910	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	RANTES	417	55
344911	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	RANTES	260	60
344912	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	RANTES	211.5	54
344913	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	RANTES	296	43
344914	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	RANTES	74.5	70
344915	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	RANTES	166	51
344916	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	RANTES	106	55
344917	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	RANTES	110	59
344918	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	RANTES	99	56
344919	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	RANTES	52.5	58
344920	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	RANTES	413	71
344921	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	RANTES	419.5	36
344922	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	RANTES	185	68
344923	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	RANTES	227	63
344924	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	RANTES	359	55
344925	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	RANTES	293.5	52
344926	20233						RA2159	51112.0										4	RANTES	251	83
344927	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	RANTES	93.5	56
344928	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	RANTES	81	59
344929	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	RANTES	87.5	56
344930	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	RANTES	178.5	50
344931	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	RANTES	109	51
344932	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	RANTES	54.5	50
344933	20233						N2586	51107.0										4	RANTES	230	65
344934	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	RANTES	218.5	58
344935	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	RANTES	315	55
344936	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	RANTES	138	61
344937	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	RANTES	302	47
344938	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	RANTES	205	32
344939	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	RANTES	196	34
344940	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	RANTES	127	57
344941	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	RANTES	169	51
344942	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	RANTES	64	53
344943	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	RANTES	67.5	62
344944	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	RANTES	160	45
344945	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	RANTES	60	75
344946	20233						RA2159	51112.0										4	RANTES	264	66
344947	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	RANTES	407	63
344948	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	RANTES	75	52
344949	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	RANTES	279	72
344950	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	RANTES	206.5	48
344951	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	RANTES	190	38
344952	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	RANTES	210	66
344953	20233						N2586	51107.0										4	RANTES	106	63
344954	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	RANTES	107	55
344955	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	RANTES	66	70
344956	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	RANTES	309	67
344957	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	RANTES	94	63
344958	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	RANTES	183	58
344959	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	RANTES	57	61
344960	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	RANTES	83	58
344961	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	RANTES	541	52
344962	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	RANTES	93	69
344963	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	RANTES	389	54
344964	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	RANTES	248	59
344965	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	RANTES	208	62
344966	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	RANTES	261	57
344967	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	RANTES	117.5	58
344968	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	RANTES	98	59
344969	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	RANTES	112.5	60
344970	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	RANTES	96.5	54
344971	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	RANTES	62	45
344972	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	RANTES	95.5	66
344973	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	RANTES	115	83
344974	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	RANTES	84.5	48
344975	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	RANTES	220.5	60
344976	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	RANTES	67	51
344977	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	RANTES	183.5	48
344978	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	RANTES	248	63
344979	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	RANTES	71	60
344980	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	RANTES	211.5	40
344981	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	RANTES	49.5	40
344982	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	RANTES	110	43
344983	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	RANTES	45	53
344984	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	RANTES	98	50
344985	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	RANTES	57	58
344986	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	RANTES	65	55
344987	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	RANTES	96.5	52
344988	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	RANTES	11078	33
344989	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	RANTES	14782	66
344990	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	RANTES	11902.5	50
344991	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	RANTES	11573	67
344992	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	RANTES	6405	49
344993	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	RANTES	12335	53
344994	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	RANTES	145	53
344995	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	RANTES	15798	53
344996	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	RANTES	16021	51
344997	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	RANTES	8624	45
344998	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	RANTES	16352.5	46
344999	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	RANTES	2086	53
345000	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	RANTES	44.5	48
345001	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	RANTES	88.5	56
345002	20233																	0	RANTES	31	36
345003	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	RANTES	21362	56
345004	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	RANTES	22867	50
345005	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	RANTES	21350	54
345006	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	RANTES	17438	54
345007	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	RANTES	12568	44
345008	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	RANTES	18179.5	48
345009	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	RANTES	173	59
345010	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	RANTES	21874.5	46
345011	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	RANTES	23791	57
345012	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	RANTES	21670	47
345013	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	RANTES	23380	41
345014	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	RANTES	9452	49
345015	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	RANTES	45.5	50
345016	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	RANTES	132	48
345017	20233																	0	RANTES	29	69
345018	20233						RA2159	51112.0										4	RANTES	61	70
345019	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	RANTES	180	41
345020	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	RANTES	56	65
345021	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	RANTES	406.5	50
345022	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	RANTES	304	53
345023	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	RANTES	79.5	38
345024	20233						RA2159	51112.0										4	RANTES	222.5	64
345025	20233						N2586	51107.0										4	RANTES	103.5	38
345026	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	RANTES	74	43
345027	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	RANTES	41	52
345028	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	RANTES	53	46
345029	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	RANTES	49	52
345030	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	RANTES	75.5	66
345031	20233						N2586	51107.0										4	RANTES	92.5	52
345032	20233								TNF-a	201285.0						100	ng/mL	0	RANTES	64	50
345033	20233								IL-1 alpha	201286.0						100	ng/mL	0	RANTES	33.5	58
345034	20233								IL-6	201287.0						100	ug/mL	0	RANTES	53	65
345035	20233								IL-17A	201288.0						100	ng/mL	0	RANTES	45	75
345036	20233								EGF	201289.0						100	ng/mL	0	RANTES	31	52
345037	20233								IGF-I	201290.0						100	ug/mL	0	RANTES	31	81
345038	20233								Adiponectin	201291.0						5	ng/mL	0	RANTES	37	68
345039	20233								Leptin	201292.0						1	ng/mL	0	RANTES	34	57
345040	20233								Visfatin	201293.0						1	ng/mL	0	RANTES	40	47
345041	20233															2	ug/mL	0	RANTES	39	58
345042	20233								TNF-a	201285.0						100	ng/mL	0	RANTES	63	51
345043	20233								IL-1 alpha	201286.0						100	ng/mL	0	RANTES	38	45
345044	20233								IL-6	201287.0						100	ug/mL	0	RANTES	45	41
345045	20233								IL-17A	201288.0						100	ng/mL	0	RANTES	41	55
345046	20233								EGF	201289.0						100	ng/mL	0	RANTES	31	41
345047	20233								IGF-I	201290.0						100	ug/mL	0	RANTES	35.5	54
345048	20233								Adiponectin	201291.0						5	ng/mL	0	RANTES	40	33
345049	20233								Leptin	201292.0						1	ng/mL	0	RANTES	32	54
345050	20233								Visfatin	201293.0						1	ng/mL	0	RANTES	31	59
345051	20233															2	ug/mL	0	RANTES	34	35
345052	20233								TNF-a	201285.0						100	ng/mL	0	RANTES	65	65
345053	20233								IL-1 alpha	201286.0						100	ng/mL	0	RANTES	31	82
345054	20233								IL-6	201287.0						100	ug/mL	0	RANTES	47	53
345055	20233								IL-17A	201288.0						100	ng/mL	0	RANTES	44	75
345056	20233								EGF	201289.0						100	ng/mL	0	RANTES	35	59
345057	20233								IGF-I	201290.0						100	ug/mL	0	RANTES	33	55
345058	20233								Adiponectin	201291.0						5	ng/mL	0	RANTES	27	55
345059	20233								Leptin	201292.0						1	ng/mL	0	RANTES	33	49
345060	20233								Visfatin	201293.0						1	ng/mL	0	RANTES	32.5	64
345061	20233															2	ug/mL	0	RANTES	33.5	48
345062	20233								TNF-a	201285.0						100	ng/mL	0	RANTES	68	39
345063	20233								IL-1 alpha	201286.0						100	ng/mL	0	RANTES	33	45
345064	20233								IL-6	201287.0						100	ug/mL	0	RANTES	48.5	40
345065	20233								IL-17A	201288.0						100	ng/mL	0	RANTES	37	49
345066	20233								EGF	201289.0						100	ng/mL	0	RANTES	32.5	56
345067	20233								IGF-I	201290.0						100	ug/mL	0	RANTES	33	65
345068	20233								Adiponectin	201291.0						5	ng/mL	0	RANTES	29	51
345069	20233								Leptin	201292.0						1	ng/mL	0	RANTES	28.5	50
345070	20233								Visfatin	201293.0						1	ng/mL	0	RANTES	31	42
345071	20233															2	ug/mL	0	RANTES	27	57
345072	20233																	0	IL-2	44	63
345073	20233						RA2159	51112.0										1	IL-2	48.5	82
345074	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-2	49	66
345075	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-2	47.5	72
345076	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-2	49	84
345077	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-2	43.5	86
345078	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-2	50	78
345079	20233						RA2159	51112.0										1	IL-2	50.5	66
345080	20233						N2586	51107.0										1	IL-2	49	77
345081	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-2	52.5	60
345082	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-2	48	74
345083	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-2	46	74
345084	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-2	41	67
345085	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-2	44	55
345086	20233						N2586	51107.0										1	IL-2	49	33
345087	20233																	0	IL-2	42.5	80
345088	20233																	0	IL-2	44	43
345089	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-2	73	57
345090	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-2	65	72
345091	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-2	61	75
345092	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-2	59	83
345093	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-2	69.5	74
345094	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-2	54	76
345095	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-2	38.5	78
345096	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-2	71	75
345097	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-2	85.5	80
345098	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-2	74	79
345099	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-2	78	58
345100	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-2	70.5	74
345101	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-2	66	71
345102	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-2	47	46
345103	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-2	70	83
345104	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-2	68	82
345105	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-2	46	79
345106	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-2	68	75
345107	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-2	73	69
345108	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-2	41	68
345109	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-2	39	68
345110	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-2	82	60
345111	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-2	76	91
345112	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-2	62	90
345113	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-2	81	66
345114	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-2	80	75
345115	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-2	55	55
345116	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-2	45	78
345117	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-2	55	77
345118	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-2	46	67
345119	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-2	51	103
345120	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-2	59.5	78
345121	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-2	53	70
345122	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-2	56	77
345123	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-2	45	87
345124	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-2	58	85
345125	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-2	40	58
345126	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-2	48.5	68
345127	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-2	58	84
345128	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-2	41	95
345129	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-2	53.5	80
345130	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-2	42	53
345131	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-2	42	56
345132	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-2	43.5	72
345133	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-2	47	79
345134	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-2	41	83
345135	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-2	46.5	74
345136	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-2	42.5	72
345137	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-2	49	76
345138	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-2	50.5	72
345139	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-2	45	75
345140	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-2	39	99
345141	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-2	44.5	56
345142	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-2	42	70
345143	20233						RA2159	51112.0										1	IL-2	45	78
345144	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-2	44	83
345145	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-2	41	88
345146	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-2	44	69
345147	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-2	51.5	56
345148	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-2	40	85
345149	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-2	49.5	58
345150	20233						N2586	51107.0										1	IL-2	46	68
345151	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-2	38	66
345152	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-2	42	40
345153	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-2	42	67
345154	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-2	47	57
345155	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-2	40	78
345156	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-2	39.5	68
345157	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-2	43	80
345158	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-2	35	66
345159	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-2	40	53
345160	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-2	39.5	84
345161	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-2	44	58
345162	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-2	40	50
345163	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-2	45	75
345164	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-2	40	70
345165	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-2	43	105
345166	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-2	43	63
345167	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-2	36	49
345168	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-2	42	70
345169	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-2	41	51
345170	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-2	39	88
345171	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-2	39	61
345172	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-2	35	62
345173	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-2	39	77
345174	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-2	40	70
345175	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-2	41	97
345176	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-2	39	70
345177	20233						RA2159	51112.0										1	IL-2	45	71
345178	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-2	39	77
345179	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-2	41	55
345180	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-2	36	79
345181	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-2	39	55
345182	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-2	39	60
345183	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-2	36	75
345184	20233						N2586	51107.0										1	IL-2	37	89
345185	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-2	38	75
345186	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-2	32	79
345187	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-2	39	94
345188	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-2	34	50
345189	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-2	38	92
345190	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-2	34	90
345191	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-2	36.5	78
345192	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-2	38	63
345193	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-2	34	56
345194	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-2	35	54
345195	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-2	40	73
345196	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-2	38	67
345197	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-2	37.5	78
345198	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-2	37	56
345199	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-2	36	72
345200	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-2	43	52
345201	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-2	36	67
345202	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-2	35	65
345203	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-2	38	56
345204	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-2	36	56
345205	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-2	35	70
345206	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-2	34	65
345207	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-2	31.5	60
345208	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-2	36	44
345209	20233						RA2159	51112.0										1	IL-2	38	67
345210	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-2	41	88
345211	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-2	39	71
345212	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-2	38	70
345213	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-2	39	84
345214	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-2	39	69
345215	20233						RA2159	51112.0										1	IL-2	38	73
345216	20233						N2586	51107.0										1	IL-2	35	73
345217	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-2	33	77
345218	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-2	35	65
345219	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-2	30	75
345220	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-2	39	73
345221	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-2	36	89
345222	20233						N2586	51107.0										1	IL-2	37	73
345223	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-2	37	57
345224	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-2	36.5	76
345225	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-2	40	73
345226	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-2	39	81
345227	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-2	39	63
345228	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-2	31	68
345229	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-2	34.5	94
345230	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-2	39	80
345231	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-2	39	87
345232	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-2	30	79
345233	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-2	33	63
345234	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-2	38	33
345235	20233																	0	IL-2	35.5	74
345236	20233						RA2159	51112.0								2	ug/mL	1	IL-2	52	79
345237	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-2	46.5	62
345238	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-2	38	67
345239	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-2	43	50
345240	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-2	44	69
345241	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-2	39.5	62
345242	20233						N2586	51107.0								2	ug/mL	1	IL-2	51.5	54
345243	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-2	48	64
345244	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-2	33	74
345245	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-2	41.5	48
345246	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-2	44	60
345247	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-2	42.5	48
345248	20233																	0	IL-2	43	58
345249	20233						RA2159	51112.0										2	IL-2	48	90
345250	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-2	39	83
345251	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-2	49	80
345252	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-2	45	91
345253	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-2	41	64
345254	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-2	43	65
345255	20233						RA2159	51112.0										2	IL-2	47	57
345256	20233						N2586	51107.0										2	IL-2	41	54
345257	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-2	41	62
345258	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-2	38	73
345259	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-2	47	34
345260	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-2	47	58
345261	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-2	45	48
345262	20233						N2586	51107.0										2	IL-2	46	43
345263	20233																	0	IL-2	45	65
345264	20233																	0	IL-2	47	57
345265	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-2	71	76
345266	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-2	64	91
345267	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-2	71	84
345268	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-2	59.5	60
345269	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-2	54.5	72
345270	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-2	51.5	66
345271	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-2	40	95
345272	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-2	64	60
345273	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-2	62	69
345274	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-2	75	79
345275	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-2	64	69
345276	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-2	67.5	64
345277	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-2	68	47
345278	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-2	40	53
345279	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-2	70	71
345280	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-2	62.5	82
345281	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-2	57.5	88
345282	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-2	68	69
345283	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-2	72	64
345284	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-2	60	95
345285	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-2	41	50
345286	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-2	70	50
345287	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-2	53	89
345288	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-2	68	79
345289	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-2	69	84
345290	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-2	68	65
345291	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-2	67	69
345292	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-2	39	57
345293	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-2	49	84
345294	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-2	49	56
345295	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-2	43.5	72
345296	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-2	46.5	62
345297	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-2	46	84
345298	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-2	44.5	88
345299	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-2	40	54
345300	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-2	45.5	70
345301	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-2	45.5	80
345302	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-2	47	74
345303	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-2	40	65
345304	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-2	42.5	72
345305	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-2	41	68
345306	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-2	42.5	64
345307	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-2	45.5	78
345308	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-2	46	95
345309	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-2	40.5	90
345310	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-2	40	76
345311	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-2	39	67
345312	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-2	47	55
345313	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-2	41	92
345314	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-2	47	64
345315	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-2	44	79
345316	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-2	36	76
345317	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-2	46.5	86
345318	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-2	43	67
345319	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-2	38	78
345320	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-2	42	70
345321	20233						RA2159	51112.0										2	IL-2	42	85
345322	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-2	41	81
345323	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-2	39	71
345324	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-2	42	56
345325	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-2	39	86
345326	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-2	39	69
345327	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-2	39	42
345328	20233						N2586	51107.0										2	IL-2	43	75
345329	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-2	39	73
345330	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-2	35	83
345331	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-2	38	72
345332	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-2	41.5	68
345333	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-2	36	40
345334	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-2	41	71
345335	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-2	37	97
345336	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-2	39.5	76
345337	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-2	41	78
345338	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-2	40	61
345339	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-2	38.5	80
345340	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-2	36	87
345341	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-2	37	101
345342	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-2	35	79
345343	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-2	37	69
345344	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-2	35	81
345345	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-2	35	62
345346	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-2	8	75
345347	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-2	41.5	88
345348	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-2	36	56
345349	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-2	43	87
345350	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-2	41	88
345351	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-2	39	90
345352	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-2	38.5	94
345353	20233						RA2159	51112.0										2	IL-2	37	83
345354	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-2	33	111
345355	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-2	37	68
345356	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-2	37.5	70
345357	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-2	30.5	66
345358	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-2	43	51
345359	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-2	31	59
345360	20233						N2586	51107.0										2	IL-2	7	63
345361	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-2	28	74
345362	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-2	40	80
345363	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-2	34	77
345364	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-2	35	91
345365	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-2	32	67
345366	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-2	34	72
345367	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-2	36	83
345368	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-2	37.5	72
345369	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-2	32	62
345370	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-2	35	63
345371	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-2	31.5	60
345372	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-2	39	58
345373	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-2	38	73
345374	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-2	36	61
345375	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-2	38	92
345376	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-2	36.5	66
345377	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-2	36	97
345378	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-2	35	74
345379	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-2	34.5	78
345380	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-2	34	48
345381	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-2	36	69
345382	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-2	35	60
345383	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-2	35	42
345384	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-2	35	77
345385	20233						RA2159	51112.0										2	IL-2	35	71
345386	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-2	43	75
345387	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-2	34.5	66
345388	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-2	35.5	100
345389	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-2	32	82
345390	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-2	37	55
345391	20233						RA2159	51112.0										2	IL-2	36	54
345392	20233						N2586	51107.0										2	IL-2	36	61
345393	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-2	35	61
345394	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-2	38	70
345395	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-2	33	49
345396	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-2	31	69
345397	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-2	34	61
345398	20233						N2586	51107.0										2	IL-2	40	55
345399	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-2	33	73
345400	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-2	36.5	62
345401	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-2	35	81
345402	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-2	34	64
345403	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-2	35.5	48
345404	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-2	36	55
345405	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-2	28.5	48
345406	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-2	37	52
345407	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-2	33	38
345408	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-2	28	36
345409	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-2	30	45
345410	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-2	30	32
345411	20233																	0	IL-2	32	54
345412	20233						RA2159	51112.0								2	ug/mL	2	IL-2	50	71
345413	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-2	41	66
345414	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-2	39.5	74
345415	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-2	43	69
345416	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-2	37	35
345417	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-2	44	47
345418	20233						N2586	51107.0								2	ug/mL	2	IL-2	47	47
345419	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-2	43	57
345420	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-2	51	44
345421	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-2	49	41
345422	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-2	37	43
345423	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-2	40	55
345424	20233																	0	IL-2	60	83
345425	20233						RA2159	51112.0								2	ug/mL	3	IL-2	74	74
345426	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-2	74	86
345427	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-2	60.5	74
345428	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-2	70	77
345429	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-2	69	76
345430	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-2	61.5	74
345431	20233						N2586	51107.0								2	ug/mL	3	IL-2	85.5	92
345432	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-2	71.5	86
345433	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-2	79	88
345434	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-2	82.5	64
345435	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-2	50.5	76
345436	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-2	68	69
345437	20233						RA2159	51112.0										3	IL-2	51.5	56
345438	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-2	54.5	70
345439	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-2	56	67
345440	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-2	56	82
345441	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-2	55	87
345442	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-2	62	53
345443	20233						RA2159	51112.0										3	IL-2	54	106
345444	20233						N2586	51107.0										3	IL-2	57.5	82
345445	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-2	55	73
345446	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-2	55	75
345447	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-2	52	86
345448	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-2	60	84
345449	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-2	54	69
345450	20233						N2586	51107.0										3	IL-2	54	73
345451	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-2	48.5	62
345452	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-2	51	47
345453	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-2	61.5	76
345454	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-2	56	73
345455	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-2	50	75
345456	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-2	56	66
345457	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-2	51	84
345458	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-2	55.5	86
345459	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-2	50.5	66
345460	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-2	45	63
345461	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-2	41	90
345462	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-2	52.5	68
345463	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-2	53	74
345464	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-2	56	79
345465	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-2	49	79
345466	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-2	53.5	68
345467	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-2	53	106
345468	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-2	54	85
345469	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-2	54.5	86
345470	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-2	51	81
345471	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-2	51	71
345472	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-2	56	75
345473	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-2	54	85
345474	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-2	54.5	86
345475	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-2	49	93
345476	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-2	57	77
345477	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-2	53	75
345478	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-2	55	70
345479	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-2	47.5	94
345480	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-2	54	99
345481	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-2	58	87
345482	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-2	50.5	80
345483	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-2	49.5	76
345484	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-2	51	69
345485	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-2	54	87
345486	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-2	56.5	84
345487	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-2	53	77
345488	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-2	54	89
345489	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-2	54	76
345490	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-2	47	66
345491	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-2	50	74
345492	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-2	56	74
345493	20233						RA2159	51112.0										3	IL-2	50	87
345494	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-2	47	75
345495	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-2	47	75
345496	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-2	49	86
345497	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-2	56	80
345498	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-2	51.5	94
345499	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-2	53	71
345500	20233						N2586	51107.0										3	IL-2	51.5	84
345501	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-2	43	81
345502	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-2	51	83
345503	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-2	52.5	82
345504	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-2	51	57
345505	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-2	37	71
345506	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-2	47	69
345507	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-2	47	73
345508	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-2	47	68
345509	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-2	56	70
345510	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-2	47	73
345511	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-2	52	79
345512	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-2	41.5	66
345513	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-2	34.5	86
345514	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-2	46	61
345515	20233						RA2159	51112.0										3	IL-2	50	95
345516	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-2	48	53
345517	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-2	45	57
345518	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-2	51	72
345519	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-2	55	67
345520	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-2	48	76
345521	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-2	45	79
345522	20233						N2586	51107.0										3	IL-2	48.5	82
345523	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-2	44.5	90
345524	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-2	51.5	66
345525	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-2	49	74
345526	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-2	45	75
345527	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-2	48	51
345528	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-2	45	67
345529	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-2	53	89
345530	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-2	58.5	78
345531	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-2	55	86
345532	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-2	51	87
345533	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-2	48	75
345534	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-2	47	69
345535	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-2	55	70
345536	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-2	52	86
345537	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-2	36	95
345538	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-2	53	83
345539	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-2	47	81
345540	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-2	45.5	66
345541	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-2	64	75
345542	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-2	63	69
345543	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-2	59	60
345544	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-2	55	82
345545	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-2	59	107
345546	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-2	51	86
345547	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-2	47.5	86
345548	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-2	57	98
345549	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-2	53	85
345550	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-2	55	77
345551	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-2	55.5	90
345552	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-2	53.5	88
345553	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-2	53	72
345554	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-2	49	79
345555	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-2	86	79
345556	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-2	79	82
345557	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-2	64	76
345558	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-2	84	86
345559	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-2	83.5	80
345560	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-2	54	90
345561	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-2	50	58
345562	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-2	81	81
345563	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-2	72	93
345564	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-2	88	64
345565	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-2	90	71
345566	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-2	56	51
345567	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-2	70	67
345568	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-2	43.5	90
345569	20233																	0	IL-2	45.5	66
345570	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-2	73	69
345571	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-2	95	70
345572	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-2	82	91
345573	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-2	89	72
345574	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-2	73	70
345575	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-2	61.5	74
345576	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-2	54	65
345577	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-2	71	76
345578	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-2	76.5	62
345579	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-2	80	76
345580	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-2	52	61
345581	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-2	53	67
345582	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-2	66	102
345583	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-2	42.5	82
345584	20233																	0	IL-2	47	69
345585	20233						RA2159	51112.0										3	IL-2	37	77
345586	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-2	56	69
345587	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-2	47	74
345588	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-2	50	77
345589	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-2	40	42
345590	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-2	44	93
345591	20233						RA2159	51112.0										3	IL-2	42	73
345592	20233						N2586	51107.0										3	IL-2	49.5	76
345593	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-2	48	77
345594	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-2	38.5	64
345595	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-2	44	61
345596	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-2	43	62
345597	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-2	43.5	64
345598	20233						N2586	51107.0										3	IL-2	41	39
345599	20233																	0	IL-2	53	68
345600	20233						RA2159	51112.0								2	ug/mL	4	IL-2	93.5	66
345601	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-2	79	61
345602	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-2	77	87
345603	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-2	86	75
345604	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-2	70.5	58
345605	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-2	73	91
345606	20233						N2586	51107.0								2	ug/mL	4	IL-2	80.5	66
345607	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-2	77	91
345608	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-2	61.5	52
345609	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-2	70	63
345610	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-2	63.5	76
345611	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-2	52	75
345612	20233						RA2159	51112.0										4	IL-2	51.5	74
345613	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-2	56	76
345614	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-2	48	73
345615	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-2	57.5	90
345616	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-2	56	73
345617	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-2	49	73
345618	20233						RA2159	51112.0										4	IL-2	59.5	88
345619	20233						N2586	51107.0										4	IL-2	52	96
345620	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-2	42	75
345621	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-2	52	64
345622	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-2	53	64
345623	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-2	48	63
345624	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-2	56	83
345625	20233						N2586	51107.0										4	IL-2	50	84
345626	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-2	56	69
345627	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-2	55	71
345628	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-2	61	81
345629	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-2	56.5	94
345630	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-2	59	67
345631	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-2	59	69
345632	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-2	55.5	90
345633	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-2	54	71
345634	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-2	55	65
345635	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-2	46	67
345636	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-2	54	61
345637	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-2	49	85
345638	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-2	53.5	94
345639	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-2	53	81
345640	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-2	59	85
345641	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-2	56	82
345642	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-2	54	90
345643	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-2	53	81
345644	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-2	55	62
345645	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-2	50	59
345646	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-2	46	81
345647	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-2	55	69
345648	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-2	55	72
345649	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-2	54.5	76
345650	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-2	56	99
345651	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-2	56.5	62
345652	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-2	58	67
345653	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-2	56	70
345654	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-2	54	61
345655	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-2	58	52
345656	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-2	47	75
345657	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-2	47.5	64
345658	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-2	48	69
345659	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-2	51	68
345660	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-2	60.5	64
345661	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-2	47	69
345662	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-2	57.5	66
345663	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-2	56	66
345664	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-2	54.5	86
345665	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-2	61.5	80
345666	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-2	52	65
345667	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-2	50	55
345668	20233						RA2159	51112.0										4	IL-2	49	73
345669	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-2	46.5	80
345670	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-2	51	87
345671	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-2	54	85
345672	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-2	56	52
345673	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-2	58	61
345674	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-2	46	57
345675	20233						N2586	51107.0										4	IL-2	48.5	86
345676	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-2	55	69
345677	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-2	55	79
345678	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-2	54	87
345679	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-2	59	61
345680	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-2	55	64
345681	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-2	56.5	38
345682	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-2	50	76
345683	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-2	53	91
345684	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-2	52	56
345685	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-2	50	61
345686	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-2	57	63
345687	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-2	48.5	102
345688	20233						RA2159	51112.0										4	IL-2	51.5	64
345689	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-2	51.5	70
345690	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-2	48	73
345691	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-2	52.5	70
345692	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-2	50	47
345693	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-2	49.5	62
345694	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-2	54.5	86
345695	20233						N2586	51107.0										4	IL-2	51.5	78
345696	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-2	51	70
345697	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-2	46	65
345698	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-2	48.5	90
345699	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-2	48	64
345700	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-2	48	71
345701	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-2	41	60
345702	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-2	46	76
345703	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-2	51	92
345704	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-2	53	71
345705	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-2	51	53
345706	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-2	50.5	78
345707	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-2	45	71
345708	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-2	51	89
345709	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-2	48	60
345710	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-2	54	80
345711	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-2	58.5	62
345712	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-2	46	75
345713	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-2	44	71
345714	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-2	50	97
345715	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-2	45	81
345716	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-2	55	59
345717	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-2	51	61
345718	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-2	53	52
345719	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-2	52	51
345720	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-2	51	69
345721	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-2	52	69
345722	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-2	42	35
345723	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-2	47	59
345724	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-2	56.5	62
345725	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-2	49	72
345726	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-2	55	52
345727	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-2	51.5	52
345728	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-2	46	71
345729	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-2	48	55
345730	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-2	80	35
345731	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-2	73	59
345732	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-2	82	68
345733	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-2	83.5	90
345734	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-2	75	55
345735	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-2	84	69
345736	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-2	52.5	66
345737	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-2	80	75
345738	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-2	76	69
345739	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-2	65	80
345740	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-2	82.5	54
345741	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-2	57	57
345742	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-2	43	52
345743	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-2	44	52
345744	20233																	0	IL-2	49	51
345745	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-2	81.5	92
345746	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-2	72	54
345747	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-2	76	67
345748	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-2	71	91
345749	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-2	63.5	72
345750	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-2	66	73
345751	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-2	47	68
345752	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-2	79	72
345753	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-2	84	46
345754	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-2	67	51
345755	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-2	67.5	52
345756	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-2	55	61
345757	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-2	48	66
345758	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-2	41	87
345759	20233																	0	IL-2	42	93
345760	20233						RA2159	51112.0										4	IL-2	43	77
345761	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-2	51	79
345762	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-2	53	83
345763	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-2	52	97
345764	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-2	48	91
345765	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-2	40.5	52
345766	20233						RA2159	51112.0										4	IL-2	43.5	62
345767	20233						N2586	51107.0										4	IL-2	49	50
345768	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-2	45	53
345769	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-2	44	75
345770	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-2	44	59
345771	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-2	44.5	64
345772	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-2	40	86
345773	20233						N2586	51107.0										4	IL-2	40	51
345774	20233								TNF-a	201285.0						100	ng/mL	0	IL-2	136	75
345775	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-2	39	93
345776	20233								IL-6	201287.0						100	ug/mL	0	IL-2	76	91
345777	20233								IL-17A	201288.0						100	ng/mL	0	IL-2	52	70
345778	20233								EGF	201289.0						100	ng/mL	0	IL-2	43	73
345779	20233								IGF-I	201290.0						100	ug/mL	0	IL-2	40.5	78
345780	20233								Adiponectin	201291.0						5	ng/mL	0	IL-2	46	85
345781	20233								Leptin	201292.0						1	ng/mL	0	IL-2	42	66
345782	20233								Visfatin	201293.0						1	ng/mL	0	IL-2	42.5	72
345783	20233															2	ug/mL	0	IL-2	45	82
345784	20233								TNF-a	201285.0						100	ng/mL	0	IL-2	121	78
345785	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-2	43	55
345786	20233								IL-6	201287.0						100	ug/mL	0	IL-2	67	53
345787	20233								IL-17A	201288.0						100	ng/mL	0	IL-2	55	69
345788	20233								EGF	201289.0						100	ng/mL	0	IL-2	47	73
345789	20233								IGF-I	201290.0						100	ug/mL	0	IL-2	39	61
345790	20233								Adiponectin	201291.0						5	ng/mL	0	IL-2	48.5	46
345791	20233								Leptin	201292.0						1	ng/mL	0	IL-2	44.5	50
345792	20233								Visfatin	201293.0						1	ng/mL	0	IL-2	50	37
345793	20233															2	ug/mL	0	IL-2	42	53
345794	20233								TNF-a	201285.0						100	ng/mL	0	IL-2	141	90
345795	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-2	44.5	80
345796	20233								IL-6	201287.0						100	ug/mL	0	IL-2	84	65
345797	20233								IL-17A	201288.0						100	ng/mL	0	IL-2	62	77
345798	20233								EGF	201289.0						100	ng/mL	0	IL-2	48	62
345799	20233								IGF-I	201290.0						100	ug/mL	0	IL-2	50	61
345800	20233								Adiponectin	201291.0						5	ng/mL	0	IL-2	44	61
345801	20233								Leptin	201292.0						1	ng/mL	0	IL-2	45.5	68
345802	20233								Visfatin	201293.0						1	ng/mL	0	IL-2	56	77
345803	20233															2	ug/mL	0	IL-2	52	82
345804	20233								TNF-a	201285.0						100	ng/mL	0	IL-2	144	79
345805	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-2	42	74
345806	20233								IL-6	201287.0						100	ug/mL	0	IL-2	79	58
345807	20233								IL-17A	201288.0						100	ng/mL	0	IL-2	57.5	70
345808	20233								EGF	201289.0						100	ng/mL	0	IL-2	48	57
345809	20233								IGF-I	201290.0						100	ug/mL	0	IL-2	53	72
345810	20233								Adiponectin	201291.0						5	ng/mL	0	IL-2	53	57
345811	20233								Leptin	201292.0						1	ng/mL	0	IL-2	46	59
345812	20233								Visfatin	201293.0						1	ng/mL	0	IL-2	44	42
345813	20233															2	ug/mL	0	IL-2	49	53
345814	20233																	0	IL-1B	14	59
345815	20233						RA2159	51112.0										1	IL-1B	60	55
345816	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-1B	37	62
345817	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-1B	26.5	58
345818	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-1B	15	61
345819	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-1B	19	67
345820	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-1B	20	52
345821	20233						RA2159	51112.0										1	IL-1B	16	50
345822	20233						N2586	51107.0										1	IL-1B	17.5	68
345823	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-1B	19	56
345824	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-1B	15.5	46
345825	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-1B	16	59
345826	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-1B	19	55
345827	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-1B	20	37
345828	20233						N2586	51107.0										1	IL-1B	18	27
345829	20233																	0	IL-1B	13	53
345830	20233																	0	IL-1B	17	49
345831	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-1B	53	56
345832	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-1B	49	51
345833	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-1B	80	55
345834	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-1B	39	69
345835	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-1B	49	63
345836	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-1B	46.5	56
345837	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-1B	15	56
345838	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-1B	59	62
345839	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-1B	64.5	66
345840	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-1B	65.5	64
345841	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-1B	75	59
345842	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-1B	66.5	54
345843	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-1B	54	58
345844	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-1B	18	32
345845	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-1B	30	55
345846	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-1B	26.5	72
345847	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-1B	18	55
345848	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-1B	30	69
345849	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-1B	29	56
345850	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-1B	18	65
345851	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-1B	16	68
345852	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-1B	33.5	50
345853	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-1B	31	60
345854	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-1B	26	66
345855	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-1B	29.5	60
345856	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-1B	34	63
345857	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-1B	18	55
345858	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-1B	15	62
345859	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-1B	21	54
345860	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-1B	19.5	76
345861	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-1B	18	87
345862	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-1B	19	83
345863	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-1B	22	71
345864	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-1B	21	65
345865	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-1B	14	59
345866	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-1B	20	75
345867	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-1B	16	63
345868	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-1B	20	50
345869	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-1B	24	53
345870	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-1B	17	64
345871	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-1B	18.5	52
345872	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-1B	15	48
345873	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-1B	18	73
345874	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-1B	16	79
345875	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-1B	17	64
345876	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-1B	15	60
345877	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-1B	18	54
345878	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-1B	17	75
345879	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-1B	18.5	66
345880	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-1B	18	63
345881	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-1B	14.5	70
345882	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-1B	11	69
345883	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-1B	14.5	66
345884	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-1B	19	62
345885	20233						RA2159	51112.0										1	IL-1B	17	68
345886	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-1B	15.5	64
345887	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-1B	14.5	66
345888	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-1B	14	56
345889	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-1B	23	50
345890	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-1B	13	68
345891	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-1B	14	48
345892	20233						N2586	51107.0										1	IL-1B	15	59
345893	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-1B	16.5	52
345894	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-1B	14.5	42
345895	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-1B	15.5	62
345896	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-1B	17.5	50
345897	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-1B	19	64
345898	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-1B	17	67
345899	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-1B	16.5	64
345900	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-1B	15	61
345901	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-1B	13.5	46
345902	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-1B	15	71
345903	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-1B	17	56
345904	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-1B	12	67
345905	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-1B	16	71
345906	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-1B	17	80
345907	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-1B	17	59
345908	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-1B	14	47
345909	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-1B	13	50
345910	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-1B	16	53
345911	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-1B	14	43
345912	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-1B	15	79
345913	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-1B	14.5	66
345914	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-1B	15	80
345915	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-1B	14	60
345916	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-1B	13	56
345917	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-1B	14	85
345918	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-1B	17	65
345919	20233						RA2159	51112.0										1	IL-1B	14	89
345920	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-1B	15.5	64
345921	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-1B	12.5	56
345922	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-1B	14	55
345923	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-1B	12	57
345924	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-1B	15	59
345925	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-1B	14	72
345926	20233						N2586	51107.0										1	IL-1B	30.5	70
345927	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-1B	15	65
345928	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-1B	15	65
345929	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-1B	16	68
345930	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-1B	17	57
345931	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-1B	16	77
345932	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-1B	15	66
345933	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-1B	15	71
345934	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-1B	15	53
345935	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-1B	14.5	60
345936	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-1B	15	44
345937	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-1B	22	63
345938	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-1B	16	53
345939	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-1B	15	55
345940	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-1B	19.5	48
345941	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-1B	13	57
345942	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-1B	12.5	58
345943	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-1B	15	66
345944	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-1B	14	47
345945	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-1B	15.5	54
345946	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-1B	15	58
345947	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-1B	14	72
345948	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-1B	13	60
345949	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-1B	13	36
345950	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-1B	15	32
345951	20233						RA2159	51112.0										1	IL-1B	15	55
345952	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-1B	17.5	64
345953	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-1B	15	77
345954	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-1B	13	40
345955	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-1B	16	66
345956	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-1B	14	57
345957	20233						RA2159	51112.0										1	IL-1B	15	70
345958	20233						N2586	51107.0										1	IL-1B	14	78
345959	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-1B	14	77
345960	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-1B	14	55
345961	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-1B	13	72
345962	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-1B	15	66
345963	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-1B	15.5	68
345964	20233						N2586	51107.0										1	IL-1B	16	56
345965	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-1B	14	51
345966	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-1B	16	67
345967	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-1B	13	81
345968	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-1B	17	68
345969	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-1B	14	45
345970	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-1B	14	62
345971	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-1B	13	62
345972	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-1B	33	53
345973	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-1B	14	64
345974	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-1B	15	56
345975	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-1B	13	50
345976	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-1B	11	33
345977	20233																	0	IL-1B	14	57
345978	20233						RA2159	51112.0								2	ug/mL	1	IL-1B	33	63
345979	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-1B	36	47
345980	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-1B	40	50
345981	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-1B	19	47
345982	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-1B	18	59
345983	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-1B	14	67
345984	20233						N2586	51107.0								2	ug/mL	1	IL-1B	28	30
345985	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-1B	21	57
345986	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-1B	12	63
345987	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-1B	15.5	32
345988	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-1B	18.5	52
345989	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-1B	16	37
345990	20233																	0	IL-1B	20.5	48
345991	20233						RA2159	51112.0										2	IL-1B	18.5	50
345992	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-1B	21.5	84
345993	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-1B	115	57
345994	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-1B	19	64
345995	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-1B	18.5	62
345996	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-1B	17.5	66
345997	20233						RA2159	51112.0										2	IL-1B	17	45
345998	20233						N2586	51107.0										2	IL-1B	18	42
345999	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-1B	16	55
346000	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-1B	16.5	60
346001	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-1B	13	49
346002	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-1B	16	55
346003	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-1B	15	50
346004	20233						N2586	51107.0										2	IL-1B	17	53
346005	20233																	0	IL-1B	17	47
346006	20233																	0	IL-1B	17	31
346007	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-1B	47	69
346008	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-1B	51	71
346009	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-1B	49	51
346010	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-1B	47	52
346011	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-1B	31.5	54
346012	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-1B	27	65
346013	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-1B	13	60
346014	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-1B	36	57
346015	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-1B	37	59
346016	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-1B	48	47
346017	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-1B	45	45
346018	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-1B	42.5	38
346019	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-1B	48	57
346020	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-1B	19	45
346021	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-1B	30.5	52
346022	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-1B	24	80
346023	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-1B	22	53
346024	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-1B	33	75
346025	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-1B	29	78
346026	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-1B	24	50
346027	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-1B	13.5	50
346028	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-1B	28	62
346029	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-1B	22	80
346030	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-1B	27	66
346031	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-1B	29	57
346032	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-1B	31	52
346033	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-1B	32	52
346034	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-1B	16	34
346035	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-1B	17	90
346036	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-1B	21	48
346037	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-1B	19	68
346038	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-1B	18	62
346039	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-1B	20	67
346040	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-1B	17	79
346041	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-1B	11	52
346042	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-1B	19	55
346043	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-1B	17	67
346044	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-1B	17	56
346045	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-1B	17.5	54
346046	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-1B	14	74
346047	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-1B	18	42
346048	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-1B	13	53
346049	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-1B	14.5	68
346050	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-1B	17	74
346051	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-1B	21	77
346052	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-1B	22	50
346053	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-1B	14.5	60
346054	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-1B	19	49
346055	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-1B	15	61
346056	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-1B	15.5	62
346057	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-1B	14	62
346058	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-1B	18.5	52
346059	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-1B	16.5	50
346060	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-1B	17	53
346061	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-1B	14.5	68
346062	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-1B	15	47
346063	20233						RA2159	51112.0										2	IL-1B	16.5	60
346064	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-1B	15	51
346065	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-1B	18	60
346066	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-1B	14	54
346067	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-1B	16	65
346068	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-1B	15	74
346069	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-1B	16	41
346070	20233						N2586	51107.0										2	IL-1B	15	56
346071	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-1B	14.5	56
346072	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-1B	15	51
346073	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-1B	16	60
346074	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-1B	11.5	56
346075	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-1B	13	45
346076	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-1B	14	56
346077	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-1B	12	65
346078	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-1B	16	60
346079	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-1B	15	66
346080	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-1B	16	44
346081	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-1B	15	79
346082	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-1B	15	73
346083	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-1B	15	68
346084	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-1B	12	54
346085	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-1B	14	64
346086	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-1B	21	59
346087	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-1B	12	48
346088	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-1B	6.5	68
346089	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-1B	13	71
346090	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-1B	15	49
346091	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-1B	15	101
346092	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-1B	13	50
346093	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-1B	14	74
346094	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-1B	14	58
346095	20233						RA2159	51112.0										2	IL-1B	17	50
346096	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-1B	16	71
346097	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-1B	14	83
346098	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-1B	15	41
346099	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-1B	12	40
346100	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-1B	14	45
346101	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-1B	11.5	60
346102	20233						N2586	51107.0										2	IL-1B	6	43
346103	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-1B	14.5	72
346104	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-1B	16.5	66
346105	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-1B	14	73
346106	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-1B	14	69
346107	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-1B	16	65
346108	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-1B	15.5	52
346109	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-1B	17.5	72
346110	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-1B	15	56
346111	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-1B	16	46
346112	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-1B	12	62
346113	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-1B	14	44
346114	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-1B	14.5	62
346115	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-1B	13	59
346116	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-1B	11	60
346117	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-1B	14.5	76
346118	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-1B	14	65
346119	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-1B	13.5	72
346120	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-1B	16	87
346121	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-1B	14	73
346122	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-1B	12	43
346123	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-1B	11.5	56
346124	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-1B	13	45
346125	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-1B	13.5	42
346126	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-1B	14	61
346127	20233						RA2159	51112.0										2	IL-1B	15	64
346128	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-1B	14	51
346129	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-1B	14	75
346130	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-1B	14.5	84
346131	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-1B	18.5	54
346132	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-1B	14	67
346133	20233						RA2159	51112.0										2	IL-1B	17	47
346134	20233						N2586	51107.0										2	IL-1B	12.5	50
346135	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-1B	14	57
346136	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-1B	16	65
346137	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-1B	12.5	40
346138	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-1B	14	53
346139	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-1B	15	51
346140	20233						N2586	51107.0										2	IL-1B	14	53
346141	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-1B	14	47
346142	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-1B	13	55
346143	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-1B	14	68
346144	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-1B	16	39
346145	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-1B	15	58
346146	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-1B	15	49
346147	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-1B	12	59
346148	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-1B	15	54
346149	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-1B	13.5	34
346150	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-1B	13	35
346151	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-1B	10	38
346152	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-1B	18	19
346153	20233																	0	IL-1B	10.5	40
346154	20233						RA2159	51112.0								2	ug/mL	2	IL-1B	23.5	62
346155	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-1B	17	49
346156	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-1B	20	71
346157	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-1B	19	59
346158	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-1B	16	33
346159	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-1B	20	51
346160	20233						N2586	51107.0								2	ug/mL	2	IL-1B	18.5	44
346161	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-1B	18	41
346162	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-1B	19	32
346163	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-1B	21	33
346164	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-1B	15	34
346165	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-1B	18	50
346166	20233																	0	IL-1B	13	74
346167	20233						RA2159	51112.0								2	ug/mL	3	IL-1B	21.5	64
346168	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-1B	30	63
346169	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-1B	18	64
346170	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-1B	24	83
346171	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-1B	23	65
346172	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-1B	20	54
346173	20233						N2586	51107.0								2	ug/mL	3	IL-1B	22.5	64
346174	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-1B	21	59
346175	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-1B	26	76
346176	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-1B	28	65
346177	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-1B	13	52
346178	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-1B	22	55
346179	20233						RA2159	51112.0										3	IL-1B	11	58
346180	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-1B	14	54
346181	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-1B	12	55
346182	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-1B	13	65
346183	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-1B	13.5	60
346184	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-1B	14.5	60
346185	20233						RA2159	51112.0										3	IL-1B	16	67
346186	20233						N2586	51107.0										3	IL-1B	11	71
346187	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-1B	12.5	54
346188	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-1B	12	69
346189	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-1B	15	50
346190	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-1B	13	66
346191	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-1B	16	60
346192	20233						N2586	51107.0										3	IL-1B	13	68
346193	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-1B	12	54
346194	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-1B	14	51
346195	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-1B	14	54
346196	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-1B	14.5	56
346197	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-1B	13.5	62
346198	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-1B	12	69
346199	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-1B	17	49
346200	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-1B	13	62
346201	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-1B	12.5	74
346202	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-1B	11.5	56
346203	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-1B	13	72
346204	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-1B	13	49
346205	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-1B	12	69
346206	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-1B	12	54
346207	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-1B	13	61
346208	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-1B	14	59
346209	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-1B	12	58
346210	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-1B	14	57
346211	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-1B	15	55
346212	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-1B	16	61
346213	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-1B	13	55
346214	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-1B	13	71
346215	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-1B	13	63
346216	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-1B	15.5	54
346217	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-1B	16	56
346218	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-1B	14.5	82
346219	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-1B	14	79
346220	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-1B	14	51
346221	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-1B	15	73
346222	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-1B	14	71
346223	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-1B	16.5	50
346224	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-1B	12	71
346225	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-1B	16	67
346226	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-1B	15	61
346227	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-1B	15	65
346228	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-1B	15.5	56
346229	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-1B	12	54
346230	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-1B	12	55
346231	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-1B	12.5	66
346232	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-1B	12	59
346233	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-1B	15	55
346234	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-1B	15.5	56
346235	20233						RA2159	51112.0										3	IL-1B	14	72
346236	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-1B	13	63
346237	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-1B	14	66
346238	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-1B	11	70
346239	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-1B	12	76
346240	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-1B	13	55
346241	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-1B	13	69
346242	20233						N2586	51107.0										3	IL-1B	14	50
346243	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-1B	16	52
346244	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-1B	14.5	52
346245	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-1B	14	59
346246	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-1B	13.5	54
346247	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-1B	11	67
346248	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-1B	15	55
346249	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-1B	11	53
346250	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-1B	14	59
346251	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-1B	14	78
346252	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-1B	12	52
346253	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-1B	15	57
346254	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-1B	11.5	72
346255	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-1B	10	73
346256	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-1B	12	50
346257	20233						RA2159	51112.0										3	IL-1B	15	60
346258	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-1B	11	51
346259	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-1B	14	64
346260	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-1B	71	75
346261	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-1B	13	77
346262	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-1B	13	51
346263	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-1B	14.5	66
346264	20233						N2586	51107.0										3	IL-1B	11	73
346265	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-1B	13	71
346266	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-1B	13	62
346267	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-1B	14	63
346268	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-1B	11.5	68
346269	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-1B	16	53
346270	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-1B	13	61
346271	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-1B	14	74
346272	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-1B	15.5	66
346273	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-1B	17	41
346274	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-1B	17.5	62
346275	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-1B	16	69
346276	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-1B	14	61
346277	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-1B	14	76
346278	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-1B	14	50
346279	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-1B	11	65
346280	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-1B	17	65
346281	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-1B	13	61
346282	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-1B	15	49
346283	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-1B	22	59
346284	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-1B	17	60
346285	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-1B	22	55
346286	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-1B	17	75
346287	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-1B	16	71
346288	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-1B	16	67
346289	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-1B	14	69
346290	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-1B	21	79
346291	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-1B	15	62
346292	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-1B	12.5	68
346293	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-1B	14	69
346294	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-1B	15	54
346295	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-1B	35	67
346296	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-1B	9.5	58
346297	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-1B	29.5	58
346298	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-1B	22.5	70
346299	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-1B	18	53
346300	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-1B	26	72
346301	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-1B	25	50
346302	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-1B	14	70
346303	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-1B	15.5	40
346304	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-1B	32.5	72
346305	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-1B	27	68
346306	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-1B	28.5	56
346307	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-1B	30.5	52
346308	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-1B	15	57
346309	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-1B	29	53
346310	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-1B	13	87
346311	20233																	0	IL-1B	10	56
346312	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-1B	81	67
346313	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-1B	116	47
346314	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-1B	102.5	62
346315	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-1B	62.5	72
346316	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-1B	49	53
346317	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-1B	47	71
346318	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-1B	11	50
346319	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-1B	42	63
346320	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-1B	38	53
346321	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-1B	55	77
346322	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-1B	25	65
346323	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-1B	31	62
346324	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-1B	45	69
346325	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-1B	12	54
346326	20233																	0	IL-1B	11	53
346327	20233						RA2159	51112.0										3	IL-1B	15	63
346328	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-1B	61	58
346329	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-1B	17.5	54
346330	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-1B	37	62
346331	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-1B	24.5	34
346332	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-1B	12	60
346333	20233						RA2159	51112.0										3	IL-1B	12.5	48
346334	20233						N2586	51107.0										3	IL-1B	13	68
346335	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-1B	12	63
346336	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-1B	12	56
346337	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-1B	13	35
346338	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-1B	13.5	38
346339	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-1B	15	58
346340	20233						N2586	51107.0										3	IL-1B	13.5	42
346341	20233																	0	IL-1B	11	61
346342	20233						RA2159	51112.0								2	ug/mL	4	IL-1B	36	48
346343	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-1B	27	59
346344	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-1B	23	67
346345	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-1B	24	57
346346	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-1B	16.5	66
346347	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-1B	19	70
346348	20233						N2586	51107.0								2	ug/mL	4	IL-1B	23	61
346349	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-1B	20	68
346350	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-1B	13.5	54
346351	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-1B	16	57
346352	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-1B	16	55
346353	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-1B	13	55
346354	20233						RA2159	51112.0										4	IL-1B	15	67
346355	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-1B	15.5	50
346356	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-1B	16	70
346357	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-1B	16	74
346358	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-1B	13	60
346359	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-1B	14	57
346360	20233						RA2159	51112.0										4	IL-1B	15	66
346361	20233						N2586	51107.0										4	IL-1B	13	84
346362	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-1B	12	58
346363	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-1B	10	50
346364	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-1B	14	52
346365	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-1B	14	50
346366	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-1B	12	74
346367	20233						N2586	51107.0										4	IL-1B	12	61
346368	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-1B	17	50
346369	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-1B	17	50
346370	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-1B	15	68
346371	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-1B	15.5	60
346372	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-1B	14	83
346373	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-1B	14	62
346374	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-1B	16	68
346375	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-1B	10.5	68
346376	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-1B	12	54
346377	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-1B	15	44
346378	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-1B	15	49
346379	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-1B	12	51
346380	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-1B	15.5	82
346381	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-1B	14	67
346382	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-1B	15	50
346383	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-1B	17	73
346384	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-1B	13	64
346385	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-1B	15	63
346386	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-1B	14	47
346387	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-1B	15	49
346388	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-1B	13	70
346389	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-1B	14	60
346390	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-1B	30	53
346391	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-1B	11	76
346392	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-1B	19	85
346393	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-1B	16.5	54
346394	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-1B	14.5	56
346395	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-1B	18	58
346396	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-1B	14	61
346397	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-1B	16	39
346398	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-1B	15	67
346399	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-1B	16	65
346400	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-1B	15	46
346401	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-1B	14	64
346402	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-1B	14	46
346403	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-1B	48	56
346404	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-1B	15	55
346405	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-1B	19	49
346406	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-1B	14	72
346407	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-1B	15	57
346408	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-1B	14	48
346409	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-1B	13	43
346410	20233						RA2159	51112.0										4	IL-1B	11.5	48
346411	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-1B	14	60
346412	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-1B	13	56
346413	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-1B	11	49
346414	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-1B	15	46
346415	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-1B	13.5	46
346416	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-1B	11	63
346417	20233						N2586	51107.0										4	IL-1B	16	86
346418	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-1B	13	47
346419	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-1B	15	61
346420	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-1B	15	43
346421	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-1B	13.5	58
346422	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-1B	14.5	44
346423	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-1B	13	44
346424	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-1B	12	65
346425	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-1B	15	59
346426	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-1B	10	55
346427	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-1B	13	50
346428	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-1B	12	51
346429	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-1B	11	67
346430	20233						RA2159	51112.0										4	IL-1B	16	47
346431	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-1B	14	69
346432	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-1B	13	47
346433	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-1B	12.5	56
346434	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-1B	14	57
346435	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-1B	12	56
346436	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-1B	14	60
346437	20233						N2586	51107.0										4	IL-1B	12	77
346438	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-1B	14	46
346439	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-1B	12	62
346440	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-1B	14	64
346441	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-1B	11	60
346442	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-1B	12	58
346443	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-1B	12	60
346444	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-1B	15	59
346445	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-1B	15	56
346446	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-1B	14	67
346447	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-1B	17.5	58
346448	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-1B	14	61
346449	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-1B	13	62
346450	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-1B	14	66
346451	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-1B	12.5	38
346452	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-1B	15	83
346453	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-1B	17	56
346454	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-1B	15	57
346455	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-1B	19	51
346456	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-1B	13.5	58
346457	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-1B	11	65
346458	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-1B	19	59
346459	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-1B	14	59
346460	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-1B	15	34
346461	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-1B	21.5	50
346462	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-1B	15.5	38
346463	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-1B	14	65
346464	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-1B	14	30
346465	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-1B	14	49
346466	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-1B	13	50
346467	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-1B	16.5	62
346468	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-1B	19	36
346469	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-1B	13.5	56
346470	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-1B	14	45
346471	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-1B	12	75
346472	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-1B	30	47
346473	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-1B	22	56
346474	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-1B	30	55
346475	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-1B	34	67
346476	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-1B	26	39
346477	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-1B	26	46
346478	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-1B	13	59
346479	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-1B	32	48
346480	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-1B	32	43
346481	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-1B	23	55
346482	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-1B	26	51
346483	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-1B	17.5	46
346484	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-1B	12.5	56
346485	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-1B	12	44
346486	20233																	0	IL-1B	12	40
346487	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-1B	52	63
346488	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-1B	48	37
346489	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-1B	44.5	72
346490	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-1B	40	82
346491	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-1B	35	57
346492	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-1B	35	39
346493	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-1B	15	58
346494	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-1B	53	49
346495	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-1B	60	47
346496	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-1B	50	51
346497	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-1B	62.5	30
346498	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-1B	47	42
346499	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-1B	37	39
346500	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-1B	10	70
346501	20233																	0	IL-1B	10	91
346502	20233						RA2159	51112.0										4	IL-1B	12	73
346503	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-1B	65	53
346504	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-1B	48	71
346505	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-1B	43	54
346506	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-1B	13	62
346507	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-1B	13	50
346508	20233						RA2159	51112.0										4	IL-1B	10	67
346509	20233						N2586	51107.0										4	IL-1B	15	50
346510	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-1B	10	38
346511	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-1B	11	60
346512	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-1B	13	57
346513	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-1B	11	47
346514	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-1B	13	61
346515	20233						N2586	51107.0										4	IL-1B	12	45
346516	20233								TNF-a	201285.0						100	ng/mL	0	IL-1B	209	69
346517	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-1B	15	69
346518	20233								IL-6	201287.0						100	ug/mL	0	IL-1B	29.5	78
346519	20233								IL-17A	201288.0						100	ng/mL	0	IL-1B	21	69
346520	20233								EGF	201289.0						100	ng/mL	0	IL-1B	15	82
346521	20233								IGF-I	201290.0						100	ug/mL	0	IL-1B	14	73
346522	20233								Adiponectin	201291.0						5	ng/mL	0	IL-1B	28	54
346523	20233								Leptin	201292.0						1	ng/mL	0	IL-1B	14	63
346524	20233								Visfatin	201293.0						1	ng/mL	0	IL-1B	14	51
346525	20233															2	ug/mL	0	IL-1B	16	73
346526	20233								TNF-a	201285.0						100	ng/mL	0	IL-1B	192	79
346527	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-1B	17	46
346528	20233								IL-6	201287.0						100	ug/mL	0	IL-1B	27	44
346529	20233								IL-17A	201288.0						100	ng/mL	0	IL-1B	21	76
346530	20233								EGF	201289.0						100	ng/mL	0	IL-1B	12	47
346531	20233								IGF-I	201290.0						100	ug/mL	0	IL-1B	15	64
346532	20233								Adiponectin	201291.0						5	ng/mL	0	IL-1B	31	43
346533	20233								Leptin	201292.0						1	ng/mL	0	IL-1B	16.5	52
346534	20233								Visfatin	201293.0						1	ng/mL	0	IL-1B	14	59
346535	20233															2	ug/mL	0	IL-1B	13	63
346536	20233								TNF-a	201285.0						100	ng/mL	0	IL-1B	254	76
346537	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-1B	14	68
346538	20233								IL-6	201287.0						100	ug/mL	0	IL-1B	46	66
346539	20233								IL-17A	201288.0						100	ng/mL	0	IL-1B	17.5	74
346540	20233								EGF	201289.0						100	ng/mL	0	IL-1B	11.5	66
346541	20233								IGF-I	201290.0						100	ug/mL	0	IL-1B	10	56
346542	20233								Adiponectin	201291.0						5	ng/mL	0	IL-1B	28	54
346543	20233								Leptin	201292.0						1	ng/mL	0	IL-1B	8	40
346544	20233								Visfatin	201293.0						1	ng/mL	0	IL-1B	10.5	72
346545	20233															2	ug/mL	0	IL-1B	12	67
346546	20233								TNF-a	201285.0						100	ng/mL	0	IL-1B	212	58
346547	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-1B	12	59
346548	20233								IL-6	201287.0						100	ug/mL	0	IL-1B	25	48
346549	20233								IL-17A	201288.0						100	ng/mL	0	IL-1B	16	63
346550	20233								EGF	201289.0						100	ng/mL	0	IL-1B	10	69
346551	20233								IGF-I	201290.0						100	ug/mL	0	IL-1B	11	67
346552	20233								Adiponectin	201291.0						5	ng/mL	0	IL-1B	23	57
346553	20233								Leptin	201292.0						1	ng/mL	0	IL-1B	9	50
346554	20233								Visfatin	201293.0						1	ng/mL	0	IL-1B	13	24
346555	20233															2	ug/mL	0	IL-1B	9	50
346556	20233																	0	Eotaxin	34	55
346557	20233						RA2159	51112.0										1	Eotaxin	43	49
346558	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	Eotaxin	38	50
346559	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	Eotaxin	44	67
346560	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	Eotaxin	36	73
346561	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	Eotaxin	38	67
346562	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	Eotaxin	38	56
346563	20233						RA2159	51112.0										1	Eotaxin	41	57
346564	20233						N2586	51107.0										1	Eotaxin	37	47
346565	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	Eotaxin	39	59
346566	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	Eotaxin	38.5	54
346567	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	Eotaxin	40	81
346568	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	Eotaxin	34	50
346569	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	Eotaxin	38	46
346570	20233						N2586	51107.0										1	Eotaxin	40	34
346571	20233																	0	Eotaxin	34	54
346572	20233																	0	Eotaxin	30	41
346573	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	Eotaxin	56.5	54
346574	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	Eotaxin	46	69
346575	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	Eotaxin	46	59
346576	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	Eotaxin	45	67
346577	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	Eotaxin	49	63
346578	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	Eotaxin	48	64
346579	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	Eotaxin	38	71
346580	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	Eotaxin	64	53
346581	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	Eotaxin	92	50
346582	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	Eotaxin	63	67
346583	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	Eotaxin	57	74
346584	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	Eotaxin	53	58
346585	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	Eotaxin	49	65
346586	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	Eotaxin	52	61
346587	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	Eotaxin	53	65
346588	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	Eotaxin	45	65
346589	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	Eotaxin	37	61
346590	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	Eotaxin	50	72
346591	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	Eotaxin	53	83
346592	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	Eotaxin	34.5	78
346593	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	Eotaxin	30	67
346594	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	Eotaxin	57	61
346595	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	Eotaxin	52	63
346596	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	Eotaxin	53.5	64
346597	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	Eotaxin	56.5	56
346598	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	Eotaxin	58	59
346599	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	Eotaxin	36	45
346600	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	Eotaxin	37	73
346601	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	Eotaxin	40.5	62
346602	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	Eotaxin	34.5	90
346603	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	Eotaxin	39.5	68
346604	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	Eotaxin	45	64
346605	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	Eotaxin	38	74
346606	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	Eotaxin	37.5	74
346607	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	Eotaxin	36	59
346608	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	Eotaxin	43	79
346609	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	Eotaxin	32	43
346610	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	Eotaxin	40.5	48
346611	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	Eotaxin	48	63
346612	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	Eotaxin	35.5	60
346613	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	Eotaxin	42	73
346614	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	Eotaxin	36	57
346615	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	Eotaxin	36.5	68
346616	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	Eotaxin	42.5	66
346617	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	Eotaxin	36	69
346618	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	Eotaxin	42	63
346619	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	Eotaxin	43	42
346620	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	Eotaxin	36.5	72
346621	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	Eotaxin	45.5	76
346622	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	Eotaxin	44	60
346623	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	Eotaxin	37	60
346624	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	Eotaxin	40	85
346625	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	Eotaxin	38	53
346626	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	Eotaxin	35	73
346627	20233						RA2159	51112.0										1	Eotaxin	41	77
346628	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	Eotaxin	36	85
346629	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	Eotaxin	32	64
346630	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	Eotaxin	35	61
346631	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	Eotaxin	36	51
346632	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	Eotaxin	42	59
346633	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	Eotaxin	36	49
346634	20233						N2586	51107.0										1	Eotaxin	33.5	68
346635	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	Eotaxin	32	66
346636	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	Eotaxin	39	31
346637	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	Eotaxin	37	55
346638	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	Eotaxin	39	31
346639	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	Eotaxin	37	53
346640	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	Eotaxin	33	51
346641	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	Eotaxin	31	65
346642	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	Eotaxin	40	61
346643	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	Eotaxin	32.5	56
346644	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	Eotaxin	32.5	78
346645	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	Eotaxin	32.5	58
346646	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	Eotaxin	30	66
346647	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	Eotaxin	32	92
346648	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	Eotaxin	32	67
346649	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	Eotaxin	36	85
346650	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	Eotaxin	31	59
346651	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	Eotaxin	30.5	42
346652	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	Eotaxin	37	53
346653	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	Eotaxin	29	49
346654	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	Eotaxin	36	72
346655	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	Eotaxin	34	73
346656	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	Eotaxin	27.5	78
346657	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	Eotaxin	29	59
346658	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	Eotaxin	33	66
346659	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	Eotaxin	33.5	72
346660	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	Eotaxin	29	67
346661	20233						RA2159	51112.0										1	Eotaxin	35	59
346662	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	Eotaxin	33	59
346663	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	Eotaxin	31	68
346664	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	Eotaxin	29	65
346665	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	Eotaxin	32	53
346666	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	Eotaxin	31.5	46
346667	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	Eotaxin	28	67
346668	20233						N2586	51107.0										1	Eotaxin	37	65
346669	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	Eotaxin	33	57
346670	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	Eotaxin	29	62
346671	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	Eotaxin	31	60
346672	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	Eotaxin	32	68
346673	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	Eotaxin	33	74
346674	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	Eotaxin	32	84
346675	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	Eotaxin	33	63
346676	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	Eotaxin	36	54
346677	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	Eotaxin	34.5	54
346678	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	Eotaxin	31	50
346679	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	Eotaxin	26	58
346680	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	Eotaxin	32	43
346681	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	Eotaxin	32	71
346682	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	Eotaxin	27	60
346683	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	Eotaxin	32	51
346684	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	Eotaxin	27	59
346685	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	Eotaxin	31.5	66
346686	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	Eotaxin	31.5	60
346687	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	Eotaxin	27	48
346688	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	Eotaxin	31.5	48
346689	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	Eotaxin	28	72
346690	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	Eotaxin	32	71
346691	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	Eotaxin	30.5	78
346692	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	Eotaxin	30	48
346693	20233						RA2159	51112.0										1	Eotaxin	36	52
346694	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	Eotaxin	37	67
346695	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	Eotaxin	34.5	50
346696	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	Eotaxin	32	61
346697	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	Eotaxin	29	65
346698	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	Eotaxin	32	51
346699	20233						RA2159	51112.0										1	Eotaxin	32	68
346700	20233						N2586	51107.0										1	Eotaxin	29	71
346701	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	Eotaxin	35	63
346702	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	Eotaxin	34	74
346703	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	Eotaxin	29	65
346704	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	Eotaxin	34	61
346705	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	Eotaxin	30	86
346706	20233						N2586	51107.0										1	Eotaxin	31	74
346707	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	Eotaxin	27	48
346708	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	Eotaxin	31	69
346709	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	Eotaxin	33	58
346710	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	Eotaxin	32	80
346711	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	Eotaxin	28.5	56
346712	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	Eotaxin	31	53
346713	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	Eotaxin	27	56
346714	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	Eotaxin	36.5	52
346715	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	Eotaxin	36	61
346716	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	Eotaxin	29	51
346717	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	Eotaxin	26	79
346718	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	Eotaxin	26	40
346719	20233																	0	Eotaxin	26	57
346720	20233						RA2159	51112.0								2	ug/mL	1	Eotaxin	38	46
346721	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	Eotaxin	36.5	48
346722	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	Eotaxin	31	59
346723	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	Eotaxin	33	42
346724	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	Eotaxin	34	54
346725	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	Eotaxin	30	66
346726	20233						N2586	51107.0								2	ug/mL	1	Eotaxin	42	55
346727	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	Eotaxin	37	67
346728	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	Eotaxin	29.5	66
346729	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	Eotaxin	32.5	36
346730	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	Eotaxin	38	59
346731	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	Eotaxin	36	43
346732	20233																	0	Eotaxin	34.5	58
346733	20233						RA2159	51112.0										2	Eotaxin	37	72
346734	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	Eotaxin	32.5	80
346735	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	Eotaxin	54	79
346736	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	Eotaxin	36.5	56
346737	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	Eotaxin	35	51
346738	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	Eotaxin	36	71
346739	20233						RA2159	51112.0										2	Eotaxin	36.5	42
346740	20233						N2586	51107.0										2	Eotaxin	35	46
346741	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	Eotaxin	32	61
346742	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	Eotaxin	36.5	64
346743	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	Eotaxin	36.5	44
346744	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	Eotaxin	38	66
346745	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	Eotaxin	38	46
346746	20233						N2586	51107.0										2	Eotaxin	31.5	36
346747	20233																	0	Eotaxin	35	49
346748	20233																	0	Eotaxin	34	45
346749	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	Eotaxin	45.5	68
346750	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	Eotaxin	46	68
346751	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	Eotaxin	46.5	56
346752	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	Eotaxin	44	53
346753	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	Eotaxin	37	60
346754	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	Eotaxin	46	58
346755	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	Eotaxin	39	50
346756	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	Eotaxin	61	47
346757	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	Eotaxin	41	70
346758	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	Eotaxin	55	69
346759	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	Eotaxin	45	61
346760	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	Eotaxin	45.5	42
346761	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	Eotaxin	51	47
346762	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	Eotaxin	34	47
346763	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	Eotaxin	51	53
346764	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	Eotaxin	46.5	70
346765	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	Eotaxin	44.5	62
346766	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	Eotaxin	52	65
346767	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	Eotaxin	52	62
346768	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	Eotaxin	38	59
346769	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	Eotaxin	36	46
346770	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	Eotaxin	52	47
346771	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	Eotaxin	40	74
346772	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	Eotaxin	45	55
346773	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	Eotaxin	52	71
346774	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	Eotaxin	43	61
346775	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	Eotaxin	53	52
346776	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	Eotaxin	29.5	46
346777	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	Eotaxin	36	85
346778	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	Eotaxin	30	54
346779	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	Eotaxin	37	78
346780	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	Eotaxin	37	47
346781	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	Eotaxin	33	80
346782	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	Eotaxin	33	74
346783	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	Eotaxin	33	62
346784	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	Eotaxin	38	65
346785	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	Eotaxin	36	66
346786	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	Eotaxin	35	58
346787	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	Eotaxin	35	58
346788	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	Eotaxin	31.5	66
346789	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	Eotaxin	36.5	58
346790	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	Eotaxin	30	51
346791	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	Eotaxin	36	57
346792	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	Eotaxin	36.5	68
346793	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	Eotaxin	36	76
346794	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	Eotaxin	35.5	78
346795	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	Eotaxin	31	61
346796	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	Eotaxin	40.5	48
346797	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	Eotaxin	30.5	66
346798	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	Eotaxin	36	51
346799	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	Eotaxin	33	64
346800	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	Eotaxin	26	51
346801	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	Eotaxin	39	54
346802	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	Eotaxin	35.5	40
346803	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	Eotaxin	34	63
346804	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	Eotaxin	37.5	52
346805	20233						RA2159	51112.0										2	Eotaxin	37	63
346806	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	Eotaxin	29	58
346807	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	Eotaxin	31	53
346808	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	Eotaxin	31.5	40
346809	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	Eotaxin	28	55
346810	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	Eotaxin	33	79
346811	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	Eotaxin	30	65
346812	20233						N2586	51107.0										2	Eotaxin	29.5	62
346813	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	Eotaxin	29	58
346814	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	Eotaxin	30	71
346815	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	Eotaxin	32	66
346816	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	Eotaxin	30.5	66
346817	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	Eotaxin	27	53
346818	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	Eotaxin	27.5	44
346819	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	Eotaxin	27	63
346820	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	Eotaxin	29	72
346821	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	Eotaxin	30	73
346822	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	Eotaxin	30.5	64
346823	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	Eotaxin	29.5	64
346824	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	Eotaxin	30	59
346825	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	Eotaxin	29	91
346826	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	Eotaxin	31.5	78
346827	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	Eotaxin	37.5	60
346828	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	Eotaxin	29	70
346829	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	Eotaxin	29	47
346830	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	Eotaxin	8	56
346831	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	Eotaxin	30.5	82
346832	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	Eotaxin	24.5	42
346833	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	Eotaxin	31	72
346834	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	Eotaxin	25	76
346835	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	Eotaxin	26	72
346836	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	Eotaxin	30	52
346837	20233						RA2159	51112.0										2	Eotaxin	33	67
346838	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	Eotaxin	31.5	78
346839	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	Eotaxin	30	81
346840	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	Eotaxin	31	65
346841	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	Eotaxin	27.5	64
346842	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	Eotaxin	35	59
346843	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	Eotaxin	28	55
346844	20233						N2586	51107.0										2	Eotaxin	8	44
346845	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	Eotaxin	27	75
346846	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	Eotaxin	29	75
346847	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	Eotaxin	25.5	60
346848	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	Eotaxin	30	65
346849	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	Eotaxin	29	75
346850	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	Eotaxin	32	47
346851	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	Eotaxin	29	68
346852	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	Eotaxin	29.5	62
346853	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	Eotaxin	30	51
346854	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	Eotaxin	27.5	68
346855	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	Eotaxin	25	36
346856	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	Eotaxin	32	49
346857	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	Eotaxin	29	58
346858	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	Eotaxin	27.5	68
346859	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	Eotaxin	26	75
346860	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	Eotaxin	28.5	52
346861	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	Eotaxin	25.5	50
346862	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	Eotaxin	31	74
346863	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	Eotaxin	28	65
346864	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	Eotaxin	31	43
346865	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	Eotaxin	28.5	50
346866	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	Eotaxin	30	58
346867	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	Eotaxin	33	41
346868	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	Eotaxin	28	68
346869	20233						RA2159	51112.0										2	Eotaxin	31	55
346870	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	Eotaxin	32	53
346871	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	Eotaxin	27	63
346872	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	Eotaxin	31	72
346873	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	Eotaxin	26	50
346874	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	Eotaxin	24.5	48
346875	20233						RA2159	51112.0										2	Eotaxin	31	55
346876	20233						N2586	51107.0										2	Eotaxin	27	55
346877	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	Eotaxin	29.5	56
346878	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	Eotaxin	25	70
346879	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	Eotaxin	29	43
346880	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	Eotaxin	30	52
346881	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	Eotaxin	29	58
346882	20233						N2586	51107.0										2	Eotaxin	31	53
346883	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	Eotaxin	29	69
346884	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	Eotaxin	26	57
346885	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	Eotaxin	29	63
346886	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	Eotaxin	30	44
346887	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	Eotaxin	27.5	30
346888	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	Eotaxin	28	36
346889	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	Eotaxin	24	49
346890	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	Eotaxin	30	52
346891	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	Eotaxin	22.5	38
346892	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	Eotaxin	27	30
346893	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	Eotaxin	26	45
346894	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	Eotaxin	30	37
346895	20233																	0	Eotaxin	25	45
346896	20233						RA2159	51112.0								2	ug/mL	2	Eotaxin	39.5	38
346897	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	Eotaxin	42	57
346898	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	Eotaxin	31	74
346899	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	Eotaxin	32	64
346900	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	Eotaxin	30	35
346901	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	Eotaxin	41	41
346902	20233						N2586	51107.0								2	ug/mL	2	Eotaxin	39	35
346903	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	Eotaxin	35	47
346904	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	Eotaxin	30	34
346905	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	Eotaxin	36.5	30
346906	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	Eotaxin	23.5	28
346907	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	Eotaxin	38	53
346908	20233																	0	Eotaxin	43	79
346909	20233						RA2159	51112.0								2	ug/mL	3	Eotaxin	58	71
346910	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	Eotaxin	56	76
346911	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	Eotaxin	48.5	60
346912	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	Eotaxin	60	64
346913	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	Eotaxin	49	56
346914	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	Eotaxin	46	67
346915	20233						N2586	51107.0								2	ug/mL	3	Eotaxin	69	65
346916	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	Eotaxin	57.5	50
346917	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	Eotaxin	56	64
346918	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	Eotaxin	66	62
346919	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	Eotaxin	44	63
346920	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	Eotaxin	53	51
346921	20233						RA2159	51112.0										3	Eotaxin	48	56
346922	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	Eotaxin	51.5	60
346923	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	Eotaxin	50	71
346924	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	Eotaxin	47	56
346925	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	Eotaxin	48	76
346926	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	Eotaxin	47	55
346927	20233						RA2159	51112.0										3	Eotaxin	41.5	66
346928	20233						N2586	51107.0										3	Eotaxin	47	66
346929	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	Eotaxin	46.5	70
346930	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	Eotaxin	44.5	58
346931	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	Eotaxin	48	69
346932	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	Eotaxin	42	79
346933	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	Eotaxin	41	53
346934	20233						N2586	51107.0										3	Eotaxin	51	49
346935	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	Eotaxin	41.5	62
346936	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	Eotaxin	43	47
346937	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	Eotaxin	48	70
346938	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	Eotaxin	42	67
346939	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	Eotaxin	46.5	68
346940	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	Eotaxin	46.5	68
346941	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	Eotaxin	47	80
346942	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	Eotaxin	45	78
346943	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	Eotaxin	43	70
346944	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	Eotaxin	41.5	46
346945	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	Eotaxin	34	73
346946	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	Eotaxin	44	83
346947	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	Eotaxin	46	77
346948	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	Eotaxin	40	79
346949	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	Eotaxin	23.5	84
346950	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	Eotaxin	42	79
346951	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	Eotaxin	45.5	70
346952	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	Eotaxin	46	78
346953	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	Eotaxin	44	91
346954	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	Eotaxin	39.5	64
346955	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	Eotaxin	39	64
346956	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	Eotaxin	46	67
346957	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	Eotaxin	46	52
346958	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	Eotaxin	39	79
346959	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	Eotaxin	46	65
346960	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	Eotaxin	42	71
346961	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	Eotaxin	43	95
346962	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	Eotaxin	39	72
346963	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	Eotaxin	41	69
346964	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	Eotaxin	45	81
346965	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	Eotaxin	48	72
346966	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	Eotaxin	42.5	78
346967	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	Eotaxin	37	72
346968	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	Eotaxin	47.5	70
346969	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	Eotaxin	41	71
346970	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	Eotaxin	39	63
346971	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	Eotaxin	47	55
346972	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	Eotaxin	36	71
346973	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	Eotaxin	36	59
346974	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	Eotaxin	43	61
346975	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	Eotaxin	40	83
346976	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	Eotaxin	39.5	68
346977	20233						RA2159	51112.0										3	Eotaxin	42	65
346978	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	Eotaxin	44	55
346979	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	Eotaxin	37	47
346980	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	Eotaxin	41	55
346981	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	Eotaxin	43.5	76
346982	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	Eotaxin	41	77
346983	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	Eotaxin	41	64
346984	20233						N2586	51107.0										3	Eotaxin	45	87
346985	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	Eotaxin	37	78
346986	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	Eotaxin	38	49
346987	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	Eotaxin	42	61
346988	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	Eotaxin	45	43
346989	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	Eotaxin	29.5	80
346990	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	Eotaxin	32	45
346991	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	Eotaxin	40	77
346992	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	Eotaxin	36	53
346993	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	Eotaxin	41.5	78
346994	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	Eotaxin	48	47
346995	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	Eotaxin	39	56
346996	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	Eotaxin	34	69
346997	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	Eotaxin	24	55
346998	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	Eotaxin	36	46
346999	20233						RA2159	51112.0										3	Eotaxin	46	77
347000	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	Eotaxin	40.5	64
347001	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	Eotaxin	41.5	60
347002	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	Eotaxin	42	76
347003	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	Eotaxin	36	93
347004	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	Eotaxin	43.5	44
347005	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	Eotaxin	34	69
347006	20233						N2586	51107.0										3	Eotaxin	38	93
347007	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	Eotaxin	38.5	68
347008	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	Eotaxin	34	59
347009	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	Eotaxin	44	69
347010	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	Eotaxin	39	75
347011	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	Eotaxin	36	53
347012	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	Eotaxin	43	88
347013	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	Eotaxin	46	65
347014	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	Eotaxin	52	79
347015	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	Eotaxin	44	51
347016	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	Eotaxin	48.5	60
347017	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	Eotaxin	48	60
347018	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	Eotaxin	50.5	60
347019	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	Eotaxin	42	64
347020	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	Eotaxin	39	75
347021	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	Eotaxin	30	70
347022	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	Eotaxin	46.5	56
347023	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	Eotaxin	45	65
347024	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	Eotaxin	39.5	56
347025	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	Eotaxin	46	60
347026	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	Eotaxin	43	63
347027	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	Eotaxin	49	61
347028	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	Eotaxin	47.5	50
347029	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	Eotaxin	44	55
347030	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	Eotaxin	39.5	70
347031	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	Eotaxin	39	86
347032	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	Eotaxin	44	66
347033	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	Eotaxin	40	75
347034	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	Eotaxin	39.5	66
347035	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	Eotaxin	46	53
347036	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	Eotaxin	37	58
347037	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	Eotaxin	37.5	74
347038	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	Eotaxin	39	65
347039	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	Eotaxin	57	57
347040	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	Eotaxin	51	67
347041	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	Eotaxin	53	75
347042	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	Eotaxin	54	63
347043	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	Eotaxin	57	69
347044	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	Eotaxin	39.5	68
347045	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	Eotaxin	48	49
347046	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	Eotaxin	57	73
347047	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	Eotaxin	48	71
347048	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	Eotaxin	64	73
347049	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	Eotaxin	68.5	60
347050	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	Eotaxin	39	46
347051	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	Eotaxin	57.5	56
347052	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	Eotaxin	37	79
347053	20233																	0	Eotaxin	40	52
347054	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	Eotaxin	58	59
347055	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	Eotaxin	58	48
347056	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	Eotaxin	49	63
347057	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	Eotaxin	52	71
347058	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	Eotaxin	54	56
347059	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	Eotaxin	43	57
347060	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	Eotaxin	34.5	66
347061	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	Eotaxin	50	73
347062	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	Eotaxin	53.5	42
347063	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	Eotaxin	61	61
347064	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	Eotaxin	47	63
347065	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	Eotaxin	42.5	60
347066	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	Eotaxin	61	71
347067	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	Eotaxin	37	69
347068	20233																	0	Eotaxin	30.5	48
347069	20233						RA2159	51112.0										3	Eotaxin	39.5	58
347070	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	Eotaxin	42.5	56
347071	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	Eotaxin	36	69
347072	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	Eotaxin	34	50
347073	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	Eotaxin	37	47
347074	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	Eotaxin	40	66
347075	20233						RA2159	51112.0										3	Eotaxin	36	58
347076	20233						N2586	51107.0										3	Eotaxin	36	71
347077	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	Eotaxin	32.5	76
347078	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	Eotaxin	38.5	60
347079	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	Eotaxin	34	35
347080	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	Eotaxin	36	41
347081	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	Eotaxin	34	58
347082	20233						N2586	51107.0										3	Eotaxin	38.5	40
347083	20233																	0	Eotaxin	47	57
347084	20233						RA2159	51112.0								2	ug/mL	4	Eotaxin	63	47
347085	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	Eotaxin	61	43
347086	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	Eotaxin	61	63
347087	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	Eotaxin	64	63
347088	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	Eotaxin	55	66
347089	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	Eotaxin	59	50
347090	20233						N2586	51107.0								2	ug/mL	4	Eotaxin	60	76
347091	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	Eotaxin	56	63
347092	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	Eotaxin	48	58
347093	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	Eotaxin	61.5	64
347094	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	Eotaxin	47	75
347095	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	Eotaxin	40	55
347096	20233						RA2159	51112.0										4	Eotaxin	46	70
347097	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	Eotaxin	43	57
347098	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	Eotaxin	41	60
347099	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	Eotaxin	52	61
347100	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	Eotaxin	40	65
347101	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	Eotaxin	46	64
347102	20233						RA2159	51112.0										4	Eotaxin	49	68
347103	20233						N2586	51107.0										4	Eotaxin	43	50
347104	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	Eotaxin	33	65
347105	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	Eotaxin	45	50
347106	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	Eotaxin	45	61
347107	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	Eotaxin	44	55
347108	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	Eotaxin	44.5	64
347109	20233						N2586	51107.0										4	Eotaxin	42	63
347110	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	Eotaxin	46	57
347111	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	Eotaxin	50	53
347112	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	Eotaxin	47	65
347113	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	Eotaxin	45	61
347114	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	Eotaxin	48	80
347115	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	Eotaxin	45	57
347116	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	Eotaxin	43.5	74
347117	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	Eotaxin	48	53
347118	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	Eotaxin	44.5	56
347119	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	Eotaxin	45	67
347120	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	Eotaxin	42.5	54
347121	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	Eotaxin	44.5	74
347122	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	Eotaxin	40.5	90
347123	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	Eotaxin	38	58
347124	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	Eotaxin	45	63
347125	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	Eotaxin	54	55
347126	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	Eotaxin	44	71
347127	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	Eotaxin	45.5	70
347128	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	Eotaxin	46	66
347129	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	Eotaxin	44.5	50
347130	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	Eotaxin	37	72
347131	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	Eotaxin	43	65
347132	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	Eotaxin	45	50
347133	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	Eotaxin	44	56
347134	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	Eotaxin	43	82
347135	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	Eotaxin	44.5	56
347136	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	Eotaxin	46.5	66
347137	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	Eotaxin	42	52
347138	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	Eotaxin	42	49
347139	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	Eotaxin	40	46
347140	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	Eotaxin	40	73
347141	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	Eotaxin	40	59
347142	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	Eotaxin	41	63
347143	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	Eotaxin	40	66
347144	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	Eotaxin	49	44
347145	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	Eotaxin	44.5	70
347146	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	Eotaxin	48	64
347147	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	Eotaxin	44	47
347148	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	Eotaxin	53	67
347149	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	Eotaxin	44	84
347150	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	Eotaxin	37.5	60
347151	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	Eotaxin	45	69
347152	20233						RA2159	51112.0										4	Eotaxin	50	60
347153	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	Eotaxin	35	67
347154	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	Eotaxin	51	63
347155	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	Eotaxin	43	55
347156	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	Eotaxin	51.5	44
347157	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	Eotaxin	41.5	40
347158	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	Eotaxin	37	65
347159	20233						N2586	51107.0										4	Eotaxin	47	55
347160	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	Eotaxin	42	56
347161	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	Eotaxin	45	59
347162	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	Eotaxin	40	51
347163	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	Eotaxin	42	28
347164	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	Eotaxin	47	46
347165	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	Eotaxin	42.5	40
347166	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	Eotaxin	42	65
347167	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	Eotaxin	39.5	78
347168	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	Eotaxin	38	60
347169	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	Eotaxin	37	56
347170	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	Eotaxin	42	54
347171	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	Eotaxin	36	75
347172	20233						RA2159	51112.0										4	Eotaxin	38.5	58
347173	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	Eotaxin	42	62
347174	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	Eotaxin	37	67
347175	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	Eotaxin	43	56
347176	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	Eotaxin	41	45
347177	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	Eotaxin	34	49
347178	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	Eotaxin	37	59
347179	20233						N2586	51107.0										4	Eotaxin	34	61
347180	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	Eotaxin	40	40
347181	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	Eotaxin	40	61
347182	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	Eotaxin	41.5	70
347183	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	Eotaxin	42	65
347184	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	Eotaxin	40	63
347185	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	Eotaxin	37	71
347186	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	Eotaxin	37	68
347187	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	Eotaxin	38	58
347188	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	Eotaxin	39	52
347189	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	Eotaxin	54	60
347190	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	Eotaxin	38	53
347191	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	Eotaxin	45	62
347192	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	Eotaxin	38	60
347193	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	Eotaxin	44	39
347194	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	Eotaxin	55	68
347195	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	Eotaxin	49.5	58
347196	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	Eotaxin	48	68
347197	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	Eotaxin	48	66
347198	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	Eotaxin	39	67
347199	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	Eotaxin	27.5	64
347200	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	Eotaxin	47	43
347201	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	Eotaxin	38.5	54
347202	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	Eotaxin	32	35
347203	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	Eotaxin	35	46
347204	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	Eotaxin	38	61
347205	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	Eotaxin	46	69
347206	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	Eotaxin	33	51
347207	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	Eotaxin	42	47
347208	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	Eotaxin	44	61
347209	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	Eotaxin	35	62
347210	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	Eotaxin	44	37
347211	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	Eotaxin	41	58
347212	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	Eotaxin	33	53
347213	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	Eotaxin	38.5	56
347214	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	Eotaxin	55	47
347215	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	Eotaxin	45	63
347216	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	Eotaxin	50	67
347217	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	Eotaxin	56.5	58
347218	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	Eotaxin	56	46
347219	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	Eotaxin	56	65
347220	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	Eotaxin	44.5	42
347221	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	Eotaxin	61.5	82
347222	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	Eotaxin	60	51
347223	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	Eotaxin	56.5	64
347224	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	Eotaxin	61	49
347225	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	Eotaxin	43.5	58
347226	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	Eotaxin	41.5	42
347227	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	Eotaxin	35	47
347228	20233																	0	Eotaxin	36	34
347229	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	Eotaxin	62	83
347230	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	Eotaxin	55	53
347231	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	Eotaxin	56.5	60
347232	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	Eotaxin	47	62
347233	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	Eotaxin	48	51
347234	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	Eotaxin	50	52
347235	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	Eotaxin	40	57
347236	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	Eotaxin	58	58
347237	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	Eotaxin	71	43
347238	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	Eotaxin	67.5	42
347239	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	Eotaxin	54	45
347240	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	Eotaxin	46.5	46
347241	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	Eotaxin	40.5	46
347242	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	Eotaxin	36	56
347243	20233																	0	Eotaxin	37	77
347244	20233						RA2159	51112.0										4	Eotaxin	36	73
347245	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	Eotaxin	34	61
347246	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	Eotaxin	36	65
347247	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	Eotaxin	33.5	66
347248	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	Eotaxin	38	74
347249	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	Eotaxin	31	49
347250	20233						RA2159	51112.0										4	Eotaxin	40	44
347251	20233						N2586	51107.0										4	Eotaxin	34.5	62
347252	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	Eotaxin	35.5	48
347253	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	Eotaxin	31	71
347254	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	Eotaxin	34	47
347255	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	Eotaxin	35	54
347256	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	Eotaxin	34	59
347257	20233						N2586	51107.0										4	Eotaxin	36	58
347258	20233								TNF-a	201285.0						100	ng/mL	0	Eotaxin	74	73
347259	20233								IL-1 alpha	201286.0						100	ng/mL	0	Eotaxin	31	79
347260	20233								IL-6	201287.0						100	ug/mL	0	Eotaxin	50	65
347261	20233								IL-17A	201288.0						100	ng/mL	0	Eotaxin	55	74
347262	20233								EGF	201289.0						100	ng/mL	0	Eotaxin	30	69
347263	20233								IGF-I	201290.0						100	ug/mL	0	Eotaxin	32	77
347264	20233								Adiponectin	201291.0						5	ng/mL	0	Eotaxin	39.5	78
347265	20233								Leptin	201292.0						1	ng/mL	0	Eotaxin	37	63
347266	20233								Visfatin	201293.0						1	ng/mL	0	Eotaxin	38	60
347267	20233															2	ug/mL	0	Eotaxin	32.5	80
347268	20233								TNF-a	201285.0						100	ng/mL	0	Eotaxin	72	79
347269	20233								IL-1 alpha	201286.0						100	ng/mL	0	Eotaxin	38	43
347270	20233								IL-6	201287.0						100	ug/mL	0	Eotaxin	48	64
347271	20233								IL-17A	201288.0						100	ng/mL	0	Eotaxin	53	60
347272	20233								EGF	201289.0						100	ng/mL	0	Eotaxin	31.5	58
347273	20233								IGF-I	201290.0						100	ug/mL	0	Eotaxin	32	55
347274	20233								Adiponectin	201291.0						5	ng/mL	0	Eotaxin	36	51
347275	20233								Leptin	201292.0						1	ng/mL	0	Eotaxin	33	53
347276	20233								Visfatin	201293.0						1	ng/mL	0	Eotaxin	36	64
347277	20233															2	ug/mL	0	Eotaxin	36	49
347278	20233								TNF-a	201285.0						100	ng/mL	0	Eotaxin	87	70
347279	20233								IL-1 alpha	201286.0						100	ng/mL	0	Eotaxin	40	48
347280	20233								IL-6	201287.0						100	ug/mL	0	Eotaxin	57	47
347281	20233								IL-17A	201288.0						100	ng/mL	0	Eotaxin	66	88
347282	20233								EGF	201289.0						100	ng/mL	0	Eotaxin	37.5	70
347283	20233								IGF-I	201290.0						100	ug/mL	0	Eotaxin	37.5	50
347284	20233								Adiponectin	201291.0						5	ng/mL	0	Eotaxin	26	56
347285	20233								Leptin	201292.0						1	ng/mL	0	Eotaxin	41	45
347286	20233								Visfatin	201293.0						1	ng/mL	0	Eotaxin	35	77
347287	20233															2	ug/mL	0	Eotaxin	42	69
347288	20233								TNF-a	201285.0						100	ng/mL	0	Eotaxin	84	89
347289	20233								IL-1 alpha	201286.0						100	ng/mL	0	Eotaxin	38	49
347290	20233								IL-6	201287.0						100	ug/mL	0	Eotaxin	54	51
347291	20233								IL-17A	201288.0						100	ng/mL	0	Eotaxin	61.5	46
347292	20233								EGF	201289.0						100	ng/mL	0	Eotaxin	35	60
347293	20233								IGF-I	201290.0						100	ug/mL	0	Eotaxin	33	63
347294	20233								Adiponectin	201291.0						5	ng/mL	0	Eotaxin	37.5	64
347295	20233								Leptin	201292.0						1	ng/mL	0	Eotaxin	36	57
347296	20233								Visfatin	201293.0						1	ng/mL	0	Eotaxin	37	39
347297	20233															2	ug/mL	0	Eotaxin	35.5	44
347298	20233																	0	FGF Basic	36	66
347299	20233						RA2159	51112.0										1	FGF Basic	42	57
347300	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	FGF Basic	38	74
347301	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	FGF Basic	43	71
347302	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	FGF Basic	43	82
347303	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	FGF Basic	41	60
347304	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	FGF Basic	38	59
347305	20233						RA2159	51112.0										1	FGF Basic	41	55
347306	20233						N2586	51107.0										1	FGF Basic	41	79
347307	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	FGF Basic	46.5	56
347308	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	FGF Basic	48	51
347309	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	FGF Basic	47	66
347310	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	FGF Basic	40	76
347311	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	FGF Basic	37	42
347312	20233						N2586	51107.0										1	FGF Basic	44	33
347313	20233																	0	FGF Basic	41	55
347314	20233																	0	FGF Basic	32	39
347315	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	FGF Basic	64	52
347316	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	FGF Basic	51	60
347317	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	FGF Basic	58	81
347318	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	FGF Basic	56	53
347319	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	FGF Basic	54.5	64
347320	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	FGF Basic	54	64
347321	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	FGF Basic	40	77
347322	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	FGF Basic	59	73
347323	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	FGF Basic	63.5	62
347324	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	FGF Basic	70	63
347325	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	FGF Basic	60.5	62
347326	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	FGF Basic	54	46
347327	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	FGF Basic	64	63
347328	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	FGF Basic	66.5	36
347329	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	FGF Basic	52	79
347330	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	FGF Basic	47	87
347331	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	FGF Basic	46	62
347332	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	FGF Basic	55.5	78
347333	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	FGF Basic	54	72
347334	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	FGF Basic	37	80
347335	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	FGF Basic	38	73
347336	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	FGF Basic	59.5	78
347337	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	FGF Basic	57	54
347338	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	FGF Basic	51	59
347339	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	FGF Basic	65.5	66
347340	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	FGF Basic	66	49
347341	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	FGF Basic	56	49
347342	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	FGF Basic	42	73
347343	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	FGF Basic	46	64
347344	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	FGF Basic	42	63
347345	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	FGF Basic	45	73
347346	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	FGF Basic	56	88
347347	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	FGF Basic	43	71
347348	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	FGF Basic	49.5	68
347349	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	FGF Basic	37	57
347350	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	FGF Basic	52	86
347351	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	FGF Basic	39	51
347352	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	FGF Basic	47.5	44
347353	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	FGF Basic	52.5	48
347354	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	FGF Basic	39	62
347355	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	FGF Basic	46.5	56
347356	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	FGF Basic	46	54
347357	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	FGF Basic	38.5	68
347358	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	FGF Basic	42.5	72
347359	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	FGF Basic	37	70
347360	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	FGF Basic	43	61
347361	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	FGF Basic	44	58
347362	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	FGF Basic	40	91
347363	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	FGF Basic	42	88
347364	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	FGF Basic	38.5	54
347365	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	FGF Basic	43	62
347366	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	FGF Basic	36	87
347367	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	FGF Basic	38	73
347368	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	FGF Basic	37	60
347369	20233						RA2159	51112.0										1	FGF Basic	50	68
347370	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	FGF Basic	40.5	72
347371	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	FGF Basic	37	78
347372	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	FGF Basic	39	52
347373	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	FGF Basic	41	73
347374	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	FGF Basic	40.5	66
347375	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	FGF Basic	35	54
347376	20233						N2586	51107.0										1	FGF Basic	38	67
347377	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	FGF Basic	35	68
347378	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	FGF Basic	46.5	44
347379	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	FGF Basic	39	50
347380	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	FGF Basic	49	45
347381	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	FGF Basic	44	68
347382	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	FGF Basic	40.5	88
347383	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	FGF Basic	39	54
347384	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	FGF Basic	42	68
347385	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	FGF Basic	35	57
347386	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	FGF Basic	36	67
347387	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	FGF Basic	36	61
347388	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	FGF Basic	36.5	56
347389	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	FGF Basic	43	90
347390	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	FGF Basic	36	80
347391	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	FGF Basic	37	60
347392	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	FGF Basic	34.5	34
347393	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	FGF Basic	41	46
347394	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	FGF Basic	36	62
347395	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	FGF Basic	41	37
347396	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	FGF Basic	42.5	82
347397	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	FGF Basic	33	77
347398	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	FGF Basic	35	71
347399	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	FGF Basic	40	50
347400	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	FGF Basic	36	97
347401	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	FGF Basic	37	85
347402	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	FGF Basic	38.5	80
347403	20233						RA2159	51112.0										1	FGF Basic	37	68
347404	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	FGF Basic	33	67
347405	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	FGF Basic	34	54
347406	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	FGF Basic	35.5	76
347407	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	FGF Basic	37.5	52
347408	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	FGF Basic	37	65
347409	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	FGF Basic	36.5	64
347410	20233						N2586	51107.0										1	FGF Basic	46	77
347411	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	FGF Basic	39.5	80
347412	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	FGF Basic	42	73
347413	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	FGF Basic	42.5	62
347414	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	FGF Basic	48.5	66
347415	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	FGF Basic	42	61
347416	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	FGF Basic	44	77
347417	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	FGF Basic	40	65
347418	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	FGF Basic	47	53
347419	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	FGF Basic	48	51
347420	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	FGF Basic	42	27
347421	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	FGF Basic	45.5	62
347422	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	FGF Basic	41.5	34
347423	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	FGF Basic	39.5	52
347424	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	FGF Basic	38	59
347425	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	FGF Basic	33.5	52
347426	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	FGF Basic	37.5	70
347427	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	FGF Basic	33	62
347428	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	FGF Basic	31	66
347429	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	FGF Basic	36	47
347430	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	FGF Basic	42	54
347431	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	FGF Basic	35	71
347432	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	FGF Basic	34	68
347433	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	FGF Basic	37	52
347434	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	FGF Basic	38	44
347435	20233						RA2159	51112.0										1	FGF Basic	32	43
347436	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	FGF Basic	41	73
347437	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	FGF Basic	37	87
347438	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	FGF Basic	49	47
347439	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	FGF Basic	33	77
347440	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	FGF Basic	37	65
347441	20233						RA2159	51112.0										1	FGF Basic	33.5	70
347442	20233						N2586	51107.0										1	FGF Basic	33	63
347443	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	FGF Basic	37	80
347444	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	FGF Basic	43	68
347445	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	FGF Basic	32	56
347446	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	FGF Basic	36	65
347447	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	FGF Basic	39	64
347448	20233						N2586	51107.0										1	FGF Basic	36	50
347449	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	FGF Basic	39	47
347450	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	FGF Basic	37	77
347451	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	FGF Basic	35.5	74
347452	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	FGF Basic	36	72
347453	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	FGF Basic	33	45
347454	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	FGF Basic	35	74
347455	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	FGF Basic	33	66
347456	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	FGF Basic	43.5	56
347457	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	FGF Basic	45	65
347458	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	FGF Basic	39	61
347459	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	FGF Basic	35	63
347460	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	FGF Basic	33	50
347461	20233																	0	FGF Basic	35	57
347462	20233						RA2159	51112.0								2	ug/mL	1	FGF Basic	49	61
347463	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	FGF Basic	40	52
347464	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	FGF Basic	43	65
347465	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	FGF Basic	42	53
347466	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	FGF Basic	47.5	66
347467	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	FGF Basic	38	66
347468	20233						N2586	51107.0								2	ug/mL	1	FGF Basic	49.5	40
347469	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	FGF Basic	51	76
347470	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	FGF Basic	35.5	64
347471	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	FGF Basic	40	47
347472	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	FGF Basic	48	57
347473	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	FGF Basic	45	44
347474	20233																	0	FGF Basic	35	53
347475	20233						RA2159	51112.0										2	FGF Basic	40	70
347476	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	FGF Basic	38	73
347477	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	FGF Basic	40	59
347478	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	FGF Basic	36.5	64
347479	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	FGF Basic	41	56
347480	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	FGF Basic	42.5	56
347481	20233						RA2159	51112.0										2	FGF Basic	38	49
347482	20233						N2586	51107.0										2	FGF Basic	36.5	52
347483	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	FGF Basic	40.5	68
347484	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	FGF Basic	30	61
347485	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	FGF Basic	39	55
347486	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	FGF Basic	53	63
347487	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	FGF Basic	40.5	44
347488	20233						N2586	51107.0										2	FGF Basic	42	42
347489	20233																	0	FGF Basic	37	45
347490	20233																	0	FGF Basic	39	46
347491	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	FGF Basic	55	83
347492	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	FGF Basic	55.5	84
347493	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	FGF Basic	57	76
347494	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	FGF Basic	52	60
347495	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	FGF Basic	42	63
347496	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	FGF Basic	44.5	60
347497	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	FGF Basic	39	60
347498	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	FGF Basic	61	40
347499	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	FGF Basic	50.5	60
347500	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	FGF Basic	62.5	64
347501	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	FGF Basic	53	60
347502	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	FGF Basic	58	45
347503	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	FGF Basic	59	64
347504	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	FGF Basic	42	39
347505	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	FGF Basic	59	51
347506	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	FGF Basic	52	80
347507	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	FGF Basic	48	69
347508	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	FGF Basic	62	69
347509	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	FGF Basic	59	69
347510	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	FGF Basic	46.5	72
347511	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	FGF Basic	39	44
347512	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	FGF Basic	57	51
347513	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	FGF Basic	47	64
347514	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	FGF Basic	53	66
347515	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	FGF Basic	61	65
347516	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	FGF Basic	59	51
347517	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	FGF Basic	52	46
347518	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	FGF Basic	37	40
347519	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	FGF Basic	40	75
347520	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	FGF Basic	40	55
347521	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	FGF Basic	37	66
347522	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	FGF Basic	45	45
347523	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	FGF Basic	41	63
347524	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	FGF Basic	38.5	80
347525	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	FGF Basic	35.5	64
347526	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	FGF Basic	37	53
347527	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	FGF Basic	38	67
347528	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	FGF Basic	37	57
347529	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	FGF Basic	44	44
347530	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	FGF Basic	42	63
347531	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	FGF Basic	38	58
347532	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	FGF Basic	38	47
347533	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	FGF Basic	38	60
347534	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	FGF Basic	36	70
347535	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	FGF Basic	39.5	84
347536	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	FGF Basic	39.5	68
347537	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	FGF Basic	40	65
347538	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	FGF Basic	43	43
347539	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	FGF Basic	30	67
347540	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	FGF Basic	34	54
347541	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	FGF Basic	37.5	66
347542	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	FGF Basic	37	52
347543	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	FGF Basic	41	75
347544	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	FGF Basic	42	53
347545	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	FGF Basic	41	59
347546	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	FGF Basic	34	60
347547	20233						RA2159	51112.0										2	FGF Basic	42	73
347548	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	FGF Basic	37.5	54
347549	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	FGF Basic	38.5	76
347550	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	FGF Basic	36	62
347551	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	FGF Basic	33	56
347552	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	FGF Basic	37.5	70
347553	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	FGF Basic	32	31
347554	20233						N2586	51107.0										2	FGF Basic	34	55
347555	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	FGF Basic	33	69
347556	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	FGF Basic	43.5	48
347557	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	FGF Basic	38.5	64
347558	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	FGF Basic	38	64
347559	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	FGF Basic	32	47
347560	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	FGF Basic	39	42
347561	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	FGF Basic	40	67
347562	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	FGF Basic	40	71
347563	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	FGF Basic	33	73
347564	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	FGF Basic	36	57
347565	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	FGF Basic	36	71
347566	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	FGF Basic	37	65
347567	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	FGF Basic	31.5	60
347568	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	FGF Basic	42	79
347569	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	FGF Basic	35	68
347570	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	FGF Basic	35	65
347571	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	FGF Basic	36	49
347572	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	FGF Basic	10	78
347573	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	FGF Basic	39.5	92
347574	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	FGF Basic	38	36
347575	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	FGF Basic	38	85
347576	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	FGF Basic	37.5	82
347577	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	FGF Basic	31	79
347578	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	FGF Basic	36	72
347579	20233						RA2159	51112.0										2	FGF Basic	39	59
347580	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	FGF Basic	36	79
347581	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	FGF Basic	32	54
347582	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	FGF Basic	35	45
347583	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	FGF Basic	35.5	62
347584	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	FGF Basic	45	59
347585	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	FGF Basic	37	58
347586	20233						N2586	51107.0										2	FGF Basic	10	63
347587	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	FGF Basic	38	96
347588	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	FGF Basic	47	70
347589	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	FGF Basic	40	63
347590	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	FGF Basic	42.5	74
347591	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	FGF Basic	42.5	70
347592	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	FGF Basic	44	45
347593	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	FGF Basic	41	80
347594	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	FGF Basic	46	61
347595	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	FGF Basic	41	60
347596	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	FGF Basic	38	57
347597	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	FGF Basic	41	42
347598	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	FGF Basic	41.5	38
347599	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	FGF Basic	32	67
347600	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	FGF Basic	34	55
347601	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	FGF Basic	32	67
347602	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	FGF Basic	37	83
347603	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	FGF Basic	32.5	66
347604	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	FGF Basic	34	73
347605	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	FGF Basic	38	86
347606	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	FGF Basic	35	48
347607	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	FGF Basic	40	48
347608	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	FGF Basic	39	56
347609	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	FGF Basic	39.5	52
347610	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	FGF Basic	33	64
347611	20233						RA2159	51112.0										2	FGF Basic	29	59
347612	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	FGF Basic	33	69
347613	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	FGF Basic	37	64
347614	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	FGF Basic	39	50
347615	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	FGF Basic	31	76
347616	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	FGF Basic	28	59
347617	20233						RA2159	51112.0										2	FGF Basic	43	45
347618	20233						N2586	51107.0										2	FGF Basic	35	55
347619	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	FGF Basic	38	48
347620	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	FGF Basic	39.5	50
347621	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	FGF Basic	33	45
347622	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	FGF Basic	38	51
347623	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	FGF Basic	37	39
347624	20233						N2586	51107.0										2	FGF Basic	33.5	50
347625	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	FGF Basic	33	64
347626	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	FGF Basic	33.5	56
347627	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	FGF Basic	31.5	70
347628	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	FGF Basic	27	40
347629	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	FGF Basic	35	48
347630	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	FGF Basic	31	41
347631	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	FGF Basic	29	51
347632	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	FGF Basic	33	39
347633	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	FGF Basic	29.5	40
347634	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	FGF Basic	35	30
347635	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	FGF Basic	38.5	36
347636	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	FGF Basic	35.5	36
347637	20233																	0	FGF Basic	31	45
347638	20233						RA2159	51112.0								2	ug/mL	2	FGF Basic	48	57
347639	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	FGF Basic	39	61
347640	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	FGF Basic	38	63
347641	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	FGF Basic	39	59
347642	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	FGF Basic	35	49
347643	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	FGF Basic	40	44
347644	20233						N2586	51107.0								2	ug/mL	2	FGF Basic	45	42
347645	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	FGF Basic	40	43
347646	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	FGF Basic	44.5	50
347647	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	FGF Basic	48	32
347648	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	FGF Basic	49	35
347649	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	FGF Basic	40	49
347650	20233																	0	FGF Basic	31.5	72
347651	20233						RA2159	51112.0								2	ug/mL	3	FGF Basic	51	60
347652	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	FGF Basic	46	66
347653	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	FGF Basic	34	66
347654	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	FGF Basic	46	68
347655	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	FGF Basic	48	89
347656	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	FGF Basic	42	81
347657	20233						N2586	51107.0								2	ug/mL	3	FGF Basic	57.5	78
347658	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	FGF Basic	51	72
347659	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	FGF Basic	50	64
347660	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	FGF Basic	58.5	64
347661	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	FGF Basic	422	75
347662	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	FGF Basic	55	71
347663	20233						RA2159	51112.0										3	FGF Basic	31.5	64
347664	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	FGF Basic	33	49
347665	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	FGF Basic	35	63
347666	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	FGF Basic	39	67
347667	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	FGF Basic	31	75
347668	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	FGF Basic	39	64
347669	20233						RA2159	51112.0										3	FGF Basic	34	86
347670	20233						N2586	51107.0										3	FGF Basic	35	59
347671	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	FGF Basic	36	72
347672	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	FGF Basic	34	59
347673	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	FGF Basic	37	71
347674	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	FGF Basic	44.5	82
347675	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	FGF Basic	42	61
347676	20233						N2586	51107.0										3	FGF Basic	41	56
347677	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	FGF Basic	35	70
347678	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	FGF Basic	36	49
347679	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	FGF Basic	36.5	82
347680	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	FGF Basic	35	74
347681	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	FGF Basic	34	61
347682	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	FGF Basic	35	74
347683	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	FGF Basic	40	69
347684	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	FGF Basic	35	67
347685	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	FGF Basic	40	85
347686	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	FGF Basic	40.5	42
347687	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	FGF Basic	59.5	58
347688	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	FGF Basic	44	65
347689	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	FGF Basic	36.5	76
347690	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	FGF Basic	28	64
347691	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	FGF Basic	24	70
347692	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	FGF Basic	35	67
347693	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	FGF Basic	30	77
347694	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	FGF Basic	40	66
347695	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	FGF Basic	35	73
347696	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	FGF Basic	40	68
347697	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	FGF Basic	35	73
347698	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	FGF Basic	39	74
347699	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	FGF Basic	94	68
347700	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	FGF Basic	37	59
347701	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	FGF Basic	44.5	64
347702	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	FGF Basic	41	73
347703	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	FGF Basic	45.5	70
347704	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	FGF Basic	41	63
347705	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	FGF Basic	41	87
347706	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	FGF Basic	42	79
347707	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	FGF Basic	44.5	68
347708	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	FGF Basic	43.5	60
347709	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	FGF Basic	46	74
347710	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	FGF Basic	47.5	72
347711	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	FGF Basic	51	59
347712	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	FGF Basic	44	51
347713	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	FGF Basic	32	70
347714	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	FGF Basic	30	80
347715	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	FGF Basic	35	69
347716	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	FGF Basic	34	65
347717	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	FGF Basic	33	89
347718	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	FGF Basic	33	53
347719	20233						RA2159	51112.0										3	FGF Basic	30	71
347720	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	FGF Basic	37.5	64
347721	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	FGF Basic	33	52
347722	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	FGF Basic	32.5	86
347723	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	FGF Basic	38	65
347724	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	FGF Basic	206.5	84
347725	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	FGF Basic	39	58
347726	20233						N2586	51107.0										3	FGF Basic	35.5	72
347727	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	FGF Basic	27	68
347728	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	FGF Basic	34	61
347729	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	FGF Basic	32	66
347730	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	FGF Basic	37	56
347731	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	FGF Basic	23	76
347732	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	FGF Basic	35	65
347733	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	FGF Basic	32	71
347734	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	FGF Basic	35	71
347735	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	FGF Basic	34	72
347736	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	FGF Basic	34	51
347737	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	FGF Basic	35.5	60
347738	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	FGF Basic	137.5	76
347739	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	FGF Basic	20.5	62
347740	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	FGF Basic	35	49
347741	20233						RA2159	51112.0										3	FGF Basic	29.5	60
347742	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	FGF Basic	31	58
347743	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	FGF Basic	32	53
347744	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	FGF Basic	31	61
347745	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	FGF Basic	31.5	60
347746	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	FGF Basic	32	53
347747	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	FGF Basic	30	76
347748	20233						N2586	51107.0										3	FGF Basic	36.5	76
347749	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	FGF Basic	30	72
347750	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	FGF Basic	33	60
347751	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	FGF Basic	35.5	80
347752	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	FGF Basic	201	49
347753	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	FGF Basic	36	71
347754	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	FGF Basic	29	63
347755	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	FGF Basic	33	58
347756	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	FGF Basic	36	61
347757	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	FGF Basic	33	73
347758	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	FGF Basic	35.5	58
347759	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	FGF Basic	35.5	78
347760	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	FGF Basic	33	59
347761	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	FGF Basic	36	70
347762	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	FGF Basic	37	73
347763	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	FGF Basic	24.5	82
347764	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	FGF Basic	35	73
347765	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	FGF Basic	51	65
347766	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	FGF Basic	44	70
347767	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	FGF Basic	36	69
347768	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	FGF Basic	38.5	58
347769	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	FGF Basic	37	74
347770	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	FGF Basic	35	68
347771	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	FGF Basic	28.5	58
347772	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	FGF Basic	36	82
347773	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	FGF Basic	28	70
347774	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	FGF Basic	39	69
347775	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	FGF Basic	37	69
347776	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	FGF Basic	38	64
347777	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	FGF Basic	39	75
347778	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	FGF Basic	354.5	74
347779	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	FGF Basic	47	63
347780	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	FGF Basic	36	62
347781	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	FGF Basic	46	66
347782	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	FGF Basic	46	66
347783	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	FGF Basic	41	79
347784	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	FGF Basic	57	69
347785	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	FGF Basic	49	72
347786	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	FGF Basic	36	61
347787	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	FGF Basic	27	51
347788	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	FGF Basic	54	81
347789	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	FGF Basic	48	84
347790	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	FGF Basic	54	71
347791	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	FGF Basic	56	65
347792	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	FGF Basic	712	63
347793	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	FGF Basic	53	77
347794	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	FGF Basic	28	81
347795	20233																	0	FGF Basic	32	61
347796	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	FGF Basic	61	43
347797	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	FGF Basic	53	45
347798	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	FGF Basic	53	69
347799	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	FGF Basic	46	74
347800	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	FGF Basic	50.5	70
347801	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	FGF Basic	49	80
347802	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	FGF Basic	28	70
347803	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	FGF Basic	56	73
347804	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	FGF Basic	48	64
347805	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	FGF Basic	54	59
347806	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	FGF Basic	30.5	54
347807	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	FGF Basic	573	72
347808	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	FGF Basic	60	61
347809	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	FGF Basic	32	67
347810	20233																	0	FGF Basic	28	47
347811	20233						RA2159	51112.0										3	FGF Basic	33.5	60
347812	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	FGF Basic	37	59
347813	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	FGF Basic	29.5	66
347814	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	FGF Basic	36	57
347815	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	FGF Basic	28.5	46
347816	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	FGF Basic	28	87
347817	20233						RA2159	51112.0										3	FGF Basic	31	66
347818	20233						N2586	51107.0										3	FGF Basic	37	66
347819	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	FGF Basic	30	73
347820	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	FGF Basic	34	62
347821	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	FGF Basic	24	51
347822	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	FGF Basic	39	49
347823	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	FGF Basic	31	55
347824	20233						N2586	51107.0										3	FGF Basic	30	44
347825	20233																	0	FGF Basic	29	61
347826	20233						RA2159	51112.0								2	ug/mL	4	FGF Basic	58.5	60
347827	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	FGF Basic	48	59
347828	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	FGF Basic	48	67
347829	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	FGF Basic	42	59
347830	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	FGF Basic	50.5	76
347831	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	FGF Basic	49	51
347832	20233						N2586	51107.0								2	ug/mL	4	FGF Basic	51.5	60
347833	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	FGF Basic	52	76
347834	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	FGF Basic	37	65
347835	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	FGF Basic	49	65
347836	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	FGF Basic	42	67
347837	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	FGF Basic	39	64
347838	20233						RA2159	51112.0										4	FGF Basic	31	48
347839	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	FGF Basic	35	67
347840	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	FGF Basic	30	53
347841	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	FGF Basic	37.5	76
347842	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	FGF Basic	28.5	62
347843	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	FGF Basic	34	67
347844	20233						RA2159	51112.0										4	FGF Basic	37	61
347845	20233						N2586	51107.0										4	FGF Basic	30.5	64
347846	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	FGF Basic	34	58
347847	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	FGF Basic	30	50
347848	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	FGF Basic	31	53
347849	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	FGF Basic	39	61
347850	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	FGF Basic	32	79
347851	20233						N2586	51107.0										4	FGF Basic	38	67
347852	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	FGF Basic	34.5	58
347853	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	FGF Basic	36	61
347854	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	FGF Basic	40	97
347855	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	FGF Basic	34	73
347856	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	FGF Basic	36.5	68
347857	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	FGF Basic	34.5	64
347858	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	FGF Basic	37	76
347859	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	FGF Basic	34.5	60
347860	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	FGF Basic	32	66
347861	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	FGF Basic	34	56
347862	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	FGF Basic	39	69
347863	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	FGF Basic	33.5	62
347864	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	FGF Basic	34	63
347865	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	FGF Basic	36	62
347866	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	FGF Basic	37.5	76
347867	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	FGF Basic	32	65
347868	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	FGF Basic	34	55
347869	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	FGF Basic	36	64
347870	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	FGF Basic	46	55
347871	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	FGF Basic	32	61
347872	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	FGF Basic	31	78
347873	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	FGF Basic	33	53
347874	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	FGF Basic	35	68
347875	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	FGF Basic	35	88
347876	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	FGF Basic	44	78
347877	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	FGF Basic	52	79
347878	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	FGF Basic	46	71
347879	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	FGF Basic	48	63
347880	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	FGF Basic	46	61
347881	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	FGF Basic	43	35
347882	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	FGF Basic	41	66
347883	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	FGF Basic	45	65
347884	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	FGF Basic	41	55
347885	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	FGF Basic	44	60
347886	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	FGF Basic	43.5	50
347887	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	FGF Basic	48	53
347888	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	FGF Basic	32	75
347889	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	FGF Basic	35	50
347890	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	FGF Basic	39.5	74
347891	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	FGF Basic	33	75
347892	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	FGF Basic	31	56
347893	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	FGF Basic	35	53
347894	20233						RA2159	51112.0										4	FGF Basic	36	43
347895	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	FGF Basic	28	66
347896	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	FGF Basic	36	47
347897	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	FGF Basic	35	73
347898	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	FGF Basic	38	66
347899	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	FGF Basic	35	62
347900	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	FGF Basic	33	62
347901	20233						N2586	51107.0										4	FGF Basic	36.5	74
347902	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	FGF Basic	35.5	70
347903	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	FGF Basic	38	61
347904	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	FGF Basic	34.5	42
347905	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	FGF Basic	31	49
347906	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	FGF Basic	30	41
347907	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	FGF Basic	36	41
347908	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	FGF Basic	34	65
347909	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	FGF Basic	33	54
347910	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	FGF Basic	30	54
347911	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	FGF Basic	32	59
347912	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	FGF Basic	36.5	60
347913	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	FGF Basic	31	75
347914	20233						RA2159	51112.0										4	FGF Basic	36	55
347915	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	FGF Basic	34	77
347916	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	FGF Basic	29.5	68
347917	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	FGF Basic	33	67
347918	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	FGF Basic	30	48
347919	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	FGF Basic	32	51
347920	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	FGF Basic	30	67
347921	20233						N2586	51107.0										4	FGF Basic	30.5	50
347922	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	FGF Basic	30	61
347923	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	FGF Basic	31	55
347924	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	FGF Basic	33	78
347925	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	FGF Basic	30	68
347926	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	FGF Basic	33	57
347927	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	FGF Basic	34.5	52
347928	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	FGF Basic	28	61
347929	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	FGF Basic	35	69
347930	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	FGF Basic	32	73
347931	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	FGF Basic	37	56
347932	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	FGF Basic	32.5	56
347933	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	FGF Basic	33	64
347934	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	FGF Basic	30	67
347935	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	FGF Basic	35.5	56
347936	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	FGF Basic	35	59
347937	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	FGF Basic	33	60
347938	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	FGF Basic	37	63
347939	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	FGF Basic	25	46
347940	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	FGF Basic	34	77
347941	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	FGF Basic	2166	75
347942	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	FGF Basic	35.5	48
347943	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	FGF Basic	32	81
347944	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	FGF Basic	27.5	46
347945	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	FGF Basic	32	45
347946	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	FGF Basic	32.5	62
347947	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	FGF Basic	33	58
347948	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	FGF Basic	29.5	38
347949	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	FGF Basic	34	53
347950	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	FGF Basic	36.5	72
347951	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	FGF Basic	35	67
347952	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	FGF Basic	43	56
347953	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	FGF Basic	38.5	70
347954	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	FGF Basic	32	68
347955	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	FGF Basic	27.5	64
347956	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	FGF Basic	55	41
347957	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	FGF Basic	45	70
347958	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	FGF Basic	51.5	80
347959	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	FGF Basic	49	52
347960	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	FGF Basic	50.5	46
347961	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	FGF Basic	50.5	60
347962	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	FGF Basic	31	58
347963	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	FGF Basic	49.5	58
347964	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	FGF Basic	57	51
347965	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	FGF Basic	48	51
347966	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	FGF Basic	53	39
347967	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	FGF Basic	42	61
347968	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	FGF Basic	25	39
347969	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	FGF Basic	29	40
347970	20233																	0	FGF Basic	27	50
347971	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	FGF Basic	55.5	72
347972	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	FGF Basic	45	44
347973	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	FGF Basic	45	69
347974	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	FGF Basic	45	61
347975	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	FGF Basic	40	49
347976	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	FGF Basic	47	47
347977	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	FGF Basic	27	67
347978	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	FGF Basic	52	62
347979	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	FGF Basic	59	51
347980	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	FGF Basic	52	53
347981	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	FGF Basic	55.5	40
347982	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	FGF Basic	56	52
347983	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	FGF Basic	2045	41
347984	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	FGF Basic	33	68
347985	20233																	0	FGF Basic	26	69
347986	20233						RA2159	51112.0										4	FGF Basic	33	81
347987	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	FGF Basic	34	60
347988	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	FGF Basic	31	69
347989	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	FGF Basic	28	87
347990	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	FGF Basic	28	72
347991	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	FGF Basic	34	44
347992	20233						RA2159	51112.0										4	FGF Basic	27.5	56
347993	20233						N2586	51107.0										4	FGF Basic	32	69
347994	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	FGF Basic	31	45
347995	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	FGF Basic	33	66
347996	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	FGF Basic	29	48
347997	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	FGF Basic	32	46
347998	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	FGF Basic	29	59
347999	20233						N2586	51107.0										4	FGF Basic	30	51
348000	20233								TNF-a	201285.0						100	ng/mL	0	FGF Basic	91	66
348001	20233								IL-1 alpha	201286.0						100	ng/mL	0	FGF Basic	37	75
348002	20233								IL-6	201287.0						100	ug/mL	0	FGF Basic	55.5	92
348003	20233								IL-17A	201288.0						100	ng/mL	0	FGF Basic	49	71
348004	20233								EGF	201289.0						100	ng/mL	0	FGF Basic	33	77
348005	20233								IGF-I	201290.0						100	ug/mL	0	FGF Basic	35.5	64
348006	20233								Adiponectin	201291.0						5	ng/mL	0	FGF Basic	73.5	60
348007	20233								Leptin	201292.0						1	ng/mL	0	FGF Basic	43.5	56
348008	20233								Visfatin	201293.0						1	ng/mL	0	FGF Basic	45.5	52
348009	20233															2	ug/mL	0	FGF Basic	39.5	68
348010	20233								TNF-a	201285.0						100	ng/mL	0	FGF Basic	73	69
348011	20233								IL-1 alpha	201286.0						100	ng/mL	0	FGF Basic	38	46
348012	20233								IL-6	201287.0						100	ug/mL	0	FGF Basic	55	63
348013	20233								IL-17A	201288.0						100	ng/mL	0	FGF Basic	55	59
348014	20233								EGF	201289.0						100	ng/mL	0	FGF Basic	41	44
348015	20233								IGF-I	201290.0						100	ug/mL	0	FGF Basic	35	69
348016	20233								Adiponectin	201291.0						5	ng/mL	0	FGF Basic	77	47
348017	20233								Leptin	201292.0						1	ng/mL	0	FGF Basic	41	39
348018	20233								Visfatin	201293.0						1	ng/mL	0	FGF Basic	45	58
348019	20233															2	ug/mL	0	FGF Basic	37	45
348020	20233								TNF-a	201285.0						100	ng/mL	0	FGF Basic	87	74
348021	20233								IL-1 alpha	201286.0						100	ng/mL	0	FGF Basic	29	79
348022	20233								IL-6	201287.0						100	ug/mL	0	FGF Basic	46.5	60
348023	20233								IL-17A	201288.0						100	ng/mL	0	FGF Basic	46	71
348024	20233								EGF	201289.0						100	ng/mL	0	FGF Basic	31	69
348025	20233								IGF-I	201290.0						100	ug/mL	0	FGF Basic	31	53
348026	20233								Adiponectin	201291.0						5	ng/mL	0	FGF Basic	61	55
348027	20233								Leptin	201292.0						1	ng/mL	0	FGF Basic	26	53
348028	20233								Visfatin	201293.0						1	ng/mL	0	FGF Basic	35	72
348029	20233															2	ug/mL	0	FGF Basic	33	66
348030	20233								TNF-a	201285.0						100	ng/mL	0	FGF Basic	79	71
348031	20233								IL-1 alpha	201286.0						100	ng/mL	0	FGF Basic	33	52
348032	20233								IL-6	201287.0						100	ug/mL	0	FGF Basic	42	45
348033	20233								IL-17A	201288.0						100	ng/mL	0	FGF Basic	53	42
348034	20233								EGF	201289.0						100	ng/mL	0	FGF Basic	28.5	64
348035	20233								IGF-I	201290.0						100	ug/mL	0	FGF Basic	27	59
348036	20233								Adiponectin	201291.0						5	ng/mL	0	FGF Basic	67	51
348037	20233								Leptin	201292.0						1	ng/mL	0	FGF Basic	28	49
348038	20233								Visfatin	201293.0						1	ng/mL	0	FGF Basic	38	43
348039	20233															2	ug/mL	0	FGF Basic	28	67
348040	20233																	0	VEGF	52.5	54
348041	20233						RA2159	51112.0										1	VEGF	673	67
348042	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	VEGF	739	63
348043	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	VEGF	600	60
348044	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	VEGF	672	68
348045	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	VEGF	835.5	68
348046	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	VEGF	866.5	64
348047	20233						RA2159	51112.0										1	VEGF	919	73
348048	20233						N2586	51107.0										1	VEGF	1185.5	70
348049	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	VEGF	1116.5	64
348050	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	VEGF	959	51
348051	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	VEGF	760.5	64
348052	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	VEGF	574	76
348053	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	VEGF	486	45
348054	20233						N2586	51107.0										1	VEGF	1343.5	30
348055	20233																	0	VEGF	54	56
348056	20233																	0	VEGF	50	40
348057	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	VEGF	1047	44
348058	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	VEGF	869	79
348059	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	VEGF	649	52
348060	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	VEGF	404	62
348061	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	VEGF	835	55
348062	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	VEGF	906	63
348063	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	VEGF	506	62
348064	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	VEGF	1069	74
348065	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	VEGF	1337	49
348066	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	VEGF	1048.5	68
348067	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	VEGF	1467	37
348068	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	VEGF	958	33
348069	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	VEGF	707.5	56
348070	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	VEGF	1240	37
348071	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	VEGF	962	39
348072	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	VEGF	1187	71
348073	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	VEGF	642	67
348074	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	VEGF	1130	60
348075	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	VEGF	1069.5	56
348076	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	VEGF	619.5	72
348077	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	VEGF	695	75
348078	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	VEGF	1595	70
348079	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	VEGF	1535	51
348080	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	VEGF	1255	65
348081	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	VEGF	1540	46
348082	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	VEGF	1744.5	46
348083	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	VEGF	1167.5	50
348084	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	VEGF	756	57
348085	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	VEGF	1042.5	82
348086	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	VEGF	731	70
348087	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	VEGF	596	74
348088	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	VEGF	489	69
348089	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	VEGF	572	59
348090	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	VEGF	701	49
348091	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	VEGF	389	55
348092	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	VEGF	962	69
348093	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	VEGF	800	54
348094	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	VEGF	1011	48
348095	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	VEGF	1172	46
348096	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	VEGF	1098	66
348097	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	VEGF	1075.5	68
348098	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	VEGF	964.5	40
348099	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	VEGF	683	53
348100	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	VEGF	570	61
348101	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	VEGF	579	71
348102	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	VEGF	801	56
348103	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	VEGF	562	52
348104	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	VEGF	685.5	64
348105	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	VEGF	1020	58
348106	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	VEGF	1186	50
348107	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	VEGF	1386	51
348108	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	VEGF	826	50
348109	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	VEGF	1159	58
348110	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	VEGF	714	78
348111	20233						RA2159	51112.0										1	VEGF	896.5	56
348112	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	VEGF	567	75
348113	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	VEGF	768	68
348114	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	VEGF	566.5	62
348115	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	VEGF	667	39
348116	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	VEGF	626.5	60
348117	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	VEGF	686.5	56
348118	20233						N2586	51107.0										1	VEGF	947.5	66
348119	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	VEGF	941	60
348120	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	VEGF	1346	54
348121	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	VEGF	1011	55
348122	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	VEGF	1400	51
348123	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	VEGF	997.5	78
348124	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	VEGF	807	74
348125	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	VEGF	1017	56
348126	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	VEGF	642	40
348127	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	VEGF	716.5	50
348128	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	VEGF	475.5	60
348129	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	VEGF	757.5	72
348130	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	VEGF	753.5	66
348131	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	VEGF	410	79
348132	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	VEGF	1034	71
348133	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	VEGF	1226	67
348134	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	VEGF	850	59
348135	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	VEGF	1206	38
348136	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	VEGF	1088.5	66
348137	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	VEGF	929	37
348138	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	VEGF	1057	55
348139	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	VEGF	762.5	66
348140	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	VEGF	407.5	50
348141	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	VEGF	890	59
348142	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	VEGF	843.5	76
348143	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	VEGF	731	84
348144	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	VEGF	705	63
348145	20233						RA2159	51112.0										1	VEGF	706	56
348146	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	VEGF	1258	64
348147	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	VEGF	1107	43
348148	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	VEGF	1179.5	62
348149	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	VEGF	1032	55
348150	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	VEGF	1026	49
348151	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	VEGF	1079.5	72
348152	20233						N2586	51107.0										1	VEGF	1134.5	100
348153	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	VEGF	562	53
348154	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	VEGF	367.5	70
348155	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	VEGF	486	62
348156	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	VEGF	634	55
348157	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	VEGF	486	67
348158	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	VEGF	329	75
348159	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	VEGF	492	45
348160	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	VEGF	783	59
348161	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	VEGF	751	58
348162	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	VEGF	574.5	50
348163	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	VEGF	539	59
348164	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	VEGF	666	51
348165	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	VEGF	693	57
348166	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	VEGF	744.5	46
348167	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	VEGF	777	63
348168	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	VEGF	643	63
348169	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	VEGF	624.5	50
348170	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	VEGF	601	77
348171	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	VEGF	1118	55
348172	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	VEGF	1015.5	46
348173	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	VEGF	951	47
348174	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	VEGF	646.5	64
348175	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	VEGF	833	57
348176	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	VEGF	1037	35
348177	20233						RA2159	51112.0										1	VEGF	715	51
348178	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	VEGF	1099	81
348179	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	VEGF	745	65
348180	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	VEGF	983	50
348181	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	VEGF	748	66
348182	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	VEGF	716.5	70
348183	20233						RA2159	51112.0										1	VEGF	689	69
348184	20233						N2586	51107.0										1	VEGF	1211	61
348185	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	VEGF	1122.5	60
348186	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	VEGF	1254	59
348187	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	VEGF	884	57
348188	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	VEGF	1116	63
348189	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	VEGF	1066	57
348190	20233						N2586	51107.0										1	VEGF	1113	65
348191	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	VEGF	833.5	52
348192	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	VEGF	913	66
348193	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	VEGF	861	61
348194	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	VEGF	837	72
348195	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	VEGF	774	32
348196	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	VEGF	393.5	76
348197	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	VEGF	764	61
348198	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	VEGF	512	57
348199	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	VEGF	1275	52
348200	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	VEGF	822	54
348201	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	VEGF	663	41
348202	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	VEGF	974.5	28
348203	20233																	0	VEGF	45	66
348204	20233						RA2159	51112.0								2	ug/mL	1	VEGF	881	49
348205	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	VEGF	734	54
348206	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	VEGF	646	60
348207	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	VEGF	798.5	46
348208	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	VEGF	861.5	42
348209	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	VEGF	733	57
348210	20233						N2586	51107.0								2	ug/mL	1	VEGF	1212	39
348211	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	VEGF	1149	57
348212	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	VEGF	809	73
348213	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	VEGF	1065	37
348214	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	VEGF	882.5	60
348215	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	VEGF	1164	46
348216	20233																	0	VEGF	56	55
348217	20233						RA2159	51112.0										2	VEGF	688	74
348218	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	VEGF	411	81
348219	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	VEGF	720	46
348220	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	VEGF	463	45
348221	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	VEGF	699	61
348222	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	VEGF	554	73
348223	20233						RA2159	51112.0										2	VEGF	411	55
348224	20233						N2586	51107.0										2	VEGF	1018	42
348225	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	VEGF	644	57
348226	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	VEGF	1117.5	48
348227	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	VEGF	580	44
348228	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	VEGF	1354	39
348229	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	VEGF	1194	49
348230	20233						N2586	51107.0										2	VEGF	1380.5	44
348231	20233																	0	VEGF	44	41
348232	20233																	0	VEGF	50	37
348233	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	VEGF	1014	55
348234	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	VEGF	585	76
348235	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	VEGF	688	45
348236	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	VEGF	784	59
348237	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	VEGF	522	56
348238	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	VEGF	738	55
348239	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	VEGF	707	58
348240	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	VEGF	1304.5	48
348241	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	VEGF	882	66
348242	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	VEGF	1244	59
348243	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	VEGF	847	75
348244	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	VEGF	1393	37
348245	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	VEGF	983.5	44
348246	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	VEGF	1042	35
348247	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	VEGF	897	53
348248	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	VEGF	648	75
348249	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	VEGF	368	73
348250	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	VEGF	1007.5	54
348251	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	VEGF	861	65
348252	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	VEGF	715	65
348253	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	VEGF	744.5	62
348254	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	VEGF	978	57
348255	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	VEGF	565	73
348256	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	VEGF	820.5	58
348257	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	VEGF	1293	65
348258	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	VEGF	1251	49
348259	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	VEGF	1013	47
348260	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	VEGF	921	43
348261	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	VEGF	643	81
348262	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	VEGF	599	45
348263	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	VEGF	410	57
348264	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	VEGF	401.5	58
348265	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	VEGF	498	56
348266	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	VEGF	444	58
348267	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	VEGF	608.5	52
348268	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	VEGF	1036	63
348269	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	VEGF	629	59
348270	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	VEGF	1008.5	60
348271	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	VEGF	1004.5	46
348272	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	VEGF	864	59
348273	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	VEGF	812.5	44
348274	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	VEGF	1085.5	50
348275	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	VEGF	679	69
348276	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	VEGF	645	73
348277	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	VEGF	430	67
348278	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	VEGF	626	50
348279	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	VEGF	553	47
348280	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	VEGF	882	43
348281	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	VEGF	455	53
348282	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	VEGF	1304	55
348283	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	VEGF	1075	63
348284	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	VEGF	460	59
348285	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	VEGF	953	72
348286	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	VEGF	1151	59
348287	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	VEGF	1165	71
348288	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	VEGF	1015	57
348289	20233						RA2159	51112.0										2	VEGF	709.5	50
348290	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	VEGF	539	55
348291	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	VEGF	523	59
348292	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	VEGF	647	37
348293	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	VEGF	522	63
348294	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	VEGF	415	64
348295	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	VEGF	530	40
348296	20233						N2586	51107.0										2	VEGF	978	43
348297	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	VEGF	915	52
348298	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	VEGF	727.5	52
348299	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	VEGF	862.5	70
348300	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	VEGF	802	64
348301	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	VEGF	725	34
348302	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	VEGF	956	56
348303	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	VEGF	452.5	72
348304	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	VEGF	575	56
348305	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	VEGF	526	59
348306	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	VEGF	437	67
348307	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	VEGF	427	64
348308	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	VEGF	581	56
348309	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	VEGF	1006	69
348310	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	VEGF	677	63
348311	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	VEGF	1015	62
348312	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	VEGF	953.5	62
348313	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	VEGF	1010.5	42
348314	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	VEGF	14	66
348315	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	VEGF	448	60
348316	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	VEGF	421	49
348317	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	VEGF	396	76
348318	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	VEGF	532.5	78
348319	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	VEGF	590.5	58
348320	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	VEGF	428	56
348321	20233						RA2159	51112.0										2	VEGF	671	67
348322	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	VEGF	855.5	70
348323	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	VEGF	705	63
348324	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	VEGF	764	57
348325	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	VEGF	883	56
348326	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	VEGF	1177	47
348327	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	VEGF	732	51
348328	20233						N2586	51107.0										2	VEGF	9	55
348329	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	VEGF	551	73
348330	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	VEGF	538.5	44
348331	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	VEGF	206	69
348332	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	VEGF	391	73
348333	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	VEGF	344.5	80
348334	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	VEGF	410.5	42
348335	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	VEGF	711	53
348336	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	VEGF	278	57
348337	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	VEGF	563	45
348338	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	VEGF	484	52
348339	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	VEGF	761	43
348340	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	VEGF	643	51
348341	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	VEGF	754	54
348342	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	VEGF	616	49
348343	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	VEGF	534	63
348344	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	VEGF	593	64
348345	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	VEGF	429.5	66
348346	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	VEGF	411	55
348347	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	VEGF	684	91
348348	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	VEGF	605.5	40
348349	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	VEGF	610	52
348350	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	VEGF	821	64
348351	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	VEGF	960	51
348352	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	VEGF	912.5	54
348353	20233						RA2159	51112.0										2	VEGF	772	52
348354	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	VEGF	759	62
348355	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	VEGF	465.5	60
348356	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	VEGF	701	68
348357	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	VEGF	571	65
348358	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	VEGF	499.5	48
348359	20233						RA2159	51112.0										2	VEGF	537	29
348360	20233						N2586	51107.0										2	VEGF	655.5	54
348361	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	VEGF	1066	57
348362	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	VEGF	1049	61
348363	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	VEGF	1178	43
348364	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	VEGF	856.5	54
348365	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	VEGF	1265	46
348366	20233						N2586	51107.0										2	VEGF	1394	43
348367	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	VEGF	687	61
348368	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	VEGF	605	40
348369	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	VEGF	636	79
348370	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	VEGF	493	47
348371	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	VEGF	532	42
348372	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	VEGF	629	45
348373	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	VEGF	535	41
348374	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	VEGF	1128	45
348375	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	VEGF	946	28
348376	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	VEGF	907	31
348377	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	VEGF	946.5	42
348378	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	VEGF	1222	31
348379	20233																	0	VEGF	39	51
348380	20233						RA2159	51112.0								2	ug/mL	2	VEGF	660.5	60
348381	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	VEGF	412	63
348382	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	VEGF	691.5	72
348383	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	VEGF	514	65
348384	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	VEGF	519.5	32
348385	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	VEGF	687.5	42
348386	20233						N2586	51107.0								2	ug/mL	2	VEGF	1085	46
348387	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	VEGF	993	39
348388	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	VEGF	541	39
348389	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	VEGF	972	33
348390	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	VEGF	1040	27
348391	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	VEGF	1141	36
348392	20233																	0	VEGF	46	71
348393	20233						RA2159	51112.0								2	ug/mL	3	VEGF	1196.5	70
348394	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	VEGF	1115	71
348395	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	VEGF	947	59
348396	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	VEGF	1420.5	66
348397	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	VEGF	1099	62
348398	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	VEGF	870	57
348399	20233						N2586	51107.0								2	ug/mL	3	VEGF	1619	57
348400	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	VEGF	1332	59
348401	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	VEGF	1305.5	56
348402	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	VEGF	1454.5	50
348403	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	VEGF	1506	68
348404	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	VEGF	1496	63
348405	20233						RA2159	51112.0										3	VEGF	949	81
348406	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	VEGF	986	61
348407	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	VEGF	1198	65
348408	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	VEGF	1065	72
348409	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	VEGF	891	65
348410	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	VEGF	894.5	58
348411	20233						RA2159	51112.0										3	VEGF	1057	69
348412	20233						N2586	51107.0										3	VEGF	1607.5	54
348413	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	VEGF	1268	73
348414	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	VEGF	1184.5	66
348415	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	VEGF	1411.5	56
348416	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	VEGF	1575	81
348417	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	VEGF	1384.5	64
348418	20233						N2586	51107.0										3	VEGF	1610	53
348419	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	VEGF	994	65
348420	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	VEGF	1018	54
348421	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	VEGF	990	67
348422	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	VEGF	881.5	64
348423	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	VEGF	912	69
348424	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	VEGF	805	56
348425	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	VEGF	1707.5	52
348426	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	VEGF	1361	53
348427	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	VEGF	1111	59
348428	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	VEGF	1246	39
348429	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	VEGF	1687.5	42
348430	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	VEGF	1417.5	56
348431	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	VEGF	979	73
348432	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	VEGF	895.5	76
348433	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	VEGF	744	65
348434	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	VEGF	1099.5	62
348435	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	VEGF	1093	64
348436	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	VEGF	823	67
348437	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	VEGF	1455	81
348438	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	VEGF	1126	65
348439	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	VEGF	1132	71
348440	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	VEGF	1214	66
348441	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	VEGF	1816	72
348442	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	VEGF	1418	51
348443	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	VEGF	691.5	60
348444	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	VEGF	855	73
348445	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	VEGF	736	67
348446	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	VEGF	824	59
348447	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	VEGF	709.5	60
348448	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	VEGF	673	74
348449	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	VEGF	1538	55
348450	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	VEGF	1087	70
348451	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	VEGF	921	61
348452	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	VEGF	1115	71
348453	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	VEGF	1562.5	56
348454	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	VEGF	1158	67
348455	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	VEGF	1074	55
348456	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	VEGF	1098	51
348457	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	VEGF	898	59
348458	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	VEGF	1041	62
348459	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	VEGF	851	81
348460	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	VEGF	653	67
348461	20233						RA2159	51112.0										3	VEGF	886	54
348462	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	VEGF	1565	61
348463	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	VEGF	1577	51
348464	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	VEGF	1074	63
348465	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	VEGF	1314	62
348466	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	VEGF	1514	76
348467	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	VEGF	1346	73
348468	20233						N2586	51107.0										3	VEGF	1452	68
348469	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	VEGF	800	63
348470	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	VEGF	1026	43
348471	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	VEGF	847	65
348472	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	VEGF	986.5	48
348473	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	VEGF	705	57
348474	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	VEGF	927.5	54
348475	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	VEGF	925.5	68
348476	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	VEGF	1586	53
348477	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	VEGF	1456	68
348478	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	VEGF	1348.5	46
348479	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	VEGF	1473	57
348480	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	VEGF	1407	57
348481	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	VEGF	1223	51
348482	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	VEGF	673	47
348483	20233						RA2159	51112.0										3	VEGF	783	51
348484	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	VEGF	963	52
348485	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	VEGF	928.5	46
348486	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	VEGF	912	51
348487	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	VEGF	846	71
348488	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	VEGF	861.5	68
348489	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	VEGF	570	50
348490	20233						N2586	51107.0										3	VEGF	882	63
348491	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	VEGF	1161	59
348492	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	VEGF	1211.5	48
348493	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	VEGF	1276	61
348494	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	VEGF	1685	57
348495	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	VEGF	1265.5	52
348496	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	VEGF	1282	75
348497	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	VEGF	880	61
348498	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	VEGF	1119.5	52
348499	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	VEGF	1035	79
348500	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	VEGF	917.5	60
348501	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	VEGF	947	54
348502	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	VEGF	811	55
348503	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	VEGF	1545	67
348504	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	VEGF	1097	69
348505	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	VEGF	918	66
348506	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	VEGF	1254	53
348507	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	VEGF	1754	59
348508	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	VEGF	1305	46
348509	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	VEGF	831.5	64
348510	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	VEGF	963	57
348511	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	VEGF	922	67
348512	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	VEGF	875	67
348513	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	VEGF	781.5	66
348514	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	VEGF	810	60
348515	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	VEGF	727.5	66
348516	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	VEGF	1362.5	70
348517	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	VEGF	1318	51
348518	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	VEGF	907.5	62
348519	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	VEGF	1351	63
348520	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	VEGF	1523.5	60
348521	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	VEGF	1269	61
348522	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	VEGF	1350.5	46
348523	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	VEGF	1273	57
348524	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	VEGF	1404	59
348525	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	VEGF	859.5	74
348526	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	VEGF	1391.5	54
348527	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	VEGF	1276.5	60
348528	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	VEGF	767	51
348529	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	VEGF	851	53
348530	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	VEGF	1862	82
348531	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	VEGF	1350.5	62
348532	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	VEGF	1297	56
348533	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	VEGF	1730	56
348534	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	VEGF	1194	35
348535	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	VEGF	1855	58
348536	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	VEGF	1259	77
348537	20233																	0	VEGF	57.5	54
348538	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	VEGF	1038	55
348539	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	VEGF	1051	59
348540	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	VEGF	733	61
348541	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	VEGF	1047.5	76
348542	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	VEGF	927.5	68
348543	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	VEGF	890	71
348544	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	VEGF	729	49
348545	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	VEGF	1524	69
348546	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	VEGF	1125	49
348547	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	VEGF	1192	65
348548	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	VEGF	22	56
348549	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	VEGF	1659	39
348550	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	VEGF	1674	59
348551	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	VEGF	1435.5	56
348552	20233																	0	VEGF	38	49
348553	20233						RA2159	51112.0										3	VEGF	764	69
348554	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	VEGF	990	51
348555	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	VEGF	873	70
348556	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	VEGF	832	65
348557	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	VEGF	844.5	46
348558	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	VEGF	809	73
348559	20233						RA2159	51112.0										3	VEGF	830.5	62
348560	20233						N2586	51107.0										3	VEGF	1644	66
348561	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	VEGF	923	64
348562	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	VEGF	1077	61
348563	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	VEGF	1125	44
348564	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	VEGF	1757	52
348565	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	VEGF	1355	71
348566	20233						N2586	51107.0										3	VEGF	1666	27
348567	20233																	0	VEGF	54.5	48
348568	20233						RA2159	51112.0								2	ug/mL	4	VEGF	1286.5	60
348569	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	VEGF	938	62
348570	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	VEGF	1070.5	72
348571	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	VEGF	1178	61
348572	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	VEGF	1130	72
348573	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	VEGF	1087	63
348574	20233						N2586	51107.0								2	ug/mL	4	VEGF	1609	54
348575	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	VEGF	1453	72
348576	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	VEGF	1300	51
348577	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	VEGF	1520	55
348578	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	VEGF	1430	61
348579	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	VEGF	1075	67
348580	20233						RA2159	51112.0										4	VEGF	1035.5	70
348581	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	VEGF	784.5	78
348582	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	VEGF	950.5	68
348583	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	VEGF	974	59
348584	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	VEGF	1047	58
348585	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	VEGF	876	67
348586	20233						RA2159	51112.0										4	VEGF	1067	55
348587	20233						N2586	51107.0										4	VEGF	1695	77
348588	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	VEGF	1248.5	60
348589	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	VEGF	1590	57
348590	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	VEGF	1419.5	54
348591	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	VEGF	1381	56
348592	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	VEGF	1210	58
348593	20233						N2586	51107.0										4	VEGF	1588.5	60
348594	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	VEGF	1096	57
348595	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	VEGF	987	46
348596	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	VEGF	919	61
348597	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	VEGF	987	62
348598	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	VEGF	943	50
348599	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	VEGF	910.5	58
348600	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	VEGF	1511.5	66
348601	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	VEGF	1464	41
348602	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	VEGF	1365	53
348603	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	VEGF	1134	45
348604	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	VEGF	1513	48
348605	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	VEGF	860	55
348606	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	VEGF	930	60
348607	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	VEGF	857	57
348608	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	VEGF	887	77
348609	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	VEGF	971.5	56
348610	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	VEGF	893	66
348611	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	VEGF	869.5	44
348612	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	VEGF	1221.5	44
348613	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	VEGF	1211	41
348614	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	VEGF	1384.5	56
348615	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	VEGF	1104	53
348616	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	VEGF	1071	58
348617	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	VEGF	886	73
348618	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	VEGF	762	56
348619	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	VEGF	727	61
348620	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	VEGF	689	65
348621	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	VEGF	694.5	70
348622	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	VEGF	758	47
348623	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	VEGF	885.5	44
348624	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	VEGF	1070	47
348625	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	VEGF	1082	58
348626	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	VEGF	1093	49
348627	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	VEGF	1165	64
348628	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	VEGF	1131	42
348629	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	VEGF	952	59
348630	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	VEGF	1123.5	50
348631	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	VEGF	992	38
348632	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	VEGF	840	75
348633	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	VEGF	909.5	50
348634	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	VEGF	903	51
348635	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	VEGF	1095.5	58
348636	20233						RA2159	51112.0										4	VEGF	1074	43
348637	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	VEGF	1472	72
348638	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	VEGF	1315	64
348639	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	VEGF	1484	49
348640	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	VEGF	1381.5	54
348641	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	VEGF	1359.5	44
348642	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	VEGF	1045.5	54
348643	20233						N2586	51107.0										4	VEGF	1481	64
348644	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	VEGF	862	57
348645	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	VEGF	746.5	50
348646	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	VEGF	721	48
348647	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	VEGF	767	41
348648	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	VEGF	804.5	40
348649	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	VEGF	902	55
348650	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	VEGF	1819	85
348651	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	VEGF	1553.5	62
348652	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	VEGF	1335.5	46
348653	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	VEGF	1442.5	46
348654	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	VEGF	1631	62
348655	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	VEGF	850.5	72
348656	20233						RA2159	51112.0										4	VEGF	774.5	52
348657	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	VEGF	674	60
348658	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	VEGF	796	47
348659	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	VEGF	820	69
348660	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	VEGF	822	39
348661	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	VEGF	828	62
348662	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	VEGF	798	56
348663	20233						N2586	51107.0										4	VEGF	1226.5	80
348664	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	VEGF	1464	44
348665	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	VEGF	1468	53
348666	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	VEGF	1382	73
348667	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	VEGF	1295	53
348668	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	VEGF	829	57
348669	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	VEGF	1164	64
348670	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	VEGF	677	47
348671	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	VEGF	591	66
348672	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	VEGF	683	71
348673	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	VEGF	729	51
348674	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	VEGF	781	50
348675	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	VEGF	796	47
348676	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	VEGF	871	58
348677	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	VEGF	1302	43
348678	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	VEGF	1209	63
348679	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	VEGF	1438.5	58
348680	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	VEGF	1076	64
348681	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	VEGF	1411	58
348682	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	VEGF	1001	57
348683	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	VEGF	1049.5	46
348684	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	VEGF	800	42
348685	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	VEGF	693	63
348686	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	VEGF	758.5	42
348687	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	VEGF	757	43
348688	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	VEGF	819	43
348689	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	VEGF	784	71
348690	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	VEGF	781	37
348691	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	VEGF	1295.5	44
348692	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	VEGF	1546	52
348693	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	VEGF	1316	53
348694	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	VEGF	1111	47
348695	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	VEGF	1318.5	54
348696	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	VEGF	763	43
348697	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	VEGF	1166.5	46
348698	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	VEGF	1403	44
348699	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	VEGF	807	59
348700	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	VEGF	1168.5	68
348701	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	VEGF	1115.5	50
348702	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	VEGF	1225	41
348703	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	VEGF	1093	64
348704	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	VEGF	660	56
348705	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	VEGF	1680	71
348706	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	VEGF	1977	61
348707	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	VEGF	1034	49
348708	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	VEGF	1968	40
348709	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	VEGF	1475	37
348710	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	VEGF	991	37
348711	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	VEGF	1342.5	52
348712	20233																	0	VEGF	47	51
348713	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	VEGF	1049	79
348714	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	VEGF	745	41
348715	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	VEGF	917	52
348716	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	VEGF	839	73
348717	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	VEGF	709	61
348718	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	VEGF	886.5	48
348719	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	VEGF	813	48
348720	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	VEGF	1714	48
348721	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	VEGF	1605	60
348722	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	VEGF	1462	49
348723	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	VEGF	1572	42
348724	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	VEGF	1457	53
348725	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	VEGF	930	56
348726	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	VEGF	1366	69
348727	20233																	0	VEGF	38	55
348728	20233						RA2159	51112.0										4	VEGF	665.5	58
348729	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	VEGF	557	64
348730	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	VEGF	755	65
348731	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	VEGF	725	57
348732	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	VEGF	807	79
348733	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	VEGF	864	41
348734	20233						RA2159	51112.0										4	VEGF	822	55
348735	20233						N2586	51107.0										4	VEGF	1542	55
348736	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	VEGF	1516.5	44
348737	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	VEGF	1328	55
348738	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	VEGF	1254	41
348739	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	VEGF	1284	51
348740	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	VEGF	1050	57
348741	20233						N2586	51107.0										4	VEGF	1399	43
348742	20233								TNF-a	201285.0						100	ng/mL	0	VEGF	107	60
348743	20233								IL-1 alpha	201286.0						100	ng/mL	0	VEGF	50	71
348744	20233								IL-6	201287.0						100	ug/mL	0	VEGF	72	93
348745	20233								IL-17A	201288.0						100	ng/mL	0	VEGF	83.5	70
348746	20233								EGF	201289.0						100	ng/mL	0	VEGF	55	67
348747	20233								IGF-I	201290.0						100	ug/mL	0	VEGF	45	65
348748	20233								Adiponectin	201291.0						5	ng/mL	0	VEGF	60	74
348749	20233								Leptin	201292.0						1	ng/mL	0	VEGF	51	52
348750	20233								Visfatin	201293.0						1	ng/mL	0	VEGF	61	41
348751	20233															2	ug/mL	0	VEGF	51	61
348752	20233								TNF-a	201285.0						100	ng/mL	0	VEGF	99	55
348753	20233								IL-1 alpha	201286.0						100	ng/mL	0	VEGF	53	38
348754	20233								IL-6	201287.0						100	ug/mL	0	VEGF	75	59
348755	20233								IL-17A	201288.0						100	ng/mL	0	VEGF	74	64
348756	20233								EGF	201289.0						100	ng/mL	0	VEGF	49	57
348757	20233								IGF-I	201290.0						100	ug/mL	0	VEGF	50.5	52
348758	20233								Adiponectin	201291.0						5	ng/mL	0	VEGF	64	39
348759	20233								Leptin	201292.0						1	ng/mL	0	VEGF	51	33
348760	20233								Visfatin	201293.0						1	ng/mL	0	VEGF	63.5	54
348761	20233															2	ug/mL	0	VEGF	50	48
348762	20233								TNF-a	201285.0						100	ng/mL	0	VEGF	112	62
348763	20233								IL-1 alpha	201286.0						100	ng/mL	0	VEGF	48.5	70
348764	20233								IL-6	201287.0						100	ug/mL	0	VEGF	69	77
348765	20233								IL-17A	201288.0						100	ng/mL	0	VEGF	86	61
348766	20233								EGF	201289.0						100	ng/mL	0	VEGF	49	71
348767	20233								IGF-I	201290.0						100	ug/mL	0	VEGF	47.5	58
348768	20233								Adiponectin	201291.0						5	ng/mL	0	VEGF	55.5	70
348769	20233								Leptin	201292.0						1	ng/mL	0	VEGF	50	45
348770	20233								Visfatin	201293.0						1	ng/mL	0	VEGF	62	69
348771	20233															2	ug/mL	0	VEGF	49	45
348772	20233								TNF-a	201285.0						100	ng/mL	0	VEGF	97	49
348773	20233								IL-1 alpha	201286.0						100	ng/mL	0	VEGF	30	43
348774	20233								IL-6	201287.0						100	ug/mL	0	VEGF	64	53
348775	20233								IL-17A	201288.0						100	ng/mL	0	VEGF	83	54
348776	20233								EGF	201289.0						100	ng/mL	0	VEGF	38	53
348777	20233								IGF-I	201290.0						100	ug/mL	0	VEGF	52	45
348778	20233								Adiponectin	201291.0						5	ng/mL	0	VEGF	55.5	48
348779	20233								Leptin	201292.0						1	ng/mL	0	VEGF	46	43
348780	20233								Visfatin	201293.0						1	ng/mL	0	VEGF	37	44
348781	20233															2	ug/mL	0	VEGF	44	40
348782	20233																	0	PDGF-BB	23	50
348783	20233						RA2159	51112.0										1	PDGF-BB	26	43
348784	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	PDGF-BB	25.5	74
348785	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	PDGF-BB	25	91
348786	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	PDGF-BB	24	69
348787	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	PDGF-BB	25	93
348788	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	PDGF-BB	29	74
348789	20233						RA2159	51112.0										1	PDGF-BB	26	69
348790	20233						N2586	51107.0										1	PDGF-BB	26	72
348791	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	PDGF-BB	25	79
348792	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	PDGF-BB	28.5	60
348793	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	PDGF-BB	29	76
348794	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	PDGF-BB	25	88
348795	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	PDGF-BB	24.5	46
348796	20233						N2586	51107.0										1	PDGF-BB	31	37
348797	20233																	0	PDGF-BB	28.5	68
348798	20233																	0	PDGF-BB	25	54
348799	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	PDGF-BB	43	67
348800	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	PDGF-BB	43	68
348801	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	PDGF-BB	41	51
348802	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	PDGF-BB	37	72
348803	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	PDGF-BB	46.5	72
348804	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	PDGF-BB	29.5	66
348805	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	PDGF-BB	30	76
348806	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	PDGF-BB	46	59
348807	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	PDGF-BB	50	49
348808	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	PDGF-BB	46	67
348809	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	PDGF-BB	43.5	68
348810	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	PDGF-BB	46	63
348811	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	PDGF-BB	35	68
348812	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	PDGF-BB	33.5	34
348813	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	PDGF-BB	40.5	70
348814	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	PDGF-BB	35	64
348815	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	PDGF-BB	32.5	78
348816	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	PDGF-BB	39.5	66
348817	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	PDGF-BB	33	60
348818	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	PDGF-BB	25	66
348819	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	PDGF-BB	26	73
348820	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	PDGF-BB	39	65
348821	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	PDGF-BB	37	53
348822	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	PDGF-BB	33	63
348823	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	PDGF-BB	40.5	54
348824	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	PDGF-BB	42.5	52
348825	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	PDGF-BB	33	40
348826	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	PDGF-BB	29	82
348827	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	PDGF-BB	33	56
348828	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	PDGF-BB	27	66
348829	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	PDGF-BB	27.5	90
348830	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	PDGF-BB	34	86
348831	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	PDGF-BB	27	63
348832	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	PDGF-BB	29	76
348833	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	PDGF-BB	24	79
348834	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	PDGF-BB	30	86
348835	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	PDGF-BB	25.5	64
348836	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	PDGF-BB	32	42
348837	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	PDGF-BB	26	60
348838	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	PDGF-BB	28.5	60
348839	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	PDGF-BB	34	71
348840	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	PDGF-BB	28	53
348841	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	PDGF-BB	32.5	70
348842	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	PDGF-BB	30.5	58
348843	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	PDGF-BB	33.5	74
348844	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	PDGF-BB	32	59
348845	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	PDGF-BB	28	57
348846	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	PDGF-BB	31	67
348847	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	PDGF-BB	30	51
348848	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	PDGF-BB	31	55
348849	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	PDGF-BB	30	77
348850	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	PDGF-BB	33	83
348851	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	PDGF-BB	27	65
348852	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	PDGF-BB	30	77
348853	20233						RA2159	51112.0										1	PDGF-BB	29	62
348854	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	PDGF-BB	23	78
348855	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	PDGF-BB	26	72
348856	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	PDGF-BB	27.5	70
348857	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	PDGF-BB	25	64
348858	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	PDGF-BB	24	61
348859	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	PDGF-BB	26	56
348860	20233						N2586	51107.0										1	PDGF-BB	25	69
348861	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	PDGF-BB	22	54
348862	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	PDGF-BB	25.5	38
348863	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	PDGF-BB	24.5	44
348864	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	PDGF-BB	30	42
348865	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	PDGF-BB	28	81
348866	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	PDGF-BB	27	70
348867	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	PDGF-BB	26	67
348868	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	PDGF-BB	27	67
348869	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	PDGF-BB	22	56
348870	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	PDGF-BB	24.5	86
348871	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	PDGF-BB	24	57
348872	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	PDGF-BB	23	59
348873	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	PDGF-BB	23	84
348874	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	PDGF-BB	21	80
348875	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	PDGF-BB	24	60
348876	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	PDGF-BB	26	62
348877	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	PDGF-BB	26	44
348878	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	PDGF-BB	23	61
348879	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	PDGF-BB	27	48
348880	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	PDGF-BB	28	74
348881	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	PDGF-BB	24.5	62
348882	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	PDGF-BB	25	69
348883	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	PDGF-BB	26	69
348884	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	PDGF-BB	24.5	68
348885	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	PDGF-BB	20	84
348886	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	PDGF-BB	27	69
348887	20233						RA2159	51112.0										1	PDGF-BB	26.5	62
348888	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	PDGF-BB	22	37
348889	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	PDGF-BB	23	63
348890	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	PDGF-BB	25	85
348891	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	PDGF-BB	22	47
348892	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	PDGF-BB	24	51
348893	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	PDGF-BB	23	77
348894	20233						N2586	51107.0										1	PDGF-BB	25	77
348895	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	PDGF-BB	27	71
348896	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	PDGF-BB	25	79
348897	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	PDGF-BB	31	63
348898	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	PDGF-BB	32.5	66
348899	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	PDGF-BB	30	71
348900	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	PDGF-BB	23	89
348901	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	PDGF-BB	27	72
348902	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	PDGF-BB	29.5	50
348903	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	PDGF-BB	29	44
348904	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	PDGF-BB	26	42
348905	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	PDGF-BB	28	55
348906	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	PDGF-BB	26	44
348907	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	PDGF-BB	29	69
348908	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	PDGF-BB	23	61
348909	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	PDGF-BB	25.5	68
348910	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	PDGF-BB	26.5	46
348911	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	PDGF-BB	24	63
348912	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	PDGF-BB	23.5	54
348913	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	PDGF-BB	25.5	56
348914	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	PDGF-BB	22	59
348915	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	PDGF-BB	22	80
348916	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	PDGF-BB	22	71
348917	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	PDGF-BB	27.5	68
348918	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	PDGF-BB	22	41
348919	20233						RA2159	51112.0										1	PDGF-BB	25.5	56
348920	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	PDGF-BB	24	81
348921	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	PDGF-BB	25	63
348922	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	PDGF-BB	28	40
348923	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	PDGF-BB	23	79
348924	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	PDGF-BB	22.5	58
348925	20233						RA2159	51112.0										1	PDGF-BB	20	75
348926	20233						N2586	51107.0										1	PDGF-BB	22	98
348927	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	PDGF-BB	23.5	70
348928	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	PDGF-BB	28.5	52
348929	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	PDGF-BB	21	65
348930	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	PDGF-BB	23	63
348931	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	PDGF-BB	22	81
348932	20233						N2586	51107.0										1	PDGF-BB	25.5	58
348933	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	PDGF-BB	23	50
348934	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	PDGF-BB	21	67
348935	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	PDGF-BB	26	70
348936	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	PDGF-BB	26	67
348937	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	PDGF-BB	25	47
348938	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	PDGF-BB	23	70
348939	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	PDGF-BB	23.5	64
348940	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	PDGF-BB	28	65
348941	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	PDGF-BB	26	64
348942	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	PDGF-BB	25	67
348943	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	PDGF-BB	21	51
348944	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	PDGF-BB	22	49
348945	20233																	0	PDGF-BB	22	53
348946	20233						RA2159	51112.0								2	ug/mL	1	PDGF-BB	45	61
348947	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	PDGF-BB	32	46
348948	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	PDGF-BB	24	52
348949	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	PDGF-BB	30.5	32
348950	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	PDGF-BB	34	78
348951	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	PDGF-BB	23	73
348952	20233						N2586	51107.0								2	ug/mL	1	PDGF-BB	37.5	46
348953	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	PDGF-BB	34.5	68
348954	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	PDGF-BB	25	48
348955	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	PDGF-BB	33	39
348956	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	PDGF-BB	29.5	56
348957	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	PDGF-BB	27	52
348958	20233																	0	PDGF-BB	29	61
348959	20233						RA2159	51112.0										2	PDGF-BB	27	64
348960	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	PDGF-BB	27	86
348961	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	PDGF-BB	29	66
348962	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	PDGF-BB	26	89
348963	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	PDGF-BB	24	62
348964	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	PDGF-BB	24.5	72
348965	20233						RA2159	51112.0										2	PDGF-BB	26	52
348966	20233						N2586	51107.0										2	PDGF-BB	25	44
348967	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	PDGF-BB	27	54
348968	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	PDGF-BB	23	67
348969	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	PDGF-BB	21	46
348970	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	PDGF-BB	26	71
348971	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	PDGF-BB	24	43
348972	20233						N2586	51107.0										2	PDGF-BB	25	45
348973	20233																	0	PDGF-BB	27.5	62
348974	20233																	0	PDGF-BB	28	46
348975	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	PDGF-BB	44	75
348976	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	PDGF-BB	44	61
348977	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	PDGF-BB	47	77
348978	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	PDGF-BB	33	41
348979	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	PDGF-BB	29	69
348980	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	PDGF-BB	36	65
348981	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	PDGF-BB	26.5	58
348982	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	PDGF-BB	43.5	66
348983	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	PDGF-BB	42	46
348984	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	PDGF-BB	46	76
348985	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	PDGF-BB	37	63
348986	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	PDGF-BB	35.5	50
348987	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	PDGF-BB	42	53
348988	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	PDGF-BB	25	41
348989	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	PDGF-BB	40	70
348990	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	PDGF-BB	48	84
348991	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	PDGF-BB	37.5	56
348992	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	PDGF-BB	38	72
348993	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	PDGF-BB	35.5	58
348994	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	PDGF-BB	33	71
348995	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	PDGF-BB	24	47
348996	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	PDGF-BB	33.5	52
348997	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	PDGF-BB	41.5	60
348998	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	PDGF-BB	41.5	72
348999	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	PDGF-BB	39	67
349000	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	PDGF-BB	38	47
349001	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	PDGF-BB	31	51
349002	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	PDGF-BB	25	62
349003	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	PDGF-BB	28	73
349004	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	PDGF-BB	25	73
349005	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	PDGF-BB	28	75
349006	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	PDGF-BB	24	55
349007	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	PDGF-BB	27	80
349008	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	PDGF-BB	24	84
349009	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	PDGF-BB	21	60
349010	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	PDGF-BB	25	62
349011	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	PDGF-BB	24	77
349012	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	PDGF-BB	23.5	70
349013	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	PDGF-BB	25	71
349014	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	PDGF-BB	25	66
349015	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	PDGF-BB	23	57
349016	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	PDGF-BB	27.5	62
349017	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	PDGF-BB	30	60
349018	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	PDGF-BB	33.5	78
349019	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	PDGF-BB	26	77
349020	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	PDGF-BB	29	63
349021	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	PDGF-BB	26.5	78
349022	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	PDGF-BB	32	43
349023	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	PDGF-BB	22	59
349024	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	PDGF-BB	26.5	52
349025	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	PDGF-BB	27	69
349026	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	PDGF-BB	25	52
349027	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	PDGF-BB	35	71
349028	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	PDGF-BB	28	55
349029	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	PDGF-BB	25.5	74
349030	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	PDGF-BB	24.5	42
349031	20233						RA2159	51112.0										2	PDGF-BB	24	55
349032	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	PDGF-BB	23.5	64
349033	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	PDGF-BB	26	71
349034	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	PDGF-BB	22	52
349035	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	PDGF-BB	24	86
349036	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	PDGF-BB	24	92
349037	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	PDGF-BB	19	42
349038	20233						N2586	51107.0										2	PDGF-BB	27	53
349039	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	PDGF-BB	25	63
349040	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	PDGF-BB	18.5	60
349041	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	PDGF-BB	25	61
349042	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	PDGF-BB	23	75
349043	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	PDGF-BB	24	56
349044	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	PDGF-BB	27	59
349045	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	PDGF-BB	24	79
349046	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	PDGF-BB	26	73
349047	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	PDGF-BB	25	66
349048	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	PDGF-BB	24.5	60
349049	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	PDGF-BB	20	58
349050	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	PDGF-BB	23	78
349051	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	PDGF-BB	24	65
349052	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	PDGF-BB	25	63
349053	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	PDGF-BB	23	69
349054	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	PDGF-BB	26	72
349055	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	PDGF-BB	26	49
349056	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	PDGF-BB	12	74
349057	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	PDGF-BB	26	89
349058	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	PDGF-BB	25	57
349059	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	PDGF-BB	25.5	86
349060	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	PDGF-BB	27	83
349061	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	PDGF-BB	25.5	84
349062	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	PDGF-BB	25	63
349063	20233						RA2159	51112.0										2	PDGF-BB	22	73
349064	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	PDGF-BB	21	76
349065	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	PDGF-BB	25	49
349066	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	PDGF-BB	20.5	56
349067	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	PDGF-BB	25	57
349068	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	PDGF-BB	26	57
349069	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	PDGF-BB	25.5	58
349070	20233						N2586	51107.0										2	PDGF-BB	11	56
349071	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	PDGF-BB	27	75
349072	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	PDGF-BB	29	50
349073	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	PDGF-BB	27	63
349074	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	PDGF-BB	29.5	58
349075	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	PDGF-BB	28	67
349076	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	PDGF-BB	25	60
349077	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	PDGF-BB	25	65
349078	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	PDGF-BB	29	55
349079	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	PDGF-BB	32.5	58
349080	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	PDGF-BB	29	63
349081	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	PDGF-BB	27	45
349082	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	PDGF-BB	25	58
349083	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	PDGF-BB	27	62
349084	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	PDGF-BB	23	58
349085	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	PDGF-BB	26.5	72
349086	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	PDGF-BB	22.5	70
349087	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	PDGF-BB	23	59
349088	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	PDGF-BB	22	56
349089	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	PDGF-BB	21	81
349090	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	PDGF-BB	19.5	42
349091	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	PDGF-BB	21	51
349092	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	PDGF-BB	21	67
349093	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	PDGF-BB	26	33
349094	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	PDGF-BB	24	69
349095	20233						RA2159	51112.0										2	PDGF-BB	30.5	74
349096	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	PDGF-BB	22	61
349097	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	PDGF-BB	23	77
349098	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	PDGF-BB	24	68
349099	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	PDGF-BB	24	69
349100	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	PDGF-BB	22	57
349101	20233						RA2159	51112.0										2	PDGF-BB	25	73
349102	20233						N2586	51107.0										2	PDGF-BB	22	59
349103	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	PDGF-BB	23	54
349104	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	PDGF-BB	24	65
349105	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	PDGF-BB	22	48
349106	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	PDGF-BB	23.5	68
349107	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	PDGF-BB	23	62
349108	20233						N2586	51107.0										2	PDGF-BB	23	65
349109	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	PDGF-BB	24	71
349110	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	PDGF-BB	22	52
349111	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	PDGF-BB	23	69
349112	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	PDGF-BB	21	55
349113	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	PDGF-BB	21	46
349114	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	PDGF-BB	23.5	52
349115	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	PDGF-BB	20	51
349116	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	PDGF-BB	26	53
349117	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	PDGF-BB	23	47
349118	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	PDGF-BB	23	26
349119	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	PDGF-BB	23	49
349120	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	PDGF-BB	25.5	32
349121	20233																	0	PDGF-BB	24	51
349122	20233						RA2159	51112.0								2	ug/mL	2	PDGF-BB	32	54
349123	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	PDGF-BB	35	62
349124	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	PDGF-BB	34	70
349125	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	PDGF-BB	27	63
349126	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	PDGF-BB	22	25
349127	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	PDGF-BB	36	48
349128	20233						N2586	51107.0								2	ug/mL	2	PDGF-BB	29	29
349129	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	PDGF-BB	34	33
349130	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	PDGF-BB	35	47
349131	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	PDGF-BB	30	53
349132	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	PDGF-BB	30	38
349133	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	PDGF-BB	26.5	48
349134	20233																	0	PDGF-BB	27	65
349135	20233						RA2159	51112.0								2	ug/mL	3	PDGF-BB	39.5	54
349136	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	PDGF-BB	37	67
349137	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	PDGF-BB	26	65
349138	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	PDGF-BB	28	78
349139	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	PDGF-BB	31	66
349140	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	PDGF-BB	26	70
349141	20233						N2586	51107.0								2	ug/mL	3	PDGF-BB	39	81
349142	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	PDGF-BB	37	70
349143	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	PDGF-BB	38	85
349144	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	PDGF-BB	38	77
349145	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	PDGF-BB	28	67
349146	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	PDGF-BB	33	68
349147	20233						RA2159	51112.0										3	PDGF-BB	24	73
349148	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	PDGF-BB	26	79
349149	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	PDGF-BB	25	81
349150	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	PDGF-BB	25	76
349151	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	PDGF-BB	25	77
349152	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	PDGF-BB	23	62
349153	20233						RA2159	51112.0										3	PDGF-BB	28	84
349154	20233						N2586	51107.0										3	PDGF-BB	24	61
349155	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	PDGF-BB	28	84
349156	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	PDGF-BB	22	67
349157	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	PDGF-BB	24	72
349158	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	PDGF-BB	23	65
349159	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	PDGF-BB	22	81
349160	20233						N2586	51107.0										3	PDGF-BB	28	57
349161	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	PDGF-BB	24	68
349162	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	PDGF-BB	23	63
349163	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	PDGF-BB	23	80
349164	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	PDGF-BB	23.5	72
349165	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	PDGF-BB	23.5	72
349166	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	PDGF-BB	22	88
349167	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	PDGF-BB	23	63
349168	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	PDGF-BB	24.5	78
349169	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	PDGF-BB	27	73
349170	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	PDGF-BB	26.5	54
349171	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	PDGF-BB	20.5	62
349172	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	PDGF-BB	25	69
349173	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	PDGF-BB	25	78
349174	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	PDGF-BB	24	82
349175	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	PDGF-BB	22	83
349176	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	PDGF-BB	24	65
349177	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	PDGF-BB	25	89
349178	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	PDGF-BB	26	68
349179	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	PDGF-BB	24	81
349180	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	PDGF-BB	26.5	78
349181	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	PDGF-BB	24	83
349182	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	PDGF-BB	21	82
349183	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	PDGF-BB	23	63
349184	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	PDGF-BB	27	62
349185	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	PDGF-BB	26	58
349186	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	PDGF-BB	27	84
349187	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	PDGF-BB	27	64
349188	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	PDGF-BB	29	65
349189	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	PDGF-BB	27	74
349190	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	PDGF-BB	27	89
349191	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	PDGF-BB	29	81
349192	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	PDGF-BB	28	75
349193	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	PDGF-BB	27	67
349194	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	PDGF-BB	26	67
349195	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	PDGF-BB	27	79
349196	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	PDGF-BB	28.5	70
349197	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	PDGF-BB	23	62
349198	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	PDGF-BB	23	73
349199	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	PDGF-BB	26	81
349200	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	PDGF-BB	22	72
349201	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	PDGF-BB	24.5	82
349202	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	PDGF-BB	21	57
349203	20233						RA2159	51112.0										3	PDGF-BB	24.5	62
349204	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	PDGF-BB	23	59
349205	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	PDGF-BB	24	55
349206	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	PDGF-BB	20	75
349207	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	PDGF-BB	24	77
349208	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	PDGF-BB	25	85
349209	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	PDGF-BB	24	73
349210	20233						N2586	51107.0										3	PDGF-BB	24	61
349211	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	PDGF-BB	22	72
349212	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	PDGF-BB	21	62
349213	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	PDGF-BB	24	59
349214	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	PDGF-BB	21.5	52
349215	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	PDGF-BB	19	84
349216	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	PDGF-BB	21	56
349217	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	PDGF-BB	22	84
349218	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	PDGF-BB	23	73
349219	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	PDGF-BB	24.5	72
349220	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	PDGF-BB	24	61
349221	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	PDGF-BB	26	51
349222	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	PDGF-BB	25	63
349223	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	PDGF-BB	17.5	60
349224	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	PDGF-BB	23	35
349225	20233						RA2159	51112.0										3	PDGF-BB	20	77
349226	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	PDGF-BB	23	66
349227	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	PDGF-BB	23	66
349228	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	PDGF-BB	22	65
349229	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	PDGF-BB	25	64
349230	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	PDGF-BB	23	63
349231	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	PDGF-BB	24	79
349232	20233						N2586	51107.0										3	PDGF-BB	24	72
349233	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	PDGF-BB	24	80
349234	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	PDGF-BB	23	63
349235	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	PDGF-BB	23.5	84
349236	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	PDGF-BB	24	74
349237	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	PDGF-BB	25	66
349238	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	PDGF-BB	23.5	62
349239	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	PDGF-BB	32.5	78
349240	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	PDGF-BB	31	73
349241	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	PDGF-BB	28	86
349242	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	PDGF-BB	30	81
349243	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	PDGF-BB	28.5	74
349244	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	PDGF-BB	32	63
349245	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	PDGF-BB	28	72
349246	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	PDGF-BB	27	74
349247	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	PDGF-BB	20	75
349248	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	PDGF-BB	29	71
349249	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	PDGF-BB	30	68
349250	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	PDGF-BB	26.5	54
349251	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	PDGF-BB	25	92
349252	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	PDGF-BB	30	66
349253	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	PDGF-BB	26	67
349254	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	PDGF-BB	27	56
349255	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	PDGF-BB	25	64
349256	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	PDGF-BB	27	79
349257	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	PDGF-BB	23	80
349258	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	PDGF-BB	25	69
349259	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	PDGF-BB	22.5	68
349260	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	PDGF-BB	24	80
349261	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	PDGF-BB	23	69
349262	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	PDGF-BB	26	77
349263	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	PDGF-BB	25	76
349264	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	PDGF-BB	24	66
349265	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	PDGF-BB	43	59
349266	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	PDGF-BB	33	76
349267	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	PDGF-BB	27	79
349268	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	PDGF-BB	36	71
349269	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	PDGF-BB	40	65
349270	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	PDGF-BB	26	53
349271	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	PDGF-BB	23	53
349272	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	PDGF-BB	32.5	88
349273	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	PDGF-BB	38	77
349274	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	PDGF-BB	37	79
349275	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	PDGF-BB	40	80
349276	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	PDGF-BB	25	61
349277	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	PDGF-BB	38	54
349278	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	PDGF-BB	20	86
349279	20233																	0	PDGF-BB	27	63
349280	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	PDGF-BB	33	57
349281	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	PDGF-BB	38	53
349282	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	PDGF-BB	130	65
349283	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	PDGF-BB	33	88
349284	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	PDGF-BB	35	64
349285	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	PDGF-BB	30	67
349286	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	PDGF-BB	20	74
349287	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	PDGF-BB	38	71
349288	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	PDGF-BB	33	51
349289	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	PDGF-BB	36.5	68
349290	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	PDGF-BB	26	50
349291	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	PDGF-BB	29	54
349292	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	PDGF-BB	35	69
349293	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	PDGF-BB	22	68
349294	20233																	0	PDGF-BB	21	63
349295	20233						RA2159	51112.0										3	PDGF-BB	22	59
349296	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	PDGF-BB	25	59
349297	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	PDGF-BB	22.5	70
349298	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	PDGF-BB	23	82
349299	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	PDGF-BB	19	43
349300	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	PDGF-BB	21	83
349301	20233						RA2159	51112.0										3	PDGF-BB	23.5	64
349302	20233						N2586	51107.0										3	PDGF-BB	30	81
349303	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	PDGF-BB	26	87
349304	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	PDGF-BB	20	73
349305	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	PDGF-BB	20	47
349306	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	PDGF-BB	24	69
349307	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	PDGF-BB	24	76
349308	20233						N2586	51107.0										3	PDGF-BB	22	48
349309	20233																	0	PDGF-BB	22	57
349310	20233						RA2159	51112.0								2	ug/mL	4	PDGF-BB	37	63
349311	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	PDGF-BB	37	58
349312	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	PDGF-BB	35.5	74
349313	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	PDGF-BB	37	57
349314	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	PDGF-BB	31	83
349315	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	PDGF-BB	32	70
349316	20233						N2586	51107.0								2	ug/mL	4	PDGF-BB	40	70
349317	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	PDGF-BB	32	78
349318	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	PDGF-BB	25	57
349319	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	PDGF-BB	30	54
349320	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	PDGF-BB	26	59
349321	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	PDGF-BB	25	81
349322	20233						RA2159	51112.0										4	PDGF-BB	22	68
349323	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	PDGF-BB	28	77
349324	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	PDGF-BB	28.5	58
349325	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	PDGF-BB	24	79
349326	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	PDGF-BB	25	76
349327	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	PDGF-BB	22.5	74
349328	20233						RA2159	51112.0										4	PDGF-BB	23	50
349329	20233						N2586	51107.0										4	PDGF-BB	24	83
349330	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	PDGF-BB	21	59
349331	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	PDGF-BB	18.5	42
349332	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	PDGF-BB	25	47
349333	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	PDGF-BB	25.5	52
349334	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	PDGF-BB	23.5	74
349335	20233						N2586	51107.0										4	PDGF-BB	24	82
349336	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	PDGF-BB	25	61
349337	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	PDGF-BB	27	72
349338	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	PDGF-BB	24	81
349339	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	PDGF-BB	25	79
349340	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	PDGF-BB	21	71
349341	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	PDGF-BB	24.5	66
349342	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	PDGF-BB	23.5	86
349343	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	PDGF-BB	21	53
349344	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	PDGF-BB	24.5	70
349345	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	PDGF-BB	23	50
349346	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	PDGF-BB	25	65
349347	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	PDGF-BB	20.5	68
349348	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	PDGF-BB	24	93
349349	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	PDGF-BB	23	76
349350	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	PDGF-BB	23.5	84
349351	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	PDGF-BB	28	57
349352	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	PDGF-BB	20	70
349353	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	PDGF-BB	25	59
349354	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	PDGF-BB	23	64
349355	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	PDGF-BB	24	43
349356	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	PDGF-BB	23	64
349357	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	PDGF-BB	25.5	54
349358	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	PDGF-BB	26.5	52
349359	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	PDGF-BB	24.5	66
349360	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	PDGF-BB	27.5	72
349361	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	PDGF-BB	28.5	44
349362	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	PDGF-BB	28.5	54
349363	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	PDGF-BB	31	65
349364	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	PDGF-BB	23	49
349365	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	PDGF-BB	26	45
349366	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	PDGF-BB	26	70
349367	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	PDGF-BB	28.5	38
349368	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	PDGF-BB	25	48
349369	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	PDGF-BB	28.5	70
349370	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	PDGF-BB	26	57
349371	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	PDGF-BB	28.5	60
349372	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	PDGF-BB	25	65
349373	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	PDGF-BB	24	53
349374	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	PDGF-BB	24	74
349375	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	PDGF-BB	25.5	68
349376	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	PDGF-BB	26	51
349377	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	PDGF-BB	22	59
349378	20233						RA2159	51112.0										4	PDGF-BB	26.5	58
349379	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	PDGF-BB	22.5	78
349380	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	PDGF-BB	22	71
349381	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	PDGF-BB	23	69
349382	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	PDGF-BB	27	54
349383	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	PDGF-BB	24	53
349384	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	PDGF-BB	20	66
349385	20233						N2586	51107.0										4	PDGF-BB	19	57
349386	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	PDGF-BB	23.5	64
349387	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	PDGF-BB	23	62
349388	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	PDGF-BB	25	77
349389	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	PDGF-BB	26	62
349390	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	PDGF-BB	25	40
349391	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	PDGF-BB	22	49
349392	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	PDGF-BB	24	71
349393	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	PDGF-BB	25	63
349394	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	PDGF-BB	22	51
349395	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	PDGF-BB	21.5	58
349396	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	PDGF-BB	22	51
349397	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	PDGF-BB	22	87
349398	20233						RA2159	51112.0										4	PDGF-BB	24	54
349399	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	PDGF-BB	22	72
349400	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	PDGF-BB	21	62
349401	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	PDGF-BB	21	75
349402	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	PDGF-BB	23.5	54
349403	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	PDGF-BB	24.5	36
349404	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	PDGF-BB	22	77
349405	20233						N2586	51107.0										4	PDGF-BB	25	64
349406	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	PDGF-BB	20	55
349407	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	PDGF-BB	20.5	60
349408	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	PDGF-BB	22.5	70
349409	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	PDGF-BB	19	70
349410	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	PDGF-BB	25	61
349411	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	PDGF-BB	22.5	66
349412	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	PDGF-BB	26	62
349413	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	PDGF-BB	26	65
349414	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	PDGF-BB	27	77
349415	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	PDGF-BB	22	74
349416	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	PDGF-BB	23	66
349417	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	PDGF-BB	29.5	68
349418	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	PDGF-BB	22.5	84
349419	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	PDGF-BB	28	56
349420	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	PDGF-BB	26	97
349421	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	PDGF-BB	26	61
349422	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	PDGF-BB	25.5	62
349423	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	PDGF-BB	29.5	54
349424	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	PDGF-BB	30	65
349425	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	PDGF-BB	23	63
349426	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	PDGF-BB	25	69
349427	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	PDGF-BB	24	63
349428	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	PDGF-BB	23.5	50
349429	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	PDGF-BB	24	43
349430	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	PDGF-BB	19	47
349431	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	PDGF-BB	22.5	72
349432	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	PDGF-BB	24	45
349433	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	PDGF-BB	23.5	52
349434	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	PDGF-BB	21	40
349435	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	PDGF-BB	23	71
349436	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	PDGF-BB	27	48
349437	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	PDGF-BB	23	57
349438	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	PDGF-BB	22	52
349439	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	PDGF-BB	25	62
349440	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	PDGF-BB	39	41
349441	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	PDGF-BB	34	53
349442	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	PDGF-BB	35	64
349443	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	PDGF-BB	37.5	66
349444	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	PDGF-BB	43	53
349445	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	PDGF-BB	35	69
349446	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	PDGF-BB	23	68
349447	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	PDGF-BB	36	64
349448	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	PDGF-BB	37.5	70
349449	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	PDGF-BB	29	49
349450	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	PDGF-BB	41.5	52
349451	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	PDGF-BB	29	49
349452	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	PDGF-BB	22	53
349453	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	PDGF-BB	24	41
349454	20233																	0	PDGF-BB	20	42
349455	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	PDGF-BB	37.5	80
349456	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	PDGF-BB	36	47
349457	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	PDGF-BB	37	77
349458	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	PDGF-BB	34	61
349459	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	PDGF-BB	39	60
349460	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	PDGF-BB	32	75
349461	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	PDGF-BB	22	64
349462	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	PDGF-BB	112	61
349463	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	PDGF-BB	52	46
349464	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	PDGF-BB	36.5	40
349465	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	PDGF-BB	37	60
349466	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	PDGF-BB	29	55
349467	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	PDGF-BB	22	43
349468	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	PDGF-BB	22	83
349469	20233																	0	PDGF-BB	23	75
349470	20233						RA2159	51112.0										4	PDGF-BB	23	75
349471	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	PDGF-BB	23	75
349472	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	PDGF-BB	21.5	72
349473	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	PDGF-BB	19	67
349474	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	PDGF-BB	20.5	66
349475	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	PDGF-BB	21	47
349476	20233						RA2159	51112.0										4	PDGF-BB	23	59
349477	20233						N2586	51107.0										4	PDGF-BB	21	50
349478	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	PDGF-BB	21.5	48
349479	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	PDGF-BB	22	63
349480	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	PDGF-BB	20.5	52
349481	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	PDGF-BB	22	37
349482	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	PDGF-BB	23	73
349483	20233						N2586	51107.0										4	PDGF-BB	20	53
349484	20233								TNF-a	201285.0						100	ng/mL	0	PDGF-BB	53	82
349485	20233								IL-1 alpha	201286.0						100	ng/mL	0	PDGF-BB	24	67
349486	20233								IL-6	201287.0						100	ug/mL	0	PDGF-BB	57	68
349487	20233								IL-17A	201288.0						100	ng/mL	0	PDGF-BB	40	81
349488	20233								EGF	201289.0						100	ng/mL	0	PDGF-BB	24	63
349489	20233								IGF-I	201290.0						100	ug/mL	0	PDGF-BB	26	79
349490	20233								Adiponectin	201291.0						5	ng/mL	0	PDGF-BB	72.5	56
349491	20233								Leptin	201292.0						1	ng/mL	0	PDGF-BB	28	77
349492	20233								Visfatin	201293.0						1	ng/mL	0	PDGF-BB	34	57
349493	20233															2	ug/mL	0	PDGF-BB	28	55
349494	20233								TNF-a	201285.0						100	ng/mL	0	PDGF-BB	46	68
349495	20233								IL-1 alpha	201286.0						100	ng/mL	0	PDGF-BB	26.5	42
349496	20233								IL-6	201287.0						100	ug/mL	0	PDGF-BB	57	53
349497	20233								IL-17A	201288.0						100	ng/mL	0	PDGF-BB	44	69
349498	20233								EGF	201289.0						100	ng/mL	0	PDGF-BB	28	48
349499	20233								IGF-I	201290.0						100	ug/mL	0	PDGF-BB	26	63
349500	20233								Adiponectin	201291.0						5	ng/mL	0	PDGF-BB	73	40
349501	20233								Leptin	201292.0						1	ng/mL	0	PDGF-BB	30	50
349502	20233								Visfatin	201293.0						1	ng/mL	0	PDGF-BB	34.5	64
349503	20233															2	ug/mL	0	PDGF-BB	27.5	72
349504	20233								TNF-a	201285.0						100	ng/mL	0	PDGF-BB	48	70
349505	20233								IL-1 alpha	201286.0						100	ng/mL	0	PDGF-BB	22	75
349506	20233								IL-6	201287.0						100	ug/mL	0	PDGF-BB	36	57
349507	20233								IL-17A	201288.0						100	ng/mL	0	PDGF-BB	44	79
349508	20233								EGF	201289.0						100	ng/mL	0	PDGF-BB	26.5	80
349509	20233								IGF-I	201290.0						100	ug/mL	0	PDGF-BB	23	69
349510	20233								Adiponectin	201291.0						5	ng/mL	0	PDGF-BB	60	59
349511	20233								Leptin	201292.0						1	ng/mL	0	PDGF-BB	22	48
349512	20233								Visfatin	201293.0						1	ng/mL	0	PDGF-BB	30	80
349513	20233															2	ug/mL	0	PDGF-BB	22	66
349514	20233								TNF-a	201285.0						100	ng/mL	0	PDGF-BB	45	57
349515	20233								IL-1 alpha	201286.0						100	ng/mL	0	PDGF-BB	24	55
349516	20233								IL-6	201287.0						100	ug/mL	0	PDGF-BB	33	61
349517	20233								IL-17A	201288.0						100	ng/mL	0	PDGF-BB	44.5	46
349518	20233								EGF	201289.0						100	ng/mL	0	PDGF-BB	24	63
349519	20233								IGF-I	201290.0						100	ug/mL	0	PDGF-BB	23	71
349520	20233								Adiponectin	201291.0						5	ng/mL	0	PDGF-BB	64.5	56
349521	20233								Leptin	201292.0						1	ng/mL	0	PDGF-BB	20	54
349522	20233								Visfatin	201293.0						1	ng/mL	0	PDGF-BB	29.5	56
349523	20233															2	ug/mL	0	PDGF-BB	22	55
349524	20233																	0	IP-10	12	75
349525	20233						RA2159	51112.0										1	IP-10	14	79
349526	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IP-10	14	82
349527	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IP-10	12.5	82
349528	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IP-10	15	75
349529	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IP-10	12	78
349530	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IP-10	15	69
349531	20233						RA2159	51112.0										1	IP-10	13	72
349532	20233						N2586	51107.0										1	IP-10	11	66
349533	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IP-10	13	79
349534	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IP-10	16	60
349535	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IP-10	14	74
349536	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IP-10	9.5	66
349537	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IP-10	11.5	50
349538	20233						N2586	51107.0										1	IP-10	14	37
349539	20233																	0	IP-10	10	67
349540	20233																	0	IP-10	12	59
349541	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IP-10	1727	69
349542	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IP-10	1692	76
349543	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IP-10	1471.5	70
349544	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IP-10	438	95
349545	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IP-10	804	63
349546	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IP-10	25.5	76
349547	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IP-10	13	85
349548	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IP-10	985	74
349549	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IP-10	1386	65
349550	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IP-10	260	73
349551	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IP-10	604	84
349552	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IP-10	553	65
349553	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IP-10	79	63
349554	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IP-10	14.5	48
349555	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IP-10	182.5	86
349556	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IP-10	156	87
349557	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IP-10	44	71
349558	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IP-10	203	71
349559	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IP-10	160	68
349560	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IP-10	13	88
349561	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IP-10	13	83
349562	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IP-10	78	74
349563	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IP-10	71	70
349564	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IP-10	44.5	72
349565	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IP-10	93	72
349566	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IP-10	76	66
349567	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IP-10	15.5	70
349568	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IP-10	13	85
349569	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IP-10	14	79
349570	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IP-10	15	79
349571	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IP-10	15	77
349572	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IP-10	16	73
349573	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IP-10	14	80
349574	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IP-10	14	97
349575	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IP-10	14	48
349576	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IP-10	14.5	82
349577	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IP-10	15	66
349578	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IP-10	16	55
349579	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IP-10	14	62
349580	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IP-10	13	68
349581	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IP-10	14.5	92
349582	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IP-10	14	48
349583	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IP-10	10.5	70
349584	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IP-10	13	58
349585	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IP-10	11	82
349586	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IP-10	14	69
349587	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IP-10	13	77
349588	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IP-10	13	92
349589	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IP-10	15	84
349590	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IP-10	15	74
349591	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IP-10	13	67
349592	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IP-10	15	102
349593	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IP-10	13	60
349594	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IP-10	12	90
349595	20233						RA2159	51112.0										1	IP-10	16	73
349596	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IP-10	14	77
349597	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IP-10	10	92
349598	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IP-10	13	82
349599	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IP-10	8	56
349600	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IP-10	12	86
349601	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IP-10	13	58
349602	20233						N2586	51107.0										1	IP-10	14	76
349603	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IP-10	11.5	56
349604	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IP-10	10	46
349605	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IP-10	14	84
349606	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IP-10	15	43
349607	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IP-10	15	76
349608	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IP-10	13	87
349609	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IP-10	12	83
349610	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IP-10	12	75
349611	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IP-10	14	78
349612	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IP-10	13	96
349613	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IP-10	12.5	86
349614	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IP-10	11	87
349615	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IP-10	16	77
349616	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IP-10	12.5	78
349617	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IP-10	12	85
349618	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IP-10	11	60
349619	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IP-10	12	48
349620	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IP-10	13	74
349621	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IP-10	15	41
349622	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IP-10	11	66
349623	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IP-10	12	77
349624	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IP-10	13	67
349625	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IP-10	12	59
349626	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IP-10	13	88
349627	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IP-10	11	93
349628	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IP-10	11	80
349629	20233						RA2159	51112.0										1	IP-10	10	76
349630	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IP-10	13	59
349631	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IP-10	12	71
349632	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IP-10	11	89
349633	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IP-10	9	65
349634	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IP-10	13	54
349635	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IP-10	9	79
349636	20233						N2586	51107.0										1	IP-10	14	92
349637	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IP-10	11	90
349638	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IP-10	13	60
349639	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IP-10	13	65
349640	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IP-10	11	55
349641	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IP-10	12	77
349642	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IP-10	11	99
349643	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IP-10	11	74
349644	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IP-10	13	49
349645	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IP-10	11	69
349646	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IP-10	12	64
349647	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IP-10	12	84
349648	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IP-10	11	49
349649	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IP-10	14	53
349650	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IP-10	9	72
349651	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IP-10	9	77
349652	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IP-10	12	77
349653	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IP-10	14	78
349654	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IP-10	11	59
349655	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IP-10	9	62
349656	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IP-10	13	51
349657	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IP-10	11	72
349658	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IP-10	14	69
349659	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IP-10	14	60
349660	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IP-10	13	41
349661	20233						RA2159	51112.0										1	IP-10	9	58
349662	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IP-10	11	89
349663	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IP-10	10	88
349664	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IP-10	12	69
349665	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IP-10	13	89
349666	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IP-10	11	85
349667	20233						RA2159	51112.0										1	IP-10	13	67
349668	20233						N2586	51107.0										1	IP-10	12	101
349669	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IP-10	12	76
349670	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IP-10	10	74
349671	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IP-10	13	86
349672	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IP-10	12	65
349673	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IP-10	11	93
349674	20233						N2586	51107.0										1	IP-10	11	81
349675	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IP-10	10	59
349676	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IP-10	12.5	58
349677	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IP-10	12	75
349678	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IP-10	11	104
349679	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IP-10	13	51
349680	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IP-10	11	61
349681	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IP-10	9	81
349682	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IP-10	11.5	84
349683	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IP-10	8	79
349684	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IP-10	12	69
349685	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IP-10	11	73
349686	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IP-10	12	39
349687	20233																	0	IP-10	10	63
349688	20233						RA2159	51112.0								2	ug/mL	1	IP-10	4910	74
349689	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IP-10	4865	53
349690	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IP-10	28	68
349691	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IP-10	753.5	50
349692	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IP-10	1565	53
349693	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IP-10	625	82
349694	20233						N2586	51107.0								2	ug/mL	1	IP-10	1170.5	48
349695	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IP-10	1810.5	70
349696	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IP-10	14.5	66
349697	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IP-10	138.5	44
349698	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IP-10	475.5	58
349699	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IP-10	40.5	54
349700	20233																	0	IP-10	10.5	56
349701	20233						RA2159	51112.0										2	IP-10	10.5	74
349702	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IP-10	13	101
349703	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IP-10	14	67
349704	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IP-10	13	70
349705	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IP-10	16	64
349706	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IP-10	11	73
349707	20233						RA2159	51112.0										2	IP-10	12	50
349708	20233						N2586	51107.0										2	IP-10	13	53
349709	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IP-10	13	51
349710	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IP-10	12.5	54
349711	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IP-10	10	44
349712	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IP-10	11	43
349713	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IP-10	13	53
349714	20233						N2586	51107.0										2	IP-10	15	48
349715	20233																	0	IP-10	13	69
349716	20233																	0	IP-10	12	39
349717	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IP-10	2976	77
349718	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IP-10	1771	80
349719	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IP-10	1817	66
349720	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IP-10	1097	43
349721	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IP-10	647	53
349722	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IP-10	616	61
349723	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IP-10	11	77
349724	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IP-10	779	61
349725	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IP-10	577	69
349726	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IP-10	2571.5	78
349727	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IP-10	1145	79
349728	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IP-10	407	44
349729	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IP-10	818	54
349730	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IP-10	12	55
349731	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IP-10	119.5	66
349732	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IP-10	331	63
349733	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IP-10	45.5	90
349734	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IP-10	121	63
349735	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IP-10	78	79
349736	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IP-10	107	71
349737	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IP-10	12	67
349738	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IP-10	115	60
349739	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IP-10	167	84
349740	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IP-10	210	86
349741	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IP-10	259	71
349742	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IP-10	161	51
349743	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IP-10	272.5	56
349744	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IP-10	14	62
349745	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IP-10	14	75
349746	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IP-10	15	58
349747	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IP-10	16	87
349748	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IP-10	13	51
349749	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IP-10	11.5	74
349750	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IP-10	10	73
349751	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IP-10	11	74
349752	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IP-10	11.5	86
349753	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IP-10	12.5	88
349754	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IP-10	12	70
349755	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IP-10	13	46
349756	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IP-10	11	69
349757	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IP-10	13.5	62
349758	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IP-10	14	58
349759	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IP-10	12	72
349760	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IP-10	13	93
349761	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IP-10	9.5	88
349762	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IP-10	13.5	68
349763	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IP-10	13	59
349764	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IP-10	13.5	50
349765	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IP-10	10.5	84
349766	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IP-10	13	61
349767	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IP-10	12	83
349768	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IP-10	12	72
349769	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IP-10	12	85
349770	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IP-10	11	52
349771	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IP-10	11	67
349772	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IP-10	12.5	62
349773	20233						RA2159	51112.0										2	IP-10	11	83
349774	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IP-10	12	63
349775	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IP-10	10	66
349776	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IP-10	12.5	56
349777	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IP-10	12	86
349778	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IP-10	12	83
349779	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IP-10	11	53
349780	20233						N2586	51107.0										2	IP-10	13	85
349781	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IP-10	11	70
349782	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IP-10	11	69
349783	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IP-10	13	63
349784	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IP-10	12	64
349785	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IP-10	11	56
349786	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IP-10	11	70
349787	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IP-10	14	66
349788	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IP-10	13	78
349789	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IP-10	9.5	74
349790	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IP-10	11	82
349791	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IP-10	10	75
349792	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IP-10	11.5	80
349793	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IP-10	8	86
349794	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IP-10	11.5	66
349795	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IP-10	11	80
349796	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IP-10	12.5	70
349797	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IP-10	9	51
349798	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IP-10	4	80
349799	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IP-10	14	111
349800	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IP-10	10	60
349801	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IP-10	13	87
349802	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IP-10	9.5	82
349803	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IP-10	9	97
349804	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IP-10	10.5	78
349805	20233						RA2159	51112.0										2	IP-10	10	75
349806	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IP-10	11	81
349807	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IP-10	10	76
349808	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IP-10	10	71
349809	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IP-10	11	63
349810	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IP-10	14.5	62
349811	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IP-10	9.5	66
349812	20233						N2586	51107.0										2	IP-10	4	62
349813	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IP-10	13	98
349814	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IP-10	12	74
349815	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IP-10	11	78
349816	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IP-10	11	85
349817	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IP-10	12	87
349818	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IP-10	12	71
349819	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IP-10	13	83
349820	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IP-10	11	70
349821	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IP-10	9	71
349822	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IP-10	12	57
349823	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IP-10	12.5	46
349824	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IP-10	12	76
349825	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IP-10	11	71
349826	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IP-10	11	72
349827	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IP-10	10	78
349828	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IP-10	12	61
349829	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IP-10	11	85
349830	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IP-10	12	92
349831	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IP-10	12	80
349832	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IP-10	8	49
349833	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IP-10	12	70
349834	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IP-10	12	62
349835	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IP-10	10	46
349836	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IP-10	11	71
349837	20233						RA2159	51112.0										2	IP-10	12	80
349838	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IP-10	12	62
349839	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IP-10	11	69
349840	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IP-10	12	63
349841	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IP-10	8	78
349842	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IP-10	12	64
349843	20233						RA2159	51112.0										2	IP-10	10.5	58
349844	20233						N2586	51107.0										2	IP-10	8	66
349845	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IP-10	11	63
349846	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IP-10	11.5	70
349847	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IP-10	12	68
349848	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IP-10	10	66
349849	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IP-10	11	77
349850	20233						N2586	51107.0										2	IP-10	9.5	52
349851	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IP-10	12	74
349852	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IP-10	12	78
349853	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IP-10	11.5	76
349854	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IP-10	11	58
349855	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IP-10	10	43
349856	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IP-10	12.5	54
349857	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IP-10	10	60
349858	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IP-10	11	66
349859	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IP-10	14	39
349860	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IP-10	10.5	34
349861	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IP-10	12	41
349862	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IP-10	8	47
349863	20233																	0	IP-10	8	60
349864	20233						RA2159	51112.0								2	ug/mL	2	IP-10	10012	69
349865	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IP-10	3144	69
349866	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IP-10	1388.5	62
349867	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IP-10	3696	75
349868	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IP-10	2156	29
349869	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IP-10	5312	53
349870	20233						N2586	51107.0								2	ug/mL	2	IP-10	362.5	42
349871	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IP-10	539	43
349872	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IP-10	906	33
349873	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IP-10	613	35
349874	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IP-10	173	45
349875	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IP-10	557	65
349876	20233																	0	IP-10	10	85
349877	20233						RA2159	51112.0								2	ug/mL	3	IP-10	4401.5	74
349878	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IP-10	6224.5	90
349879	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IP-10	23	91
349880	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IP-10	720	83
349881	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IP-10	1061	73
349882	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IP-10	371	89
349883	20233						N2586	51107.0								2	ug/mL	3	IP-10	622	89
349884	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IP-10	424	68
349885	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IP-10	783.5	98
349886	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IP-10	947.5	62
349887	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IP-10	11.5	78
349888	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IP-10	483	69
349889	20233						RA2159	51112.0										3	IP-10	11.5	68
349890	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IP-10	12	72
349891	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IP-10	11	65
349892	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IP-10	11	70
349893	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IP-10	12	79
349894	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IP-10	12	68
349895	20233						RA2159	51112.0										3	IP-10	11	102
349896	20233						N2586	51107.0										3	IP-10	10	79
349897	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IP-10	10	81
349898	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IP-10	10	67
349899	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IP-10	13	70
349900	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IP-10	10	73
349901	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IP-10	10	71
349902	20233						N2586	51107.0										3	IP-10	11	80
349903	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IP-10	14	77
349904	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IP-10	17	70
349905	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IP-10	11.5	66
349906	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IP-10	12	69
349907	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IP-10	13	81
349908	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IP-10	9.5	72
349909	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IP-10	13	56
349910	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IP-10	13	82
349911	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IP-10	11	85
349912	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IP-10	9.5	52
349913	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IP-10	11	74
349914	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IP-10	12	73
349915	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IP-10	14	90
349916	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IP-10	11	71
349917	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IP-10	11	79
349918	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IP-10	8	78
349919	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IP-10	15.5	78
349920	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IP-10	11	76
349921	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IP-10	12	88
349922	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IP-10	12	73
349923	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IP-10	12	81
349924	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IP-10	11	94
349925	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IP-10	11	72
349926	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IP-10	11	66
349927	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IP-10	11	74
349928	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IP-10	11	79
349929	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IP-10	10	96
349930	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IP-10	14	70
349931	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IP-10	12	79
349932	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IP-10	11	93
349933	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IP-10	10	87
349934	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IP-10	12	72
349935	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IP-10	13	73
349936	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IP-10	13	83
349937	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IP-10	11	89
349938	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IP-10	12	71
349939	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IP-10	11	57
349940	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IP-10	12	79
349941	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IP-10	10	61
349942	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IP-10	11.5	60
349943	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IP-10	10	77
349944	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IP-10	11	64
349945	20233						RA2159	51112.0										3	IP-10	13	57
349946	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IP-10	14	68
349947	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IP-10	13	57
349948	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IP-10	12	79
349949	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IP-10	10.5	90
349950	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IP-10	12	85
349951	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IP-10	13	91
349952	20233						N2586	51107.0										3	IP-10	10	80
349953	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IP-10	10	89
349954	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IP-10	9	72
349955	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IP-10	10	80
349956	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IP-10	11	54
349957	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IP-10	9	69
349958	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IP-10	12	63
349959	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IP-10	10	75
349960	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IP-10	10.5	74
349961	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IP-10	11	75
349962	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IP-10	10	57
349963	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IP-10	11	59
349964	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IP-10	10	53
349965	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IP-10	8	82
349966	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IP-10	9	39
349967	20233						RA2159	51112.0										3	IP-10	12.5	72
349968	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IP-10	9	69
349969	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IP-10	13	58
349970	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IP-10	11	65
349971	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IP-10	10	78
349972	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IP-10	9	65
349973	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IP-10	11	70
349974	20233						N2586	51107.0										3	IP-10	12	99
349975	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IP-10	12	81
349976	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IP-10	11	65
349977	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IP-10	11	77
349978	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IP-10	8	66
349979	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IP-10	11	70
349980	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IP-10	11	71
349981	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IP-10	13	68
349982	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IP-10	14	71
349983	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IP-10	11	89
349984	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IP-10	11.5	76
349985	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IP-10	11	90
349986	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IP-10	9	91
349987	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IP-10	15	80
349988	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IP-10	10	84
349989	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IP-10	10	95
349990	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IP-10	13	67
349991	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IP-10	11	71
349992	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IP-10	9.5	58
349993	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IP-10	14	77
349994	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IP-10	13	71
349995	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IP-10	13	79
349996	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IP-10	10	76
349997	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IP-10	11	82
349998	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IP-10	13.5	78
349999	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IP-10	8	69
350000	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IP-10	10	68
350001	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IP-10	13	62
350002	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IP-10	13	77
350003	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IP-10	13	80
350004	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IP-10	10	69
350005	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IP-10	11	81
350006	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IP-10	11	78
350007	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IP-10	575	52
350008	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IP-10	293	67
350009	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IP-10	52	90
350010	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IP-10	243	73
350011	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IP-10	150	85
350012	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IP-10	11	65
350013	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IP-10	11	55
350014	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IP-10	97	74
350015	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IP-10	235	78
350016	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IP-10	404.5	82
350017	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IP-10	211	65
350018	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IP-10	13	69
350019	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IP-10	66	76
350020	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IP-10	9	102
350021	20233																	0	IP-10	10.5	58
350022	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IP-10	3249	61
350023	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IP-10	3847	65
350024	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IP-10	1325	59
350025	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IP-10	647	88
350026	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IP-10	906	84
350027	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IP-10	21.5	76
350028	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IP-10	10	63
350029	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IP-10	966	71
350030	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IP-10	1249	63
350031	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IP-10	2039.5	84
350032	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IP-10	1279	64
350033	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IP-10	14	64
350034	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IP-10	597	77
350035	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IP-10	10	68
350036	20233																	0	IP-10	9	59
350037	20233						RA2159	51112.0										3	IP-10	11.5	60
350038	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IP-10	7	61
350039	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IP-10	11	80
350040	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IP-10	11	67
350041	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IP-10	11	59
350042	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IP-10	11	104
350043	20233						RA2159	51112.0										3	IP-10	10.5	68
350044	20233						N2586	51107.0										3	IP-10	13	82
350045	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IP-10	8	72
350046	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IP-10	10	81
350047	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IP-10	9	62
350048	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IP-10	12	59
350049	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IP-10	7	79
350050	20233						N2586	51107.0										3	IP-10	6	35
350051	20233																	0	IP-10	12	65
350052	20233						RA2159	51112.0								2	ug/mL	4	IP-10	7452	59
350053	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IP-10	2069	61
350054	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IP-10	2150.5	82
350055	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IP-10	3009	57
350056	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IP-10	2153	69
350057	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IP-10	4428	71
350058	20233						N2586	51107.0								2	ug/mL	4	IP-10	1428.5	72
350059	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IP-10	1335.5	92
350060	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IP-10	14	65
350061	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IP-10	108	66
350062	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IP-10	24.5	70
350063	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IP-10	9	67
350064	20233						RA2159	51112.0										4	IP-10	10	79
350065	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IP-10	13	77
350066	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IP-10	12	75
350067	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IP-10	11.5	84
350068	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IP-10	11	69
350069	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IP-10	12	67
350070	20233						RA2159	51112.0										4	IP-10	11	74
350071	20233						N2586	51107.0										4	IP-10	11	86
350072	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IP-10	7	64
350073	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IP-10	13	71
350074	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IP-10	10	59
350075	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IP-10	11	71
350076	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IP-10	9	75
350077	20233						N2586	51107.0										4	IP-10	13	80
350078	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IP-10	14	76
350079	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IP-10	13	61
350080	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IP-10	13	93
350081	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IP-10	13	85
350082	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IP-10	7	77
350083	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IP-10	12	84
350084	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IP-10	13	84
350085	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IP-10	11	63
350086	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IP-10	11	71
350087	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IP-10	10	67
350088	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IP-10	10	57
350089	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IP-10	11	74
350090	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IP-10	12	83
350091	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IP-10	12	86
350092	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IP-10	12.5	90
350093	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IP-10	11	78
350094	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IP-10	11	82
350095	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IP-10	11	79
350096	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IP-10	12	52
350097	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IP-10	10	57
350098	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IP-10	11	87
350099	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IP-10	11	67
350100	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IP-10	11	65
350101	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IP-10	11	74
350102	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IP-10	12	101
350103	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IP-10	14	73
350104	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IP-10	14	66
350105	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IP-10	11	78
350106	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IP-10	10	52
350107	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IP-10	11	58
350108	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IP-10	13	74
350109	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IP-10	10	76
350110	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IP-10	11.5	72
350111	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IP-10	12	75
350112	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IP-10	10	46
350113	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IP-10	9.5	88
350114	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IP-10	12	69
350115	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IP-10	13	53
350116	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IP-10	12	70
350117	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IP-10	12	82
350118	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IP-10	10	64
350119	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IP-10	11	48
350120	20233						RA2159	51112.0										4	IP-10	12	72
350121	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IP-10	10	77
350122	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IP-10	13	65
350123	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IP-10	9	65
350124	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IP-10	12	53
350125	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IP-10	10	69
350126	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IP-10	10	63
350127	20233						N2586	51107.0										4	IP-10	11	78
350128	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IP-10	11	84
350129	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IP-10	11	80
350130	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IP-10	11	61
350131	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IP-10	15	41
350132	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IP-10	13	51
350133	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IP-10	10.5	50
350134	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IP-10	12	75
350135	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IP-10	10	63
350136	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IP-10	11	61
350137	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IP-10	11	64
350138	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IP-10	11	62
350139	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IP-10	11	64
350140	20233						RA2159	51112.0										4	IP-10	8	61
350141	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IP-10	9	73
350142	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IP-10	11.5	72
350143	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IP-10	12.5	66
350144	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IP-10	11	49
350145	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IP-10	9	65
350146	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IP-10	9	63
350147	20233						N2586	51107.0										4	IP-10	9	62
350148	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IP-10	12	73
350149	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IP-10	11	74
350150	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IP-10	10	89
350151	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IP-10	12	68
350152	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IP-10	8	62
350153	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IP-10	9	71
350154	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IP-10	11	77
350155	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IP-10	13	75
350156	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IP-10	12	71
350157	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IP-10	15	68
350158	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IP-10	10	76
350159	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IP-10	12	77
350160	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IP-10	13	65
350161	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IP-10	12	69
350162	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IP-10	11	67
350163	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IP-10	11	69
350164	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IP-10	10	83
350165	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IP-10	56	65
350166	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IP-10	10	81
350167	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IP-10	8	72
350168	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IP-10	13	70
350169	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IP-10	12	60
350170	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IP-10	10	54
350171	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IP-10	10	56
350172	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IP-10	10	61
350173	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IP-10	12	83
350174	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IP-10	12.5	52
350175	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IP-10	12	49
350176	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IP-10	13	66
350177	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IP-10	10	77
350178	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IP-10	13	60
350179	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IP-10	11	62
350180	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IP-10	12	59
350181	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IP-10	13	71
350182	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IP-10	136	50
350183	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IP-10	339	66
350184	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IP-10	105.5	68
350185	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IP-10	90	68
350186	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IP-10	38.5	64
350187	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IP-10	216	67
350188	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IP-10	11	67
350189	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IP-10	92	83
350190	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IP-10	146	71
350191	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IP-10	32	54
350192	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IP-10	97.5	34
350193	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IP-10	13	56
350194	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IP-10	8.5	60
350195	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IP-10	11.5	52
350196	20233																	0	IP-10	13	55
350197	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IP-10	1889	97
350198	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IP-10	1585.5	58
350199	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IP-10	1557	66
350200	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IP-10	640	93
350201	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IP-10	579	56
350202	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IP-10	608.5	66
350203	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IP-10	9.5	64
350204	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IP-10	1242	73
350205	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IP-10	2093	50
350206	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IP-10	310	62
350207	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IP-10	566.5	52
350208	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IP-10	25	64
350209	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IP-10	9	55
350210	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IP-10	8	63
350211	20233																	0	IP-10	9	74
350212	20233						RA2159	51112.0										4	IP-10	9	78
350213	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IP-10	10	80
350214	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IP-10	11	73
350215	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IP-10	10	67
350216	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IP-10	9	91
350217	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IP-10	10	58
350218	20233						RA2159	51112.0										4	IP-10	10	58
350219	20233						N2586	51107.0										4	IP-10	9	51
350220	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IP-10	11	58
350221	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IP-10	10	69
350222	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IP-10	8	58
350223	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IP-10	10	53
350224	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IP-10	9.5	84
350225	20233						N2586	51107.0										4	IP-10	12	55
350226	20233								TNF-a	201285.0						100	ng/mL	0	IP-10	28.5	84
350227	20233								IL-1 alpha	201286.0						100	ng/mL	0	IP-10	11	86
350228	20233								IL-6	201287.0						100	ug/mL	0	IP-10	20	70
350229	20233								IL-17A	201288.0						100	ng/mL	0	IP-10	14.5	62
350230	20233								EGF	201289.0						100	ng/mL	0	IP-10	11.5	68
350231	20233								IGF-I	201290.0						100	ug/mL	0	IP-10	11.5	64
350232	20233								Adiponectin	201291.0						5	ng/mL	0	IP-10	17	81
350233	20233								Leptin	201292.0						1	ng/mL	0	IP-10	13	77
350234	20233								Visfatin	201293.0						1	ng/mL	0	IP-10	13	58
350235	20233															2	ug/mL	0	IP-10	10	69
350236	20233								TNF-a	201285.0						100	ng/mL	0	IP-10	28.5	90
350237	20233								IL-1 alpha	201286.0						100	ng/mL	0	IP-10	13	43
350238	20233								IL-6	201287.0						100	ug/mL	0	IP-10	20	58
350239	20233								IL-17A	201288.0						100	ng/mL	0	IP-10	15	73
350240	20233								EGF	201289.0						100	ng/mL	0	IP-10	12	61
350241	20233								IGF-I	201290.0						100	ug/mL	0	IP-10	12	81
350242	20233								Adiponectin	201291.0						5	ng/mL	0	IP-10	18	53
350243	20233								Leptin	201292.0						1	ng/mL	0	IP-10	12.5	42
350244	20233								Visfatin	201293.0						1	ng/mL	0	IP-10	12	64
350245	20233															2	ug/mL	0	IP-10	13	60
350246	20233								TNF-a	201285.0						100	ng/mL	0	IP-10	30	79
350247	20233								IL-1 alpha	201286.0						100	ng/mL	0	IP-10	9	78
350248	20233								IL-6	201287.0						100	ug/mL	0	IP-10	14.5	66
350249	20233								IL-17A	201288.0						100	ng/mL	0	IP-10	15	80
350250	20233								EGF	201289.0						100	ng/mL	0	IP-10	17	61
350251	20233								IGF-I	201290.0						100	ug/mL	0	IP-10	11	62
350252	20233								Adiponectin	201291.0						5	ng/mL	0	IP-10	11	81
350253	20233								Leptin	201292.0						1	ng/mL	0	IP-10	10	74
350254	20233								Visfatin	201293.0						1	ng/mL	0	IP-10	11	98
350255	20233															2	ug/mL	0	IP-10	10	66
350256	20233								TNF-a	201285.0						100	ng/mL	0	IP-10	27	65
350257	20233								IL-1 alpha	201286.0						100	ng/mL	0	IP-10	8	61
350258	20233								IL-6	201287.0						100	ug/mL	0	IP-10	19	47
350259	20233								IL-17A	201288.0						100	ng/mL	0	IP-10	12	62
350260	20233								EGF	201289.0						100	ng/mL	0	IP-10	8	68
350261	20233								IGF-I	201290.0						100	ug/mL	0	IP-10	9	86
350262	20233								Adiponectin	201291.0						5	ng/mL	0	IP-10	13	73
350263	20233								Leptin	201292.0						1	ng/mL	0	IP-10	9	72
350264	20233								Visfatin	201293.0						1	ng/mL	0	IP-10	9	36
350265	20233															2	ug/mL	0	IP-10	9	59
350266	20233																	0	IL-13	17.5	68
350267	20233						RA2159	51112.0										1	IL-13	36	71
350268	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-13	28	55
350269	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-13	40	65
350270	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-13	38.5	82
350271	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-13	34	47
350272	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-13	36	63
350273	20233						RA2159	51112.0										1	IL-13	34	49
350274	20233						N2586	51107.0										1	IL-13	39.5	54
350275	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-13	37	61
350276	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-13	56.5	50
350277	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-13	39	66
350278	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-13	40	64
350279	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-13	29	49
350280	20233						N2586	51107.0										1	IL-13	30	36
350281	20233																	0	IL-13	16	71
350282	20233																	0	IL-13	14	37
350283	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-13	42.5	46
350284	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-13	35	56
350285	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-13	33	50
350286	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-13	35	80
350287	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-13	40	55
350288	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-13	33	65
350289	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-13	23	50
350290	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-13	58	61
350291	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-13	37.5	56
350292	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-13	67	56
350293	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-13	50	59
350294	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-13	38	43
350295	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-13	54	55
350296	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-13	45	39
350297	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-13	46	65
350298	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-13	46.5	76
350299	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-13	33	64
350300	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-13	44	54
350301	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-13	35	61
350302	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-13	39	64
350303	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-13	25	63
350304	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-13	62	57
350305	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-13	44	53
350306	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-13	39	53
350307	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-13	52	52
350308	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-13	60	57
350309	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-13	51.5	50
350310	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-13	34.5	62
350311	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-13	39	75
350312	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-13	27	57
350313	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-13	30	61
350314	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-13	33	87
350315	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-13	35	76
350316	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-13	35	55
350317	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-13	22	58
350318	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-13	44.5	68
350319	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-13	26.5	54
350320	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-13	46.5	48
350321	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-13	49	51
350322	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-13	37.5	62
350323	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-13	40	73
350324	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-13	35	47
350325	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-13	33	62
350326	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-13	37	59
350327	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-13	37	58
350328	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-13	39	67
350329	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-13	45	58
350330	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-13	38	57
350331	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-13	58.5	74
350332	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-13	52	51
350333	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-13	48	76
350334	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-13	34.5	70
350335	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-13	44	59
350336	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-13	42	69
350337	20233						RA2159	51112.0										1	IL-13	35	68
350338	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-13	34	64
350339	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-13	32	55
350340	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-13	30	55
350341	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-13	28	51
350342	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-13	44	66
350343	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-13	35.5	42
350344	20233						N2586	51107.0										1	IL-13	36	57
350345	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-13	37	44
350346	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-13	43	41
350347	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-13	37	46
350348	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-13	48	43
350349	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-13	42	68
350350	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-13	34	71
350351	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-13	39	65
350352	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-13	32	57
350353	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-13	32	51
350354	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-13	30.5	50
350355	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-13	40	62
350356	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-13	29	54
350357	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-13	26	89
350358	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-13	53	65
350359	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-13	33	64
350360	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-13	41.5	56
350361	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-13	32	57
350362	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-13	32	57
350363	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-13	37	44
350364	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-13	36.5	62
350365	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-13	30	59
350366	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-13	24	55
350367	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-13	31	41
350368	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-13	28	77
350369	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-13	28	81
350370	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-13	28	52
350371	20233						RA2159	51112.0										1	IL-13	34.5	50
350372	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-13	42	53
350373	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-13	36	62
350374	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-13	36	57
350375	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-13	35	34
350376	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-13	30	67
350377	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-13	34	55
350378	20233						N2586	51107.0										1	IL-13	53	77
350379	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-13	34.5	76
350380	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-13	23.5	50
350381	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-13	31	57
350382	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-13	34	54
350383	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-13	30.5	76
350384	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-13	30	60
350385	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-13	38.5	64
350386	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-13	33.5	48
350387	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-13	41	51
350388	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-13	34	43
350389	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-13	34	55
350390	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-13	34	41
350391	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-13	38	52
350392	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-13	26	53
350393	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-13	32	61
350394	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-13	29	59
350395	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-13	30	71
350396	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-13	30	50
350397	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-13	44	51
350398	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-13	34	43
350399	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-13	40	68
350400	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-13	32.5	64
350401	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-13	34	45
350402	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-13	36	43
350403	20233						RA2159	51112.0										1	IL-13	36.5	48
350404	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-13	36	59
350405	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-13	35	81
350406	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-13	29	46
350407	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-13	31	63
350408	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-13	31	66
350409	20233						RA2159	51112.0										1	IL-13	39	75
350410	20233						N2586	51107.0										1	IL-13	44.5	80
350411	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-13	40.5	78
350412	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-13	41.5	70
350413	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-13	31	69
350414	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-13	47	49
350415	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-13	38.5	92
350416	20233						N2586	51107.0										1	IL-13	42	56
350417	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-13	31.5	64
350418	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-13	41.5	70
350419	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-13	38	65
350420	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-13	34.5	78
350421	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-13	34	47
350422	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-13	30	57
350423	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-13	36	52
350424	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-13	27.5	56
350425	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-13	30	53
350426	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-13	27	63
350427	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-13	30	64
350428	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-13	30	25
350429	20233																	0	IL-13	14	65
350430	20233						RA2159	51112.0								2	ug/mL	1	IL-13	35.5	50
350431	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-13	47	51
350432	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-13	77.5	66
350433	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-13	35.5	48
350434	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-13	37	66
350435	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-13	26.5	50
350436	20233						N2586	51107.0								2	ug/mL	1	IL-13	54	30
350437	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-13	54	75
350438	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-13	29	54
350439	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-13	41	43
350440	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-13	34	53
350441	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-13	42	41
350442	20233																	0	IL-13	13	41
350443	20233						RA2159	51112.0										2	IL-13	29	59
350444	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-13	30	71
350445	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-13	100	51
350446	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-13	29	51
350447	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-13	28	50
350448	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-13	30	79
350449	20233						RA2159	51112.0										2	IL-13	27	45
350450	20233						N2586	51107.0										2	IL-13	30.5	36
350451	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-13	30	47
350452	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-13	26	52
350453	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-13	29	45
350454	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-13	35	45
350455	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-13	33	35
350456	20233						N2586	51107.0										2	IL-13	42	38
350457	20233																	0	IL-13	14	51
350458	20233																	0	IL-13	15	46
350459	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-13	31	67
350460	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-13	26	65
350461	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-13	35	52
350462	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-13	35	41
350463	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-13	28	69
350464	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-13	30	46
350465	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-13	34	53
350466	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-13	38	46
350467	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-13	36	55
350468	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-13	45	57
350469	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-13	46	50
350470	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-13	46	43
350471	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-13	44	61
350472	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-13	33	49
350473	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-13	38	52
350474	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-13	37	55
350475	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-13	26	50
350476	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-13	26.5	64
350477	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-13	35	55
350478	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-13	38.5	60
350479	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-13	25	46
350480	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-13	41.5	42
350481	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-13	36	75
350482	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-13	52.5	56
350483	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-13	44.5	80
350484	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-13	41	45
350485	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-13	38	55
350486	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-13	31.5	44
350487	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-13	34	75
350488	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-13	26	62
350489	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-13	26	63
350490	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-13	26	60
350491	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-13	34	63
350492	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-13	30	77
350493	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-13	26.5	62
350494	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-13	39	55
350495	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-13	32	77
350496	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-13	31.5	42
350497	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-13	37.5	44
350498	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-13	34.5	56
350499	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-13	50	42
350500	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-13	56	50
350501	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-13	27	53
350502	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-13	33	83
350503	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-13	36	77
350504	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-13	32	63
350505	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-13	31	54
350506	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-13	45	51
350507	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-13	32.5	74
350508	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-13	35.5	42
350509	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-13	36	59
350510	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-13	30	61
350511	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-13	33	50
350512	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-13	31.5	54
350513	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-13	38	64
350514	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-13	34	46
350515	20233						RA2159	51112.0										2	IL-13	30	61
350516	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-13	25	63
350517	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-13	25	73
350518	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-13	24	51
350519	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-13	31.5	56
350520	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-13	29	57
350521	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-13	25	48
350522	20233						N2586	51107.0										2	IL-13	30.5	48
350523	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-13	41	59
350524	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-13	37	61
350525	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-13	27	75
350526	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-13	37	47
350527	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-13	29	42
350528	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-13	29	54
350529	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-13	26.5	80
350530	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-13	31	67
350531	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-13	27	55
350532	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-13	25	60
350533	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-13	21	56
350534	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-13	24	54
350535	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-13	30.5	52
350536	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-13	31	58
350537	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-13	35	51
350538	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-13	42	46
350539	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-13	27	37
350540	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-13	8.5	78
350541	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-13	25	85
350542	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-13	23	46
350543	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-13	23	67
350544	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-13	28	58
350545	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-13	26	77
350546	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-13	30.5	60
350547	20233						RA2159	51112.0										2	IL-13	25.5	66
350548	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-13	36	66
350549	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-13	30	69
350550	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-13	31.5	52
350551	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-13	27	53
350552	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-13	43	45
350553	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-13	29	49
350554	20233						N2586	51107.0										2	IL-13	8	61
350555	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-13	24.5	62
350556	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-13	23.5	68
350557	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-13	21	49
350558	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-13	23	75
350559	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-13	22	57
350560	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-13	31	75
350561	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-13	38.5	52
350562	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-13	27	54
350563	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-13	29.5	46
350564	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-13	30	58
350565	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-13	33.5	58
350566	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-13	33	48
350567	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-13	30	48
350568	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-13	23	47
350569	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-13	20	53
350570	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-13	29	61
350571	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-13	21	59
350572	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-13	22	61
350573	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-13	27.5	74
350574	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-13	30	41
350575	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-13	28	45
350576	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-13	26.5	56
350577	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-13	33	41
350578	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-13	31	70
350579	20233						RA2159	51112.0										2	IL-13	35.5	58
350580	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-13	34	59
350581	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-13	31.5	56
350582	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-13	30	71
350583	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-13	28	65
350584	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-13	26	50
350585	20233						RA2159	51112.0										2	IL-13	25	55
350586	20233						N2586	51107.0										2	IL-13	32.5	42
350587	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-13	31	43
350588	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-13	35	53
350589	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-13	33.5	46
350590	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-13	30	40
350591	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-13	31	45
350592	20233						N2586	51107.0										2	IL-13	30	41
350593	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-13	23	47
350594	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-13	28	61
350595	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-13	25	70
350596	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-13	22	45
350597	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-13	28.5	44
350598	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-13	28	47
350599	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-13	25	51
350600	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-13	29	39
350601	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-13	26	38
350602	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-13	31.5	32
350603	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-13	39	31
350604	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-13	32	51
350605	20233																	0	IL-13	8	47
350606	20233						RA2159	51112.0								2	ug/mL	2	IL-13	39.5	50
350607	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-13	25.5	62
350608	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-13	27	54
350609	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-13	39	72
350610	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-13	23	34
350611	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-13	42.5	36
350612	20233						N2586	51107.0								2	ug/mL	2	IL-13	35.5	32
350613	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-13	36	32
350614	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-13	31	25
350615	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-13	40	33
350616	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-13	25	27
350617	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-13	46.5	42
350618	20233																	0	IL-13	14	66
350619	20233						RA2159	51112.0								2	ug/mL	3	IL-13	51	66
350620	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-13	53.5	72
350621	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-13	41	62
350622	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-13	46.5	58
350623	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-13	50	57
350624	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-13	44	65
350625	20233						N2586	51107.0								2	ug/mL	3	IL-13	54	54
350626	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-13	50	65
350627	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-13	45	63
350628	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-13	49.5	58
350629	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-13	54	63
350630	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-13	71	71
350631	20233						RA2159	51112.0										3	IL-13	39	63
350632	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-13	49	51
350633	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-13	43	41
350634	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-13	42	53
350635	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-13	40	80
350636	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-13	48	55
350637	20233						RA2159	51112.0										3	IL-13	38	83
350638	20233						N2586	51107.0										3	IL-13	48	52
350639	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-13	46	60
350640	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-13	60.5	54
350641	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-13	47	50
350642	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-13	44	67
350643	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-13	50.5	66
350644	20233						N2586	51107.0										3	IL-13	53	43
350645	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-13	38	53
350646	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-13	35	52
350647	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-13	41	65
350648	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-13	46	67
350649	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-13	31	67
350650	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-13	51	67
350651	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-13	60	67
350652	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-13	55	66
350653	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-13	48	69
350654	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-13	44	57
350655	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-13	43	60
350656	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-13	52	49
350657	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-13	39	55
350658	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-13	45	67
350659	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-13	27	64
350660	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-13	35	81
350661	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-13	35.5	62
350662	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-13	41	83
350663	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-13	44.5	72
350664	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-13	48	57
350665	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-13	42	65
350666	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-13	55	58
350667	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-13	47	52
350668	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-13	54	60
350669	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-13	37	69
350670	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-13	41	76
350671	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-13	38.5	70
350672	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-13	30	43
350673	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-13	34.5	70
350674	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-13	42	59
350675	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-13	54	65
350676	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-13	56	57
350677	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-13	45	65
350678	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-13	38	65
350679	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-13	53.5	50
350680	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-13	53	51
350681	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-13	35.5	68
350682	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-13	39	79
350683	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-13	39	67
350684	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-13	49	64
350685	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-13	45.5	60
350686	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-13	35.5	44
350687	20233						RA2159	51112.0										3	IL-13	39.5	62
350688	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-13	49	74
350689	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-13	50	51
350690	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-13	42	68
350691	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-13	53	69
350692	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-13	59	73
350693	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-13	48	65
350694	20233						N2586	51107.0										3	IL-13	44	67
350695	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-13	32.5	52
350696	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-13	43.5	56
350697	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-13	41	64
350698	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-13	35	49
350699	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-13	32	67
350700	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-13	36	51
350701	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-13	42.5	58
350702	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-13	40	68
350703	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-13	49	86
350704	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-13	50	47
350705	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-13	52	59
350706	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-13	48	69
350707	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-13	23.5	56
350708	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-13	30	49
350709	20233						RA2159	51112.0										3	IL-13	33.5	66
350710	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-13	35	49
350711	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-13	37.5	50
350712	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-13	36	69
350713	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-13	42	51
350714	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-13	32	59
350715	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-13	31	69
350716	20233						N2586	51107.0										3	IL-13	43.5	50
350717	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-13	52	71
350718	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-13	40.5	62
350719	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-13	46.5	50
350720	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-13	64.5	60
350721	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-13	34	66
350722	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-13	46	54
350723	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-13	38	68
350724	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-13	50	61
350725	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-13	41	67
350726	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-13	47	62
350727	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-13	28.5	42
350728	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-13	49.5	46
350729	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-13	49	67
350730	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-13	40	61
350731	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-13	33	84
350732	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-13	48	64
350733	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-13	48	50
350734	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-13	48	49
350735	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-13	35	70
350736	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-13	46	59
350737	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-13	39	63
350738	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-13	35.5	64
350739	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-13	35	72
350740	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-13	33	67
350741	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-13	31	68
350742	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-13	45	81
350743	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-13	40.5	52
350744	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-13	30.5	62
350745	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-13	50	72
350746	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-13	48	55
350747	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-13	50.5	80
350748	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-13	37	45
350749	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-13	59	49
350750	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-13	55	81
350751	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-13	41	71
350752	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-13	54	59
350753	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-13	61	72
350754	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-13	32.5	52
350755	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-13	43.5	48
350756	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-13	61	56
350757	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-13	61.5	76
350758	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-13	45	63
350759	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-13	57.5	70
350760	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-13	35	57
350761	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-13	59	63
350762	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-13	42.5	66
350763	20233																	0	IL-13	17	50
350764	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-13	48.5	62
350765	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-13	90	49
350766	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-13	47	69
350767	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-13	61	65
350768	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-13	46	59
350769	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-13	51	53
350770	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-13	36	51
350771	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-13	49.5	66
350772	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-13	48	49
350773	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-13	52.5	64
350774	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-13	38	55
350775	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-13	71	57
350776	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-13	65.5	72
350777	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-13	52.5	64
350778	20233																	0	IL-13	14	53
350779	20233						RA2159	51112.0										3	IL-13	39.5	58
350780	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-13	62	60
350781	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-13	35	74
350782	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-13	49	75
350783	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-13	35.5	34
350784	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-13	28	57
350785	20233						RA2159	51112.0										3	IL-13	39	67
350786	20233						N2586	51107.0										3	IL-13	59	71
350787	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-13	55	67
350788	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-13	40.5	50
350789	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-13	43.5	44
350790	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-13	54	43
350791	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-13	46	63
350792	20233						N2586	51107.0										3	IL-13	55	36
350793	20233																	0	IL-13	16	45
350794	20233						RA2159	51112.0								2	ug/mL	4	IL-13	43	49
350795	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-13	48	55
350796	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-13	46.5	66
350797	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-13	49	60
350798	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-13	44.5	74
350799	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-13	44	71
350800	20233						N2586	51107.0								2	ug/mL	4	IL-13	58.5	70
350801	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-13	46.5	56
350802	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-13	51	49
350803	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-13	56.5	54
350804	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-13	61	59
350805	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-13	39	59
350806	20233						RA2159	51112.0										4	IL-13	45	61
350807	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-13	44	75
350808	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-13	38	61
350809	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-13	43	50
350810	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-13	37	65
350811	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-13	38	64
350812	20233						RA2159	51112.0										4	IL-13	40	67
350813	20233						N2586	51107.0										4	IL-13	37	70
350814	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-13	35	53
350815	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-13	32	48
350816	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-13	68	51
350817	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-13	44	68
350818	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-13	53	73
350819	20233						N2586	51107.0										4	IL-13	46.5	44
350820	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-13	52	71
350821	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-13	37	44
350822	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-13	43	67
350823	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-13	39.5	64
350824	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-13	42	70
350825	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-13	39.5	66
350826	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-13	50	80
350827	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-13	46	47
350828	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-13	54.5	54
350829	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-13	47	43
350830	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-13	37.5	58
350831	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-13	39	61
350832	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-13	32	61
350833	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-13	42	75
350834	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-13	43	70
350835	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-13	42	59
350836	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-13	40	61
350837	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-13	36.5	64
350838	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-13	43	41
350839	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-13	54	49
350840	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-13	38.5	66
350841	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-13	52	55
350842	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-13	40	55
350843	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-13	43	63
350844	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-13	43	76
350845	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-13	44.5	58
350846	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-13	48	51
350847	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-13	42.5	50
350848	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-13	36	36
350849	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-13	38	39
350850	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-13	44	61
350851	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-13	47.5	46
350852	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-13	52.5	56
350853	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-13	51.5	54
350854	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-13	66.5	56
350855	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-13	41.5	60
350856	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-13	40.5	58
350857	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-13	41	52
350858	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-13	39	60
350859	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-13	42.5	78
350860	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-13	37.5	46
350861	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-13	39	47
350862	20233						RA2159	51112.0										4	IL-13	52	47
350863	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-13	34	63
350864	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-13	54.5	52
350865	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-13	63	57
350866	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-13	58	45
350867	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-13	51	47
350868	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-13	48	60
350869	20233						N2586	51107.0										4	IL-13	60	58
350870	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-13	38	61
350871	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-13	45	51
350872	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-13	36	56
350873	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-13	43.5	54
350874	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-13	39	22
350875	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-13	49	48
350876	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-13	62.5	54
350877	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-13	54	70
350878	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-13	58.5	52
350879	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-13	39	56
350880	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-13	54	48
350881	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-13	30	69
350882	20233						RA2159	51112.0										4	IL-13	37	57
350883	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-13	31.5	50
350884	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-13	36	46
350885	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-13	35.5	64
350886	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-13	47.5	50
350887	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-13	36	43
350888	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-13	39	64
350889	20233						N2586	51107.0										4	IL-13	35	71
350890	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-13	61.5	50
350891	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-13	56	52
350892	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-13	42	82
350893	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-13	45	59
350894	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-13	31.5	58
350895	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-13	38.5	58
350896	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-13	39.5	58
350897	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-13	31	46
350898	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-13	36	58
350899	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-13	46	42
350900	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-13	38	53
350901	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-13	39	49
350902	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-13	40.5	64
350903	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-13	53	47
350904	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-13	59	51
350905	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-13	45	53
350906	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-13	61.5	58
350907	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-13	34	69
350908	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-13	55	55
350909	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-13	37	47
350910	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-13	47.5	56
350911	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-13	32	57
350912	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-13	31	41
350913	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-13	61	32
350914	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-13	38	47
350915	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-13	58	51
350916	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-13	39	35
350917	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-13	39.5	48
350918	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-13	38.5	44
350919	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-13	43.5	66
350920	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-13	43	47
350921	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-13	40	63
350922	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-13	31	47
350923	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-13	63	43
350924	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-13	54	39
350925	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-13	60	56
350926	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-13	53.5	52
350927	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-13	47.5	70
350928	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-13	45	43
350929	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-13	44	55
350930	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-13	26	55
350931	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-13	74	68
350932	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-13	64	51
350933	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-13	52	45
350934	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-13	63	41
350935	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-13	66	64
350936	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-13	46.5	46
350937	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-13	56	48
350938	20233																	0	IL-13	17	38
350939	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-13	44.5	74
350940	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-13	38.5	38
350941	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-13	46.5	66
350942	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-13	55	63
350943	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-13	38	38
350944	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-13	43	53
350945	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-13	32	44
350946	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-13	67	50
350947	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-13	73	54
350948	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-13	58.5	50
350949	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-13	64	50
350950	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-13	47	37
350951	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-13	33	57
350952	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-13	40	59
350953	20233																	0	IL-13	15	57
350954	20233						RA2159	51112.0										4	IL-13	38	64
350955	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-13	53	60
350956	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-13	40.5	62
350957	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-13	41	53
350958	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-13	40	67
350959	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-13	48	55
350960	20233						RA2159	51112.0										4	IL-13	32	44
350961	20233						N2586	51107.0										4	IL-13	45	49
350962	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-13	52	45
350963	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-13	39	45
350964	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-13	43	65
350965	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-13	39.5	48
350966	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-13	45	50
350967	20233						N2586	51107.0										4	IL-13	56	51
350968	20233								TNF-a	201285.0						100	ng/mL	0	IL-13	16	78
350969	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-13	15	82
350970	20233								IL-6	201287.0						100	ug/mL	0	IL-13	53	77
350971	20233								IL-17A	201288.0						100	ng/mL	0	IL-13	35	63
350972	20233								EGF	201289.0						100	ng/mL	0	IL-13	14	55
350973	20233								IGF-I	201290.0						100	ug/mL	0	IL-13	14	73
350974	20233								Adiponectin	201291.0						5	ng/mL	0	IL-13	20	62
350975	20233								Leptin	201292.0						1	ng/mL	0	IL-13	15	73
350976	20233								Visfatin	201293.0						1	ng/mL	0	IL-13	21	47
350977	20233															2	ug/mL	0	IL-13	15	52
350978	20233								TNF-a	201285.0						100	ng/mL	0	IL-13	14.5	72
350979	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-13	22	31
350980	20233								IL-6	201287.0						100	ug/mL	0	IL-13	58.5	54
350981	20233								IL-17A	201288.0						100	ng/mL	0	IL-13	33	55
350982	20233								EGF	201289.0						100	ng/mL	0	IL-13	14	52
350983	20233								IGF-I	201290.0						100	ug/mL	0	IL-13	14	59
350984	20233								Adiponectin	201291.0						5	ng/mL	0	IL-13	18.5	42
350985	20233								Leptin	201292.0						1	ng/mL	0	IL-13	15	54
350986	20233								Visfatin	201293.0						1	ng/mL	0	IL-13	18	47
350987	20233															2	ug/mL	0	IL-13	13	56
350988	20233								TNF-a	201285.0						100	ng/mL	0	IL-13	18	71
350989	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-13	21	45
350990	20233								IL-6	201287.0						100	ug/mL	0	IL-13	29.5	54
350991	20233								IL-17A	201288.0						100	ng/mL	0	IL-13	46	56
350992	20233								EGF	201289.0						100	ng/mL	0	IL-13	15.5	62
350993	20233								IGF-I	201290.0						100	ug/mL	0	IL-13	20	64
350994	20233								Adiponectin	201291.0						5	ng/mL	0	IL-13	20	74
350995	20233								Leptin	201292.0						1	ng/mL	0	IL-13	15	43
350996	20233								Visfatin	201293.0						1	ng/mL	0	IL-13	19.5	70
350997	20233															2	ug/mL	0	IL-13	15	54
350998	20233								TNF-a	201285.0						100	ng/mL	0	IL-13	21	62
350999	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-13	14	39
351000	20233								IL-6	201287.0						100	ug/mL	0	IL-13	18.5	50
351001	20233								IL-17A	201288.0						100	ng/mL	0	IL-13	32	49
351002	20233								EGF	201289.0						100	ng/mL	0	IL-13	16.5	54
351003	20233								IGF-I	201290.0						100	ug/mL	0	IL-13	17	65
351004	20233								Adiponectin	201291.0						5	ng/mL	0	IL-13	18.5	40
351005	20233								Leptin	201292.0						1	ng/mL	0	IL-13	19	46
351006	20233								Visfatin	201293.0						1	ng/mL	0	IL-13	18.5	38
351007	20233															2	ug/mL	0	IL-13	17.5	60
351008	20233																	0	IL-4	22	52
351009	20233						RA2159	51112.0										1	IL-4	29	61
351010	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-4	21	56
351011	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-4	25	50
351012	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-4	26	55
351013	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-4	27	48
351014	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-4	27	54
351015	20233						RA2159	51112.0										1	IL-4	27	61
351016	20233						N2586	51107.0										1	IL-4	27	55
351017	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-4	28	54
351018	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-4	24	43
351019	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-4	23	64
351020	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-4	25	60
351021	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-4	22	40
351022	20233						N2586	51107.0										1	IL-4	26.5	26
351023	20233																	0	IL-4	20	53
351024	20233																	0	IL-4	21	29
351025	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-4	66	39
351026	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-4	46.5	56
351027	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-4	45.5	62
351028	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-4	42	60
351029	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-4	46.5	54
351030	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-4	34	46
351031	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-4	23	52
351032	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-4	56.5	50
351033	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-4	52.5	40
351034	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-4	55	50
351035	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-4	58	56
351036	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-4	43	33
351037	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-4	44	56
351038	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-4	22	35
351039	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-4	61	53
351040	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-4	47	57
351041	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-4	32	50
351042	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-4	59	61
351043	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-4	60	48
351044	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-4	26	59
351045	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-4	22	41
351046	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-4	61	58
351047	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-4	59.5	50
351048	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-4	54	39
351049	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-4	57	56
351050	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-4	66.5	42
351051	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-4	34	51
351052	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-4	23.5	48
351053	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-4	36	60
351054	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-4	26.5	50
351055	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-4	30	65
351056	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-4	33.5	64
351057	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-4	36	50
351058	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-4	29	49
351059	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-4	19	54
351060	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-4	30	50
351061	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-4	28	60
351062	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-4	29.5	36
351063	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-4	40	45
351064	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-4	29.5	52
351065	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-4	34.5	66
351066	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-4	28	53
351067	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-4	27	69
351068	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-4	25	59
351069	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-4	28.5	46
351070	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-4	24	56
351071	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-4	26	41
351072	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-4	21	50
351073	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-4	32	50
351074	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-4	30	54
351075	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-4	24	50
351076	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-4	23.5	70
351077	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-4	26	55
351078	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-4	26	71
351079	20233						RA2159	51112.0										1	IL-4	22	55
351080	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-4	24	50
351081	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-4	21	56
351082	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-4	22	55
351083	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-4	24	43
351084	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-4	20	47
351085	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-4	22	48
351086	20233						N2586	51107.0										1	IL-4	24	46
351087	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-4	19	55
351088	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-4	23	35
351089	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-4	19	47
351090	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-4	24	35
351091	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-4	21	53
351092	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-4	20	50
351093	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-4	24	52
351094	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-4	20	59
351095	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-4	25	48
351096	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-4	23	63
351097	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-4	24	60
351098	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-4	21	56
351099	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-4	22	50
351100	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-4	22	50
351101	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-4	21	51
351102	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-4	22	47
351103	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-4	20	37
351104	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-4	23	44
351105	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-4	21	30
351106	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-4	25	62
351107	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-4	28	56
351108	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-4	21	50
351109	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-4	20	41
351110	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-4	25.5	50
351111	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-4	17	50
351112	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-4	21	68
351113	20233						RA2159	51112.0										1	IL-4	21	59
351114	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-4	21	41
351115	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-4	19	49
351116	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-4	18	65
351117	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-4	19	45
351118	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-4	21	43
351119	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-4	20	63
351120	20233						N2586	51107.0										1	IL-4	27	71
351121	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-4	21	66
351122	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-4	16	52
351123	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-4	18	50
351124	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-4	20.5	46
351125	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-4	21.5	58
351126	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-4	22	49
351127	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-4	19.5	46
351128	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-4	21	45
351129	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-4	25	35
351130	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-4	22	38
351131	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-4	19	34
351132	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-4	24	43
351133	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-4	23	58
351134	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-4	20	41
351135	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-4	21.5	56
351136	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-4	22	49
351137	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-4	23	54
351138	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-4	21	69
351139	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-4	18	45
351140	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-4	20	35
351141	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-4	20	60
351142	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-4	19.5	40
351143	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-4	23	44
351144	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-4	23	37
351145	20233						RA2159	51112.0										1	IL-4	20.5	44
351146	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-4	22	65
351147	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-4	23	58
351148	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-4	18	43
351149	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-4	19	43
351150	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-4	20	58
351151	20233						RA2159	51112.0										1	IL-4	21	65
351152	20233						N2586	51107.0										1	IL-4	27	49
351153	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-4	23.5	66
351154	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-4	19.5	52
351155	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-4	21	60
351156	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-4	24	46
351157	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-4	24.5	60
351158	20233						N2586	51107.0										1	IL-4	21	57
351159	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-4	19	38
351160	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-4	20	50
351161	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-4	21.5	42
351162	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-4	17	57
351163	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-4	21.5	34
351164	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-4	17	53
351165	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-4	20.5	42
351166	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-4	20	51
351167	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-4	23	46
351168	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-4	19	49
351169	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-4	17.5	42
351170	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-4	23	24
351171	20233																	0	IL-4	19	46
351172	20233						RA2159	51112.0								2	ug/mL	1	IL-4	39	53
351173	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-4	29.5	42
351174	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-4	22	58
351175	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-4	27	38
351176	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-4	33	63
351177	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-4	24	55
351178	20233						N2586	51107.0								2	ug/mL	1	IL-4	41.5	38
351179	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-4	33	54
351180	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-4	22	51
351181	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-4	28	22
351182	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-4	39.5	38
351183	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-4	26	30
351184	20233																	0	IL-4	22	45
351185	20233						RA2159	51112.0										2	IL-4	21	57
351186	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-4	19	69
351187	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-4	24.5	46
351188	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-4	26	49
351189	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-4	23	37
351190	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-4	27	55
351191	20233						RA2159	51112.0										2	IL-4	26.5	42
351192	20233						N2586	51107.0										2	IL-4	27.5	38
351193	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-4	21.5	40
351194	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-4	25	38
351195	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-4	21	37
351196	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-4	23	47
351197	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-4	24	42
351198	20233						N2586	51107.0										2	IL-4	25	37
351199	20233																	0	IL-4	23	45
351200	20233																	0	IL-4	22	27
351201	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-4	54	52
351202	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-4	46	50
351203	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-4	49.5	44
351204	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-4	45.5	48
351205	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-4	42	46
351206	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-4	42	41
351207	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-4	20	50
351208	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-4	46	47
351209	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-4	40	48
351210	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-4	56	57
351211	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-4	51	43
351212	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-4	49.5	38
351213	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-4	47	32
351214	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-4	22	43
351215	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-4	59	55
351216	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-4	41	58
351217	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-4	43	63
351218	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-4	63	48
351219	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-4	53	52
351220	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-4	48.5	64
351221	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-4	22	46
351222	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-4	52.5	42
351223	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-4	38.5	48
351224	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-4	58	34
351225	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-4	60	51
351226	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-4	50.5	40
351227	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-4	60	45
351228	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-4	23	35
351229	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-4	28.5	58
351230	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-4	31	46
351231	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-4	31.5	66
351232	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-4	30	43
351233	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-4	28	54
351234	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-4	24	61
351235	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-4	21	53
351236	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-4	28	55
351237	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-4	22.5	50
351238	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-4	30	38
351239	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-4	31	41
351240	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-4	22	43
351241	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-4	27.5	42
351242	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-4	21	37
351243	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-4	26	50
351244	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-4	26.5	50
351245	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-4	28	49
351246	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-4	25	64
351247	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-4	19	51
351248	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-4	28	28
351249	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-4	21	66
351250	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-4	27.5	44
351251	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-4	21	54
351252	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-4	21	55
351253	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-4	27	55
351254	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-4	26	39
351255	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-4	22.5	50
351256	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-4	22.5	38
351257	20233						RA2159	51112.0										2	IL-4	21	51
351258	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-4	23	49
351259	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-4	25	54
351260	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-4	22.5	38
351261	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-4	22.5	58
351262	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-4	21	46
351263	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-4	20	37
351264	20233						N2586	51107.0										2	IL-4	21	43
351265	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-4	23	49
351266	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-4	17.5	42
351267	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-4	25.5	52
351268	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-4	21	41
351269	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-4	18	39
351270	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-4	21	35
351271	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-4	23	55
351272	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-4	24	60
351273	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-4	22	53
351274	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-4	22	56
351275	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-4	18.5	58
351276	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-4	20.5	74
351277	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-4	17	50
351278	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-4	22	53
351279	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-4	22	59
351280	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-4	23	51
351281	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-4	20	47
351282	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-4	8	51
351283	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-4	19	51
351284	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-4	22	33
351285	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-4	20	45
351286	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-4	22	65
351287	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-4	18	75
351288	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-4	20	57
351289	20233						RA2159	51112.0										2	IL-4	18	50
351290	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-4	23	67
351291	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-4	20	67
351292	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-4	24	53
351293	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-4	21	38
351294	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-4	22	47
351295	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-4	21	36
351296	20233						N2586	51107.0										2	IL-4	9	41
351297	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-4	15	59
351298	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-4	22	56
351299	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-4	16	52
351300	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-4	18	50
351301	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-4	20	49
351302	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-4	20	55
351303	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-4	18.5	56
351304	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-4	17.5	52
351305	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-4	19	60
351306	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-4	18.5	44
351307	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-4	22	37
351308	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-4	18.5	40
351309	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-4	22	56
351310	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-4	19	45
351311	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-4	19	67
351312	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-4	22	52
351313	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-4	20	60
351314	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-4	23.5	50
351315	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-4	22	60
351316	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-4	22	37
351317	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-4	18	54
351318	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-4	16	32
351319	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-4	19.5	46
351320	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-4	22	47
351321	20233						RA2159	51112.0										2	IL-4	21.5	44
351322	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-4	21.5	58
351323	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-4	20	42
351324	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-4	19	56
351325	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-4	19.5	50
351326	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-4	20	35
351327	20233						RA2159	51112.0										2	IL-4	22.5	42
351328	20233						N2586	51107.0										2	IL-4	21	49
351329	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-4	17	54
351330	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-4	20	51
351331	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-4	19	40
351332	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-4	21	40
351333	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-4	19	41
351334	20233						N2586	51107.0										2	IL-4	21	39
351335	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-4	21	60
351336	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-4	20	43
351337	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-4	20.5	52
351338	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-4	21.5	40
351339	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-4	17.5	38
351340	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-4	19	35
351341	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-4	15	37
351342	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-4	19	37
351343	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-4	19.5	32
351344	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-4	21	23
351345	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-4	16	33
351346	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-4	22	33
351347	20233																	0	IL-4	15	37
351348	20233						RA2159	51112.0								2	ug/mL	2	IL-4	42	47
351349	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-4	26	39
351350	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-4	36	63
351351	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-4	27	45
351352	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-4	24.5	38
351353	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-4	34	31
351354	20233						N2586	51107.0								2	ug/mL	2	IL-4	32.5	42
351355	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-4	27	35
351356	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-4	47	29
351357	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-4	32	30
351358	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-4	25	21
351359	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-4	32.5	48
351360	20233																	0	IL-4	15	54
351361	20233						RA2159	51112.0								2	ug/mL	3	IL-4	39	51
351362	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-4	41	42
351363	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-4	17	54
351364	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-4	31	59
351365	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-4	30	51
351366	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-4	22	50
351367	20233						N2586	51107.0								2	ug/mL	3	IL-4	48.5	42
351368	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-4	37	55
351369	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-4	48.5	62
351370	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-4	45.5	50
351371	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-4	20.5	58
351372	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-4	32	51
351373	20233						RA2159	51112.0										3	IL-4	18.5	60
351374	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-4	15	39
351375	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-4	16	46
351376	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-4	20	47
351377	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-4	22	47
351378	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-4	21	57
351379	20233						RA2159	51112.0										3	IL-4	20	49
351380	20233						N2586	51107.0										3	IL-4	21	51
351381	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-4	20.5	50
351382	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-4	18	62
351383	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-4	20	35
351384	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-4	16	87
351385	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-4	21	50
351386	20233						N2586	51107.0										3	IL-4	19.5	42
351387	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-4	21	55
351388	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-4	18	33
351389	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-4	19	54
351390	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-4	16	51
351391	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-4	20	54
351392	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-4	20.5	46
351393	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-4	20	58
351394	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-4	20	51
351395	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-4	17	60
351396	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-4	20	31
351397	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-4	17	50
351398	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-4	22	48
351399	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-4	21	50
351400	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-4	17	52
351401	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-4	13	55
351402	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-4	20	59
351403	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-4	18.5	58
351404	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-4	20.5	50
351405	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-4	17.5	66
351406	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-4	17	58
351407	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-4	18	59
351408	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-4	23	68
351409	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-4	18.5	50
351410	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-4	17	51
351411	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-4	18	55
351412	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-4	17	62
351413	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-4	17	46
351414	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-4	19	64
351415	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-4	17	58
351416	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-4	18.5	58
351417	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-4	17.5	74
351418	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-4	18	57
351419	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-4	20.5	50
351420	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-4	22.5	50
351421	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-4	19	52
351422	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-4	16	53
351423	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-4	18	50
351424	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-4	19.5	50
351425	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-4	15	47
351426	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-4	19.5	42
351427	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-4	19.5	52
351428	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-4	19.5	56
351429	20233						RA2159	51112.0										3	IL-4	21	50
351430	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-4	18	55
351431	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-4	18	55
351432	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-4	20.5	60
351433	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-4	19	49
351434	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-4	20	41
351435	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-4	23	65
351436	20233						N2586	51107.0										3	IL-4	20	50
351437	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-4	17.5	58
351438	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-4	20	43
351439	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-4	21	41
351440	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-4	17.5	36
351441	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-4	10	62
351442	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-4	19	45
351443	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-4	14	59
351444	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-4	19	40
351445	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-4	17	50
351446	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-4	22	63
351447	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-4	21.5	52
351448	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-4	18	50
351449	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-4	12	57
351450	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-4	19	44
351451	20233						RA2159	51112.0										3	IL-4	19	56
351452	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-4	24	58
351453	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-4	20	43
351454	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-4	19	41
351455	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-4	15.5	42
351456	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-4	16	42
351457	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-4	16	53
351458	20233						N2586	51107.0										3	IL-4	20	55
351459	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-4	17	69
351460	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-4	17	50
351461	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-4	20	51
351462	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-4	18.5	42
351463	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-4	16.5	34
351464	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-4	17	54
351465	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-4	22	40
351466	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-4	18.5	54
351467	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-4	16.5	64
351468	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-4	19	45
351469	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-4	21	40
351470	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-4	20	61
351471	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-4	23	54
351472	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-4	19	56
351473	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-4	16	56
351474	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-4	21	60
351475	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-4	21	56
351476	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-4	20.5	48
351477	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-4	29	52
351478	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-4	31	49
351479	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-4	24	43
351480	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-4	28	50
351481	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-4	27.5	54
351482	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-4	28.5	50
351483	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-4	13	50
351484	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-4	23.5	48
351485	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-4	28	63
351486	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-4	20	50
351487	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-4	26	58
351488	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-4	24	37
351489	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-4	23	57
351490	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-4	16	57
351491	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-4	59	43
351492	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-4	41	60
351493	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-4	29	47
351494	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-4	54	62
351495	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-4	51	59
351496	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-4	18	57
351497	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-4	17	47
351498	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-4	58.5	50
351499	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-4	43	46
351500	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-4	58.5	54
351501	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-4	54	43
351502	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-4	28	43
351503	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-4	48	56
351504	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-4	17	62
351505	20233																	0	IL-4	13	52
351506	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-4	45	39
351507	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-4	42	45
351508	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-4	43	50
351509	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-4	41	52
351510	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-4	40.5	62
351511	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-4	26	54
351512	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-4	18	55
351513	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-4	50	49
351514	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-4	43	42
351515	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-4	54	57
351516	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-4	25	57
351517	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-4	25	39
351518	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-4	44.5	48
351519	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-4	15	44
351520	20233																	0	IL-4	15	34
351521	20233						RA2159	51112.0										3	IL-4	15	61
351522	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-4	20	49
351523	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-4	15	71
351524	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-4	17	53
351525	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-4	18	35
351526	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-4	17	59
351527	20233						RA2159	51112.0										3	IL-4	19	36
351528	20233						N2586	51107.0										3	IL-4	20	61
351529	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-4	21	67
351530	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-4	18	37
351531	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-4	16.5	38
351532	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-4	16	30
351533	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-4	17.5	42
351534	20233						N2586	51107.0										3	IL-4	18	37
351535	20233																	0	IL-4	16.5	46
351536	20233						RA2159	51112.0								2	ug/mL	4	IL-4	47	50
351537	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-4	35	44
351538	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-4	49	53
351539	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-4	46	59
351540	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-4	29.5	52
351541	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-4	33	40
351542	20233						N2586	51107.0								2	ug/mL	4	IL-4	47.5	54
351543	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-4	39.5	50
351544	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-4	21.5	40
351545	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-4	31	57
351546	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-4	24.5	50
351547	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-4	18	60
351548	20233						RA2159	51112.0										4	IL-4	18	56
351549	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-4	21	51
351550	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-4	21	51
351551	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-4	19	71
351552	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-4	20	50
351553	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-4	20.5	72
351554	20233						RA2159	51112.0										4	IL-4	25	52
351555	20233						N2586	51107.0										4	IL-4	19.5	58
351556	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-4	17	53
351557	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-4	19.5	40
351558	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-4	20	23
351559	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-4	19.5	54
351560	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-4	17	50
351561	20233						N2586	51107.0										4	IL-4	22	64
351562	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-4	23	41
351563	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-4	21	46
351564	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-4	22	50
351565	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-4	22	55
351566	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-4	20.5	64
351567	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-4	22	56
351568	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-4	20	67
351569	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-4	17	47
351570	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-4	20	57
351571	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-4	17	53
351572	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-4	20.5	40
351573	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-4	19	50
351574	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-4	22	50
351575	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-4	19.5	42
351576	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-4	24	59
351577	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-4	22.5	50
351578	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-4	18	46
351579	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-4	19	48
351580	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-4	18	47
351581	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-4	20	37
351582	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-4	17	66
351583	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-4	18	70
351584	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-4	19	38
351585	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-4	18	54
351586	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-4	20.5	60
351587	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-4	25	63
351588	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-4	23.5	48
351589	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-4	24	51
351590	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-4	19	47
351591	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-4	20	36
351592	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-4	18	52
351593	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-4	16	50
351594	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-4	19	41
351595	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-4	17	50
351596	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-4	16	31
351597	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-4	18	55
351598	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-4	20.5	50
351599	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-4	20	43
351600	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-4	22	50
351601	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-4	19	58
351602	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-4	15	36
351603	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-4	21	43
351604	20233						RA2159	51112.0										4	IL-4	20	46
351605	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-4	19	59
351606	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-4	18	57
351607	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-4	17.5	38
351608	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-4	17	40
351609	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-4	17	36
351610	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-4	18	49
351611	20233						N2586	51107.0										4	IL-4	19	41
351612	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-4	17	46
351613	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-4	22.5	64
351614	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-4	18	49
351615	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-4	20	35
351616	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-4	16.5	28
351617	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-4	20.5	42
351618	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-4	21	59
351619	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-4	19	47
351620	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-4	19	40
351621	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-4	18	45
351622	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-4	18	45
351623	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-4	18	50
351624	20233						RA2159	51112.0										4	IL-4	20.5	40
351625	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-4	21	50
351626	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-4	18.5	48
351627	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-4	20	61
351628	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-4	22	41
351629	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-4	20	33
351630	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-4	16	41
351631	20233						N2586	51107.0										4	IL-4	18	61
351632	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-4	18	51
351633	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-4	18	56
351634	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-4	19	64
351635	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-4	18	51
351636	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-4	16.5	50
351637	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-4	16	50
351638	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-4	21	48
351639	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-4	21	65
351640	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-4	23.5	40
351641	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-4	21	43
351642	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-4	24	30
351643	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-4	25	45
351644	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-4	20	44
351645	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-4	22	49
351646	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-4	21	49
351647	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-4	20.5	48
351648	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-4	19.5	42
351649	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-4	19	45
351650	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-4	16.5	60
351651	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-4	14	59
351652	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-4	26	53
351653	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-4	23	43
351654	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-4	19	44
351655	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-4	23	41
351656	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-4	19	35
351657	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-4	20.5	58
351658	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-4	16.5	26
351659	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-4	25.5	36
351660	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-4	28	45
351661	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-4	27	43
351662	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-4	27	35
351663	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-4	23	45
351664	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-4	22	41
351665	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-4	18.5	48
351666	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-4	58	43
351667	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-4	42	56
351668	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-4	58	52
351669	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-4	56	58
351670	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-4	60.5	36
351671	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-4	61	57
351672	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-4	16	37
351673	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-4	62	47
351674	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-4	52	29
351675	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-4	37.5	52
351676	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-4	55	29
351677	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-4	32	41
351678	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-4	16	32
351679	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-4	19	33
351680	20233																	0	IL-4	13	24
351681	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-4	49	54
351682	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-4	40	38
351683	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-4	45	54
351684	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-4	39	54
351685	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-4	34	39
351686	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-4	38	27
351687	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-4	19.5	52
351688	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-4	53	47
351689	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-4	47	37
351690	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-4	37.5	42
351691	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-4	50	47
351692	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-4	38	31
351693	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-4	19	42
351694	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-4	16	59
351695	20233																	0	IL-4	14	47
351696	20233						RA2159	51112.0										4	IL-4	16	58
351697	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-4	15.5	30
351698	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-4	19	50
351699	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-4	18	60
351700	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-4	20	59
351701	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-4	16.5	34
351702	20233						RA2159	51112.0										4	IL-4	18	44
351703	20233						N2586	51107.0										4	IL-4	21.5	50
351704	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-4	14	39
351705	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-4	16.5	46
351706	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-4	19	47
351707	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-4	14	39
351708	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-4	17.5	68
351709	20233						N2586	51107.0										4	IL-4	17	51
351710	20233								TNF-a	201285.0						100	ng/mL	0	IL-4	87.5	60
351711	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-4	19.5	50
351712	20233								IL-6	201287.0						100	ug/mL	0	IL-4	61.5	50
351713	20233								IL-17A	201288.0						100	ng/mL	0	IL-4	33.5	40
351714	20233								EGF	201289.0						100	ng/mL	0	IL-4	21	50
351715	20233								IGF-I	201290.0						100	ug/mL	0	IL-4	21	55
351716	20233								Adiponectin	201291.0						5	ng/mL	0	IL-4	27	65
351717	20233								Leptin	201292.0						1	ng/mL	0	IL-4	21	57
351718	20233								Visfatin	201293.0						1	ng/mL	0	IL-4	23	42
351719	20233															2	ug/mL	0	IL-4	21	50
351720	20233								TNF-a	201285.0						100	ng/mL	0	IL-4	81	50
351721	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-4	21	26
351722	20233								IL-6	201287.0						100	ug/mL	0	IL-4	56	45
351723	20233								IL-17A	201288.0						100	ng/mL	0	IL-4	34	56
351724	20233								EGF	201289.0						100	ng/mL	0	IL-4	25	39
351725	20233								IGF-I	201290.0						100	ug/mL	0	IL-4	20	43
351726	20233								Adiponectin	201291.0						5	ng/mL	0	IL-4	23.5	36
351727	20233								Leptin	201292.0						1	ng/mL	0	IL-4	25	32
351728	20233								Visfatin	201293.0						1	ng/mL	0	IL-4	22	63
351729	20233															2	ug/mL	0	IL-4	19	30
351730	20233								TNF-a	201285.0						100	ng/mL	0	IL-4	89	63
351731	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-4	14.5	58
351732	20233								IL-6	201287.0						100	ug/mL	0	IL-4	51	46
351733	20233								IL-17A	201288.0						100	ng/mL	0	IL-4	28	50
351734	20233								EGF	201289.0						100	ng/mL	0	IL-4	13	54
351735	20233								IGF-I	201290.0						100	ug/mL	0	IL-4	14	36
351736	20233								Adiponectin	201291.0						5	ng/mL	0	IL-4	11	48
351737	20233								Leptin	201292.0						1	ng/mL	0	IL-4	12	35
351738	20233								Visfatin	201293.0						1	ng/mL	0	IL-4	15	63
351739	20233															2	ug/mL	0	IL-4	14	39
351740	20233								TNF-a	201285.0						100	ng/mL	0	IL-4	81	52
351741	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-4	14	38
351742	20233								IL-6	201287.0						100	ug/mL	0	IL-4	50	37
351743	20233								IL-17A	201288.0						100	ng/mL	0	IL-4	19	41
351744	20233								EGF	201289.0						100	ng/mL	0	IL-4	14	64
351745	20233								IGF-I	201290.0						100	ug/mL	0	IL-4	14	51
351746	20233								Adiponectin	201291.0						5	ng/mL	0	IL-4	18.5	48
351747	20233								Leptin	201292.0						1	ng/mL	0	IL-4	15	33
351748	20233								Visfatin	201293.0						1	ng/mL	0	IL-4	13	39
351749	20233															2	ug/mL	0	IL-4	15	34
351750	20233																	0	MCP-1 (MCAF)	61.5	66
351751	20233						RA2159	51112.0										1	MCP-1 (MCAF)	3127	81
351752	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MCP-1 (MCAF)	1959	76
351753	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MCP-1 (MCAF)	2110.5	84
351754	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MCP-1 (MCAF)	2543	65
351755	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MCP-1 (MCAF)	3248.5	88
351756	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MCP-1 (MCAF)	1650	73
351757	20233						RA2159	51112.0										1	MCP-1 (MCAF)	3449	63
351758	20233						N2586	51107.0										1	MCP-1 (MCAF)	5993.5	100
351759	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MCP-1 (MCAF)	6124	77
351760	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MCP-1 (MCAF)	5216	57
351761	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MCP-1 (MCAF)	6079	70
351762	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MCP-1 (MCAF)	6275	74
351763	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MCP-1 (MCAF)	4398	49
351764	20233						N2586	51107.0										1	MCP-1 (MCAF)	6729	36
351765	20233																	0	MCP-1 (MCAF)	45	83
351766	20233																	0	MCP-1 (MCAF)	68	57
351767	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	MCP-1 (MCAF)	14222.5	56
351768	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	MCP-1 (MCAF)	13167	77
351769	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	13736.5	64
351770	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	12103	94
351771	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	14271	84
351772	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	MCP-1 (MCAF)	6302.5	72
351773	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	MCP-1 (MCAF)	3231	61
351774	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	MCP-1 (MCAF)	14759	79
351775	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	MCP-1 (MCAF)	14834	67
351776	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	15730	78
351777	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	15189.5	72
351778	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	14697	69
351779	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	MCP-1 (MCAF)	13960.5	70
351780	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	MCP-1 (MCAF)	7449	43
351781	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	MCP-1 (MCAF)	13567	87
351782	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	MCP-1 (MCAF)	11491	79
351783	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	10176	74
351784	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	13853.5	76
351785	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	14634	83
351786	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	MCP-1 (MCAF)	2046	83
351787	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	MCP-1 (MCAF)	3448	82
351788	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	MCP-1 (MCAF)	15490	71
351789	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	MCP-1 (MCAF)	14669	83
351790	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	14300.5	62
351791	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	14427	60
351792	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	15263	71
351793	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	MCP-1 (MCAF)	9911	54
351794	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	MCP-1 (MCAF)	6772.5	58
351795	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	MCP-1 (MCAF)	3014	73
351796	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	MCP-1 (MCAF)	1688	102
351797	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MCP-1 (MCAF)	1963	81
351798	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MCP-1 (MCAF)	2894.5	92
351799	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MCP-1 (MCAF)	2868	77
351800	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	MCP-1 (MCAF)	1529	64
351801	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	MCP-1 (MCAF)	2291.5	80
351802	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	MCP-1 (MCAF)	7935	68
351803	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	MCP-1 (MCAF)	5279	57
351804	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MCP-1 (MCAF)	4718	59
351805	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MCP-1 (MCAF)	6953.5	52
351806	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MCP-1 (MCAF)	5986	59
351807	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	MCP-1 (MCAF)	6395	82
351808	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	MCP-1 (MCAF)	7604	54
351809	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	MCP-1 (MCAF)	3816	76
351810	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	MCP-1 (MCAF)	1856.5	70
351811	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	4720.5	54
351812	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	4324	77
351813	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	5167	73
351814	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	MCP-1 (MCAF)	1711	62
351815	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	MCP-1 (MCAF)	10234	79
351816	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	MCP-1 (MCAF)	9542	68
351817	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	9873	66
351818	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	9647	88
351819	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	9171	77
351820	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	MCP-1 (MCAF)	6729.5	94
351821	20233						RA2159	51112.0										1	MCP-1 (MCAF)	3524	96
351822	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MCP-1 (MCAF)	1971.5	80
351823	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MCP-1 (MCAF)	2440.5	72
351824	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MCP-1 (MCAF)	3160	63
351825	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MCP-1 (MCAF)	3741	64
351826	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MCP-1 (MCAF)	1648.5	74
351827	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	MCP-1 (MCAF)	1443	60
351828	20233						N2586	51107.0										1	MCP-1 (MCAF)	7521	70
351829	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MCP-1 (MCAF)	6707	70
351830	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MCP-1 (MCAF)	6832	59
351831	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MCP-1 (MCAF)	6926	49
351832	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MCP-1 (MCAF)	8502	49
351833	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MCP-1 (MCAF)	5890	79
351834	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	MCP-1 (MCAF)	1907	67
351835	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	MCP-1 (MCAF)	3844	71
351836	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	MCP-1 (MCAF)	2527	67
351837	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	3295	71
351838	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	3303	103
351839	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	4445	71
351840	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	MCP-1 (MCAF)	1344	63
351841	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	MCP-1 (MCAF)	2246	67
351842	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	MCP-1 (MCAF)	8396	83
351843	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	MCP-1 (MCAF)	8005	72
351844	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	6072	67
351845	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	8193	42
351846	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MCP-1 (MCAF)	8397	70
351847	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	MCP-1 (MCAF)	6344	39
351848	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	MCP-1 (MCAF)	5680	77
351849	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	MCP-1 (MCAF)	2786.5	66
351850	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	MCP-1 (MCAF)	1484	56
351851	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MCP-1 (MCAF)	1809	69
351852	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MCP-1 (MCAF)	2663.5	60
351853	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MCP-1 (MCAF)	2851.5	104
351854	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	MCP-1 (MCAF)	1570.5	80
351855	20233						RA2159	51112.0										1	MCP-1 (MCAF)	3140	79
351856	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	MCP-1 (MCAF)	6548.5	74
351857	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	MCP-1 (MCAF)	6694	71
351858	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MCP-1 (MCAF)	5601.5	86
351859	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MCP-1 (MCAF)	7135	59
351860	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MCP-1 (MCAF)	6550	61
351861	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	MCP-1 (MCAF)	4795	79
351862	20233						N2586	51107.0										1	MCP-1 (MCAF)	6802	79
351863	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	MCP-1 (MCAF)	2083	74
351864	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	MCP-1 (MCAF)	1182	71
351865	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MCP-1 (MCAF)	1293	70
351866	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MCP-1 (MCAF)	2250.5	60
351867	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MCP-1 (MCAF)	2297	68
351868	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	MCP-1 (MCAF)	897.5	88
351869	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	MCP-1 (MCAF)	6064	65
351870	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	MCP-1 (MCAF)	7055.5	58
351871	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MCP-1 (MCAF)	4695	57
351872	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MCP-1 (MCAF)	5382.5	60
351873	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MCP-1 (MCAF)	5973	67
351874	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	MCP-1 (MCAF)	6321	62
351875	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	MCP-1 (MCAF)	2363	81
351876	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	MCP-1 (MCAF)	1483	61
351877	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MCP-1 (MCAF)	1607	71
351878	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MCP-1 (MCAF)	2585	57
351879	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MCP-1 (MCAF)	2500	85
351880	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	MCP-1 (MCAF)	1012.5	68
351881	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	MCP-1 (MCAF)	7355	52
351882	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	MCP-1 (MCAF)	6047.5	60
351883	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MCP-1 (MCAF)	4394	83
351884	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MCP-1 (MCAF)	6530	66
351885	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MCP-1 (MCAF)	7152	79
351886	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	MCP-1 (MCAF)	6086	43
351887	20233						RA2159	51112.0										1	MCP-1 (MCAF)	3285	59
351888	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MCP-1 (MCAF)	2248	51
351889	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MCP-1 (MCAF)	1712	67
351890	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MCP-1 (MCAF)	2492.5	58
351891	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MCP-1 (MCAF)	2839	78
351892	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MCP-1 (MCAF)	1186	69
351893	20233						RA2159	51112.0										1	MCP-1 (MCAF)	2754	76
351894	20233						N2586	51107.0										1	MCP-1 (MCAF)	6286	72
351895	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MCP-1 (MCAF)	5973	83
351896	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MCP-1 (MCAF)	5087	76
351897	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MCP-1 (MCAF)	6427	87
351898	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MCP-1 (MCAF)	6473	65
351899	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MCP-1 (MCAF)	4587	73
351900	20233						N2586	51107.0										1	MCP-1 (MCAF)	6594	51
351901	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	MCP-1 (MCAF)	2290	63
351902	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	MCP-1 (MCAF)	1697	77
351903	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MCP-1 (MCAF)	2106	76
351904	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MCP-1 (MCAF)	2988	78
351905	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MCP-1 (MCAF)	2590	49
351906	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	MCP-1 (MCAF)	837	64
351907	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	MCP-1 (MCAF)	5260.5	66
351908	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	MCP-1 (MCAF)	5765	68
351909	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MCP-1 (MCAF)	5073	69
351910	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MCP-1 (MCAF)	5228	78
351911	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MCP-1 (MCAF)	6040	79
351912	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	MCP-1 (MCAF)	5220	47
351913	20233																	0	MCP-1 (MCAF)	47	56
351914	20233						RA2159	51112.0								2	ug/mL	1	MCP-1 (MCAF)	10547	63
351915	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	MCP-1 (MCAF)	8491	38
351916	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MCP-1 (MCAF)	5731.5	66
351917	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MCP-1 (MCAF)	8773	55
351918	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MCP-1 (MCAF)	8895	73
351919	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	MCP-1 (MCAF)	3327	79
351920	20233						N2586	51107.0								2	ug/mL	1	MCP-1 (MCAF)	13632	48
351921	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	MCP-1 (MCAF)	12875	78
351922	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MCP-1 (MCAF)	9032	59
351923	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MCP-1 (MCAF)	11694	28
351924	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MCP-1 (MCAF)	11606	63
351925	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	MCP-1 (MCAF)	10475	51
351926	20233																	0	MCP-1 (MCAF)	59	49
351927	20233						RA2159	51112.0										2	MCP-1 (MCAF)	1848.5	66
351928	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MCP-1 (MCAF)	2397	79
351929	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MCP-1 (MCAF)	2788.5	70
351930	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MCP-1 (MCAF)	2447	71
351931	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MCP-1 (MCAF)	1136	41
351932	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MCP-1 (MCAF)	2164.5	64
351933	20233						RA2159	51112.0										2	MCP-1 (MCAF)	1559.5	46
351934	20233						N2586	51107.0										2	MCP-1 (MCAF)	6404	56
351935	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MCP-1 (MCAF)	5576	55
351936	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MCP-1 (MCAF)	6049	60
351937	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MCP-1 (MCAF)	4407	48
351938	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MCP-1 (MCAF)	2445	59
351939	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MCP-1 (MCAF)	5208	46
351940	20233						N2586	51107.0										2	MCP-1 (MCAF)	7001	57
351941	20233																	0	MCP-1 (MCAF)	59.5	62
351942	20233																	0	MCP-1 (MCAF)	53	41
351943	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	MCP-1 (MCAF)	14294	68
351944	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	MCP-1 (MCAF)	13329	97
351945	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	MCP-1 (MCAF)	13560	79
351946	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	13129	57
351947	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	11927	65
351948	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	MCP-1 (MCAF)	12299	54
351949	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	MCP-1 (MCAF)	2555	77
351950	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	MCP-1 (MCAF)	14434	55
351951	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	MCP-1 (MCAF)	13573	65
351952	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	MCP-1 (MCAF)	15822	72
351953	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	14160.5	80
351954	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	14237	49
351955	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	MCP-1 (MCAF)	14403	56
351956	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	MCP-1 (MCAF)	5625.5	56
351957	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	MCP-1 (MCAF)	13328	61
351958	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	MCP-1 (MCAF)	13774	85
351959	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	MCP-1 (MCAF)	11495	79
351960	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	14901.5	70
351961	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	13420	80
351962	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	MCP-1 (MCAF)	12399	61
351963	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	MCP-1 (MCAF)	2352	66
351964	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	MCP-1 (MCAF)	13172.5	56
351965	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	MCP-1 (MCAF)	12973.5	90
351966	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	MCP-1 (MCAF)	14672	74
351967	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	13634	83
351968	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	13083	61
351969	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	MCP-1 (MCAF)	13749.5	62
351970	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	MCP-1 (MCAF)	3641	57
351971	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	MCP-1 (MCAF)	3166.5	108
351972	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	MCP-1 (MCAF)	3508.5	68
351973	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	MCP-1 (MCAF)	2844	73
351974	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	MCP-1 (MCAF)	3096.5	80
351975	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	MCP-1 (MCAF)	1144	68
351976	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	MCP-1 (MCAF)	2501.5	74
351977	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	MCP-1 (MCAF)	2507	69
351978	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	MCP-1 (MCAF)	6030.5	90
351979	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	MCP-1 (MCAF)	5312	91
351980	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	MCP-1 (MCAF)	5684.5	86
351981	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	MCP-1 (MCAF)	6269	65
351982	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	MCP-1 (MCAF)	2091	64
351983	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	MCP-1 (MCAF)	5426	69
351984	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	MCP-1 (MCAF)	5404	52
351985	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	MCP-1 (MCAF)	4618	74
351986	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	MCP-1 (MCAF)	5820	76
351987	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	MCP-1 (MCAF)	4736	66
351988	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	4783	71
351989	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	1512	64
351990	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	MCP-1 (MCAF)	4493	51
351991	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	MCP-1 (MCAF)	3435	53
351992	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	MCP-1 (MCAF)	9059.5	58
351993	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	MCP-1 (MCAF)	9013	70
351994	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	MCP-1 (MCAF)	7049.5	66
351995	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	9318	72
351996	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	3152	51
351997	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	MCP-1 (MCAF)	6937.5	74
351998	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	MCP-1 (MCAF)	4732	53
351999	20233						RA2159	51112.0										2	MCP-1 (MCAF)	3872	67
352000	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MCP-1 (MCAF)	3919	68
352001	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MCP-1 (MCAF)	2927	65
352002	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MCP-1 (MCAF)	3222	46
352003	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MCP-1 (MCAF)	1047.5	62
352004	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MCP-1 (MCAF)	2980	66
352005	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	MCP-1 (MCAF)	1853.5	46
352006	20233						N2586	51107.0										2	MCP-1 (MCAF)	7120	67
352007	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MCP-1 (MCAF)	7197.5	64
352008	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MCP-1 (MCAF)	6518.5	86
352009	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MCP-1 (MCAF)	6666	75
352010	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MCP-1 (MCAF)	2660.5	68
352011	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MCP-1 (MCAF)	3544.5	42
352012	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	MCP-1 (MCAF)	3658	60
352013	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	MCP-1 (MCAF)	3627	77
352014	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	MCP-1 (MCAF)	5007	75
352015	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	MCP-1 (MCAF)	2952	73
352016	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	2922	55
352017	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	871	69
352018	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	MCP-1 (MCAF)	2870	94
352019	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	MCP-1 (MCAF)	8086	73
352020	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	MCP-1 (MCAF)	7409	67
352021	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	MCP-1 (MCAF)	7548	65
352022	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	7388	70
352023	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	MCP-1 (MCAF)	2845	51
352024	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	MCP-1 (MCAF)	36.5	80
352025	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	MCP-1 (MCAF)	2713	88
352026	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	MCP-1 (MCAF)	3147.5	52
352027	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	MCP-1 (MCAF)	2783	75
352028	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MCP-1 (MCAF)	3208	82
352029	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MCP-1 (MCAF)	845	78
352030	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	MCP-1 (MCAF)	2777.5	76
352031	20233						RA2159	51112.0										2	MCP-1 (MCAF)	2966	86
352032	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	MCP-1 (MCAF)	5794	85
352033	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	MCP-1 (MCAF)	6158.5	78
352034	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	MCP-1 (MCAF)	5714.5	74
352035	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MCP-1 (MCAF)	5869	75
352036	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MCP-1 (MCAF)	1924	69
352037	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	MCP-1 (MCAF)	4574	41
352038	20233						N2586	51107.0										2	MCP-1 (MCAF)	16	43
352039	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	MCP-1 (MCAF)	2345	81
352040	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	MCP-1 (MCAF)	3273.5	68
352041	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	MCP-1 (MCAF)	1978	85
352042	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MCP-1 (MCAF)	2322	63
352043	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MCP-1 (MCAF)	808	58
352044	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	MCP-1 (MCAF)	2098	58
352045	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	MCP-1 (MCAF)	5425	66
352046	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	MCP-1 (MCAF)	4338	79
352047	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	MCP-1 (MCAF)	4696.5	58
352048	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MCP-1 (MCAF)	5423.5	62
352049	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MCP-1 (MCAF)	1595	51
352050	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	MCP-1 (MCAF)	4632.5	62
352051	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	MCP-1 (MCAF)	3318	71
352052	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	MCP-1 (MCAF)	2906	82
352053	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	MCP-1 (MCAF)	2506.5	76
352054	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	MCP-1 (MCAF)	2453	68
352055	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	MCP-1 (MCAF)	721.5	70
352056	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	MCP-1 (MCAF)	2132.5	88
352057	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	MCP-1 (MCAF)	6254.5	70
352058	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	MCP-1 (MCAF)	4989	43
352059	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	MCP-1 (MCAF)	6063.5	62
352060	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	MCP-1 (MCAF)	5601	63
352061	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	MCP-1 (MCAF)	1787.5	52
352062	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	MCP-1 (MCAF)	5322	67
352063	20233						RA2159	51112.0										2	MCP-1 (MCAF)	3184	77
352064	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MCP-1 (MCAF)	3155	68
352065	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MCP-1 (MCAF)	1921.5	74
352066	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MCP-1 (MCAF)	2466	98
352067	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MCP-1 (MCAF)	800	75
352068	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MCP-1 (MCAF)	2061.5	56
352069	20233						RA2159	51112.0										2	MCP-1 (MCAF)	1900	62
352070	20233						N2586	51107.0										2	MCP-1 (MCAF)	5461	52
352071	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MCP-1 (MCAF)	5497	59
352072	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MCP-1 (MCAF)	6050	70
352073	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MCP-1 (MCAF)	5860	71
352074	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MCP-1 (MCAF)	2566	53
352075	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MCP-1 (MCAF)	4910.5	48
352076	20233						N2586	51107.0										2	MCP-1 (MCAF)	6532.5	60
352077	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	MCP-1 (MCAF)	3031	70
352078	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	MCP-1 (MCAF)	3179	59
352079	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	MCP-1 (MCAF)	2481	85
352080	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MCP-1 (MCAF)	2462	70
352081	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MCP-1 (MCAF)	689	39
352082	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	MCP-1 (MCAF)	2253	60
352083	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	MCP-1 (MCAF)	5972.5	62
352084	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	MCP-1 (MCAF)	6567	53
352085	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	MCP-1 (MCAF)	5132	39
352086	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MCP-1 (MCAF)	6267	37
352087	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MCP-1 (MCAF)	1855	36
352088	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	MCP-1 (MCAF)	5853	47
352089	20233																	0	MCP-1 (MCAF)	40	36
352090	20233						RA2159	51112.0								2	ug/mL	2	MCP-1 (MCAF)	11449	75
352091	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	MCP-1 (MCAF)	8866	71
352092	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	MCP-1 (MCAF)	8563	73
352093	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	MCP-1 (MCAF)	9097	73
352094	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	MCP-1 (MCAF)	4173	31
352095	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	MCP-1 (MCAF)	9103	48
352096	20233						N2586	51107.0								2	ug/mL	2	MCP-1 (MCAF)	13444	29
352097	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	MCP-1 (MCAF)	11544	45
352098	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	MCP-1 (MCAF)	10182	41
352099	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	MCP-1 (MCAF)	11631.5	36
352100	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	MCP-1 (MCAF)	5856	37
352101	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	MCP-1 (MCAF)	11454	65
352102	20233																	0	MCP-1 (MCAF)	59.5	80
352103	20233						RA2159	51112.0								2	ug/mL	3	MCP-1 (MCAF)	10127	81
352104	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	MCP-1 (MCAF)	9520	78
352105	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MCP-1 (MCAF)	8011	69
352106	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MCP-1 (MCAF)	9200	81
352107	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MCP-1 (MCAF)	8752	87
352108	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	MCP-1 (MCAF)	3304	75
352109	20233						N2586	51107.0								2	ug/mL	3	MCP-1 (MCAF)	11845	76
352110	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	MCP-1 (MCAF)	11344.5	90
352111	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MCP-1 (MCAF)	11690	67
352112	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MCP-1 (MCAF)	12078	65
352113	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MCP-1 (MCAF)	8793	63
352114	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	MCP-1 (MCAF)	9449	79
352115	20233						RA2159	51112.0										3	MCP-1 (MCAF)	2326.5	78
352116	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MCP-1 (MCAF)	2076	93
352117	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MCP-1 (MCAF)	2242.5	54
352118	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MCP-1 (MCAF)	2917	71
352119	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MCP-1 (MCAF)	2735	63
352120	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MCP-1 (MCAF)	1279	67
352121	20233						RA2159	51112.0										3	MCP-1 (MCAF)	3261	113
352122	20233						N2586	51107.0										3	MCP-1 (MCAF)	7454	61
352123	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MCP-1 (MCAF)	5893	93
352124	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MCP-1 (MCAF)	5057	68
352125	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MCP-1 (MCAF)	6445.5	86
352126	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MCP-1 (MCAF)	4989	61
352127	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MCP-1 (MCAF)	4267	73
352128	20233						N2586	51107.0										3	MCP-1 (MCAF)	7335	67
352129	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	MCP-1 (MCAF)	3464	91
352130	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	MCP-1 (MCAF)	2178.5	68
352131	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MCP-1 (MCAF)	2862	61
352132	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MCP-1 (MCAF)	2955	73
352133	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MCP-1 (MCAF)	2786	74
352134	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	MCP-1 (MCAF)	1373.5	78
352135	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	MCP-1 (MCAF)	7365	73
352136	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	MCP-1 (MCAF)	7222	61
352137	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MCP-1 (MCAF)	6429	90
352138	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MCP-1 (MCAF)	6410.5	64
352139	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MCP-1 (MCAF)	4560	61
352140	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	MCP-1 (MCAF)	3749.5	74
352141	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	MCP-1 (MCAF)	3075	85
352142	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	MCP-1 (MCAF)	1934	57
352143	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MCP-1 (MCAF)	430	88
352144	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MCP-1 (MCAF)	3104	87
352145	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MCP-1 (MCAF)	2830	83
352146	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	MCP-1 (MCAF)	1331	93
352147	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	MCP-1 (MCAF)	7472	93
352148	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	MCP-1 (MCAF)	6948	88
352149	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MCP-1 (MCAF)	6212	74
352150	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MCP-1 (MCAF)	6310	83
352151	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MCP-1 (MCAF)	5691	75
352152	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	MCP-1 (MCAF)	3488.5	78
352153	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	MCP-1 (MCAF)	2515	69
352154	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	MCP-1 (MCAF)	1764	87
352155	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MCP-1 (MCAF)	2590	87
352156	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MCP-1 (MCAF)	2658	55
352157	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MCP-1 (MCAF)	2575	81
352158	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	MCP-1 (MCAF)	1243	99
352159	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	MCP-1 (MCAF)	8779	81
352160	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	MCP-1 (MCAF)	6729	80
352161	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MCP-1 (MCAF)	6775	73
352162	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MCP-1 (MCAF)	7049	71
352163	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MCP-1 (MCAF)	5125.5	62
352164	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	MCP-1 (MCAF)	3448.5	80
352165	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	MCP-1 (MCAF)	2938	73
352166	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	MCP-1 (MCAF)	1988	85
352167	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MCP-1 (MCAF)	2415	77
352168	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MCP-1 (MCAF)	3167.5	68
352169	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MCP-1 (MCAF)	3120	67
352170	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	MCP-1 (MCAF)	1334.5	70
352171	20233						RA2159	51112.0										3	MCP-1 (MCAF)	4044	73
352172	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	MCP-1 (MCAF)	7956	63
352173	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	MCP-1 (MCAF)	7796	65
352174	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MCP-1 (MCAF)	6123.5	70
352175	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MCP-1 (MCAF)	7545	88
352176	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MCP-1 (MCAF)	5705	83
352177	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	MCP-1 (MCAF)	3211	74
352178	20233						N2586	51107.0										3	MCP-1 (MCAF)	7555.5	84
352179	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	MCP-1 (MCAF)	3417.5	90
352180	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	MCP-1 (MCAF)	2416	77
352181	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	4368	77
352182	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	4297.5	60
352183	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	3491	71
352184	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	MCP-1 (MCAF)	1360	54
352185	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	MCP-1 (MCAF)	2301.5	80
352186	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	MCP-1 (MCAF)	8863.5	74
352187	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	MCP-1 (MCAF)	8680	71
352188	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	7674	58
352189	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	8847	71
352190	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	5735	60
352191	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	MCP-1 (MCAF)	3197	73
352192	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	MCP-1 (MCAF)	1809	60
352193	20233						RA2159	51112.0										3	MCP-1 (MCAF)	2874.5	70
352194	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MCP-1 (MCAF)	2072.5	70
352195	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MCP-1 (MCAF)	2504.5	52
352196	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MCP-1 (MCAF)	3394	74
352197	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MCP-1 (MCAF)	3285	73
352198	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MCP-1 (MCAF)	1593	63
352199	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	MCP-1 (MCAF)	1003	76
352200	20233						N2586	51107.0										3	MCP-1 (MCAF)	7705	77
352201	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MCP-1 (MCAF)	7153.5	84
352202	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MCP-1 (MCAF)	6338	71
352203	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MCP-1 (MCAF)	7942	91
352204	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MCP-1 (MCAF)	6295	73
352205	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MCP-1 (MCAF)	3414	61
352206	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	MCP-1 (MCAF)	5250	73
352207	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	MCP-1 (MCAF)	4281.5	76
352208	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	MCP-1 (MCAF)	2507.5	82
352209	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	6134.5	82
352210	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	4327	69
352211	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	4046	66
352212	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	MCP-1 (MCAF)	1485	85
352213	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	MCP-1 (MCAF)	8758	89
352214	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	MCP-1 (MCAF)	7866	86
352215	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	7090	85
352216	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	9514.5	70
352217	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	6684	71
352218	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	MCP-1 (MCAF)	4263	60
352219	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	MCP-1 (MCAF)	2522.5	66
352220	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	MCP-1 (MCAF)	2125	87
352221	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MCP-1 (MCAF)	2287	63
352222	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MCP-1 (MCAF)	2842	85
352223	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MCP-1 (MCAF)	2610	67
352224	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	MCP-1 (MCAF)	1190	83
352225	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	MCP-1 (MCAF)	3185.5	84
352226	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	MCP-1 (MCAF)	7172	81
352227	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	MCP-1 (MCAF)	7502	79
352228	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MCP-1 (MCAF)	5993	93
352229	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MCP-1 (MCAF)	7206	68
352230	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MCP-1 (MCAF)	5219	73
352231	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	MCP-1 (MCAF)	3107	70
352232	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	MCP-1 (MCAF)	5929	65
352233	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	MCP-1 (MCAF)	12859	89
352234	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	MCP-1 (MCAF)	11461.5	78
352235	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	11743.5	78
352236	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	13362.5	90
352237	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	13556	73
352238	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	MCP-1 (MCAF)	1686	64
352239	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	MCP-1 (MCAF)	3807	59
352240	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	MCP-1 (MCAF)	12984.5	88
352241	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	MCP-1 (MCAF)	12458.5	74
352242	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	13232	67
352243	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	12575	75
352244	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	10789	79
352245	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	MCP-1 (MCAF)	12302	69
352246	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	MCP-1 (MCAF)	4110	87
352247	20233																	0	MCP-1 (MCAF)	60	65
352248	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	MCP-1 (MCAF)	12144	54
352249	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	MCP-1 (MCAF)	11738.5	50
352250	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	13016	55
352251	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	13130	97
352252	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	12866.5	74
352253	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	MCP-1 (MCAF)	5409	53
352254	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	MCP-1 (MCAF)	3958	63
352255	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	MCP-1 (MCAF)	12016	81
352256	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	MCP-1 (MCAF)	13439	74
352257	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	13646	65
352258	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	10623	78
352259	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MCP-1 (MCAF)	11318	68
352260	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	MCP-1 (MCAF)	11726	78
352261	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	MCP-1 (MCAF)	5858	73
352262	20233																	0	MCP-1 (MCAF)	70	59
352263	20233						RA2159	51112.0										3	MCP-1 (MCAF)	2000	73
352264	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MCP-1 (MCAF)	1959	61
352265	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MCP-1 (MCAF)	2171.5	66
352266	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MCP-1 (MCAF)	2698	81
352267	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MCP-1 (MCAF)	2394	48
352268	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MCP-1 (MCAF)	1062	80
352269	20233						RA2159	51112.0										3	MCP-1 (MCAF)	3162	67
352270	20233						N2586	51107.0										3	MCP-1 (MCAF)	7186	61
352271	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MCP-1 (MCAF)	5600	88
352272	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MCP-1 (MCAF)	4940.5	72
352273	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MCP-1 (MCAF)	6198.5	44
352274	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MCP-1 (MCAF)	4544	43
352275	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MCP-1 (MCAF)	3535	73
352276	20233						N2586	51107.0										3	MCP-1 (MCAF)	6856	47
352277	20233																	0	MCP-1 (MCAF)	56	61
352278	20233						RA2159	51112.0								2	ug/mL	4	MCP-1 (MCAF)	11956	82
352279	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	MCP-1 (MCAF)	10033	75
352280	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	MCP-1 (MCAF)	10336.5	64
352281	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	MCP-1 (MCAF)	9856	83
352282	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	MCP-1 (MCAF)	5571.5	78
352283	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	MCP-1 (MCAF)	9256.5	66
352284	20233						N2586	51107.0								2	ug/mL	4	MCP-1 (MCAF)	12140.5	76
352285	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	MCP-1 (MCAF)	10762	81
352286	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	MCP-1 (MCAF)	9824	73
352287	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	MCP-1 (MCAF)	10333	63
352288	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	MCP-1 (MCAF)	8482.5	60
352289	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	MCP-1 (MCAF)	1914.5	56
352290	20233						RA2159	51112.0										4	MCP-1 (MCAF)	2618	59
352291	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MCP-1 (MCAF)	2901	69
352292	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MCP-1 (MCAF)	2387	79
352293	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MCP-1 (MCAF)	2808	84
352294	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MCP-1 (MCAF)	1528.5	72
352295	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MCP-1 (MCAF)	2328.5	64
352296	20233						RA2159	51112.0										4	MCP-1 (MCAF)	3243	74
352297	20233						N2586	51107.0										4	MCP-1 (MCAF)	6499.5	88
352298	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MCP-1 (MCAF)	5697	65
352299	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MCP-1 (MCAF)	4659	50
352300	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MCP-1 (MCAF)	6418	59
352301	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MCP-1 (MCAF)	4278	65
352302	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MCP-1 (MCAF)	3700	81
352303	20233						N2586	51107.0										4	MCP-1 (MCAF)	6071	67
352304	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	MCP-1 (MCAF)	3776	52
352305	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	MCP-1 (MCAF)	4020	58
352306	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	MCP-1 (MCAF)	3644	82
352307	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MCP-1 (MCAF)	3989	91
352308	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MCP-1 (MCAF)	1512.5	76
352309	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	MCP-1 (MCAF)	3382	61
352310	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	MCP-1 (MCAF)	7233	82
352311	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	MCP-1 (MCAF)	7101	57
352312	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	MCP-1 (MCAF)	5184	73
352313	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MCP-1 (MCAF)	6870.5	70
352314	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MCP-1 (MCAF)	5355	69
352315	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	MCP-1 (MCAF)	2019	76
352316	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	MCP-1 (MCAF)	3672	75
352317	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	MCP-1 (MCAF)	4102	68
352318	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	MCP-1 (MCAF)	4207	90
352319	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	MCP-1 (MCAF)	4235	80
352320	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	MCP-1 (MCAF)	1774	63
352321	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	MCP-1 (MCAF)	3476	80
352322	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	MCP-1 (MCAF)	6813.5	66
352323	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	MCP-1 (MCAF)	6494	45
352324	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	MCP-1 (MCAF)	4349.5	78
352325	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	MCP-1 (MCAF)	6972.5	70
352326	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	MCP-1 (MCAF)	4878	80
352327	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	MCP-1 (MCAF)	1897	89
352328	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	MCP-1 (MCAF)	3987	88
352329	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	MCP-1 (MCAF)	4503	69
352330	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	MCP-1 (MCAF)	3648	60
352331	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MCP-1 (MCAF)	4410	63
352332	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MCP-1 (MCAF)	1582	67
352333	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	MCP-1 (MCAF)	3802	49
352334	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	MCP-1 (MCAF)	6635	87
352335	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	MCP-1 (MCAF)	7264	66
352336	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	MCP-1 (MCAF)	5341.5	56
352337	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MCP-1 (MCAF)	7065	75
352338	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MCP-1 (MCAF)	4576	57
352339	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	MCP-1 (MCAF)	2150	64
352340	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	MCP-1 (MCAF)	4109	66
352341	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	MCP-1 (MCAF)	5369	70
352342	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	MCP-1 (MCAF)	3947	93
352343	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MCP-1 (MCAF)	4432.5	80
352344	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MCP-1 (MCAF)	1758	61
352345	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	MCP-1 (MCAF)	3946	65
352346	20233						RA2159	51112.0										4	MCP-1 (MCAF)	4150	75
352347	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	MCP-1 (MCAF)	6576	74
352348	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	MCP-1 (MCAF)	6566	71
352349	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	MCP-1 (MCAF)	5782	82
352350	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MCP-1 (MCAF)	7592	56
352351	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MCP-1 (MCAF)	4731	59
352352	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	MCP-1 (MCAF)	2633	64
352353	20233						N2586	51107.0										4	MCP-1 (MCAF)	6569.5	62
352354	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	MCP-1 (MCAF)	4684	69
352355	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	MCP-1 (MCAF)	5171	85
352356	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	MCP-1 (MCAF)	3588	63
352357	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	4649	62
352358	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	1990	40
352359	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	MCP-1 (MCAF)	3979.5	64
352360	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	MCP-1 (MCAF)	8899	103
352361	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	MCP-1 (MCAF)	8238	73
352362	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	MCP-1 (MCAF)	6578	58
352363	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	7671	64
352364	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	5953	52
352365	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	MCP-1 (MCAF)	2626.5	96
352366	20233						RA2159	51112.0										4	MCP-1 (MCAF)	4105	48
352367	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MCP-1 (MCAF)	3956	85
352368	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MCP-1 (MCAF)	3774	57
352369	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MCP-1 (MCAF)	3658	80
352370	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MCP-1 (MCAF)	1710	48
352371	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MCP-1 (MCAF)	3539	53
352372	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	MCP-1 (MCAF)	2291	70
352373	20233						N2586	51107.0										4	MCP-1 (MCAF)	6988	77
352374	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MCP-1 (MCAF)	7952	63
352375	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MCP-1 (MCAF)	6147	63
352376	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MCP-1 (MCAF)	7976	73
352377	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MCP-1 (MCAF)	6129	63
352378	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MCP-1 (MCAF)	2703	61
352379	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	MCP-1 (MCAF)	2660	64
352380	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	MCP-1 (MCAF)	3558	79
352381	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	MCP-1 (MCAF)	4721	65
352382	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	MCP-1 (MCAF)	4055	75
352383	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	5013.5	60
352384	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	2252.5	60
352385	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	MCP-1 (MCAF)	4441	75
352386	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	MCP-1 (MCAF)	3320.5	80
352387	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	MCP-1 (MCAF)	8383	67
352388	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	MCP-1 (MCAF)	8898	68
352389	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	MCP-1 (MCAF)	9861	77
352390	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	9157	77
352391	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	6591.5	80
352392	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	MCP-1 (MCAF)	2653	101
352393	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	MCP-1 (MCAF)	1490	53
352394	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	MCP-1 (MCAF)	2806	61
352395	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	MCP-1 (MCAF)	3127.5	60
352396	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	MCP-1 (MCAF)	2409	53
352397	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	MCP-1 (MCAF)	3349.5	52
352398	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	MCP-1 (MCAF)	1511	54
352399	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	MCP-1 (MCAF)	3085.5	86
352400	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	MCP-1 (MCAF)	3352	25
352401	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	MCP-1 (MCAF)	6701.5	44
352402	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	MCP-1 (MCAF)	6777	61
352403	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	MCP-1 (MCAF)	5577	73
352404	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	MCP-1 (MCAF)	7206	54
352405	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	MCP-1 (MCAF)	5453.5	56
352406	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	MCP-1 (MCAF)	2206	76
352407	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	MCP-1 (MCAF)	6801.5	66
352408	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	MCP-1 (MCAF)	11132	41
352409	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	MCP-1 (MCAF)	11440	76
352410	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	MCP-1 (MCAF)	12778	79
352411	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	13235	73
352412	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	12190	52
352413	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	MCP-1 (MCAF)	12961	75
352414	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	MCP-1 (MCAF)	2076	65
352415	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	MCP-1 (MCAF)	13996	94
352416	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	MCP-1 (MCAF)	12225	76
352417	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	MCP-1 (MCAF)	12742	63
352418	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	13280	48
352419	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	9669	42
352420	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	MCP-1 (MCAF)	2463	75
352421	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	MCP-1 (MCAF)	7149	65
352422	20233																	0	MCP-1 (MCAF)	64.5	48
352423	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	MCP-1 (MCAF)	12801	77
352424	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	MCP-1 (MCAF)	11736	53
352425	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	MCP-1 (MCAF)	12453	64
352426	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	12170	76
352427	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	10780	56
352428	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	MCP-1 (MCAF)	11915	80
352429	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	MCP-1 (MCAF)	2520	63
352430	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	MCP-1 (MCAF)	11535.5	60
352431	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	MCP-1 (MCAF)	11996	77
352432	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	MCP-1 (MCAF)	12988.5	66
352433	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	13525.5	64
352434	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MCP-1 (MCAF)	11031.5	54
352435	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	MCP-1 (MCAF)	1851.5	62
352436	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	MCP-1 (MCAF)	6257	75
352437	20233																	0	MCP-1 (MCAF)	53	87
352438	20233						RA2159	51112.0										4	MCP-1 (MCAF)	2470	75
352439	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MCP-1 (MCAF)	2655	74
352440	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MCP-1 (MCAF)	2517.5	74
352441	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MCP-1 (MCAF)	2537	69
352442	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MCP-1 (MCAF)	1375	75
352443	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MCP-1 (MCAF)	2163	56
352444	20233						RA2159	51112.0										4	MCP-1 (MCAF)	2922	54
352445	20233						N2586	51107.0										4	MCP-1 (MCAF)	6756	57
352446	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MCP-1 (MCAF)	6032	39
352447	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MCP-1 (MCAF)	5211	65
352448	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MCP-1 (MCAF)	6042	62
352449	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MCP-1 (MCAF)	3501	54
352450	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MCP-1 (MCAF)	3379	86
352451	20233						N2586	51107.0										4	MCP-1 (MCAF)	5976	51
352452	20233								TNF-a	201285.0						100	ng/mL	0	MCP-1 (MCAF)	124.5	74
352453	20233								IL-1 alpha	201286.0						100	ng/mL	0	MCP-1 (MCAF)	52	78
352454	20233								IL-6	201287.0						100	ug/mL	0	MCP-1 (MCAF)	87	93
352455	20233								IL-17A	201288.0						100	ng/mL	0	MCP-1 (MCAF)	73	61
352456	20233								EGF	201289.0						100	ng/mL	0	MCP-1 (MCAF)	50.5	72
352457	20233								IGF-I	201290.0						100	ug/mL	0	MCP-1 (MCAF)	47	78
352458	20233								Adiponectin	201291.0						5	ng/mL	0	MCP-1 (MCAF)	70	63
352459	20233								Leptin	201292.0						1	ng/mL	0	MCP-1 (MCAF)	88.5	70
352460	20233								Visfatin	201293.0						1	ng/mL	0	MCP-1 (MCAF)	82	71
352461	20233															2	ug/mL	0	MCP-1 (MCAF)	59	81
352462	20233								TNF-a	201285.0						100	ng/mL	0	MCP-1 (MCAF)	116	73
352463	20233								IL-1 alpha	201286.0						100	ng/mL	0	MCP-1 (MCAF)	66	32
352464	20233								IL-6	201287.0						100	ug/mL	0	MCP-1 (MCAF)	85.5	60
352465	20233								IL-17A	201288.0						100	ng/mL	0	MCP-1 (MCAF)	70.5	62
352466	20233								EGF	201289.0						100	ng/mL	0	MCP-1 (MCAF)	51	67
352467	20233								IGF-I	201290.0						100	ug/mL	0	MCP-1 (MCAF)	64.5	66
352468	20233								Adiponectin	201291.0						5	ng/mL	0	MCP-1 (MCAF)	68	50
352469	20233								Leptin	201292.0						1	ng/mL	0	MCP-1 (MCAF)	85	39
352470	20233								Visfatin	201293.0						1	ng/mL	0	MCP-1 (MCAF)	58.5	58
352471	20233															2	ug/mL	0	MCP-1 (MCAF)	62.5	58
352472	20233								TNF-a	201285.0						100	ng/mL	0	MCP-1 (MCAF)	125.5	86
352473	20233								IL-1 alpha	201286.0						100	ng/mL	0	MCP-1 (MCAF)	59.5	62
352474	20233								IL-6	201287.0						100	ug/mL	0	MCP-1 (MCAF)	99	65
352475	20233								IL-17A	201288.0						100	ng/mL	0	MCP-1 (MCAF)	92	60
352476	20233								EGF	201289.0						100	ng/mL	0	MCP-1 (MCAF)	65.5	70
352477	20233								IGF-I	201290.0						100	ug/mL	0	MCP-1 (MCAF)	73	60
352478	20233								Adiponectin	201291.0						5	ng/mL	0	MCP-1 (MCAF)	60	77
352479	20233								Leptin	201292.0						1	ng/mL	0	MCP-1 (MCAF)	96	56
352480	20233								Visfatin	201293.0						1	ng/mL	0	MCP-1 (MCAF)	79.5	88
352481	20233															2	ug/mL	0	MCP-1 (MCAF)	54	66
352482	20233								TNF-a	201285.0						100	ng/mL	0	MCP-1 (MCAF)	122	71
352483	20233								IL-1 alpha	201286.0						100	ng/mL	0	MCP-1 (MCAF)	51	48
352484	20233								IL-6	201287.0						100	ug/mL	0	MCP-1 (MCAF)	90	69
352485	20233								IL-17A	201288.0						100	ng/mL	0	MCP-1 (MCAF)	50	57
352486	20233								EGF	201289.0						100	ng/mL	0	MCP-1 (MCAF)	48	62
352487	20233								IGF-I	201290.0						100	ug/mL	0	MCP-1 (MCAF)	51.5	72
352488	20233								Adiponectin	201291.0						5	ng/mL	0	MCP-1 (MCAF)	74	51
352489	20233								Leptin	201292.0						1	ng/mL	0	MCP-1 (MCAF)	86	52
352490	20233								Visfatin	201293.0						1	ng/mL	0	MCP-1 (MCAF)	51	41
352491	20233															2	ug/mL	0	MCP-1 (MCAF)	51	65
352492	20233																	0	IL-8	17	63
352493	20233						RA2159	51112.0										1	IL-8	646.5	88
352494	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-8	375	76
352495	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-8	350.5	80
352496	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-8	511.5	74
352497	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-8	816	81
352498	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-8	291	55
352499	20233						RA2159	51112.0										1	IL-8	569.5	80
352500	20233						N2586	51107.0										1	IL-8	980	80
352501	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-8	1019.5	78
352502	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-8	987	59
352503	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-8	832	63
352504	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-8	1053	68
352505	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-8	555	60
352506	20233						N2586	51107.0										1	IL-8	1216.5	28
352507	20233																	0	IL-8	18	71
352508	20233																	0	IL-8	15	67
352509	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-8	6974	59
352510	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-8	6723.5	72
352511	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-8	6943	91
352512	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-8	12111	99
352513	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-8	10584	67
352514	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-8	2612	77
352515	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-8	384	82
352516	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-8	11713	63
352517	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-8	8177.5	70
352518	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-8	14119	57
352519	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-8	13379	73
352520	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-8	11503	59
352521	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-8	8822	73
352522	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-8	907	33
352523	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-8	13785	74
352524	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-8	8406	90
352525	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-8	8135	53
352526	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-8	12554	74
352527	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-8	12033	78
352528	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-8	660	96
352529	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-8	887	68
352530	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-8	12084	63
352531	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-8	11395.5	86
352532	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-8	9238	73
352533	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-8	10480	73
352534	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-8	12188.5	70
352535	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-8	4771	51
352536	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-8	809	76
352537	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-8	591.5	74
352538	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-8	362	50
352539	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-8	307.5	86
352540	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-8	883	79
352541	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-8	983	74
352542	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-8	336	68
352543	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-8	557.5	76
352544	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-8	1374	84
352545	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-8	571	59
352546	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-8	753	61
352547	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-8	932	80
352548	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-8	794	76
352549	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-8	781.5	70
352550	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-8	1188	65
352551	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-8	1126	69
352552	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-8	433	75
352553	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-8	1898	93
352554	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-8	1820	83
352555	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-8	2316.5	62
352556	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-8	594	91
352557	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-8	2367	71
352558	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-8	2653	67
352559	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-8	1940	77
352560	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-8	2957	79
352561	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-8	1915.5	64
352562	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-8	1106.5	80
352563	20233						RA2159	51112.0										1	IL-8	643.5	66
352564	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-8	461	57
352565	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-8	385	78
352566	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-8	1019	67
352567	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-8	1181	59
352568	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-8	434	77
352569	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-8	377	58
352570	20233						N2586	51107.0										1	IL-8	670	73
352571	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-8	922	55
352572	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-8	1192.5	56
352573	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-8	1414	55
352574	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-8	1285	48
352575	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-8	799.5	68
352576	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-8	282.5	72
352577	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-8	987.5	82
352578	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-8	446	77
352579	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-8	631	77
352580	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-8	912	87
352581	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-8	1344	79
352582	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-8	465	57
352583	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-8	436.5	74
352584	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-8	2120.5	88
352585	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-8	1577	69
352586	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-8	1790.5	54
352587	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-8	1933	44
352588	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-8	1413	75
352589	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-8	948	31
352590	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-8	941.5	90
352591	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-8	399.5	56
352592	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-8	225.5	68
352593	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-8	412	58
352594	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-8	616	79
352595	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-8	644	105
352596	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-8	219	73
352597	20233						RA2159	51112.0										1	IL-8	861	70
352598	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-8	736	73
352599	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-8	816	64
352600	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-8	580.5	84
352601	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-8	1102.5	60
352602	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-8	809	41
352603	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-8	389	88
352604	20233						N2586	51107.0										1	IL-8	1052	77
352605	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-8	462.5	80
352606	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-8	174	85
352607	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-8	233	83
352608	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-8	695	58
352609	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-8	720	73
352610	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-8	233.5	94
352611	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-8	527	71
352612	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-8	769.5	56
352613	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-8	695	65
352614	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-8	1197.5	44
352615	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-8	1035	58
352616	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-8	527	63
352617	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-8	412	71
352618	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-8	372	67
352619	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-8	260	71
352620	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-8	494	73
352621	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-8	634.5	68
352622	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-8	230.5	62
352623	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-8	681	63
352624	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-8	551	67
352625	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-8	546	64
352626	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-8	900	53
352627	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-8	930	77
352628	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-8	510	37
352629	20233						RA2159	51112.0										1	IL-8	872.5	56
352630	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-8	360	61
352631	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-8	356	70
352632	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-8	662	69
352633	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-8	734	92
352634	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-8	343	67
352635	20233						RA2159	51112.0										1	IL-8	670	69
352636	20233						N2586	51107.0										1	IL-8	670.5	70
352637	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-8	963	75
352638	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-8	973	59
352639	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-8	771.5	74
352640	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-8	944	70
352641	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-8	568	68
352642	20233						N2586	51107.0										1	IL-8	714	59
352643	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-8	460	52
352644	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-8	259	87
352645	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-8	294	69
352646	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-8	716	77
352647	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-8	390	35
352648	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-8	199	63
352649	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-8	484	87
352650	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-8	782	72
352651	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-8	466	66
352652	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-8	680	67
352653	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-8	815	66
352654	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-8	471	37
352655	20233																	0	IL-8	15.5	64
352656	20233						RA2159	51112.0								2	ug/mL	1	IL-8	5363.5	58
352657	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-8	3018	60
352658	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-8	1074.5	68
352659	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-8	5375	45
352660	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-8	4406	75
352661	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-8	702	81
352662	20233						N2586	51107.0								2	ug/mL	1	IL-8	6708.5	52
352663	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-8	3989	60
352664	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-8	2259	79
352665	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-8	5063	45
352666	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-8	4733	52
352667	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-8	2187	38
352668	20233																	0	IL-8	15	57
352669	20233						RA2159	51112.0										2	IL-8	434	66
352670	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-8	231	85
352671	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-8	471	73
352672	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-8	324	66
352673	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-8	228	54
352674	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-8	427.5	78
352675	20233						RA2159	51112.0										2	IL-8	518	51
352676	20233						N2586	51107.0										2	IL-8	642	50
352677	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-8	557	55
352678	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-8	806	80
352679	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-8	812	40
352680	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-8	800.5	68
352681	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-8	750	45
352682	20233						N2586	51107.0										2	IL-8	1125	46
352683	20233																	0	IL-8	18	67
352684	20233																	0	IL-8	16	45
352685	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-8	7332	61
352686	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-8	9012	92
352687	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-8	9613	66
352688	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-8	8031	61
352689	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-8	5747	68
352690	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-8	6124	69
352691	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-8	429.5	58
352692	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-8	12451	73
352693	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-8	8056.5	54
352694	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-8	10773.5	66
352695	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-8	8680	70
352696	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-8	10679	47
352697	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-8	10740	57
352698	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-8	648	66
352699	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-8	9651	66
352700	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-8	8397	71
352701	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-8	12533	79
352702	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-8	8827	68
352703	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-8	10466	69
352704	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-8	9240.5	70
352705	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-8	307	45
352706	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-8	11267	52
352707	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-8	7482.5	82
352708	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-8	11191.5	60
352709	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-8	10892	87
352710	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-8	10960	59
352711	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-8	11862	55
352712	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-8	457	56
352713	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-8	545.5	88
352714	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-8	912.5	54
352715	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-8	685	63
352716	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-8	802.5	64
352717	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-8	235	57
352718	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-8	497.5	72
352719	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-8	489	58
352720	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-8	587	79
352721	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-8	344	90
352722	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-8	676.5	68
352723	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-8	1353	65
352724	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-8	337	74
352725	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-8	593	46
352726	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-8	842	58
352727	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-8	1029.5	78
352728	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-8	1347	86
352729	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-8	1606	78
352730	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-8	2279	60
352731	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-8	420	55
352732	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-8	1366.5	56
352733	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-8	512	76
352734	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-8	1800.5	54
352735	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-8	966.5	68
352736	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-8	943.5	66
352737	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-8	1282	70
352738	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-8	816	78
352739	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-8	958	69
352740	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-8	858.5	62
352741	20233						RA2159	51112.0										2	IL-8	861	63
352742	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-8	800.5	74
352743	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-8	646	91
352744	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-8	757.5	56
352745	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-8	253.5	64
352746	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-8	583	73
352747	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-8	411.5	58
352748	20233						N2586	51107.0										2	IL-8	868	77
352749	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-8	667	61
352750	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-8	1040	62
352751	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-8	1022	54
352752	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-8	345	79
352753	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-8	698.5	48
352754	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-8	339	57
352755	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-8	1030	82
352756	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-8	846	50
352757	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-8	629.5	84
352758	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-8	990.5	74
352759	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-8	302	69
352760	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-8	493.5	86
352761	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-8	988	83
352762	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-8	913	75
352763	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-8	1041	77
352764	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-8	1441.5	74
352765	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-8	363	56
352766	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-8	16	79
352767	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-8	375	73
352768	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-8	874.5	46
352769	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-8	403	85
352770	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-8	762.5	66
352771	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-8	179	88
352772	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-8	381	85
352773	20233						RA2159	51112.0										2	IL-8	467.5	80
352774	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-8	722	76
352775	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-8	292	74
352776	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-8	713	55
352777	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-8	503	78
352778	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-8	280	85
352779	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-8	468	57
352780	20233						N2586	51107.0										2	IL-8	9.5	60
352781	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-8	472	72
352782	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-8	431.5	78
352783	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-8	515	81
352784	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-8	481	93
352785	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-8	182.5	74
352786	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-8	340	67
352787	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-8	658	61
352788	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-8	268	61
352789	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-8	551	65
352790	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-8	535	66
352791	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-8	317	56
352792	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-8	420	59
352793	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-8	571	68
352794	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-8	548	71
352795	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-8	269.5	82
352796	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-8	565.5	70
352797	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-8	132.5	72
352798	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-8	394	81
352799	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-8	645	95
352800	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-8	371.5	60
352801	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-8	664	70
352802	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-8	486	54
352803	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-8	234	39
352804	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-8	521.5	74
352805	20233						RA2159	51112.0										2	IL-8	449	85
352806	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-8	350.5	62
352807	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-8	338	67
352808	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-8	463	105
352809	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-8	141	91
352810	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-8	379	55
352811	20233						RA2159	51112.0										2	IL-8	397	62
352812	20233						N2586	51107.0										2	IL-8	782	49
352813	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-8	426	54
352814	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-8	857.5	82
352815	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-8	648	57
352816	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-8	432	69
352817	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-8	692	57
352818	20233						N2586	51107.0										2	IL-8	916	49
352819	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-8	470	79
352820	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-8	301	69
352821	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-8	272.5	82
352822	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-8	342	53
352823	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-8	134	39
352824	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-8	304.5	54
352825	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-8	334	62
352826	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-8	507	47
352827	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-8	356.5	40
352828	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-8	445.5	40
352829	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-8	262	46
352830	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-8	466	41
352831	20233																	0	IL-8	13	58
352832	20233						RA2159	51112.0								2	ug/mL	2	IL-8	4024	57
352833	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-8	2094	65
352834	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-8	3750	75
352835	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-8	3283	82
352836	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-8	1229.5	46
352837	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-8	3613	59
352838	20233						N2586	51107.0								2	ug/mL	2	IL-8	6095.5	38
352839	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-8	3599	57
352840	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-8	3805.5	42
352841	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-8	4567	43
352842	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-8	2479	30
352843	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-8	3825	41
352844	20233																	0	IL-8	15	64
352845	20233						RA2159	51112.0								2	ug/mL	3	IL-8	5335	77
352846	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-8	4031.5	78
352847	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-8	1570	81
352848	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-8	5129	67
352849	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-8	5017.5	64
352850	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-8	1325	73
352851	20233						N2586	51107.0								2	ug/mL	3	IL-8	7159	73
352852	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-8	5159	60
352853	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-8	6917	73
352854	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-8	9061	80
352855	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-8	2569	71
352856	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-8	4802	53
352857	20233						RA2159	51112.0										3	IL-8	427.5	72
352858	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-8	313	75
352859	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-8	391	58
352860	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-8	716.5	60
352861	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-8	620	77
352862	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-8	369	56
352863	20233						RA2159	51112.0										3	IL-8	507	80
352864	20233						N2586	51107.0										3	IL-8	1166	73
352865	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-8	900	76
352866	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-8	575.5	60
352867	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-8	1118.5	70
352868	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-8	696	79
352869	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-8	792	79
352870	20233						N2586	51107.0										3	IL-8	1067	60
352871	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-8	783.5	84
352872	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-8	353	63
352873	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-8	588	68
352874	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-8	630	65
352875	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-8	788	74
352876	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-8	337.5	90
352877	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-8	1026	53
352878	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-8	1076	75
352879	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-8	1132	91
352880	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-8	568	58
352881	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-8	848.5	86
352882	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-8	550	73
352883	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-8	828	83
352884	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-8	383.5	70
352885	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-8	23.5	72
352886	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-8	616	79
352887	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-8	886.5	92
352888	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-8	305	75
352889	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-8	1109	79
352890	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-8	853.5	82
352891	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-8	1005	69
352892	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-8	1179.5	84
352893	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-8	904	87
352894	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-8	758	79
352895	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-8	520	79
352896	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-8	375	87
352897	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-8	457	73
352898	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-8	833	87
352899	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-8	686	88
352900	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-8	421	83
352901	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-8	1820	82
352902	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-8	1096	68
352903	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-8	1276	79
352904	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-8	1363.5	64
352905	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-8	852	85
352906	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-8	689	73
352907	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-8	600	64
352908	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-8	473	72
352909	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-8	356	77
352910	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-8	795.5	74
352911	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-8	924	85
352912	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-8	214.5	70
352913	20233						RA2159	51112.0										3	IL-8	653	69
352914	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-8	1527	73
352915	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-8	676	88
352916	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-8	795	86
352917	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-8	1506	90
352918	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-8	843	80
352919	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-8	656	85
352920	20233						N2586	51107.0										3	IL-8	1458	90
352921	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-8	708.5	76
352922	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-8	693	54
352923	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-8	781	73
352924	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-8	1380.5	46
352925	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-8	614	74
352926	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-8	377.5	58
352927	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-8	548	85
352928	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-8	2634	81
352929	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-8	1436	83
352930	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-8	1333	63
352931	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-8	2203	63
352932	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-8	943	75
352933	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-8	228	63
352934	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-8	232	50
352935	20233						RA2159	51112.0										3	IL-8	449	71
352936	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-8	472	61
352937	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-8	625	69
352938	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-8	1245	69
352939	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-8	944	96
352940	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-8	396	63
352941	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-8	279	87
352942	20233						N2586	51107.0										3	IL-8	1298	82
352943	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-8	813.5	104
352944	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-8	1053	59
352945	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-8	1509	77
352946	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-8	1061	75
352947	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-8	717.5	68
352948	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-8	732	54
352949	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-8	1435	65
352950	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-8	689	58
352951	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-8	1137.5	72
352952	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-8	2708	55
352953	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-8	1595	48
352954	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-8	477	65
352955	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-8	2041.5	82
352956	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-8	1389	89
352957	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-8	553	98
352958	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-8	2236.5	70
352959	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-8	2323	59
352960	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-8	990	63
352961	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-8	455	80
352962	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-8	284	79
352963	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-8	250	71
352964	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-8	805	84
352965	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-8	692	86
352966	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-8	304.5	70
352967	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-8	699	75
352968	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-8	1066	92
352969	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-8	859	91
352970	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-8	798	73
352971	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-8	958	87
352972	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-8	1261	73
352973	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-8	682	76
352974	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-8	1172	71
352975	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-8	9955.5	82
352976	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-8	10893.5	76
352977	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-8	7248.5	72
352978	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-8	11381.5	80
352979	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-8	12497	75
352980	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-8	996	74
352981	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-8	725.5	54
352982	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-8	9271	80
352983	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-8	9169.5	62
352984	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-8	8512	71
352985	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-8	10862	73
352986	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-8	7635	50
352987	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-8	9338	64
352988	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-8	603	93
352989	20233																	0	IL-8	13	65
352990	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-8	9459	65
352991	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-8	6934	55
352992	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-8	7002	73
352993	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-8	12594	76
352994	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-8	10695	71
352995	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-8	3205	72
352996	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-8	655.5	62
352997	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-8	10872	73
352998	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-8	10403	67
352999	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-8	8691.5	80
353000	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-8	444	68
353001	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-8	5657	77
353002	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-8	11005.5	72
353003	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-8	842	72
353004	20233																	0	IL-8	13	43
353005	20233						RA2159	51112.0										3	IL-8	223	77
353006	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-8	387	69
353007	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-8	351	81
353008	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-8	592.5	64
353009	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-8	686	46
353010	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-8	235.5	74
353011	20233						RA2159	51112.0										3	IL-8	657.5	70
353012	20233						N2586	51107.0										3	IL-8	1201.5	58
353013	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-8	563	67
353014	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-8	711	61
353015	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-8	909	35
353016	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-8	746	53
353017	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-8	585	75
353018	20233						N2586	51107.0										3	IL-8	1130.5	36
353019	20233																	0	IL-8	17	47
353020	20233						RA2159	51112.0								2	ug/mL	4	IL-8	5984.5	70
353021	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-8	4710	66
353022	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-8	6224	93
353023	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-8	5828	73
353024	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-8	2103	73
353025	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-8	4085	65
353026	20233						N2586	51107.0								2	ug/mL	4	IL-8	6846	83
353027	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-8	5789	93
353028	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-8	2030.5	66
353029	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-8	5062	65
353030	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-8	1738.5	74
353031	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-8	213.5	60
353032	20233						RA2159	51112.0										4	IL-8	386	65
353033	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-8	515	79
353034	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-8	570	69
353035	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-8	751	67
353036	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-8	544	67
353037	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-8	382	73
353038	20233						RA2159	51112.0										4	IL-8	672	67
353039	20233						N2586	51107.0										4	IL-8	679	79
353040	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-8	873	61
353041	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-8	577.5	60
353042	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-8	951	55
353043	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-8	606	63
353044	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-8	496	76
353045	20233						N2586	51107.0										4	IL-8	1069	51
353046	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-8	681	65
353047	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-8	891	63
353048	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-8	1041	87
353049	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-8	982	71
353050	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-8	470.5	74
353051	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-8	929	80
353052	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-8	909	69
353053	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-8	684	55
353054	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-8	1054	61
353055	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-8	1112	62
353056	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-8	533.5	70
353057	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-8	267	64
353058	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-8	989.5	78
353059	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-8	1087	79
353060	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-8	1156	73
353061	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-8	944	69
353062	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-8	387	69
353063	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-8	1025.5	58
353064	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-8	1032.5	64
353065	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-8	631	57
353066	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-8	610	69
353067	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-8	1224	68
353068	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-8	728	75
353069	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-8	247	85
353070	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-8	1010.5	62
353071	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-8	1055	65
353072	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-8	1798.5	72
353073	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-8	1054	74
353074	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-8	611	55
353075	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-8	1277	53
353076	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-8	980	80
353077	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-8	1071	63
353078	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-8	683.5	56
353079	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-8	1439.5	58
353080	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-8	619.5	60
353081	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-8	312	63
353082	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-8	943.5	74
353083	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-8	1392	63
353084	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-8	1008.5	80
353085	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-8	1295	68
353086	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-8	571	46
353087	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-8	1176	50
353088	20233						RA2159	51112.0										4	IL-8	1115	85
353089	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-8	744	59
353090	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-8	831	75
353091	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-8	591.5	64
353092	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-8	1426	44
353093	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-8	524	50
353094	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-8	291	73
353095	20233						N2586	51107.0										4	IL-8	1009	73
353096	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-8	1215	80
353097	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-8	1309	85
353098	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-8	1355	65
353099	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-8	1345.5	48
353100	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-8	643.5	38
353101	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-8	1329.5	44
353102	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-8	2201.5	76
353103	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-8	1328.5	70
353104	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-8	1443.5	56
353105	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-8	1619	63
353106	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-8	934	67
353107	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-8	265	87
353108	20233						RA2159	51112.0										4	IL-8	732	63
353109	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-8	1187	87
353110	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-8	1122.5	68
353111	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-8	874	71
353112	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-8	619	57
353113	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-8	1052	50
353114	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-8	564	70
353115	20233						N2586	51107.0										4	IL-8	1152.5	72
353116	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-8	891	52
353117	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-8	994	79
353118	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-8	1688	65
353119	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-8	575	67
353120	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-8	230	71
353121	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-8	441	63
353122	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-8	1083	73
353123	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-8	1584	71
353124	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-8	2085.5	92
353125	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-8	2242	57
353126	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-8	763	60
353127	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-8	894.5	68
353128	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-8	1156	70
353129	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-8	1762	59
353130	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-8	1828	71
353131	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-8	4384	61
353132	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-8	2146.5	88
353133	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-8	976	59
353134	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-8	314	79
353135	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-8	154	73
353136	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-8	713.5	72
353137	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-8	556	82
353138	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-8	680.5	54
353139	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-8	1195.5	70
353140	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-8	563.5	50
353141	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-8	654.5	66
353142	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-8	462	32
353143	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-8	961	75
353144	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-8	698	68
353145	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-8	950	47
353146	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-8	1120	65
353147	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-8	430	68
353148	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-8	148	57
353149	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-8	1152.5	44
353150	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-8	10827	40
353151	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-8	9512	61
353152	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-8	8888	67
353153	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-8	12413	66
353154	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-8	7927	55
353155	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-8	11816	60
353156	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-8	489	74
353157	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-8	12072	69
353158	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-8	11016	77
353159	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-8	8439	58
353160	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-8	8581.5	38
353161	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-8	5736	50
353162	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-8	304.5	56
353163	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-8	926.5	30
353164	20233																	0	IL-8	17	51
353165	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-8	9999	67
353166	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-8	6860	55
353167	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-8	10350	68
353168	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-8	11850	77
353169	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-8	7279	64
353170	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-8	6871.5	58
353171	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-8	534	52
353172	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-8	11839	65
353173	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-8	11353.5	68
353174	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-8	10264	68
353175	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-8	11395	59
353176	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-8	6650	47
353177	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-8	177.5	54
353178	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-8	616	84
353179	20233																	0	IL-8	13	74
353180	20233						RA2159	51112.0										4	IL-8	329	81
353181	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-8	389.5	60
353182	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-8	412	97
353183	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-8	619	79
353184	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-8	387	67
353185	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-8	465	48
353186	20233						RA2159	51112.0										4	IL-8	548	61
353187	20233						N2586	51107.0										4	IL-8	908	57
353188	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-8	929	45
353189	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-8	635	60
353190	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-8	671	63
353191	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-8	250	63
353192	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-8	420.5	72
353193	20233						N2586	51107.0										4	IL-8	1181	51
353194	20233								TNF-a	201285.0						100	ng/mL	0	IL-8	39	73
353195	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-8	16	118
353196	20233								IL-6	201287.0						100	ug/mL	0	IL-8	28	62
353197	20233								IL-17A	201288.0						100	ng/mL	0	IL-8	22	65
353198	20233								EGF	201289.0						100	ng/mL	0	IL-8	12.5	86
353199	20233								IGF-I	201290.0						100	ug/mL	0	IL-8	15	77
353200	20233								Adiponectin	201291.0						5	ng/mL	0	IL-8	25	74
353201	20233								Leptin	201292.0						1	ng/mL	0	IL-8	15	79
353202	20233								Visfatin	201293.0						1	ng/mL	0	IL-8	17	53
353203	20233															2	ug/mL	0	IL-8	16.5	82
353204	20233								TNF-a	201285.0						100	ng/mL	0	IL-8	34.5	72
353205	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-8	17	46
353206	20233								IL-6	201287.0						100	ug/mL	0	IL-8	26	66
353207	20233								IL-17A	201288.0						100	ng/mL	0	IL-8	23	74
353208	20233								EGF	201289.0						100	ng/mL	0	IL-8	17	46
353209	20233								IGF-I	201290.0						100	ug/mL	0	IL-8	15	60
353210	20233								Adiponectin	201291.0						5	ng/mL	0	IL-8	28.5	46
353211	20233								Leptin	201292.0						1	ng/mL	0	IL-8	16	41
353212	20233								Visfatin	201293.0						1	ng/mL	0	IL-8	16.5	66
353213	20233															2	ug/mL	0	IL-8	16	61
353214	20233								TNF-a	201285.0						100	ng/mL	0	IL-8	41	79
353215	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-8	14.5	70
353216	20233								IL-6	201287.0						100	ug/mL	0	IL-8	23	68
353217	20233								IL-17A	201288.0						100	ng/mL	0	IL-8	21	66
353218	20233								EGF	201289.0						100	ng/mL	0	IL-8	16	65
353219	20233								IGF-I	201290.0						100	ug/mL	0	IL-8	11.5	62
353220	20233								Adiponectin	201291.0						5	ng/mL	0	IL-8	16	75
353221	20233								Leptin	201292.0						1	ng/mL	0	IL-8	16	55
353222	20233								Visfatin	201293.0						1	ng/mL	0	IL-8	11	77
353223	20233															2	ug/mL	0	IL-8	13	73
353224	20233								TNF-a	201285.0						100	ng/mL	0	IL-8	34	72
353225	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-8	13.5	52
353226	20233								IL-6	201287.0						100	ug/mL	0	IL-8	20.5	54
353227	20233								IL-17A	201288.0						100	ng/mL	0	IL-8	20	57
353228	20233								EGF	201289.0						100	ng/mL	0	IL-8	15	81
353229	20233								IGF-I	201290.0						100	ug/mL	0	IL-8	11	81
353230	20233								Adiponectin	201291.0						5	ng/mL	0	IL-8	21.5	56
353231	20233								Leptin	201292.0						1	ng/mL	0	IL-8	14	53
353232	20233								Visfatin	201293.0						1	ng/mL	0	IL-8	14	46
353233	20233															2	ug/mL	0	IL-8	13	48
353234	20233																	0	MIP-1A	19.5	36
353235	20233						RA2159	51112.0										1	MIP-1A	21	64
353236	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MIP-1A	22	72
353237	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MIP-1A	24	61
353238	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MIP-1A	24	69
353239	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MIP-1A	22	74
353240	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MIP-1A	19.5	52
353241	20233						RA2159	51112.0										1	MIP-1A	23	63
353242	20233						N2586	51107.0										1	MIP-1A	24	71
353243	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MIP-1A	25	76
353244	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MIP-1A	20	57
353245	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MIP-1A	20	73
353246	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MIP-1A	18	74
353247	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MIP-1A	21.5	44
353248	20233						N2586	51107.0										1	MIP-1A	20	28
353249	20233																	0	MIP-1A	19	58
353250	20233																	0	MIP-1A	18	51
353251	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	MIP-1A	31	66
353252	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	MIP-1A	28	54
353253	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIP-1A	30	60
353254	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIP-1A	27	92
353255	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIP-1A	29	60
353256	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	MIP-1A	23.5	64
353257	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	MIP-1A	21.5	84
353258	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	MIP-1A	36	59
353259	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	MIP-1A	45	55
353260	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIP-1A	35.5	64
353261	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIP-1A	36	59
353262	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIP-1A	36	63
353263	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	MIP-1A	31	61
353264	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	MIP-1A	21.5	36
353265	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	MIP-1A	61	67
353266	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	MIP-1A	33	61
353267	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIP-1A	23	64
353268	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIP-1A	48	73
353269	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIP-1A	47	56
353270	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	MIP-1A	22	70
353271	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	MIP-1A	19	70
353272	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	MIP-1A	68	64
353273	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	MIP-1A	90.5	54
353274	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIP-1A	30	59
353275	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIP-1A	90	68
353276	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIP-1A	96.5	56
353277	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	MIP-1A	22	46
353278	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	MIP-1A	19	71
353279	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	MIP-1A	25	63
353280	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	MIP-1A	19.5	54
353281	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIP-1A	20.5	82
353282	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIP-1A	26	81
353283	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIP-1A	23	71
353284	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	MIP-1A	25	72
353285	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	MIP-1A	24	57
353286	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	MIP-1A	24	85
353287	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	MIP-1A	23	61
353288	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIP-1A	24	50
353289	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIP-1A	26.5	62
353290	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIP-1A	23	71
353291	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	MIP-1A	29.5	60
353292	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	MIP-1A	23	56
353293	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	MIP-1A	23	88
353294	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	MIP-1A	23.5	68
353295	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIP-1A	23.5	72
353296	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIP-1A	25	66
353297	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIP-1A	28	58
353298	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	MIP-1A	26	68
353299	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	MIP-1A	27.5	68
353300	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	MIP-1A	24	51
353301	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIP-1A	25.5	54
353302	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIP-1A	19	93
353303	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIP-1A	22	57
353304	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	MIP-1A	24	85
353305	20233						RA2159	51112.0										1	MIP-1A	30	50
353306	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MIP-1A	19	67
353307	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MIP-1A	19	77
353308	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MIP-1A	19	50
353309	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MIP-1A	21	49
353310	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MIP-1A	17	75
353311	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	MIP-1A	20	53
353312	20233						N2586	51107.0										1	MIP-1A	20.5	70
353313	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MIP-1A	21	61
353314	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MIP-1A	22	34
353315	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MIP-1A	22.5	54
353316	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MIP-1A	20.5	66
353317	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MIP-1A	26	61
353318	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	MIP-1A	21	66
353319	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	MIP-1A	22	65
353320	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	MIP-1A	19	63
353321	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIP-1A	19	52
353322	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIP-1A	19	71
353323	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIP-1A	18	70
353324	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	MIP-1A	18	63
353325	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	MIP-1A	22	102
353326	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	MIP-1A	20	85
353327	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	MIP-1A	18	65
353328	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIP-1A	20	43
353329	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIP-1A	22.5	50
353330	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIP-1A	19	66
353331	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	MIP-1A	21.5	42
353332	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	MIP-1A	22	74
353333	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	MIP-1A	23	74
353334	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	MIP-1A	19.5	62
353335	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIP-1A	19	63
353336	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIP-1A	18	67
353337	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIP-1A	21	99
353338	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	MIP-1A	20	81
353339	20233						RA2159	51112.0										1	MIP-1A	20	73
353340	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	MIP-1A	20	73
353341	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	MIP-1A	18	58
353342	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIP-1A	17	74
353343	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIP-1A	18	53
353344	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIP-1A	17	45
353345	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	MIP-1A	19	79
353346	20233						N2586	51107.0										1	MIP-1A	25	81
353347	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	MIP-1A	18	61
353348	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	MIP-1A	20	67
353349	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIP-1A	22.5	50
353350	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIP-1A	18	53
353351	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIP-1A	21	76
353352	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	MIP-1A	19	80
353353	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	MIP-1A	19	82
353354	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	MIP-1A	19	57
353355	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIP-1A	22	50
353356	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIP-1A	18.5	58
353357	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIP-1A	22	71
353358	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	MIP-1A	21	43
353359	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	MIP-1A	21	72
353360	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	MIP-1A	17	58
353361	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIP-1A	18.5	64
353362	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIP-1A	17.5	62
353363	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIP-1A	20	65
353364	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	MIP-1A	16	54
353365	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	MIP-1A	18.5	42
353366	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	MIP-1A	18	61
353367	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIP-1A	16	83
353368	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIP-1A	20	68
353369	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIP-1A	18	63
353370	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	MIP-1A	18	36
353371	20233						RA2159	51112.0										1	MIP-1A	17	57
353372	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MIP-1A	18	81
353373	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MIP-1A	21	67
353374	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MIP-1A	17.5	52
353375	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MIP-1A	19	76
353376	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MIP-1A	20	62
353377	20233						RA2159	51112.0										1	MIP-1A	19.5	84
353378	20233						N2586	51107.0										1	MIP-1A	19	73
353379	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MIP-1A	18.5	54
353380	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MIP-1A	20	62
353381	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MIP-1A	19	72
353382	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MIP-1A	19	47
353383	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MIP-1A	21	61
353384	20233						N2586	51107.0										1	MIP-1A	22	60
353385	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	MIP-1A	18	53
353386	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	MIP-1A	19	82
353387	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIP-1A	20	59
353388	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIP-1A	19	77
353389	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIP-1A	18	53
353390	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	MIP-1A	17	67
353391	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	MIP-1A	19	61
353392	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	MIP-1A	19	81
353393	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIP-1A	20	61
353394	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIP-1A	18	67
353395	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIP-1A	16.5	60
353396	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	MIP-1A	19	38
353397	20233																	0	MIP-1A	20	71
353398	20233						RA2159	51112.0								2	ug/mL	1	MIP-1A	27	65
353399	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	MIP-1A	29	49
353400	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MIP-1A	18.5	64
353401	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MIP-1A	23	51
353402	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MIP-1A	23.5	72
353403	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	MIP-1A	19	61
353404	20233						N2586	51107.0								2	ug/mL	1	MIP-1A	26	35
353405	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	MIP-1A	25.5	74
353406	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MIP-1A	20.5	52
353407	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MIP-1A	24.5	32
353408	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MIP-1A	23	66
353409	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	MIP-1A	22.5	48
353410	20233																	0	MIP-1A	24	53
353411	20233						RA2159	51112.0										2	MIP-1A	23	76
353412	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MIP-1A	23	69
353413	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MIP-1A	32	78
353414	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MIP-1A	20	68
353415	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MIP-1A	20	53
353416	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MIP-1A	20.5	70
353417	20233						RA2159	51112.0										2	MIP-1A	19	35
353418	20233						N2586	51107.0										2	MIP-1A	22	54
353419	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MIP-1A	20	58
353420	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MIP-1A	20	59
353421	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MIP-1A	18.5	40
353422	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MIP-1A	26	47
353423	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MIP-1A	22.5	52
353424	20233						N2586	51107.0										2	MIP-1A	19	30
353425	20233																	0	MIP-1A	17.5	48
353426	20233																	0	MIP-1A	20	37
353427	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	MIP-1A	37	50
353428	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	MIP-1A	34.5	74
353429	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	MIP-1A	26	61
353430	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIP-1A	31.5	52
353431	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIP-1A	24	55
353432	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	MIP-1A	27	51
353433	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	MIP-1A	18	72
353434	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	MIP-1A	36	48
353435	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	MIP-1A	32	63
353436	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	MIP-1A	38	58
353437	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIP-1A	31	54
353438	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIP-1A	29	47
353439	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	MIP-1A	36	59
353440	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	MIP-1A	21.5	40
353441	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	MIP-1A	34.5	54
353442	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	MIP-1A	33	66
353443	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	MIP-1A	34	68
353444	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIP-1A	105	56
353445	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIP-1A	39	78
353446	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	MIP-1A	45.5	62
353447	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	MIP-1A	18.5	48
353448	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	MIP-1A	51	60
353449	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	MIP-1A	37.5	80
353450	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	MIP-1A	89	56
353451	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIP-1A	327	84
353452	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIP-1A	50	47
353453	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	MIP-1A	171	61
353454	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	MIP-1A	20.5	62
353455	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	MIP-1A	21.5	68
353456	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	MIP-1A	22	58
353457	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	MIP-1A	22	71
353458	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIP-1A	18.5	62
353459	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIP-1A	19	73
353460	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	MIP-1A	21	66
353461	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	MIP-1A	17	56
353462	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	MIP-1A	22	59
353463	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	MIP-1A	22	88
353464	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	MIP-1A	21	63
353465	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIP-1A	24	46
353466	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIP-1A	19	56
353467	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	MIP-1A	21	49
353468	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	MIP-1A	20	43
353469	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	MIP-1A	23.5	60
353470	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	MIP-1A	24	79
353471	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	MIP-1A	22.5	66
353472	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIP-1A	20	65
353473	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIP-1A	21	61
353474	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	MIP-1A	26	58
353475	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	MIP-1A	17	70
353476	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	MIP-1A	22	51
353477	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	MIP-1A	23.5	62
353478	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	MIP-1A	19.5	60
353479	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIP-1A	26	67
353480	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIP-1A	22	54
353481	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	MIP-1A	22	89
353482	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	MIP-1A	20.5	50
353483	20233						RA2159	51112.0										2	MIP-1A	21	57
353484	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MIP-1A	19	67
353485	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MIP-1A	20	65
353486	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MIP-1A	18.5	58
353487	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MIP-1A	20.5	56
353488	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MIP-1A	20	74
353489	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	MIP-1A	21.5	46
353490	20233						N2586	51107.0										2	MIP-1A	20	52
353491	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MIP-1A	19	56
353492	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MIP-1A	18	49
353493	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MIP-1A	17	71
353494	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MIP-1A	18	57
353495	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MIP-1A	18	47
353496	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	MIP-1A	22	53
353497	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	MIP-1A	18	60
353498	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	MIP-1A	19	75
353499	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	MIP-1A	16	75
353500	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	MIP-1A	20	62
353501	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	MIP-1A	18.5	70
353502	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	MIP-1A	18	76
353503	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	MIP-1A	16	71
353504	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	MIP-1A	16	61
353505	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	MIP-1A	20	77
353506	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	MIP-1A	17	57
353507	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	MIP-1A	18	53
353508	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	MIP-1A	7	87
353509	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	MIP-1A	17	66
353510	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	MIP-1A	21.5	42
353511	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	MIP-1A	18	69
353512	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIP-1A	19	73
353513	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIP-1A	20	79
353514	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	MIP-1A	16	73
353515	20233						RA2159	51112.0										2	MIP-1A	19	68
353516	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	MIP-1A	20	76
353517	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	MIP-1A	19	63
353518	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	MIP-1A	18	58
353519	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIP-1A	22	63
353520	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIP-1A	20	52
353521	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	MIP-1A	19	68
353522	20233						N2586	51107.0										2	MIP-1A	7	51
353523	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	MIP-1A	17	76
353524	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	MIP-1A	20	64
353525	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	MIP-1A	18	67
353526	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIP-1A	22	74
353527	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIP-1A	18	74
353528	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	MIP-1A	20	65
353529	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	MIP-1A	16	60
353530	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	MIP-1A	20	59
353531	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	MIP-1A	18	56
353532	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIP-1A	23	50
353533	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIP-1A	17	35
353534	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	MIP-1A	23	55
353535	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	MIP-1A	20	66
353536	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	MIP-1A	19	57
353537	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	MIP-1A	18	76
353538	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIP-1A	19	79
353539	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIP-1A	20	80
353540	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	MIP-1A	18.5	62
353541	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	MIP-1A	17	81
353542	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	MIP-1A	15	50
353543	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	MIP-1A	18	59
353544	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIP-1A	16.5	54
353545	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIP-1A	19	48
353546	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	MIP-1A	17	66
353547	20233						RA2159	51112.0										2	MIP-1A	16	62
353548	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MIP-1A	18.5	64
353549	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MIP-1A	18.5	66
353550	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MIP-1A	17.5	86
353551	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MIP-1A	20	76
353552	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MIP-1A	21.5	44
353553	20233						RA2159	51112.0										2	MIP-1A	17	49
353554	20233						N2586	51107.0										2	MIP-1A	17	53
353555	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MIP-1A	18	42
353556	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MIP-1A	19	67
353557	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MIP-1A	19	59
353558	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MIP-1A	21	42
353559	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MIP-1A	18	53
353560	20233						N2586	51107.0										2	MIP-1A	19	49
353561	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	MIP-1A	16	68
353562	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	MIP-1A	18	67
353563	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	MIP-1A	17.5	58
353564	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIP-1A	18	43
353565	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIP-1A	14.5	52
353566	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	MIP-1A	19	40
353567	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	MIP-1A	14.5	40
353568	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	MIP-1A	17.5	48
353569	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	MIP-1A	17	36
353570	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIP-1A	18	48
353571	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIP-1A	17	39
353572	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	MIP-1A	19	38
353573	20233																	0	MIP-1A	10	45
353574	20233						RA2159	51112.0								2	ug/mL	2	MIP-1A	36	50
353575	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	MIP-1A	20	55
353576	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	MIP-1A	22	56
353577	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	MIP-1A	30	65
353578	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	MIP-1A	22	27
353579	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	MIP-1A	33	45
353580	20233						N2586	51107.0								2	ug/mL	2	MIP-1A	23	37
353581	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	MIP-1A	22	54
353582	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	MIP-1A	24	41
353583	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	MIP-1A	30	31
353584	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	MIP-1A	22	31
353585	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	MIP-1A	23	50
353586	20233																	0	MIP-1A	18	81
353587	20233						RA2159	51112.0								2	ug/mL	3	MIP-1A	27	62
353588	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	MIP-1A	27	65
353589	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MIP-1A	18	69
353590	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MIP-1A	25	75
353591	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MIP-1A	23	73
353592	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	MIP-1A	21	68
353593	20233						N2586	51107.0								2	ug/mL	3	MIP-1A	41	71
353594	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	MIP-1A	31	69
353595	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MIP-1A	28	65
353596	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MIP-1A	32.5	62
353597	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MIP-1A	18	57
353598	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	MIP-1A	24	72
353599	20233						RA2159	51112.0										3	MIP-1A	17	80
353600	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MIP-1A	17.5	54
353601	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MIP-1A	19	69
353602	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MIP-1A	20	68
353603	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MIP-1A	23	67
353604	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MIP-1A	23	62
353605	20233						RA2159	51112.0										3	MIP-1A	19.5	78
353606	20233						N2586	51107.0										3	MIP-1A	20.5	60
353607	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MIP-1A	20	70
353608	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MIP-1A	16	63
353609	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MIP-1A	18.5	56
353610	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MIP-1A	19	80
353611	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MIP-1A	20	73
353612	20233						N2586	51107.0										3	MIP-1A	18	55
353613	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	MIP-1A	19	67
353614	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	MIP-1A	20	67
353615	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIP-1A	19	68
353616	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIP-1A	21	49
353617	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIP-1A	20	69
353618	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	MIP-1A	20	81
353619	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	MIP-1A	17	66
353620	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	MIP-1A	19	85
353621	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIP-1A	19.5	70
353622	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIP-1A	19	60
353623	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIP-1A	17	60
353624	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	MIP-1A	20	60
353625	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	MIP-1A	20	84
353626	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	MIP-1A	18.5	66
353627	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIP-1A	13.5	60
353628	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIP-1A	19	77
353629	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIP-1A	20	72
353630	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	MIP-1A	18	69
353631	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	MIP-1A	17	82
353632	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	MIP-1A	17	57
353633	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIP-1A	17	71
353634	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIP-1A	18	71
353635	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIP-1A	17	58
353636	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	MIP-1A	19	61
353637	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	MIP-1A	17	55
353638	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	MIP-1A	19	81
353639	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIP-1A	19	89
353640	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIP-1A	19	56
353641	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIP-1A	19	83
353642	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	MIP-1A	21	94
353643	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	MIP-1A	20	66
353644	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	MIP-1A	18	61
353645	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIP-1A	21.5	68
353646	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIP-1A	20	76
353647	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIP-1A	19	78
353648	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	MIP-1A	22	66
353649	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	MIP-1A	17	73
353650	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	MIP-1A	17	73
353651	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIP-1A	17	56
353652	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIP-1A	18	75
353653	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIP-1A	19	57
353654	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	MIP-1A	21	45
353655	20233						RA2159	51112.0										3	MIP-1A	18	73
353656	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	MIP-1A	18	75
353657	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	MIP-1A	19	54
353658	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIP-1A	15	71
353659	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIP-1A	18.5	72
353660	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIP-1A	16	71
353661	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	MIP-1A	19	73
353662	20233						N2586	51107.0										3	MIP-1A	16	85
353663	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	MIP-1A	20	68
353664	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	MIP-1A	15	63
353665	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIP-1A	19	65
353666	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIP-1A	19	42
353667	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIP-1A	13.5	76
353668	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	MIP-1A	22	57
353669	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	MIP-1A	16	69
353670	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	MIP-1A	19	77
353671	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	MIP-1A	19	81
353672	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIP-1A	19.5	58
353673	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIP-1A	18	51
353674	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIP-1A	19.5	62
353675	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	MIP-1A	13	69
353676	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	MIP-1A	15	39
353677	20233						RA2159	51112.0										3	MIP-1A	17.5	52
353678	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MIP-1A	18	60
353679	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MIP-1A	16.5	54
353680	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MIP-1A	18	60
353681	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MIP-1A	19	69
353682	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MIP-1A	17	56
353683	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	MIP-1A	16.5	70
353684	20233						N2586	51107.0										3	MIP-1A	19	70
353685	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MIP-1A	16	81
353686	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MIP-1A	17	61
353687	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MIP-1A	18	83
353688	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MIP-1A	15	57
353689	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MIP-1A	18.5	44
353690	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	MIP-1A	19	68
353691	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	MIP-1A	23	70
353692	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	MIP-1A	27.5	64
353693	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIP-1A	21	63
353694	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIP-1A	24.5	60
353695	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIP-1A	27	67
353696	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	MIP-1A	21	66
353697	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	MIP-1A	22	82
353698	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	MIP-1A	19	99
353699	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIP-1A	18	86
353700	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIP-1A	22	54
353701	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIP-1A	21	80
353702	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	MIP-1A	22	59
353703	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	MIP-1A	25	67
353704	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	MIP-1A	22	61
353705	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIP-1A	22	61
353706	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIP-1A	24	68
353707	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIP-1A	18	76
353708	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	MIP-1A	21	77
353709	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	MIP-1A	19	71
353710	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	MIP-1A	21	87
353711	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	MIP-1A	21	72
353712	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIP-1A	19	68
353713	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIP-1A	21	73
353714	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIP-1A	21	61
353715	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	MIP-1A	18	84
353716	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	MIP-1A	15	75
353717	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	MIP-1A	56	63
353718	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	MIP-1A	36	80
353719	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIP-1A	21	78
353720	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIP-1A	59	68
353721	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIP-1A	56	66
353722	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	MIP-1A	17	45
353723	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	MIP-1A	18.5	54
353724	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	MIP-1A	133	100
353725	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	MIP-1A	40	68
353726	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIP-1A	152	57
353727	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIP-1A	490	63
353728	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIP-1A	23.5	52
353729	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	MIP-1A	36	63
353730	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	MIP-1A	18	67
353731	20233																	0	MIP-1A	17	61
353732	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	MIP-1A	39	71
353733	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	MIP-1A	31	59
353734	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIP-1A	29	66
353735	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIP-1A	26	82
353736	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIP-1A	27	59
353737	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	MIP-1A	24	63
353738	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	MIP-1A	16	65
353739	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	MIP-1A	40	69
353740	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	MIP-1A	31	66
353741	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIP-1A	39	65
353742	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIP-1A	15	59
353743	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIP-1A	22.5	62
353744	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	MIP-1A	37	57
353745	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	MIP-1A	17	60
353746	20233																	0	MIP-1A	13.5	54
353747	20233						RA2159	51112.0										3	MIP-1A	14.5	62
353748	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MIP-1A	16	58
353749	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MIP-1A	15	76
353750	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MIP-1A	16.5	64
353751	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MIP-1A	15	49
353752	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MIP-1A	17	72
353753	20233						RA2159	51112.0										3	MIP-1A	19	58
353754	20233						N2586	51107.0										3	MIP-1A	19	69
353755	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MIP-1A	16.5	50
353756	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MIP-1A	18.5	64
353757	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MIP-1A	15.5	50
353758	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MIP-1A	15	37
353759	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MIP-1A	18	58
353760	20233						N2586	51107.0										3	MIP-1A	16	29
353761	20233																	0	MIP-1A	18	59
353762	20233						RA2159	51112.0								2	ug/mL	4	MIP-1A	41	73
353763	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	MIP-1A	29	61
353764	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	MIP-1A	33	69
353765	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	MIP-1A	30	74
353766	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	MIP-1A	19	61
353767	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	MIP-1A	37	65
353768	20233						N2586	51107.0								2	ug/mL	4	MIP-1A	31	75
353769	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	MIP-1A	28	77
353770	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	MIP-1A	21.5	52
353771	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	MIP-1A	20.5	46
353772	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	MIP-1A	18	67
353773	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	MIP-1A	17	59
353774	20233						RA2159	51112.0										4	MIP-1A	17	71
353775	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MIP-1A	19.5	60
353776	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MIP-1A	18.5	82
353777	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MIP-1A	20.5	66
353778	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MIP-1A	16	60
353779	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MIP-1A	18	62
353780	20233						RA2159	51112.0										4	MIP-1A	20	81
353781	20233						N2586	51107.0										4	MIP-1A	18	77
353782	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MIP-1A	16	64
353783	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MIP-1A	15	52
353784	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MIP-1A	17	49
353785	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MIP-1A	17	61
353786	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MIP-1A	16.5	70
353787	20233						N2586	51107.0										4	MIP-1A	19	67
353788	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	MIP-1A	19	54
353789	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	MIP-1A	19	60
353790	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	MIP-1A	18	73
353791	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIP-1A	19.5	82
353792	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIP-1A	21	70
353793	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	MIP-1A	17	63
353794	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	MIP-1A	21	77
353795	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	MIP-1A	18.5	52
353796	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	MIP-1A	22	50
353797	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIP-1A	16.5	52
353798	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIP-1A	21	55
353799	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	MIP-1A	19	67
353800	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	MIP-1A	18	75
353801	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	MIP-1A	18	71
353802	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	MIP-1A	21	75
353803	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIP-1A	19.5	62
353804	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIP-1A	18	73
353805	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	MIP-1A	19	71
353806	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	MIP-1A	20	42
353807	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	MIP-1A	17.5	54
353808	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	MIP-1A	19	76
353809	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIP-1A	15	59
353810	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIP-1A	15	69
353811	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	MIP-1A	18	73
353812	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	MIP-1A	21	67
353813	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	MIP-1A	21	65
353814	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	MIP-1A	24	58
353815	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIP-1A	23	54
353816	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIP-1A	21	57
353817	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	MIP-1A	19	44
353818	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	MIP-1A	17	61
353819	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	MIP-1A	18	52
353820	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	MIP-1A	18	65
353821	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIP-1A	19	69
353822	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIP-1A	20	42
353823	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	MIP-1A	20	67
353824	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	MIP-1A	20	70
353825	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	MIP-1A	19	58
353826	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	MIP-1A	19	63
353827	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIP-1A	19	79
353828	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIP-1A	18	62
353829	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	MIP-1A	18	57
353830	20233						RA2159	51112.0										4	MIP-1A	17	71
353831	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	MIP-1A	19	66
353832	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	MIP-1A	17	65
353833	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	MIP-1A	19	44
353834	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIP-1A	20	44
353835	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIP-1A	19	49
353836	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	MIP-1A	17	51
353837	20233						N2586	51107.0										4	MIP-1A	20	76
353838	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	MIP-1A	19.5	86
353839	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	MIP-1A	19.5	62
353840	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	MIP-1A	20	63
353841	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	MIP-1A	20	52
353842	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	MIP-1A	16	37
353843	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	MIP-1A	18.5	46
353844	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	MIP-1A	19	83
353845	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	MIP-1A	20	61
353846	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	MIP-1A	17	57
353847	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	MIP-1A	18.5	48
353848	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	MIP-1A	17	58
353849	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	MIP-1A	17	85
353850	20233						RA2159	51112.0										4	MIP-1A	18	70
353851	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MIP-1A	18	69
353852	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MIP-1A	16.5	60
353853	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MIP-1A	17	65
353854	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MIP-1A	16	55
353855	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MIP-1A	16.5	52
353856	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	MIP-1A	20.5	56
353857	20233						N2586	51107.0										4	MIP-1A	18	78
353858	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MIP-1A	17	64
353859	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MIP-1A	18.5	74
353860	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MIP-1A	19	79
353861	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MIP-1A	18	59
353862	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MIP-1A	16	67
353863	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	MIP-1A	18	77
353864	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	MIP-1A	18	58
353865	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	MIP-1A	24	64
353866	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	MIP-1A	21	67
353867	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIP-1A	19.5	60
353868	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIP-1A	20.5	54
353869	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	MIP-1A	21.5	70
353870	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	MIP-1A	18	48
353871	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	MIP-1A	22.5	56
353872	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	MIP-1A	22.5	74
353873	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	MIP-1A	21.5	60
353874	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIP-1A	20	65
353875	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIP-1A	23	67
353876	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	MIP-1A	21	83
353877	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	MIP-1A	14	69
353878	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	MIP-1A	19	59
353879	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	MIP-1A	17.5	50
353880	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	MIP-1A	15	44
353881	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIP-1A	17.5	52
353882	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIP-1A	15	61
353883	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	MIP-1A	20	69
353884	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	MIP-1A	15	42
353885	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	MIP-1A	19	40
353886	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	MIP-1A	21	47
353887	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	MIP-1A	19.5	58
353888	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIP-1A	19	39
353889	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIP-1A	20	75
353890	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	MIP-1A	15	55
353891	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	MIP-1A	19.5	54
353892	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	MIP-1A	45	45
353893	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	MIP-1A	29	69
353894	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	MIP-1A	42	58
353895	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIP-1A	77	69
353896	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIP-1A	31	41
353897	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	MIP-1A	102.5	60
353898	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	MIP-1A	17.5	54
353899	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	MIP-1A	103	61
353900	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	MIP-1A	99	61
353901	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	MIP-1A	26	52
353902	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIP-1A	99.5	50
353903	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIP-1A	25	51
353904	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	MIP-1A	14.5	60
353905	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	MIP-1A	20	46
353906	20233																	0	MIP-1A	18	40
353907	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	MIP-1A	30.5	68
353908	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	MIP-1A	30	55
353909	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	MIP-1A	30	64
353910	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIP-1A	26.5	70
353911	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIP-1A	23	49
353912	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	MIP-1A	26	62
353913	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	MIP-1A	18	47
353914	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	MIP-1A	41.5	54
353915	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	MIP-1A	35	60
353916	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	MIP-1A	24	69
353917	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIP-1A	35	63
353918	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIP-1A	22.5	48
353919	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	MIP-1A	18	51
353920	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	MIP-1A	15	73
353921	20233																	0	MIP-1A	16	82
353922	20233						RA2159	51112.0										4	MIP-1A	17	72
353923	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MIP-1A	18	49
353924	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MIP-1A	18	76
353925	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MIP-1A	15	54
353926	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MIP-1A	17	65
353927	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MIP-1A	18.5	48
353928	20233						RA2159	51112.0										4	MIP-1A	16	47
353929	20233						N2586	51107.0										4	MIP-1A	17	52
353930	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MIP-1A	17	48
353931	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MIP-1A	18	63
353932	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MIP-1A	16	51
353933	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MIP-1A	16.5	50
353934	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MIP-1A	16	63
353935	20233						N2586	51107.0										4	MIP-1A	17	54
353936	20233								TNF-a	201285.0						100	ng/mL	0	MIP-1A	52	79
353937	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIP-1A	19	65
353938	20233								IL-6	201287.0						100	ug/mL	0	MIP-1A	35	66
353939	20233								IL-17A	201288.0						100	ng/mL	0	MIP-1A	41.5	68
353940	20233								EGF	201289.0						100	ng/mL	0	MIP-1A	17	62
353941	20233								IGF-I	201290.0						100	ug/mL	0	MIP-1A	15.5	56
353942	20233								Adiponectin	201291.0						5	ng/mL	0	MIP-1A	31	65
353943	20233								Leptin	201292.0						1	ng/mL	0	MIP-1A	25	67
353944	20233								Visfatin	201293.0						1	ng/mL	0	MIP-1A	19	47
353945	20233															2	ug/mL	0	MIP-1A	19.5	70
353946	20233								TNF-a	201285.0						100	ng/mL	0	MIP-1A	36	59
353947	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIP-1A	20	44
353948	20233								IL-6	201287.0						100	ug/mL	0	MIP-1A	33	68
353949	20233								IL-17A	201288.0						100	ng/mL	0	MIP-1A	39.5	66
353950	20233								EGF	201289.0						100	ng/mL	0	MIP-1A	18	33
353951	20233								IGF-I	201290.0						100	ug/mL	0	MIP-1A	19	57
353952	20233								Adiponectin	201291.0						5	ng/mL	0	MIP-1A	31.5	48
353953	20233								Leptin	201292.0						1	ng/mL	0	MIP-1A	22	37
353954	20233								Visfatin	201293.0						1	ng/mL	0	MIP-1A	20.5	60
353955	20233															2	ug/mL	0	MIP-1A	16	45
353956	20233								TNF-a	201285.0						100	ng/mL	0	MIP-1A	44	79
353957	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIP-1A	16	66
353958	20233								IL-6	201287.0						100	ug/mL	0	MIP-1A	28.5	68
353959	20233								IL-17A	201288.0						100	ng/mL	0	MIP-1A	34	85
353960	20233								EGF	201289.0						100	ng/mL	0	MIP-1A	15.5	84
353961	20233								IGF-I	201290.0						100	ug/mL	0	MIP-1A	16	53
353962	20233								Adiponectin	201291.0						5	ng/mL	0	MIP-1A	24	66
353963	20233								Leptin	201292.0						1	ng/mL	0	MIP-1A	16.5	62
353964	20233								Visfatin	201293.0						1	ng/mL	0	MIP-1A	16	79
353965	20233															2	ug/mL	0	MIP-1A	17	73
353966	20233								TNF-a	201285.0						100	ng/mL	0	MIP-1A	47	57
353967	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIP-1A	15	56
353968	20233								IL-6	201287.0						100	ug/mL	0	MIP-1A	30	39
353969	20233								IL-17A	201288.0						100	ng/mL	0	MIP-1A	30	66
353970	20233								EGF	201289.0						100	ng/mL	0	MIP-1A	16	69
353971	20233								IGF-I	201290.0						100	ug/mL	0	MIP-1A	17	72
353972	20233								Adiponectin	201291.0						5	ng/mL	0	MIP-1A	25	62
353973	20233								Leptin	201292.0						1	ng/mL	0	MIP-1A	18	54
353974	20233								Visfatin	201293.0						1	ng/mL	0	MIP-1A	15	47
353975	20233															2	ug/mL	0	MIP-1A	17	62
353976	20233																	0	IL-10	28	57
353977	20233						RA2159	51112.0										1	IL-10	48.5	56
353978	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-10	55	67
353979	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-10	71	72
353980	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-10	51	50
353981	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-10	63	55
353982	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-10	58	56
353983	20233						RA2159	51112.0										1	IL-10	65	54
353984	20233						N2586	51107.0										1	IL-10	74	71
353985	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-10	62	57
353986	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-10	63	47
353987	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-10	83	59
353988	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-10	57	69
353989	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-10	53	41
353990	20233						N2586	51107.0										1	IL-10	58.5	28
353991	20233																	0	IL-10	27	48
353992	20233																	0	IL-10	24.5	58
353993	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-10	72	49
353994	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-10	52	50
353995	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-10	51	53
353996	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-10	58.5	50
353997	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-10	66	55
353998	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-10	68	46
353999	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-10	50	57
354000	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-10	97	69
354001	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-10	85	57
354002	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-10	79.5	62
354003	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-10	74	67
354004	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-10	69	48
354005	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-10	70.5	58
354006	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-10	72.5	28
354007	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-10	73	59
354008	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-10	82	77
354009	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-10	44.5	50
354010	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-10	79.5	52
354011	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-10	84	55
354012	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-10	59	69
354013	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-10	47	54
354014	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-10	81	49
354015	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-10	74	53
354016	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-10	66	51
354017	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-10	94	56
354018	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-10	84	61
354019	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-10	87	44
354020	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-10	65	58
354021	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-10	61	63
354022	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-10	56.5	56
354023	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-10	50	69
354024	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-10	64.5	64
354025	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-10	66.5	56
354026	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-10	55	65
354027	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-10	52	38
354028	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-10	81	56
354029	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-10	46	58
354030	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-10	69	57
354031	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-10	70	44
354032	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-10	70	59
354033	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-10	81	56
354034	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-10	64.5	48
354035	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-10	48	55
354036	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-10	54.5	50
354037	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-10	54	63
354038	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-10	62	53
354039	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-10	50	56
354040	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-10	60	57
354041	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-10	88	57
354042	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-10	70	47
354043	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-10	81	62
354044	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-10	65.5	70
354045	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-10	73	53
354046	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-10	64.5	50
354047	20233						RA2159	51112.0										1	IL-10	70	65
354048	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-10	59	57
354049	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-10	61	65
354050	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-10	51	60
354051	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-10	73	47
354052	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-10	53.5	64
354053	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-10	60	45
354054	20233						N2586	51107.0										1	IL-10	72	53
354055	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-10	60.5	42
354056	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-10	75	35
354057	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-10	74	53
354058	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-10	80	43
354059	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-10	79	61
354060	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-10	60	54
354061	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-10	49	60
354062	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-10	55	55
354063	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-10	51.5	54
354064	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-10	44	68
354065	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-10	73	65
354066	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-10	50.5	52
354067	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-10	44.5	66
354068	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-10	76	59
354069	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-10	72	49
354070	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-10	66	51
354071	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-10	57	46
354072	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-10	68	51
354073	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-10	66.5	36
354074	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-10	70	53
354075	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-10	56	58
354076	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-10	49	50
354077	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-10	48	47
354078	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-10	59	57
354079	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-10	64	81
354080	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-10	59	69
354081	20233						RA2159	51112.0										1	IL-10	57.5	60
354082	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-10	59.5	54
354083	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-10	72	44
354084	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-10	65	61
354085	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-10	65	53
354086	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-10	60	57
354087	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-10	72.5	50
354088	20233						N2586	51107.0										1	IL-10	75	55
354089	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-10	53.5	50
354090	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-10	41	60
354091	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-10	46.5	62
354092	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-10	52	43
354093	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-10	52	57
354094	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-10	35.5	56
354095	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-10	56	60
354096	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-10	62	35
354097	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-10	71	49
354098	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-10	51	57
354099	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-10	42	54
354100	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-10	72	47
354101	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-10	42	58
354102	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-10	57	50
354103	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-10	48	59
354104	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-10	69	53
354105	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-10	60.5	60
354106	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-10	47.5	46
354107	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-10	60	43
354108	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-10	68	53
354109	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-10	61.5	72
354110	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-10	43	33
354111	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-10	73	46
354112	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-10	63.5	28
354113	20233						RA2159	51112.0										1	IL-10	58	49
354114	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-10	66	77
354115	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-10	55	57
354116	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-10	63	61
354117	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-10	53.5	62
354118	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-10	51	48
354119	20233						RA2159	51112.0										1	IL-10	51	41
354120	20233						N2586	51107.0										1	IL-10	73	56
354121	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-10	72	64
354122	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-10	84	51
354123	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-10	58	56
354124	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-10	88.5	46
354125	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-10	82.5	66
354126	20233						N2586	51107.0										1	IL-10	77	53
354127	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-10	42	51
354128	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-10	55	65
354129	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-10	54.5	46
354130	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-10	75	50
354131	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-10	63	44
354132	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-10	43.5	56
354133	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-10	52	60
354134	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-10	69	51
354135	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-10	80	57
354136	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-10	51	59
354137	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-10	71.5	54
354138	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-10	58	23
354139	20233																	0	IL-10	27	63
354140	20233						RA2159	51112.0								2	ug/mL	1	IL-10	59	59
354141	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-10	59	48
354142	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-10	62	58
354143	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-10	83.5	36
354144	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-10	64	57
354145	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-10	52	57
354146	20233						N2586	51107.0								2	ug/mL	1	IL-10	68	35
354147	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-10	65	65
354148	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-10	49	43
354149	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-10	97	29
354150	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-10	62.5	44
354151	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-10	85	37
354152	20233																	0	IL-10	25	42
354153	20233						RA2159	51112.0										2	IL-10	46.5	56
354154	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-10	51.5	62
354155	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-10	64	60
354156	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-10	44	61
354157	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-10	50.5	54
354158	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-10	50.5	68
354159	20233						RA2159	51112.0										2	IL-10	49	53
354160	20233						N2586	51107.0										2	IL-10	72.5	44
354161	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-10	45	49
354162	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-10	69.5	54
354163	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-10	52	46
354164	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-10	78	56
354165	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-10	63	39
354166	20233						N2586	51107.0										2	IL-10	69	43
354167	20233																	0	IL-10	24.5	46
354168	20233																	0	IL-10	28	37
354169	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-10	56.5	64
354170	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-10	58	56
354171	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-10	47.5	60
354172	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-10	51	49
354173	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-10	53	50
354174	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-10	57	52
354175	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-10	50	55
354176	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-10	74.5	48
354177	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-10	64.5	54
354178	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-10	67	47
354179	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-10	68	47
354180	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-10	63	33
354181	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-10	87	29
354182	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-10	61	27
354183	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-10	57	67
354184	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-10	57	73
354185	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-10	38	55
354186	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-10	58.5	34
354187	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-10	60	50
354188	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-10	39.5	58
354189	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-10	64	43
354190	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-10	83	37
354191	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-10	55	52
354192	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-10	81	55
354193	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-10	66	67
354194	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-10	85	48
354195	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-10	73	50
354196	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-10	53	39
354197	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-10	62	69
354198	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-10	39	43
354199	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-10	45	65
354200	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-10	48	53
354201	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-10	37	59
354202	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-10	41.5	50
354203	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-10	47.5	38
354204	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-10	52	62
354205	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-10	51.5	70
354206	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-10	54	41
354207	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-10	65.5	54
354208	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-10	56.5	36
354209	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-10	73	45
354210	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-10	72	51
354211	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-10	57.5	62
354212	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-10	49.5	60
354213	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-10	48.5	60
354214	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-10	47	50
354215	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-10	45	61
354216	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-10	50	39
354217	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-10	39	43
354218	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-10	86	57
354219	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-10	78	52
354220	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-10	64	50
354221	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-10	57.5	64
354222	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-10	59	61
354223	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-10	62	59
354224	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-10	60.5	42
354225	20233						RA2159	51112.0										2	IL-10	47	62
354226	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-10	47	49
354227	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-10	53	53
354228	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-10	35	43
354229	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-10	38	52
354230	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-10	45.5	56
354231	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-10	37	52
354232	20233						N2586	51107.0										2	IL-10	69	50
354233	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-10	51.5	42
354234	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-10	52	43
354235	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-10	59.5	56
354236	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-10	49.5	46
354237	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-10	44	46
354238	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-10	70	34
354239	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-10	45.5	50
354240	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-10	53.5	70
354241	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-10	46	50
354242	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-10	37	47
354243	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-10	37	57
354244	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-10	45.5	66
354245	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-10	62.5	66
354246	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-10	61	50
354247	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-10	59	55
354248	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-10	71	47
354249	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-10	55	43
354250	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-10	8	53
354251	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-10	48	76
354252	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-10	53	36
354253	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-10	54.5	58
354254	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-10	50	78
354255	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-10	50	51
354256	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-10	46.5	58
354257	20233						RA2159	51112.0										2	IL-10	47	51
354258	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-10	56.5	58
354259	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-10	60	57
354260	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-10	39.5	50
354261	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-10	62	49
354262	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-10	66	44
354263	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-10	48	42
354264	20233						N2586	51107.0										2	IL-10	7	42
354265	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-10	31	61
354266	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-10	41	57
354267	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-10	38	67
354268	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-10	46.5	76
354269	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-10	46	49
354270	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-10	55	49
354271	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-10	59	56
354272	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-10	38.5	56
354273	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-10	54	59
354274	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-10	42	57
354275	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-10	65	44
354276	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-10	63	36
354277	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-10	49	49
354278	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-10	52	55
354279	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-10	39	59
354280	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-10	40	53
354281	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-10	44	83
354282	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-10	43.5	62
354283	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-10	52.5	82
354284	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-10	59	39
354285	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-10	42.5	48
354286	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-10	55	37
354287	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-10	53	29
354288	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-10	58	57
354289	20233						RA2159	51112.0										2	IL-10	59	54
354290	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-10	49	60
354291	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-10	34	54
354292	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-10	45	48
354293	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-10	46.5	66
354294	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-10	43	53
354295	20233						RA2159	51112.0										2	IL-10	45.5	54
354296	20233						N2586	51107.0										2	IL-10	43	41
354297	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-10	58.5	36
354298	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-10	70	52
354299	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-10	58	31
354300	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-10	52	52
354301	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-10	65	41
354302	20233						N2586	51107.0										2	IL-10	84	51
354303	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-10	41	57
354304	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-10	50	36
354305	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-10	48	57
354306	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-10	50.5	44
354307	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-10	36.5	38
354308	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-10	55.5	34
354309	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-10	66	41
354310	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-10	59.5	42
354311	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-10	37	33
354312	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-10	53	37
354313	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-10	59.5	36
354314	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-10	44	30
354315	20233																	0	IL-10	17	45
354316	20233						RA2159	51112.0								2	ug/mL	2	IL-10	58	38
354317	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-10	35	59
354318	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-10	44	58
354319	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-10	48.5	74
354320	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-10	35	35
354321	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-10	53	39
354322	20233						N2586	51107.0								2	ug/mL	2	IL-10	70	29
354323	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-10	62	35
354324	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-10	78	31
354325	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-10	52	27
354326	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-10	46	33
354327	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-10	63	36
354328	20233																	0	IL-10	28	57
354329	20233						RA2159	51112.0								2	ug/mL	3	IL-10	75.5	50
354330	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-10	81	61
354331	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-10	67	56
354332	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-10	64	47
354333	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-10	88	43
354334	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-10	63	57
354335	20233						N2586	51107.0								2	ug/mL	3	IL-10	94	44
354336	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-10	80	65
354337	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-10	80.5	60
354338	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-10	84	50
354339	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-10	74	64
354340	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-10	94	70
354341	20233						RA2159	51112.0										3	IL-10	75	67
354342	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-10	78	53
354343	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-10	63.5	42
354344	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-10	71	62
354345	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-10	86.5	56
354346	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-10	74	50
354347	20233						RA2159	51112.0										3	IL-10	66	58
354348	20233						N2586	51107.0										3	IL-10	84	52
354349	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-10	77	50
354350	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-10	91	59
354351	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-10	82.5	42
354352	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-10	74	46
354353	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-10	77	55
354354	20233						N2586	51107.0										3	IL-10	104	42
354355	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-10	60.5	50
354356	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-10	62.5	48
354357	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-10	85.5	50
354358	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-10	49	57
354359	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-10	63.5	46
354360	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-10	69	65
354361	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-10	78.5	58
354362	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-10	92	68
354363	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-10	82	67
354364	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-10	75	53
354365	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-10	70.5	62
354366	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-10	81.5	54
354367	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-10	58	59
354368	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-10	72	53
354369	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-10	45	68
354370	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-10	74	71
354371	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-10	53	70
354372	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-10	56.5	82
354373	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-10	79	69
354374	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-10	76	57
354375	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-10	73	61
354376	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-10	67	65
354377	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-10	107	71
354378	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-10	98	50
354379	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-10	65.5	56
354380	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-10	80	49
354381	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-10	59	67
354382	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-10	82	55
354383	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-10	64	59
354384	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-10	71.5	56
354385	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-10	85	67
354386	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-10	79	69
354387	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-10	88.5	58
354388	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-10	99.5	64
354389	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-10	87	67
354390	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-10	105	50
354391	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-10	64	68
354392	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-10	67.5	68
354393	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-10	64	51
354394	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-10	66	63
354395	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-10	63	72
354396	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-10	69	59
354397	20233						RA2159	51112.0										3	IL-10	74	54
354398	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-10	76.5	56
354399	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-10	75	47
354400	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-10	71.5	50
354401	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-10	112	64
354402	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-10	89	63
354403	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-10	94	55
354404	20233						N2586	51107.0										3	IL-10	75	53
354405	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-10	73.5	58
354406	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-10	76	40
354407	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-10	60	55
354408	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-10	75	50
354409	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-10	34	61
354410	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-10	59.5	48
354411	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-10	67	50
354412	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-10	95.5	60
354413	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-10	96	65
354414	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-10	80	49
354415	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-10	98	60
354416	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-10	85	60
354417	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-10	31	66
354418	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-10	52	30
354419	20233						RA2159	51112.0										3	IL-10	52	56
354420	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-10	72.5	48
354421	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-10	73	55
354422	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-10	60	65
354423	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-10	63.5	60
354424	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-10	51	45
354425	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-10	65	59
354426	20233						N2586	51107.0										3	IL-10	58	57
354427	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-10	88.5	50
354428	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-10	60	53
354429	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-10	83	60
354430	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-10	84	41
354431	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-10	65.5	54
354432	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-10	83	51
354433	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-10	56.5	64
354434	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-10	82.5	58
354435	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-10	66	64
354436	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-10	62	55
354437	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-10	52.5	60
354438	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-10	67	53
354439	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-10	79	69
354440	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-10	73	71
354441	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-10	25	75
354442	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-10	65	63
354443	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-10	80.5	54
354444	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-10	78	47
354445	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-10	52.5	40
354446	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-10	81	57
354447	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-10	62	59
354448	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-10	73	61
354449	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-10	57	53
354450	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-10	64	59
354451	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-10	60.5	58
354452	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-10	75.5	74
354453	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-10	72.5	54
354454	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-10	69	60
354455	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-10	103	69
354456	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-10	92	58
354457	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-10	60	71
354458	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-10	71	54
354459	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-10	89	59
354460	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-10	75.5	62
354461	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-10	64	47
354462	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-10	95	48
354463	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-10	86	58
354464	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-10	46	59
354465	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-10	64	52
354466	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-10	105.5	72
354467	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-10	83	66
354468	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-10	97	69
354469	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-10	112.5	52
354470	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-10	71	52
354471	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-10	88	58
354472	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-10	83	79
354473	20233																	0	IL-10	24	50
354474	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-10	71.5	50
354475	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-10	114	35
354476	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-10	55.5	64
354477	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-10	84	61
354478	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-10	69	67
354479	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-10	64	59
354480	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-10	69	65
354481	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-10	72.5	52
354482	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-10	70	39
354483	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-10	95.5	68
354484	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-10	45	56
354485	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-10	97.5	54
354486	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-10	109	59
354487	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-10	84	59
354488	20233																	0	IL-10	27	43
354489	20233						RA2159	51112.0										3	IL-10	51	49
354490	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-10	75	59
354491	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-10	72	53
354492	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-10	65	55
354493	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-10	82.5	32
354494	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-10	59	70
354495	20233						RA2159	51112.0										3	IL-10	63	57
354496	20233						N2586	51107.0										3	IL-10	82	57
354497	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-10	92	51
354498	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-10	80	54
354499	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-10	76.5	54
354500	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-10	92	47
354501	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-10	71	57
354502	20233						N2586	51107.0										3	IL-10	55	28
354503	20233																	0	IL-10	23.5	60
354504	20233						RA2159	51112.0								2	ug/mL	4	IL-10	91	57
354505	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-10	80	49
354506	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-10	70.5	54
354507	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-10	77	63
354508	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-10	72	59
354509	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-10	91	53
354510	20233						N2586	51107.0								2	ug/mL	4	IL-10	87.5	62
354511	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-10	86.5	56
354512	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-10	82	63
354513	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-10	88	50
354514	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-10	114	57
354515	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-10	48.5	56
354516	20233						RA2159	51112.0										4	IL-10	61	62
354517	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-10	68.5	72
354518	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-10	74	50
354519	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-10	69	63
354520	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-10	75	51
354521	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-10	51	50
354522	20233						RA2159	51112.0										4	IL-10	70.5	50
354523	20233						N2586	51107.0										4	IL-10	71	66
354524	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-10	51	50
354525	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-10	50	39
354526	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-10	98.5	42
354527	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-10	87	53
354528	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-10	64	55
354529	20233						N2586	51107.0										4	IL-10	77	67
354530	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-10	82.5	48
354531	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-10	74	49
354532	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-10	81	59
354533	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-10	66.5	66
354534	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-10	65	50
354535	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-10	68	60
354536	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-10	84	67
354537	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-10	87	52
354538	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-10	82	66
354539	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-10	107	47
354540	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-10	75	51
354541	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-10	45	51
354542	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-10	74	58
354543	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-10	61	75
354544	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-10	64.5	60
354545	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-10	60.5	62
354546	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-10	75	53
354547	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-10	73	57
354548	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-10	69	44
354549	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-10	127.5	44
354550	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-10	68	61
354551	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-10	76	65
354552	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-10	62	51
354553	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-10	71	69
354554	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-10	73	72
354555	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-10	75	65
354556	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-10	69	65
354557	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-10	81	51
354558	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-10	69	50
354559	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-10	71	40
354560	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-10	64.5	62
354561	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-10	83	49
354562	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-10	95.5	46
354563	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-10	78	61
354564	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-10	88	45
354565	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-10	64	61
354566	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-10	77	54
354567	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-10	71	47
354568	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-10	72.5	62
354569	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-10	59	57
354570	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-10	49	41
354571	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-10	85	43
354572	20233						RA2159	51112.0										4	IL-10	87	53
354573	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-10	68.5	68
354574	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-10	72	51
354575	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-10	97	71
354576	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-10	85	39
354577	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-10	86	49
354578	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-10	56	53
354579	20233						N2586	51107.0										4	IL-10	115	67
354580	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-10	55.5	54
354581	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-10	60	51
354582	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-10	64	51
354583	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-10	68.5	36
354584	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-10	68	42
354585	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-10	66	39
354586	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-10	109	50
354587	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-10	101	48
354588	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-10	86	53
354589	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-10	75	33
354590	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-10	91	36
354591	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-10	79	59
354592	20233						RA2159	51112.0										4	IL-10	51	56
354593	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-10	55	61
354594	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-10	65.5	50
354595	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-10	80	50
354596	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-10	63	45
354597	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-10	52	39
354598	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-10	55	53
354599	20233						N2586	51107.0										4	IL-10	74	56
354600	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-10	75.5	50
354601	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-10	87	66
354602	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-10	89	45
354603	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-10	88	53
354604	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-10	66.5	50
354605	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-10	76	53
354606	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-10	56	61
354607	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-10	47.5	66
354608	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-10	65	47
354609	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-10	65	49
354610	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-10	67.5	58
354611	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-10	66	63
354612	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-10	52	57
354613	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-10	66.5	50
354614	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-10	75	59
354615	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-10	88	61
354616	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-10	87	63
354617	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-10	56	42
354618	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-10	73	41
354619	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-10	68	48
354620	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-10	63	45
354621	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-10	52	39
354622	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-10	34	31
354623	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-10	83	41
354624	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-10	56	45
354625	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-10	69	49
354626	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-10	37	35
354627	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-10	97	41
354628	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-10	64	47
354629	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-10	68	47
354630	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-10	74.5	32
354631	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-10	78	50
354632	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-10	53	52
354633	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-10	74.5	48
354634	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-10	90	48
354635	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-10	74	53
354636	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-10	69.5	50
354637	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-10	97	52
354638	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-10	85.5	34
354639	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-10	78	38
354640	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-10	70.5	38
354641	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-10	97	58
354642	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-10	109	58
354643	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-10	102	40
354644	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-10	102.5	44
354645	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-10	91.5	44
354646	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-10	92	41
354647	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-10	86	34
354648	20233																	0	IL-10	27	31
354649	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-10	62	67
354650	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-10	63	51
354651	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-10	73	53
354652	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-10	58	50
354653	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-10	73	48
354654	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-10	75	41
354655	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-10	70	49
354656	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-10	105	59
354657	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-10	83	45
354658	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-10	80.5	52
354659	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-10	104	37
354660	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-10	85	40
354661	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-10	67	33
354662	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-10	74	67
354663	20233																	0	IL-10	26	59
354664	20233						RA2159	51112.0										4	IL-10	49	57
354665	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-10	64	75
354666	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-10	63	69
354667	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-10	62	41
354668	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-10	75	50
354669	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-10	74	54
354670	20233						RA2159	51112.0										4	IL-10	62	61
354671	20233						N2586	51107.0										4	IL-10	76.5	52
354672	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-10	83	45
354673	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-10	94	51
354674	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-10	78	45
354675	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-10	83	42
354676	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-10	69	48
354677	20233						N2586	51107.0										4	IL-10	75.5	44
354678	20233								TNF-a	201285.0						100	ng/mL	0	IL-10	31	69
354679	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-10	21	57
354680	20233								IL-6	201287.0						100	ug/mL	0	IL-10	32	56
354681	20233								IL-17A	201288.0						100	ng/mL	0	IL-10	34	58
354682	20233								EGF	201289.0						100	ng/mL	0	IL-10	26	67
354683	20233								IGF-I	201290.0						100	ug/mL	0	IL-10	25	57
354684	20233								Adiponectin	201291.0						5	ng/mL	0	IL-10	34	65
354685	20233								Leptin	201292.0						1	ng/mL	0	IL-10	27	43
354686	20233								Visfatin	201293.0						1	ng/mL	0	IL-10	25	60
354687	20233															2	ug/mL	0	IL-10	29	59
354688	20233								TNF-a	201285.0						100	ng/mL	0	IL-10	28	67
354689	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-10	27	40
354690	20233								IL-6	201287.0						100	ug/mL	0	IL-10	25.5	52
354691	20233								IL-17A	201288.0						100	ng/mL	0	IL-10	29	60
354692	20233								EGF	201289.0						100	ng/mL	0	IL-10	30	51
354693	20233								IGF-I	201290.0						100	ug/mL	0	IL-10	30	47
354694	20233								Adiponectin	201291.0						5	ng/mL	0	IL-10	32	37
354695	20233								Leptin	201292.0						1	ng/mL	0	IL-10	27.5	40
354696	20233								Visfatin	201293.0						1	ng/mL	0	IL-10	30	43
354697	20233															2	ug/mL	0	IL-10	25.5	40
354698	20233								TNF-a	201285.0						100	ng/mL	0	IL-10	30	50
354699	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-10	25.5	60
354700	20233								IL-6	201287.0						100	ug/mL	0	IL-10	32	55
354701	20233								IL-17A	201288.0						100	ng/mL	0	IL-10	28	60
354702	20233								EGF	201289.0						100	ng/mL	0	IL-10	26	61
354703	20233								IGF-I	201290.0						100	ug/mL	0	IL-10	21	57
354704	20233								Adiponectin	201291.0						5	ng/mL	0	IL-10	26	63
354705	20233								Leptin	201292.0						1	ng/mL	0	IL-10	24.5	40
354706	20233								Visfatin	201293.0						1	ng/mL	0	IL-10	22	50
354707	20233															2	ug/mL	0	IL-10	28	49
354708	20233								TNF-a	201285.0						100	ng/mL	0	IL-10	30	47
354709	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-10	21	52
354710	20233								IL-6	201287.0						100	ug/mL	0	IL-10	27.5	40
354711	20233								IL-17A	201288.0						100	ng/mL	0	IL-10	34	50
354712	20233								EGF	201289.0						100	ng/mL	0	IL-10	20	60
354713	20233								IGF-I	201290.0						100	ug/mL	0	IL-10	20.5	68
354714	20233								Adiponectin	201291.0						5	ng/mL	0	IL-10	29	55
354715	20233								Leptin	201292.0						1	ng/mL	0	IL-10	25.5	38
354716	20233								Visfatin	201293.0						1	ng/mL	0	IL-10	22	39
354717	20233															2	ug/mL	0	IL-10	22.5	56
354718	20233																	0	G-CSF	11	56
354719	20233						RA2159	51112.0										1	G-CSF	13	80
354720	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	G-CSF	10	56
354721	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	G-CSF	13	89
354722	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	G-CSF	11	67
354723	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	G-CSF	13	82
354724	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	G-CSF	9	61
354725	20233						RA2159	51112.0										1	G-CSF	14	62
354726	20233						N2586	51107.0										1	G-CSF	10	59
354727	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	G-CSF	15.5	50
354728	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	G-CSF	12	48
354729	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	G-CSF	12	71
354730	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	G-CSF	11	68
354731	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	G-CSF	13	54
354732	20233						N2586	51107.0										1	G-CSF	14	35
354733	20233																	0	G-CSF	10	68
354734	20233																	0	G-CSF	12	58
354735	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	G-CSF	23	58
354736	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	G-CSF	20	63
354737	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	G-CSF	19	62
354738	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	G-CSF	20	75
354739	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	G-CSF	21	57
354740	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	G-CSF	15	59
354741	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	G-CSF	14	52
354742	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	G-CSF	29.5	50
354743	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	G-CSF	25	60
354744	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	G-CSF	22	72
354745	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	G-CSF	24.5	64
354746	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	G-CSF	32	57
354747	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	G-CSF	22	62
354748	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	G-CSF	12	36
354749	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	G-CSF	232	61
354750	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	G-CSF	28	63
354751	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	G-CSF	21	63
354752	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	G-CSF	255	67
354753	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	G-CSF	390	55
354754	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	G-CSF	13	55
354755	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	G-CSF	9.5	62
354756	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	G-CSF	1054	55
354757	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	G-CSF	170.5	64
354758	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	G-CSF	143.5	84
354759	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	G-CSF	760	62
354760	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	G-CSF	665	54
354761	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	G-CSF	33	38
354762	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	G-CSF	13	64
354763	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	G-CSF	14	80
354764	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	G-CSF	15	69
354765	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	G-CSF	12	97
354766	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	G-CSF	14	80
354767	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	G-CSF	14	81
354768	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	G-CSF	12.5	70
354769	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	G-CSF	10	81
354770	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	G-CSF	14	73
354771	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	G-CSF	13	54
354772	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	G-CSF	13	49
354773	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	G-CSF	17	54
354774	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	G-CSF	15	55
354775	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	G-CSF	18	63
354776	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	G-CSF	13.5	56
354777	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	G-CSF	16	59
354778	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	G-CSF	13	75
354779	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	G-CSF	11	65
354780	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	G-CSF	13	73
354781	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	G-CSF	14	69
354782	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	G-CSF	16	77
354783	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	G-CSF	14.5	64
354784	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	G-CSF	19	59
354785	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	G-CSF	15	59
354786	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	G-CSF	14	76
354787	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	G-CSF	15.5	48
354788	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	G-CSF	16	85
354789	20233						RA2159	51112.0										1	G-CSF	12	76
354790	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	G-CSF	12.5	64
354791	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	G-CSF	13	74
354792	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	G-CSF	10	51
354793	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	G-CSF	11	57
354794	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	G-CSF	10	72
354795	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	G-CSF	9	57
354796	20233						N2586	51107.0										1	G-CSF	10	54
354797	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	G-CSF	14	47
354798	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	G-CSF	13	43
354799	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	G-CSF	12	65
354800	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	G-CSF	13	47
354801	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	G-CSF	14	65
354802	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	G-CSF	16	74
354803	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	G-CSF	11	65
354804	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	G-CSF	10	49
354805	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	G-CSF	10	55
354806	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	G-CSF	11.5	58
354807	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	G-CSF	11	64
354808	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	G-CSF	11	56
354809	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	G-CSF	12	68
354810	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	G-CSF	11	80
354811	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	G-CSF	11	50
354812	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	G-CSF	10	68
354813	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	G-CSF	14	49
354814	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	G-CSF	11	64
354815	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	G-CSF	14	36
354816	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	G-CSF	16	69
354817	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	G-CSF	15	67
354818	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	G-CSF	10.5	52
354819	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	G-CSF	10	66
354820	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	G-CSF	11	78
354821	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	G-CSF	10	78
354822	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	G-CSF	12	69
354823	20233						RA2159	51112.0										1	G-CSF	12	89
354824	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	G-CSF	11	61
354825	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	G-CSF	15	44
354826	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	G-CSF	10.5	56
354827	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	G-CSF	9	45
354828	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	G-CSF	14	48
354829	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	G-CSF	11	69
354830	20233						N2586	51107.0										1	G-CSF	20.5	78
354831	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	G-CSF	14.5	62
354832	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	G-CSF	12	73
354833	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	G-CSF	12	69
354834	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	G-CSF	15	72
354835	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	G-CSF	12	77
354836	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	G-CSF	11	60
354837	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	G-CSF	12	59
354838	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	G-CSF	12	51
354839	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	G-CSF	16.5	30
354840	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	G-CSF	12	58
354841	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	G-CSF	14	56
354842	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	G-CSF	15.5	50
354843	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	G-CSF	12	63
354844	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	G-CSF	11	47
354845	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	G-CSF	12	57
354846	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	G-CSF	11	77
354847	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	G-CSF	10	61
354848	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	G-CSF	10	65
354849	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	G-CSF	11	54
354850	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	G-CSF	12	35
354851	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	G-CSF	11.5	62
354852	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	G-CSF	10	52
354853	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	G-CSF	14	54
354854	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	G-CSF	11	38
354855	20233						RA2159	51112.0										1	G-CSF	13	63
354856	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	G-CSF	10	73
354857	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	G-CSF	12	76
354858	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	G-CSF	9	60
354859	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	G-CSF	11	65
354860	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	G-CSF	10	60
354861	20233						RA2159	51112.0										1	G-CSF	10	89
354862	20233						N2586	51107.0										1	G-CSF	12	77
354863	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	G-CSF	12	50
354864	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	G-CSF	12	77
354865	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	G-CSF	12	67
354866	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	G-CSF	9	61
354867	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	G-CSF	10	63
354868	20233						N2586	51107.0										1	G-CSF	13	63
354869	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	G-CSF	12	60
354870	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	G-CSF	13	67
354871	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	G-CSF	12	63
354872	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	G-CSF	9	77
354873	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	G-CSF	10	45
354874	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	G-CSF	9	61
354875	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	G-CSF	10.5	66
354876	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	G-CSF	11	58
354877	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	G-CSF	11	54
354878	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	G-CSF	7	59
354879	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	G-CSF	11	51
354880	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	G-CSF	10	37
354881	20233																	0	G-CSF	12	56
354882	20233						RA2159	51112.0								2	ug/mL	1	G-CSF	19	57
354883	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	G-CSF	17.5	42
354884	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	G-CSF	12	62
354885	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	G-CSF	16	37
354886	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	G-CSF	17	77
354887	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	G-CSF	13	70
354888	20233						N2586	51107.0								2	ug/mL	1	G-CSF	25	45
354889	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	G-CSF	23.5	50
354890	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	G-CSF	13.5	58
354891	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	G-CSF	20	47
354892	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	G-CSF	13	41
354893	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	G-CSF	16	39
354894	20233																	0	G-CSF	12	62
354895	20233						RA2159	51112.0										2	G-CSF	11.5	68
354896	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	G-CSF	11	95
354897	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	G-CSF	17	69
354898	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	G-CSF	14	46
354899	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	G-CSF	10	55
354900	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	G-CSF	9	76
354901	20233						RA2159	51112.0										2	G-CSF	11	44
354902	20233						N2586	51107.0										2	G-CSF	17	43
354903	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	G-CSF	13	49
354904	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	G-CSF	10	70
354905	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	G-CSF	14	33
354906	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	G-CSF	11	50
354907	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	G-CSF	12	69
354908	20233						N2586	51107.0										2	G-CSF	12	47
354909	20233																	0	G-CSF	9	48
354910	20233																	0	G-CSF	9	47
354911	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	G-CSF	21	65
354912	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	G-CSF	30	80
354913	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	G-CSF	22	55
354914	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	G-CSF	19	53
354915	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	G-CSF	15	57
354916	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	G-CSF	17	64
354917	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	G-CSF	11	55
354918	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	G-CSF	31	63
354919	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	G-CSF	28	69
354920	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	G-CSF	36	70
354921	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	G-CSF	25	66
354922	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	G-CSF	23	39
354923	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	G-CSF	37	39
354924	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	G-CSF	12	56
354925	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	G-CSF	201	73
354926	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	G-CSF	96.5	64
354927	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	G-CSF	114	57
354928	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	G-CSF	285	67
354929	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	G-CSF	273	55
354930	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	G-CSF	139.5	78
354931	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	G-CSF	14	51
354932	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	G-CSF	464.5	56
354933	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	G-CSF	108.5	60
354934	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	G-CSF	296	66
354935	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	G-CSF	642.5	68
354936	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	G-CSF	746	52
354937	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	G-CSF	425	48
354938	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	G-CSF	11	56
354939	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	G-CSF	11	85
354940	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	G-CSF	14.5	50
354941	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	G-CSF	12	59
354942	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	G-CSF	13	77
354943	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	G-CSF	10.5	68
354944	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	G-CSF	12	69
354945	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	G-CSF	13	48
354946	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	G-CSF	11	72
354947	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	G-CSF	12	77
354948	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	G-CSF	11	63
354949	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	G-CSF	12	47
354950	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	G-CSF	12	51
354951	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	G-CSF	16	48
354952	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	G-CSF	10	47
354953	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	G-CSF	12	71
354954	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	G-CSF	14	72
354955	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	G-CSF	14	76
354956	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	G-CSF	16	66
354957	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	G-CSF	13	58
354958	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	G-CSF	12	47
354959	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	G-CSF	10	70
354960	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	G-CSF	13	51
354961	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	G-CSF	15.5	66
354962	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	G-CSF	12	59
354963	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	G-CSF	16	81
354964	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	G-CSF	12.5	70
354965	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	G-CSF	15.5	62
354966	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	G-CSF	12	45
354967	20233						RA2159	51112.0										2	G-CSF	11	61
354968	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	G-CSF	12	63
354969	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	G-CSF	12	57
354970	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	G-CSF	14	39
354971	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	G-CSF	8	64
354972	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	G-CSF	10	75
354973	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	G-CSF	9	51
354974	20233						N2586	51107.0										2	G-CSF	10	45
354975	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	G-CSF	11	55
354976	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	G-CSF	11	73
354977	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	G-CSF	12	68
354978	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	G-CSF	12	67
354979	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	G-CSF	13	36
354980	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	G-CSF	10	52
354981	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	G-CSF	13	52
354982	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	G-CSF	15	63
354983	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	G-CSF	12	70
354984	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	G-CSF	10	69
354985	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	G-CSF	10	73
354986	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	G-CSF	9	65
354987	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	G-CSF	12	101
354988	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	G-CSF	13	69
354989	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	G-CSF	11.5	74
354990	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	G-CSF	11	66
354991	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	G-CSF	10	61
354992	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	G-CSF	7	79
354993	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	G-CSF	9	71
354994	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	G-CSF	10	43
354995	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	G-CSF	11	87
354996	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	G-CSF	11	80
354997	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	G-CSF	9	83
354998	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	G-CSF	9	84
354999	20233						RA2159	51112.0										2	G-CSF	9.5	76
355000	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	G-CSF	11	78
355001	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	G-CSF	11	59
355002	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	G-CSF	13	52
355003	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	G-CSF	10	57
355004	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	G-CSF	10	53
355005	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	G-CSF	15	45
355006	20233						N2586	51107.0										2	G-CSF	5	54
355007	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	G-CSF	12.5	80
355008	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	G-CSF	15	64
355009	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	G-CSF	13	53
355010	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	G-CSF	12	87
355011	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	G-CSF	11	80
355012	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	G-CSF	12.5	62
355013	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	G-CSF	13	68
355014	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	G-CSF	11	51
355015	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	G-CSF	13	52
355016	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	G-CSF	12	56
355017	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	G-CSF	11	41
355018	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	G-CSF	13	47
355019	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	G-CSF	13	75
355020	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	G-CSF	10	51
355021	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	G-CSF	11	70
355022	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	G-CSF	10	65
355023	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	G-CSF	9	84
355024	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	G-CSF	10	74
355025	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	G-CSF	13	83
355026	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	G-CSF	12	43
355027	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	G-CSF	11	58
355028	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	G-CSF	14	55
355029	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	G-CSF	8	53
355030	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	G-CSF	13	66
355031	20233						RA2159	51112.0										2	G-CSF	10	79
355032	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	G-CSF	11.5	76
355033	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	G-CSF	8	69
355034	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	G-CSF	11	65
355035	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	G-CSF	10	79
355036	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	G-CSF	8	60
355037	20233						RA2159	51112.0										2	G-CSF	11	50
355038	20233						N2586	51107.0										2	G-CSF	10	54
355039	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	G-CSF	13	63
355040	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	G-CSF	11	76
355041	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	G-CSF	9	39
355042	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	G-CSF	13	46
355043	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	G-CSF	11	50
355044	20233						N2586	51107.0										2	G-CSF	10	49
355045	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	G-CSF	10	61
355046	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	G-CSF	10	59
355047	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	G-CSF	12	60
355048	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	G-CSF	10	49
355049	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	G-CSF	8	41
355050	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	G-CSF	8	51
355051	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	G-CSF	13	27
355052	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	G-CSF	12.5	52
355053	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	G-CSF	11	44
355054	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	G-CSF	12	26
355055	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	G-CSF	9	36
355056	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	G-CSF	11	35
355057	20233																	0	G-CSF	10	41
355058	20233						RA2159	51112.0								2	ug/mL	2	G-CSF	22	68
355059	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	G-CSF	15.5	50
355060	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	G-CSF	15	65
355061	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	G-CSF	13.5	64
355062	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	G-CSF	12	45
355063	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	G-CSF	18.5	36
355064	20233						N2586	51107.0								2	ug/mL	2	G-CSF	24.5	34
355065	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	G-CSF	15	26
355066	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	G-CSF	24.5	40
355067	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	G-CSF	13	37
355068	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	G-CSF	10.5	28
355069	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	G-CSF	16	42
355070	20233																	0	G-CSF	11	53
355071	20233						RA2159	51112.0								2	ug/mL	3	G-CSF	19	58
355072	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	G-CSF	21	89
355073	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	G-CSF	14	50
355074	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	G-CSF	20	75
355075	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	G-CSF	17	67
355076	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	G-CSF	12	82
355077	20233						N2586	51107.0								2	ug/mL	3	G-CSF	36	77
355078	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	G-CSF	23	52
355079	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	G-CSF	33	79
355080	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	G-CSF	32	61
355081	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	G-CSF	13	62
355082	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	G-CSF	18.5	72
355083	20233						RA2159	51112.0										3	G-CSF	9.5	72
355084	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	G-CSF	8.5	50
355085	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	G-CSF	12.5	66
355086	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	G-CSF	9.5	58
355087	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	G-CSF	9	77
355088	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	G-CSF	9	75
355089	20233						RA2159	51112.0										3	G-CSF	11	89
355090	20233						N2586	51107.0										3	G-CSF	8.5	52
355091	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	G-CSF	11	62
355092	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	G-CSF	11	59
355093	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	G-CSF	12	60
355094	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	G-CSF	12	73
355095	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	G-CSF	11	54
355096	20233						N2586	51107.0										3	G-CSF	13	53
355097	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	G-CSF	14	64
355098	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	G-CSF	12	69
355099	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	G-CSF	10.5	64
355100	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	G-CSF	12	74
355101	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	G-CSF	10	72
355102	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	G-CSF	11	73
355103	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	G-CSF	12	50
355104	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	G-CSF	12	73
355105	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	G-CSF	13	71
355106	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	G-CSF	14	46
355107	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	G-CSF	10	65
355108	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	G-CSF	10	67
355109	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	G-CSF	11.5	76
355110	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	G-CSF	13	83
355111	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	G-CSF	10	75
355112	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	G-CSF	12	82
355113	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	G-CSF	10	90
355114	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	G-CSF	11	96
355115	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	G-CSF	12	92
355116	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	G-CSF	10	66
355117	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	G-CSF	10	87
355118	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	G-CSF	13	70
355119	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	G-CSF	11	66
355120	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	G-CSF	12	57
355121	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	G-CSF	13	58
355122	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	G-CSF	13	87
355123	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	G-CSF	11	70
355124	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	G-CSF	11.5	64
355125	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	G-CSF	10	90
355126	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	G-CSF	13	83
355127	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	G-CSF	15	80
355128	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	G-CSF	18	59
355129	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	G-CSF	13	59
355130	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	G-CSF	12.5	90
355131	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	G-CSF	13.5	72
355132	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	G-CSF	13	64
355133	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	G-CSF	11	52
355134	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	G-CSF	10	97
355135	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	G-CSF	9	78
355136	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	G-CSF	9	64
355137	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	G-CSF	10	76
355138	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	G-CSF	10	62
355139	20233						RA2159	51112.0										3	G-CSF	10	69
355140	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	G-CSF	9	89
355141	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	G-CSF	12	50
355142	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	G-CSF	12	69
355143	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	G-CSF	11	70
355144	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	G-CSF	10	93
355145	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	G-CSF	10.5	70
355146	20233						N2586	51107.0										3	G-CSF	10.5	70
355147	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	G-CSF	8.5	60
355148	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	G-CSF	12	59
355149	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	G-CSF	10	61
355150	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	G-CSF	9	52
355151	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	G-CSF	8	70
355152	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	G-CSF	10	75
355153	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	G-CSF	8	71
355154	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	G-CSF	12	79
355155	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	G-CSF	13	84
355156	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	G-CSF	12	63
355157	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	G-CSF	11	64
355158	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	G-CSF	11.5	62
355159	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	G-CSF	10	74
355160	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	G-CSF	8	42
355161	20233						RA2159	51112.0										3	G-CSF	11	73
355162	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	G-CSF	14	68
355163	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	G-CSF	10	64
355164	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	G-CSF	10	80
355165	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	G-CSF	10	73
355166	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	G-CSF	11	56
355167	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	G-CSF	11	69
355168	20233						N2586	51107.0										3	G-CSF	13	82
355169	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	G-CSF	11.5	82
355170	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	G-CSF	11	67
355171	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	G-CSF	15	68
355172	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	G-CSF	11	64
355173	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	G-CSF	13	70
355174	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	G-CSF	10	68
355175	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	G-CSF	11	69
355176	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	G-CSF	11	69
355177	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	G-CSF	12	78
355178	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	G-CSF	13.5	68
355179	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	G-CSF	13	67
355180	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	G-CSF	11	67
355181	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	G-CSF	15	67
355182	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	G-CSF	12.5	78
355183	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	G-CSF	10	86
355184	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	G-CSF	17	57
355185	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	G-CSF	12.5	74
355186	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	G-CSF	16	47
355187	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	G-CSF	12	75
355188	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	G-CSF	14	68
355189	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	G-CSF	11	71
355190	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	G-CSF	11	63
355191	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	G-CSF	11.5	72
355192	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	G-CSF	9	77
355193	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	G-CSF	10	75
355194	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	G-CSF	13	112
355195	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	G-CSF	13.5	68
355196	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	G-CSF	11	77
355197	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	G-CSF	10	88
355198	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	G-CSF	13	65
355199	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	G-CSF	11.5	72
355200	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	G-CSF	11.5	56
355201	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	G-CSF	368	60
355202	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	G-CSF	34	67
355203	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	G-CSF	21	75
355204	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	G-CSF	262.5	76
355205	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	G-CSF	348	68
355206	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	G-CSF	13	64
355207	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	G-CSF	10	80
355208	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	G-CSF	834.5	84
355209	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	G-CSF	138	71
355210	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	G-CSF	564	83
355211	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	G-CSF	939	73
355212	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	G-CSF	39.5	56
355213	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	G-CSF	517	83
355214	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	G-CSF	10.5	86
355215	20233																	0	G-CSF	10.5	44
355216	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	G-CSF	18	61
355217	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	G-CSF	23	48
355218	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	G-CSF	20	79
355219	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	G-CSF	18	71
355220	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	G-CSF	22	80
355221	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	G-CSF	13	56
355222	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	G-CSF	12	55
355223	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	G-CSF	26.5	84
355224	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	G-CSF	25.5	68
355225	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	G-CSF	35	72
355226	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	G-CSF	17	66
355227	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	G-CSF	15	64
355228	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	G-CSF	30.5	76
355229	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	G-CSF	9	52
355230	20233																	0	G-CSF	11.5	52
355231	20233						RA2159	51112.0										3	G-CSF	9	68
355232	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	G-CSF	10	63
355233	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	G-CSF	9.5	76
355234	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	G-CSF	8	75
355235	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	G-CSF	8	38
355236	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	G-CSF	11	66
355237	20233						RA2159	51112.0										3	G-CSF	9.5	62
355238	20233						N2586	51107.0										3	G-CSF	16	69
355239	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	G-CSF	11.5	82
355240	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	G-CSF	10	68
355241	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	G-CSF	10.5	40
355242	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	G-CSF	10	51
355243	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	G-CSF	7	47
355244	20233						N2586	51107.0										3	G-CSF	9	35
355245	20233																	0	G-CSF	12	40
355246	20233						RA2159	51112.0								2	ug/mL	4	G-CSF	32.5	70
355247	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	G-CSF	20	60
355248	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	G-CSF	26	79
355249	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	G-CSF	21	60
355250	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	G-CSF	15.5	58
355251	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	G-CSF	27	59
355252	20233						N2586	51107.0								2	ug/mL	4	G-CSF	33	75
355253	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	G-CSF	21	79
355254	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	G-CSF	13	59
355255	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	G-CSF	16	77
355256	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	G-CSF	16	63
355257	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	G-CSF	9.5	48
355258	20233						RA2159	51112.0										4	G-CSF	10	66
355259	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	G-CSF	10.5	70
355260	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	G-CSF	10	68
355261	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	G-CSF	11	63
355262	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	G-CSF	12	45
355263	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	G-CSF	11	76
355264	20233						RA2159	51112.0										4	G-CSF	9	63
355265	20233						N2586	51107.0										4	G-CSF	9	60
355266	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	G-CSF	12	58
355267	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	G-CSF	10.5	48
355268	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	G-CSF	11	47
355269	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	G-CSF	11.5	54
355270	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	G-CSF	10	74
355271	20233						N2586	51107.0										4	G-CSF	12.5	64
355272	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	G-CSF	12	51
355273	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	G-CSF	10.5	52
355274	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	G-CSF	12	72
355275	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	G-CSF	11	76
355276	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	G-CSF	10	81
355277	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	G-CSF	10	55
355278	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	G-CSF	14	74
355279	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	G-CSF	11	43
355280	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	G-CSF	9	64
355281	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	G-CSF	12	51
355282	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	G-CSF	15	49
355283	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	G-CSF	12	61
355284	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	G-CSF	12	65
355285	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	G-CSF	11	61
355286	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	G-CSF	12	75
355287	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	G-CSF	10	75
355288	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	G-CSF	12	61
355289	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	G-CSF	12	67
355290	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	G-CSF	12	46
355291	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	G-CSF	13	43
355292	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	G-CSF	10	60
355293	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	G-CSF	11	75
355294	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	G-CSF	12	58
355295	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	G-CSF	10	85
355296	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	G-CSF	12	79
355297	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	G-CSF	12	61
355298	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	G-CSF	13.5	64
355299	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	G-CSF	11	66
355300	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	G-CSF	12	60
355301	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	G-CSF	13	45
355302	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	G-CSF	12	52
355303	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	G-CSF	15	50
355304	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	G-CSF	14	41
355305	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	G-CSF	12.5	52
355306	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	G-CSF	13	49
355307	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	G-CSF	12	80
355308	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	G-CSF	14	72
355309	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	G-CSF	10	41
355310	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	G-CSF	14	77
355311	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	G-CSF	13	72
355312	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	G-CSF	10	58
355313	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	G-CSF	11	51
355314	20233						RA2159	51112.0										4	G-CSF	11	63
355315	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	G-CSF	8	71
355316	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	G-CSF	12	63
355317	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	G-CSF	11	76
355318	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	G-CSF	11	65
355319	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	G-CSF	9.5	50
355320	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	G-CSF	11	55
355321	20233						N2586	51107.0										4	G-CSF	12	63
355322	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	G-CSF	9	66
355323	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	G-CSF	11	52
355324	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	G-CSF	9.5	58
355325	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	G-CSF	12.5	62
355326	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	G-CSF	6	30
355327	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	G-CSF	9	57
355328	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	G-CSF	13	58
355329	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	G-CSF	11.5	58
355330	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	G-CSF	11	56
355331	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	G-CSF	11	57
355332	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	G-CSF	8.5	30
355333	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	G-CSF	11	84
355334	20233						RA2159	51112.0										4	G-CSF	10	55
355335	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	G-CSF	11	64
355336	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	G-CSF	10	65
355337	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	G-CSF	11	60
355338	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	G-CSF	8	39
355339	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	G-CSF	8.5	52
355340	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	G-CSF	10	82
355341	20233						N2586	51107.0										4	G-CSF	10	64
355342	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	G-CSF	10.5	50
355343	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	G-CSF	9	61
355344	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	G-CSF	11	71
355345	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	G-CSF	9	69
355346	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	G-CSF	10	67
355347	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	G-CSF	9	74
355348	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	G-CSF	11.5	72
355349	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	G-CSF	12	107
355350	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	G-CSF	11	51
355351	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	G-CSF	10	54
355352	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	G-CSF	11	67
355353	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	G-CSF	12	67
355354	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	G-CSF	10	69
355355	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	G-CSF	10	59
355356	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	G-CSF	13.5	72
355357	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	G-CSF	17	67
355358	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	G-CSF	16	50
355359	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	G-CSF	31	49
355360	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	G-CSF	13.5	68
355361	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	G-CSF	10	70
355362	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	G-CSF	11	46
355363	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	G-CSF	9	54
355364	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	G-CSF	8	35
355365	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	G-CSF	11	43
355366	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	G-CSF	11	67
355367	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	G-CSF	9.5	68
355368	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	G-CSF	9	53
355369	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	G-CSF	11	43
355370	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	G-CSF	12.5	58
355371	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	G-CSF	12	76
355372	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	G-CSF	12.5	46
355373	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	G-CSF	12.5	70
355374	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	G-CSF	9	57
355375	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	G-CSF	9.5	56
355376	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	G-CSF	310.5	34
355377	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	G-CSF	77	61
355378	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	G-CSF	233	52
355379	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	G-CSF	402.5	72
355380	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	G-CSF	205.5	56
355381	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	G-CSF	351	55
355382	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	G-CSF	11	59
355383	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	G-CSF	584	47
355384	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	G-CSF	195.5	64
355385	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	G-CSF	96	47
355386	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	G-CSF	705	37
355387	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	G-CSF	37.5	40
355388	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	G-CSF	11	59
355389	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	G-CSF	12	45
355390	20233																	0	G-CSF	9.5	44
355391	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	G-CSF	21	74
355392	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	G-CSF	21	45
355393	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	G-CSF	19	59
355394	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	G-CSF	16	85
355395	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	G-CSF	14	62
355396	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	G-CSF	13	51
355397	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	G-CSF	9	64
355398	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	G-CSF	23	45
355399	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	G-CSF	22	50
355400	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	G-CSF	21	48
355401	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	G-CSF	24	48
355402	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	G-CSF	16	49
355403	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	G-CSF	12	46
355404	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	G-CSF	10	102
355405	20233																	0	G-CSF	12	62
355406	20233						RA2159	51112.0										4	G-CSF	7.5	76
355407	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	G-CSF	8	67
355408	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	G-CSF	12	78
355409	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	G-CSF	9	60
355410	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	G-CSF	8	66
355411	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	G-CSF	8.5	68
355412	20233						RA2159	51112.0										4	G-CSF	9	64
355413	20233						N2586	51107.0										4	G-CSF	10	67
355414	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	G-CSF	10	49
355415	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	G-CSF	11	53
355416	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	G-CSF	11	63
355417	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	G-CSF	9	53
355418	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	G-CSF	11	73
355419	20233						N2586	51107.0										4	G-CSF	12	56
355420	20233								TNF-a	201285.0						100	ng/mL	0	G-CSF	27	61
355421	20233								IL-1 alpha	201286.0						100	ng/mL	0	G-CSF	11.5	70
355422	20233								IL-6	201287.0						100	ug/mL	0	G-CSF	40	57
355423	20233								IL-17A	201288.0						100	ng/mL	0	G-CSF	15	70
355424	20233								EGF	201289.0						100	ng/mL	0	G-CSF	10	50
355425	20233								IGF-I	201290.0						100	ug/mL	0	G-CSF	11	71
355426	20233								Adiponectin	201291.0						5	ng/mL	0	G-CSF	56	69
355427	20233								Leptin	201292.0						1	ng/mL	0	G-CSF	12	64
355428	20233								Visfatin	201293.0						1	ng/mL	0	G-CSF	12	60
355429	20233															2	ug/mL	0	G-CSF	12	64
355430	20233								TNF-a	201285.0						100	ng/mL	0	G-CSF	23	55
355431	20233								IL-1 alpha	201286.0						100	ng/mL	0	G-CSF	12	37
355432	20233								IL-6	201287.0						100	ug/mL	0	G-CSF	30	49
355433	20233								IL-17A	201288.0						100	ng/mL	0	G-CSF	13	57
355434	20233								EGF	201289.0						100	ng/mL	0	G-CSF	10	45
355435	20233								IGF-I	201290.0						100	ug/mL	0	G-CSF	9	63
355436	20233								Adiponectin	201291.0						5	ng/mL	0	G-CSF	51.5	62
355437	20233								Leptin	201292.0						1	ng/mL	0	G-CSF	11	44
355438	20233								Visfatin	201293.0						1	ng/mL	0	G-CSF	13	66
355439	20233															2	ug/mL	0	G-CSF	11	59
355440	20233								TNF-a	201285.0						100	ng/mL	0	G-CSF	26	60
355441	20233								IL-1 alpha	201286.0						100	ng/mL	0	G-CSF	10	62
355442	20233								IL-6	201287.0						100	ug/mL	0	G-CSF	26	68
355443	20233								IL-17A	201288.0						100	ng/mL	0	G-CSF	13	80
355444	20233								EGF	201289.0						100	ng/mL	0	G-CSF	12	63
355445	20233								IGF-I	201290.0						100	ug/mL	0	G-CSF	10	47
355446	20233								Adiponectin	201291.0						5	ng/mL	0	G-CSF	42.5	66
355447	20233								Leptin	201292.0						1	ng/mL	0	G-CSF	10	54
355448	20233								Visfatin	201293.0						1	ng/mL	0	G-CSF	13	80
355449	20233															2	ug/mL	0	G-CSF	14	61
355450	20233								TNF-a	201285.0						100	ng/mL	0	G-CSF	24	71
355451	20233								IL-1 alpha	201286.0						100	ng/mL	0	G-CSF	10	61
355452	20233								IL-6	201287.0						100	ug/mL	0	G-CSF	21	64
355453	20233								IL-17A	201288.0						100	ng/mL	0	G-CSF	13	65
355454	20233								EGF	201289.0						100	ng/mL	0	G-CSF	10	71
355455	20233								IGF-I	201290.0						100	ug/mL	0	G-CSF	11	67
355456	20233								Adiponectin	201291.0						5	ng/mL	0	G-CSF	50	51
355457	20233								Leptin	201292.0						1	ng/mL	0	G-CSF	12	42
355458	20233								Visfatin	201293.0						1	ng/mL	0	G-CSF	15	30
355459	20233															2	ug/mL	0	G-CSF	10	52
355460	20233																	0	IL-15	82	47
355461	20233						RA2159	51112.0										1	IL-15	100	58
355462	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-15	75	47
355463	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-15	99	51
355464	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-15	80	80
355465	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-15	82	64
355466	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-15	86	68
355467	20233						RA2159	51112.0										1	IL-15	78.5	56
355468	20233						N2586	51107.0										1	IL-15	86	71
355469	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-15	83	63
355470	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-15	91	47
355471	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-15	89	57
355472	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-15	96	69
355473	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-15	78.5	46
355474	20233						N2586	51107.0										1	IL-15	90	23
355475	20233																	0	IL-15	86.5	52
355476	20233																	0	IL-15	77	47
355477	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-15	121	55
355478	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-15	119	65
355479	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-15	121.5	54
355480	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-15	109	52
355481	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-15	118	59
355482	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-15	98	49
355483	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-15	81	72
355484	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-15	135	65
355485	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-15	145	55
355486	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-15	154	65
355487	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-15	137.5	56
355488	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-15	121	41
355489	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-15	110	75
355490	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-15	123.5	42
355491	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-15	119	67
355492	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-15	120	59
355493	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-15	90.5	62
355494	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-15	106.5	74
355495	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-15	119	59
355496	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-15	79.5	58
355497	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-15	78.5	84
355498	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-15	122.5	58
355499	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-15	127	53
355500	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-15	98.5	60
355501	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-15	123	70
355502	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-15	119	51
355503	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-15	95.5	50
355504	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-15	83	63
355505	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-15	95.5	50
355506	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-15	88.5	58
355507	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-15	86	70
355508	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-15	121	67
355509	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-15	103	59
355510	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-15	105.5	46
355511	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-15	87	54
355512	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-15	114	63
355513	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-15	83.5	44
355514	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-15	96.5	50
355515	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-15	103	54
355516	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-15	86	50
355517	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-15	99	59
355518	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-15	98	46
355519	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-15	81.5	58
355520	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-15	84	55
355521	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-15	113	63
355522	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-15	80	67
355523	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-15	94	68
355524	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-15	72.5	66
355525	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-15	87	75
355526	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-15	88	55
355527	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-15	85	58
355528	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-15	79	75
355529	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-15	79.5	70
355530	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-15	82	70
355531	20233						RA2159	51112.0										1	IL-15	111	61
355532	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-15	89	65
355533	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-15	79	53
355534	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-15	98	54
355535	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-15	99	45
355536	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-15	81.5	58
355537	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-15	95	63
355538	20233						N2586	51107.0										1	IL-15	72.5	50
355539	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-15	74	52
355540	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-15	104	41
355541	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-15	90	51
355542	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-15	91	50
355543	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-15	92	71
355544	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-15	83	72
355545	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-15	79	68
355546	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-15	80	61
355547	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-15	81	43
355548	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-15	84	62
355549	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-15	82	55
355550	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-15	71	63
355551	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-15	93	62
355552	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-15	78	87
355553	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-15	78	70
355554	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-15	74	49
355555	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-15	89	35
355556	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-15	80	49
355557	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-15	87.5	40
355558	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-15	83	73
355559	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-15	86	56
355560	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-15	67.5	54
355561	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-15	78.5	40
355562	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-15	77.5	56
355563	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-15	79	76
355564	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-15	79	77
355565	20233						RA2159	51112.0										1	IL-15	73	56
355566	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-15	76	56
355567	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-15	70	49
355568	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-15	73	73
355569	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-15	70	45
355570	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-15	78	53
355571	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-15	71	79
355572	20233						N2586	51107.0										1	IL-15	91	61
355573	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-15	70	53
355574	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-15	87	51
355575	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-15	81	57
355576	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-15	84.5	48
355577	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-15	80	73
355578	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-15	69.5	60
355579	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-15	71.5	74
355580	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-15	78.5	52
355581	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-15	94	55
355582	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-15	78	40
355583	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-15	69.5	58
355584	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-15	87	43
355585	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-15	79	60
355586	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-15	95	53
355587	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-15	67	37
355588	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-15	76	38
355589	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-15	71.5	52
355590	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-15	74	45
355591	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-15	68	31
355592	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-15	71.5	38
355593	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-15	69	71
355594	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-15	70.5	58
355595	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-15	74	61
355596	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-15	83.5	38
355597	20233						RA2159	51112.0										1	IL-15	77.5	62
355598	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-15	81	79
355599	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-15	84.5	68
355600	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-15	94.5	62
355601	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-15	73	60
355602	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-15	67.5	50
355603	20233						RA2159	51112.0										1	IL-15	65	69
355604	20233						N2586	51107.0										1	IL-15	68	73
355605	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-15	81	58
355606	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-15	91.5	70
355607	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-15	67.5	70
355608	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-15	89	53
355609	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-15	73	65
355610	20233						N2586	51107.0										1	IL-15	74	63
355611	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-15	71	41
355612	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-15	81	74
355613	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-15	94	47
355614	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-15	89	59
355615	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-15	65.5	42
355616	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-15	73	55
355617	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-15	68	49
355618	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-15	93	67
355619	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-15	93	60
355620	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-15	73	75
355621	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-15	67	49
355622	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-15	76	26
355623	20233																	0	IL-15	63	50
355624	20233						RA2159	51112.0								2	ug/mL	1	IL-15	100	47
355625	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-15	111	47
355626	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-15	99.5	44
355627	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-15	85	38
355628	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-15	83.5	58
355629	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-15	73.5	62
355630	20233						N2586	51107.0								2	ug/mL	1	IL-15	94.5	48
355631	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-15	93.5	60
355632	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-15	70	49
355633	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-15	76.5	30
355634	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-15	110	52
355635	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-15	86	42
355636	20233																	0	IL-15	80.5	56
355637	20233						RA2159	51112.0										2	IL-15	92.5	60
355638	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-15	87	78
355639	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-15	142	50
355640	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-15	83	75
355641	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-15	83.5	46
355642	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-15	80.5	56
355643	20233						RA2159	51112.0										2	IL-15	89	33
355644	20233						N2586	51107.0										2	IL-15	85	37
355645	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-15	88.5	40
355646	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-15	82	44
355647	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-15	76	37
355648	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-15	76	61
355649	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-15	82	53
355650	20233						N2586	51107.0										2	IL-15	94	33
355651	20233																	0	IL-15	88	56
355652	20233																	0	IL-15	81	39
355653	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-15	123	58
355654	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-15	133	59
355655	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-15	123.5	64
355656	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-15	114	43
355657	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-15	95	57
355658	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-15	106	49
355659	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-15	77.5	72
355660	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-15	116	52
355661	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-15	122	77
355662	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-15	128	58
355663	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-15	115	62
355664	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-15	122.5	26
355665	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-15	118	55
355666	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-15	81	39
355667	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-15	117.5	54
355668	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-15	99.5	56
355669	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-15	110.5	62
355670	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-15	108	70
355671	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-15	114	75
355672	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-15	103	58
355673	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-15	80	47
355674	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-15	113	43
355675	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-15	108	60
355676	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-15	117	55
355677	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-15	118.5	52
355678	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-15	109.5	46
355679	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-15	116	47
355680	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-15	68.5	50
355681	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-15	83	68
355682	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-15	81	50
355683	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-15	84	58
355684	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-15	79	61
355685	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-15	82	57
355686	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-15	83	58
355687	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-15	84	51
355688	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-15	76	56
355689	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-15	78	67
355690	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-15	82	45
355691	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-15	81	57
355692	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-15	74	43
355693	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-15	78	39
355694	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-15	77	45
355695	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-15	76	53
355696	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-15	86.5	72
355697	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-15	86	65
355698	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-15	76.5	56
355699	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-15	72.5	54
355700	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-15	83	48
355701	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-15	76	64
355702	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-15	79.5	58
355703	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-15	83	73
355704	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-15	73	54
355705	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-15	90	58
355706	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-15	69	48
355707	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-15	72	83
355708	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-15	87	37
355709	20233						RA2159	51112.0										2	IL-15	78.5	56
355710	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-15	78	55
355711	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-15	84	68
355712	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-15	86	37
355713	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-15	80	55
355714	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-15	83	69
355715	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-15	67	42
355716	20233						N2586	51107.0										2	IL-15	71	47
355717	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-15	69	59
355718	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-15	71.5	46
355719	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-15	75	69
355720	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-15	71.5	66
355721	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-15	67.5	40
355722	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-15	78	51
355723	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-15	77	57
355724	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-15	66	65
355725	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-15	86	50
355726	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-15	69	67
355727	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-15	71	66
355728	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-15	79	59
355729	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-15	73	63
355730	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-15	72	57
355731	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-15	77	50
355732	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-15	72	62
355733	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-15	66.5	62
355734	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-15	20	64
355735	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-15	74	78
355736	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-15	69.5	42
355737	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-15	71	87
355738	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-15	79	68
355739	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-15	76	51
355740	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-15	72.5	56
355741	20233						RA2159	51112.0										2	IL-15	77.5	64
355742	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-15	71	78
355743	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-15	80.5	60
355744	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-15	73	58
355745	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-15	76.5	58
355746	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-15	75	56
355747	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-15	72	45
355748	20233						N2586	51107.0										2	IL-15	18	43
355749	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-15	64	55
355750	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-15	65	58
355751	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-15	71	69
355752	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-15	64	70
355753	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-15	68	74
355754	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-15	72	45
355755	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-15	67	55
355756	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-15	67.5	54
355757	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-15	63	40
355758	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-15	78	49
355759	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-15	69	40
355760	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-15	78	37
355761	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-15	65	61
355762	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-15	73	59
355763	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-15	69	49
355764	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-15	70	65
355765	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-15	73	55
355766	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-15	68	68
355767	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-15	68.5	78
355768	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-15	79	29
355769	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-15	74.5	48
355770	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-15	69	49
355771	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-15	67	31
355772	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-15	68	58
355773	20233						RA2159	51112.0										2	IL-15	71.5	64
355774	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-15	75	67
355775	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-15	72	53
355776	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-15	68	62
355777	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-15	66.5	82
355778	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-15	64.5	46
355779	20233						RA2159	51112.0										2	IL-15	72	42
355780	20233						N2586	51107.0										2	IL-15	62	49
355781	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-15	71.5	48
355782	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-15	70	50
355783	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-15	67	40
355784	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-15	66.5	56
355785	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-15	72.5	36
355786	20233						N2586	51107.0										2	IL-15	73	41
355787	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-15	63.5	64
355788	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-15	75	65
355789	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-15	69	47
355790	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-15	75	31
355791	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-15	73	36
355792	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-15	72	42
355793	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-15	58	52
355794	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-15	68	45
355795	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-15	61	45
355796	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-15	79	30
355797	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-15	63	27
355798	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-15	70	28
355799	20233																	0	IL-15	69.5	48
355800	20233						RA2159	51112.0								2	ug/mL	2	IL-15	93	47
355801	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-15	81.5	54
355802	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-15	78	50
355803	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-15	84	41
355804	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-15	64	28
355805	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-15	86	58
355806	20233						N2586	51107.0								2	ug/mL	2	IL-15	89	41
355807	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-15	79.5	32
355808	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-15	95.5	44
355809	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-15	80.5	26
355810	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-15	67.5	30
355811	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-15	88	45
355812	20233																	0	IL-15	123	72
355813	20233						RA2159	51112.0								2	ug/mL	3	IL-15	146	55
355814	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-15	142	69
355815	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-15	117	74
355816	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-15	146	63
355817	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-15	127	56
355818	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-15	134	71
355819	20233						N2586	51107.0								2	ug/mL	3	IL-15	159	68
355820	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-15	151.5	50
355821	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-15	160	79
355822	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-15	156	50
355823	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-15	104	63
355824	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-15	126	90
355825	20233						RA2159	51112.0										3	IL-15	105	55
355826	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-15	117	49
355827	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-15	118	55
355828	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-15	108.5	64
355829	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-15	119	67
355830	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-15	111	61
355831	20233						RA2159	51112.0										3	IL-15	107	88
355832	20233						N2586	51107.0										3	IL-15	111.5	56
355833	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-15	120	79
355834	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-15	111	63
355835	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-15	124	65
355836	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-15	102	78
355837	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-15	115.5	58
355838	20233						N2586	51107.0										3	IL-15	117	44
355839	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-15	100.5	56
355840	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-15	128	41
355841	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-15	128	59
355842	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-15	109	52
355843	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-15	103.5	58
355844	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-15	129	53
355845	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-15	117.5	56
355846	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-15	123.5	60
355847	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-15	119	71
355848	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-15	138	43
355849	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-15	84.5	62
355850	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-15	125	51
355851	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-15	116	71
355852	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-15	116.5	66
355853	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-15	87	66
355854	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-15	119	69
355855	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-15	113	59
355856	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-15	130	55
355857	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-15	116.5	64
355858	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-15	124	73
355859	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-15	111	56
355860	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-15	117	86
355861	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-15	107	71
355862	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-15	117	49
355863	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-15	104	57
355864	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-15	109	64
355865	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-15	110	74
355866	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-15	111	66
355867	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-15	106	65
355868	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-15	121	66
355869	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-15	121.5	70
355870	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-15	121.5	50
355871	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-15	111	65
355872	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-15	114	68
355873	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-15	110	61
355874	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-15	105	60
355875	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-15	100	61
355876	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-15	122	62
355877	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-15	112	63
355878	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-15	118	61
355879	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-15	109.5	66
355880	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-15	100	49
355881	20233						RA2159	51112.0										3	IL-15	110	56
355882	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-15	110.5	58
355883	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-15	114.5	70
355884	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-15	110	57
355885	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-15	116	71
355886	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-15	102	76
355887	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-15	110	61
355888	20233						N2586	51107.0										3	IL-15	114.5	66
355889	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-15	102	68
355890	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-15	100.5	50
355891	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-15	111	64
355892	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-15	128	42
355893	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-15	94	73
355894	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-15	93	54
355895	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-15	101	59
355896	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-15	104	57
355897	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-15	106.5	60
355898	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-15	109.5	56
355899	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-15	105	51
355900	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-15	96	63
355901	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-15	71.5	56
355902	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-15	109	37
355903	20233						RA2159	51112.0										3	IL-15	104	65
355904	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-15	110	50
355905	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-15	103	58
355906	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-15	116.5	56
355907	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-15	116	70
355908	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-15	109	73
355909	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-15	106.5	56
355910	20233						N2586	51107.0										3	IL-15	108.5	70
355911	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-15	107.5	50
355912	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-15	112	54
355913	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-15	109	63
355914	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-15	107.5	70
355915	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-15	102	57
355916	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-15	101.5	50
355917	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-15	104	62
355918	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-15	111	55
355919	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-15	118	53
355920	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-15	113	63
355921	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-15	111	66
355922	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-15	95	52
355923	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-15	112	71
355924	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-15	109.5	76
355925	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-15	90	67
355926	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-15	111	68
355927	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-15	105	61
355928	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-15	120.5	52
355929	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-15	114.5	54
355930	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-15	123	59
355931	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-15	134.5	58
355932	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-15	118	75
355933	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-15	109	65
355934	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-15	111	65
355935	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-15	114	73
355936	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-15	112	65
355937	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-15	104.5	66
355938	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-15	107.5	54
355939	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-15	114	59
355940	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-15	105	75
355941	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-15	114	64
355942	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-15	97	66
355943	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-15	141	65
355944	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-15	139.5	58
355945	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-15	131	69
355946	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-15	155	69
355947	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-15	163.5	66
355948	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-15	111	71
355949	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-15	112	62
355950	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-15	153	69
355951	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-15	143.5	64
355952	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-15	159.5	66
355953	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-15	162	45
355954	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-15	108	55
355955	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-15	138	55
355956	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-15	103.5	62
355957	20233																	0	IL-15	123	56
355958	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-15	172	60
355959	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-15	267	41
355960	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-15	178	61
355961	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-15	158	49
355962	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-15	165	62
355963	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-15	125.5	50
355964	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-15	105.5	70
355965	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-15	139	69
355966	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-15	161	53
355967	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-15	160.5	68
355968	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-15	90	41
355969	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-15	106	45
355970	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-15	137.5	70
355971	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-15	98	53
355972	20233																	0	IL-15	113	41
355973	20233						RA2159	51112.0										3	IL-15	98	49
355974	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-15	181	68
355975	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-15	102	64
355976	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-15	140.5	68
355977	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-15	113	40
355978	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-15	108	51
355979	20233						RA2159	51112.0										3	IL-15	89.5	56
355980	20233						N2586	51107.0										3	IL-15	111	59
355981	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-15	106	65
355982	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-15	100.5	50
355983	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-15	104	41
355984	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-15	105	31
355985	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-15	101.5	60
355986	20233						N2586	51107.0										3	IL-15	84	40
355987	20233																	0	IL-15	110.5	36
355988	20233						RA2159	51112.0								2	ug/mL	4	IL-15	150	50
355989	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-15	165	55
355990	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-15	136	69
355991	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-15	160	62
355992	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-15	132	49
355993	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-15	132	54
355994	20233						N2586	51107.0								2	ug/mL	4	IL-15	152.5	60
355995	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-15	159	52
355996	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-15	128	62
355997	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-15	134	65
355998	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-15	126	64
355999	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-15	109	57
356000	20233						RA2159	51112.0										4	IL-15	118	59
356001	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-15	121	69
356002	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-15	118.5	66
356003	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-15	114	78
356004	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-15	111	67
356005	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-15	121	64
356006	20233						RA2159	51112.0										4	IL-15	120	63
356007	20233						N2586	51107.0										4	IL-15	113	69
356008	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-15	105	51
356009	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-15	118	56
356010	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-15	99	55
356011	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-15	101	61
356012	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-15	111	64
356013	20233						N2586	51107.0										4	IL-15	104	61
356014	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-15	126	62
356015	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-15	126.5	50
356016	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-15	119	83
356017	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-15	122	74
356018	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-15	132	51
356019	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-15	116.5	60
356020	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-15	119	77
356021	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-15	123	60
356022	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-15	128	49
356023	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-15	106	54
356024	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-15	117	57
356025	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-15	105	55
356026	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-15	110	85
356027	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-15	119	63
356028	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-15	130.5	76
356029	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-15	118.5	56
356030	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-15	118	59
356031	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-15	121	58
356032	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-15	120	47
356033	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-15	107	45
356034	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-15	110	55
356035	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-15	111.5	62
356036	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-15	99	49
356037	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-15	121.5	68
356038	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-15	130	50
356039	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-15	126	54
356040	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-15	123.5	56
356041	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-15	125	55
356042	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-15	126	51
356043	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-15	92	31
356044	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-15	118	68
356045	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-15	111	53
356046	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-15	113	55
356047	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-15	111	75
356048	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-15	112	38
356049	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-15	106	50
356050	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-15	118	55
356051	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-15	114.5	38
356052	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-15	116	67
356053	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-15	119	77
356054	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-15	104.5	50
356055	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-15	110	55
356056	20233						RA2159	51112.0										4	IL-15	107	59
356057	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-15	103.5	62
356058	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-15	116	71
356059	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-15	109	47
356060	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-15	120	47
356061	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-15	111	38
356062	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-15	112	63
356063	20233						N2586	51107.0										4	IL-15	116	57
356064	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-15	111	69
356065	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-15	122	59
356066	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-15	116	61
356067	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-15	132	51
356068	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-15	99.5	38
356069	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-15	108.5	44
356070	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-15	117	65
356071	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-15	108	64
356072	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-15	115.5	50
356073	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-15	105	43
356074	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-15	108	53
356075	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-15	111	64
356076	20233						RA2159	51112.0										4	IL-15	117	38
356077	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-15	117	75
356078	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-15	121	64
356079	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-15	115	59
356080	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-15	111	39
356081	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-15	106	44
356082	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-15	111.5	60
356083	20233						N2586	51107.0										4	IL-15	111	55
356084	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-15	109.5	50
356085	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-15	110.5	50
356086	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-15	114	83
356087	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-15	104	57
356088	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-15	111	64
356089	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-15	101	61
356090	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-15	110.5	68
356091	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-15	117	74
356092	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-15	110	57
356093	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-15	121.5	62
356094	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-15	101	62
356095	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-15	110	55
356096	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-15	107	55
356097	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-15	106	46
356098	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-15	113	50
356099	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-15	115	56
356100	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-15	105.5	68
356101	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-15	85	58
356102	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-15	97	66
356103	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-15	93	65
356104	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-15	122	47
356105	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-15	108	49
356106	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-15	101	50
356107	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-15	107	39
356108	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-15	112.5	56
356109	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-15	101	65
356110	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-15	97	39
356111	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-15	107	43
356112	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-15	108	49
356113	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-15	109.5	60
356114	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-15	116	43
356115	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-15	104	57
356116	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-15	93	55
356117	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-15	108	63
356118	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-15	150	32
356119	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-15	146.5	54
356120	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-15	134.5	50
356121	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-15	165	55
356122	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-15	147	50
356123	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-15	149	56
356124	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-15	100	46
356125	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-15	156.5	66
356126	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-15	141	49
356127	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-15	135.5	52
356128	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-15	157	39
356129	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-15	116.5	44
356130	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-15	111	43
356131	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-15	104	45
356132	20233																	0	IL-15	109.5	38
356133	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-15	154	62
356134	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-15	143.5	36
356135	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-15	143.5	62
356136	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-15	138	65
356137	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-15	127	52
356138	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-15	128	53
356139	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-15	106	52
356140	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-15	156	73
356141	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-15	170	60
356142	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-15	149	41
356143	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-15	142	47
356144	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-15	134	46
356145	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-15	99.5	50
356146	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-15	88	77
356147	20233																	0	IL-15	115.5	72
356148	20233						RA2159	51112.0										4	IL-15	103	65
356149	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-15	179	53
356150	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-15	147	61
356151	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-15	144	56
356152	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-15	100.5	64
356153	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-15	96	44
356154	20233						RA2159	51112.0										4	IL-15	116.5	42
356155	20233						N2586	51107.0										4	IL-15	107.5	56
356156	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-15	102	48
356157	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-15	86	55
356158	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-15	103.5	60
356159	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-15	89	36
356160	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-15	85.5	66
356161	20233						N2586	51107.0										4	IL-15	98	51
356162	20233								TNF-a	201285.0						100	ng/mL	0	IL-15	135	68
356163	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-15	70.5	66
356164	20233								IL-6	201287.0						100	ug/mL	0	IL-15	104	53
356165	20233								IL-17A	201288.0						100	ng/mL	0	IL-15	97	62
356166	20233								EGF	201289.0						100	ng/mL	0	IL-15	87	65
356167	20233								IGF-I	201290.0						100	ug/mL	0	IL-15	80.5	70
356168	20233								Adiponectin	201291.0						5	ng/mL	0	IL-15	76	65
356169	20233								Leptin	201292.0						1	ng/mL	0	IL-15	78	47
356170	20233								Visfatin	201293.0						1	ng/mL	0	IL-15	96	46
356171	20233															2	ug/mL	0	IL-15	90.5	64
356172	20233								TNF-a	201285.0						100	ng/mL	0	IL-15	142	58
356173	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-15	79.5	50
356174	20233								IL-6	201287.0						100	ug/mL	0	IL-15	105	51
356175	20233								IL-17A	201288.0						100	ng/mL	0	IL-15	88.5	54
356176	20233								EGF	201289.0						100	ng/mL	0	IL-15	91	49
356177	20233								IGF-I	201290.0						100	ug/mL	0	IL-15	83	53
356178	20233								Adiponectin	201291.0						5	ng/mL	0	IL-15	77	31
356179	20233								Leptin	201292.0						1	ng/mL	0	IL-15	80	41
356180	20233								Visfatin	201293.0						1	ng/mL	0	IL-15	99	54
356181	20233															2	ug/mL	0	IL-15	81	41
356182	20233								TNF-a	201285.0						100	ng/mL	0	IL-15	180	61
356183	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-15	105	57
356184	20233								IL-6	201287.0						100	ug/mL	0	IL-15	159	55
356185	20233								IL-17A	201288.0						100	ng/mL	0	IL-15	126	59
356186	20233								EGF	201289.0						100	ng/mL	0	IL-15	119	55
356187	20233								IGF-I	201290.0						100	ug/mL	0	IL-15	122.5	56
356188	20233								Adiponectin	201291.0						5	ng/mL	0	IL-15	92.5	44
356189	20233								Leptin	201292.0						1	ng/mL	0	IL-15	115	52
356190	20233								Visfatin	201293.0						1	ng/mL	0	IL-15	146.5	54
356191	20233															2	ug/mL	0	IL-15	130	65
356192	20233								TNF-a	201285.0						100	ng/mL	0	IL-15	185	53
356193	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-15	103	39
356194	20233								IL-6	201287.0						100	ug/mL	0	IL-15	130	49
356195	20233								IL-17A	201288.0						100	ng/mL	0	IL-15	120	44
356196	20233								EGF	201289.0						100	ng/mL	0	IL-15	102	55
356197	20233								IGF-I	201290.0						100	ug/mL	0	IL-15	105	65
356198	20233								Adiponectin	201291.0						5	ng/mL	0	IL-15	92	47
356199	20233								Leptin	201292.0						1	ng/mL	0	IL-15	103	47
356200	20233								Visfatin	201293.0						1	ng/mL	0	IL-15	131	53
356201	20233															2	ug/mL	0	IL-15	113	61
356202	20233																	0	IL-7	9	55
356203	20233						RA2159	51112.0										1	IL-7	15	86
356204	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-7	14	86
356205	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-7	15.5	80
356206	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-7	16	67
356207	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-7	16	82
356208	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-7	15	76
356209	20233						RA2159	51112.0										1	IL-7	14.5	76
356210	20233						N2586	51107.0										1	IL-7	17.5	70
356211	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-7	17	73
356212	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-7	18	67
356213	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-7	14.5	68
356214	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-7	15	69
356215	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-7	17	48
356216	20233						N2586	51107.0										1	IL-7	18	37
356217	20233																	0	IL-7	9	56
356218	20233																	0	IL-7	9.5	56
356219	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-7	22	67
356220	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-7	20	68
356221	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-7	14	61
356222	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-7	17.5	84
356223	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-7	20	81
356224	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-7	14	72
356225	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-7	15	83
356226	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-7	26	72
356227	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-7	29	85
356228	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-7	29.5	60
356229	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-7	26	65
356230	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-7	23	61
356231	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-7	22	53
356232	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-7	16	47
356233	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-7	19.5	72
356234	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-7	19	93
356235	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-7	16.5	66
356236	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-7	19	66
356237	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-7	18	73
356238	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-7	13	87
356239	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-7	15	79
356240	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-7	21	72
356241	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-7	23	86
356242	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-7	22.5	62
356243	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-7	24.5	46
356244	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-7	24	47
356245	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-7	20	59
356246	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-7	17	85
356247	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-7	15	83
356248	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-7	15	85
356249	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-7	13	89
356250	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-7	14	85
356251	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-7	16	83
356252	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-7	13	72
356253	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-7	10	58
356254	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-7	19	88
356255	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-7	15.5	62
356256	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-7	16	65
356257	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-7	16	71
356258	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-7	16	70
356259	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-7	26.5	86
356260	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-7	16	57
356261	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-7	17	84
356262	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-7	10.5	72
356263	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-7	13	79
356264	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-7	15	80
356265	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-7	15	58
356266	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-7	14.5	86
356267	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-7	20	87
356268	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-7	16	69
356269	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-7	23.5	70
356270	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-7	13	91
356271	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-7	17	55
356272	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-7	17	77
356273	20233						RA2159	51112.0										1	IL-7	17	68
356274	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-7	13	89
356275	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-7	16	80
356276	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-7	13.5	74
356277	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-7	16.5	68
356278	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-7	13	65
356279	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-7	14	65
356280	20233						N2586	51107.0										1	IL-7	17.5	80
356281	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-7	14	57
356282	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-7	18.5	56
356283	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-7	18	59
356284	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-7	18	59
356285	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-7	15	77
356286	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-7	16	74
356287	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-7	17	73
356288	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-7	16	64
356289	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-7	14	67
356290	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-7	11	76
356291	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-7	17	65
356292	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-7	13	65
356293	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-7	13	101
356294	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-7	18	81
356295	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-7	15	77
356296	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-7	16	51
356297	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-7	18	56
356298	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-7	14.5	66
356299	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-7	17	53
356300	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-7	19.5	66
356301	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-7	13.5	84
356302	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-7	12	79
356303	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-7	14	84
356304	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-7	16.5	76
356305	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-7	14	104
356306	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-7	14	81
356307	20233						RA2159	51112.0										1	IL-7	17	70
356308	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-7	15	66
356309	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-7	20.5	70
356310	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-7	15	87
356311	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-7	16	56
356312	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-7	15	57
356313	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-7	13	66
356314	20233						N2586	51107.0										1	IL-7	24	88
356315	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-7	30	72
356316	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-7	20.5	66
356317	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-7	22	66
356318	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-7	26	68
356319	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-7	31	74
356320	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-7	21	96
356321	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-7	21.5	68
356322	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-7	24	65
356323	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-7	25	47
356324	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-7	24	52
356325	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-7	24	49
356326	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-7	22.5	50
356327	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-7	14	89
356328	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-7	12	76
356329	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-7	14	92
356330	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-7	16	69
356331	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-7	15	91
356332	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-7	14	65
356333	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-7	16	47
356334	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-7	15.5	54
356335	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-7	13	71
356336	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-7	17	50
356337	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-7	13	63
356338	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-7	11	41
356339	20233						RA2159	51112.0										1	IL-7	18	61
356340	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-7	15	79
356341	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-7	13	61
356342	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-7	14	59
356343	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-7	13	86
356344	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-7	12	78
356345	20233						RA2159	51112.0										1	IL-7	15	100
356346	20233						N2586	51107.0										1	IL-7	17	69
356347	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-7	15	85
356348	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-7	18	65
356349	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-7	13	72
356350	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-7	17	66
356351	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-7	14	80
356352	20233						N2586	51107.0										1	IL-7	17	67
356353	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-7	15	70
356354	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-7	15	87
356355	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-7	16	71
356356	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-7	15	90
356357	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-7	15	61
356358	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-7	12	61
356359	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-7	11	76
356360	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-7	14	62
356361	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-7	17	79
356362	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-7	12	68
356363	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-7	11	50
356364	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-7	19	43
356365	20233																	0	IL-7	8	74
356366	20233						RA2159	51112.0								2	ug/mL	1	IL-7	17	65
356367	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-7	21	60
356368	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-7	16	65
356369	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-7	21	63
356370	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-7	18	59
356371	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-7	14	61
356372	20233						N2586	51107.0								2	ug/mL	1	IL-7	24	53
356373	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-7	20.5	78
356374	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-7	15	76
356375	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-7	21	39
356376	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-7	17	64
356377	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-7	20	56
356378	20233																	0	IL-7	7	65
356379	20233						RA2159	51112.0										2	IL-7	14	85
356380	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-7	11.5	90
356381	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-7	15	86
356382	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-7	11	73
356383	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-7	14	73
356384	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-7	14.5	64
356385	20233						RA2159	51112.0										2	IL-7	15	49
356386	20233						N2586	51107.0										2	IL-7	14	47
356387	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-7	17	74
356388	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-7	13.5	68
356389	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-7	13	46
356390	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-7	14	60
356391	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-7	18	73
356392	20233						N2586	51107.0										2	IL-7	20	55
356393	20233																	0	IL-7	8.5	66
356394	20233																	0	IL-7	9	54
356395	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-7	19.5	76
356396	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-7	23	68
356397	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-7	21	78
356398	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-7	19	57
356399	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-7	17	77
356400	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-7	17	70
356401	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-7	13.5	74
356402	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-7	23	47
356403	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-7	17.5	64
356404	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-7	22.5	80
356405	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-7	17	87
356406	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-7	23	42
356407	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-7	26	61
356408	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-7	16.5	62
356409	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-7	18	73
356410	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-7	15	87
356411	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-7	15	71
356412	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-7	21	59
356413	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-7	21	67
356414	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-7	17	83
356415	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-7	12	58
356416	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-7	23	64
356417	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-7	20.5	86
356418	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-7	17	66
356419	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-7	20	77
356420	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-7	20	49
356421	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-7	19.5	78
356422	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-7	13	67
356423	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-7	14	86
356424	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-7	15	56
356425	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-7	12.5	78
356426	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-7	11.5	66
356427	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-7	13.5	88
356428	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-7	12	85
356429	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-7	13	69
356430	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-7	14	67
356431	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-7	15	79
356432	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-7	20	62
356433	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-7	12	57
356434	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-7	14	85
356435	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-7	20.5	48
356436	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-7	18	54
356437	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-7	13	81
356438	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-7	13	90
356439	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-7	13	95
356440	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-7	14	66
356441	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-7	13	61
356442	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-7	15	55
356443	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-7	11	77
356444	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-7	18	54
356445	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-7	20	62
356446	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-7	13	71
356447	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-7	16.5	74
356448	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-7	19	57
356449	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-7	16.5	74
356450	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-7	13	56
356451	20233						RA2159	51112.0										2	IL-7	16	69
356452	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-7	11	72
356453	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-7	14	75
356454	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-7	12	50
356455	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-7	14	67
356456	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-7	13	69
356457	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-7	12.5	42
356458	20233						N2586	51107.0										2	IL-7	14	61
356459	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-7	14	63
356460	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-7	9	58
356461	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-7	15	62
356462	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-7	14	61
356463	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-7	13	56
356464	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-7	12	59
356465	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-7	12	63
356466	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-7	13	67
356467	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-7	11.5	62
356468	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-7	12	80
356469	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-7	11	73
356470	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-7	12	75
356471	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-7	12	76
356472	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-7	18	65
356473	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-7	18	76
356474	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-7	12	69
356475	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-7	12	44
356476	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-7	5.5	82
356477	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-7	12	86
356478	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-7	11	59
356479	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-7	14	72
356480	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-7	12	90
356481	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-7	13	62
356482	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-7	12	83
356483	20233						RA2159	51112.0										2	IL-7	12	69
356484	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-7	13	86
356485	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-7	14	80
356486	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-7	13	65
356487	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-7	15.5	70
356488	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-7	15	64
356489	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-7	12	63
356490	20233						N2586	51107.0										2	IL-7	6	57
356491	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-7	23	77
356492	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-7	25.5	74
356493	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-7	20	79
356494	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-7	25.5	66
356495	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-7	26	69
356496	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-7	22	61
356497	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-7	25	88
356498	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-7	18	83
356499	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-7	24	64
356500	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-7	23.5	56
356501	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-7	25	54
356502	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-7	22.5	54
356503	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-7	13	75
356504	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-7	13.5	60
356505	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-7	12	71
356506	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-7	12	55
356507	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-7	10.5	78
356508	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-7	13	93
356509	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-7	14	75
356510	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-7	13.5	42
356511	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-7	17	57
356512	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-7	12.5	60
356513	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-7	14	54
356514	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-7	15	76
356515	20233						RA2159	51112.0										2	IL-7	14	82
356516	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-7	14	76
356517	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-7	12	62
356518	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-7	13	90
356519	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-7	12	91
356520	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-7	12	59
356521	20233						RA2159	51112.0										2	IL-7	15.5	70
356522	20233						N2586	51107.0										2	IL-7	11	65
356523	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-7	17	61
356524	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-7	14	71
356525	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-7	17.5	48
356526	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-7	15.5	56
356527	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-7	16	53
356528	20233						N2586	51107.0										2	IL-7	16	64
356529	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-7	13.5	74
356530	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-7	11	74
356531	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-7	13.5	80
356532	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-7	9	49
356533	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-7	11	45
356534	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-7	13	49
356535	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-7	14	49
356536	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-7	17	60
356537	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-7	18	36
356538	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-7	14	36
356539	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-7	14	43
356540	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-7	16	40
356541	20233																	0	IL-7	7	61
356542	20233						RA2159	51112.0								2	ug/mL	2	IL-7	15.5	64
356543	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-7	12	53
356544	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-7	15	65
356545	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-7	13	70
356546	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-7	16	53
356547	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-7	16	59
356548	20233						N2586	51107.0								2	ug/mL	2	IL-7	16	33
356549	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-7	14	49
356550	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-7	16.5	54
356551	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-7	12.5	40
356552	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-7	15	33
356553	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-7	19	65
356554	20233																	0	IL-7	9	85
356555	20233						RA2159	51112.0								2	ug/mL	3	IL-7	21	61
356556	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-7	23	96
356557	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-7	17	94
356558	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-7	17	77
356559	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-7	22	75
356560	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-7	20	73
356561	20233						N2586	51107.0								2	ug/mL	3	IL-7	26	91
356562	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-7	21	74
356563	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-7	24	85
356564	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-7	24	78
356565	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-7	21	71
356566	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-7	25	85
356567	20233						RA2159	51112.0										3	IL-7	13	83
356568	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-7	16	79
356569	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-7	14	63
356570	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-7	15	76
356571	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-7	15	74
356572	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-7	17	74
356573	20233						RA2159	51112.0										3	IL-7	14	94
356574	20233						N2586	51107.0										3	IL-7	17.5	64
356575	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-7	15.5	88
356576	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-7	16	52
356577	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-7	17	77
356578	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-7	17	98
356579	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-7	19	71
356580	20233						N2586	51107.0										3	IL-7	17	66
356581	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-7	17	61
356582	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-7	16	69
356583	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-7	12	81
356584	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-7	16	83
356585	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-7	16	77
356586	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-7	19.5	72
356587	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-7	24	77
356588	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-7	18	80
356589	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-7	16.5	84
356590	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-7	15	59
356591	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-7	14	78
356592	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-7	18	75
356593	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-7	13.5	70
356594	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-7	13	75
356595	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-7	11	79
356596	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-7	18	84
356597	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-7	14	97
356598	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-7	14.5	82
356599	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-7	18	104
356600	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-7	18	87
356601	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-7	15.5	90
356602	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-7	20	70
356603	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-7	20	75
356604	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-7	15	68
356605	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-7	20.5	72
356606	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-7	22	85
356607	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-7	24	103
356608	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-7	24	77
356609	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-7	25	89
356610	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-7	22	80
356611	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-7	24	86
356612	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-7	21	79
356613	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-7	22	86
356614	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-7	22	97
356615	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-7	26	96
356616	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-7	24	83
356617	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-7	15	73
356618	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-7	15	78
356619	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-7	14	88
356620	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-7	20	75
356621	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-7	16	81
356622	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-7	14	72
356623	20233						RA2159	51112.0										3	IL-7	16	86
356624	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-7	21	79
356625	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-7	15.5	72
356626	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-7	17	86
356627	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-7	19	79
356628	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-7	20	78
356629	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-7	18	71
356630	20233						N2586	51107.0										3	IL-7	19	78
356631	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-7	13	79
356632	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-7	18	72
356633	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-7	17	69
356634	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-7	14	71
356635	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-7	12	78
356636	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-7	15.5	56
356637	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-7	14	84
356638	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-7	23	88
356639	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-7	21	89
356640	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-7	16.5	62
356641	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-7	18	57
356642	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-7	16	88
356643	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-7	12	63
356644	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-7	15	59
356645	20233						RA2159	51112.0										3	IL-7	15	81
356646	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-7	16	74
356647	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-7	13	68
356648	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-7	16	61
356649	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-7	12.5	66
356650	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-7	13	82
356651	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-7	12	78
356652	20233						N2586	51107.0										3	IL-7	18	87
356653	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-7	14	87
356654	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-7	15	86
356655	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-7	20	89
356656	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-7	17	66
356657	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-7	15	63
356658	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-7	18	79
356659	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-7	17	71
356660	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-7	16	82
356661	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-7	14	78
356662	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-7	14	85
356663	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-7	13	67
356664	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-7	16	86
356665	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-7	16	79
356666	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-7	18	97
356667	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-7	14	81
356668	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-7	16	83
356669	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-7	20	84
356670	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-7	17	71
356671	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-7	14	73
356672	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-7	16.5	76
356673	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-7	17	90
356674	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-7	14	74
356675	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-7	13	84
356676	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-7	14	95
356677	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-7	15.5	90
356678	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-7	19.5	94
356679	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-7	19.5	78
356680	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-7	18	81
356681	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-7	16	81
356682	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-7	23	79
356683	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-7	16	77
356684	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-7	16.5	76
356685	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-7	24	64
356686	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-7	19	79
356687	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-7	16	77
356688	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-7	23	86
356689	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-7	22	84
356690	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-7	14	75
356691	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-7	14	67
356692	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-7	20	83
356693	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-7	22	104
356694	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-7	23	75
356695	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-7	20.5	78
356696	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-7	15	49
356697	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-7	25	77
356698	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-7	13	101
356699	20233																	0	IL-7	7	56
356700	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-7	21	54
356701	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-7	23	65
356702	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-7	17.5	78
356703	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-7	22	90
356704	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-7	24	75
356705	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-7	16	76
356706	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-7	17	80
356707	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-7	22	83
356708	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-7	21	85
356709	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-7	22	75
356710	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-7	12	63
356711	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-7	18	72
356712	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-7	22	86
356713	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-7	18	72
356714	20233																	0	IL-7	8	69
356715	20233						RA2159	51112.0										3	IL-7	14	68
356716	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-7	15	68
356717	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-7	16.5	70
356718	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-7	13.5	64
356719	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-7	16	44
356720	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-7	16	78
356721	20233						RA2159	51112.0										3	IL-7	13.5	68
356722	20233						N2586	51107.0										3	IL-7	24	70
356723	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-7	15	79
356724	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-7	16	74
356725	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-7	18	61
356726	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-7	17	67
356727	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-7	14	65
356728	20233						N2586	51107.0										3	IL-7	21	44
356729	20233																	0	IL-7	8	61
356730	20233						RA2159	51112.0								2	ug/mL	4	IL-7	19	74
356731	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-7	19.5	78
356732	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-7	21	65
356733	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-7	21	74
356734	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-7	17	86
356735	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-7	20	81
356736	20233						N2586	51107.0								2	ug/mL	4	IL-7	22.5	78
356737	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-7	21	83
356738	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-7	17	67
356739	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-7	18	69
356740	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-7	19.5	82
356741	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-7	13.5	68
356742	20233						RA2159	51112.0										4	IL-7	18	77
356743	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-7	16	79
356744	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-7	16	73
356745	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-7	14	87
356746	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-7	15	77
356747	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-7	13	87
356748	20233						RA2159	51112.0										4	IL-7	16	74
356749	20233						N2586	51107.0										4	IL-7	16	73
356750	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-7	13	83
356751	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-7	15	58
356752	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-7	17	71
356753	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-7	18	80
356754	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-7	14	85
356755	20233						N2586	51107.0										4	IL-7	14.5	66
356756	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-7	14	78
356757	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-7	18	65
356758	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-7	18	77
356759	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-7	16.5	74
356760	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-7	16	83
356761	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-7	18	62
356762	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-7	15	94
356763	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-7	15	61
356764	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-7	16	72
356765	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-7	19	63
356766	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-7	17	70
356767	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-7	17.5	80
356768	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-7	13	80
356769	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-7	13	78
356770	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-7	15	101
356771	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-7	16	68
356772	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-7	16	77
356773	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-7	15.5	72
356774	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-7	18	50
356775	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-7	22	53
356776	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-7	14	61
356777	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-7	18	67
356778	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-7	18	63
356779	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-7	14.5	82
356780	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-7	24.5	90
356781	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-7	27.5	68
356782	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-7	27	72
356783	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-7	25	69
356784	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-7	22	59
356785	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-7	24.5	44
356786	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-7	24	73
356787	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-7	26	73
356788	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-7	24	62
356789	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-7	21	67
356790	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-7	21	49
356791	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-7	24.5	68
356792	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-7	15	86
356793	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-7	21	52
356794	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-7	15	83
356795	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-7	15	90
356796	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-7	14	58
356797	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-7	17	77
356798	20233						RA2159	51112.0										4	IL-7	15.5	68
356799	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-7	12	87
356800	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-7	18.5	66
356801	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-7	21	64
356802	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-7	17	47
356803	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-7	16	69
356804	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-7	17	63
356805	20233						N2586	51107.0										4	IL-7	22.5	74
356806	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-7	17	68
356807	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-7	16	77
356808	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-7	16	70
356809	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-7	14	54
356810	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-7	12.5	48
356811	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-7	17	42
356812	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-7	20	75
356813	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-7	18	83
356814	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-7	17	55
356815	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-7	19	64
356816	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-7	18	45
356817	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-7	15	91
356818	20233						RA2159	51112.0										4	IL-7	16	64
356819	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-7	15	82
356820	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-7	15	59
356821	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-7	16	78
356822	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-7	13	49
356823	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-7	13	54
356824	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-7	13	62
356825	20233						N2586	51107.0										4	IL-7	15	71
356826	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-7	18	61
356827	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-7	14.5	74
356828	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-7	18	87
356829	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-7	22	57
356830	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-7	15	75
356831	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-7	16	69
356832	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-7	12	66
356833	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-7	16	73
356834	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-7	15	77
356835	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-7	14	77
356836	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-7	14.5	62
356837	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-7	17.5	84
356838	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-7	14	66
356839	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-7	16	56
356840	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-7	16	64
356841	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-7	17.5	76
356842	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-7	15	80
356843	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-7	16	80
356844	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-7	18	85
356845	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-7	12	82
356846	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-7	13	55
356847	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-7	12	67
356848	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-7	11	64
356849	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-7	16	43
356850	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-7	14	66
356851	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-7	13	67
356852	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-7	11	49
356853	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-7	16	53
356854	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-7	13	69
356855	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-7	15	58
356856	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-7	16	61
356857	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-7	12	59
356858	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-7	14	65
356859	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-7	21	55
356860	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-7	22	47
356861	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-7	21	77
356862	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-7	19	83
356863	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-7	19	84
356864	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-7	21	49
356865	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-7	23	55
356866	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-7	14	65
356867	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-7	26	83
356868	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-7	21	65
356869	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-7	20.5	68
356870	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-7	28.5	36
356871	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-7	19	44
356872	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-7	15	50
356873	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-7	19	59
356874	20233																	0	IL-7	8	41
356875	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-7	21	104
356876	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-7	20.5	64
356877	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-7	18	74
356878	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-7	15	86
356879	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-7	16	51
356880	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-7	19	61
356881	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-7	17	57
356882	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-7	28	67
356883	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-7	24	53
356884	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-7	20	65
356885	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-7	23.5	56
356886	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-7	16	62
356887	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-7	15	59
356888	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-7	15	105
356889	20233																	0	IL-7	8	78
356890	20233						RA2159	51112.0										4	IL-7	16	89
356891	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-7	14	77
356892	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-7	15	79
356893	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-7	14	75
356894	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-7	11	76
356895	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-7	16	53
356896	20233						RA2159	51112.0										4	IL-7	12	60
356897	20233						N2586	51107.0										4	IL-7	16	51
356898	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-7	14	51
356899	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-7	15	55
356900	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-7	16	47
356901	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-7	15	63
356902	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-7	17	86
356903	20233						N2586	51107.0										4	IL-7	13	47
356904	20233								TNF-a	201285.0						100	ng/mL	0	IL-7	11	76
356905	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-7	10	95
356906	20233								IL-6	201287.0						100	ug/mL	0	IL-7	12	69
356907	20233								IL-17A	201288.0						100	ng/mL	0	IL-7	13	69
356908	20233								EGF	201289.0						100	ng/mL	0	IL-7	11	74
356909	20233								IGF-I	201290.0						100	ug/mL	0	IL-7	8	75
356910	20233								Adiponectin	201291.0						5	ng/mL	0	IL-7	54	81
356911	20233								Leptin	201292.0						1	ng/mL	0	IL-7	11	73
356912	20233								Visfatin	201293.0						1	ng/mL	0	IL-7	11	66
356913	20233															2	ug/mL	0	IL-7	10	81
356914	20233								TNF-a	201285.0						100	ng/mL	0	IL-7	11	76
356915	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-7	8	44
356916	20233								IL-6	201287.0						100	ug/mL	0	IL-7	14	68
356917	20233								IL-17A	201288.0						100	ng/mL	0	IL-7	13.5	52
356918	20233								EGF	201289.0						100	ng/mL	0	IL-7	12	57
356919	20233								IGF-I	201290.0						100	ug/mL	0	IL-7	7.5	58
356920	20233								Adiponectin	201291.0						5	ng/mL	0	IL-7	51	49
356921	20233								Leptin	201292.0						1	ng/mL	0	IL-7	9	47
356922	20233								Visfatin	201293.0						1	ng/mL	0	IL-7	11	58
356923	20233															2	ug/mL	0	IL-7	9	59
356924	20233								TNF-a	201285.0						100	ng/mL	0	IL-7	11	85
356925	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-7	9	86
356926	20233								IL-6	201287.0						100	ug/mL	0	IL-7	11	59
356927	20233								IL-17A	201288.0						100	ng/mL	0	IL-7	15	83
356928	20233								EGF	201289.0						100	ng/mL	0	IL-7	13	66
356929	20233								IGF-I	201290.0						100	ug/mL	0	IL-7	8.5	62
356930	20233								Adiponectin	201291.0						5	ng/mL	0	IL-7	49	71
356931	20233								Leptin	201292.0						1	ng/mL	0	IL-7	6	47
356932	20233								Visfatin	201293.0						1	ng/mL	0	IL-7	11	98
356933	20233															2	ug/mL	0	IL-7	9	69
356934	20233								TNF-a	201285.0						100	ng/mL	0	IL-7	12	80
356935	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-7	8	64
356936	20233								IL-6	201287.0						100	ug/mL	0	IL-7	7	49
356937	20233								IL-17A	201288.0						100	ng/mL	0	IL-7	15	69
356938	20233								EGF	201289.0						100	ng/mL	0	IL-7	9	58
356939	20233								IGF-I	201290.0						100	ug/mL	0	IL-7	8	79
356940	20233								Adiponectin	201291.0						5	ng/mL	0	IL-7	50.5	62
356941	20233								Leptin	201292.0						1	ng/mL	0	IL-7	7.5	70
356942	20233								Visfatin	201293.0						1	ng/mL	0	IL-7	10	36
356943	20233															2	ug/mL	0	IL-7	8	65
356944	20233																	0	IL-12 (p70)	14	59
356945	20233						RA2159	51112.0										1	IL-12 (p70)	47	74
356946	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-12 (p70)	44	59
356947	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-12 (p70)	66	69
356948	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-12 (p70)	51	81
356949	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-12 (p70)	41	70
356950	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-12 (p70)	45.5	74
356951	20233						RA2159	51112.0										1	IL-12 (p70)	44	51
356952	20233						N2586	51107.0										1	IL-12 (p70)	56	68
356953	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-12 (p70)	64	77
356954	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-12 (p70)	72	51
356955	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-12 (p70)	62	69
356956	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-12 (p70)	54	63
356957	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-12 (p70)	56	49
356958	20233						N2586	51107.0										1	IL-12 (p70)	55	35
356959	20233																	0	IL-12 (p70)	15.5	60
356960	20233																	0	IL-12 (p70)	16	49
356961	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-12 (p70)	56	57
356962	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-12 (p70)	48	73
356963	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	48	64
356964	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	50	83
356965	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	60.5	48
356966	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-12 (p70)	52	65
356967	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-12 (p70)	34.5	66
356968	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-12 (p70)	85	64
356969	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-12 (p70)	73	73
356970	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	73	56
356971	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	81	59
356972	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	59.5	60
356973	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-12 (p70)	70	65
356974	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-12 (p70)	70	30
356975	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-12 (p70)	60	64
356976	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-12 (p70)	58	77
356977	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	38	65
356978	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	74.5	64
356979	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	71	74
356980	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-12 (p70)	52	60
356981	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-12 (p70)	44	74
356982	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-12 (p70)	79.5	56
356983	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-12 (p70)	71.5	66
356984	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	64.5	54
356985	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	82	51
356986	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	80	68
356987	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-12 (p70)	71	53
356988	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-12 (p70)	50	77
356989	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-12 (p70)	65.5	70
356990	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-12 (p70)	38.5	64
356991	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-12 (p70)	47	77
356992	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-12 (p70)	35	83
356993	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-12 (p70)	47	57
356994	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-12 (p70)	57	62
356995	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-12 (p70)	35	64
356996	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-12 (p70)	52	73
356997	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-12 (p70)	46	64
356998	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-12 (p70)	82	61
356999	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-12 (p70)	59	60
357000	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-12 (p70)	49	59
357001	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-12 (p70)	59	69
357002	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-12 (p70)	59.5	68
357003	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-12 (p70)	39	69
357004	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-12 (p70)	52	54
357005	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	49	81
357006	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	58.5	74
357007	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	58	59
357008	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-12 (p70)	53	71
357009	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-12 (p70)	86	81
357010	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-12 (p70)	77.5	46
357011	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	73.5	54
357012	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	58	85
357013	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	56	62
357014	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-12 (p70)	56	81
357015	20233						RA2159	51112.0										1	IL-12 (p70)	52	51
357016	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-12 (p70)	38	67
357017	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-12 (p70)	53	75
357018	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-12 (p70)	47	59
357019	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-12 (p70)	55	47
357020	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-12 (p70)	39	81
357021	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-12 (p70)	52.5	56
357022	20233						N2586	51107.0										1	IL-12 (p70)	53	74
357023	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-12 (p70)	62	57
357024	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-12 (p70)	67	35
357025	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-12 (p70)	56	61
357026	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-12 (p70)	70	45
357027	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-12 (p70)	82	60
357028	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-12 (p70)	63.5	76
357029	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-12 (p70)	52	68
357030	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-12 (p70)	53.5	64
357031	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	46	66
357032	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	38	73
357033	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	57	78
357034	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-12 (p70)	44	67
357035	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-12 (p70)	42	89
357036	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-12 (p70)	63	84
357037	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-12 (p70)	77.5	58
357038	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	56.5	42
357039	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	62	37
357040	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-12 (p70)	63	56
357041	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-12 (p70)	80	36
357042	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-12 (p70)	58	80
357043	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-12 (p70)	48	59
357044	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-12 (p70)	44	79
357045	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-12 (p70)	55	59
357046	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-12 (p70)	50	65
357047	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-12 (p70)	43	91
357048	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-12 (p70)	40	50
357049	20233						RA2159	51112.0										1	IL-12 (p70)	41	55
357050	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-12 (p70)	56	39
357051	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-12 (p70)	70	62
357052	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-12 (p70)	66.5	72
357053	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-12 (p70)	68.5	48
357054	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-12 (p70)	48	51
357055	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-12 (p70)	61.5	70
357056	20233						N2586	51107.0										1	IL-12 (p70)	63	72
357057	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-12 (p70)	39	77
357058	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-12 (p70)	31	73
357059	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-12 (p70)	35.5	50
357060	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-12 (p70)	38	58
357061	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-12 (p70)	41	66
357062	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-12 (p70)	31.5	70
357063	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-12 (p70)	55.5	72
357064	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-12 (p70)	60.5	62
357065	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-12 (p70)	65	45
357066	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-12 (p70)	41	43
357067	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-12 (p70)	45	54
357068	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-12 (p70)	59	48
357069	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-12 (p70)	38.5	58
357070	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-12 (p70)	36	47
357071	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-12 (p70)	51	71
357072	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-12 (p70)	44	58
357073	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-12 (p70)	39.5	62
357074	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-12 (p70)	38	51
357075	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-12 (p70)	52	51
357076	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-12 (p70)	51	66
357077	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-12 (p70)	57.5	68
357078	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-12 (p70)	51	68
357079	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-12 (p70)	45	51
357080	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-12 (p70)	45	35
357081	20233						RA2159	51112.0										1	IL-12 (p70)	48.5	58
357082	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-12 (p70)	60.5	62
357083	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-12 (p70)	52	73
357084	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-12 (p70)	53	61
357085	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-12 (p70)	44	67
357086	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-12 (p70)	43	76
357087	20233						RA2159	51112.0										1	IL-12 (p70)	50	75
357088	20233						N2586	51107.0										1	IL-12 (p70)	66	67
357089	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-12 (p70)	63	79
357090	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-12 (p70)	94.5	50
357091	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-12 (p70)	50	69
357092	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-12 (p70)	67.5	54
357093	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-12 (p70)	58	66
357094	20233						N2586	51107.0										1	IL-12 (p70)	66	63
357095	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-12 (p70)	43	53
357096	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-12 (p70)	48.5	54
357097	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-12 (p70)	53.5	56
357098	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-12 (p70)	58	70
357099	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-12 (p70)	42.5	44
357100	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-12 (p70)	36	74
357101	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-12 (p70)	31	59
357102	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-12 (p70)	55	62
357103	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-12 (p70)	61	75
357104	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-12 (p70)	35.5	66
357105	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-12 (p70)	55	56
357106	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-12 (p70)	64	45
357107	20233																	0	IL-12 (p70)	12	70
357108	20233						RA2159	51112.0								2	ug/mL	1	IL-12 (p70)	57.5	60
357109	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-12 (p70)	51	50
357110	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-12 (p70)	42.5	52
357111	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-12 (p70)	63	49
357112	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-12 (p70)	49	66
357113	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-12 (p70)	47	70
357114	20233						N2586	51107.0								2	ug/mL	1	IL-12 (p70)	55	36
357115	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-12 (p70)	76	71
357116	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-12 (p70)	46	71
357117	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-12 (p70)	55	41
357118	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-12 (p70)	68.5	48
357119	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-12 (p70)	57.5	46
357120	20233																	0	IL-12 (p70)	15	45
357121	20233						RA2159	51112.0										2	IL-12 (p70)	38	75
357122	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-12 (p70)	30	60
357123	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-12 (p70)	47.5	58
357124	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-12 (p70)	33.5	62
357125	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-12 (p70)	37	59
357126	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-12 (p70)	35	69
357127	20233						RA2159	51112.0										2	IL-12 (p70)	39	48
357128	20233						N2586	51107.0										2	IL-12 (p70)	58	47
357129	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-12 (p70)	44	49
357130	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-12 (p70)	59	47
357131	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-12 (p70)	43.5	40
357132	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-12 (p70)	58	54
357133	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-12 (p70)	53	51
357134	20233						N2586	51107.0										2	IL-12 (p70)	67	43
357135	20233																	0	IL-12 (p70)	16	59
357136	20233																	0	IL-12 (p70)	12	42
357137	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-12 (p70)	45	58
357138	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-12 (p70)	47	69
357139	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-12 (p70)	45.5	54
357140	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-12 (p70)	49	57
357141	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-12 (p70)	34	62
357142	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-12 (p70)	33	51
357143	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-12 (p70)	46	56
357144	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-12 (p70)	59	44
357145	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-12 (p70)	53	77
357146	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-12 (p70)	62	53
357147	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-12 (p70)	40	58
357148	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-12 (p70)	81	55
357149	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-12 (p70)	69	51
357150	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-12 (p70)	54	35
357151	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-12 (p70)	60	68
357152	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-12 (p70)	49	65
357153	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-12 (p70)	33	55
357154	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-12 (p70)	43.5	66
357155	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-12 (p70)	61.5	68
357156	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-12 (p70)	47	59
357157	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-12 (p70)	46	56
357158	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-12 (p70)	67	42
357159	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-12 (p70)	40	69
357160	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-12 (p70)	73	70
357161	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-12 (p70)	65	65
357162	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-12 (p70)	84	66
357163	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-12 (p70)	71	51
357164	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-12 (p70)	46	53
357165	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-12 (p70)	36	65
357166	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-12 (p70)	35	47
357167	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-12 (p70)	32	68
357168	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-12 (p70)	33	64
357169	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-12 (p70)	29	64
357170	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-12 (p70)	30	83
357171	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-12 (p70)	37	55
357172	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-12 (p70)	68	71
357173	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-12 (p70)	44	63
357174	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-12 (p70)	51	53
357175	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-12 (p70)	58.5	52
357176	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-12 (p70)	56	44
357177	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-12 (p70)	51	54
357178	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-12 (p70)	68	45
357179	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-12 (p70)	41	61
357180	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-12 (p70)	41	69
357181	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-12 (p70)	40	72
357182	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-12 (p70)	37	69
357183	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-12 (p70)	40.5	60
357184	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-12 (p70)	52	53
357185	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-12 (p70)	43	59
357186	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-12 (p70)	86	57
357187	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-12 (p70)	53	68
357188	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-12 (p70)	52	59
357189	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-12 (p70)	53.5	70
357190	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-12 (p70)	49	55
357191	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-12 (p70)	47	73
357192	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-12 (p70)	51	50
357193	20233						RA2159	51112.0										2	IL-12 (p70)	41	61
357194	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-12 (p70)	37	73
357195	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-12 (p70)	36	72
357196	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-12 (p70)	33.5	40
357197	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-12 (p70)	30	54
357198	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-12 (p70)	34.5	70
357199	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-12 (p70)	32	30
357200	20233						N2586	51107.0										2	IL-12 (p70)	54.5	54
357201	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-12 (p70)	50	63
357202	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-12 (p70)	44	69
357203	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-12 (p70)	42.5	64
357204	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-12 (p70)	51	61
357205	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-12 (p70)	40	55
357206	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-12 (p70)	46	45
357207	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-12 (p70)	29	95
357208	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-12 (p70)	37	71
357209	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-12 (p70)	32	60
357210	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-12 (p70)	29	57
357211	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-12 (p70)	26	77
357212	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-12 (p70)	35.5	68
357213	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-12 (p70)	50	61
357214	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-12 (p70)	52	66
357215	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-12 (p70)	46	66
357216	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-12 (p70)	50	58
357217	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-12 (p70)	47	61
357218	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-12 (p70)	4	62
357219	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-12 (p70)	36	93
357220	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-12 (p70)	31	53
357221	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-12 (p70)	31	85
357222	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-12 (p70)	35	78
357223	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-12 (p70)	29	73
357224	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-12 (p70)	33	72
357225	20233						RA2159	51112.0										2	IL-12 (p70)	39	69
357226	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-12 (p70)	46.5	80
357227	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-12 (p70)	59	65
357228	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-12 (p70)	40	51
357229	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-12 (p70)	50.5	62
357230	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-12 (p70)	46	52
357231	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-12 (p70)	40	54
357232	20233						N2586	51107.0										2	IL-12 (p70)	4	60
357233	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-12 (p70)	42	61
357234	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-12 (p70)	35.5	70
357235	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-12 (p70)	23	72
357236	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-12 (p70)	28	62
357237	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-12 (p70)	42	55
357238	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-12 (p70)	38	65
357239	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-12 (p70)	66	78
357240	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-12 (p70)	28	51
357241	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-12 (p70)	43	62
357242	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-12 (p70)	44	53
357243	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-12 (p70)	44	61
357244	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-12 (p70)	58	56
357245	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-12 (p70)	41.5	70
357246	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-12 (p70)	34	63
357247	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-12 (p70)	30	71
357248	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-12 (p70)	29.5	50
357249	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-12 (p70)	29	67
357250	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-12 (p70)	33	74
357251	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-12 (p70)	38	85
357252	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-12 (p70)	53	23
357253	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-12 (p70)	41	55
357254	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-12 (p70)	41	52
357255	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-12 (p70)	52.5	52
357256	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-12 (p70)	49	65
357257	20233						RA2159	51112.0										2	IL-12 (p70)	63	63
357258	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-12 (p70)	37.5	66
357259	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-12 (p70)	30	71
357260	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-12 (p70)	40	66
357261	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-12 (p70)	35.5	76
357262	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-12 (p70)	37	52
357263	20233						RA2159	51112.0										2	IL-12 (p70)	35.5	38
357264	20233						N2586	51107.0										2	IL-12 (p70)	63	50
357265	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-12 (p70)	59.5	48
357266	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-12 (p70)	47.5	70
357267	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-12 (p70)	54	60
357268	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-12 (p70)	55	60
357269	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-12 (p70)	58	43
357270	20233						N2586	51107.0										2	IL-12 (p70)	56.5	56
357271	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-12 (p70)	42	60
357272	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-12 (p70)	36.5	52
357273	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-12 (p70)	32	61
357274	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-12 (p70)	35	59
357275	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-12 (p70)	37	39
357276	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-12 (p70)	30.5	44
357277	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-12 (p70)	39	55
357278	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-12 (p70)	48	49
357279	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-12 (p70)	45.5	42
357280	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-12 (p70)	68.5	18
357281	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-12 (p70)	63	42
357282	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-12 (p70)	49	31
357283	20233																	0	IL-12 (p70)	12	49
357284	20233						RA2159	51112.0								2	ug/mL	2	IL-12 (p70)	34.5	56
357285	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-12 (p70)	31	67
357286	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-12 (p70)	36	66
357287	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-12 (p70)	40	58
357288	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-12 (p70)	32.5	44
357289	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-12 (p70)	42	40
357290	20233						N2586	51107.0								2	ug/mL	2	IL-12 (p70)	89	35
357291	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-12 (p70)	49.5	36
357292	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-12 (p70)	26	27
357293	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-12 (p70)	85	34
357294	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-12 (p70)	55	27
357295	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-12 (p70)	59	48
357296	20233																	0	IL-12 (p70)	13	71
357297	20233						RA2159	51112.0								2	ug/mL	3	IL-12 (p70)	64	69
357298	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-12 (p70)	66	64
357299	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-12 (p70)	60.5	56
357300	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-12 (p70)	61	59
357301	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-12 (p70)	50	63
357302	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-12 (p70)	56.5	78
357303	20233						N2586	51107.0								2	ug/mL	3	IL-12 (p70)	95	62
357304	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-12 (p70)	75	64
357305	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-12 (p70)	59	77
357306	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-12 (p70)	79	77
357307	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-12 (p70)	79	56
357308	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-12 (p70)	89	63
357309	20233						RA2159	51112.0										3	IL-12 (p70)	62	61
357310	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-12 (p70)	61	63
357311	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-12 (p70)	57	63
357312	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-12 (p70)	52	53
357313	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-12 (p70)	66	61
357314	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-12 (p70)	70.5	60
357315	20233						RA2159	51112.0										3	IL-12 (p70)	53.5	88
357316	20233						N2586	51107.0										3	IL-12 (p70)	94	73
357317	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-12 (p70)	62	74
357318	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-12 (p70)	63.5	56
357319	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-12 (p70)	80	65
357320	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-12 (p70)	91.5	82
357321	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-12 (p70)	85	67
357322	20233						N2586	51107.0										3	IL-12 (p70)	91	55
357323	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-12 (p70)	50	60
357324	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-12 (p70)	75	52
357325	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-12 (p70)	63	55
357326	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-12 (p70)	51	59
357327	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-12 (p70)	49	68
357328	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-12 (p70)	58	63
357329	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-12 (p70)	90	55
357330	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-12 (p70)	80.5	76
357331	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-12 (p70)	68	54
357332	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-12 (p70)	72	55
357333	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-12 (p70)	68	41
357334	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-12 (p70)	68	61
357335	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-12 (p70)	52	70
357336	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-12 (p70)	54.5	66
357337	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-12 (p70)	26.5	76
357338	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-12 (p70)	64.5	64
357339	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-12 (p70)	57	81
357340	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-12 (p70)	53	69
357341	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-12 (p70)	78.5	94
357342	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-12 (p70)	59.5	68
357343	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-12 (p70)	42.5	48
357344	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-12 (p70)	71.5	68
357345	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-12 (p70)	89.5	64
357346	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-12 (p70)	81.5	70
357347	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-12 (p70)	51.5	70
357348	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-12 (p70)	68	69
357349	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-12 (p70)	56	71
357350	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-12 (p70)	54	58
357351	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-12 (p70)	49	73
357352	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-12 (p70)	47.5	74
357353	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-12 (p70)	83	72
357354	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-12 (p70)	75.5	74
357355	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-12 (p70)	55.5	68
357356	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-12 (p70)	92.5	62
357357	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-12 (p70)	100	71
357358	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-12 (p70)	86	61
357359	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-12 (p70)	52.5	68
357360	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-12 (p70)	47	63
357361	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-12 (p70)	65	67
357362	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-12 (p70)	52	63
357363	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-12 (p70)	56	73
357364	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-12 (p70)	58.5	62
357365	20233						RA2159	51112.0										3	IL-12 (p70)	59	62
357366	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-12 (p70)	79.5	56
357367	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-12 (p70)	67	67
357368	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-12 (p70)	64	77
357369	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-12 (p70)	91	65
357370	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-12 (p70)	77	75
357371	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-12 (p70)	82.5	68
357372	20233						N2586	51107.0										3	IL-12 (p70)	75	72
357373	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-12 (p70)	51	68
357374	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-12 (p70)	45	65
357375	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	58	58
357376	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	59	41
357377	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	37	75
357378	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-12 (p70)	46.5	48
357379	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-12 (p70)	54	81
357380	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-12 (p70)	92.5	56
357381	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-12 (p70)	71.5	78
357382	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	70	53
357383	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	78	59
357384	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	62.5	66
357385	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-12 (p70)	67	63
357386	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-12 (p70)	42	39
357387	20233						RA2159	51112.0										3	IL-12 (p70)	46	60
357388	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-12 (p70)	68	53
357389	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-12 (p70)	55.5	54
357390	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-12 (p70)	49	58
357391	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-12 (p70)	43	67
357392	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-12 (p70)	44	71
357393	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-12 (p70)	36	69
357394	20233						N2586	51107.0										3	IL-12 (p70)	62.5	62
357395	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-12 (p70)	57	58
357396	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-12 (p70)	52	72
357397	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-12 (p70)	65	67
357398	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-12 (p70)	84.5	68
357399	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-12 (p70)	51	67
357400	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-12 (p70)	75	53
357401	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-12 (p70)	53	54
357402	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-12 (p70)	93	69
357403	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	60	72
357404	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	56	75
357405	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	52.5	60
357406	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-12 (p70)	55	67
357407	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-12 (p70)	65	64
357408	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-12 (p70)	70	84
357409	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	31	58
357410	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	59	71
357411	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	108	51
357412	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-12 (p70)	78	65
357413	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-12 (p70)	57	78
357414	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-12 (p70)	52	75
357415	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-12 (p70)	53	65
357416	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-12 (p70)	40.5	74
357417	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-12 (p70)	47	77
357418	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-12 (p70)	36	59
357419	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-12 (p70)	44.5	72
357420	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-12 (p70)	76	81
357421	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-12 (p70)	67	63
357422	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-12 (p70)	51	69
357423	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-12 (p70)	78	79
357424	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-12 (p70)	78.5	72
357425	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-12 (p70)	83	57
357426	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-12 (p70)	70.5	70
357427	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-12 (p70)	89	61
357428	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-12 (p70)	89	59
357429	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	67.5	52
357430	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	84.5	60
357431	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	70	87
357432	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-12 (p70)	45	52
357433	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-12 (p70)	40	62
357434	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-12 (p70)	102	66
357435	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-12 (p70)	68	77
357436	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	98	55
357437	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	97.5	72
357438	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	73	41
357439	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-12 (p70)	103	77
357440	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-12 (p70)	71	85
357441	20233																	0	IL-12 (p70)	14	53
357442	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-12 (p70)	86	55
357443	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-12 (p70)	68.5	62
357444	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	52	67
357445	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	76	78
357446	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	62	63
357447	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-12 (p70)	48.5	64
357448	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-12 (p70)	44	62
357449	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-12 (p70)	80	72
357450	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-12 (p70)	73	68
357451	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	74.5	78
357452	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	43	49
357453	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-12 (p70)	98	46
357454	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-12 (p70)	92.5	70
357455	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-12 (p70)	93.5	70
357456	20233																	0	IL-12 (p70)	9	66
357457	20233						RA2159	51112.0										3	IL-12 (p70)	47	68
357458	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-12 (p70)	58	55
357459	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-12 (p70)	51	62
357460	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-12 (p70)	66.5	52
357461	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-12 (p70)	36.5	34
357462	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-12 (p70)	44	77
357463	20233						RA2159	51112.0										3	IL-12 (p70)	56	64
357464	20233						N2586	51107.0										3	IL-12 (p70)	90	56
357465	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-12 (p70)	70.5	68
357466	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-12 (p70)	57	51
357467	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-12 (p70)	81	53
357468	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-12 (p70)	82	49
357469	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-12 (p70)	79.5	70
357470	20233						N2586	51107.0										3	IL-12 (p70)	68	31
357471	20233																	0	IL-12 (p70)	11.5	58
357472	20233						RA2159	51112.0								2	ug/mL	4	IL-12 (p70)	84.5	46
357473	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-12 (p70)	75	47
357474	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-12 (p70)	64	67
357475	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-12 (p70)	72	71
357476	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-12 (p70)	55	54
357477	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-12 (p70)	64	61
357478	20233						N2586	51107.0								2	ug/mL	4	IL-12 (p70)	87	65
357479	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-12 (p70)	78.5	76
357480	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-12 (p70)	76	73
357481	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-12 (p70)	69	39
357482	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-12 (p70)	80	72
357483	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-12 (p70)	59	79
357484	20233						RA2159	51112.0										4	IL-12 (p70)	59	67
357485	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-12 (p70)	54	69
357486	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-12 (p70)	49	75
357487	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-12 (p70)	59	83
357488	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-12 (p70)	63	63
357489	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-12 (p70)	49	53
357490	20233						RA2159	51112.0										4	IL-12 (p70)	63	59
357491	20233						N2586	51107.0										4	IL-12 (p70)	51.5	66
357492	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-12 (p70)	70.5	60
357493	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-12 (p70)	64	61
357494	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-12 (p70)	70	57
357495	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-12 (p70)	58	55
357496	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-12 (p70)	70	71
357497	20233						N2586	51107.0										4	IL-12 (p70)	67.5	58
357498	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-12 (p70)	61	71
357499	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-12 (p70)	74.5	54
357500	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-12 (p70)	57	63
357501	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-12 (p70)	57	79
357502	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-12 (p70)	54.5	72
357503	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-12 (p70)	53.5	50
357504	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-12 (p70)	65	77
357505	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-12 (p70)	63	51
357506	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-12 (p70)	73	51
357507	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-12 (p70)	60	56
357508	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-12 (p70)	73	63
357509	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-12 (p70)	54.5	50
357510	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-12 (p70)	63	89
357511	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-12 (p70)	52	67
357512	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-12 (p70)	56	66
357513	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-12 (p70)	58	67
357514	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-12 (p70)	59	49
357515	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-12 (p70)	55	71
357516	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-12 (p70)	72	53
357517	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-12 (p70)	75.5	60
357518	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-12 (p70)	61	59
357519	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-12 (p70)	65	85
357520	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-12 (p70)	75	69
357521	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-12 (p70)	49.5	76
357522	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-12 (p70)	51	73
357523	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-12 (p70)	59	55
357524	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-12 (p70)	56	50
357525	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-12 (p70)	55.5	68
357526	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-12 (p70)	53	52
357527	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-12 (p70)	74	48
357528	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-12 (p70)	61	65
357529	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-12 (p70)	67	49
357530	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-12 (p70)	83	52
357531	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-12 (p70)	68	57
357532	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-12 (p70)	75	57
357533	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-12 (p70)	55	58
357534	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-12 (p70)	62	71
357535	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-12 (p70)	62	47
357536	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-12 (p70)	52	74
357537	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-12 (p70)	53	64
357538	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-12 (p70)	54.5	62
357539	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-12 (p70)	69.5	68
357540	20233						RA2159	51112.0										4	IL-12 (p70)	58	54
357541	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-12 (p70)	68.5	50
357542	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-12 (p70)	80.5	58
357543	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-12 (p70)	74.5	50
357544	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-12 (p70)	70	53
357545	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-12 (p70)	67	65
357546	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-12 (p70)	81	61
357547	20233						N2586	51107.0										4	IL-12 (p70)	79	89
357548	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-12 (p70)	53	73
357549	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-12 (p70)	54	74
357550	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-12 (p70)	53	60
357551	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-12 (p70)	70	42
357552	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-12 (p70)	62	19
357553	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-12 (p70)	61	45
357554	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-12 (p70)	89.5	68
357555	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-12 (p70)	97	77
357556	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-12 (p70)	77	59
357557	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-12 (p70)	76.5	44
357558	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-12 (p70)	63	49
357559	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-12 (p70)	64	79
357560	20233						RA2159	51112.0										4	IL-12 (p70)	40	54
357561	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-12 (p70)	59.5	72
357562	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-12 (p70)	49.5	66
357563	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-12 (p70)	57	61
357564	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-12 (p70)	34.5	48
357565	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-12 (p70)	49.5	52
357566	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-12 (p70)	46	49
357567	20233						N2586	51107.0										4	IL-12 (p70)	49	64
357568	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-12 (p70)	80.5	42
357569	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-12 (p70)	88	65
357570	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-12 (p70)	56	66
357571	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-12 (p70)	78	56
357572	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-12 (p70)	47.5	80
357573	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-12 (p70)	73.5	58
357574	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-12 (p70)	49	55
357575	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-12 (p70)	44	75
357576	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-12 (p70)	44	69
357577	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-12 (p70)	61	47
357578	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-12 (p70)	55.5	52
357579	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-12 (p70)	67	73
357580	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-12 (p70)	50.5	66
357581	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-12 (p70)	64	41
357582	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-12 (p70)	71	66
357583	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-12 (p70)	94	59
357584	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-12 (p70)	62	71
357585	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-12 (p70)	48.5	56
357586	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-12 (p70)	73	73
357587	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-12 (p70)	43	65
357588	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-12 (p70)	53	52
357589	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-12 (p70)	42	71
357590	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-12 (p70)	42.5	38
357591	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-12 (p70)	59.5	46
357592	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-12 (p70)	49	63
357593	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-12 (p70)	49	55
357594	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-12 (p70)	56.5	38
357595	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-12 (p70)	67	50
357596	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-12 (p70)	78	49
357597	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-12 (p70)	69	38
357598	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-12 (p70)	75	50
357599	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-12 (p70)	64	65
357600	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-12 (p70)	37.5	52
357601	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-12 (p70)	78	63
357602	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-12 (p70)	78	51
357603	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-12 (p70)	53	71
357604	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-12 (p70)	74.5	66
357605	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-12 (p70)	75	55
357606	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-12 (p70)	70	49
357607	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-12 (p70)	69	77
357608	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-12 (p70)	53	57
357609	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-12 (p70)	105	79
357610	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-12 (p70)	90.5	50
357611	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-12 (p70)	87	46
357612	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-12 (p70)	94	53
357613	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-12 (p70)	75.5	50
357614	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-12 (p70)	84	57
357615	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-12 (p70)	58	40
357616	20233																	0	IL-12 (p70)	12	57
357617	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-12 (p70)	64	75
357618	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-12 (p70)	53	41
357619	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-12 (p70)	55.5	60
357620	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-12 (p70)	55.5	72
357621	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-12 (p70)	58.5	50
357622	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-12 (p70)	59	55
357623	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-12 (p70)	56	57
357624	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-12 (p70)	98	61
357625	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-12 (p70)	102	52
357626	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-12 (p70)	72	41
357627	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-12 (p70)	90	51
357628	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-12 (p70)	71	49
357629	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-12 (p70)	60.5	58
357630	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-12 (p70)	71	71
357631	20233																	0	IL-12 (p70)	10	61
357632	20233						RA2159	51112.0										4	IL-12 (p70)	52	67
357633	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-12 (p70)	44	62
357634	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-12 (p70)	51.5	80
357635	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-12 (p70)	58	56
357636	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-12 (p70)	44	74
357637	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-12 (p70)	52	47
357638	20233						RA2159	51112.0										4	IL-12 (p70)	72	48
357639	20233						N2586	51107.0										4	IL-12 (p70)	101	47
357640	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-12 (p70)	52	33
357641	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-12 (p70)	77.5	58
357642	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-12 (p70)	79	57
357643	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-12 (p70)	55	38
357644	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-12 (p70)	53	67
357645	20233						N2586	51107.0										4	IL-12 (p70)	58.5	52
357646	20233								TNF-a	201285.0						100	ng/mL	0	IL-12 (p70)	21	75
357647	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-12 (p70)	14	64
357648	20233								IL-6	201287.0						100	ug/mL	0	IL-12 (p70)	18.5	58
357649	20233								IL-17A	201288.0						100	ng/mL	0	IL-12 (p70)	30	72
357650	20233								EGF	201289.0						100	ng/mL	0	IL-12 (p70)	14	61
357651	20233								IGF-I	201290.0						100	ug/mL	0	IL-12 (p70)	10	53
357652	20233								Adiponectin	201291.0						5	ng/mL	0	IL-12 (p70)	22	67
357653	20233								Leptin	201292.0						1	ng/mL	0	IL-12 (p70)	14	67
357654	20233								Visfatin	201293.0						1	ng/mL	0	IL-12 (p70)	16	45
357655	20233															2	ug/mL	0	IL-12 (p70)	13	73
357656	20233								TNF-a	201285.0						100	ng/mL	0	IL-12 (p70)	15.5	60
357657	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-12 (p70)	14	42
357658	20233								IL-6	201287.0						100	ug/mL	0	IL-12 (p70)	16	52
357659	20233								IL-17A	201288.0						100	ng/mL	0	IL-12 (p70)	26.5	52
357660	20233								EGF	201289.0						100	ng/mL	0	IL-12 (p70)	11	50
357661	20233								IGF-I	201290.0						100	ug/mL	0	IL-12 (p70)	11	54
357662	20233								Adiponectin	201291.0						5	ng/mL	0	IL-12 (p70)	26	38
357663	20233								Leptin	201292.0						1	ng/mL	0	IL-12 (p70)	15.5	26
357664	20233								Visfatin	201293.0						1	ng/mL	0	IL-12 (p70)	15	64
357665	20233															2	ug/mL	0	IL-12 (p70)	12	45
357666	20233								TNF-a	201285.0						100	ng/mL	0	IL-12 (p70)	19	67
357667	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-12 (p70)	13	60
357668	20233								IL-6	201287.0						100	ug/mL	0	IL-12 (p70)	16	53
357669	20233								IL-17A	201288.0						100	ng/mL	0	IL-12 (p70)	30	55
357670	20233								EGF	201289.0						100	ng/mL	0	IL-12 (p70)	13.5	60
357671	20233								IGF-I	201290.0						100	ug/mL	0	IL-12 (p70)	13	61
357672	20233								Adiponectin	201291.0						5	ng/mL	0	IL-12 (p70)	14	60
357673	20233								Leptin	201292.0						1	ng/mL	0	IL-12 (p70)	9.5	40
357674	20233								Visfatin	201293.0						1	ng/mL	0	IL-12 (p70)	15	71
357675	20233															2	ug/mL	0	IL-12 (p70)	11	57
357676	20233								TNF-a	201285.0						100	ng/mL	0	IL-12 (p70)	20	62
357677	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-12 (p70)	14	59
357678	20233								IL-6	201287.0						100	ug/mL	0	IL-12 (p70)	12	54
357679	20233								IL-17A	201288.0						100	ng/mL	0	IL-12 (p70)	32	57
357680	20233								EGF	201289.0						100	ng/mL	0	IL-12 (p70)	9	77
357681	20233								IGF-I	201290.0						100	ug/mL	0	IL-12 (p70)	11	84
357682	20233								Adiponectin	201291.0						5	ng/mL	0	IL-12 (p70)	19	56
357683	20233								Leptin	201292.0						1	ng/mL	0	IL-12 (p70)	15	47
357684	20233								Visfatin	201293.0						1	ng/mL	0	IL-12 (p70)	13	35
357685	20233															2	ug/mL	0	IL-12 (p70)	11	62
357686	20233																	0	IL-17	61	61
357687	20233						RA2159	51112.0										1	IL-17	57	70
357688	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-17	53	52
357689	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-17	58	81
357690	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-17	59	73
357691	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-17	50.5	60
357692	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-17	57	52
357693	20233						RA2159	51112.0										1	IL-17	60	65
357694	20233						N2586	51107.0										1	IL-17	56.5	76
357695	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-17	55	55
357696	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-17	57	65
357697	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-17	58	64
357698	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-17	54	61
357699	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-17	53	51
357700	20233						N2586	51107.0										1	IL-17	63	24
357701	20233																	0	IL-17	55	60
357702	20233																	0	IL-17	54	41
357703	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-17	69	47
357704	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-17	68.5	64
357705	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-17	65.5	54
357706	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-17	65.5	70
357707	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-17	74	46
357708	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-17	65	71
357709	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-17	60	57
357710	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-17	70	63
357711	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-17	74.5	58
357712	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-17	80.5	48
357713	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-17	76	65
357714	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-17	73	66
357715	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-17	63	66
357716	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-17	77	51
357717	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-17	67	73
357718	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-17	67	83
357719	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-17	55	71
357720	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-17	70	57
357721	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-17	74.5	78
357722	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-17	51	67
357723	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-17	46.5	82
357724	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-17	75	65
357725	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-17	69	52
357726	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-17	63.5	60
357727	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-17	67	61
357728	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-17	72	48
357729	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-17	60.5	56
357730	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-17	59.5	62
357731	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-17	65	71
357732	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-17	51	69
357733	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-17	50	61
357734	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-17	65	84
357735	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-17	56	66
357736	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-17	61	77
357737	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-17	51	62
357738	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-17	57.5	80
357739	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-17	53	58
357740	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-17	59	55
357741	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-17	54.5	52
357742	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-17	52	85
357743	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-17	63	69
357744	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-17	59	59
357745	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-17	2878	76
357746	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-17	2828	76
357747	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-17	2862	62
357748	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-17	4239	61
357749	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-17	5115	50
357750	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-17	5428	79
357751	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-17	9566	80
357752	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-17	5499	49
357753	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-17	3361	71
357754	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-17	4458.5	78
357755	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-17	4159	71
357756	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-17	4316	75
357757	20233						RA2159	51112.0										1	IL-17	59	75
357758	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-17	50	71
357759	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-17	53	68
357760	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-17	54	59
357761	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-17	51	45
357762	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-17	49.5	82
357763	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-17	57	53
357764	20233						N2586	51107.0										1	IL-17	52	64
357765	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-17	48	61
357766	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-17	51.5	40
357767	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-17	48	53
357768	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-17	51	49
357769	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-17	52.5	56
357770	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-17	54	76
357771	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-17	54	71
357772	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-17	48.5	48
357773	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-17	51	75
357774	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-17	50	66
357775	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-17	50.5	68
357776	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-17	48	65
357777	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-17	51	86
357778	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-17	51	73
357779	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-17	50.5	52
357780	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-17	49	63
357781	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-17	49	39
357782	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-17	49	52
357783	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-17	51	39
357784	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-17	56	54
357785	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-17	49	71
357786	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-17	41	75
357787	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-17	52.5	56
357788	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-17	49.5	68
357789	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-17	45.5	72
357790	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-17	46	87
357791	20233						RA2159	51112.0										1	IL-17	49	69
357792	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-17	47	50
357793	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-17	43.5	72
357794	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-17	50.5	72
357795	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-17	46	47
357796	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-17	46.5	54
357797	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-17	49	59
357798	20233						N2586	51107.0										1	IL-17	61.5	82
357799	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-17	44	63
357800	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-17	45	60
357801	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-17	49	66
357802	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-17	44	53
357803	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-17	48	60
357804	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-17	46	63
357805	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-17	41	65
357806	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-17	42.5	50
357807	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-17	54	53
357808	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-17	47	44
357809	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-17	45	69
357810	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-17	48	47
357811	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-17	54	76
357812	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-17	46	57
357813	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-17	50	79
357814	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-17	50	54
357815	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-17	43.5	60
357816	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-17	50	62
357817	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-17	47	64
357818	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-17	44	58
357819	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-17	46.5	60
357820	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-17	39.5	80
357821	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-17	45	54
357822	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-17	43.5	48
357823	20233						RA2159	51112.0										1	IL-17	49	53
357824	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-17	44	59
357825	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-17	51	66
357826	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-17	54	55
357827	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-17	44	61
357828	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-17	50	50
357829	20233						RA2159	51112.0										1	IL-17	43.5	76
357830	20233						N2586	51107.0										1	IL-17	49.5	86
357831	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-17	53	75
357832	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-17	42	68
357833	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-17	46	63
357834	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-17	52	67
357835	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-17	46	56
357836	20233						N2586	51107.0										1	IL-17	45.5	62
357837	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-17	44	53
357838	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-17	51	62
357839	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-17	49	90
357840	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-17	46	66
357841	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-17	37	52
357842	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-17	45	58
357843	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-17	40	54
357844	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-17	50.5	54
357845	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-17	44	77
357846	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-17	41.5	54
357847	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-17	38.5	72
357848	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-17	42	37
357849	20233																	0	IL-17	43	49
357850	20233						RA2159	51112.0								2	ug/mL	1	IL-17	60.5	46
357851	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-17	52	57
357852	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-17	52	61
357853	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-17	55	33
357854	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-17	47	68
357855	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-17	47	77
357856	20233						N2586	51107.0								2	ug/mL	1	IL-17	59	33
357857	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-17	54	63
357858	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-17	43	70
357859	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-17	49	43
357860	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-17	52.5	40
357861	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-17	51	45
357862	20233																	0	IL-17	59	49
357863	20233						RA2159	51112.0										2	IL-17	59.5	70
357864	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-17	54	71
357865	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-17	66	71
357866	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-17	53	60
357867	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-17	50	55
357868	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-17	53	69
357869	20233						RA2159	51112.0										2	IL-17	56	31
357870	20233						N2586	51107.0										2	IL-17	60	41
357871	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-17	53	47
357872	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-17	50	56
357873	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-17	45	43
357874	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-17	57	61
357875	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-17	50.5	42
357876	20233						N2586	51107.0										2	IL-17	54	41
357877	20233																	0	IL-17	57	55
357878	20233																	0	IL-17	59	45
357879	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-17	67	79
357880	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-17	70	73
357881	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-17	68	65
357882	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-17	64	51
357883	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-17	59	59
357884	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-17	58	47
357885	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-17	51	53
357886	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-17	70	55
357887	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-17	65	57
357888	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-17	71	57
357889	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-17	63	61
357890	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-17	67	55
357891	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-17	77	49
357892	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-17	51	51
357893	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-17	75.5	66
357894	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-17	66	70
357895	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-17	64	79
357896	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-17	67	53
357897	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-17	71	68
357898	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-17	64.5	54
357899	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-17	47	41
357900	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-17	72	57
357901	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-17	65	71
357902	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-17	71.5	54
357903	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-17	68	58
357904	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-17	70	41
357905	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-17	67.5	48
357906	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-17	52	40
357907	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-17	62	52
357908	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-17	53	61
357909	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-17	57.5	62
357910	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-17	51.5	64
357911	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-17	50	71
357912	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-17	53	85
357913	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-17	46	43
357914	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-17	53.5	60
357915	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-17	52	74
357916	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-17	53	61
357917	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-17	54	54
357918	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-17	49	65
357919	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-17	53	49
357920	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-17	58	57
357921	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-17	2288	67
357922	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-17	3183	63
357923	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-17	2494	71
357924	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-17	3040.5	56
357925	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-17	2160	65
357926	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-17	2078	49
357927	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-17	52	57
357928	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-17	2749	47
357929	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-17	3147.5	58
357930	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-17	1788	69
357931	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-17	3070	81
357932	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-17	1976.5	64
357933	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-17	2118	80
357934	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-17	61	56
357935	20233						RA2159	51112.0										2	IL-17	53.5	52
357936	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-17	49	55
357937	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-17	54	63
357938	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-17	52.5	52
357939	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-17	52	61
357940	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-17	47.5	62
357941	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-17	45	43
357942	20233						N2586	51107.0										2	IL-17	44	56
357943	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-17	43.5	60
357944	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-17	42	59
357945	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-17	51	77
357946	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-17	53	53
357947	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-17	35	45
357948	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-17	54.5	46
357949	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-17	47	64
357950	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-17	51	75
357951	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-17	46	68
357952	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-17	43.5	50
357953	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-17	44	66
357954	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-17	45	81
357955	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-17	45	72
357956	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-17	48	64
357957	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-17	44	67
357958	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-17	42	52
357959	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-17	42	43
357960	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-17	10	56
357961	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-17	47	83
357962	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-17	48	44
357963	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-17	48.5	68
357964	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-17	49.5	60
357965	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-17	47	66
357966	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-17	44	65
357967	20233						RA2159	51112.0										2	IL-17	54	56
357968	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-17	44.5	82
357969	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-17	46	59
357970	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-17	50.5	46
357971	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-17	39	69
357972	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-17	55.5	46
357973	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-17	41	59
357974	20233						N2586	51107.0										2	IL-17	7.5	54
357975	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-17	42	67
357976	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-17	43	64
357977	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-17	46.5	58
357978	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-17	53	76
357979	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-17	51	68
357980	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-17	47.5	52
357981	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-17	40	71
357982	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-17	42	60
357983	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-17	40	65
357984	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-17	42	42
357985	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-17	44	57
357986	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-17	49	64
357987	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-17	49	52
357988	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-17	43	78
357989	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-17	47	65
357990	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-17	48.5	72
357991	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-17	42	67
357992	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-17	47	86
357993	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-17	43	75
357994	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-17	42	53
357995	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-17	40	55
357996	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-17	44	71
357997	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-17	48	47
357998	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-17	44	52
357999	20233						RA2159	51112.0										2	IL-17	44	56
358000	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-17	45	59
358001	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-17	41	59
358002	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-17	48	57
358003	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-17	41.5	74
358004	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-17	44	57
358005	20233						RA2159	51112.0										2	IL-17	46	49
358006	20233						N2586	51107.0										2	IL-17	36	31
358007	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-17	46.5	58
358008	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-17	42.5	62
358009	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-17	45.5	64
358010	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-17	44	40
358011	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-17	47	67
358012	20233						N2586	51107.0										2	IL-17	45	47
358013	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-17	45	72
358014	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-17	45	57
358015	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-17	40	69
358016	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-17	48	48
358017	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-17	39.5	48
358018	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-17	46.5	40
358019	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-17	34	50
358020	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-17	43	52
358021	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-17	41	39
358022	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-17	38	40
358023	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-17	44	43
358024	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-17	37.5	36
358025	20233																	0	IL-17	38.5	48
358026	20233						RA2159	51112.0								2	ug/mL	2	IL-17	45.5	52
358027	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-17	48	55
358028	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-17	47	79
358029	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-17	52.5	66
358030	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-17	48.5	40
358031	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-17	51	58
358032	20233						N2586	51107.0								2	ug/mL	2	IL-17	56.5	40
358033	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-17	50	36
358034	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-17	51	43
358035	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-17	49	40
358036	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-17	40	39
358037	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-17	55	46
358038	20233																	0	IL-17	49	51
358039	20233						RA2159	51112.0								2	ug/mL	3	IL-17	65.5	78
358040	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-17	60	67
358041	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-17	52	61
358042	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-17	65	62
358043	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-17	55	61
358044	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-17	56	69
358045	20233						N2586	51107.0								2	ug/mL	3	IL-17	65.5	78
358046	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-17	58	57
358047	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-17	68	61
358048	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-17	68	74
358049	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-17	49	63
358050	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-17	62	62
358051	20233						RA2159	51112.0										3	IL-17	41	63
358052	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-17	51.5	70
358053	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-17	46	62
358054	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-17	52	84
358055	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-17	51	68
358056	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-17	52	66
358057	20233						RA2159	51112.0										3	IL-17	53	72
358058	20233						N2586	51107.0										3	IL-17	55	77
358059	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-17	55	90
358060	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-17	45	59
358061	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-17	51.5	56
358062	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-17	48	85
358063	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-17	48	73
358064	20233						N2586	51107.0										3	IL-17	53.5	56
358065	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-17	49.5	64
358066	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-17	52	54
358067	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-17	48	84
358068	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-17	52	71
358069	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-17	50	62
358070	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-17	53	73
358071	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-17	46	69
358072	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-17	50.5	74
358073	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-17	48	88
358074	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-17	47	53
358075	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-17	40	57
358076	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-17	43	64
358077	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-17	51	74
358078	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-17	48.5	70
358079	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-17	34	89
358080	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-17	49	88
358081	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-17	42	60
358082	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-17	52	76
358083	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-17	43.5	86
358084	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-17	49	71
358085	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-17	43	73
358086	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-17	44	75
358087	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-17	48.5	84
358088	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-17	50.5	70
358089	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-17	45	72
358090	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-17	46.5	84
358091	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-17	45	78
358092	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-17	53	62
358093	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-17	44	64
358094	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-17	49	69
358095	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-17	48	73
358096	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-17	48	55
358097	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-17	46	66
358098	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-17	50.5	62
358099	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-17	47	59
358100	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-17	47	63
358101	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-17	48	72
358102	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-17	47	67
358103	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-17	44	72
358104	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-17	45	69
358105	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-17	45	77
358106	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-17	48.5	68
358107	20233						RA2159	51112.0										3	IL-17	50	62
358108	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-17	49	63
358109	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-17	42.5	52
358110	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-17	42	74
358111	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-17	46	69
358112	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-17	42.5	82
358113	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-17	47	50
358114	20233						N2586	51107.0										3	IL-17	54	65
358115	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-17	40.5	60
358116	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-17	41	53
358117	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-17	44.5	68
358118	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-17	45.5	34
358119	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-17	37	59
358120	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-17	37.5	52
358121	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-17	41	82
358122	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-17	47	69
358123	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-17	47	65
358124	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-17	47	61
358125	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-17	43	68
358126	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-17	41	67
358127	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-17	36	52
358128	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-17	44.5	60
358129	20233						RA2159	51112.0										3	IL-17	46.5	74
358130	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-17	49	59
358131	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-17	41	55
358132	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-17	44	49
358133	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-17	48	74
358134	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-17	44	68
358135	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-17	41.5	58
358136	20233						N2586	51107.0										3	IL-17	47	59
358137	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-17	44	83
358138	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-17	43	71
358139	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-17	48	93
358140	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-17	39	69
358141	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-17	49	56
358142	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-17	48	61
358143	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-17	5904	65
358144	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-17	6847.5	64
358145	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-17	5725	74
358146	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-17	6241.5	70
358147	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-17	7132.5	56
358148	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-17	6163	57
358149	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-17	2724	72
358150	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-17	3962	74
358151	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-17	2107	60
358152	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-17	3439.5	56
358153	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-17	3619	61
358154	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-17	3204	55
358155	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-17	52	62
358156	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-17	49	77
358157	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-17	47	52
358158	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-17	51	66
358159	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-17	48	70
358160	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-17	47	79
358161	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-17	48.5	66
358162	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-17	45	76
358163	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-17	45	69
358164	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-17	47	74
358165	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-17	47	50
358166	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-17	46	71
358167	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-17	49	79
358168	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-17	45	65
358169	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-17	65	58
358170	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-17	59	68
358171	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-17	51	65
358172	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-17	67	60
358173	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-17	65.5	74
358174	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-17	45	61
358175	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-17	45.5	46
358176	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-17	64.5	72
358177	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-17	60	65
358178	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-17	63	78
358179	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-17	64	48
358180	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-17	53	49
358181	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-17	55.5	60
358182	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-17	39	65
358183	20233																	0	IL-17	51	61
358184	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-17	71	51
358185	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-17	67.5	46
358186	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-17	53	50
358187	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-17	63	67
358188	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-17	53.5	66
358189	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-17	48	81
358190	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-17	42.5	60
358191	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-17	51	71
358192	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-17	59	51
358193	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-17	57	83
358194	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-17	23.5	52
358195	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-17	46	43
358196	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-17	60	61
358197	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-17	46	59
358198	20233																	0	IL-17	37	55
358199	20233						RA2159	51112.0										3	IL-17	44	62
358200	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-17	49	61
358201	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-17	40	71
358202	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-17	45	61
358203	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-17	35	53
358204	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-17	42	51
358205	20233						RA2159	51112.0										3	IL-17	43	52
358206	20233						N2586	51107.0										3	IL-17	47	67
358207	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-17	40	70
358208	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-17	43.5	60
358209	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-17	47	49
358210	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-17	44	33
358211	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-17	43	63
358212	20233						N2586	51107.0										3	IL-17	38	45
358213	20233																	0	IL-17	48	70
358214	20233						RA2159	51112.0								2	ug/mL	4	IL-17	64.5	56
358215	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-17	68	67
358216	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-17	71	58
358217	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-17	69	51
358218	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-17	57	70
358219	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-17	58.5	78
358220	20233						N2586	51107.0								2	ug/mL	4	IL-17	60	57
358221	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-17	63	77
358222	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-17	49	61
358223	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-17	59	65
358224	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-17	57	84
358225	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-17	49	64
358226	20233						RA2159	51112.0										4	IL-17	49.5	58
358227	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-17	51.5	80
358228	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-17	50	88
358229	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-17	48	79
358230	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-17	57	61
358231	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-17	45	69
358232	20233						RA2159	51112.0										4	IL-17	57	61
358233	20233						N2586	51107.0										4	IL-17	45	65
358234	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-17	42	70
358235	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-17	48	55
358236	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-17	47	58
358237	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-17	49	66
358238	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-17	50	79
358239	20233						N2586	51107.0										4	IL-17	49.5	58
358240	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-17	53	64
358241	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-17	53	57
358242	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-17	51	63
358243	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-17	49	81
358244	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-17	44	76
358245	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-17	51	61
358246	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-17	48	67
358247	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-17	45	69
358248	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-17	47	62
358249	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-17	47.5	52
358250	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-17	53	52
358251	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-17	45	60
358252	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-17	43	67
358253	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-17	47	77
358254	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-17	56	81
358255	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-17	51	69
358256	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-17	47.5	76
358257	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-17	48	67
358258	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-17	44	60
358259	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-17	50.5	42
358260	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-17	42.5	66
358261	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-17	48	81
358262	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-17	47	56
358263	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-17	46.5	88
358264	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-17	47	80
358265	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-17	51	68
358266	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-17	46	53
358267	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-17	49	62
358268	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-17	50.5	50
358269	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-17	46.5	54
358270	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-17	48	89
358271	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-17	42	65
358272	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-17	46.5	56
358273	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-17	47.5	42
358274	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-17	49	47
358275	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-17	51	58
358276	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-17	49	63
358277	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-17	50	45
358278	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-17	47	71
358279	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-17	48	70
358280	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-17	43	63
358281	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-17	43	57
358282	20233						RA2159	51112.0										4	IL-17	48	56
358283	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-17	41.5	66
358284	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-17	41	57
358285	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-17	46	67
358286	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-17	45	40
358287	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-17	41.5	60
358288	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-17	41.5	52
358289	20233						N2586	51107.0										4	IL-17	48	75
358290	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-17	49	63
358291	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-17	45.5	62
358292	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-17	48.5	68
358293	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-17	50	53
358294	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-17	47	37
358295	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-17	50	44
358296	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-17	45	69
358297	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-17	46	71
358298	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-17	45	65
358299	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-17	46.5	46
358300	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-17	43	54
358301	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-17	47	95
358302	20233						RA2159	51112.0										4	IL-17	45	68
358303	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-17	47	58
358304	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-17	50	51
358305	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-17	45	72
358306	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-17	43	45
358307	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-17	40	41
358308	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-17	43	57
358309	20233						N2586	51107.0										4	IL-17	47	75
358310	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-17	47	53
358311	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-17	43	56
358312	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-17	47	70
358313	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-17	45	65
358314	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-17	41	71
358315	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-17	45	65
358316	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-17	2337	48
358317	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-17	2325	69
358318	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-17	3004.5	80
358319	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-17	2664	35
358320	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-17	2452	51
358321	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-17	2516	73
358322	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-17	48	63
358323	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-17	5823	45
358324	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-17	5481.5	76
358325	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-17	5068	67
358326	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-17	4624	61
358327	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-17	4805.5	74
358328	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-17	5087	68
358329	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-17	37.5	56
358330	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-17	48	48
358331	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-17	47	53
358332	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-17	41	46
358333	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-17	43	40
358334	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-17	48	57
358335	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-17	42	58
358336	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-17	50.5	40
358337	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-17	39	49
358338	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-17	49.5	68
358339	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-17	44.5	54
358340	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-17	46.5	48
358341	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-17	45.5	56
358342	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-17	41	55
358343	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-17	44	46
358344	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-17	64.5	38
358345	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-17	63	56
358346	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-17	64	69
358347	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-17	69	57
358348	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-17	56	44
358349	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-17	64.5	70
358350	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-17	41	51
358351	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-17	67	74
358352	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-17	65	55
358353	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-17	51	52
358354	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-17	60	45
358355	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-17	52	37
358356	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-17	38.5	44
358357	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-17	49	51
358358	20233																	0	IL-17	47	39
358359	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-17	57	76
358360	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-17	56	57
358361	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-17	62	63
358362	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-17	59	53
358363	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-17	58	53
358364	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-17	47	41
358365	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-17	44	49
358366	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-17	67	51
358367	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-17	66.5	44
358368	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-17	53	43
358369	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-17	62	60
358370	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-17	54	57
358371	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-17	38	36
358372	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-17	38	76
358373	20233																	0	IL-17	41	75
358374	20233						RA2159	51112.0										4	IL-17	40	53
358375	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-17	41	63
358376	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-17	41	67
358377	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-17	42	63
358378	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-17	41	60
358379	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-17	39.5	50
358380	20233						RA2159	51112.0										4	IL-17	38	53
358381	20233						N2586	51107.0										4	IL-17	42	52
358382	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-17	44	43
358383	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-17	41	65
358384	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-17	45	55
358385	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-17	37	37
358386	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-17	43.5	62
358387	20233						N2586	51107.0										4	IL-17	45	49
358388	20233								TNF-a	201285.0						100	ng/mL	0	IL-17	93	60
358389	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-17	54	85
358390	20233								IL-6	201287.0						100	ug/mL	0	IL-17	71	68
358391	20233								IL-17A	201288.0						100	ng/mL	0	IL-17	17768	72
358392	20233								EGF	201289.0						100	ng/mL	0	IL-17	56	71
358393	20233								IGF-I	201290.0						100	ug/mL	0	IL-17	51	61
358394	20233								Adiponectin	201291.0						5	ng/mL	0	IL-17	54	65
358395	20233								Leptin	201292.0						1	ng/mL	0	IL-17	58	57
358396	20233								Visfatin	201293.0						1	ng/mL	0	IL-17	59.5	44
358397	20233															2	ug/mL	0	IL-17	59	80
358398	20233								TNF-a	201285.0						100	ng/mL	0	IL-17	75.5	70
358399	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-17	54.5	46
358400	20233								IL-6	201287.0						100	ug/mL	0	IL-17	67	60
358401	20233								IL-17A	201288.0						100	ng/mL	0	IL-17	17677	69
358402	20233								EGF	201289.0						100	ng/mL	0	IL-17	55.5	40
358403	20233								IGF-I	201290.0						100	ug/mL	0	IL-17	57	61
358404	20233								Adiponectin	201291.0						5	ng/mL	0	IL-17	51	43
358405	20233								Leptin	201292.0						1	ng/mL	0	IL-17	60	53
358406	20233								Visfatin	201293.0						1	ng/mL	0	IL-17	54.5	48
358407	20233															2	ug/mL	0	IL-17	53	57
358408	20233								TNF-a	201285.0						100	ng/mL	0	IL-17	80	68
358409	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-17	43	78
358410	20233								IL-6	201287.0						100	ug/mL	0	IL-17	65.5	56
358411	20233								IL-17A	201288.0						100	ng/mL	0	IL-17	18522	69
358412	20233								EGF	201289.0						100	ng/mL	0	IL-17	38.5	50
358413	20233								IGF-I	201290.0						100	ug/mL	0	IL-17	42	64
358414	20233								Adiponectin	201291.0						5	ng/mL	0	IL-17	40	70
358415	20233								Leptin	201292.0						1	ng/mL	0	IL-17	45	44
358416	20233								Visfatin	201293.0						1	ng/mL	0	IL-17	45	83
358417	20233															2	ug/mL	0	IL-17	46	62
358418	20233								TNF-a	201285.0						100	ng/mL	0	IL-17	78	65
358419	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-17	42	65
358420	20233								IL-6	201287.0						100	ug/mL	0	IL-17	58	51
358421	20233								IL-17A	201288.0						100	ng/mL	0	IL-17	16492	55
358422	20233								EGF	201289.0						100	ng/mL	0	IL-17	40	57
358423	20233								IGF-I	201290.0						100	ug/mL	0	IL-17	39	84
358424	20233								Adiponectin	201291.0						5	ng/mL	0	IL-17	45	61
358425	20233								Leptin	201292.0						1	ng/mL	0	IL-17	41	45
358426	20233								Visfatin	201293.0						1	ng/mL	0	IL-17	41	34
358427	20233															2	ug/mL	0	IL-17	38	52
358428	20233																	0	IL-9	44	53
358429	20233						RA2159	51112.0										1	IL-9	67	83
358430	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-9	60	78
358431	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-9	65	76
358432	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-9	67	73
358433	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-9	70	95
358434	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-9	67	68
358435	20233						RA2159	51112.0										1	IL-9	76.5	70
358436	20233						N2586	51107.0										1	IL-9	75	80
358437	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-9	67	60
358438	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-9	86	56
358439	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-9	87	85
358440	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-9	80.5	58
358441	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-9	66	58
358442	20233						N2586	51107.0										1	IL-9	67.5	32
358443	20233																	0	IL-9	50	68
358444	20233																	0	IL-9	54.5	44
358445	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-9	182	60
358446	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-9	159	57
358447	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-9	127.5	62
358448	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-9	146	88
358449	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-9	179.5	72
358450	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-9	91	70
358451	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-9	60	76
358452	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-9	202	75
358453	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-9	209	60
358454	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-9	212	73
358455	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-9	238	71
358456	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-9	188.5	48
358457	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-9	163	73
358458	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-9	89.5	30
358459	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-9	176	69
358460	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-9	138	83
358461	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-9	109	70
358462	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-9	205	63
358463	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-9	191	70
358464	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-9	67	63
358465	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-9	67.5	62
358466	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-9	233	71
358467	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-9	173	65
358468	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-9	179.5	78
358469	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-9	226	60
358470	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-9	217.5	56
358471	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-9	115.5	52
358472	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-9	77	98
358473	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-9	89	68
358474	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-9	61	80
358475	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-9	66	73
358476	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-9	89	87
358477	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-9	74	87
358478	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-9	72.5	60
358479	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-9	72.5	66
358480	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-9	88	75
358481	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-9	62	60
358482	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-9	76.5	56
358483	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-9	84	69
358484	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-9	79	77
358485	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-9	79	79
358486	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-9	89	55
358487	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-9	286	74
358488	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-9	336	60
358489	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-9	331.5	76
358490	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-9	493	74
358491	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-9	530	70
358492	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-9	541	83
358493	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-9	844	83
358494	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-9	499	57
358495	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-9	378	80
358496	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-9	434	93
358497	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-9	478	62
358498	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-9	440	72
358499	20233						RA2159	51112.0										1	IL-9	86	85
358500	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-9	67	69
358501	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-9	65	79
358502	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-9	86.5	66
358503	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-9	83.5	80
358504	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-9	69	78
358505	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-9	78.5	60
358506	20233						N2586	51107.0										1	IL-9	75	73
358507	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-9	66	54
358508	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-9	95	61
358509	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-9	82	54
358510	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-9	96.5	52
358511	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-9	83	66
358512	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-9	62	69
358513	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-9	62	78
358514	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-9	82.5	60
358515	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-9	67	59
358516	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-9	61	80
358517	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-9	80	84
358518	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-9	61	60
358519	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-9	65	85
358520	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-9	78	88
358521	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-9	75	72
358522	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-9	80	61
358523	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-9	90	39
358524	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-9	68	70
358525	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-9	77	47
358526	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-9	73	85
358527	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-9	69	71
358528	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-9	54	77
358529	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-9	57	48
358530	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-9	62.5	80
358531	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-9	59	81
358532	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-9	64.5	78
358533	20233						RA2159	51112.0										1	IL-9	56	71
358534	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-9	73.5	72
358535	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-9	65.5	48
358536	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-9	64	71
358537	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-9	76	47
358538	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-9	68	39
358539	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-9	57	79
358540	20233						N2586	51107.0										1	IL-9	77	96
358541	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-9	58	79
358542	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-9	57.5	68
358543	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-9	56	61
358544	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-9	63	63
358545	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-9	73	64
358546	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-9	52.5	74
358547	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-9	61	71
358548	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-9	70	53
358549	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-9	64.5	56
358550	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-9	73.5	66
358551	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-9	66.5	58
358552	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-9	71	45
358553	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-9	63	89
358554	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-9	70	65
358555	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-9	56	59
358556	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-9	60.5	82
358557	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-9	56	71
358558	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-9	53	52
358559	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-9	56	58
358560	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-9	60	49
358561	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-9	57	76
358562	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-9	57	75
358563	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-9	69	73
358564	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-9	58.5	30
358565	20233						RA2159	51112.0										1	IL-9	79	60
358566	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-9	75	61
358567	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-9	70	78
358568	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-9	80	49
358569	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-9	65.5	82
358570	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-9	65	84
358571	20233						RA2159	51112.0										1	IL-9	63	89
358572	20233						N2586	51107.0										1	IL-9	72	88
358573	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-9	76.5	78
358574	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-9	85.5	72
358575	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-9	57	78
358576	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-9	79	63
358577	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-9	65	71
358578	20233						N2586	51107.0										1	IL-9	68	63
358579	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-9	57	70
358580	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-9	68	75
358581	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-9	62	62
358582	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-9	73.5	78
358583	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-9	54	58
358584	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-9	50	71
358585	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-9	56.5	76
358586	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-9	75	77
358587	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-9	74	71
358588	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-9	70.5	72
358589	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-9	56	72
358590	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-9	62.5	48
358591	20233																	0	IL-9	41.5	78
358592	20233						RA2159	51112.0								2	ug/mL	1	IL-9	134	61
358593	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-9	103.5	70
358594	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-9	68	52
358595	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-9	104	46
358596	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-9	109.5	52
358597	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-9	67	82
358598	20233						N2586	51107.0								2	ug/mL	1	IL-9	137.5	38
358599	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-9	107	61
358600	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-9	68	68
358601	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-9	113	31
358602	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-9	140	47
358603	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-9	86	60
358604	20233																	0	IL-9	52	63
358605	20233						RA2159	51112.0										2	IL-9	76.5	84
358606	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-9	58	89
358607	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-9	63.5	62
358608	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-9	59.5	72
358609	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-9	54.5	56
358610	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-9	57	77
358611	20233						RA2159	51112.0										2	IL-9	63	68
358612	20233						N2586	51107.0										2	IL-9	65.5	58
358613	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-9	71.5	60
358614	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-9	64.5	54
358615	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-9	70.5	54
358616	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-9	73.5	52
358617	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-9	64	43
358618	20233						N2586	51107.0										2	IL-9	81	53
358619	20233																	0	IL-9	57	70
358620	20233																	0	IL-9	49.5	56
358621	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-9	170	77
358622	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-9	169.5	86
358623	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-9	167	79
358624	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-9	195.5	64
358625	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-9	103	55
358626	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-9	131	67
358627	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-9	59.5	62
358628	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-9	158.5	66
358629	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-9	160.5	62
358630	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-9	171	65
358631	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-9	162.5	68
358632	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-9	185.5	50
358633	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-9	181.5	68
358634	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-9	63.5	48
358635	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-9	193	79
358636	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-9	137	77
358637	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-9	133	66
358638	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-9	168	76
358639	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-9	158	69
358640	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-9	135	63
358641	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-9	57	60
358642	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-9	249	58
358643	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-9	145	76
358644	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-9	181	75
358645	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-9	181	65
358646	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-9	184	69
358647	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-9	151	57
358648	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-9	58	51
358649	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-9	70	79
358650	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-9	73.5	56
358651	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-9	67.5	78
358652	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-9	59	63
358653	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-9	54.5	70
358654	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-9	60	69
358655	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-9	64	69
358656	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-9	62.5	72
358657	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-9	58.5	76
358658	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-9	70	68
358659	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-9	67	67
358660	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-9	60	67
358661	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-9	65	54
358662	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-9	74	60
358663	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-9	231.5	58
358664	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-9	390.5	76
358665	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-9	267	74
358666	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-9	386	73
358667	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-9	232	57
358668	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-9	323	58
358669	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-9	62	74
358670	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-9	326.5	58
358671	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-9	358.5	70
358672	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-9	252	72
358673	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-9	338	86
358674	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-9	279	67
358675	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-9	266	67
358676	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-9	67	56
358677	20233						RA2159	51112.0										2	IL-9	69	73
358678	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-9	69	55
358679	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-9	61.5	74
358680	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-9	51	45
358681	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-9	55	75
358682	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-9	64	63
358683	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-9	53.5	44
358684	20233						N2586	51107.0										2	IL-9	71	55
358685	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-9	54.5	58
358686	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-9	68	67
358687	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-9	82	67
358688	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-9	54	73
358689	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-9	57.5	46
358690	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-9	59	56
358691	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-9	51	71
358692	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-9	56	66
358693	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-9	61	77
358694	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-9	53.5	54
358695	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-9	48	84
358696	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-9	57	71
358697	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-9	62.5	86
358698	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-9	61.5	82
358699	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-9	71	67
358700	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-9	71	61
358701	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-9	52.5	46
358702	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-9	12	57
358703	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-9	60	77
358704	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-9	67	43
358705	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-9	57	87
358706	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-9	60	93
358707	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-9	52	91
358708	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-9	53	70
358709	20233						RA2159	51112.0										2	IL-9	66	70
358710	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-9	53	84
358711	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-9	51	66
358712	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-9	60	67
358713	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-9	62	67
358714	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-9	68.5	66
358715	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-9	55	49
358716	20233						N2586	51107.0										2	IL-9	12	47
358717	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-9	52.5	70
358718	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-9	61	82
358719	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-9	62	67
358720	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-9	59	95
358721	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-9	53	63
358722	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-9	58	65
358723	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-9	66	68
358724	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-9	51	87
358725	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-9	47.5	74
358726	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-9	69	49
358727	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-9	57	59
358728	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-9	65	65
358729	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-9	54	69
358730	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-9	59	68
358731	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-9	53	73
358732	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-9	52.5	80
358733	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-9	48.5	84
358734	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-9	61	69
358735	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-9	60	95
358736	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-9	51.5	46
358737	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-9	59	60
358738	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-9	58	43
358739	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-9	59.5	38
358740	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-9	52	69
358741	20233						RA2159	51112.0										2	IL-9	57	81
358742	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-9	60	85
358743	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-9	57.5	66
358744	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-9	59	81
358745	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-9	47	82
358746	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-9	55	65
358747	20233						RA2159	51112.0										2	IL-9	56	63
358748	20233						N2586	51107.0										2	IL-9	59	65
358749	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-9	50.5	52
358750	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-9	70	84
358751	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-9	56	51
358752	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-9	58	63
358753	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-9	61	65
358754	20233						N2586	51107.0										2	IL-9	71	63
358755	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-9	55.5	68
358756	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-9	65	47
358757	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-9	59	72
358758	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-9	54	38
358759	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-9	45.5	54
358760	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-9	56	37
358761	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-9	53	54
358762	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-9	59	60
358763	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-9	70	39
358764	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-9	70	34
358765	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-9	49	54
358766	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-9	58	47
358767	20233																	0	IL-9	41.5	54
358768	20233						RA2159	51112.0								2	ug/mL	2	IL-9	119.5	60
358769	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-9	97.5	40
358770	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-9	90	73
358771	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-9	110	70
358772	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-9	65	31
358773	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-9	99	38
358774	20233						N2586	51107.0								2	ug/mL	2	IL-9	137.5	30
358775	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-9	121	50
358776	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-9	116	33
358777	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-9	100.5	26
358778	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-9	93	36
358779	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-9	93	50
358780	20233																	0	IL-9	53	71
358781	20233						RA2159	51112.0								2	ug/mL	3	IL-9	110.5	88
358782	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-9	126	65
358783	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-9	90	66
358784	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-9	125	73
358785	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-9	108	79
358786	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-9	82	58
358787	20233						N2586	51107.0								2	ug/mL	3	IL-9	169	72
358788	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-9	124.5	82
358789	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-9	146.5	80
358790	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-9	146	76
358791	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-9	98	69
358792	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-9	118.5	50
358793	20233						RA2159	51112.0										3	IL-9	67.5	78
358794	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-9	70	61
358795	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-9	63	59
358796	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-9	71	68
358797	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-9	73	70
358798	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-9	63	82
358799	20233						RA2159	51112.0										3	IL-9	65	85
358800	20233						N2586	51107.0										3	IL-9	84	84
358801	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-9	75	75
358802	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-9	72.5	62
358803	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-9	82	76
358804	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-9	65.5	68
358805	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-9	71	76
358806	20233						N2586	51107.0										3	IL-9	64.5	54
358807	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-9	75	63
358808	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-9	74	78
358809	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-9	69	109
358810	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-9	72	73
358811	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-9	64.5	70
358812	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-9	68.5	80
358813	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-9	76	79
358814	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-9	86.5	70
358815	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-9	83	63
358816	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-9	73	55
358817	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-9	62	69
358818	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-9	72.5	58
358819	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-9	65	60
358820	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-9	66.5	58
358821	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-9	52	71
358822	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-9	76.5	82
358823	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-9	75	71
358824	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-9	66	85
358825	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-9	80	92
358826	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-9	86	74
358827	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-9	72	79
358828	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-9	73	93
358829	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-9	73	63
358830	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-9	67	77
358831	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-9	65.5	58
358832	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-9	63	93
358833	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-9	72	80
358834	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-9	68	63
358835	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-9	64	83
358836	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-9	68	81
358837	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-9	82	71
358838	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-9	80.5	72
358839	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-9	74.5	78
358840	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-9	75	77
358841	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-9	81	81
358842	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-9	82	79
358843	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-9	62	59
358844	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-9	68	82
358845	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-9	68	81
358846	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-9	73	74
358847	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-9	77	90
358848	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-9	62	53
358849	20233						RA2159	51112.0										3	IL-9	74.5	66
358850	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-9	81.5	68
358851	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-9	73	61
358852	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-9	71	79
358853	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-9	87	70
358854	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-9	73.5	76
358855	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-9	70	87
358856	20233						N2586	51107.0										3	IL-9	87	63
358857	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-9	64	60
358858	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-9	65	73
358859	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-9	68	72
358860	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-9	79	58
358861	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-9	56	83
358862	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-9	61.5	56
358863	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-9	59.5	88
358864	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-9	83	66
358865	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-9	84	90
358866	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-9	85	48
358867	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-9	87	59
358868	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-9	74.5	86
358869	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-9	49	70
358870	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-9	55.5	56
358871	20233						RA2159	51112.0										3	IL-9	66	59
358872	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-9	67	59
358873	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-9	61	64
358874	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-9	73	66
358875	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-9	72	73
358876	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-9	57	69
358877	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-9	56	81
358878	20233						N2586	51107.0										3	IL-9	81.5	76
358879	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-9	73.5	80
358880	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-9	68	69
358881	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-9	80	75
358882	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-9	75	76
358883	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-9	64.5	72
358884	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-9	71	63
358885	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-9	549	86
358886	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-9	597	65
358887	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-9	561	85
358888	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-9	645	68
358889	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-9	517	59
358890	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-9	653	69
358891	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-9	366	77
358892	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-9	403	91
358893	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-9	242	80
358894	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-9	440	73
358895	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-9	339	77
358896	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-9	420	50
358897	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-9	63.5	70
358898	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-9	57	83
358899	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-9	62.5	78
358900	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-9	65	81
358901	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-9	71	73
358902	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-9	64.5	88
358903	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-9	62	83
358904	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-9	72	96
358905	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-9	73	76
358906	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-9	58	68
358907	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-9	62	60
358908	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-9	73	91
358909	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-9	82	53
358910	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-9	79	88
358911	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-9	180.5	74
358912	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-9	179	71
358913	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-9	117	78
358914	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-9	194.5	84
358915	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-9	186	59
358916	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-9	68	69
358917	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-9	65	62
358918	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-9	225.5	84
358919	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-9	183	82
358920	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-9	206	60
358921	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-9	193	69
358922	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-9	127	53
358923	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-9	160	74
358924	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-9	69.5	84
358925	20233																	0	IL-9	49	71
358926	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-9	201	66
358927	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-9	166	64
358928	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-9	163	75
358929	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-9	203.5	84
358930	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-9	174.5	60
358931	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-9	83	76
358932	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-9	73.5	72
358933	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-9	234	67
358934	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-9	155	63
358935	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-9	178	57
358936	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-9	35	75
358937	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-9	130.5	74
358938	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-9	198	67
358939	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-9	71	65
358940	20233																	0	IL-9	43	61
358941	20233						RA2159	51112.0										3	IL-9	63.5	84
358942	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-9	64	66
358943	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-9	57.5	80
358944	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-9	65	95
358945	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-9	65	42
358946	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-9	60.5	90
358947	20233						RA2159	51112.0										3	IL-9	72	56
358948	20233						N2586	51107.0										3	IL-9	86	57
358949	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-9	76.5	82
358950	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-9	64	58
358951	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-9	76	60
358952	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-9	68	48
358953	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-9	70	74
358954	20233						N2586	51107.0										3	IL-9	77.5	40
358955	20233																	0	IL-9	61	47
358956	20233						RA2159	51112.0								2	ug/mL	4	IL-9	154	54
358957	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-9	122.5	64
358958	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-9	148	76
358959	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-9	133.5	82
358960	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-9	88	74
358961	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-9	117	73
358962	20233						N2586	51107.0								2	ug/mL	4	IL-9	144	74
358963	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-9	129	63
358964	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-9	88.5	68
358965	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-9	132	59
358966	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-9	85	61
358967	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-9	56.5	72
358968	20233						RA2159	51112.0										4	IL-9	63	57
358969	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-9	66	77
358970	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-9	68	78
358971	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-9	71	89
358972	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-9	63	70
358973	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-9	67.5	88
358974	20233						RA2159	51112.0										4	IL-9	74	65
358975	20233						N2586	51107.0										4	IL-9	69.5	82
358976	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-9	77	62
358977	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-9	53	41
358978	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-9	75.5	72
358979	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-9	66	72
358980	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-9	76	82
358981	20233						N2586	51107.0										4	IL-9	74	79
358982	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-9	76	68
358983	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-9	70	67
358984	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-9	77	80
358985	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-9	77.5	88
358986	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-9	64.5	86
358987	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-9	74.5	56
358988	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-9	72	93
358989	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-9	68.5	62
358990	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-9	74.5	70
358991	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-9	82	63
358992	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-9	76	71
358993	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-9	63	61
358994	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-9	76	89
358995	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-9	71.5	68
358996	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-9	77	81
358997	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-9	87	63
358998	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-9	73	65
358999	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-9	79	69
359000	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-9	70	53
359001	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-9	72	63
359002	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-9	55.5	86
359003	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-9	84.5	82
359004	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-9	71	65
359005	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-9	66	78
359006	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-9	81	93
359007	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-9	91	55
359008	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-9	81	67
359009	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-9	90	65
359010	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-9	71	62
359011	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-9	66	53
359012	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-9	68	86
359013	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-9	85	56
359014	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-9	71	61
359015	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-9	76	60
359016	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-9	67	56
359017	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-9	66.5	82
359018	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-9	79	73
359019	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-9	82	59
359020	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-9	81	67
359021	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-9	78	88
359022	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-9	67	69
359023	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-9	78	51
359024	20233						RA2159	51112.0										4	IL-9	69	61
359025	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-9	62	85
359026	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-9	79	85
359027	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-9	66.5	60
359028	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-9	75	57
359029	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-9	66	62
359030	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-9	68	71
359031	20233						N2586	51107.0										4	IL-9	79	84
359032	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-9	80.5	72
359033	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-9	83	73
359034	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-9	83	56
359035	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-9	90	61
359036	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-9	64	49
359037	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-9	70	59
359038	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-9	77	78
359039	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-9	87	58
359040	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-9	69	64
359041	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-9	80	62
359042	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-9	62	57
359043	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-9	59	82
359044	20233						RA2159	51112.0										4	IL-9	66	73
359045	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-9	80	75
359046	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-9	72	62
359047	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-9	69	57
359048	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-9	83	49
359049	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-9	78	49
359050	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-9	60	78
359051	20233						N2586	51107.0										4	IL-9	68	89
359052	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-9	74	50
359053	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-9	76	69
359054	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-9	65	77
359055	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-9	72.5	70
359056	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-9	59.5	50
359057	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-9	67	67
359058	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-9	240	73
359059	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-9	282	63
359060	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-9	297	66
359061	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-9	358	74
359062	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-9	337.5	74
359063	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-9	339	69
359064	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-9	72.5	60
359065	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-9	445.5	52
359066	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-9	464.5	74
359067	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-9	534.5	62
359068	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-9	544	71
359069	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-9	319	65
359070	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-9	537	71
359071	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-9	47	61
359072	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-9	80	71
359073	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-9	66	73
359074	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-9	53	49
359075	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-9	71.5	52
359076	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-9	70	59
359077	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-9	75	63
359078	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-9	65	53
359079	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-9	71	53
359080	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-9	66	53
359081	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-9	62	69
359082	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-9	72	45
359083	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-9	65.5	58
359084	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-9	55	56
359085	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-9	70	55
359086	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-9	198	57
359087	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-9	159	69
359088	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-9	206	65
359089	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-9	180.5	64
359090	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-9	241	54
359091	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-9	203	55
359092	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-9	64.5	60
359093	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-9	205.5	84
359094	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-9	196	67
359095	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-9	142	49
359096	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-9	194	51
359097	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-9	106	55
359098	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-9	61	51
359099	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-9	74	61
359100	20233																	0	IL-9	53	52
359101	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-9	214	78
359102	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-9	165	50
359103	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-9	195	69
359104	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-9	172	80
359105	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-9	139	45
359106	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-9	183.5	86
359107	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-9	66	63
359108	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-9	185	71
359109	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-9	199.5	58
359110	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-9	203	57
359111	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-9	222.5	60
359112	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-9	128	59
359113	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-9	57	71
359114	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-9	62	82
359115	20233																	0	IL-9	38	77
359116	20233						RA2159	51112.0										4	IL-9	58.5	72
359117	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-9	60	64
359118	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-9	55	72
359119	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-9	67	63
359120	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-9	64	71
359121	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-9	53.5	44
359122	20233						RA2159	51112.0										4	IL-9	62	53
359123	20233						N2586	51107.0										4	IL-9	79.5	66
359124	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-9	56	53
359125	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-9	60	74
359126	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-9	64	50
359127	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-9	67	57
359128	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-9	65	52
359129	20233						N2586	51107.0										4	IL-9	71	43
359130	20233								TNF-a	201285.0						100	ng/mL	0	IL-9	54.5	80
359131	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-9	49	63
359132	20233								IL-6	201287.0						100	ug/mL	0	IL-9	58	93
359133	20233								IL-17A	201288.0						100	ng/mL	0	IL-9	1848	91
359134	20233								EGF	201289.0						100	ng/mL	0	IL-9	46	86
359135	20233								IGF-I	201290.0						100	ug/mL	0	IL-9	47.5	66
359136	20233								Adiponectin	201291.0						5	ng/mL	0	IL-9	70	77
359137	20233								Leptin	201292.0						1	ng/mL	0	IL-9	56	65
359138	20233								Visfatin	201293.0						1	ng/mL	0	IL-9	52.5	46
359139	20233															2	ug/mL	0	IL-9	54	67
359140	20233								TNF-a	201285.0						100	ng/mL	0	IL-9	51	66
359141	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-9	55	49
359142	20233								IL-6	201287.0						100	ug/mL	0	IL-9	53	57
359143	20233								IL-17A	201288.0						100	ng/mL	0	IL-9	1709	73
359144	20233								EGF	201289.0						100	ng/mL	0	IL-9	50.5	56
359145	20233								IGF-I	201290.0						100	ug/mL	0	IL-9	46	63
359146	20233								Adiponectin	201291.0						5	ng/mL	0	IL-9	76	43
359147	20233								Leptin	201292.0						1	ng/mL	0	IL-9	54	43
359148	20233								Visfatin	201293.0						1	ng/mL	0	IL-9	67	59
359149	20233															2	ug/mL	0	IL-9	52	62
359150	20233								TNF-a	201285.0						100	ng/mL	0	IL-9	51	83
359151	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-9	45	68
359152	20233								IL-6	201287.0						100	ug/mL	0	IL-9	48	81
359153	20233								IL-17A	201288.0						100	ng/mL	0	IL-9	2052.5	76
359154	20233								EGF	201289.0						100	ng/mL	0	IL-9	47	63
359155	20233								IGF-I	201290.0						100	ug/mL	0	IL-9	49	71
359156	20233								Adiponectin	201291.0						5	ng/mL	0	IL-9	55	77
359157	20233								Leptin	201292.0						1	ng/mL	0	IL-9	49	53
359158	20233								Visfatin	201293.0						1	ng/mL	0	IL-9	54.5	90
359159	20233															2	ug/mL	0	IL-9	47	70
359160	20233								TNF-a	201285.0						100	ng/mL	0	IL-9	58	75
359161	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-9	42	67
359162	20233								IL-6	201287.0						100	ug/mL	0	IL-9	45	58
359163	20233								IL-17A	201288.0						100	ng/mL	0	IL-9	1705	64
359164	20233								EGF	201289.0						100	ng/mL	0	IL-9	43	61
359165	20233								IGF-I	201290.0						100	ug/mL	0	IL-9	41	72
359166	20233								Adiponectin	201291.0						5	ng/mL	0	IL-9	63	65
359167	20233								Leptin	201292.0						1	ng/mL	0	IL-9	46	47
359168	20233								Visfatin	201293.0						1	ng/mL	0	IL-9	43	55
359169	20233															2	ug/mL	0	IL-9	41.5	66
359170	20233																	0	IL2-Ra	15	56
359171	20233						RA2159	51112.0										1	IL2-Ra	16	79
359172	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL2-Ra	18	77
359173	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL2-Ra	13	59
359174	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL2-Ra	15	65
359175	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL2-Ra	15.5	64
359176	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL2-Ra	14	53
359177	20233						RA2159	51112.0										1	IL2-Ra	17	59
359178	20233						N2586	51107.0										1	IL2-Ra	12	63
359179	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL2-Ra	15	69
359180	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL2-Ra	15	74
359181	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL2-Ra	17	51
359182	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL2-Ra	19	39
359183	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL2-Ra	11	36
359184	20233						N2586	51107.0										1	IL2-Ra	18	39
359185	20233																	0	IL2-Ra	18	57
359186	20233																	0	IL2-Ra	13.5	36
359187	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL2-Ra	16	70
359188	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL2-Ra	14	91
359189	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL2-Ra	17	66
359190	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL2-Ra	13	62
359191	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL2-Ra	17	76
359192	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL2-Ra	15	70
359193	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL2-Ra	14.5	68
359194	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL2-Ra	18	50
359195	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL2-Ra	19	32
359196	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL2-Ra	21	42
359197	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL2-Ra	23	67
359198	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL2-Ra	17	75
359199	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL2-Ra	22	43
359200	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL2-Ra	17	68
359201	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL2-Ra	19	61
359202	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL2-Ra	20	80
359203	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL2-Ra	16	49
359204	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL2-Ra	20	63
359205	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL2-Ra	21	62
359206	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL2-Ra	17.5	56
359207	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL2-Ra	14	60
359208	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL2-Ra	21.5	52
359209	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL2-Ra	23	45
359210	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL2-Ra	22	57
359211	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL2-Ra	24	65
359212	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL2-Ra	20	60
359213	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL2-Ra	21	39
359214	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL2-Ra	13	43
359215	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL2-Ra	18	62
359216	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL2-Ra	12.5	62
359217	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL2-Ra	15	66
359218	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL2-Ra	14	67
359219	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL2-Ra	17.5	76
359220	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL2-Ra	14	69
359221	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL2-Ra	16	63
359222	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL2-Ra	15.5	54
359223	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL2-Ra	15	72
359224	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL2-Ra	15	59
359225	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL2-Ra	15	51
359226	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL2-Ra	14	65
359227	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL2-Ra	14	44
359228	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL2-Ra	19	53
359229	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL2-Ra	15	66
359230	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL2-Ra	16	61
359231	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL2-Ra	15	65
359232	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL2-Ra	14	81
359233	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL2-Ra	12	51
359234	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL2-Ra	14	68
359235	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL2-Ra	11.5	36
359236	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL2-Ra	13	39
359237	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL2-Ra	18	29
359238	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL2-Ra	18	40
359239	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL2-Ra	19	35
359240	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL2-Ra	18	54
359241	20233						RA2159	51112.0										1	IL2-Ra	17	47
359242	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL2-Ra	21	73
359243	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL2-Ra	14	68
359244	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL2-Ra	14	83
359245	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL2-Ra	13	51
359246	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL2-Ra	13	67
359247	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL2-Ra	15	55
359248	20233						N2586	51107.0										1	IL2-Ra	13	47
359249	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL2-Ra	18	51
359250	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL2-Ra	12	54
359251	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL2-Ra	15	63
359252	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL2-Ra	17.5	56
359253	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL2-Ra	19	59
359254	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL2-Ra	14	38
359255	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL2-Ra	16	52
359256	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL2-Ra	14	77
359257	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL2-Ra	12	75
359258	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL2-Ra	15	60
359259	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL2-Ra	16	59
359260	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL2-Ra	16	86
359261	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL2-Ra	13	63
359262	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL2-Ra	13.5	82
359263	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL2-Ra	15	69
359264	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL2-Ra	14	63
359265	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL2-Ra	15.5	78
359266	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL2-Ra	14	60
359267	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL2-Ra	16	59
359268	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL2-Ra	15	58
359269	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL2-Ra	16	68
359270	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL2-Ra	16	63
359271	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL2-Ra	14	61
359272	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL2-Ra	13	52
359273	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL2-Ra	12	64
359274	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL2-Ra	17	52
359275	20233						RA2159	51112.0										1	IL2-Ra	18	64
359276	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL2-Ra	14	45
359277	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL2-Ra	14.5	80
359278	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL2-Ra	14	58
359279	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL2-Ra	13	62
359280	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL2-Ra	17	31
359281	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL2-Ra	15.5	54
359282	20233						N2586	51107.0										1	IL2-Ra	14.5	30
359283	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL2-Ra	55	72
359284	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL2-Ra	70.5	66
359285	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL2-Ra	71	57
359286	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL2-Ra	60	65
359287	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL2-Ra	69.5	60
359288	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL2-Ra	57	65
359289	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL2-Ra	53	80
359290	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL2-Ra	45	50
359291	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL2-Ra	51	33
359292	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL2-Ra	44	37
359293	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL2-Ra	51	45
359294	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL2-Ra	52.5	48
359295	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL2-Ra	19.5	66
359296	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL2-Ra	15.5	52
359297	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL2-Ra	14	53
359298	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL2-Ra	12	70
359299	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL2-Ra	12	39
359300	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL2-Ra	16	43
359301	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL2-Ra	17	33
359302	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL2-Ra	12	53
359303	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL2-Ra	14	63
359304	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL2-Ra	14	37
359305	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL2-Ra	12	37
359306	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL2-Ra	13	53
359307	20233						RA2159	51112.0										1	IL2-Ra		0
359308	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL2-Ra		0
359309	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL2-Ra		0
359310	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL2-Ra		0
359311	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL2-Ra		0
359312	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL2-Ra		0
359313	20233						RA2159	51112.0										1	IL2-Ra		0
359314	20233						N2586	51107.0										1	IL2-Ra		0
359315	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL2-Ra		0
359316	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL2-Ra		0
359317	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL2-Ra		0
359318	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL2-Ra		0
359319	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL2-Ra		0
359320	20233						N2586	51107.0										1	IL2-Ra		0
359321	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL2-Ra	13.5	50
359322	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL2-Ra	13	67
359323	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL2-Ra	17	63
359324	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL2-Ra	14	60
359325	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL2-Ra	13	67
359326	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL2-Ra	17	43
359327	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL2-Ra	17	41
359328	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL2-Ra	23	38
359329	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL2-Ra	21.5	56
359330	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL2-Ra	13	49
359331	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL2-Ra	13	45
359332	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL2-Ra	18	31
359333	20233																	0	IL2-Ra	17	50
359334	20233						RA2159	51112.0								2	ug/mL	1	IL2-Ra	15	48
359335	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL2-Ra	15	57
359336	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL2-Ra	16.5	48
359337	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL2-Ra	15	54
359338	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL2-Ra	15.5	76
359339	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL2-Ra	14.5	62
359340	20233						N2586	51107.0								2	ug/mL	1	IL2-Ra	16	40
359341	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL2-Ra	14.5	40
359342	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL2-Ra	10.5	40
359343	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL2-Ra	19	40
359344	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL2-Ra	14	53
359345	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL2-Ra	17	39
359346	20233																	0	IL2-Ra	17.5	60
359347	20233						RA2159	51112.0										2	IL2-Ra	18.5	66
359348	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL2-Ra	13	57
359349	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL2-Ra	16	53
359350	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL2-Ra	14.5	68
359351	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL2-Ra	15	67
359352	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL2-Ra	16.5	78
359353	20233						RA2159	51112.0										2	IL2-Ra	12	57
359354	20233						N2586	51107.0										2	IL2-Ra	13	60
359355	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL2-Ra	12	32
359356	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL2-Ra	16	58
359357	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL2-Ra	16	55
359358	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL2-Ra	16	63
359359	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL2-Ra	18	43
359360	20233						N2586	51107.0										2	IL2-Ra	16	68
359361	20233																	0	IL2-Ra	16	58
359362	20233																	0	IL2-Ra	14.5	56
359363	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL2-Ra	19	73
359364	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL2-Ra	15	57
359365	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL2-Ra	17.5	50
359366	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL2-Ra	16	88
359367	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL2-Ra	15	52
359368	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL2-Ra	15	62
359369	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL2-Ra	12.5	50
359370	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL2-Ra	18	45
359371	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL2-Ra	18	63
359372	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL2-Ra	15	69
359373	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL2-Ra	20	34
359374	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL2-Ra	17.5	56
359375	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL2-Ra	20.5	46
359376	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL2-Ra	11.5	48
359377	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL2-Ra	23	55
359378	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL2-Ra	19	68
359379	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL2-Ra	17	63
359380	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL2-Ra	22	75
359381	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL2-Ra	18	77
359382	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL2-Ra	18	59
359383	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL2-Ra	14	56
359384	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL2-Ra	25	75
359385	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL2-Ra	17.5	66
359386	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL2-Ra	21	56
359387	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL2-Ra	30	55
359388	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL2-Ra	38	54
359389	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL2-Ra	19	44
359390	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL2-Ra	15	69
359391	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL2-Ra	20	54
359392	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL2-Ra	12	50
359393	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL2-Ra	19	67
359394	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL2-Ra	14	59
359395	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL2-Ra	12	65
359396	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL2-Ra	13.5	36
359397	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL2-Ra	14	56
359398	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL2-Ra	14	84
359399	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL2-Ra	14	60
359400	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL2-Ra	16	61
359401	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL2-Ra	13	66
359402	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL2-Ra	13.5	66
359403	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL2-Ra	18.5	60
359404	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL2-Ra	15	65
359405	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL2-Ra	13	57
359406	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL2-Ra	11	60
359407	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL2-Ra	13.5	82
359408	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL2-Ra	15	53
359409	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL2-Ra	12	65
359410	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL2-Ra	13	44
359411	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL2-Ra	11.5	36
359412	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL2-Ra	15	48
359413	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL2-Ra	15	76
359414	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL2-Ra	15	16
359415	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL2-Ra	13	20
359416	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL2-Ra	20	56
359417	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL2-Ra	19	76
359418	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL2-Ra	20	66
359419	20233						RA2159	51112.0										2	IL2-Ra	15	83
359420	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL2-Ra	14	45
359421	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL2-Ra	14.5	58
359422	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL2-Ra	17.5	38
359423	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL2-Ra	13	86
359424	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL2-Ra	12	78
359425	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL2-Ra	15.5	78
359426	20233						N2586	51107.0										2	IL2-Ra	13	52
359427	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL2-Ra	13.5	70
359428	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL2-Ra	13	79
359429	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL2-Ra	12	69
359430	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL2-Ra	12	49
359431	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL2-Ra	17	58
359432	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL2-Ra	16	69
359433	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL2-Ra	18	77
359434	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL2-Ra	16	69
359435	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL2-Ra	18	58
359436	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL2-Ra	14	63
359437	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL2-Ra	12	69
359438	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL2-Ra	15	52
359439	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL2-Ra	16	63
359440	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL2-Ra	15	41
359441	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL2-Ra	15	79
359442	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL2-Ra	19	62
359443	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL2-Ra	15	52
359444	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL2-Ra	19	74
359445	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL2-Ra	12.5	64
359446	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL2-Ra	14	73
359447	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL2-Ra	13	72
359448	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL2-Ra	18	79
359449	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL2-Ra	14	53
359450	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL2-Ra	13	45
359451	20233						RA2159	51112.0										2	IL2-Ra	16	51
359452	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL2-Ra	13	43
359453	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL2-Ra	17	58
359454	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL2-Ra	16	71
359455	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL2-Ra	16	55
359456	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL2-Ra	15	90
359457	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL2-Ra	17	55
359458	20233						N2586	51107.0										2	IL2-Ra	18	58
359459	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL2-Ra	47.5	70
359460	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL2-Ra	47	58
359461	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL2-Ra	55	51
359462	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL2-Ra	52.5	70
359463	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL2-Ra	53	60
359464	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL2-Ra	53	64
359465	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL2-Ra	45	54
359466	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL2-Ra	49	56
359467	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL2-Ra	57	47
359468	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL2-Ra	56	41
359469	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL2-Ra	62	54
359470	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL2-Ra	45	50
359471	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL2-Ra	17	55
359472	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL2-Ra	13	57
359473	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL2-Ra	12.5	82
359474	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL2-Ra	12	65
359475	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL2-Ra	11.5	70
359476	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL2-Ra	11	72
359477	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL2-Ra	11	73
359478	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL2-Ra	17	54
359479	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL2-Ra	13	64
359480	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL2-Ra	16	57
359481	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL2-Ra	13.5	66
359482	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL2-Ra	14	55
359483	20233						RA2159	51112.0										2	IL2-Ra		0
359484	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL2-Ra		0
359485	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL2-Ra		0
359486	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL2-Ra		0
359487	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL2-Ra		0
359488	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL2-Ra		0
359489	20233						RA2159	51112.0										2	IL2-Ra		0
359490	20233						N2586	51107.0										2	IL2-Ra		0
359491	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL2-Ra		0
359492	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL2-Ra		0
359493	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL2-Ra		0
359494	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL2-Ra		0
359495	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL2-Ra		0
359496	20233						N2586	51107.0										2	IL2-Ra		0
359497	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL2-Ra	14.5	48
359498	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL2-Ra	14	94
359499	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL2-Ra	12	54
359500	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL2-Ra	15	54
359501	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL2-Ra	14	63
359502	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL2-Ra	11	68
359503	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL2-Ra	12	75
359504	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL2-Ra	12.5	54
359505	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL2-Ra	13	66
359506	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL2-Ra	14	55
359507	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL2-Ra	14	54
359508	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL2-Ra	15	45
359509	20233																	0	IL2-Ra	15	59
359510	20233						RA2159	51112.0								2	ug/mL	2	IL2-Ra	19	76
359511	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL2-Ra	15	38
359512	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL2-Ra	17	49
359513	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL2-Ra	13.5	60
359514	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL2-Ra	12	64
359515	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL2-Ra	15.5	66
359516	20233						N2586	51107.0								2	ug/mL	2	IL2-Ra	19.5	46
359517	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL2-Ra	17.5	54
359518	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL2-Ra	15	52
359519	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL2-Ra	16	53
359520	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL2-Ra	13.5	48
359521	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL2-Ra	14	48
359522	20233																	0	IL2-Ra	15	59
359523	20233						RA2159	51112.0								2	ug/mL	3	IL2-Ra	14	65
359524	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL2-Ra	16	74
359525	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL2-Ra	13	57
359526	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL2-Ra	12	81
359527	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL2-Ra	13	73
359528	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL2-Ra	13	53
359529	20233						N2586	51107.0								2	ug/mL	3	IL2-Ra	17	57
359530	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL2-Ra	24.5	60
359531	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL2-Ra	17	61
359532	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL2-Ra	17	50
359533	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL2-Ra	13	52
359534	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL2-Ra	14	55
359535	20233						RA2159	51112.0										3	IL2-Ra		0
359536	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL2-Ra		0
359537	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL2-Ra		0
359538	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL2-Ra		0
359539	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL2-Ra		0
359540	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL2-Ra		0
359541	20233						RA2159	51112.0										3	IL2-Ra		0
359542	20233						N2586	51107.0										3	IL2-Ra		0
359543	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL2-Ra		0
359544	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL2-Ra		0
359545	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL2-Ra		0
359546	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL2-Ra		0
359547	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL2-Ra		0
359548	20233						N2586	51107.0										3	IL2-Ra		0
359549	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL2-Ra	13.5	60
359550	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL2-Ra	15	51
359551	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL2-Ra	14.5	66
359552	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL2-Ra	15	54
359553	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL2-Ra	14	74
359554	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL2-Ra	15	63
359555	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL2-Ra	13	76
359556	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL2-Ra	12	75
359557	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL2-Ra	13.5	60
359558	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL2-Ra	14	66
359559	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL2-Ra	14	58
359560	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL2-Ra	15	76
359561	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL2-Ra	16	57
359562	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL2-Ra	13	57
359563	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL2-Ra	13.5	62
359564	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL2-Ra	13	55
359565	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL2-Ra	14	65
359566	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL2-Ra	11	74
359567	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL2-Ra	13	51
359568	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL2-Ra	12.5	50
359569	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL2-Ra	13	72
359570	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL2-Ra	14	48
359571	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL2-Ra	14	67
359572	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL2-Ra	14	53
359573	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL2-Ra	53.5	58
359574	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL2-Ra	50	79
359575	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL2-Ra	43	59
359576	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL2-Ra	55	73
359577	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL2-Ra	46	56
359578	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL2-Ra	47	74
359579	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL2-Ra	39	58
359580	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL2-Ra	40	71
359581	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL2-Ra	50	77
359582	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL2-Ra	38	55
359583	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL2-Ra	45	51
359584	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL2-Ra	39	73
359585	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL2-Ra	13	59
359586	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL2-Ra	15	59
359587	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL2-Ra	14	71
359588	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL2-Ra	13	75
359589	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL2-Ra	14	52
359590	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL2-Ra	13	64
359591	20233						RA2159	51112.0										3	IL2-Ra	14.5	50
359592	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL2-Ra	14	57
359593	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL2-Ra	12.5	74
359594	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL2-Ra	14	58
359595	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL2-Ra	14.5	72
359596	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL2-Ra	14.5	46
359597	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL2-Ra	14	59
359598	20233						N2586	51107.0										3	IL2-Ra	17	53
359599	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL2-Ra	13	72
359600	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL2-Ra	12.5	50
359601	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL2-Ra	15	51
359602	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL2-Ra	13	57
359603	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL2-Ra	14	64
359604	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL2-Ra	11	54
359605	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL2-Ra	13	54
359606	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL2-Ra	15	71
359607	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL2-Ra	12	66
359608	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL2-Ra	18	61
359609	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL2-Ra	19	59
359610	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL2-Ra	14	78
359611	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL2-Ra	13	72
359612	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL2-Ra	13	50
359613	20233						RA2159	51112.0										3	IL2-Ra	14	65
359614	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL2-Ra	10	69
359615	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL2-Ra	12	57
359616	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL2-Ra	13	64
359617	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL2-Ra	12	67
359618	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL2-Ra	12	48
359619	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL2-Ra	13	81
359620	20233						N2586	51107.0										3	IL2-Ra	14	78
359621	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL2-Ra	14	67
359622	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL2-Ra	15	56
359623	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL2-Ra	19	63
359624	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL2-Ra	15	73
359625	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL2-Ra	15.5	50
359626	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL2-Ra	14	58
359627	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL2-Ra	12	65
359628	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL2-Ra	14	77
359629	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL2-Ra	14	56
359630	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL2-Ra	13.5	56
359631	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL2-Ra	16	65
359632	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL2-Ra	13	67
359633	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL2-Ra	13.5	60
359634	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL2-Ra	14	47
359635	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL2-Ra	12	75
359636	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL2-Ra	16	47
359637	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL2-Ra	11	64
359638	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL2-Ra	14.5	56
359639	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL2-Ra	12	74
359640	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL2-Ra	15	51
359641	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL2-Ra	11.5	68
359642	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL2-Ra	11	55
359643	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL2-Ra	13	68
359644	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL2-Ra	14	65
359645	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL2-Ra	13	67
359646	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL2-Ra	16	73
359647	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL2-Ra	12	49
359648	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL2-Ra	13	57
359649	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL2-Ra	11.5	56
359650	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL2-Ra	13	73
359651	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL2-Ra	13	83
359652	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL2-Ra	13	58
359653	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL2-Ra	17.5	70
359654	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL2-Ra	16	61
359655	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL2-Ra	15	78
359656	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL2-Ra	15	71
359657	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL2-Ra	16	63
359658	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL2-Ra	15	62
359659	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL2-Ra	12	55
359660	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL2-Ra	21.5	68
359661	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL2-Ra	16.5	50
359662	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL2-Ra	21	50
359663	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL2-Ra	19	64
359664	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL2-Ra	17	51
359665	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL2-Ra	17	84
359666	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL2-Ra	13	77
359667	20233																	0	IL2-Ra	17	53
359668	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL2-Ra	18	61
359669	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL2-Ra	14	54
359670	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL2-Ra	12	76
359671	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL2-Ra	15	42
359672	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL2-Ra	11.5	52
359673	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL2-Ra	12	70
359674	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL2-Ra	13	43
359675	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL2-Ra	15	60
359676	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL2-Ra	14	67
359677	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL2-Ra	16.5	62
359678	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL2-Ra	13	57
359679	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL2-Ra	12	77
359680	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL2-Ra	14	78
359681	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL2-Ra	19	39
359682	20233																	0	IL2-Ra	14	54
359683	20233						RA2159	51112.0										3	IL2-Ra	16	85
359684	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL2-Ra	11	60
359685	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL2-Ra	15	67
359686	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL2-Ra	12	51
359687	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL2-Ra	12	59
359688	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL2-Ra	14	54
359689	20233						RA2159	51112.0										3	IL2-Ra	15	69
359690	20233						N2586	51107.0										3	IL2-Ra	13.5	60
359691	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL2-Ra	11	59
359692	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL2-Ra	14	60
359693	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL2-Ra	14	67
359694	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL2-Ra	13	62
359695	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL2-Ra	13	51
359696	20233						N2586	51107.0										3	IL2-Ra	14	58
359697	20233																	0	IL2-Ra	16	52
359698	20233						RA2159	51112.0								2	ug/mL	4	IL2-Ra	13.5	66
359699	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL2-Ra	14	60
359700	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL2-Ra	14	71
359701	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL2-Ra	15.5	62
359702	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL2-Ra	13.5	70
359703	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL2-Ra	12	73
359704	20233						N2586	51107.0								2	ug/mL	4	IL2-Ra	15	66
359705	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL2-Ra	16	70
359706	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL2-Ra	13	53
359707	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL2-Ra	11	40
359708	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL2-Ra	14	62
359709	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL2-Ra	11	37
359710	20233						RA2159	51112.0										4	IL2-Ra		0
359711	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL2-Ra		0
359712	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL2-Ra		0
359713	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL2-Ra		0
359714	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL2-Ra		0
359715	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL2-Ra		0
359716	20233						RA2159	51112.0										4	IL2-Ra		0
359717	20233						N2586	51107.0										4	IL2-Ra		0
359718	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL2-Ra		0
359719	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL2-Ra		0
359720	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL2-Ra		0
359721	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL2-Ra		0
359722	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL2-Ra		0
359723	20233						N2586	51107.0										4	IL2-Ra		0
359724	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL2-Ra	16	46
359725	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL2-Ra	13	56
359726	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL2-Ra	15	68
359727	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL2-Ra	14	65
359728	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL2-Ra	12	57
359729	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL2-Ra	13	71
359730	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL2-Ra	14	59
359731	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL2-Ra	13	55
359732	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL2-Ra	13	65
359733	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL2-Ra	13.5	64
359734	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL2-Ra	12	74
359735	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL2-Ra	13	56
359736	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL2-Ra	13	56
359737	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL2-Ra	13	44
359738	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL2-Ra	13	71
359739	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL2-Ra	13	70
359740	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL2-Ra	21	66
359741	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL2-Ra	12.5	48
359742	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL2-Ra	14	57
359743	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL2-Ra	13.5	44
359744	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL2-Ra	15	50
359745	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL2-Ra	15	61
359746	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL2-Ra	13.5	56
359747	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL2-Ra	15	51
359748	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL2-Ra	49	92
359749	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL2-Ra	43	67
359750	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL2-Ra	48	89
359751	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL2-Ra	43.5	84
359752	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL2-Ra	38.5	68
359753	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL2-Ra	37	95
359754	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL2-Ra	45.5	74
359755	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL2-Ra	38	51
359756	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL2-Ra	41	61
359757	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL2-Ra	36.5	64
359758	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL2-Ra	46	55
359759	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL2-Ra	42	75
359760	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL2-Ra	13	59
359761	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL2-Ra	11	68
359762	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL2-Ra	13	67
359763	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL2-Ra	12.5	70
359764	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL2-Ra	10	58
359765	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL2-Ra	14	59
359766	20233						RA2159	51112.0										4	IL2-Ra	12.5	62
359767	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL2-Ra	11	55
359768	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL2-Ra	13	82
359769	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL2-Ra	15	65
359770	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL2-Ra	12.5	42
359771	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL2-Ra	13	60
359772	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL2-Ra	14	70
359773	20233						N2586	51107.0										4	IL2-Ra	12	71
359774	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL2-Ra	17	73
359775	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL2-Ra	10	63
359776	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL2-Ra	14	69
359777	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL2-Ra	13	53
359778	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL2-Ra	13	59
359779	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL2-Ra	14	78
359780	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL2-Ra	13	51
359781	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL2-Ra	14	72
359782	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL2-Ra	13	51
359783	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL2-Ra	20	55
359784	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL2-Ra	13	47
359785	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL2-Ra	14	64
359786	20233						RA2159	51112.0										4	IL2-Ra	11	76
359787	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL2-Ra	14	53
359788	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL2-Ra	12	46
359789	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL2-Ra	11	64
359790	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL2-Ra	13.5	46
359791	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL2-Ra	16	23
359792	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL2-Ra	11	7
359793	20233						N2586	51107.0										4	IL2-Ra	14	11
359794	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL2-Ra	9	12
359795	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL2-Ra	11	61
359796	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL2-Ra	15	51
359797	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL2-Ra	11	35
359798	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL2-Ra	16	66
359799	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL2-Ra	14.5	50
359800	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL2-Ra	13	50
359801	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL2-Ra	13	64
359802	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL2-Ra	13	78
359803	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL2-Ra	11	63
359804	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL2-Ra	13	50
359805	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL2-Ra	14	69
359806	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL2-Ra	9	23
359807	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL2-Ra	14.5	50
359808	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL2-Ra	13	64
359809	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL2-Ra	13	50
359810	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL2-Ra	14	72
359811	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL2-Ra	13	66
359812	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL2-Ra	12	67
359813	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL2-Ra	14	47
359814	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL2-Ra	20	71
359815	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL2-Ra	12	75
359816	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL2-Ra	11	49
359817	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL2-Ra	14	57
359818	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL2-Ra	13	53
359819	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL2-Ra	13.5	48
359820	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL2-Ra	13	61
359821	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL2-Ra	15	53
359822	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL2-Ra	15	50
359823	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL2-Ra	10	39
359824	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL2-Ra	12	55
359825	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL2-Ra	11	63
359826	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL2-Ra	12	33
359827	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL2-Ra	12	51
359828	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL2-Ra	18	74
359829	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL2-Ra	17.5	62
359830	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL2-Ra	25	76
359831	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL2-Ra	15	67
359832	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL2-Ra	15.5	62
359833	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL2-Ra	19	54
359834	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL2-Ra	15	64
359835	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL2-Ra	18	55
359836	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL2-Ra	16	72
359837	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL2-Ra	18	42
359838	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL2-Ra	23	49
359839	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL2-Ra	16	55
359840	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL2-Ra	14.5	58
359841	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL2-Ra	15	71
359842	20233																	0	IL2-Ra	18	67
359843	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL2-Ra	11	45
359844	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL2-Ra	13	63
359845	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL2-Ra	13	51
359846	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL2-Ra	10	71
359847	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL2-Ra	13	55
359848	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL2-Ra	14	58
359849	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL2-Ra	13	55
359850	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL2-Ra	14	49
359851	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL2-Ra	15	68
359852	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL2-Ra	15	63
359853	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL2-Ra	15	39
359854	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL2-Ra	14	36
359855	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL2-Ra	14	49
359856	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL2-Ra	13	51
359857	20233																	0	IL2-Ra	15	49
359858	20233						RA2159	51112.0										4	IL2-Ra	13	57
359859	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL2-Ra	9.5	72
359860	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL2-Ra	14	62
359861	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL2-Ra	11	55
359862	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL2-Ra	12	69
359863	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL2-Ra	11	75
359864	20233						RA2159	51112.0										4	IL2-Ra	12	62
359865	20233						N2586	51107.0										4	IL2-Ra	12	71
359866	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL2-Ra	11	48
359867	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL2-Ra	12	59
359868	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL2-Ra	10	62
359869	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL2-Ra	11.5	52
359870	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL2-Ra	9	36
359871	20233						N2586	51107.0										4	IL2-Ra	14	61
359872	20233								TNF-a	201285.0						100	ng/mL	0	IL2-Ra	22	65
359873	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL2-Ra	22	71
359874	20233								IL-6	201287.0						100	ug/mL	0	IL2-Ra	20	47
359875	20233								IL-17A	201288.0						100	ng/mL	0	IL2-Ra	17	79
359876	20233								EGF	201289.0						100	ng/mL	0	IL2-Ra	20	72
359877	20233								IGF-I	201290.0						100	ug/mL	0	IL2-Ra	17.5	62
359878	20233								Adiponectin	201291.0						5	ng/mL	0	IL2-Ra	332	49
359879	20233								Leptin	201292.0						1	ng/mL	0	IL2-Ra	17.5	56
359880	20233								Visfatin	201293.0						1	ng/mL	0	IL2-Ra	21	63
359881	20233															2	ug/mL	0	IL2-Ra	16	40
359882	20233								TNF-a	201285.0						100	ng/mL	0	IL2-Ra	18.5	48
359883	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL2-Ra	20	68
359884	20233								IL-6	201287.0						100	ug/mL	0	IL2-Ra	17	62
359885	20233								IL-17A	201288.0						100	ng/mL	0	IL2-Ra	16	68
359886	20233								EGF	201289.0						100	ng/mL	0	IL2-Ra	16	61
359887	20233								IGF-I	201290.0						100	ug/mL	0	IL2-Ra	20.5	48
359888	20233								Adiponectin	201291.0						5	ng/mL	0	IL2-Ra	323.5	46
359889	20233								Leptin	201292.0						1	ng/mL	0	IL2-Ra	15.5	58
359890	20233								Visfatin	201293.0						1	ng/mL	0	IL2-Ra	17	55
359891	20233															2	ug/mL	0	IL2-Ra	19	54
359892	20233								TNF-a	201285.0						100	ng/mL	0	IL2-Ra	15	69
359893	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL2-Ra	18	71
359894	20233								IL-6	201287.0						100	ug/mL	0	IL2-Ra	17	56
359895	20233								IL-17A	201288.0						100	ng/mL	0	IL2-Ra	15	65
359896	20233								EGF	201289.0						100	ng/mL	0	IL2-Ra	14	54
359897	20233								IGF-I	201290.0						100	ug/mL	0	IL2-Ra	15	61
359898	20233								Adiponectin	201291.0						5	ng/mL	0	IL2-Ra	320.5	60
359899	20233								Leptin	201292.0						1	ng/mL	0	IL2-Ra	15	42
359900	20233								Visfatin	201293.0						1	ng/mL	0	IL2-Ra	16	56
359901	20233															2	ug/mL	0	IL2-Ra	15	47
359902	20233								TNF-a	201285.0						100	ng/mL	0	IL2-Ra	15	50
359903	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL2-Ra	21	68
359904	20233								IL-6	201287.0						100	ug/mL	0	IL2-Ra	21	66
359905	20233								IL-17A	201288.0						100	ng/mL	0	IL2-Ra	12.5	50
359906	20233								EGF	201289.0						100	ng/mL	0	IL2-Ra	14	71
359907	20233								IGF-I	201290.0						100	ug/mL	0	IL2-Ra	13.5	40
359908	20233								Adiponectin	201291.0						5	ng/mL	0	IL2-Ra	370.5	54
359909	20233								Leptin	201292.0						1	ng/mL	0	IL2-Ra	20	49
359910	20233								Visfatin	201293.0						1	ng/mL	0	IL2-Ra	19	52
359911	20233															2	ug/mL	0	IL2-Ra	15	57
359912	20233																	0	MIG	14.5	70
359913	20233						RA2159	51112.0										1	MIG	16	67
359914	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MIG	22	50
359915	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MIG	18	83
359916	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MIG	19	74
359917	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MIG	19	45
359918	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MIG	20	72
359919	20233						RA2159	51112.0										1	MIG	18	63
359920	20233						N2586	51107.0										1	MIG	39	79
359921	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MIG	44.5	70
359922	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MIG	40	63
359923	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MIG	38	55
359924	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MIG	39	47
359925	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MIG	37	50
359926	20233						N2586	51107.0										1	MIG	33	34
359927	20233																	0	MIG	13	65
359928	20233																	0	MIG	13.5	44
359929	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	MIG	58	46
359930	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	MIG	64.5	74
359931	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIG	84	68
359932	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIG	68	51
359933	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIG	73	79
359934	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	MIG	35	51
359935	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	MIG	18	49
359936	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	MIG	191.5	70
359937	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	MIG	181.5	48
359938	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIG	136	37
359939	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIG	204	54
359940	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIG	198.5	54
359941	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	MIG	172	43
359942	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	MIG	45	57
359943	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	MIG	40	78
359944	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	MIG	40.5	80
359945	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIG	48.5	48
359946	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIG	43	51
359947	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIG	39	79
359948	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	MIG	19.5	50
359949	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	MIG	18	53
359950	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	MIG	131	45
359951	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	MIG	123	47
359952	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIG	186	52
359953	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIG	151	57
359954	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIG	128	52
359955	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	MIG	78	47
359956	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	MIG	35	38
359957	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	MIG	18.5	68
359958	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	MIG	17	50
359959	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIG	17	45
359960	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIG	18	59
359961	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIG	17	58
359962	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	MIG	17	55
359963	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	MIG	20	58
359964	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	MIG	48.5	70
359965	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	MIG	44	68
359966	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIG	36	63
359967	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIG	45	47
359968	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIG	35	55
359969	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	MIG	47	44
359970	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	MIG	56	53
359971	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	MIG	16	50
359972	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	MIG	19	70
359973	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIG	18	62
359974	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIG	18	69
359975	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIG	20	56
359976	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	MIG	18	68
359977	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	MIG	70	37
359978	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	MIG	57	30
359979	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIG	52	30
359980	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIG	59	46
359981	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIG	48	43
359982	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	MIG	46.5	64
359983	20233						RA2159	51112.0										1	MIG	18	52
359984	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MIG	23	75
359985	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MIG	15	76
359986	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MIG	17.5	80
359987	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MIG	18	54
359988	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MIG	17	63
359989	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	MIG	22	54
359990	20233						N2586	51107.0										1	MIG	47	46
359991	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MIG	46	55
359992	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MIG	40	41
359993	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MIG	46	50
359994	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MIG	47	69
359995	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MIG	41	50
359996	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	MIG	36	48
359997	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	MIG	22	58
359998	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	MIG	19	73
359999	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIG	16	52
360000	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIG	19.5	66
360001	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIG	20	59
360002	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	MIG	20	67
360003	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	MIG	19	62
360004	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	MIG	54	75
360005	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	MIG	48	68
360006	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIG	41	51
360007	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIG	58	65
360008	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIG	59	53
360009	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	MIG	43	52
360010	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	MIG	47	43
360011	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	MIG	17.5	50
360012	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	MIG	15	63
360013	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIG	16	57
360014	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIG	19	58
360015	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIG	17	70
360016	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	MIG	19	54
360017	20233						RA2159	51112.0										1	MIG	19.5	64
360018	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	MIG	56	57
360019	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	MIG	44.5	64
360020	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIG	37	49
360021	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIG	62	63
360022	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIG	59	31
360023	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	MIG	54	41
360024	20233						N2586	51107.0										1	MIG	43	44
360025	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	MIG	61	73
360026	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	MIG	62.5	56
360027	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIG	66	63
360028	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIG	55	51
360029	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIG	82	66
360030	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	MIG	71	64
360031	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	MIG	87	63
360032	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	MIG	70	68
360033	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIG	79	41
360034	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIG	75	46
360035	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIG	66	50
360036	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	MIG	68	58
360037	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	MIG	16.5	52
360038	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	MIG	16	50
360039	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIG	16	66
360040	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIG	16	62
360041	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIG	14	28
360042	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	MIG	15	37
360043	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	MIG	40	29
360044	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	MIG	39.5	42
360045	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIG	34	61
360046	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIG	44.5	28
360047	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIG	38	39
360048	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	MIG	36	37
360049	20233						RA2159	51112.0										1	MIG		0
360050	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MIG		0
360051	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MIG		0
360052	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MIG		0
360053	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MIG		0
360054	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MIG		0
360055	20233						RA2159	51112.0										1	MIG		0
360056	20233						N2586	51107.0										1	MIG		0
360057	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MIG		0
360058	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MIG		0
360059	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MIG		0
360060	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MIG		0
360061	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MIG		0
360062	20233						N2586	51107.0										1	MIG		0
360063	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	MIG	16.5	50
360064	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	MIG	20	60
360065	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIG	19	52
360066	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIG	18	67
360067	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIG	17	57
360068	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	MIG	21	46
360069	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	MIG	37.5	42
360070	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	MIG	42	53
360071	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIG	48	58
360072	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIG	39	48
360073	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIG	47	37
360074	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	MIG	38.5	34
360075	20233																	0	MIG	9.5	58
360076	20233						RA2159	51112.0								2	ug/mL	1	MIG	25	43
360077	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	MIG	30	59
360078	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MIG	21.5	46
360079	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MIG	23	59
360080	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MIG	19	54
360081	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	MIG	15	62
360082	20233						N2586	51107.0								2	ug/mL	1	MIG	73	58
360083	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	MIG	58	45
360084	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MIG	54	51
360085	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MIG	61	49
360086	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MIG	65	45
360087	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	MIG	54	22
360088	20233																	0	MIG	17.5	40
360089	20233						RA2159	51112.0										2	MIG	17	66
360090	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MIG	19.5	60
360091	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MIG	13	61
360092	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MIG	16	82
360093	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MIG	14	64
360094	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MIG	19.5	68
360095	20233						RA2159	51112.0										2	MIG	18	65
360096	20233						N2586	51107.0										2	MIG	38	48
360097	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MIG	45	55
360098	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MIG	42.5	70
360099	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MIG	45.5	40
360100	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MIG	36	55
360101	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MIG	43	40
360102	20233						N2586	51107.0										2	MIG	50	60
360103	20233																	0	MIG	11	53
360104	20233																	0	MIG	13	59
360105	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	MIG	68.5	62
360106	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	MIG	60.5	64
360107	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	MIG	63	77
360108	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIG	61.5	58
360109	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIG	48	54
360110	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	MIG	41	69
360111	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	MIG	18.5	50
360112	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	MIG	167	65
360113	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	MIG	151	55
360114	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	MIG	122	44
360115	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIG	180.5	52
360116	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIG	100	61
360117	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	MIG	132	31
360118	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	MIG	41	43
360119	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	MIG	38	69
360120	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	MIG	68	60
360121	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	MIG	41.5	62
360122	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIG	52	62
360123	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIG	38.5	58
360124	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	MIG	44	69
360125	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	MIG	18.5	66
360126	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	MIG	116.5	60
360127	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	MIG	229	59
360128	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	MIG	137	64
360129	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIG	193	51
360130	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIG	90	51
360131	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	MIG	115	49
360132	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	MIG	37	69
360133	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	MIG	21	58
360134	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	MIG	17	61
360135	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	MIG	20	58
360136	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIG	18.5	68
360137	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIG	17	62
360138	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	MIG	20	51
360139	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	MIG	19	60
360140	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	MIG	49	61
360141	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	MIG	49.5	84
360142	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	MIG	40	60
360143	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIG	51	70
360144	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIG	33	61
360145	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	MIG	37	41
360146	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	MIG	43	57
360147	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	MIG	19	65
360148	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	MIG	27	52
360149	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	MIG	21	61
360150	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIG	25	65
360151	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIG	20	51
360152	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	MIG	22	35
360153	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	MIG	15	31
360154	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	MIG	60	39
360155	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	MIG	60	59
360156	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	MIG	48	13
360157	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIG	67	28
360158	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIG	37.5	50
360159	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	MIG	41.5	50
360160	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	MIG	35.5	74
360161	20233						RA2159	51112.0										2	MIG	21	60
360162	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MIG	20	57
360163	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MIG	19	50
360164	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MIG	18.5	38
360165	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MIG	16	69
360166	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MIG	16.5	52
360167	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	MIG	23	73
360168	20233						N2586	51107.0										2	MIG	54	55
360169	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MIG	52	57
360170	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MIG	38.5	72
360171	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MIG	64	87
360172	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MIG	30	45
360173	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MIG	35	55
360174	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	MIG	33.5	64
360175	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	MIG	19	82
360176	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	MIG	20.5	66
360177	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	MIG	19	63
360178	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	MIG	16	57
360179	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	MIG	18	64
360180	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	MIG	19	51
360181	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	MIG	50	66
360182	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	MIG	59.5	50
360183	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	MIG	37	61
360184	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	MIG	57	55
360185	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	MIG	39	67
360186	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	MIG	42	55
360187	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	MIG	15	57
360188	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	MIG	19	79
360189	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	MIG	16	58
360190	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIG	20	53
360191	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIG	10	48
360192	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	MIG	16	37
360193	20233						RA2159	51112.0										2	MIG	16.5	50
360194	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	MIG	37	43
360195	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	MIG	51	50
360196	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	MIG	36	76
360197	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIG	55	49
360198	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIG	33	71
360199	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	MIG	39	59
360200	20233						N2586	51107.0										2	MIG	37	73
360201	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	MIG	45	59
360202	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	MIG	43	57
360203	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	MIG	48	55
360204	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIG	47	55
360205	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIG	45.5	62
360206	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	MIG	49	65
360207	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	MIG	71	58
360208	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	MIG	79	74
360209	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	MIG	85.5	52
360210	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIG	89	29
360211	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIG	76	64
360212	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	MIG	76.5	58
360213	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	MIG	16.5	64
360214	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	MIG	17	61
360215	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	MIG	18	69
360216	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIG	20	71
360217	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIG	15	56
360218	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	MIG	18	59
360219	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	MIG	37	79
360220	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	MIG	34	58
360221	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	MIG	29.5	66
360222	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIG	48	59
360223	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIG	22.5	50
360224	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	MIG	33	57
360225	20233						RA2159	51112.0										2	MIG		0
360226	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MIG		0
360227	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MIG		0
360228	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MIG		0
360229	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MIG		0
360230	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MIG		0
360231	20233						RA2159	51112.0										2	MIG		0
360232	20233						N2586	51107.0										2	MIG		0
360233	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MIG		0
360234	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MIG		0
360235	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MIG		0
360236	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MIG		0
360237	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MIG		0
360238	20233						N2586	51107.0										2	MIG		0
360239	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	MIG	13.5	50
360240	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	MIG	16	80
360241	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	MIG	16	65
360242	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIG	18	55
360243	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIG	15.5	66
360244	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	MIG	15	76
360245	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	MIG	42	55
360246	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	MIG	41.5	52
360247	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	MIG	34	69
360248	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIG	52.5	48
360249	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIG	27.5	68
360250	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	MIG	40	45
360251	20233																	0	MIG	10	80
360252	20233						RA2159	51112.0								2	ug/mL	2	MIG	32.5	74
360253	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	MIG	30	43
360254	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	MIG	21.5	58
360255	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	MIG	23.5	52
360256	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	MIG	18	68
360257	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	MIG	20	49
360258	20233						N2586	51107.0								2	ug/mL	2	MIG	66	61
360259	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	MIG	73	33
360260	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	MIG	66	47
360261	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	MIG	73	46
360262	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	MIG	49	45
360263	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	MIG	49	55
360264	20233																	0	MIG	11.5	66
360265	20233						RA2159	51112.0								2	ug/mL	3	MIG	25	66
360266	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	MIG	30	56
360267	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MIG	22	52
360268	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MIG	25	59
360269	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MIG	27	82
360270	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	MIG	22	58
360271	20233						N2586	51107.0								2	ug/mL	3	MIG	84	55
360272	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	MIG	174	60
360273	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MIG	68	72
360274	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MIG	119	49
360275	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MIG	51.5	56
360276	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	MIG	75	54
360277	20233						RA2159	51112.0										3	MIG		0
360278	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MIG		0
360279	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MIG		0
360280	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MIG		0
360281	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MIG		0
360282	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MIG		0
360283	20233						RA2159	51112.0										3	MIG		0
360284	20233						N2586	51107.0										3	MIG		0
360285	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MIG		0
360286	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MIG		0
360287	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MIG		0
360288	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MIG		0
360289	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MIG		0
360290	20233						N2586	51107.0										3	MIG		0
360291	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	MIG	23	59
360292	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	MIG	18.5	62
360293	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIG	16.5	76
360294	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIG	17	64
360295	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIG	17	51
360296	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	MIG	17	61
360297	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	MIG	51	68
360298	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	MIG	57	61
360299	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIG	44	57
360300	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIG	56.5	56
360301	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIG	49	61
360302	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	MIG	42	56
360303	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	MIG	18	72
360304	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	MIG	18	63
360305	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIG	16	53
360306	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIG	16	61
360307	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIG	15	68
360308	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	MIG	19.5	62
360309	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	MIG	49	50
360310	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	MIG	55	67
360311	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIG	42.5	72
360312	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIG	56	75
360313	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIG	37	69
360314	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	MIG	40	45
360315	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	MIG	50.5	50
360316	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	MIG	46	52
360317	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIG	50	57
360318	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIG	51	68
360319	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIG	54	75
360320	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	MIG	51	68
360321	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	MIG	89	57
360322	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	MIG	99.5	62
360323	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIG	75	73
360324	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIG	82	67
360325	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIG	79	53
360326	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	MIG	80	55
360327	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	MIG	17	55
360328	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	MIG	17	60
360329	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIG	17	66
360330	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIG	15	60
360331	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIG	21	59
360332	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	MIG	17	58
360333	20233						RA2159	51112.0										3	MIG	17	52
360334	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	MIG	62	52
360335	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	MIG	66	75
360336	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIG	39.5	52
360337	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIG	66	80
360338	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIG	38	64
360339	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	MIG	40	50
360340	20233						N2586	51107.0										3	MIG	49	77
360341	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	MIG	18.5	62
360342	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	MIG	19.5	58
360343	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIG	16	69
360344	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIG	22	63
360345	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIG	21.5	68
360346	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	MIG	20	73
360347	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	MIG	19.5	84
360348	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	MIG	55.5	66
360349	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	MIG	71.5	66
360350	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIG	54	71
360351	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIG	90	57
360352	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIG	41.5	72
360353	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	MIG	39	65
360354	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	MIG	30	55
360355	20233						RA2159	51112.0										3	MIG	16	65
360356	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MIG	14.5	56
360357	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MIG	14.5	66
360358	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MIG	19	52
360359	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MIG	16	53
360360	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MIG	16	50
360361	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	MIG	20	66
360362	20233						N2586	51107.0										3	MIG	54.5	70
360363	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MIG	57	65
360364	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MIG	44	56
360365	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MIG	87	67
360366	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MIG	45	62
360367	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MIG	34	71
360368	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	MIG	41	54
360369	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	MIG	18	69
360370	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	MIG	17	83
360371	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIG	19.5	72
360372	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIG	17	53
360373	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIG	19	69
360374	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	MIG	20.5	52
360375	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	MIG	57	51
360376	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	MIG	60	55
360377	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIG	43	50
360378	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIG	94	55
360379	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIG	35	66
360380	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	MIG	34	49
360381	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	MIG	15	59
360382	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	MIG	19	63
360383	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIG	16	61
360384	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIG	18	53
360385	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIG	17	62
360386	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	MIG	17.5	46
360387	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	MIG	19	76
360388	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	MIG	63.5	62
360389	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	MIG	57	46
360390	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIG	38	52
360391	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIG	53.5	58
360392	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIG	35	59
360393	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	MIG	36	61
360394	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	MIG	47	63
360395	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	MIG	42.5	72
360396	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	MIG	47	50
360397	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIG	53	81
360398	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIG	53	51
360399	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIG	42	56
360400	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	MIG	24	57
360401	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	MIG	17	80
360402	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	MIG	128	54
360403	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	MIG	215	53
360404	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIG	162	57
360405	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIG	206	65
360406	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIG	47	54
360407	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	MIG	68	71
360408	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	MIG	40	62
360409	20233																	0	MIG	12	58
360410	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	MIG	73.5	64
360411	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	MIG	73	55
360412	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIG	88	64
360413	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIG	75	40
360414	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIG	83.5	54
360415	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	MIG	41	65
360416	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	MIG	14	28
360417	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	MIG	184	45
360418	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	MIG	150	78
360419	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIG	164.5	70
360420	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIG	192	77
360421	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIG	72	54
360422	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	MIG	124.5	68
360423	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	MIG	54	48
360424	20233																	0	MIG	8	43
360425	20233						RA2159	51112.0										3	MIG	19	62
360426	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MIG	21	47
360427	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MIG	22.5	60
360428	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MIG	18	42
360429	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MIG	15	73
360430	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MIG	17	42
360431	20233						RA2159	51112.0										3	MIG	18	51
360432	20233						N2586	51107.0										3	MIG	50.5	52
360433	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MIG	45.5	54
360434	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MIG	36	59
360435	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MIG	49	63
360436	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MIG	39	48
360437	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MIG	35	27
360438	20233						N2586	51107.0										3	MIG	42	49
360439	20233																	0	MIG	9.5	46
360440	20233						RA2159	51112.0								2	ug/mL	4	MIG	40	67
360441	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	MIG	41	51
360442	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	MIG	25	51
360443	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	MIG	36	60
360444	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	MIG	25	67
360445	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	MIG	24	61
360446	20233						N2586	51107.0								2	ug/mL	4	MIG	95	51
360447	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	MIG	97	52
360448	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	MIG	68	51
360449	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	MIG	120	39
360450	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	MIG	58.5	62
360451	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	MIG	38	41
360452	20233						RA2159	51112.0										4	MIG		0
360453	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MIG		0
360454	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MIG		0
360455	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MIG		0
360456	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MIG		0
360457	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MIG		0
360458	20233						RA2159	51112.0										4	MIG		0
360459	20233						N2586	51107.0										4	MIG		0
360460	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MIG		0
360461	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MIG		0
360462	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MIG		0
360463	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MIG		0
360464	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MIG		0
360465	20233						N2586	51107.0										4	MIG		0
360466	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	MIG	22.5	50
360467	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	MIG	24	51
360468	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	MIG	19	57
360469	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIG	23	68
360470	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIG	19	69
360471	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	MIG	19	69
360472	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	MIG	54	67
360473	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	MIG	48	58
360474	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	MIG	38	47
360475	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIG	53.5	68
360476	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIG	49.5	66
360477	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	MIG	29	46
360478	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	MIG	19	61
360479	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	MIG	20	54
360480	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	MIG	20	66
360481	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIG	22	56
360482	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIG	31.5	74
360483	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	MIG	16.5	48
360484	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	MIG	54.5	56
360485	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	MIG	44	59
360486	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	MIG	40	41
360487	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIG	51	49
360488	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIG	42	55
360489	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	MIG	36.5	54
360490	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	MIG	58	97
360491	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	MIG	52	62
360492	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	MIG	54	65
360493	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIG	52	81
360494	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIG	54	65
360495	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	MIG	44.5	66
360496	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	MIG	84.5	56
360497	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	MIG	84	61
360498	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	MIG	77.5	60
360499	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIG	77.5	64
360500	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIG	85	48
360501	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	MIG	60	67
360502	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	MIG	22.5	54
360503	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	MIG	23	58
360504	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	MIG	24	50
360505	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIG	23	57
360506	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIG	18	50
360507	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	MIG	18	64
360508	20233						RA2159	51112.0										4	MIG	19	66
360509	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	MIG	55	59
360510	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	MIG	65	78
360511	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	MIG	43.5	60
360512	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIG	51	42
360513	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIG	59	59
360514	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	MIG	36	71
360515	20233						N2586	51107.0										4	MIG	41	67
360516	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	MIG	25.5	64
360517	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	MIG	22	51
360518	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	MIG	19	53
360519	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	MIG	19	65
360520	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	MIG	21	51
360521	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	MIG	20	60
360522	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	MIG	67	49
360523	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	MIG	65.5	60
360524	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	MIG	39	60
360525	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	MIG	91	55
360526	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	MIG	48	58
360527	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	MIG	37	62
360528	20233						RA2159	51112.0										4	MIG	20	85
360529	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MIG	21	46
360530	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MIG	19	55
360531	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MIG	19	69
360532	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MIG	18	44
360533	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MIG	17	15
360534	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	MIG	15.5	18
360535	20233						N2586	51107.0										4	MIG		2
360536	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MIG		6
360537	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MIG	38	62
360538	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MIG	57	42
360539	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MIG	48	57
360540	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MIG	31	51
360541	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	MIG	48	41
360542	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	MIG	19.5	58
360543	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	MIG	25	51
360544	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	MIG	22	46
360545	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIG	21	55
360546	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIG	23	88
360547	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	MIG	22	49
360548	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	MIG	20.5	36
360549	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	MIG	63.5	48
360550	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	MIG	65.5	66
360551	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	MIG	57.5	40
360552	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIG	59	57
360553	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIG	105	57
360554	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	MIG	40	53
360555	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	MIG	32	43
360556	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	MIG	29	71
360557	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	MIG	21	79
360558	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	MIG	21	66
360559	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIG	23	65
360560	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIG	18	53
360561	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	MIG	16	55
360562	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	MIG	19	53
360563	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	MIG	44	55
360564	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	MIG	51.5	54
360565	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	MIG	37	33
360566	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIG	54	46
360567	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIG	39	65
360568	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	MIG	38	51
360569	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	MIG	59	54
360570	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	MIG	61	55
360571	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	MIG	86.5	50
360572	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	MIG	74.5	70
360573	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIG	50.5	68
360574	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIG	39	59
360575	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	MIG	51	50
360576	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	MIG	19	68
360577	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	MIG	136	59
360578	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	MIG	157.5	56
360579	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	MIG	187	55
360580	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIG	186	49
360581	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIG	96	43
360582	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	MIG	37	51
360583	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	MIG	43	47
360584	20233																	0	MIG	12	68
360585	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	MIG	71.5	48
360586	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	MIG	81	47
360587	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	MIG	76	44
360588	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIG	65.5	70
360589	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIG	60	38
360590	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	MIG	43	61
360591	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	MIG	17	49
360592	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	MIG	222.5	48
360593	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	MIG	227	75
360594	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	MIG	210	61
360595	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIG	276	45
360596	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIG	166.5	42
360597	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	MIG	43	46
360598	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	MIG	45	51
360599	20233																	0	MIG	12.5	42
360600	20233						RA2159	51112.0										4	MIG	15	67
360601	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MIG	18.5	52
360602	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MIG	18	61
360603	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MIG	21	50
360604	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MIG	19	72
360605	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MIG	16	56
360606	20233						RA2159	51112.0										4	MIG	20	61
360607	20233						N2586	51107.0										4	MIG	53.5	58
360608	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MIG	51	64
360609	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MIG	44	49
360610	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MIG	48.5	52
360611	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MIG	41	49
360612	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MIG	38.5	58
360613	20233						N2586	51107.0										4	MIG	47	41
360614	20233								TNF-a	201285.0						100	ng/mL	0	MIG	12	76
360615	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIG	16	61
360616	20233								IL-6	201287.0						100	ug/mL	0	MIG	13	46
360617	20233								IL-17A	201288.0						100	ng/mL	0	MIG	13	61
360618	20233								EGF	201289.0						100	ng/mL	0	MIG	17	66
360619	20233								IGF-I	201290.0						100	ug/mL	0	MIG	13	51
360620	20233								Adiponectin	201291.0						5	ng/mL	0	MIG	293	48
360621	20233								Leptin	201292.0						1	ng/mL	0	MIG	12	48
360622	20233								Visfatin	201293.0						1	ng/mL	0	MIG	13.5	54
360623	20233															2	ug/mL	0	MIG	12	53
360624	20233								TNF-a	201285.0						100	ng/mL	0	MIG	10	50
360625	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIG	17	61
360626	20233								IL-6	201287.0						100	ug/mL	0	MIG	11	60
360627	20233								IL-17A	201288.0						100	ng/mL	0	MIG	12	63
360628	20233								EGF	201289.0						100	ng/mL	0	MIG	11.5	44
360629	20233								IGF-I	201290.0						100	ug/mL	0	MIG	14.5	48
360630	20233								Adiponectin	201291.0						5	ng/mL	0	MIG	296	61
360631	20233								Leptin	201292.0						1	ng/mL	0	MIG	11	58
360632	20233								Visfatin	201293.0						1	ng/mL	0	MIG	10	64
360633	20233															2	ug/mL	0	MIG	13	47
360634	20233								TNF-a	201285.0						100	ng/mL	0	MIG	10	63
360635	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIG	15.5	50
360636	20233								IL-6	201287.0						100	ug/mL	0	MIG	13.5	52
360637	20233								IL-17A	201288.0						100	ng/mL	0	MIG	13	56
360638	20233								EGF	201289.0						100	ng/mL	0	MIG	14	42
360639	20233								IGF-I	201290.0						100	ug/mL	0	MIG	12.5	54
360640	20233								Adiponectin	201291.0						5	ng/mL	0	MIG	219.5	62
360641	20233								Leptin	201292.0						1	ng/mL	0	MIG	10	41
360642	20233								Visfatin	201293.0						1	ng/mL	0	MIG	11	65
360643	20233															2	ug/mL	0	MIG	13.5	54
360644	20233								TNF-a	201285.0						100	ng/mL	0	MIG	11	42
360645	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIG	13	57
360646	20233								IL-6	201287.0						100	ug/mL	0	MIG	15	73
360647	20233								IL-17A	201288.0						100	ng/mL	0	MIG	13	41
360648	20233								EGF	201289.0						100	ng/mL	0	MIG	9	75
360649	20233								IGF-I	201290.0						100	ug/mL	0	MIG	14	52
360650	20233								Adiponectin	201291.0						5	ng/mL	0	MIG	347.5	50
360651	20233								Leptin	201292.0						1	ng/mL	0	MIG	14	55
360652	20233								Visfatin	201293.0						1	ng/mL	0	MIG	11	43
360653	20233															2	ug/mL	0	MIG	11	39
360654	20233																	0	IFN-a2	18	68
360655	20233						RA2159	51112.0										1	IFN-a2	22	58
360656	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IFN-a2	26	55
360657	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IFN-a2	20	56
360658	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IFN-a2	21	68
360659	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IFN-a2	23	77
360660	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IFN-a2	24	69
360661	20233						RA2159	51112.0										1	IFN-a2	26	82
360662	20233						N2586	51107.0										1	IFN-a2	38	64
360663	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IFN-a2	49	40
360664	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IFN-a2	39	57
360665	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IFN-a2	38	57
360666	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IFN-a2	40	54
360667	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IFN-a2	38.5	50
360668	20233						N2586	51107.0										1	IFN-a2	36.5	28
360669	20233																	0	IFN-a2	18.5	54
360670	20233																	0	IFN-a2	16	40
360671	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IFN-a2	52.5	66
360672	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IFN-a2	58	69
360673	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IFN-a2	84	71
360674	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IFN-a2	56	51
360675	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IFN-a2	70.5	64
360676	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IFN-a2	34	61
360677	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IFN-a2	22	63
360678	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IFN-a2	147	51
360679	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IFN-a2	159	43
360680	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IFN-a2	152	37
360681	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IFN-a2	181	64
360682	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IFN-a2	198	63
360683	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IFN-a2	163	36
360684	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IFN-a2	45	82
360685	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IFN-a2	38	63
360686	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IFN-a2	39	51
360687	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IFN-a2	50	62
360688	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IFN-a2	41	63
360689	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IFN-a2	39.5	64
360690	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IFN-a2	26	65
360691	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IFN-a2	21	67
360692	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IFN-a2	109	49
360693	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IFN-a2	115.5	58
360694	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IFN-a2	171	53
360695	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IFN-a2	125	73
360696	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IFN-a2	115.5	56
360697	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IFN-a2	59	40
360698	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IFN-a2	35	57
360699	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IFN-a2	22	69
360700	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IFN-a2	20	78
360701	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IFN-a2	17	59
360702	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IFN-a2	20	52
360703	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IFN-a2	24	64
360704	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IFN-a2	21	61
360705	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IFN-a2	22	61
360706	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IFN-a2	51	53
360707	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IFN-a2	45.5	56
360708	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IFN-a2	39	49
360709	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IFN-a2	44	33
360710	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IFN-a2	42	43
360711	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IFN-a2	39	49
360712	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IFN-a2	53	33
360713	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IFN-a2	21.5	50
360714	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IFN-a2	23	61
360715	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IFN-a2	20	51
360716	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IFN-a2	25	53
360717	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IFN-a2	23.5	72
360718	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IFN-a2	19.5	64
360719	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IFN-a2	60	26
360720	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IFN-a2	45	33
360721	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IFN-a2	47.5	40
360722	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IFN-a2	62	43
360723	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IFN-a2	45	43
360724	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IFN-a2	46	49
360725	20233						RA2159	51112.0										1	IFN-a2	22	43
360726	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IFN-a2	26	64
360727	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IFN-a2	21	77
360728	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IFN-a2	23	80
360729	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IFN-a2	20	50
360730	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IFN-a2	22	76
360731	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IFN-a2	24	52
360732	20233						N2586	51107.0										1	IFN-a2	47	48
360733	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IFN-a2	49	52
360734	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IFN-a2	50.5	52
360735	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IFN-a2	45	58
360736	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IFN-a2	44	67
360737	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IFN-a2	39.5	40
360738	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IFN-a2	44	33
360739	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IFN-a2	24	58
360740	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IFN-a2	21	60
360741	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IFN-a2	18	71
360742	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IFN-a2	22	53
360743	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IFN-a2	20.5	58
360744	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IFN-a2	21	83
360745	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IFN-a2	22	65
360746	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IFN-a2	55	58
360747	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IFN-a2	55	63
360748	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IFN-a2	41	51
360749	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IFN-a2	49	74
360750	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IFN-a2	53	60
360751	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IFN-a2	45	52
360752	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IFN-a2	34	38
360753	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IFN-a2	21	57
360754	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IFN-a2	25	69
360755	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IFN-a2	20	58
360756	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IFN-a2	18	54
360757	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IFN-a2	21.5	60
360758	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IFN-a2	23	59
360759	20233						RA2159	51112.0										1	IFN-a2	18	72
360760	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IFN-a2	47.5	58
360761	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IFN-a2	55.5	78
360762	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IFN-a2	51	40
360763	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IFN-a2	41	58
360764	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IFN-a2	54	42
360765	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IFN-a2	51	38
360766	20233						N2586	51107.0										1	IFN-a2	35	53
360767	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IFN-a2	78	69
360768	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IFN-a2	79	75
360769	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IFN-a2	90	61
360770	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IFN-a2	68.5	66
360771	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IFN-a2	109	67
360772	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IFN-a2	95	58
360773	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IFN-a2	92.5	70
360774	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IFN-a2	83.5	60
360775	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IFN-a2	91	35
360776	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IFN-a2	83	55
360777	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IFN-a2	91	48
360778	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IFN-a2	76.5	50
360779	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IFN-a2	22	49
360780	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IFN-a2	19	55
360781	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IFN-a2	18	53
360782	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IFN-a2	18	52
360783	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IFN-a2	21.5	36
360784	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IFN-a2	24	35
360785	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IFN-a2	50	33
360786	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IFN-a2	41	47
360787	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IFN-a2	35	47
360788	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IFN-a2	42	37
360789	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IFN-a2	33.5	42
360790	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IFN-a2	42	35
360791	20233						RA2159	51112.0										1	IFN-a2		0
360792	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IFN-a2		0
360793	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IFN-a2		0
360794	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IFN-a2		0
360795	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IFN-a2		0
360796	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IFN-a2		0
360797	20233						RA2159	51112.0										1	IFN-a2		0
360798	20233						N2586	51107.0										1	IFN-a2		0
360799	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IFN-a2		0
360800	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IFN-a2		0
360801	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IFN-a2		0
360802	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IFN-a2		0
360803	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IFN-a2		0
360804	20233						N2586	51107.0										1	IFN-a2		0
360805	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IFN-a2	19	54
360806	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IFN-a2	21.5	54
360807	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IFN-a2	19	67
360808	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IFN-a2	19	65
360809	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IFN-a2	18.5	50
360810	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IFN-a2	16.5	56
360811	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IFN-a2	36.5	38
360812	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IFN-a2	43	34
360813	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IFN-a2	44	49
360814	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IFN-a2	45	55
360815	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IFN-a2	46	29
360816	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IFN-a2	38.5	40
360817	20233																	0	IFN-a2	14	53
360818	20233						RA2159	51112.0								2	ug/mL	1	IFN-a2	24.5	50
360819	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IFN-a2	26	51
360820	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IFN-a2	25	49
360821	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IFN-a2	25	54
360822	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IFN-a2	24	67
360823	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IFN-a2	18	79
360824	20233						N2586	51107.0								2	ug/mL	1	IFN-a2	60	55
360825	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IFN-a2	50	30
360826	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IFN-a2	59	43
360827	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IFN-a2	76	39
360828	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IFN-a2	55	54
360829	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IFN-a2	55.5	30
360830	20233																	0	IFN-a2	18	59
360831	20233						RA2159	51112.0										2	IFN-a2	22.5	66
360832	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IFN-a2	22	61
360833	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IFN-a2	22	52
360834	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IFN-a2	23	58
360835	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IFN-a2	20	58
360836	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IFN-a2	22	58
360837	20233						RA2159	51112.0										2	IFN-a2	22	63
360838	20233						N2586	51107.0										2	IFN-a2	37	50
360839	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IFN-a2	45	55
360840	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IFN-a2	44	66
360841	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IFN-a2	46	65
360842	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IFN-a2	36.5	82
360843	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IFN-a2	34.5	40
360844	20233						N2586	51107.0										2	IFN-a2	48.5	56
360845	20233																	0	IFN-a2	18	52
360846	20233																	0	IFN-a2	14.5	62
360847	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IFN-a2	65.5	50
360848	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IFN-a2	50	64
360849	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IFN-a2	60	65
360850	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IFN-a2	60	65
360851	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IFN-a2	44	55
360852	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IFN-a2	41	72
360853	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IFN-a2	23	66
360854	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IFN-a2	144.5	52
360855	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IFN-a2	132	61
360856	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IFN-a2	110	73
360857	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IFN-a2	174	37
360858	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IFN-a2	100.5	54
360859	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IFN-a2	127	34
360860	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IFN-a2	44	53
360861	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IFN-a2	34	63
360862	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IFN-a2	60	50
360863	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IFN-a2	40	63
360864	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IFN-a2	51	64
360865	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IFN-a2	36.5	90
360866	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IFN-a2	38	55
360867	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IFN-a2	18.5	64
360868	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IFN-a2	114	43
360869	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IFN-a2	206.5	54
360870	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IFN-a2	118	56
360871	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IFN-a2	151.5	52
360872	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IFN-a2	81	63
360873	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IFN-a2	105	59
360874	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IFN-a2	37	69
360875	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IFN-a2	20.5	76
360876	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IFN-a2	18	60
360877	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IFN-a2	25	84
360878	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IFN-a2	22.5	44
360879	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IFN-a2	20.5	58
360880	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IFN-a2	17.5	30
360881	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IFN-a2	21.5	50
360882	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IFN-a2	48	66
360883	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IFN-a2	43	75
360884	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IFN-a2	45	57
360885	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IFN-a2	49	67
360886	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IFN-a2	35	49
360887	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IFN-a2	33	60
360888	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IFN-a2	38.5	60
360889	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IFN-a2	22.5	60
360890	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IFN-a2	21	55
360891	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IFN-a2	23	67
360892	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IFN-a2	26.5	78
360893	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IFN-a2	22	52
360894	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IFN-a2	22	43
360895	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IFN-a2	15	39
360896	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IFN-a2	49	55
360897	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IFN-a2	61	79
360898	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IFN-a2	45	17
360899	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IFN-a2	62	16
360900	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IFN-a2	37.5	52
360901	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IFN-a2	40	55
360902	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IFN-a2	33	72
360903	20233						RA2159	51112.0										2	IFN-a2	24	72
360904	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IFN-a2	22	55
360905	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IFN-a2	20	44
360906	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IFN-a2	21	54
360907	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IFN-a2	19	51
360908	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IFN-a2	22	64
360909	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IFN-a2	25	59
360910	20233						N2586	51107.0										2	IFN-a2	43	64
360911	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IFN-a2	51	82
360912	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IFN-a2	37	77
360913	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IFN-a2	65	55
360914	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IFN-a2	34	69
360915	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IFN-a2	40	56
360916	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IFN-a2	32.5	72
360917	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IFN-a2	23	58
360918	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IFN-a2	23	87
360919	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IFN-a2	20	51
360920	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IFN-a2	23	55
360921	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IFN-a2	23	63
360922	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IFN-a2	21	63
360923	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IFN-a2	47	56
360924	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IFN-a2	57	45
360925	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IFN-a2	43.5	56
360926	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IFN-a2	56	63
360927	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IFN-a2	36.5	58
360928	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IFN-a2	50	61
360929	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IFN-a2	20	57
360930	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IFN-a2	21	71
360931	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IFN-a2	21	54
360932	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IFN-a2	20	61
360933	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IFN-a2	16	49
360934	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IFN-a2	17	43
360935	20233						RA2159	51112.0										2	IFN-a2	21	44
360936	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IFN-a2	38	47
360937	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IFN-a2	51	63
360938	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IFN-a2	38	62
360939	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IFN-a2	45	39
360940	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IFN-a2	28.5	78
360941	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IFN-a2	34.5	62
360942	20233						N2586	51107.0										2	IFN-a2	36	67
360943	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IFN-a2	61	64
360944	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IFN-a2	58.5	74
360945	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IFN-a2	61	35
360946	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IFN-a2	66.5	56
360947	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IFN-a2	64	62
360948	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IFN-a2	57.5	72
360949	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IFN-a2	84.5	54
360950	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IFN-a2	92.5	52
360951	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IFN-a2	94	51
360952	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IFN-a2	107	36
360953	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IFN-a2	86	53
360954	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IFN-a2	82	63
360955	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IFN-a2	21	64
360956	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IFN-a2	17	59
360957	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IFN-a2	20	78
360958	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IFN-a2	19	67
360959	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IFN-a2	20	51
360960	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IFN-a2	18	55
360961	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IFN-a2	39	75
360962	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IFN-a2	38	39
360963	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IFN-a2	34	73
360964	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IFN-a2	39	51
360965	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IFN-a2	33	63
360966	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IFN-a2	30.5	66
360967	20233						RA2159	51112.0										2	IFN-a2		0
360968	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IFN-a2		0
360969	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IFN-a2		0
360970	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IFN-a2		0
360971	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IFN-a2		0
360972	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IFN-a2		0
360973	20233						RA2159	51112.0										2	IFN-a2		0
360974	20233						N2586	51107.0										2	IFN-a2		0
360975	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IFN-a2		0
360976	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IFN-a2		0
360977	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IFN-a2		0
360978	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IFN-a2		0
360979	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IFN-a2		0
360980	20233						N2586	51107.0										2	IFN-a2		0
360981	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IFN-a2	21	55
360982	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IFN-a2	19	69
360983	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IFN-a2	21	51
360984	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IFN-a2	20	70
360985	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IFN-a2	17.5	80
360986	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IFN-a2	17	52
360987	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IFN-a2	42	75
360988	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IFN-a2	44	72
360989	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IFN-a2	35	55
360990	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IFN-a2	43	64
360991	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IFN-a2	27.5	46
360992	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IFN-a2	35	43
360993	20233																	0	IFN-a2	17	64
360994	20233						RA2159	51112.0								2	ug/mL	2	IFN-a2	24.5	66
360995	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IFN-a2	36	47
360996	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IFN-a2	21	49
360997	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IFN-a2	23	50
360998	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IFN-a2	21	53
360999	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IFN-a2	21	63
361000	20233						N2586	51107.0								2	ug/mL	2	IFN-a2	62	69
361001	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IFN-a2	78	33
361002	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IFN-a2	80	39
361003	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IFN-a2	70.5	50
361004	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IFN-a2	41	39
361005	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IFN-a2	49.5	60
361006	20233																	0	IFN-a2	17	68
361007	20233						RA2159	51112.0								2	ug/mL	3	IFN-a2	25.5	50
361008	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IFN-a2	33	70
361009	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IFN-a2	24	53
361010	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IFN-a2	28	55
361011	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IFN-a2	26	69
361012	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IFN-a2	25	61
361013	20233						N2586	51107.0								2	ug/mL	3	IFN-a2	82.5	54
361014	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IFN-a2	151	63
361015	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IFN-a2	73	63
361016	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IFN-a2	97	51
361017	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IFN-a2	50	62
361018	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IFN-a2	64.5	56
361019	20233						RA2159	51112.0										3	IFN-a2		0
361020	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IFN-a2		0
361021	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IFN-a2		0
361022	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IFN-a2		0
361023	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IFN-a2		0
361024	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IFN-a2		0
361025	20233						RA2159	51112.0										3	IFN-a2		0
361026	20233						N2586	51107.0										3	IFN-a2		0
361027	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IFN-a2		0
361028	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IFN-a2		0
361029	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IFN-a2		0
361030	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IFN-a2		0
361031	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IFN-a2		0
361032	20233						N2586	51107.0										3	IFN-a2		0
361033	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IFN-a2	25	55
361034	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IFN-a2	22	69
361035	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IFN-a2	22.5	62
361036	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IFN-a2	21	65
361037	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IFN-a2	20.5	50
361038	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IFN-a2	24	57
361039	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IFN-a2	49	59
361040	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IFN-a2	50.5	62
361041	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IFN-a2	39	63
361042	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IFN-a2	57	71
361043	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IFN-a2	50	60
361044	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IFN-a2	42	59
361045	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IFN-a2	19.5	54
361046	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IFN-a2	19	61
361047	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IFN-a2	21	72
361048	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IFN-a2	22	64
361049	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IFN-a2	18	63
361050	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IFN-a2	21.5	62
361051	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IFN-a2	52	71
361052	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IFN-a2	48.5	70
361053	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IFN-a2	44.5	64
361054	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IFN-a2	44	59
361055	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IFN-a2	36	71
361056	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IFN-a2	52	60
361057	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IFN-a2	72	62
361058	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IFN-a2	58	72
361059	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IFN-a2	66.5	64
361060	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IFN-a2	62	63
361061	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IFN-a2	62	55
361062	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IFN-a2	62.5	54
361063	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IFN-a2	96	73
361064	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IFN-a2	102	75
361065	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IFN-a2	89	55
361066	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IFN-a2	92	57
361067	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IFN-a2	89.5	52
361068	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IFN-a2	94	66
361069	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IFN-a2	21	56
361070	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IFN-a2	23	59
361071	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IFN-a2	20	70
361072	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IFN-a2	19	63
361073	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IFN-a2	20	67
361074	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IFN-a2	22	52
361075	20233						RA2159	51112.0										3	IFN-a2	21	56
361076	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IFN-a2	64	63
361077	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IFN-a2	65	50
361078	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IFN-a2	43.5	52
361079	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IFN-a2	62	46
361080	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IFN-a2	36	67
361081	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IFN-a2	42	80
361082	20233						N2586	51107.0										3	IFN-a2	47	61
361083	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IFN-a2	20.5	52
361084	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IFN-a2	21	77
361085	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IFN-a2	20.5	72
361086	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IFN-a2	23	57
361087	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IFN-a2	25	56
361088	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IFN-a2	21	60
361089	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IFN-a2	21.5	56
361090	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IFN-a2	61	66
361091	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IFN-a2	64	71
361092	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IFN-a2	57	71
361093	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IFN-a2	77	76
361094	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IFN-a2	41	70
361095	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IFN-a2	39	78
361096	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IFN-a2	28	70
361097	20233						RA2159	51112.0										3	IFN-a2	21	68
361098	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IFN-a2	19.5	52
361099	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IFN-a2	19.5	72
361100	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IFN-a2	24	56
361101	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IFN-a2	22	53
361102	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IFN-a2	21	45
361103	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IFN-a2	20	55
361104	20233						N2586	51107.0										3	IFN-a2	54.5	80
361105	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IFN-a2	63	70
361106	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IFN-a2	41	54
361107	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IFN-a2	78	63
361108	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IFN-a2	41	50
361109	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IFN-a2	39	61
361110	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IFN-a2	43	50
361111	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IFN-a2	21	54
361112	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IFN-a2	20	52
361113	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IFN-a2	23	50
361114	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IFN-a2	24	50
361115	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IFN-a2	20	77
361116	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IFN-a2	22	48
361117	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IFN-a2	58	76
361118	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IFN-a2	59	54
361119	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IFN-a2	44	73
361120	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IFN-a2	100	61
361121	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IFN-a2	43	61
361122	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IFN-a2	39.5	44
361123	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IFN-a2	21	53
361124	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IFN-a2	20	69
361125	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IFN-a2	21.5	44
361126	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IFN-a2	16	65
361127	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IFN-a2	18.5	64
361128	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IFN-a2	21	56
361129	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IFN-a2	21.5	72
361130	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IFN-a2	52	57
361131	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IFN-a2	46	59
361132	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IFN-a2	37	58
361133	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IFN-a2	47.5	60
361134	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IFN-a2	35	56
361135	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IFN-a2	38	69
361136	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IFN-a2	43.5	56
361137	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IFN-a2	37.5	66
361138	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IFN-a2	44	80
361139	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IFN-a2	53	93
361140	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IFN-a2	52	67
361141	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IFN-a2	44	65
361142	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IFN-a2	26	70
361143	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IFN-a2	20	59
361144	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IFN-a2	120	50
361145	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IFN-a2	170.5	72
361146	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IFN-a2	162	55
361147	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IFN-a2	187.5	58
361148	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IFN-a2	49.5	46
361149	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IFN-a2	56.5	74
361150	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IFN-a2	31	56
361151	20233																	0	IFN-a2	16	50
361152	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IFN-a2	82.5	56
361153	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IFN-a2	71	61
361154	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IFN-a2	73	72
361155	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IFN-a2	67	47
361156	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IFN-a2	65.5	58
361157	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IFN-a2	39	67
361158	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IFN-a2	21	27
361159	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IFN-a2	156	68
361160	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IFN-a2	163.5	66
361161	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IFN-a2	143.5	70
361162	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IFN-a2	176	83
361163	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IFN-a2	67	59
361164	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IFN-a2	133.5	68
361165	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IFN-a2	48.5	54
361166	20233																	0	IFN-a2	11	51
361167	20233						RA2159	51112.0										3	IFN-a2	21	63
361168	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IFN-a2	18	51
361169	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IFN-a2	22	60
361170	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IFN-a2	19	44
361171	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IFN-a2	23	51
361172	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IFN-a2	18	51
361173	20233						RA2159	51112.0										3	IFN-a2	22.5	62
361174	20233						N2586	51107.0										3	IFN-a2	55	43
361175	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IFN-a2	41.5	54
361176	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IFN-a2	31	47
361177	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IFN-a2	46	64
361178	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IFN-a2	42	66
361179	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IFN-a2	32	40
361180	20233						N2586	51107.0										3	IFN-a2	44	59
361181	20233																	0	IFN-a2	17	63
361182	20233						RA2159	51112.0								2	ug/mL	4	IFN-a2	32.5	68
361183	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IFN-a2	36.5	56
361184	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IFN-a2	35	59
361185	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IFN-a2	32	50
361186	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IFN-a2	27.5	64
361187	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IFN-a2	30.5	62
361188	20233						N2586	51107.0								2	ug/mL	4	IFN-a2	87	67
361189	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IFN-a2	94	54
361190	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IFN-a2	65	63
361191	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IFN-a2	83	51
361192	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IFN-a2	59	51
361193	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IFN-a2	36	47
361194	20233						RA2159	51112.0										4	IFN-a2		0
361195	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IFN-a2		0
361196	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IFN-a2		0
361197	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IFN-a2		0
361198	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IFN-a2		0
361199	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IFN-a2		0
361200	20233						RA2159	51112.0										4	IFN-a2		0
361201	20233						N2586	51107.0										4	IFN-a2		0
361202	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IFN-a2		0
361203	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IFN-a2		0
361204	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IFN-a2		0
361205	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IFN-a2		0
361206	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IFN-a2		0
361207	20233						N2586	51107.0										4	IFN-a2		0
361208	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IFN-a2	24	57
361209	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IFN-a2	24	51
361210	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IFN-a2	24	50
361211	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IFN-a2	23	78
361212	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IFN-a2	21	67
361213	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IFN-a2	21	83
361214	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IFN-a2	50	49
361215	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IFN-a2	47	53
361216	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IFN-a2	32	55
361217	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IFN-a2	47.5	78
361218	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IFN-a2	47	45
361219	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IFN-a2	31.5	54
361220	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IFN-a2	23	51
361221	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IFN-a2	24	39
361222	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IFN-a2	24.5	74
361223	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IFN-a2	23.5	56
361224	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IFN-a2	30	77
361225	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IFN-a2	19.5	50
361226	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IFN-a2	50	79
361227	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IFN-a2	41.5	50
361228	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IFN-a2	43	39
361229	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IFN-a2	48	52
361230	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IFN-a2	45	55
361231	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IFN-a2	37.5	36
361232	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IFN-a2	71	72
361233	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IFN-a2	62	57
361234	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IFN-a2	76	70
361235	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IFN-a2	64	72
361236	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IFN-a2	70	50
361237	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IFN-a2	56.5	66
361238	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IFN-a2	84	57
361239	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IFN-a2	92	59
361240	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IFN-a2	86.5	58
361241	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IFN-a2	88	61
361242	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IFN-a2	94	65
361243	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IFN-a2	69	52
361244	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IFN-a2	23	50
361245	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IFN-a2	27	80
361246	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IFN-a2	24	70
361247	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IFN-a2	22	62
361248	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IFN-a2	23	63
361249	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IFN-a2	22	77
361250	20233						RA2159	51112.0										4	IFN-a2	20.5	50
361251	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IFN-a2	51	62
361252	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IFN-a2	52	76
361253	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IFN-a2	36	62
361254	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IFN-a2	52	32
361255	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IFN-a2	56.5	68
361256	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IFN-a2	38	76
361257	20233						N2586	51107.0										4	IFN-a2	48	52
361258	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IFN-a2	29.5	68
361259	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IFN-a2	27.5	68
361260	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IFN-a2	24	67
361261	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IFN-a2	23	55
361262	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IFN-a2	24.5	46
361263	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IFN-a2	24	61
361264	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IFN-a2	66	55
361265	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IFN-a2	72	63
361266	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IFN-a2	42	86
361267	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IFN-a2	77	60
361268	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IFN-a2	49.5	44
361269	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IFN-a2	34	73
361270	20233						RA2159	51112.0										4	IFN-a2	24	68
361271	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IFN-a2	28	51
361272	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IFN-a2	24	48
361273	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IFN-a2	23	77
361274	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IFN-a2	23	27
361275	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IFN-a2	20.5	22
361276	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IFN-a2		6
361277	20233						N2586	51107.0										4	IFN-a2	49.5	8
361278	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IFN-a2	105	10
361279	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IFN-a2	33	65
361280	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IFN-a2	58	42
361281	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IFN-a2	53	28
361282	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IFN-a2	32	36
361283	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IFN-a2	49.5	60
361284	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IFN-a2	21.5	58
361285	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IFN-a2	26	63
361286	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IFN-a2	28	66
361287	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IFN-a2	23	65
361288	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IFN-a2	25	71
361289	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IFN-a2	19	41
361290	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IFN-a2	24.5	28
361291	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IFN-a2	64	51
361292	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IFN-a2	61	66
361293	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IFN-a2	68	52
361294	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IFN-a2	56	52
361295	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IFN-a2	47	57
361296	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IFN-a2	34	53
361297	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IFN-a2	28.5	52
361298	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IFN-a2	29	53
361299	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IFN-a2	25	59
361300	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IFN-a2	22	59
361301	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IFN-a2	25	50
361302	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IFN-a2	21	49
361303	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IFN-a2	17	49
361304	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IFN-a2	22	49
361305	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IFN-a2	43	52
361306	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IFN-a2	54	55
361307	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IFN-a2	41	40
361308	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IFN-a2	51	63
361309	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IFN-a2	39	53
361310	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IFN-a2	32	41
361311	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IFN-a2	62	56
361312	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IFN-a2	56	73
361313	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IFN-a2	77	58
361314	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IFN-a2	74	67
361315	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IFN-a2	48.5	52
361316	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IFN-a2	41	42
361317	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IFN-a2	52	67
361318	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IFN-a2	23	68
361319	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IFN-a2	139.5	56
361320	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IFN-a2	159	67
361321	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IFN-a2	170	60
361322	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IFN-a2	150	50
361323	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IFN-a2	82	45
361324	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IFN-a2	42	61
361325	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IFN-a2	39	66
361326	20233																	0	IFN-a2	16	57
361327	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IFN-a2	74	55
361328	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IFN-a2	74.5	40
361329	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IFN-a2	71	47
361330	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IFN-a2	70	62
361331	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IFN-a2	55	49
361332	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IFN-a2	42.5	80
361333	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IFN-a2	20	50
361334	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IFN-a2	173	55
361335	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IFN-a2	228	79
361336	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IFN-a2	176.5	60
361337	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IFN-a2	227	39
361338	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IFN-a2	165	54
361339	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IFN-a2	36	55
361340	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IFN-a2	47	48
361341	20233																	0	IFN-a2	13	57
361342	20233						RA2159	51112.0										4	IFN-a2	21	62
361343	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IFN-a2	18.5	54
361344	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IFN-a2	23	61
361345	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IFN-a2	20	60
361346	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IFN-a2	23	79
361347	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IFN-a2	19	61
361348	20233						RA2159	51112.0										4	IFN-a2	21	50
361349	20233						N2586	51107.0										4	IFN-a2	50	67
361350	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IFN-a2	53	51
361351	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IFN-a2	44	47
361352	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IFN-a2	51	52
361353	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IFN-a2	37	61
361354	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IFN-a2	34	57
361355	20233						N2586	51107.0										4	IFN-a2	48.5	50
361356	20233								TNF-a	201285.0						100	ng/mL	0	IFN-a2	16	59
361357	20233								IL-1 alpha	201286.0						100	ng/mL	0	IFN-a2	19.5	50
361358	20233								IL-6	201287.0						100	ug/mL	0	IFN-a2	19	41
361359	20233								IL-17A	201288.0						100	ng/mL	0	IFN-a2	17	70
361360	20233								EGF	201289.0						100	ng/mL	0	IFN-a2	18.5	48
361361	20233								IGF-I	201290.0						100	ug/mL	0	IFN-a2	17	60
361362	20233								Adiponectin	201291.0						5	ng/mL	0	IFN-a2	339.5	62
361363	20233								Leptin	201292.0						1	ng/mL	0	IFN-a2	15	59
361364	20233								Visfatin	201293.0						1	ng/mL	0	IFN-a2	18	59
361365	20233															2	ug/mL	0	IFN-a2	16	52
361366	20233								TNF-a	201285.0						100	ng/mL	0	IFN-a2	18	45
361367	20233								IL-1 alpha	201286.0						100	ng/mL	0	IFN-a2	20	53
361368	20233								IL-6	201287.0						100	ug/mL	0	IFN-a2	16	69
361369	20233								IL-17A	201288.0						100	ng/mL	0	IFN-a2	19	59
361370	20233								EGF	201289.0						100	ng/mL	0	IFN-a2	17.5	48
361371	20233								IGF-I	201290.0						100	ug/mL	0	IFN-a2	16	44
361372	20233								Adiponectin	201291.0						5	ng/mL	0	IFN-a2	345.5	54
361373	20233								Leptin	201292.0						1	ng/mL	0	IFN-a2	16	75
361374	20233								Visfatin	201293.0						1	ng/mL	0	IFN-a2	18	57
361375	20233															2	ug/mL	0	IFN-a2	18.5	54
361376	20233								TNF-a	201285.0						100	ng/mL	0	IFN-a2	15	69
361377	20233								IL-1 alpha	201286.0						100	ng/mL	0	IFN-a2	15	58
361378	20233								IL-6	201287.0						100	ug/mL	0	IFN-a2	16	70
361379	20233								IL-17A	201288.0						100	ng/mL	0	IFN-a2	13	52
361380	20233								EGF	201289.0						100	ng/mL	0	IFN-a2	13.5	56
361381	20233								IGF-I	201290.0						100	ug/mL	0	IFN-a2	17	57
361382	20233								Adiponectin	201291.0						5	ng/mL	0	IFN-a2	278.5	66
361383	20233								Leptin	201292.0						1	ng/mL	0	IFN-a2	15	38
361384	20233								Visfatin	201293.0						1	ng/mL	0	IFN-a2	13	60
361385	20233															2	ug/mL	0	IFN-a2	15.5	52
361386	20233								TNF-a	201285.0						100	ng/mL	0	IFN-a2	15	40
361387	20233								IL-1 alpha	201286.0						100	ng/mL	0	IFN-a2	18	81
361388	20233								IL-6	201287.0						100	ug/mL	0	IFN-a2	19	69
361389	20233								IL-17A	201288.0						100	ng/mL	0	IFN-a2	14.5	62
361390	20233								EGF	201289.0						100	ng/mL	0	IFN-a2	16	61
361391	20233								IGF-I	201290.0						100	ug/mL	0	IFN-a2	14.5	44
361392	20233								Adiponectin	201291.0						5	ng/mL	0	IFN-a2	390	51
361393	20233								Leptin	201292.0						1	ng/mL	0	IFN-a2	17	58
361394	20233								Visfatin	201293.0						1	ng/mL	0	IFN-a2	17	51
361395	20233															2	ug/mL	0	IFN-a2	16	36
361396	20233																	0	SDF1-a	17	69
361397	20233						RA2159	51112.0										1	SDF1-a	28	72
361398	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	SDF1-a	31	86
361399	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	SDF1-a	22	89
361400	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	SDF1-a	24	66
361401	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	SDF1-a	28	62
361402	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	SDF1-a	27	64
361403	20233						RA2159	51112.0										1	SDF1-a	35	87
361404	20233						N2586	51107.0										1	SDF1-a	52	53
361405	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	SDF1-a	49.5	66
361406	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	SDF1-a	31	67
361407	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	SDF1-a	50	50
361408	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	SDF1-a	51.5	46
361409	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	SDF1-a	36.5	42
361410	20233						N2586	51107.0										1	SDF1-a	64.5	20
361411	20233																	0	SDF1-a	21.5	54
361412	20233																	0	SDF1-a	10.5	26
361413	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	SDF1-a	75	57
361414	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	SDF1-a	69	72
361415	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SDF1-a	65	55
361416	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SDF1-a	63	74
361417	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SDF1-a	81	63
361418	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	SDF1-a	42	51
361419	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	SDF1-a	33	68
361420	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	SDF1-a	150	46
361421	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	SDF1-a	149.5	44
361422	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SDF1-a	120	41
361423	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SDF1-a	177	69
361424	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SDF1-a	159	59
361425	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	SDF1-a	146.5	50
361426	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	SDF1-a	54	62
361427	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	SDF1-a	104	59
361428	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	SDF1-a	99	72
361429	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SDF1-a	89	43
361430	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SDF1-a	87	54
361431	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SDF1-a	91	53
361432	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	SDF1-a	36.5	60
361433	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	SDF1-a	29	44
361434	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	SDF1-a	127	48
361435	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	SDF1-a	163.5	74
361436	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SDF1-a	143	59
361437	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SDF1-a	151	61
361438	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SDF1-a	149	71
361439	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	SDF1-a	91	43
361440	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	SDF1-a	46	53
361441	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	SDF1-a	28	62
361442	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	SDF1-a	25	75
361443	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SDF1-a	21	48
361444	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SDF1-a	23.5	68
361445	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SDF1-a	28	61
361446	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	SDF1-a	25	64
361447	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	SDF1-a	25	80
361448	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	SDF1-a	54	51
361449	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	SDF1-a	41.5	54
361450	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SDF1-a	34	50
361451	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SDF1-a	41	29
361452	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SDF1-a	39	59
361453	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	SDF1-a	38	53
361454	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	SDF1-a	62	58
361455	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	SDF1-a	39	61
361456	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	SDF1-a	33	64
361457	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SDF1-a	42	57
361458	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SDF1-a	42	51
361459	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SDF1-a	54	39
361460	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	SDF1-a	28	65
361461	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	SDF1-a	91	34
361462	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	SDF1-a	77.5	40
361463	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SDF1-a	99	47
361464	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SDF1-a	81	36
361465	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SDF1-a	55.5	38
361466	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	SDF1-a	64	57
361467	20233						RA2159	51112.0										1	SDF1-a	22.5	44
361468	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	SDF1-a	56	108
361469	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	SDF1-a	18.5	54
361470	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	SDF1-a	22	75
361471	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	SDF1-a	28	79
361472	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	SDF1-a	23	73
361473	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	SDF1-a	25	54
361474	20233						N2586	51107.0										1	SDF1-a	40.5	52
361475	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	SDF1-a	47	39
361476	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	SDF1-a	42	43
361477	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	SDF1-a	40	65
361478	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	SDF1-a	46.5	68
361479	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	SDF1-a	32	53
361480	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	SDF1-a	31	39
361481	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	SDF1-a	31.5	52
361482	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	SDF1-a	21	72
361483	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SDF1-a	23	67
361484	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SDF1-a	33.5	50
361485	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SDF1-a	31	61
361486	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	SDF1-a	25	65
361487	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	SDF1-a	20	66
361488	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	SDF1-a	57	51
361489	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	SDF1-a	51	54
361490	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SDF1-a	43	55
361491	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SDF1-a	53	79
361492	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SDF1-a	65.5	50
361493	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	SDF1-a	44	30
361494	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	SDF1-a	35.5	48
361495	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	SDF1-a	33	78
361496	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	SDF1-a	21	50
361497	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SDF1-a	26	50
361498	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SDF1-a	26	44
361499	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SDF1-a	21	61
361500	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	SDF1-a	25.5	52
361501	20233						RA2159	51112.0										1	SDF1-a	29	66
361502	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	SDF1-a	48	47
361503	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	SDF1-a	48	69
361504	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SDF1-a	42	40
361505	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SDF1-a	41.5	60
361506	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SDF1-a	48	51
361507	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	SDF1-a	51.5	30
361508	20233						N2586	51107.0										1	SDF1-a	40	53
361509	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	SDF1-a	72	72
361510	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	SDF1-a	68	59
361511	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SDF1-a	78.5	44
361512	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SDF1-a	71	50
361513	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SDF1-a	92.5	58
361514	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	SDF1-a	85	50
361515	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	SDF1-a	73	61
361516	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	SDF1-a	80	65
361517	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SDF1-a	79	36
361518	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SDF1-a	84	52
361519	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SDF1-a	80	37
361520	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	SDF1-a	71	75
361521	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	SDF1-a	25.5	58
361522	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	SDF1-a	17	48
361523	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SDF1-a	15	56
361524	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SDF1-a	28	45
361525	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SDF1-a	15.5	42
361526	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	SDF1-a	20	33
361527	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	SDF1-a	42	30
361528	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	SDF1-a	41	57
361529	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SDF1-a	36	53
361530	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SDF1-a	48	32
361531	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SDF1-a	37	38
361532	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	SDF1-a	40	48
361533	20233						RA2159	51112.0										1	SDF1-a		0
361534	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	SDF1-a		0
361535	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	SDF1-a		0
361536	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	SDF1-a		0
361537	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	SDF1-a		0
361538	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	SDF1-a		0
361539	20233						RA2159	51112.0										1	SDF1-a		0
361540	20233						N2586	51107.0										1	SDF1-a		0
361541	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	SDF1-a		0
361542	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	SDF1-a		0
361543	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	SDF1-a		0
361544	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	SDF1-a		0
361545	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	SDF1-a		0
361546	20233						N2586	51107.0										1	SDF1-a		0
361547	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	SDF1-a	20.5	58
361548	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	SDF1-a	30	77
361549	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SDF1-a	19	61
361550	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SDF1-a	23	63
361551	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SDF1-a	22	42
361552	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	SDF1-a	24	31
361553	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	SDF1-a	44	31
361554	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	SDF1-a	43	49
361555	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SDF1-a	44	55
361556	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SDF1-a	47	58
361557	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SDF1-a	43.5	42
361558	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	SDF1-a	33	21
361559	20233																	0	SDF1-a	14	55
361560	20233						RA2159	51112.0								2	ug/mL	1	SDF1-a	48	59
361561	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	SDF1-a	52	48
361562	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	SDF1-a	29	55
361563	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	SDF1-a	48	69
361564	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	SDF1-a	44	77
361565	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	SDF1-a	33	82
361566	20233						N2586	51107.0								2	ug/mL	1	SDF1-a	85.5	54
361567	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	SDF1-a	83.5	36
361568	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	SDF1-a	52	42
361569	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	SDF1-a	86	46
361570	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	SDF1-a	77	43
361571	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	SDF1-a	76	33
361572	20233																	0	SDF1-a	14	55
361573	20233						RA2159	51112.0										2	SDF1-a	27	59
361574	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	SDF1-a	27.5	58
361575	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	SDF1-a	27	73
361576	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	SDF1-a	29	73
361577	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	SDF1-a	23	62
361578	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	SDF1-a	36	64
361579	20233						RA2159	51112.0										2	SDF1-a	29.5	50
361580	20233						N2586	51107.0										2	SDF1-a	47.5	60
361581	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	SDF1-a	47.5	42
361582	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	SDF1-a	43.5	66
361583	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	SDF1-a	60	67
361584	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	SDF1-a	39	71
361585	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	SDF1-a	53	43
361586	20233						N2586	51107.0										2	SDF1-a	56	57
361587	20233																	0	SDF1-a	16	77
361588	20233																	0	SDF1-a	33	91
361589	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	SDF1-a	75.5	66
361590	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	SDF1-a	73	69
361591	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	SDF1-a	70	58
361592	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	SDF1-a	71.5	74
361593	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	SDF1-a	54	55
361594	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	SDF1-a	63.5	54
361595	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	SDF1-a	31	59
361596	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	SDF1-a	149	49
361597	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	SDF1-a	109	67
361598	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	SDF1-a	122	48
361599	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	SDF1-a	137	58
361600	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	SDF1-a	113.5	58
361601	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	SDF1-a	116	38
361602	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	SDF1-a	46.5	40
361603	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	SDF1-a	103	75
361604	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	SDF1-a	101.5	50
361605	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	SDF1-a	93	65
361606	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	SDF1-a	89	68
361607	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	SDF1-a	87	73
361608	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	SDF1-a	95	87
361609	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	SDF1-a	22	61
361610	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	SDF1-a	136.5	64
361611	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	SDF1-a	186	65
361612	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	SDF1-a	120	44
361613	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	SDF1-a	167	53
361614	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	SDF1-a	118	60
361615	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	SDF1-a	149	50
361616	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	SDF1-a	43	80
361617	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	SDF1-a	33.5	94
361618	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	SDF1-a	19.5	58
361619	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	SDF1-a	36	55
361620	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	SDF1-a	36	71
361621	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	SDF1-a	19	66
361622	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	SDF1-a	28.5	52
361623	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	SDF1-a	26	69
361624	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	SDF1-a	47	52
361625	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	SDF1-a	53	87
361626	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	SDF1-a	51	59
361627	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	SDF1-a	50	67
361628	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	SDF1-a	35	58
361629	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	SDF1-a	44	70
361630	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	SDF1-a	49.5	62
361631	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	SDF1-a	43	59
361632	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	SDF1-a	46	64
361633	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	SDF1-a	40	62
361634	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	SDF1-a	52	71
361635	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	SDF1-a	27	59
361636	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	SDF1-a	41	38
361637	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	SDF1-a	25	30
361638	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	SDF1-a	79	43
361639	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	SDF1-a	71	55
361640	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	SDF1-a	51.5	16
361641	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	SDF1-a	64.5	26
361642	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	SDF1-a	56.5	42
361643	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	SDF1-a	70	81
361644	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	SDF1-a	46	63
361645	20233						RA2159	51112.0										2	SDF1-a	24	82
361646	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	SDF1-a	24.5	60
361647	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	SDF1-a	30	54
361648	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	SDF1-a	24	47
361649	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	SDF1-a	20	60
361650	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	SDF1-a	25	53
361651	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	SDF1-a	31	67
361652	20233						N2586	51107.0										2	SDF1-a	46	75
361653	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	SDF1-a	41	63
361654	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	SDF1-a	38.5	64
361655	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	SDF1-a	53.5	56
361656	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	SDF1-a	33	59
361657	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	SDF1-a	40.5	68
361658	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	SDF1-a	45	62
361659	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	SDF1-a	27	69
361660	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	SDF1-a	27	65
361661	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	SDF1-a	26	75
361662	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	SDF1-a	22	60
361663	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	SDF1-a	22.5	66
361664	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	SDF1-a	23	57
361665	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	SDF1-a	54	83
361666	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	SDF1-a	48.5	42
361667	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	SDF1-a	41	78
361668	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	SDF1-a	56	71
361669	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	SDF1-a	47	60
361670	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	SDF1-a	51	65
361671	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	SDF1-a	30	73
361672	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	SDF1-a	21	80
361673	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	SDF1-a	20	67
361674	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	SDF1-a	38	78
361675	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	SDF1-a	21.5	48
361676	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	SDF1-a	29.5	38
361677	20233						RA2159	51112.0										2	SDF1-a	23.5	44
361678	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	SDF1-a	42	43
361679	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	SDF1-a	52	63
361680	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	SDF1-a	42	83
361681	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	SDF1-a	51	45
361682	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	SDF1-a	34	57
361683	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	SDF1-a	43	60
361684	20233						N2586	51107.0										2	SDF1-a	61	87
361685	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	SDF1-a	65	63
361686	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	SDF1-a	59.5	70
361687	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	SDF1-a	68	56
361688	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	SDF1-a	66.5	50
361689	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	SDF1-a	58	68
361690	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	SDF1-a	65.5	62
361691	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	SDF1-a	80	50
361692	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	SDF1-a	77	64
361693	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	SDF1-a	99	35
361694	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	SDF1-a	102.5	42
361695	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	SDF1-a	80	57
361696	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	SDF1-a	86	83
361697	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	SDF1-a	28	65
361698	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	SDF1-a	21	59
361699	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	SDF1-a	22	55
361700	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	SDF1-a	26	50
361701	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	SDF1-a	19.5	54
361702	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	SDF1-a	30	60
361703	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	SDF1-a	37	49
361704	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	SDF1-a	39	49
361705	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	SDF1-a	39.5	90
361706	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	SDF1-a	41	58
361707	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	SDF1-a	35	65
361708	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	SDF1-a	40	63
361709	20233						RA2159	51112.0										2	SDF1-a		0
361710	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	SDF1-a		0
361711	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	SDF1-a		0
361712	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	SDF1-a		0
361713	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	SDF1-a		0
361714	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	SDF1-a		0
361715	20233						RA2159	51112.0										2	SDF1-a		0
361716	20233						N2586	51107.0										2	SDF1-a		0
361717	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	SDF1-a		0
361718	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	SDF1-a		0
361719	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	SDF1-a		0
361720	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	SDF1-a		0
361721	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	SDF1-a		0
361722	20233						N2586	51107.0										2	SDF1-a		0
361723	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	SDF1-a	27	55
361724	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	SDF1-a	30	80
361725	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	SDF1-a	24.5	58
361726	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	SDF1-a	24.5	64
361727	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	SDF1-a	15	50
361728	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	SDF1-a	24	66
361729	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	SDF1-a	45	65
361730	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	SDF1-a	44	51
361731	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	SDF1-a	38	74
361732	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	SDF1-a	44	55
361733	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	SDF1-a	39	65
361734	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	SDF1-a	44	41
361735	20233																	0	SDF1-a	12.5	50
361736	20233						RA2159	51112.0								2	ug/mL	2	SDF1-a	66	67
361737	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	SDF1-a	51.5	48
361738	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	SDF1-a	44	64
361739	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	SDF1-a	56	79
361740	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	SDF1-a	37	59
361741	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	SDF1-a	54	69
361742	20233						N2586	51107.0								2	ug/mL	2	SDF1-a	94	70
361743	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	SDF1-a	71	50
361744	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	SDF1-a	87	56
361745	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	SDF1-a	86.5	54
361746	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	SDF1-a	49	49
361747	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	SDF1-a	76	58
361748	20233																	0	SDF1-a	15	100
361749	20233						RA2159	51112.0								2	ug/mL	3	SDF1-a	55	55
361750	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	SDF1-a	53.5	58
361751	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	SDF1-a	34	79
361752	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	SDF1-a	54.5	54
361753	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	SDF1-a	46.5	52
361754	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	SDF1-a	29	58
361755	20233						N2586	51107.0								2	ug/mL	3	SDF1-a	111.5	68
361756	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	SDF1-a	157	64
361757	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	SDF1-a	93	67
361758	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	SDF1-a	106	57
361759	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	SDF1-a	41	53
361760	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	SDF1-a	91	48
361761	20233						RA2159	51112.0										3	SDF1-a		0
361762	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	SDF1-a		0
361763	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	SDF1-a		0
361764	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	SDF1-a		0
361765	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	SDF1-a		0
361766	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	SDF1-a		0
361767	20233						RA2159	51112.0										3	SDF1-a		0
361768	20233						N2586	51107.0										3	SDF1-a		0
361769	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	SDF1-a		0
361770	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	SDF1-a		0
361771	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	SDF1-a		0
361772	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	SDF1-a		0
361773	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	SDF1-a		0
361774	20233						N2586	51107.0										3	SDF1-a		0
361775	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	SDF1-a	41	71
361776	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	SDF1-a	27	59
361777	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SDF1-a	28	55
361778	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SDF1-a	24	53
361779	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SDF1-a	24.5	60
361780	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	SDF1-a	25	62
361781	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	SDF1-a	47	73
361782	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	SDF1-a	41	59
361783	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SDF1-a	37	73
361784	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SDF1-a	46	59
361785	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SDF1-a	41	69
361786	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	SDF1-a	39	63
361787	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	SDF1-a	29	50
361788	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	SDF1-a	23.5	66
361789	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SDF1-a	21	70
361790	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SDF1-a	25	69
361791	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SDF1-a	28.5	66
361792	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	SDF1-a	22	50
361793	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	SDF1-a	43	51
361794	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	SDF1-a	48	67
361795	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SDF1-a	45	60
361796	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SDF1-a	44	70
361797	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SDF1-a	41.5	80
361798	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	SDF1-a	41	49
361799	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	SDF1-a	71	60
361800	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	SDF1-a	73	75
361801	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SDF1-a	67	69
361802	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SDF1-a	70.5	78
361803	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SDF1-a	70.5	76
361804	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	SDF1-a	63	72
361805	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	SDF1-a	86	57
361806	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	SDF1-a	80	72
361807	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SDF1-a	85	54
361808	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SDF1-a	79.5	42
361809	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SDF1-a	74.5	58
361810	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	SDF1-a	82	62
361811	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	SDF1-a	30	70
361812	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	SDF1-a	23	47
361813	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SDF1-a	25	78
361814	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SDF1-a	24	57
361815	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SDF1-a	22.5	44
361816	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	SDF1-a	20	55
361817	20233						RA2159	51112.0										3	SDF1-a	25.5	56
361818	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	SDF1-a	56	63
361819	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	SDF1-a	57	59
361820	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SDF1-a	39.5	62
361821	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SDF1-a	94	77
361822	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SDF1-a	38.5	74
361823	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	SDF1-a	43	67
361824	20233						N2586	51107.0										3	SDF1-a	61	66
361825	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	SDF1-a	28	75
361826	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	SDF1-a	22	59
361827	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SDF1-a	24	73
361828	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SDF1-a	34	54
361829	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SDF1-a	31	92
361830	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	SDF1-a	21.5	76
361831	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	SDF1-a	27	68
361832	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	SDF1-a	54	66
361833	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	SDF1-a	61.5	72
361834	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SDF1-a	43	50
361835	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SDF1-a	66	69
361836	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SDF1-a	35	50
361837	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	SDF1-a	35	81
361838	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	SDF1-a	26	69
361839	20233						RA2159	51112.0										3	SDF1-a	24.5	74
361840	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	SDF1-a	24	76
361841	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	SDF1-a	15	75
361842	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	SDF1-a	26	56
361843	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	SDF1-a	24.5	62
361844	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	SDF1-a	23	43
361845	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	SDF1-a	19	78
361846	20233						N2586	51107.0										3	SDF1-a	46.5	80
361847	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	SDF1-a	49	65
361848	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	SDF1-a	38	60
361849	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	SDF1-a	86	65
361850	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	SDF1-a	98	107
361851	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	SDF1-a	36	61
361852	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	SDF1-a	46	79
361853	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	SDF1-a	44	63
361854	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	SDF1-a	31	63
361855	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SDF1-a	58.5	60
361856	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SDF1-a	46	67
361857	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SDF1-a	50	77
361858	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	SDF1-a	22	64
361859	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	SDF1-a	70.5	84
361860	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	SDF1-a	60	56
361861	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SDF1-a	55	69
361862	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SDF1-a	118	72
361863	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SDF1-a	59	50
361864	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	SDF1-a	52	53
361865	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	SDF1-a	26.5	62
361866	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	SDF1-a	23	65
361867	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SDF1-a	21	68
361868	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SDF1-a	19.5	60
361869	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SDF1-a	21	57
361870	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	SDF1-a	22	54
361871	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	SDF1-a	27	84
361872	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	SDF1-a	50	76
361873	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	SDF1-a	36	72
361874	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SDF1-a	34	54
361875	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SDF1-a	44	55
361876	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SDF1-a	32	56
361877	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	SDF1-a	37	77
361878	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	SDF1-a	49	67
361879	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	SDF1-a	96	51
361880	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	SDF1-a	90	45
361881	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SDF1-a	77	75
361882	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SDF1-a	98	57
361883	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SDF1-a	88	72
361884	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	SDF1-a	30	63
361885	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	SDF1-a	25	79
361886	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	SDF1-a	137	65
361887	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	SDF1-a	187	62
361888	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SDF1-a	146	51
361889	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SDF1-a	175.5	60
361890	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SDF1-a	67	60
361891	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	SDF1-a	94	72
361892	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	SDF1-a	29	59
361893	20233																	0	SDF1-a	20	65
361894	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	SDF1-a	80	63
361895	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	SDF1-a	68	50
361896	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SDF1-a	70.5	66
361897	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SDF1-a	63	37
361898	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SDF1-a	72	67
361899	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	SDF1-a	33	50
361900	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	SDF1-a	30	42
361901	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	SDF1-a	143	56
361902	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	SDF1-a	136	91
361903	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SDF1-a	109	83
361904	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SDF1-a	127.5	48
361905	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SDF1-a	55	75
361906	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	SDF1-a	119	63
361907	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	SDF1-a	66	67
361908	20233																	0	SDF1-a	15	57
361909	20233						RA2159	51112.0										3	SDF1-a	28	54
361910	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	SDF1-a	22	53
361911	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	SDF1-a	26	47
361912	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	SDF1-a	24	42
361913	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	SDF1-a	22.5	78
361914	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	SDF1-a	23	49
361915	20233						RA2159	51112.0										3	SDF1-a	32	56
361916	20233						N2586	51107.0										3	SDF1-a	51	55
361917	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	SDF1-a	37	51
361918	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	SDF1-a	34	54
361919	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	SDF1-a	44	60
361920	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	SDF1-a	40	55
361921	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	SDF1-a	39.5	32
361922	20233						N2586	51107.0										3	SDF1-a	51	65
361923	20233																	0	SDF1-a	14	61
361924	20233						RA2159	51112.0								2	ug/mL	4	SDF1-a	77	63
361925	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	SDF1-a	68.5	56
361926	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	SDF1-a	73	68
361927	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	SDF1-a	63.5	62
361928	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	SDF1-a	38	50
361929	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	SDF1-a	51	54
361930	20233						N2586	51107.0								2	ug/mL	4	SDF1-a	114	50
361931	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	SDF1-a	113	59
361932	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	SDF1-a	63	52
361933	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	SDF1-a	104.5	52
361934	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	SDF1-a	65	67
361935	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	SDF1-a	32.5	60
361936	20233						RA2159	51112.0										4	SDF1-a		0
361937	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	SDF1-a		0
361938	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	SDF1-a		0
361939	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	SDF1-a		0
361940	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	SDF1-a		0
361941	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	SDF1-a		0
361942	20233						RA2159	51112.0										4	SDF1-a		0
361943	20233						N2586	51107.0										4	SDF1-a		0
361944	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	SDF1-a		0
361945	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	SDF1-a		0
361946	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	SDF1-a		0
361947	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	SDF1-a		0
361948	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	SDF1-a		0
361949	20233						N2586	51107.0										4	SDF1-a		0
361950	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	SDF1-a	40	54
361951	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	SDF1-a	33.5	36
361952	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	SDF1-a	31	73
361953	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	SDF1-a	34	77
361954	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	SDF1-a	29	58
361955	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	SDF1-a	33	74
361956	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	SDF1-a	47	62
361957	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	SDF1-a	43	51
361958	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	SDF1-a	39	51
361959	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	SDF1-a	47	55
361960	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	SDF1-a	41.5	80
361961	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	SDF1-a	31	67
361962	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	SDF1-a	34	61
361963	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	SDF1-a	29.5	44
361964	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	SDF1-a	30	67
361965	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	SDF1-a	28	53
361966	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	SDF1-a	40	74
361967	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	SDF1-a	27	47
361968	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	SDF1-a	49	53
361969	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	SDF1-a	42	65
361970	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	SDF1-a	36.5	48
361971	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	SDF1-a	51	51
361972	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	SDF1-a	38	38
361973	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	SDF1-a	41.5	42
361974	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	SDF1-a	75	101
361975	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	SDF1-a	64	65
361976	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	SDF1-a	71	57
361977	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	SDF1-a	71	76
361978	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	SDF1-a	57	58
361979	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	SDF1-a	57.5	80
361980	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	SDF1-a	83	54
361981	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	SDF1-a	68	63
361982	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	SDF1-a	76	61
361983	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	SDF1-a	76	50
361984	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	SDF1-a	84.5	60
361985	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	SDF1-a	57	58
361986	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	SDF1-a	32	67
361987	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	SDF1-a	30.5	64
361988	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	SDF1-a	33	50
361989	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	SDF1-a	29.5	58
361990	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	SDF1-a	22	61
361991	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	SDF1-a	27	65
361992	20233						RA2159	51112.0										4	SDF1-a	27	58
361993	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	SDF1-a	45	52
361994	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	SDF1-a	54	81
361995	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	SDF1-a	43	61
361996	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	SDF1-a	46	47
361997	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	SDF1-a	55	67
361998	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	SDF1-a	29.5	74
361999	20233						N2586	51107.0										4	SDF1-a	50	67
362000	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	SDF1-a	34	65
362001	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	SDF1-a	24	76
362002	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	SDF1-a	25	57
362003	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	SDF1-a	25.5	54
362004	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	SDF1-a	24.5	60
362005	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	SDF1-a	31	98
362006	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	SDF1-a	66.5	54
362007	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	SDF1-a	57	72
362008	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	SDF1-a	43	89
362009	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	SDF1-a	82.5	64
362010	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	SDF1-a	42	57
362011	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	SDF1-a	24	57
362012	20233						RA2159	51112.0										4	SDF1-a	29	77
362013	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	SDF1-a	27.5	42
362014	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	SDF1-a	29	59
362015	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	SDF1-a	24.5	60
362016	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	SDF1-a	22	39
362017	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	SDF1-a	29	19
362018	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	SDF1-a	21.5	14
362019	20233						N2586	51107.0										4	SDF1-a	45	7
362020	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	SDF1-a	58.5	18
362021	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	SDF1-a	34	57
362022	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	SDF1-a	43	43
362023	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	SDF1-a	42.5	46
362024	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	SDF1-a	32	56
362025	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	SDF1-a	40	51
362026	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	SDF1-a	38.5	66
362027	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	SDF1-a	41	53
362028	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	SDF1-a	41	64
362029	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	SDF1-a	53	57
362030	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	SDF1-a	24.5	62
362031	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	SDF1-a	42	46
362032	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	SDF1-a	23	24
362033	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	SDF1-a	82.5	66
362034	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	SDF1-a	74.5	54
362035	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	SDF1-a	93.5	60
362036	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	SDF1-a	69	76
362037	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	SDF1-a	54	85
362038	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	SDF1-a	26	59
362039	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	SDF1-a	30	48
362040	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	SDF1-a	46.5	60
362041	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	SDF1-a	27.5	60
362042	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	SDF1-a	22	65
362043	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	SDF1-a	27	69
362044	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	SDF1-a	18	45
362045	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	SDF1-a	25	50
362046	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	SDF1-a	26	58
362047	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	SDF1-a	46.5	44
362048	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	SDF1-a	56	60
362049	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	SDF1-a	44	43
362050	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	SDF1-a	53	53
362051	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	SDF1-a	43	63
362052	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	SDF1-a	26	46
362053	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	SDF1-a	54	52
362054	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	SDF1-a	107.5	60
362055	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	SDF1-a	115.5	50
362056	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	SDF1-a	128	64
362057	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	SDF1-a	97	57
362058	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	SDF1-a	77	58
362059	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	SDF1-a	98	60
362060	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	SDF1-a	20	73
362061	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	SDF1-a	144	61
362062	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	SDF1-a	152	71
362063	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	SDF1-a	149.5	50
362064	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	SDF1-a	142.5	44
362065	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	SDF1-a	109	62
362066	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	SDF1-a	35.5	60
362067	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	SDF1-a	42	57
362068	20233																	0	SDF1-a	13.5	50
362069	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	SDF1-a	81	68
362070	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	SDF1-a	76	46
362071	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	SDF1-a	75	49
362072	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	SDF1-a	69	80
362073	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	SDF1-a	53	51
362074	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	SDF1-a	58	70
362075	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	SDF1-a	23	46
362076	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	SDF1-a	161	49
362077	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	SDF1-a	146	69
362078	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	SDF1-a	140	51
362079	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	SDF1-a	201	36
362080	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	SDF1-a	130	60
362081	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	SDF1-a	35	40
362082	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	SDF1-a	48	70
362083	20233																	0	SDF1-a	10	59
362084	20233						RA2159	51112.0										4	SDF1-a	31	60
362085	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	SDF1-a	26	65
362086	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	SDF1-a	25	60
362087	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	SDF1-a	25	62
362088	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	SDF1-a	28	78
362089	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	SDF1-a	25.5	56
362090	20233						RA2159	51112.0										4	SDF1-a	31	69
362091	20233						N2586	51107.0										4	SDF1-a	56	52
362092	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	SDF1-a	41.5	40
362093	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	SDF1-a	38.5	64
362094	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	SDF1-a	46	51
362095	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	SDF1-a	37	64
362096	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	SDF1-a	30	45
362097	20233						N2586	51107.0										4	SDF1-a	61	48
362098	20233								TNF-a	201285.0						100	ng/mL	0	SDF1-a	19	55
362099	20233								IL-1 alpha	201286.0						100	ng/mL	0	SDF1-a	19.5	52
362100	20233								IL-6	201287.0						100	ug/mL	0	SDF1-a	17	47
362101	20233								IL-17A	201288.0						100	ng/mL	0	SDF1-a	14	53
362102	20233								EGF	201289.0						100	ng/mL	0	SDF1-a	22	53
362103	20233								IGF-I	201290.0						100	ug/mL	0	SDF1-a	15	68
362104	20233								Adiponectin	201291.0						5	ng/mL	0	SDF1-a	325.5	62
362105	20233								Leptin	201292.0						1	ng/mL	0	SDF1-a	14	33
362106	20233								Visfatin	201293.0						1	ng/mL	0	SDF1-a	16	47
362107	20233															2	ug/mL	0	SDF1-a	16	41
362108	20233								TNF-a	201285.0						100	ng/mL	0	SDF1-a	18	50
362109	20233								IL-1 alpha	201286.0						100	ng/mL	0	SDF1-a	23.5	62
362110	20233								IL-6	201287.0						100	ug/mL	0	SDF1-a	14	72
362111	20233								IL-17A	201288.0						100	ng/mL	0	SDF1-a	16	33
362112	20233								EGF	201289.0						100	ng/mL	0	SDF1-a	27	68
362113	20233								IGF-I	201290.0						100	ug/mL	0	SDF1-a	20	58
362114	20233								Adiponectin	201291.0						5	ng/mL	0	SDF1-a	301.5	42
362115	20233								Leptin	201292.0						1	ng/mL	0	SDF1-a	14	57
362116	20233								Visfatin	201293.0						1	ng/mL	0	SDF1-a	15	56
362117	20233															2	ug/mL	0	SDF1-a	16	47
362118	20233								TNF-a	201285.0						100	ng/mL	0	SDF1-a	17	59
362119	20233								IL-1 alpha	201286.0						100	ng/mL	0	SDF1-a	17	66
362120	20233								IL-6	201287.0						100	ug/mL	0	SDF1-a	15	63
362121	20233								IL-17A	201288.0						100	ng/mL	0	SDF1-a	19	76
362122	20233								EGF	201289.0						100	ng/mL	0	SDF1-a	13	53
362123	20233								IGF-I	201290.0						100	ug/mL	0	SDF1-a	14.5	52
362124	20233								Adiponectin	201291.0						5	ng/mL	0	SDF1-a	298	83
362125	20233								Leptin	201292.0						1	ng/mL	0	SDF1-a	17	44
362126	20233								Visfatin	201293.0						1	ng/mL	0	SDF1-a	14	51
362127	20233															2	ug/mL	0	SDF1-a	15	55
362128	20233								TNF-a	201285.0						100	ng/mL	0	SDF1-a	16	48
362129	20233								IL-1 alpha	201286.0						100	ng/mL	0	SDF1-a	17	49
362130	20233								IL-6	201287.0						100	ug/mL	0	SDF1-a	19.5	48
362131	20233								IL-17A	201288.0						100	ng/mL	0	SDF1-a	17	55
362132	20233								EGF	201289.0						100	ng/mL	0	SDF1-a	14	78
362133	20233								IGF-I	201290.0						100	ug/mL	0	SDF1-a	14	41
362134	20233								Adiponectin	201291.0						5	ng/mL	0	SDF1-a	380	59
362135	20233								Leptin	201292.0						1	ng/mL	0	SDF1-a	22	47
362136	20233								Visfatin	201293.0						1	ng/mL	0	SDF1-a	24	48
362137	20233															2	ug/mL	0	SDF1-a	14	27
362138	20233																	0	MCP3	21	77
362139	20233						RA2159	51112.0										1	MCP3	31	65
362140	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MCP3	31	61
362141	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MCP3	28	62
362142	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MCP3	26	78
362143	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MCP3	29.5	56
362144	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MCP3	32	61
362145	20233						RA2159	51112.0										1	MCP3	36	76
362146	20233						N2586	51107.0										1	MCP3	64	67
362147	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MCP3	61	69
362148	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MCP3	53	79
362149	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MCP3	57	73
362150	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MCP3	61.5	50
362151	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MCP3	57.5	46
362152	20233						N2586	51107.0										1	MCP3	67	36
362153	20233																	0	MCP3	21	52
362154	20233																	0	MCP3	22	49
362155	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	MCP3	97	65
362156	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	MCP3	81	63
362157	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MCP3	112.5	60
362158	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MCP3	80	69
362159	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MCP3	100	66
362160	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	MCP3	50	41
362161	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	MCP3	28	76
362162	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	MCP3	239	33
362163	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	MCP3	180	47
362164	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MCP3	170.5	40
362165	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MCP3	240.5	58
362166	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MCP3	270	66
362167	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	MCP3	276.5	40
362168	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	MCP3	57	61
362169	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	MCP3	158	65
362170	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	MCP3	63	61
362171	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MCP3	70.5	42
362172	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MCP3	128	65
362173	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MCP3	111	53
362174	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	MCP3	30	70
362175	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	MCP3	29	63
362176	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	MCP3	666.5	56
362177	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	MCP3	272	49
362178	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MCP3	357	53
362179	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MCP3	778	61
362180	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MCP3	697	57
362181	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	MCP3	157	41
362182	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	MCP3	49.5	40
362183	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	MCP3	28	66
362184	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	MCP3	25	72
362185	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MCP3	28	69
362186	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MCP3	24	64
362187	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MCP3	25	78
362188	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	MCP3	27.5	64
362189	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	MCP3	31	79
362190	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	MCP3	62	77
362191	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	MCP3	56	62
362192	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MCP3	53	53
362193	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MCP3	67	31
362194	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MCP3	54	68
362195	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	MCP3	55.5	48
362196	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	MCP3	73	37
362197	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	MCP3	24	81
362198	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	MCP3	27	67
362199	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MCP3	30	65
362200	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MCP3	29	78
362201	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MCP3	29	59
362202	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	MCP3	27	65
362203	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	MCP3	86.5	42
362204	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	MCP3	72	44
362205	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MCP3	71	42
362206	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MCP3	57	51
362207	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MCP3	61.5	52
362208	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	MCP3	73	45
362209	20233						RA2159	51112.0										1	MCP3	24	56
362210	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MCP3	35.5	68
362211	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MCP3	28	67
362212	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MCP3	23	57
362213	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MCP3	25	83
362214	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MCP3	24	76
362215	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	MCP3	30	45
362216	20233						N2586	51107.0										1	MCP3	57	54
362217	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MCP3	57	46
362218	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MCP3	49	55
362219	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MCP3	60	63
362220	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MCP3	63	73
362221	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MCP3	53	47
362222	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	MCP3	41.5	46
362223	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	MCP3	28.5	60
362224	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	MCP3	24	68
362225	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MCP3	25	82
362226	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MCP3	26	62
362227	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MCP3	33	59
362228	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	MCP3	28.5	64
362229	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	MCP3	29	49
362230	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	MCP3	75.5	62
362231	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	MCP3	65	73
362232	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MCP3	48	56
362233	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MCP3	69	77
362234	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MCP3	78	54
362235	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	MCP3	61	62
362236	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	MCP3	53	53
362237	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	MCP3	26	69
362238	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	MCP3	28	67
362239	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MCP3	22	69
362240	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MCP3	23	57
362241	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MCP3	27.5	60
362242	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	MCP3	26	65
362243	20233						RA2159	51112.0										1	MCP3	27.5	60
362244	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	MCP3	53	49
362245	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	MCP3	64	72
362246	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MCP3	49	35
362247	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MCP3	65	47
362248	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MCP3	53	36
362249	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	MCP3	54	37
362250	20233						N2586	51107.0										1	MCP3	51.5	44
362251	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	MCP3	48.5	68
362252	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	MCP3	46	50
362253	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MCP3	53	56
362254	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MCP3	47	63
362255	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MCP3	53	64
362256	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	MCP3	51	66
362257	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	MCP3	87	78
362258	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	MCP3	70	57
362259	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MCP3	76	35
362260	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MCP3	74	57
362261	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MCP3	83	47
362262	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	MCP3	65	60
362263	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	MCP3	20	67
362264	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	MCP3	24	56
362265	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MCP3	22	66
362266	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MCP3	23	49
362267	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MCP3	21.5	34
362268	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	MCP3	20.5	30
362269	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	MCP3	52	33
362270	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	MCP3	49	46
362271	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MCP3	41	54
362272	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MCP3	48	39
362273	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MCP3	43	29
362274	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	MCP3	43	48
362275	20233						RA2159	51112.0										1	MCP3		0
362276	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MCP3		0
362277	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MCP3		0
362278	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MCP3		0
362279	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MCP3		0
362280	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MCP3		0
362281	20233						RA2159	51112.0										1	MCP3		0
362282	20233						N2586	51107.0										1	MCP3		0
362283	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MCP3		0
362284	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MCP3		0
362285	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MCP3		0
362286	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MCP3		0
362287	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MCP3		0
362288	20233						N2586	51107.0										1	MCP3		0
362289	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	MCP3	27	51
362290	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	MCP3	25	76
362291	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MCP3	23	67
362292	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MCP3	24	59
362293	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MCP3	22.5	54
362294	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	MCP3	22	46
362295	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	MCP3	46	47
362296	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	MCP3	48	37
362297	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MCP3	50.5	70
362298	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MCP3	56	46
362299	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MCP3	66	39
362300	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	MCP3	42	32
362301	20233																	0	MCP3	19	71
362302	20233						RA2159	51112.0								2	ug/mL	1	MCP3	32.5	46
362303	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	MCP3	33	49
362304	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MCP3	24	45
362305	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MCP3	31	59
362306	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MCP3	30.5	62
362307	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	MCP3	21	71
362308	20233						N2586	51107.0								2	ug/mL	1	MCP3	96.5	58
362309	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	MCP3	70	39
362310	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MCP3	64	47
362311	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MCP3	77	38
362312	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MCP3	88	49
362313	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	MCP3	83.5	36
362314	20233																	0	MCP3	20	67
362315	20233						RA2159	51112.0										2	MCP3	26	64
362316	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MCP3	28	54
362317	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MCP3	27.5	66
362318	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MCP3	32	83
362319	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MCP3	26	68
362320	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MCP3	32	56
362321	20233						RA2159	51112.0										2	MCP3	32	59
362322	20233						N2586	51107.0										2	MCP3	56	74
362323	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MCP3	59	59
362324	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MCP3	55	66
362325	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MCP3	69	55
362326	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MCP3	49	55
362327	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MCP3	57	39
362328	20233						N2586	51107.0										2	MCP3	71	65
362329	20233																	0	MCP3	19	63
362330	20233																	0	MCP3	20	64
362331	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	MCP3	102.5	76
362332	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	MCP3	76	60
362333	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	MCP3	81	61
362334	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MCP3	76.5	64
362335	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MCP3	66	61
362336	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	MCP3	57	59
362337	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	MCP3	29	73
362338	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	MCP3	237.5	44
362339	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	MCP3	160.5	50
362340	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	MCP3	202	64
362341	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MCP3	237.5	48
362342	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MCP3	173	51
362343	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	MCP3	182	35
362344	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	MCP3	57	49
362345	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	MCP3	201.5	62
362346	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	MCP3	110.5	54
362347	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	MCP3	132.5	50
362348	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MCP3	177.5	62
362349	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MCP3	191	56
362350	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	MCP3	111.5	56
362351	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	MCP3	25	66
362352	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	MCP3	764	77
362353	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	MCP3	400	65
362354	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	MCP3	710.5	56
362355	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MCP3	785	40
362356	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MCP3	734	65
362357	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	MCP3	429	46
362358	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	MCP3	48	67
362359	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	MCP3	30	63
362360	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	MCP3	23	67
362361	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	MCP3	29.5	62
362362	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	MCP3	26.5	64
362363	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	MCP3	22	54
362364	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	MCP3	24	54
362365	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	MCP3	27.5	52
362366	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	MCP3	54	73
362367	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	MCP3	59	77
362368	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	MCP3	56	71
362369	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	MCP3	65.5	54
362370	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	MCP3	36	60
362371	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	MCP3	48	51
362372	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	MCP3	53	63
362373	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	MCP3	30	64
362374	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	MCP3	32.5	50
362375	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	MCP3	31	67
362376	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MCP3	29.5	66
362377	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MCP3	28	55
362378	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	MCP3	26.5	32
362379	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	MCP3	21	37
362380	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	MCP3	69.5	40
362381	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	MCP3	80	71
362382	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	MCP3	59	15
362383	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MCP3	100	20
362384	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MCP3	53	37
362385	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	MCP3	64.5	52
362386	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	MCP3	51	83
362387	20233						RA2159	51112.0										2	MCP3	28	82
362388	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MCP3	28	59
362389	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MCP3	29	45
362390	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MCP3	27	52
362391	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MCP3	20	63
362392	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MCP3	22	68
362393	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	MCP3	28	63
362394	20233						N2586	51107.0										2	MCP3	66	59
362395	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MCP3	57	64
362396	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MCP3	55	71
362397	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MCP3	69.5	62
362398	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MCP3	41.5	54
362399	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MCP3	56	55
362400	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	MCP3	47	73
362401	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	MCP3	27.5	62
362402	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	MCP3	31	65
362403	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	MCP3	27	57
362404	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	MCP3	25.5	68
362405	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	MCP3	23	53
362406	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	MCP3	26	62
362407	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	MCP3	73.5	52
362408	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	MCP3	78	47
362409	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	MCP3	51	55
362410	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	MCP3	74	57
362411	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	MCP3	50	75
362412	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	MCP3	61.5	56
362413	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	MCP3	23	52
362414	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	MCP3	27	63
362415	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	MCP3	26	55
362416	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MCP3	29	57
362417	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MCP3	25	62
362418	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	MCP3	22	29
362419	20233						RA2159	51112.0										2	MCP3	26	56
362420	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	MCP3	53.5	54
362421	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	MCP3	64	60
362422	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	MCP3	50	79
362423	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MCP3	59	43
362424	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MCP3	43	77
362425	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	MCP3	45	69
362426	20233						N2586	51107.0										2	MCP3	54.5	70
362427	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	MCP3	42	52
362428	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	MCP3	41	65
362429	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	MCP3	44	65
362430	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MCP3	42	57
362431	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MCP3	40	61
362432	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	MCP3	40.5	70
362433	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	MCP3	79	52
362434	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	MCP3	73	50
362435	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	MCP3	78	49
362436	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MCP3	96	37
362437	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MCP3	65.5	62
362438	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	MCP3	78	78
362439	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	MCP3	29	69
362440	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	MCP3	22.5	70
362441	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	MCP3	23	57
362442	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	MCP3	28	61
362443	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	MCP3	21	55
362444	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	MCP3	25.5	58
362445	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	MCP3	48	71
362446	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	MCP3	47	63
362447	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	MCP3	41.5	82
362448	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	MCP3	53.5	42
362449	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	MCP3	34	55
362450	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	MCP3	45	55
362451	20233						RA2159	51112.0										2	MCP3		0
362452	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MCP3		0
362453	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MCP3		0
362454	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MCP3		0
362455	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MCP3		0
362456	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MCP3		0
362457	20233						RA2159	51112.0										2	MCP3		0
362458	20233						N2586	51107.0										2	MCP3		0
362459	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MCP3		0
362460	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MCP3		0
362461	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MCP3		0
362462	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MCP3		0
362463	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MCP3		0
362464	20233						N2586	51107.0										2	MCP3		0
362465	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	MCP3	22.5	34
362466	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	MCP3	23.5	84
362467	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	MCP3	23	60
362468	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MCP3	27	53
362469	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MCP3	22	57
362470	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	MCP3	24.5	50
362471	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	MCP3	48.5	50
362472	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	MCP3	52	53
362473	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	MCP3	50	67
362474	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MCP3	54	57
362475	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MCP3	37	73
362476	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	MCP3	46.5	56
362477	20233																	0	MCP3	19	61
362478	20233						RA2159	51112.0								2	ug/mL	2	MCP3	54	64
362479	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	MCP3	37	53
362480	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	MCP3	27.5	44
362481	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	MCP3	35	50
362482	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	MCP3	33	55
362483	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	MCP3	30	48
362484	20233						N2586	51107.0								2	ug/mL	2	MCP3	102.5	68
362485	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	MCP3	97	48
362486	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	MCP3	122	49
362487	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	MCP3	104	46
362488	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	MCP3	48.5	46
362489	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	MCP3	80	39
362490	20233																	0	MCP3	17	60
362491	20233						RA2159	51112.0								2	ug/mL	3	MCP3	49	52
362492	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	MCP3	44	57
362493	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MCP3	26.5	68
362494	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MCP3	38	67
362495	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MCP3	34	75
362496	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	MCP3	32	63
362497	20233						N2586	51107.0								2	ug/mL	3	MCP3	171	52
362498	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	MCP3	201	60
362499	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MCP3	135.5	54
362500	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MCP3	142.5	60
362501	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MCP3	61.5	62
362502	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	MCP3	102	59
362503	20233						RA2159	51112.0										3	MCP3		0
362504	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MCP3		0
362505	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MCP3		0
362506	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MCP3		0
362507	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MCP3		0
362508	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MCP3		0
362509	20233						RA2159	51112.0										3	MCP3		0
362510	20233						N2586	51107.0										3	MCP3		0
362511	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MCP3		0
362512	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MCP3		0
362513	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MCP3		0
362514	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MCP3		0
362515	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MCP3		0
362516	20233						N2586	51107.0										3	MCP3		0
362517	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	MCP3	31.5	52
362518	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	MCP3	25	79
362519	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MCP3	23	64
362520	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MCP3	23	63
362521	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MCP3	23	71
362522	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	MCP3	25	69
362523	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	MCP3	66	57
362524	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	MCP3	60	62
362525	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MCP3	49	66
362526	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MCP3	67	51
362527	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MCP3	57	68
362528	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	MCP3	50	69
362529	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	MCP3	25.5	56
362530	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	MCP3	24	73
362531	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MCP3	23	71
362532	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MCP3	25.5	54
362533	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MCP3	23	79
362534	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	MCP3	26	72
362535	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	MCP3	56	65
362536	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	MCP3	60.5	70
362537	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MCP3	55.5	76
362538	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MCP3	71	59
362539	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MCP3	48.5	74
362540	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	MCP3	57	55
362541	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	MCP3	44.5	74
362542	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	MCP3	36.5	72
362543	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MCP3	36.5	66
362544	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MCP3	36	56
362545	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MCP3	37	73
362546	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	MCP3	37	50
362547	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	MCP3	94	69
362548	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	MCP3	84	80
362549	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MCP3	75.5	64
362550	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MCP3	82	54
362551	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MCP3	68.5	40
362552	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	MCP3	67	66
362553	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	MCP3	24	74
362554	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	MCP3	28	67
362555	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MCP3	24	64
362556	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MCP3	20	67
362557	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MCP3	24	67
362558	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	MCP3	26	63
362559	20233						RA2159	51112.0										3	MCP3	28	71
362560	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	MCP3	78	61
362561	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	MCP3	75.5	64
362562	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MCP3	49.5	72
362563	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MCP3	69	61
362564	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MCP3	47	70
362565	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	MCP3	48	61
362566	20233						N2586	51107.0										3	MCP3	61	60
362567	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	MCP3	28	57
362568	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	MCP3	26	69
362569	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MCP3	24	59
362570	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MCP3	27	50
362571	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MCP3	27	60
362572	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	MCP3	27	62
362573	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	MCP3	28	58
362574	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	MCP3	87	52
362575	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	MCP3	78	83
362576	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MCP3	65.5	68
362577	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MCP3	108	58
362578	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MCP3	49.5	72
362579	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	MCP3	52.5	58
362580	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	MCP3	34.5	60
362581	20233						RA2159	51112.0										3	MCP3	26	73
362582	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MCP3	27	65
362583	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MCP3	18.5	58
362584	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MCP3	24	63
362585	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MCP3	22.5	54
362586	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MCP3	25	67
362587	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	MCP3	22.5	72
362588	20233						N2586	51107.0										3	MCP3	75.5	68
362589	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MCP3	77	89
362590	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MCP3	57	69
362591	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MCP3	92	63
362592	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MCP3	56	73
362593	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MCP3	40	52
362594	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	MCP3	56	63
362595	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	MCP3	24	66
362596	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	MCP3	25	85
362597	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MCP3	26.5	70
362598	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MCP3	28	59
362599	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MCP3	22.5	76
362600	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	MCP3	22	57
362601	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	MCP3	74.5	72
362602	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	MCP3	76	68
362603	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MCP3	59	82
362604	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MCP3	105	64
362605	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MCP3	50.5	56
362606	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	MCP3	48	56
362607	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	MCP3	23.5	66
362608	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	MCP3	26.5	66
362609	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MCP3	19.5	52
362610	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MCP3	22	56
362611	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MCP3	22	66
362612	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	MCP3	24.5	52
362613	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	MCP3	28	70
362614	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	MCP3	72	76
362615	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	MCP3	58	59
362616	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MCP3	44	67
362617	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MCP3	70.5	58
362618	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MCP3	42	61
362619	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	MCP3	45	73
362620	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	MCP3	54	51
362621	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	MCP3	236.5	68
362622	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	MCP3	55	49
362623	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MCP3	76	76
362624	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MCP3	188	72
362625	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MCP3	169	62
362626	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	MCP3	26	60
362627	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	MCP3	24	59
362628	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	MCP3	818	69
362629	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	MCP3	339	59
362630	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MCP3	651	61
362631	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MCP3	773	50
362632	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MCP3	71.5	52
362633	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	MCP3	326	71
362634	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	MCP3	43	61
362635	20233																	0	MCP3	17	63
362636	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	MCP3	111.5	50
362637	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	MCP3	86	50
362638	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MCP3	89	72
362639	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MCP3	97	39
362640	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MCP3	97	57
362641	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	MCP3	42	53
362642	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	MCP3	21	43
362643	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	MCP3	255	67
362644	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	MCP3	191.5	90
362645	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MCP3	208	71
362646	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MCP3	243	62
362647	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MCP3	83	64
362648	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	MCP3	188.5	76
362649	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	MCP3	60	65
362650	20233																	0	MCP3	14	51
362651	20233						RA2159	51112.0										3	MCP3	24.5	78
362652	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MCP3	26	47
362653	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MCP3	26.5	46
362654	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MCP3	24.5	56
362655	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MCP3	22	63
362656	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MCP3	22	41
362657	20233						RA2159	51112.0										3	MCP3	27	69
362658	20233						N2586	51107.0										3	MCP3	67	43
362659	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MCP3	47	45
362660	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MCP3	44	49
362661	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MCP3	51	52
362662	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MCP3	50	65
362663	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MCP3	50	47
362664	20233						N2586	51107.0										3	MCP3	61	53
362665	20233																	0	MCP3	17.5	58
362666	20233						RA2159	51112.0								2	ug/mL	4	MCP3	102	80
362667	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	MCP3	52.5	50
362668	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	MCP3	54.5	64
362669	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	MCP3	52	57
362670	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	MCP3	36	71
362671	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	MCP3	46	49
362672	20233						N2586	51107.0								2	ug/mL	4	MCP3	168.5	58
362673	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	MCP3	132	72
362674	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	MCP3	92	49
362675	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	MCP3	135.5	50
362676	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	MCP3	100	67
362677	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	MCP3	43	48
362678	20233						RA2159	51112.0										4	MCP3		0
362679	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MCP3		0
362680	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MCP3		0
362681	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MCP3		0
362682	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MCP3		0
362683	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MCP3		0
362684	20233						RA2159	51112.0										4	MCP3		0
362685	20233						N2586	51107.0										4	MCP3		0
362686	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MCP3		0
362687	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MCP3		0
362688	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MCP3		0
362689	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MCP3		0
362690	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MCP3		0
362691	20233						N2586	51107.0										4	MCP3		0
362692	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	MCP3	29	47
362693	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	MCP3	31	50
362694	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	MCP3	26	66
362695	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MCP3	33	69
362696	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MCP3	23	57
362697	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	MCP3	28	70
362698	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	MCP3	75	64
362699	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	MCP3	63	61
362700	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	MCP3	50	61
362701	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MCP3	61	61
362702	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MCP3	61	66
362703	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	MCP3	39	57
362704	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	MCP3	23.5	52
362705	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	MCP3	27	39
362706	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	MCP3	32.5	70
362707	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	MCP3	27	56
362708	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	MCP3	37	67
362709	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	MCP3	27.5	56
362710	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	MCP3	68	71
362711	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	MCP3	52	59
362712	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	MCP3	46	47
362713	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	MCP3	57	56
362714	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	MCP3	56	47
362715	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	MCP3	44.5	50
362716	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	MCP3	47	95
362717	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	MCP3	43	80
362718	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	MCP3	44	53
362719	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MCP3	39	63
362720	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MCP3	43	79
362721	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	MCP3	36.5	68
362722	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	MCP3	81.5	60
362723	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	MCP3	81.5	66
362724	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	MCP3	68	65
362725	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MCP3	79	72
362726	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MCP3	79	72
362727	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	MCP3	46	62
362728	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	MCP3	28	64
362729	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	MCP3	32.5	60
362730	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	MCP3	34	75
362731	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MCP3	26	50
362732	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MCP3	31	67
362733	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	MCP3	23.5	70
362734	20233						RA2159	51112.0										4	MCP3	26.5	66
362735	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	MCP3	62.5	50
362736	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	MCP3	68	75
362737	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	MCP3	48	52
362738	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MCP3	59	51
362739	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MCP3	70	74
362740	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	MCP3	43.5	78
362741	20233						N2586	51107.0										4	MCP3	63	51
362742	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	MCP3	37	73
362743	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	MCP3	30	56
362744	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	MCP3	27	75
362745	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	MCP3	27	61
362746	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	MCP3	28	54
362747	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	MCP3	30	74
362748	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	MCP3	106	64
362749	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	MCP3	77	73
362750	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	MCP3	54	63
362751	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	MCP3	100.5	56
362752	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	MCP3	63	48
362753	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	MCP3	41	63
362754	20233						RA2159	51112.0										4	MCP3	26	79
362755	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MCP3	30	48
362756	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MCP3	27.5	42
362757	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MCP3	27	62
362758	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MCP3	24	32
362759	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MCP3	27	23
362760	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	MCP3	20	14
362761	20233						N2586	51107.0										4	MCP3	68	7
362762	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MCP3	91	9
362763	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MCP3	52	61
362764	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MCP3	70	50
362765	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MCP3	60	45
362766	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MCP3	44	67
362767	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	MCP3	58	53
362768	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	MCP3	24	55
362769	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	MCP3	37.5	54
362770	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	MCP3	26	67
362771	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MCP3	26	57
362772	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MCP3	29	57
362773	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	MCP3	26	45
362774	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	MCP3	33.5	26
362775	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	MCP3	87	59
362776	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	MCP3	76	57
362777	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	MCP3	79	48
362778	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MCP3	71	65
362779	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MCP3	62.5	58
362780	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	MCP3	40	44
362781	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	MCP3	34	53
362782	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	MCP3	27	67
362783	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	MCP3	26	84
362784	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	MCP3	28	53
362785	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	MCP3	27	65
362786	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	MCP3	24.5	50
362787	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	MCP3	26	59
362788	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	MCP3	29	55
362789	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	MCP3	59	59
362790	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	MCP3	57	49
362791	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	MCP3	51	35
362792	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	MCP3	62	50
362793	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	MCP3	49.5	62
362794	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	MCP3	43.5	56
362795	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	MCP3	72	56
362796	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	MCP3	194	73
362797	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	MCP3	124.5	60
362798	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	MCP3	277	69
362799	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MCP3	165	72
362800	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MCP3	172.5	48
362801	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	MCP3	206	63
362802	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	MCP3	22.5	52
362803	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	MCP3	780.5	56
362804	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	MCP3	384	61
362805	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	MCP3	359	49
362806	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MCP3	864	65
362807	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MCP3	149	37
362808	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	MCP3	43	61
362809	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	MCP3	54	53
362810	20233																	0	MCP3	21	51
362811	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	MCP3	104	51
362812	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	MCP3	93.5	56
362813	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	MCP3	102	49
362814	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MCP3	92	65
362815	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MCP3	77	38
362816	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	MCP3	62.5	58
362817	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	MCP3	22	57
362818	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	MCP3	294.5	52
362819	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	MCP3	224	73
362820	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	MCP3	228	73
362821	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MCP3	301	41
362822	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MCP3	228	48
362823	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	MCP3	38	41
362824	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	MCP3	62.5	60
362825	20233																	0	MCP3	15	49
362826	20233						RA2159	51112.0										4	MCP3	22	53
362827	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MCP3	26.5	52
362828	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MCP3	25.5	76
362829	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MCP3	29	62
362830	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MCP3	24	74
362831	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MCP3	22	64
362832	20233						RA2159	51112.0										4	MCP3	26	57
362833	20233						N2586	51107.0										4	MCP3	67	53
362834	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MCP3	62	62
362835	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MCP3	52	47
362836	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MCP3	58	63
362837	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MCP3	54	45
362838	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MCP3	44	71
362839	20233						N2586	51107.0										4	MCP3	54	48
362840	20233								TNF-a	201285.0						100	ng/mL	0	MCP3	24	63
362841	20233								IL-1 alpha	201286.0						100	ng/mL	0	MCP3	25	67
362842	20233								IL-6	201287.0						100	ug/mL	0	MCP3	23	43
362843	20233								IL-17A	201288.0						100	ng/mL	0	MCP3	21.5	72
362844	20233								EGF	201289.0						100	ng/mL	0	MCP3	25.5	52
362845	20233								IGF-I	201290.0						100	ug/mL	0	MCP3	21	55
362846	20233								Adiponectin	201291.0						5	ng/mL	0	MCP3	206	45
362847	20233								Leptin	201292.0						1	ng/mL	0	MCP3	21	49
362848	20233								Visfatin	201293.0						1	ng/mL	0	MCP3	20	50
362849	20233															2	ug/mL	0	MCP3	21	43
362850	20233								TNF-a	201285.0						100	ng/mL	0	MCP3	20	43
362851	20233								IL-1 alpha	201286.0						100	ng/mL	0	MCP3	22	55
362852	20233								IL-6	201287.0						100	ug/mL	0	MCP3	21	66
362853	20233								IL-17A	201288.0						100	ng/mL	0	MCP3	21	62
362854	20233								EGF	201289.0						100	ng/mL	0	MCP3	23	59
362855	20233								IGF-I	201290.0						100	ug/mL	0	MCP3	23	43
362856	20233								Adiponectin	201291.0						5	ng/mL	0	MCP3	189	59
362857	20233								Leptin	201292.0						1	ng/mL	0	MCP3	19	65
362858	20233								Visfatin	201293.0						1	ng/mL	0	MCP3	21	63
362859	20233															2	ug/mL	0	MCP3	22	52
362860	20233								TNF-a	201285.0						100	ng/mL	0	MCP3	16	75
362861	20233								IL-1 alpha	201286.0						100	ng/mL	0	MCP3	19.5	56
362862	20233								IL-6	201287.0						100	ug/mL	0	MCP3	19.5	66
362863	20233								IL-17A	201288.0						100	ng/mL	0	MCP3	20	75
362864	20233								EGF	201289.0						100	ng/mL	0	MCP3	17	61
362865	20233								IGF-I	201290.0						100	ug/mL	0	MCP3	18.5	44
362866	20233								Adiponectin	201291.0						5	ng/mL	0	MCP3	117	59
362867	20233								Leptin	201292.0						1	ng/mL	0	MCP3	18.5	46
362868	20233								Visfatin	201293.0						1	ng/mL	0	MCP3	16.5	46
362869	20233															2	ug/mL	0	MCP3	18	67
362870	20233								TNF-a	201285.0						100	ng/mL	0	MCP3	19	39
362871	20233								IL-1 alpha	201286.0						100	ng/mL	0	MCP3	20	65
362872	20233								IL-6	201287.0						100	ug/mL	0	MCP3	22	59
362873	20233								IL-17A	201288.0						100	ng/mL	0	MCP3	18	67
362874	20233								EGF	201289.0						100	ng/mL	0	MCP3	18	72
362875	20233								IGF-I	201290.0						100	ug/mL	0	MCP3	16	40
362876	20233								Adiponectin	201291.0						5	ng/mL	0	MCP3	175	53
362877	20233								Leptin	201292.0						1	ng/mL	0	MCP3	18.5	46
362878	20233								Visfatin	201293.0						1	ng/mL	0	MCP3	16.5	46
362879	20233															2	ug/mL	0	MCP3	16.5	46
362880	20233																	0	IL-16	21	65
362881	20233						RA2159	51112.0										1	IL-16	21	66
362882	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-16	23	62
362883	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-16	21	59
362884	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-16	21	73
362885	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-16	20	53
362886	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-16	20	67
362887	20233						RA2159	51112.0										1	IL-16	23.5	54
362888	20233						N2586	51107.0										1	IL-16	22	75
362889	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-16	23	63
362890	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-16	20	77
362891	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-16	25	66
362892	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-16	22.5	42
362893	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-16	20	46
362894	20233						N2586	51107.0										1	IL-16	19	35
362895	20233																	0	IL-16	22	60
362896	20233																	0	IL-16	23	37
362897	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL-16	21	60
362898	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-16	21	72
362899	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-16	23	74
362900	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-16	20	62
362901	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-16	25	48
362902	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-16	19	65
362903	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL-16	20	61
362904	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL-16	21	44
362905	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL-16	24	41
362906	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-16	19.5	26
362907	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-16	24	75
362908	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL-16	25	51
362909	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL-16	22	40
362910	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL-16	20.5	76
362911	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-16	25	70
362912	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-16	22	56
362913	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-16	25	58
362914	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-16	23	57
362915	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-16	22	82
362916	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-16	20	53
362917	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL-16	20	65
362918	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL-16	24	63
362919	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL-16	27	48
362920	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-16	24	70
362921	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-16	24	71
362922	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL-16	26	57
362923	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL-16	23	49
362924	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL-16	21.5	54
362925	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL-16	18	51
362926	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-16	19	65
362927	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-16	17	55
362928	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-16	18.5	58
362929	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-16	17.5	88
362930	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-16	17	63
362931	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL-16	20	67
362932	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL-16	23	57
362933	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL-16	18	57
362934	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-16	18.5	50
362935	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-16	19	33
362936	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL-16	20.5	58
362937	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL-16	18	54
362938	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL-16	19.5	44
362939	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL-16	20.5	62
362940	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-16	17	75
362941	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-16	18	66
362942	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-16	16	71
362943	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-16	20	47
362944	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-16	20.5	58
362945	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL-16	26	29
362946	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL-16	19	48
362947	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-16	20	41
362948	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-16	21.5	34
362949	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL-16	20	48
362950	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL-16	17	61
362951	20233						RA2159	51112.0										1	IL-16	20	55
362952	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-16	22	69
362953	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-16	19	58
362954	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-16	19	67
362955	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-16	20	67
362956	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-16	19	72
362957	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL-16	18	48
362958	20233						N2586	51107.0										1	IL-16	19.5	50
362959	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-16	18	65
362960	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-16	18.5	58
362961	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-16	21	69
362962	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-16	19	67
362963	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-16	19	59
362964	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL-16	18	40
362965	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL-16	24	73
362966	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-16	19	79
362967	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-16	21.5	42
362968	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-16	21	65
362969	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-16	18	73
362970	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-16	20.5	76
362971	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL-16	21	57
362972	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL-16	18	77
362973	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL-16	19	82
362974	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-16	16	71
362975	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-16	19	84
362976	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL-16	20	58
362977	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL-16	17	53
362978	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL-16	20	49
362979	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL-16	23	51
362980	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-16	19	57
362981	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-16	19	42
362982	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-16	20	59
362983	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-16	19	69
362984	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-16	19	61
362985	20233						RA2159	51112.0										1	IL-16	18	61
362986	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL-16	21	58
362987	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL-16	21.5	78
362988	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-16	19	51
362989	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-16	17	57
362990	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL-16	17	34
362991	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL-16	21	43
362992	20233						N2586	51107.0										1	IL-16	15	47
362993	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL-16	29	61
362994	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-16	31	61
362995	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-16	34	73
362996	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-16	29.5	56
362997	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-16	37	51
362998	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-16	33.5	52
362999	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL-16	35	68
363000	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL-16	28	67
363001	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-16	28	57
363002	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-16	25	43
363003	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL-16	32.5	52
363004	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL-16	26	52
363005	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL-16	17	73
363006	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-16	18.5	48
363007	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-16	16.5	44
363008	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-16	17	58
363009	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-16	14	30
363010	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-16	21	36
363011	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL-16	24	31
363012	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL-16	19.5	62
363013	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-16	19	55
363014	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-16	21	31
363015	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL-16	19.5	46
363016	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL-16	18	30
363017	20233						RA2159	51112.0										1	IL-16		0
363018	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL-16		0
363019	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL-16		0
363020	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL-16		0
363021	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL-16		0
363022	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL-16		0
363023	20233						RA2159	51112.0										1	IL-16		0
363024	20233						N2586	51107.0										1	IL-16		0
363025	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL-16		0
363026	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL-16		0
363027	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL-16		0
363028	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL-16		0
363029	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL-16		0
363030	20233						N2586	51107.0										1	IL-16		0
363031	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL-16	21	57
363032	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-16	17.5	60
363033	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-16	18	50
363034	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-16	15	70
363035	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-16	18	70
363036	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-16	17.5	56
363037	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL-16	19	43
363038	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL-16	22	41
363039	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-16	22	53
363040	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-16	20.5	46
363041	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL-16	16.5	36
363042	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL-16	15	39
363043	20233																	0	IL-16	19	69
363044	20233						RA2159	51112.0								2	ug/mL	1	IL-16	18	61
363045	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL-16	22	54
363046	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-16	21	41
363047	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-16	23	46
363048	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL-16	17	77
363049	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL-16	18	68
363050	20233						N2586	51107.0								2	ug/mL	1	IL-16	17	53
363051	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL-16	28	31
363052	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-16	20	46
363053	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-16	17	58
363054	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL-16	17.5	46
363055	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL-16	15	25
363056	20233																	0	IL-16	18	48
363057	20233						RA2159	51112.0										2	IL-16	20.5	60
363058	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-16	19	55
363059	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-16	19	52
363060	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-16	20.5	70
363061	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-16	20	77
363062	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-16	23.5	46
363063	20233						RA2159	51112.0										2	IL-16	20	51
363064	20233						N2586	51107.0										2	IL-16	19	63
363065	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-16	19.5	48
363066	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-16	19.5	46
363067	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-16	21	53
363068	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-16	20	64
363069	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-16	21	42
363070	20233						N2586	51107.0										2	IL-16	21	81
363071	20233																	0	IL-16	17	59
363072	20233																	0	IL-16	19	46
363073	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL-16	21	62
363074	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-16	18	60
363075	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-16	23	63
363076	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-16	23	61
363077	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-16	21	62
363078	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-16	20	67
363079	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL-16	17	59
363080	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL-16	22	49
363081	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL-16	20.5	60
363082	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL-16	21	50
363083	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-16	20.5	44
363084	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL-16	22	66
363085	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL-16	22.5	40
363086	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL-16	20	58
363087	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-16	26	66
363088	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-16	24	68
363089	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-16	23	70
363090	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-16	23.5	90
363091	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-16	23	72
363092	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-16	20.5	62
363093	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL-16	21	68
363094	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL-16	26	71
363095	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL-16	26	50
363096	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL-16	23	63
363097	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-16	23	55
363098	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL-16	17	36
363099	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL-16	23.5	40
363100	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL-16	20	71
363101	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL-16	25	65
363102	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-16	19	51
363103	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-16	21	64
363104	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-16	23	67
363105	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-16	19	65
363106	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-16	18.5	44
363107	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL-16	18	68
363108	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL-16	18	76
363109	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL-16	19	68
363110	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL-16	18.5	52
363111	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-16	19.5	50
363112	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL-16	19	55
363113	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL-16	18	49
363114	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL-16	21.5	60
363115	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL-16	19	63
363116	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-16	19	73
363117	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-16	19	62
363118	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-16	18	50
363119	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-16	20	62
363120	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-16	19	36
363121	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL-16	21	37
363122	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL-16	17.5	46
363123	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL-16	17	71
363124	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL-16	15	19
363125	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-16	17	17
363126	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL-16	19.5	46
363127	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL-16	23	57
363128	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL-16	20.5	74
363129	20233						RA2159	51112.0										2	IL-16	18	82
363130	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-16	19	53
363131	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-16	18	60
363132	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-16	18	46
363133	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-16	20	62
363134	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-16	17.5	74
363135	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL-16	20	64
363136	20233						N2586	51107.0										2	IL-16	18	59
363137	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-16	18	50
363138	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-16	19	74
363139	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-16	23	83
363140	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-16	18	49
363141	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-16	20	53
363142	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL-16	18	74
363143	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL-16	19	57
363144	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-16	18	71
363145	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-16	17	77
363146	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-16	20	53
363147	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-16	20	75
363148	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-16	18	61
363149	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL-16	21	77
363150	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL-16	16	49
363151	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL-16	17	75
363152	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-16	17	57
363153	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL-16	21	69
363154	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL-16	20.5	74
363155	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL-16	19.5	58
363156	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-16	18	77
363157	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-16	19	71
363158	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-16	20	83
363159	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-16	16.5	56
363160	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-16	21	49
363161	20233						RA2159	51112.0										2	IL-16	18	56
363162	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL-16	18	53
363163	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL-16	19	64
363164	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL-16	19	78
363165	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-16	20	38
363166	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL-16	18	81
363167	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL-16	20	74
363168	20233						N2586	51107.0										2	IL-16	23	53
363169	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL-16	26.5	64
363170	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-16	21.5	72
363171	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-16	26	61
363172	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-16	27.5	66
363173	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-16	26	68
363174	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-16	24.5	70
363175	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL-16	30.5	54
363176	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL-16	25	63
363177	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL-16	33	50
363178	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-16	32.5	30
363179	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL-16	33.5	54
363180	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL-16	27	64
363181	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL-16	18	60
363182	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-16	16	73
363183	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-16	20	55
363184	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-16	19	59
363185	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-16	16.5	58
363186	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-16	18	52
363187	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL-16	18	60
363188	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL-16	19.5	68
363189	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL-16	21.5	50
363190	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-16	18	47
363191	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL-16	18.5	50
363192	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL-16	16	50
363193	20233						RA2159	51112.0										2	IL-16		0
363194	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL-16		0
363195	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL-16		0
363196	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL-16		0
363197	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL-16		0
363198	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL-16		0
363199	20233						RA2159	51112.0										2	IL-16		0
363200	20233						N2586	51107.0										2	IL-16		0
363201	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL-16		0
363202	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL-16		0
363203	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL-16		0
363204	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL-16		0
363205	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL-16		0
363206	20233						N2586	51107.0										2	IL-16		0
363207	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL-16	16	50
363208	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-16	17.5	90
363209	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-16	17	63
363210	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-16	19.5	54
363211	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-16	18	66
363212	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-16	18	59
363213	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL-16	19.5	72
363214	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL-16	18	55
363215	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL-16	16	59
363216	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-16	19	53
363217	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL-16	20	65
363218	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL-16	16.5	50
363219	20233																	0	IL-16	17	76
363220	20233						RA2159	51112.0								2	ug/mL	2	IL-16	17	62
363221	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL-16	18	43
363222	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL-16	21	33
363223	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL-16	19	69
363224	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL-16	19	59
363225	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL-16	15	55
363226	20233						N2586	51107.0								2	ug/mL	2	IL-16	21	49
363227	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL-16	18.5	46
363228	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL-16	17	43
363229	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL-16	17	33
363230	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL-16	16	37
363231	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL-16	19	61
363232	20233																	0	IL-16	17	76
363233	20233						RA2159	51112.0								2	ug/mL	3	IL-16	18	53
363234	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL-16	18	59
363235	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-16	16.5	52
363236	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-16	17	61
363237	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL-16	21	69
363238	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL-16	16	61
363239	20233						N2586	51107.0								2	ug/mL	3	IL-16	20.5	54
363240	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL-16	30	54
363241	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-16	20	51
363242	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-16	19	50
363243	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL-16	19	57
363244	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL-16	20	45
363245	20233						RA2159	51112.0										3	IL-16		0
363246	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-16		0
363247	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-16		0
363248	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-16		0
363249	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-16		0
363250	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-16		0
363251	20233						RA2159	51112.0										3	IL-16		0
363252	20233						N2586	51107.0										3	IL-16		0
363253	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-16		0
363254	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-16		0
363255	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-16		0
363256	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-16		0
363257	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-16		0
363258	20233						N2586	51107.0										3	IL-16		0
363259	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL-16	23.5	64
363260	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-16	18	56
363261	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-16	18	50
363262	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-16	16	54
363263	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-16	19	70
363264	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-16	15	50
363265	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL-16	19	59
363266	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL-16	20	64
363267	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-16	17.5	66
363268	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-16	16.5	62
363269	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL-16	20	63
363270	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL-16	18	71
363271	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL-16	19	61
363272	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-16	17	61
363273	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-16	18.5	66
363274	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-16	17.5	54
363275	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-16	17	60
363276	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-16	16	66
363277	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL-16	20	63
363278	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL-16	18.5	86
363279	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-16	21.5	64
363280	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-16	18	63
363281	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL-16	22	84
363282	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL-16	17	61
363283	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL-16	26	69
363284	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-16	24	71
363285	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-16	30	62
363286	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-16	24	77
363287	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-16	24	70
363288	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-16	24	75
363289	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL-16	25	81
363290	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL-16	25	79
363291	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-16	26	61
363292	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-16	25	57
363293	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL-16	25.5	36
363294	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL-16	28	80
363295	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL-16	18.5	60
363296	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-16	16	59
363297	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-16	19.5	70
363298	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-16	19	65
363299	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-16	16	67
363300	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-16	16	51
363301	20233						RA2159	51112.0										3	IL-16	18.5	54
363302	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL-16	19	68
363303	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL-16	16	60
363304	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-16	18	75
363305	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-16	21	68
363306	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL-16	20	65
363307	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL-16	18	53
363308	20233						N2586	51107.0										3	IL-16	20	57
363309	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL-16	17	76
363310	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-16	15	55
363311	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-16	19	81
363312	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-16	21	74
363313	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-16	18	65
363314	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-16	16.5	70
363315	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL-16	18	68
363316	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL-16	16	69
363317	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL-16	18.5	64
363318	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-16	21	71
363319	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-16	26	57
363320	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL-16	17	75
363321	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL-16	17	57
363322	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL-16	19	70
363323	20233						RA2159	51112.0										3	IL-16	16	76
363324	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-16	16	67
363325	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-16	18	61
363326	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-16	17	59
363327	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-16	16	50
363328	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-16	17	45
363329	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL-16	18	68
363330	20233						N2586	51107.0										3	IL-16	19.5	62
363331	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-16	18	59
363332	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-16	15	66
363333	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-16	22	65
363334	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-16	18.5	66
363335	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-16	16	67
363336	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL-16	20	67
363337	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL-16	17	55
363338	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-16	17	57
363339	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-16	19	79
363340	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-16	16	74
363341	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-16	19	75
363342	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-16	19	66
363343	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL-16	18	83
363344	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL-16	15	59
363345	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-16	18	69
363346	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-16	23	71
363347	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL-16	17	59
363348	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL-16	21	61
363349	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL-16	16	55
363350	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-16	16.5	58
363351	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-16	15	69
363352	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-16	13	56
363353	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-16	16	82
363354	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-16	17.5	52
363355	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL-16	15.5	50
363356	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL-16	21	68
363357	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL-16	16	44
363358	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-16	18	63
363359	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-16	18.5	52
363360	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL-16	15	59
363361	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL-16	16.5	54
363362	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL-16	22	66
363363	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-16	18	50
363364	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-16	21	69
363365	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-16	19	62
363366	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-16	19	63
363367	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-16	23	68
363368	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-16	22	61
363369	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL-16	17	57
363370	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL-16	22	76
363371	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL-16	23	59
363372	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-16	21	63
363373	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-16	21	63
363374	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL-16	18	73
363375	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL-16	19	71
363376	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL-16	19.5	58
363377	20233																	0	IL-16	22	55
363378	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL-16	27.5	54
363379	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-16	20	66
363380	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-16	19	60
363381	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-16	14	48
363382	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-16	17	63
363383	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-16	20	61
363384	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL-16	20	31
363385	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL-16	18	65
363386	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL-16	20	80
363387	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-16	17	74
363388	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-16	18	55
363389	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL-16	15	73
363390	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL-16	19	63
363391	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL-16	20	61
363392	20233																	0	IL-16	17	52
363393	20233						RA2159	51112.0										3	IL-16	16	74
363394	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL-16	14	52
363395	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL-16	21	59
363396	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL-16	15	42
363397	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL-16	16	70
363398	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL-16	17	51
363399	20233						RA2159	51112.0										3	IL-16	19	45
363400	20233						N2586	51107.0										3	IL-16	20	47
363401	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL-16	14	67
363402	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL-16	18	58
363403	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL-16	18	60
363404	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL-16	17	59
363405	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL-16	19.5	24
363406	20233						N2586	51107.0										3	IL-16	17	51
363407	20233																	0	IL-16	18	52
363408	20233						RA2159	51112.0								2	ug/mL	4	IL-16	27	55
363409	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL-16	19.5	50
363410	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL-16	21	78
363411	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL-16	18.5	76
363412	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL-16	19	66
363413	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL-16	20	71
363414	20233						N2586	51107.0								2	ug/mL	4	IL-16	23.5	74
363415	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL-16	22	61
363416	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL-16	14.5	58
363417	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL-16	22	34
363418	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL-16	20	77
363419	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL-16	19.5	42
363420	20233						RA2159	51112.0										4	IL-16		0
363421	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-16		0
363422	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-16		0
363423	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-16		0
363424	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-16		0
363425	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-16		0
363426	20233						RA2159	51112.0										4	IL-16		0
363427	20233						N2586	51107.0										4	IL-16		0
363428	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-16		0
363429	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-16		0
363430	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-16		0
363431	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-16		0
363432	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-16		0
363433	20233						N2586	51107.0										4	IL-16		0
363434	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL-16	20.5	34
363435	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-16	21	45
363436	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-16	23	57
363437	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-16	20	57
363438	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-16	16	70
363439	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-16	20	82
363440	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL-16	18	68
363441	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL-16	18	63
363442	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL-16	19	47
363443	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-16	17.5	72
363444	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL-16	17	67
363445	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL-16	17	70
363446	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL-16	16	58
363447	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-16	18	49
363448	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-16	17	64
363449	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-16	17	56
363450	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-16	28	73
363451	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-16	18	39
363452	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL-16	18	70
363453	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL-16	19	58
363454	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL-16	15.5	44
363455	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-16	18	50
363456	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL-16	16	49
363457	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL-16	23	41
363458	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL-16	28	87
363459	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-16	23.5	66
363460	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-16	27	72
363461	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-16	22.5	74
363462	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-16	25	67
363463	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-16	26	75
363464	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL-16	23	62
363465	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL-16	25.5	50
363466	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL-16	28	49
363467	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-16	27	77
363468	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL-16	24	46
363469	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL-16	23	73
363470	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL-16	19	65
363471	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-16	18	62
363472	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-16	16	58
363473	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-16	18	65
363474	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-16	18	73
363475	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-16	19	56
363476	20233						RA2159	51112.0										4	IL-16	15	68
363477	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL-16	20	65
363478	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL-16	20	70
363479	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL-16	19	56
363480	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-16	18	39
363481	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL-16	19	55
363482	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL-16	17	73
363483	20233						N2586	51107.0										4	IL-16	16.5	52
363484	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL-16	20	52
363485	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-16	16	86
363486	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-16	19	79
363487	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-16	16	71
363488	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-16	16.5	66
363489	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-16	21	82
363490	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL-16	20	57
363491	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL-16	22	75
363492	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL-16	15	65
363493	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-16	24	61
363494	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL-16	16	73
363495	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL-16	17	73
363496	20233						RA2159	51112.0										4	IL-16	18	74
363497	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-16	16	43
363498	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-16	18	46
363499	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-16	18.5	70
363500	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-16	16	33
363501	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-16	17.5	20
363502	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL-16	18	7
363503	20233						N2586	51107.0										4	IL-16		5
363504	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-16		6
363505	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-16	19	58
363506	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-16	19	43
363507	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-16	17.5	38
363508	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-16	19	60
363509	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL-16	18.5	54
363510	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL-16	18	63
363511	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-16	18	58
363512	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-16	15	61
363513	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-16	18	75
363514	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-16	17	75
363515	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-16	17	52
363516	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL-16	19	27
363517	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL-16	14.5	54
363518	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL-16	18	60
363519	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL-16	15	53
363520	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-16	20	53
363521	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL-16	20	65
363522	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL-16	15	45
363523	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL-16	18	46
363524	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL-16	24	54
363525	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-16	14	71
363526	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-16	16	46
363527	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-16	17	55
363528	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-16	15	53
363529	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-16	14	55
363530	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL-16	20	63
363531	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL-16	16	41
363532	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL-16	19	53
363533	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL-16	19	46
363534	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-16	17	58
363535	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL-16	15	41
363536	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL-16	16.5	46
363537	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL-16	18	49
363538	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-16	21.5	70
363539	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-16	22	72
363540	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-16	34.5	64
363541	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-16	21	72
363542	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-16	21	56
363543	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-16	26	58
363544	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL-16	15	70
363545	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL-16	21.5	64
363546	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL-16	25	55
363547	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL-16	25	62
363548	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-16	23	63
363549	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL-16	19.5	40
363550	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL-16	19	61
363551	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL-16	21	54
363552	20233																	0	IL-16	20	68
363553	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL-16	18	66
363554	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-16	17	46
363555	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-16	16	38
363556	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-16	18	63
363557	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-16	16	48
363558	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-16	17	59
363559	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL-16	18	51
363560	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL-16	23	55
363561	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL-16	22.5	68
363562	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL-16	20	59
363563	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-16	21	41
363564	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL-16	19	57
363565	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL-16	15	37
363566	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL-16	16	54
363567	20233																	0	IL-16	14.5	58
363568	20233						RA2159	51112.0										4	IL-16	18	57
363569	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL-16	17	57
363570	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL-16	16	58
363571	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL-16	20	57
363572	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL-16	15	70
363573	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL-16	14	63
363574	20233						RA2159	51112.0										4	IL-16	18	62
363575	20233						N2586	51107.0										4	IL-16	17	66
363576	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL-16	20	45
363577	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL-16	19.5	52
363578	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL-16	17	61
363579	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL-16	17	53
363580	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL-16	19	48
363581	20233						N2586	51107.0										4	IL-16	20	54
363582	20233								TNF-a	201285.0						100	ng/mL	0	IL-16	19	69
363583	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-16	25	57
363584	20233								IL-6	201287.0						100	ug/mL	0	IL-16	22	44
363585	20233								IL-17A	201288.0						100	ng/mL	0	IL-16	19	48
363586	20233								EGF	201289.0						100	ng/mL	0	IL-16	25	72
363587	20233								IGF-I	201290.0						100	ug/mL	0	IL-16	22	54
363588	20233								Adiponectin	201291.0						5	ng/mL	0	IL-16	114	63
363589	20233								Leptin	201292.0						1	ng/mL	0	IL-16	19	52
363590	20233								Visfatin	201293.0						1	ng/mL	0	IL-16	20	67
363591	20233															2	ug/mL	0	IL-16	18	70
363592	20233								TNF-a	201285.0						100	ng/mL	0	IL-16	21	48
363593	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-16	23	73
363594	20233								IL-6	201287.0						100	ug/mL	0	IL-16	21	61
363595	20233								IL-17A	201288.0						100	ng/mL	0	IL-16	17	61
363596	20233								EGF	201289.0						100	ng/mL	0	IL-16	20.5	72
363597	20233								IGF-I	201290.0						100	ug/mL	0	IL-16	21.5	56
363598	20233								Adiponectin	201291.0						5	ng/mL	0	IL-16	101.5	74
363599	20233								Leptin	201292.0						1	ng/mL	0	IL-16	20	64
363600	20233								Visfatin	201293.0						1	ng/mL	0	IL-16	16	66
363601	20233															2	ug/mL	0	IL-16	22	49
363602	20233								TNF-a	201285.0						100	ng/mL	0	IL-16	18	68
363603	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-16	20	64
363604	20233								IL-6	201287.0						100	ug/mL	0	IL-16	15	81
363605	20233								IL-17A	201288.0						100	ng/mL	0	IL-16	17	57
363606	20233								EGF	201289.0						100	ng/mL	0	IL-16	17	60
363607	20233								IGF-I	201290.0						100	ug/mL	0	IL-16	16	63
363608	20233								Adiponectin	201291.0						5	ng/mL	0	IL-16	67	65
363609	20233								Leptin	201292.0						1	ng/mL	0	IL-16	16	47
363610	20233								Visfatin	201293.0						1	ng/mL	0	IL-16	17	55
363611	20233															2	ug/mL	0	IL-16	17	63
363612	20233								TNF-a	201285.0						100	ng/mL	0	IL-16	17	39
363613	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL-16	21	80
363614	20233								IL-6	201287.0						100	ug/mL	0	IL-16	21	78
363615	20233								IL-17A	201288.0						100	ng/mL	0	IL-16	17	67
363616	20233								EGF	201289.0						100	ng/mL	0	IL-16	17	64
363617	20233								IGF-I	201290.0						100	ug/mL	0	IL-16	17.5	46
363618	20233								Adiponectin	201291.0						5	ng/mL	0	IL-16	105	42
363619	20233								Leptin	201292.0						1	ng/mL	0	IL-16	20	39
363620	20233								Visfatin	201293.0						1	ng/mL	0	IL-16	17	64
363621	20233															2	ug/mL	0	IL-16	20	38
363622	20233																	0	IL12(p40)	61	72
363623	20233						RA2159	51112.0										1	IL12(p40)	66	66
363624	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL12(p40)	63	61
363625	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL12(p40)	62.5	78
363626	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL12(p40)	60	58
363627	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL12(p40)	72	56
363628	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL12(p40)	67	54
363629	20233						RA2159	51112.0										1	IL12(p40)	74.5	62
363630	20233						N2586	51107.0										1	IL12(p40)	70.5	68
363631	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL12(p40)	62	63
363632	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL12(p40)	76	63
363633	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL12(p40)	71.5	58
363634	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL12(p40)	63.5	38
363635	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL12(p40)	59	49
363636	20233						N2586	51107.0										1	IL12(p40)	62	27
363637	20233																	0	IL12(p40)	65	56
363638	20233																	0	IL12(p40)	64	35
363639	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL12(p40)	65	60
363640	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL12(p40)	68	50
363641	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL12(p40)	66	59
363642	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL12(p40)	63.5	56
363643	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL12(p40)	74	63
363644	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL12(p40)	58	49
363645	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL12(p40)	60	68
363646	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL12(p40)	70.5	42
363647	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL12(p40)	76	39
363648	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL12(p40)	58	41
363649	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL12(p40)	66	78
363650	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL12(p40)	67.5	64
363651	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL12(p40)	60	34
363652	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL12(p40)	58	57
363653	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL12(p40)	79.5	62
363654	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL12(p40)	67	56
363655	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL12(p40)	69	43
363656	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL12(p40)	63	61
363657	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL12(p40)	66.5	62
363658	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL12(p40)	64	60
363659	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL12(p40)	66	56
363660	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL12(p40)	68.5	36
363661	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL12(p40)	71	50
363662	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL12(p40)	77.5	56
363663	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL12(p40)	68.5	58
363664	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL12(p40)	59.5	50
363665	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL12(p40)	70	46
363666	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL12(p40)	59.5	52
363667	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL12(p40)	57	70
363668	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL12(p40)	70	59
363669	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL12(p40)	59	57
363670	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL12(p40)	51	47
363671	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL12(p40)	57.5	82
363672	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL12(p40)	58	40
363673	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL12(p40)	62.5	76
363674	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL12(p40)	64	49
363675	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL12(p40)	65	59
363676	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL12(p40)	57	68
363677	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL12(p40)	57.5	42
363678	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL12(p40)	60	45
363679	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL12(p40)	64	47
363680	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL12(p40)	70	56
363681	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL12(p40)	56	84
363682	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL12(p40)	54	66
363683	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL12(p40)	58	53
363684	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL12(p40)	56.5	78
363685	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL12(p40)	58.5	44
363686	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL12(p40)	58.5	62
363687	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL12(p40)	70	35
363688	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL12(p40)	61	42
363689	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL12(p40)	68.5	24
363690	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL12(p40)	68	35
363691	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL12(p40)	57	58
363692	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL12(p40)	66.5	48
363693	20233						RA2159	51112.0										1	IL12(p40)	62.5	44
363694	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL12(p40)	224	69
363695	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL12(p40)	58.5	56
363696	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL12(p40)	57	67
363697	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL12(p40)	51.5	68
363698	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL12(p40)	58.5	66
363699	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL12(p40)	65	59
363700	20233						N2586	51107.0										1	IL12(p40)	60	56
363701	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL12(p40)	60	53
363702	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL12(p40)	57.5	46
363703	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL12(p40)	61	70
363704	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL12(p40)	55	41
363705	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL12(p40)	59.5	46
363706	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL12(p40)	57	42
363707	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL12(p40)	74	73
363708	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL12(p40)	51	64
363709	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL12(p40)	56	62
363710	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL12(p40)	62	53
363711	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL12(p40)	56	71
363712	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL12(p40)	54	68
363713	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL12(p40)	60.5	52
363714	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL12(p40)	51	50
363715	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL12(p40)	65	62
363716	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL12(p40)	60	57
363717	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL12(p40)	51	61
363718	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL12(p40)	55.5	58
363719	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL12(p40)	55	51
363720	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL12(p40)	57	36
363721	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL12(p40)	71	60
363722	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL12(p40)	67	64
363723	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL12(p40)	67.5	56
363724	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL12(p40)	65	53
363725	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL12(p40)	62.5	52
363726	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL12(p40)	79	55
363727	20233						RA2159	51112.0										1	IL12(p40)	48.5	62
363728	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL12(p40)	62	41
363729	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL12(p40)	65	50
363730	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL12(p40)	66	49
363731	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL12(p40)	69.5	58
363732	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL12(p40)	69	39
363733	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL12(p40)	86	47
363734	20233						N2586	51107.0										1	IL12(p40)	60	52
363735	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL12(p40)	109	59
363736	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL12(p40)	112.5	50
363737	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL12(p40)	145	65
363738	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL12(p40)	113	64
363739	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL12(p40)	146	67
363740	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL12(p40)	149.5	66
363741	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL12(p40)	115	47
363742	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL12(p40)	104	69
363743	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL12(p40)	99	45
363744	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL12(p40)	86	45
363745	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL12(p40)	102.5	44
363746	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL12(p40)	80	67
363747	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL12(p40)	56	49
363748	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL12(p40)	56	50
363749	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL12(p40)	56	45
363750	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL12(p40)	56.5	52
363751	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL12(p40)	50	51
363752	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL12(p40)	48	43
363753	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL12(p40)	59	27
363754	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL12(p40)	59	35
363755	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL12(p40)	57.5	58
363756	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL12(p40)	60	33
363757	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL12(p40)	43	33
363758	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL12(p40)	61	47
363759	20233						RA2159	51112.0										1	IL12(p40)		0
363760	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL12(p40)		0
363761	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL12(p40)		0
363762	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL12(p40)		0
363763	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL12(p40)		0
363764	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL12(p40)		0
363765	20233						RA2159	51112.0										1	IL12(p40)		0
363766	20233						N2586	51107.0										1	IL12(p40)		0
363767	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL12(p40)		0
363768	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL12(p40)		0
363769	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL12(p40)		0
363770	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL12(p40)		0
363771	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL12(p40)		0
363772	20233						N2586	51107.0										1	IL12(p40)		0
363773	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL12(p40)	66	59
363774	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL12(p40)	57	59
363775	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL12(p40)	55	54
363776	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL12(p40)	60	57
363777	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL12(p40)	60	52
363778	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL12(p40)	53	41
363779	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL12(p40)	64	39
363780	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL12(p40)	96.5	34
363781	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL12(p40)	141	63
363782	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL12(p40)	55.5	58
363783	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL12(p40)	60	30
363784	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL12(p40)	61	42
363785	20233																	0	IL12(p40)	57	61
363786	20233						RA2159	51112.0								2	ug/mL	1	IL12(p40)	57	43
363787	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL12(p40)	67	52
363788	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL12(p40)	48	50
363789	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL12(p40)	71	65
363790	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL12(p40)	48	78
363791	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL12(p40)	50	72
363792	20233						N2586	51107.0								2	ug/mL	1	IL12(p40)	54	45
363793	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL12(p40)	64	35
363794	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL12(p40)	83	35
363795	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL12(p40)	71	44
363796	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL12(p40)	47.5	34
363797	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL12(p40)	76	24
363798	20233																	0	IL12(p40)	63	69
363799	20233						RA2159	51112.0										2	IL12(p40)	63.5	52
363800	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL12(p40)	72	65
363801	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL12(p40)	64	47
363802	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL12(p40)	65.5	62
363803	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL12(p40)	66	78
363804	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL12(p40)	73	59
363805	20233						RA2159	51112.0										2	IL12(p40)	69.5	64
363806	20233						N2586	51107.0										2	IL12(p40)	57	48
363807	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL12(p40)	58.5	54
363808	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL12(p40)	62	55
363809	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL12(p40)	76	40
363810	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL12(p40)	68	65
363811	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL12(p40)	56	41
363812	20233						N2586	51107.0										2	IL12(p40)	82	65
363813	20233																	0	IL12(p40)	64.5	52
363814	20233																	0	IL12(p40)	60.5	64
363815	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL12(p40)	67	59
363816	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL12(p40)	70.5	62
363817	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL12(p40)	76	53
363818	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL12(p40)	68	50
363819	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL12(p40)	64	54
363820	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL12(p40)	62	59
363821	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL12(p40)	64	51
363822	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL12(p40)	73	34
363823	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL12(p40)	64	73
363824	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL12(p40)	71	59
363825	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL12(p40)	70.5	36
363826	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL12(p40)	69	54
363827	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL12(p40)	59	43
363828	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL12(p40)	78	45
363829	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL12(p40)	72	66
363830	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL12(p40)	66.5	60
363831	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL12(p40)	67	71
363832	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL12(p40)	70	64
363833	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL12(p40)	64	54
363834	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL12(p40)	65	58
363835	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL12(p40)	65	69
363836	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL12(p40)	74	61
363837	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL12(p40)	75	71
363838	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL12(p40)	69	55
363839	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL12(p40)	74	49
363840	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL12(p40)	82	57
363841	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL12(p40)	61	31
363842	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL12(p40)	74	60
363843	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL12(p40)	161	60
363844	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL12(p40)	57	53
363845	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL12(p40)	123	59
363846	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL12(p40)	60	68
363847	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL12(p40)	56	53
363848	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL12(p40)	56	32
363849	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL12(p40)	61	80
363850	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL12(p40)	56	57
363851	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL12(p40)	58.5	74
363852	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL12(p40)	63	66
363853	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL12(p40)	73	50
363854	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL12(p40)	60	46
363855	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL12(p40)	60	58
363856	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL12(p40)	63	73
363857	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL12(p40)	67.5	54
363858	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL12(p40)	59	57
363859	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL12(p40)	62	49
363860	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL12(p40)	76	74
363861	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL12(p40)	58	56
363862	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL12(p40)	54	39
363863	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL12(p40)	68	31
363864	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL12(p40)	55	25
363865	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL12(p40)	57	57
363866	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL12(p40)	50	16
363867	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL12(p40)	53	25
363868	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL12(p40)	69	51
363869	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL12(p40)	98	66
363870	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL12(p40)	65	57
363871	20233						RA2159	51112.0										2	IL12(p40)	57	59
363872	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL12(p40)	60	55
363873	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL12(p40)	62	61
363874	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL12(p40)	58	41
363875	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL12(p40)	66	72
363876	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL12(p40)	58.5	66
363877	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL12(p40)	131	74
363878	20233						N2586	51107.0										2	IL12(p40)	60	53
363879	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL12(p40)	60	80
363880	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL12(p40)	58	69
363881	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL12(p40)	60.5	50
363882	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL12(p40)	59	51
363883	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL12(p40)	53.5	62
363884	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL12(p40)	57	61
363885	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL12(p40)	67	53
363886	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL12(p40)	56	50
363887	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL12(p40)	60	63
363888	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL12(p40)	56.5	50
363889	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL12(p40)	46	63
363890	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL12(p40)	55.5	54
363891	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL12(p40)	78.5	38
363892	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL12(p40)	59	43
363893	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL12(p40)	62.5	56
363894	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL12(p40)	56	69
363895	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL12(p40)	79.5	84
363896	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL12(p40)	67	74
363897	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL12(p40)	58	61
363898	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL12(p40)	52	61
363899	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL12(p40)	61	65
363900	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL12(p40)	61.5	50
363901	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL12(p40)	61	57
363902	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL12(p40)	67	41
363903	20233						RA2159	51112.0										2	IL12(p40)	57	58
363904	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL12(p40)	52	47
363905	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL12(p40)	71.5	50
363906	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL12(p40)	63	77
363907	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL12(p40)	56	54
363908	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL12(p40)	59	84
363909	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL12(p40)	47	63
363910	20233						N2586	51107.0										2	IL12(p40)	74	52
363911	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL12(p40)	95	67
363912	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL12(p40)	103	51
363913	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL12(p40)	123	61
363914	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL12(p40)	91.5	44
363915	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL12(p40)	104	67
363916	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL12(p40)	105	55
363917	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL12(p40)	113	53
363918	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL12(p40)	112	54
363919	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL12(p40)	136	57
363920	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL12(p40)	129.5	28
363921	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL12(p40)	132	51
363922	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL12(p40)	132	62
363923	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL12(p40)	49.5	56
363924	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL12(p40)	54.5	62
363925	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL12(p40)	55	55
363926	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL12(p40)	52	76
363927	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL12(p40)	62	52
363928	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL12(p40)	53	57
363929	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL12(p40)	58	74
363930	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL12(p40)	65.5	54
363931	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL12(p40)	71	62
363932	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL12(p40)	52.5	42
363933	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL12(p40)	54	53
363934	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL12(p40)	55	62
363935	20233						RA2159	51112.0										2	IL12(p40)		0
363936	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL12(p40)		0
363937	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL12(p40)		0
363938	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL12(p40)		0
363939	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL12(p40)		0
363940	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL12(p40)		0
363941	20233						RA2159	51112.0										2	IL12(p40)		0
363942	20233						N2586	51107.0										2	IL12(p40)		0
363943	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL12(p40)		0
363944	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL12(p40)		0
363945	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL12(p40)		0
363946	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL12(p40)		0
363947	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL12(p40)		0
363948	20233						N2586	51107.0										2	IL12(p40)		0
363949	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL12(p40)	59	31
363950	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL12(p40)	58	85
363951	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL12(p40)	58	81
363952	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL12(p40)	54	57
363953	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL12(p40)	57	67
363954	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL12(p40)	55.5	70
363955	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL12(p40)	56	65
363956	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL12(p40)	60	62
363957	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL12(p40)	59	67
363958	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL12(p40)	57	49
363959	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL12(p40)	50	57
363960	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL12(p40)	56	31
363961	20233																	0	IL12(p40)	59	59
363962	20233						RA2159	51112.0								2	ug/mL	2	IL12(p40)	79	69
363963	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL12(p40)	72	45
363964	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL12(p40)	63	36
363965	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL12(p40)	50.5	52
363966	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL12(p40)	47.5	64
363967	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL12(p40)	54	62
363968	20233						N2586	51107.0								2	ug/mL	2	IL12(p40)	56	61
363969	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL12(p40)	51	42
363970	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL12(p40)	54.5	44
363971	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL12(p40)	63	34
363972	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL12(p40)	54	47
363973	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL12(p40)	48	56
363974	20233																	0	IL12(p40)	52	53
363975	20233						RA2159	51112.0								2	ug/mL	3	IL12(p40)	53	81
363976	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL12(p40)	62.5	58
363977	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL12(p40)	51	60
363978	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL12(p40)	64	55
363979	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL12(p40)	60	63
363980	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL12(p40)	52	64
363981	20233						N2586	51107.0								2	ug/mL	3	IL12(p40)	58	60
363982	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL12(p40)	262	55
363983	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL12(p40)	51	51
363984	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL12(p40)	54	54
363985	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL12(p40)	51.5	50
363986	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL12(p40)	63.5	60
363987	20233						RA2159	51112.0										3	IL12(p40)		0
363988	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL12(p40)		0
363989	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL12(p40)		0
363990	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL12(p40)		0
363991	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL12(p40)		0
363992	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL12(p40)		0
363993	20233						RA2159	51112.0										3	IL12(p40)		0
363994	20233						N2586	51107.0										3	IL12(p40)		0
363995	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL12(p40)		0
363996	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL12(p40)		0
363997	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL12(p40)		0
363998	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL12(p40)		0
363999	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL12(p40)		0
364000	20233						N2586	51107.0										3	IL12(p40)		0
364001	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL12(p40)	184	62
364002	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL12(p40)	87.5	70
364003	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL12(p40)	58	56
364004	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL12(p40)	57	51
364005	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL12(p40)	55	77
364006	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL12(p40)	54	55
364007	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL12(p40)	58	63
364008	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL12(p40)	52	66
364009	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL12(p40)	48.5	60
364010	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL12(p40)	48	66
364011	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL12(p40)	62	62
364012	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL12(p40)	49	71
364013	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL12(p40)	52	51
364014	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL12(p40)	46	47
364015	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL12(p40)	50	57
364016	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL12(p40)	52	54
364017	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL12(p40)	51.5	78
364018	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL12(p40)	50	59
364019	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL12(p40)	42	70
364020	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL12(p40)	56.5	60
364021	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL12(p40)	54.5	76
364022	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL12(p40)	47	61
364023	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL12(p40)	52	61
364024	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL12(p40)	54	67
364025	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL12(p40)	84	57
364026	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL12(p40)	84.5	78
364027	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL12(p40)	104.5	66
364028	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL12(p40)	76	61
364029	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL12(p40)	85	62
364030	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL12(p40)	94	72
364031	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL12(p40)	87	83
364032	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL12(p40)	93.5	66
364033	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL12(p40)	78	55
364034	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL12(p40)	89	50
364035	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL12(p40)	82	41
364036	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL12(p40)	93.5	50
364037	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL12(p40)	58	67
364038	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL12(p40)	61	65
364039	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL12(p40)	52	70
364040	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL12(p40)	44.5	42
364041	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL12(p40)	45.5	60
364042	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL12(p40)	53.5	54
364043	20233						RA2159	51112.0										3	IL12(p40)	53	55
364044	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL12(p40)	61	68
364045	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL12(p40)	57	69
364046	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL12(p40)	46	67
364047	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL12(p40)	61	64
364048	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL12(p40)	55	60
364049	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL12(p40)	46	61
364050	20233						N2586	51107.0										3	IL12(p40)	87	61
364051	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL12(p40)	48	62
364052	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL12(p40)	59	64
364053	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL12(p40)	53	68
364054	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL12(p40)	126.5	54
364055	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL12(p40)	59.5	62
364056	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL12(p40)	46	70
364057	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL12(p40)	61	50
364058	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL12(p40)	61	66
364059	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL12(p40)	57.5	68
364060	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL12(p40)	120	67
364061	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL12(p40)	161.5	62
364062	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL12(p40)	51	71
364063	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL12(p40)	51.5	74
364064	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL12(p40)	43	78
364065	20233						RA2159	51112.0										3	IL12(p40)	46	79
364066	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL12(p40)	47.5	54
364067	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL12(p40)	45.5	68
364068	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL12(p40)	46	51
364069	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL12(p40)	52	59
364070	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL12(p40)	56	49
364071	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL12(p40)	52	79
364072	20233						N2586	51107.0										3	IL12(p40)	46	56
364073	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL12(p40)	54	76
364074	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL12(p40)	46	73
364075	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL12(p40)	184	57
364076	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL12(p40)	164	67
364077	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL12(p40)	51	81
364078	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL12(p40)	53.5	58
364079	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL12(p40)	45.5	48
364080	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL12(p40)	47.5	64
364081	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL12(p40)	50.5	66
364082	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL12(p40)	52	62
364083	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL12(p40)	48	77
364084	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL12(p40)	49	53
364085	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL12(p40)	45	63
364086	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL12(p40)	49.5	70
364087	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL12(p40)	42	71
364088	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL12(p40)	229	62
364089	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL12(p40)	47.5	58
364090	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL12(p40)	44.5	40
364091	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL12(p40)	45.5	50
364092	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL12(p40)	47	57
364093	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL12(p40)	45	65
364094	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL12(p40)	45.5	58
364095	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL12(p40)	50	62
364096	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL12(p40)	48	52
364097	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL12(p40)	55	76
364098	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL12(p40)	121	65
364099	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL12(p40)	53	49
364100	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL12(p40)	45	43
364101	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL12(p40)	43	55
364102	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL12(p40)	46.5	56
364103	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL12(p40)	47	50
364104	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL12(p40)	48	50
364105	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL12(p40)	45	63
364106	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL12(p40)	52.5	50
364107	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL12(p40)	52.5	82
364108	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL12(p40)	55	59
364109	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL12(p40)	53	65
364110	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL12(p40)	60	60
364111	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL12(p40)	51	81
364112	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL12(p40)	64	68
364113	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL12(p40)	50	46
364114	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL12(p40)	54.5	64
364115	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL12(p40)	63	52
364116	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL12(p40)	57	52
364117	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL12(p40)	50	77
364118	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL12(p40)	43	60
364119	20233																	0	IL12(p40)	58	51
364120	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL12(p40)	68	57
364121	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL12(p40)	47	51
364122	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL12(p40)	50	72
364123	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL12(p40)	43	32
364124	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL12(p40)	52	55
364125	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL12(p40)	43.5	60
364126	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL12(p40)	49	35
364127	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL12(p40)	49.5	56
364128	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL12(p40)	51	94
364129	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL12(p40)	46.5	62
364130	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL12(p40)	48	75
364131	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL12(p40)	58.5	54
364132	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL12(p40)	50.5	74
364133	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL12(p40)	262	61
364134	20233																	0	IL12(p40)	44	51
364135	20233						RA2159	51112.0										3	IL12(p40)	52	60
364136	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL12(p40)	47	47
364137	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL12(p40)	115	64
364138	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL12(p40)	46	51
364139	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL12(p40)	57	65
364140	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL12(p40)	46	49
364141	20233						RA2159	51112.0										3	IL12(p40)	118	60
364142	20233						N2586	51107.0										3	IL12(p40)	51	41
364143	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL12(p40)	48	43
364144	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL12(p40)	50	43
364145	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL12(p40)	55	71
364146	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL12(p40)	48	75
364147	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL12(p40)	45	31
364148	20233						N2586	51107.0										3	IL12(p40)	45.5	46
364149	20233																	0	IL12(p40)	56	43
364150	20233						RA2159	51112.0								2	ug/mL	4	IL12(p40)	59	54
364151	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL12(p40)	59	53
364152	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL12(p40)	53	60
364153	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL12(p40)	58	56
364154	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL12(p40)	49.5	58
364155	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL12(p40)	48.5	66
364156	20233						N2586	51107.0								2	ug/mL	4	IL12(p40)	60	68
364157	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL12(p40)	55.5	50
364158	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL12(p40)	53	49
364159	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL12(p40)	58	46
364160	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL12(p40)	55.5	62
364161	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL12(p40)	46	48
364162	20233						RA2159	51112.0										4	IL12(p40)		0
364163	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL12(p40)		0
364164	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL12(p40)		0
364165	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL12(p40)		0
364166	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL12(p40)		0
364167	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL12(p40)		0
364168	20233						RA2159	51112.0										4	IL12(p40)		0
364169	20233						N2586	51107.0										4	IL12(p40)		0
364170	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL12(p40)		0
364171	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL12(p40)		0
364172	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL12(p40)		0
364173	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL12(p40)		0
364174	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL12(p40)		0
364175	20233						N2586	51107.0										4	IL12(p40)		0
364176	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL12(p40)	51	46
364177	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL12(p40)	56	53
364178	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL12(p40)	71.5	64
364179	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL12(p40)	64	61
364180	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL12(p40)	62	58
364181	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL12(p40)	97	63
364182	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL12(p40)	54.5	50
364183	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL12(p40)	52	67
364184	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL12(p40)	51	59
364185	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL12(p40)	54.5	68
364186	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL12(p40)	49	73
364187	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL12(p40)	55	49
364188	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL12(p40)	49	45
364189	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL12(p40)	53	41
364190	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL12(p40)	61	63
364191	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL12(p40)	57	62
364192	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL12(p40)	285	73
364193	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL12(p40)	45	31
364194	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL12(p40)	52	65
364195	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL12(p40)	55	38
364196	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL12(p40)	54	51
364197	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL12(p40)	59	58
364198	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL12(p40)	43	61
364199	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL12(p40)	105	46
364200	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL12(p40)	86	86
364201	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL12(p40)	88	59
364202	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL12(p40)	89.5	74
364203	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL12(p40)	81	69
364204	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL12(p40)	90.5	60
364205	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL12(p40)	82	74
364206	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL12(p40)	84.5	56
364207	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL12(p40)	88.5	54
364208	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL12(p40)	85	69
364209	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL12(p40)	79	67
364210	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL12(p40)	92.5	58
364211	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL12(p40)	72	68
364212	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL12(p40)	46	71
364213	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL12(p40)	53.5	66
364214	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL12(p40)	71	56
364215	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL12(p40)	46	77
364216	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL12(p40)	47.5	62
364217	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL12(p40)	52.5	58
364218	20233						RA2159	51112.0										4	IL12(p40)	55	65
364219	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL12(p40)	53	66
364220	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL12(p40)	92.5	58
364221	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL12(p40)	87	54
364222	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL12(p40)	52.5	58
364223	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL12(p40)	51.5	62
364224	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL12(p40)	46	81
364225	20233						N2586	51107.0										4	IL12(p40)	48	63
364226	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL12(p40)	114	71
364227	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL12(p40)	45	56
364228	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL12(p40)	44	65
364229	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL12(p40)	48.5	54
364230	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL12(p40)	50	59
364231	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL12(p40)	142	96
364232	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL12(p40)	75	51
364233	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL12(p40)	114	76
364234	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL12(p40)	44	70
364235	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL12(p40)	191	55
364236	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL12(p40)	44	47
364237	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL12(p40)	49	49
364238	20233						RA2159	51112.0										4	IL12(p40)	47	72
364239	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL12(p40)	54	35
364240	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL12(p40)	48	52
364241	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL12(p40)	45	52
364242	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL12(p40)	44	38
364243	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL12(p40)	47.5	20
364244	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL12(p40)	40	10
364245	20233						N2586	51107.0										4	IL12(p40)	47.5	8
364246	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL12(p40)	100	7
364247	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL12(p40)	53	58
364248	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL12(p40)	47	47
364249	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL12(p40)	46.5	38
364250	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL12(p40)	47	51
364251	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL12(p40)	96	49
364252	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL12(p40)	43	63
364253	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL12(p40)	48	55
364254	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL12(p40)	52	61
364255	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL12(p40)	56	55
364256	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL12(p40)	51	63
364257	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL12(p40)	42.5	58
364258	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL12(p40)	43	25
364259	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL12(p40)	46	59
364260	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL12(p40)	46.5	56
364261	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL12(p40)	53	58
364262	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL12(p40)	44.5	40
364263	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL12(p40)	48	62
364264	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL12(p40)	45.5	52
364265	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL12(p40)	46	56
364266	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL12(p40)	229.5	86
364267	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL12(p40)	52	71
364268	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL12(p40)	48	57
364269	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL12(p40)	53.5	62
364270	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL12(p40)	50.5	46
364271	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL12(p40)	44	47
364272	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL12(p40)	49	65
364273	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL12(p40)	47	50
364274	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL12(p40)	67	41
364275	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL12(p40)	45	38
364276	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL12(p40)	50	57
364277	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL12(p40)	48	55
364278	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL12(p40)	45	41
364279	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL12(p40)	46	46
364280	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL12(p40)	61	55
364281	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL12(p40)	52	60
364282	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL12(p40)	313	73
364283	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL12(p40)	50	53
364284	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL12(p40)	57	47
364285	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL12(p40)	140.5	56
364286	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL12(p40)	47	66
364287	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL12(p40)	56	51
364288	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL12(p40)	54	57
364289	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL12(p40)	57	59
364290	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL12(p40)	96	53
364291	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL12(p40)	45	43
364292	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL12(p40)	59	45
364293	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL12(p40)	49	55
364294	20233																	0	IL12(p40)	54	57
364295	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL12(p40)	51	51
364296	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL12(p40)	53	43
364297	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL12(p40)	51	43
364298	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL12(p40)	54.5	50
364299	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL12(p40)	42	41
364300	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL12(p40)	46	61
364301	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL12(p40)	44	52
364302	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL12(p40)	58	56
364303	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL12(p40)	53	75
364304	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL12(p40)	57.5	50
364305	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL12(p40)	52	39
364306	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL12(p40)	52	38
364307	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL12(p40)	58	47
364308	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL12(p40)	52	52
364309	20233																	0	IL12(p40)	46.5	46
364310	20233						RA2159	51112.0										4	IL12(p40)	44.5	66
364311	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL12(p40)	49	50
364312	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL12(p40)	44	44
364313	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL12(p40)	45	65
364314	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL12(p40)	55	84
364315	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL12(p40)	42	67
364316	20233						RA2159	51112.0										4	IL12(p40)	42.5	70
364317	20233						N2586	51107.0										4	IL12(p40)	45	64
364318	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL12(p40)	47	44
364319	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL12(p40)	76.5	42
364320	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL12(p40)	41	57
364321	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL12(p40)	39	47
364322	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL12(p40)	46.5	66
364323	20233						N2586	51107.0										4	IL12(p40)	113	55
364324	20233								TNF-a	201285.0						100	ng/mL	0	IL12(p40)	77.5	70
364325	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL12(p40)	79	61
364326	20233								IL-6	201287.0						100	ug/mL	0	IL12(p40)	92	51
364327	20233								IL-17A	201288.0						100	ng/mL	0	IL12(p40)	65.5	52
364328	20233								EGF	201289.0						100	ng/mL	0	IL12(p40)	170.5	64
364329	20233								IGF-I	201290.0						100	ug/mL	0	IL12(p40)	71	39
364330	20233								Adiponectin	201291.0						5	ng/mL	0	IL12(p40)	356	57
364331	20233								Leptin	201292.0						1	ng/mL	0	IL12(p40)	60	54
364332	20233								Visfatin	201293.0						1	ng/mL	0	IL12(p40)	65	51
364333	20233															2	ug/mL	0	IL12(p40)	64	55
364334	20233								TNF-a	201285.0						100	ng/mL	0	IL12(p40)	73.5	40
364335	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL12(p40)	67	49
364336	20233								IL-6	201287.0						100	ug/mL	0	IL12(p40)	74	65
364337	20233								IL-17A	201288.0						100	ng/mL	0	IL12(p40)	68	55
364338	20233								EGF	201289.0						100	ng/mL	0	IL12(p40)	74	54
364339	20233								IGF-I	201290.0						100	ug/mL	0	IL12(p40)	71	58
364340	20233								Adiponectin	201291.0						5	ng/mL	0	IL12(p40)	312	50
364341	20233								Leptin	201292.0						1	ng/mL	0	IL12(p40)	68	61
364342	20233								Visfatin	201293.0						1	ng/mL	0	IL12(p40)	60	52
364343	20233															2	ug/mL	0	IL12(p40)	80.5	42
364344	20233								TNF-a	201285.0						100	ng/mL	0	IL12(p40)	54	67
364345	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL12(p40)	62	51
364346	20233								IL-6	201287.0						100	ug/mL	0	IL12(p40)	70	64
364347	20233								IL-17A	201288.0						100	ng/mL	0	IL12(p40)	53	62
364348	20233								EGF	201289.0						100	ng/mL	0	IL12(p40)	56	57
364349	20233								IGF-I	201290.0						100	ug/mL	0	IL12(p40)	55	57
364350	20233								Adiponectin	201291.0						5	ng/mL	0	IL12(p40)	231	59
364351	20233								Leptin	201292.0						1	ng/mL	0	IL12(p40)	44	33
364352	20233								Visfatin	201293.0						1	ng/mL	0	IL12(p40)	64	59
364353	20233															2	ug/mL	0	IL12(p40)	54	75
364354	20233								TNF-a	201285.0						100	ng/mL	0	IL12(p40)	54	44
364355	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL12(p40)	59.5	68
364356	20233								IL-6	201287.0						100	ug/mL	0	IL12(p40)	178	65
364357	20233								IL-17A	201288.0						100	ng/mL	0	IL12(p40)	58	63
364358	20233								EGF	201289.0						100	ng/mL	0	IL12(p40)	53.5	46
364359	20233								IGF-I	201290.0						100	ug/mL	0	IL12(p40)	48	56
364360	20233								Adiponectin	201291.0						5	ng/mL	0	IL12(p40)	350	56
364361	20233								Leptin	201292.0						1	ng/mL	0	IL12(p40)	241.5	48
364362	20233								Visfatin	201293.0						1	ng/mL	0	IL12(p40)	51	52
364363	20233															2	ug/mL	0	IL12(p40)	48	32
364364	20233																	0	LIF	102.5	76
364365	20233						RA2159	51112.0										1	LIF	79	52
364366	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	LIF	84	64
364367	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	LIF	99	53
364368	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	LIF	76.5	50
364369	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	LIF	100	51
364370	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	LIF	104.5	56
364371	20233						RA2159	51112.0										1	LIF	104	67
364372	20233						N2586	51107.0										1	LIF	173	52
364373	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	LIF	146.5	48
364374	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	LIF	126.5	50
364375	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	LIF	129.5	62
364376	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	LIF	155	43
364377	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	LIF	120	32
364378	20233						N2586	51107.0										1	LIF	139	33
364379	20233																	0	LIF	121	67
364380	20233																	0	LIF	78	31
364381	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	LIF	187	39
364382	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	LIF	193	61
364383	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	LIF	182	48
364384	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	LIF	175.5	62
364385	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	LIF	205.5	62
364386	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	LIF	123	57
364387	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	LIF	112.5	60
364388	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	LIF	420.5	42
364389	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	LIF	339	32
364390	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	LIF	299	35
364391	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	LIF	399.5	54
364392	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	LIF	420	57
364393	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	LIF	329	35
364394	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	LIF	125	61
364395	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	LIF	309	54
364396	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	LIF	210.5	50
364397	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	LIF	198	64
364398	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	LIF	319	40
364399	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	LIF	265	50
364400	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	LIF	131	61
364401	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	LIF	105	40
364402	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	LIF	599	41
364403	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	LIF	422	58
364404	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	LIF	485	35
364405	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	LIF	564.5	50
364406	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	LIF	569	35
364407	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	LIF	229.5	46
364408	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	LIF	126	44
364409	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	LIF	101	61
364410	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	LIF	101.5	50
364411	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	LIF	88	51
364412	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	LIF	79	40
364413	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	LIF	88	52
364414	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	LIF	106	53
364415	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	LIF	84	56
364416	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	LIF	133	55
364417	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	LIF	119	45
364418	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	LIF	108.5	52
364419	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	LIF	116	40
364420	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	LIF	123	44
364421	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	LIF	119.5	44
364422	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	LIF	149	30
364423	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	LIF	87	59
364424	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	LIF	86.5	50
364425	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	LIF	82	55
364426	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	LIF	71.5	66
364427	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	LIF	81.5	64
364428	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	LIF	94	63
364429	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	LIF	174.5	30
364430	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	LIF	150	42
364431	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	LIF	201	19
364432	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	LIF	163.5	34
364433	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	LIF	115.5	28
364434	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	LIF	150	47
364435	20233						RA2159	51112.0										1	LIF	89.5	46
364436	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	LIF	213.5	50
364437	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	LIF	98.5	50
364438	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	LIF	85	59
364439	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	LIF	76	65
364440	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	LIF	85.5	64
364441	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	LIF	76	35
364442	20233						N2586	51107.0										1	LIF	117	57
364443	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	LIF	121.5	54
364444	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	LIF	125	30
364445	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	LIF	123	61
364446	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	LIF	116	51
364447	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	LIF	111.5	52
364448	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	LIF	106	32
364449	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	LIF	134	50
364450	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	LIF	83.5	50
364451	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	LIF	88	59
364452	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	LIF	106	69
364453	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	LIF	129.5	48
364454	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	LIF	81	50
364455	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	LIF	72	57
364456	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	LIF	131	54
364457	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	LIF	150	47
364458	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	LIF	112.5	50
364459	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	LIF	146.5	66
364460	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	LIF	177	59
364461	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	LIF	116	59
364462	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	LIF	120	68
364463	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	LIF	114.5	58
364464	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	LIF	114	56
364465	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	LIF	169	53
364466	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	LIF	125.5	40
364467	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	LIF	112	45
364468	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	LIF	118	60
364469	20233						RA2159	51112.0										1	LIF	82.5	68
364470	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	LIF	167	57
364471	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	LIF	129.5	72
364472	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	LIF	122.5	48
364473	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	LIF	140	49
364474	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	LIF	133	36
364475	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	LIF	166	41
364476	20233						N2586	51107.0										1	LIF	118	41
364477	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	LIF	115	56
364478	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	LIF	109	59
364479	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	LIF	116	49
364480	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	LIF	116	57
364481	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	LIF	150	62
364482	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	LIF	143	51
364483	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	LIF	171	67
364484	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	LIF	151	60
364485	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	LIF	140.5	46
364486	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	LIF	145	51
364487	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	LIF	195	34
364488	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	LIF	128.5	58
364489	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	LIF	81	55
364490	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	LIF	76.5	54
364491	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	LIF	69	48
364492	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	LIF	99	59
364493	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	LIF	72.5	32
364494	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	LIF	89.5	36
364495	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	LIF	129	25
364496	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	LIF	146	37
364497	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	LIF	110	43
364498	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	LIF	111	31
364499	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	LIF	128	34
364500	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	LIF	132	43
364501	20233						RA2159	51112.0										1	LIF		0
364502	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	LIF		0
364503	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	LIF		0
364504	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	LIF		0
364505	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	LIF		0
364506	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	LIF		0
364507	20233						RA2159	51112.0										1	LIF		0
364508	20233						N2586	51107.0										1	LIF		0
364509	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	LIF		0
364510	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	LIF		0
364511	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	LIF		0
364512	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	LIF		0
364513	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	LIF		0
364514	20233						N2586	51107.0										1	LIF		0
364515	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	LIF	73	51
364516	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	LIF	134	52
364517	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	LIF	70	59
364518	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	LIF	81	71
364519	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	LIF	79.5	42
364520	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	LIF	81	42
364521	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	LIF	109	37
364522	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	LIF	202	33
364523	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	LIF	227.5	72
364524	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	LIF	126	55
364525	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	LIF	138	37
364526	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	LIF	127	31
364527	20233																	0	LIF	64	66
364528	20233						RA2159	51112.0								2	ug/mL	1	LIF	104	47
364529	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	LIF	113	55
364530	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	LIF	72	51
364531	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	LIF	101	51
364532	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	LIF	87	50
364533	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	LIF	90	50
364534	20233						N2586	51107.0								2	ug/mL	1	LIF	175	43
364535	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	LIF	154.5	26
364536	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	LIF	170.5	44
364537	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	LIF	194	35
364538	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	LIF	153	29
364539	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	LIF	183	23
364540	20233																	0	LIF	85	69
364541	20233						RA2159	51112.0										2	LIF	91	57
364542	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	LIF	98	53
364543	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	LIF	84	47
364544	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	LIF	94.5	68
364545	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	LIF	96.5	66
364546	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	LIF	127	55
364547	20233						RA2159	51112.0										2	LIF	105	62
364548	20233						N2586	51107.0										2	LIF	145.5	62
364549	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	LIF	133	56
364550	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	LIF	117	87
364551	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	LIF	169	42
364552	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	LIF	114.5	52
364553	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	LIF	158.5	34
364554	20233						N2586	51107.0										2	LIF	172	51
364555	20233																	0	LIF	88	54
364556	20233																	0	LIF	113	57
364557	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	LIF	162	65
364558	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	LIF	167	62
364559	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	LIF	175.5	50
364560	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	LIF	161	72
364561	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	LIF	128	67
364562	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	LIF	176	59
364563	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	LIF	94	61
364564	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	LIF	372	47
364565	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	LIF	241	53
364566	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	LIF	252	63
364567	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	LIF	343	39
364568	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	LIF	281	48
364569	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	LIF	276	47
364570	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	LIF	127	49
364571	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	LIF	310.5	50
364572	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	LIF	243	63
364573	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	LIF	265.5	62
364574	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	LIF	333	66
364575	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	LIF	292.5	52
364576	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	LIF	244	50
364577	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	LIF	87	76
364578	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	LIF	581	67
364579	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	LIF	469	59
364580	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	LIF	531	57
364581	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	LIF	665	53
364582	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	LIF	573	67
364583	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	LIF	494	54
364584	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	LIF	129	63
364585	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	LIF	207	62
364586	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	LIF	71.5	50
364587	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	LIF	160.5	68
364588	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	LIF	99	49
364589	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	LIF	82	59
364590	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	LIF	115	49
364591	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	LIF	96	63
364592	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	LIF	127	67
364593	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	LIF	155	42
364594	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	LIF	141	55
364595	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	LIF	144	61
364596	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	LIF	102	65
364597	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	LIF	98	44
364598	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	LIF	135	51
364599	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	LIF	96	59
364600	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	LIF	93	50
364601	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	LIF	90.5	54
364602	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	LIF	114	64
364603	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	LIF	74	65
364604	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	LIF	86.5	32
364605	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	LIF	87.5	34
364606	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	LIF	134.5	42
364607	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	LIF	186	79
364608	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	LIF	131	13
364609	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	LIF	171	28
364610	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	LIF	146	41
364611	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	LIF	181	59
364612	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	LIF	125	50
364613	20233						RA2159	51112.0										2	LIF	79	66
364614	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	LIF	95	57
364615	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	LIF	92	49
364616	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	LIF	84	49
364617	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	LIF	91.5	58
364618	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	LIF	85.5	64
364619	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	LIF	157	67
364620	20233						N2586	51107.0										2	LIF	120.5	50
364621	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	LIF	166	52
364622	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	LIF	150	66
364623	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	LIF	138	57
364624	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	LIF	115	38
364625	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	LIF	112	59
364626	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	LIF	124	55
364627	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	LIF	106	63
364628	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	LIF	87	95
364629	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	LIF	84	50
364630	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	LIF	92	68
364631	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	LIF	72	55
364632	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	LIF	92.5	50
364633	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	LIF	193	59
364634	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	LIF	146	38
364635	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	LIF	118	65
364636	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	LIF	168	59
364637	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	LIF	151	74
364638	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	LIF	155.5	50
364639	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	LIF	116	62
364640	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	LIF	76	50
364641	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	LIF	86.5	52
364642	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	LIF	147	69
364643	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	LIF	86.5	50
364644	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	LIF	91.5	56
364645	20233						RA2159	51112.0										2	LIF	76	41
364646	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	LIF	118.5	48
364647	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	LIF	176	57
364648	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	LIF	110	62
364649	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	LIF	120	40
364650	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	LIF	100	61
364651	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	LIF	98	50
364652	20233						N2586	51107.0										2	LIF	131.5	50
364653	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	LIF	108	59
364654	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	LIF	103	47
364655	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	LIF	123	49
364656	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	LIF	126.5	32
364657	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	LIF	108	50
364658	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	LIF	107	66
364659	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	LIF	153	70
364660	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	LIF	151	67
364661	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	LIF	157	59
364662	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	LIF	162.5	40
364663	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	LIF	146	57
364664	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	LIF	147	58
364665	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	LIF	74	50
364666	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	LIF	104	59
364667	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	LIF	78	66
364668	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	LIF	68.5	72
364669	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	LIF	66	53
364670	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	LIF	90	55
364671	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	LIF	117	63
364672	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	LIF	132.5	50
364673	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	LIF	109	75
364674	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	LIF	113.5	46
364675	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	LIF	93	44
364676	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	LIF	108.5	60
364677	20233						RA2159	51112.0										2	LIF		0
364678	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	LIF		0
364679	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	LIF		0
364680	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	LIF		0
364681	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	LIF		0
364682	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	LIF		0
364683	20233						RA2159	51112.0										2	LIF		0
364684	20233						N2586	51107.0										2	LIF		0
364685	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	LIF		0
364686	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	LIF		0
364687	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	LIF		0
364688	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	LIF		0
364689	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	LIF		0
364690	20233						N2586	51107.0										2	LIF		0
364691	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	LIF	79	46
364692	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	LIF	93.5	50
364693	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	LIF	89	58
364694	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	LIF	107	61
364695	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	LIF	73	73
364696	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	LIF	73	53
364697	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	LIF	126	63
364698	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	LIF	121	63
364699	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	LIF	107	70
364700	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	LIF	112	41
364701	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	LIF	104	52
364702	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	LIF	108.5	30
364703	20233																	0	LIF	67	56
364704	20233						RA2159	51112.0								2	ug/mL	2	LIF	148	59
364705	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	LIF	106.5	44
364706	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	LIF	112.5	50
364707	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	LIF	85	53
364708	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	LIF	80	59
364709	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	LIF	96	65
364710	20233						N2586	51107.0								2	ug/mL	2	LIF	175	56
364711	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	LIF	168	33
364712	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	LIF	162.5	34
364713	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	LIF	178.5	40
364714	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	LIF	105	37
364715	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	LIF	137	55
364716	20233																	0	LIF	79.5	68
364717	20233						RA2159	51112.0								2	ug/mL	3	LIF	104	75
364718	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	LIF	128	52
364719	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	LIF	96.5	50
364720	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	LIF	140	47
364721	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	LIF	100	60
364722	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	LIF	105	53
364723	20233						N2586	51107.0								2	ug/mL	3	LIF	248	50
364724	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	LIF	470	69
364725	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	LIF	233.5	52
364726	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	LIF	215	53
364727	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	LIF	128	60
364728	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	LIF	196	48
364729	20233						RA2159	51112.0										3	LIF		0
364730	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	LIF		0
364731	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	LIF		0
364732	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	LIF		0
364733	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	LIF		0
364734	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	LIF		0
364735	20233						RA2159	51112.0										3	LIF		0
364736	20233						N2586	51107.0										3	LIF		0
364737	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	LIF		0
364738	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	LIF		0
364739	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	LIF		0
364740	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	LIF		0
364741	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	LIF		0
364742	20233						N2586	51107.0										3	LIF		0
364743	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	LIF	206	55
364744	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	LIF	119.5	68
364745	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	LIF	104.5	70
364746	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	LIF	73.5	36
364747	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	LIF	83	73
364748	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	LIF	81	52
364749	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	LIF	147	58
364750	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	LIF	141	48
364751	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	LIF	102.5	52
364752	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	LIF	127.5	46
364753	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	LIF	139	71
364754	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	LIF	116	60
364755	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	LIF	102	60
364756	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	LIF	71.5	52
364757	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	LIF	75	66
364758	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	LIF	77.5	58
364759	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	LIF	94	57
364760	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	LIF	86	68
364761	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	LIF	133	51
364762	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	LIF	157.5	68
364763	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	LIF	110	59
364764	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	LIF	140.5	46
364765	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	LIF	114	70
364766	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	LIF	114	74
364767	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	LIF	124	60
364768	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	LIF	129	46
364769	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	LIF	151	72
364770	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	LIF	109	45
364771	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	LIF	130	65
364772	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	LIF	128	59
364773	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	LIF	187	54
364774	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	LIF	155	71
364775	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	LIF	139	73
364776	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	LIF	148	45
364777	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	LIF	128.5	38
364778	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	LIF	173.5	70
364779	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	LIF	96	59
364780	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	LIF	105	79
364781	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	LIF	110	52
364782	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	LIF	91	57
364783	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	LIF	79	63
364784	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	LIF	79.5	44
364785	20233						RA2159	51112.0										3	LIF	76.5	66
364786	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	LIF	158	49
364787	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	LIF	177	53
364788	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	LIF	114	57
364789	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	LIF	497.5	74
364790	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	LIF	113	74
364791	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	LIF	108	54
364792	20233						N2586	51107.0										3	LIF	184.5	50
364793	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	LIF	86	65
364794	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	LIF	87	55
364795	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	LIF	121	67
364796	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	LIF	148.5	44
364797	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	LIF	103	55
364798	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	LIF	73	50
364799	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	LIF	127	55
364800	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	LIF	173	47
364801	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	LIF	168.5	50
364802	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	LIF	175	67
364803	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	LIF	296.5	58
364804	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	LIF	128	63
364805	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	LIF	126	72
364806	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	LIF	77.5	64
364807	20233						RA2159	51112.0										3	LIF	97.5	50
364808	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	LIF	81	50
364809	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	LIF	68	73
364810	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	LIF	92.5	50
364811	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	LIF	87.5	72
364812	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	LIF	107	51
364813	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	LIF	96	59
364814	20233						N2586	51107.0										3	LIF	129.5	62
364815	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	LIF	158	79
364816	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	LIF	113	63
364817	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	LIF	351	56
364818	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	LIF	196.5	62
364819	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	LIF	109	79
364820	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	LIF	123	65
364821	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	LIF	115	54
364822	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	LIF	91	74
364823	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	LIF	97	60
364824	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	LIF	80	55
364825	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	LIF	75	53
364826	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	LIF	77.5	68
364827	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	LIF	147	61
364828	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	LIF	136	67
364829	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	LIF	127.5	60
364830	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	LIF	330	46
364831	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	LIF	119	50
364832	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	LIF	115.5	52
364833	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	LIF	84	51
364834	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	LIF	90	50
364835	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	LIF	77	49
364836	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	LIF	69	55
364837	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	LIF	66	59
364838	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	LIF	75	47
364839	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	LIF	98	68
364840	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	LIF	214	64
364841	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	LIF	117	59
364842	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	LIF	100	67
364843	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	LIF	115	51
364844	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	LIF	88.5	62
364845	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	LIF	105	73
364846	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	LIF	132	63
364847	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	LIF	281.5	70
364848	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	LIF	170.5	44
364849	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	LIF	184	62
364850	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	LIF	310	67
364851	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	LIF	274	55
364852	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	LIF	137.5	62
364853	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	LIF	76.5	52
364854	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	LIF	571.5	72
364855	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	LIF	440.5	62
364856	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	LIF	506.5	66
364857	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	LIF	651.5	48
364858	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	LIF	198	43
364859	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	LIF	314.5	74
364860	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	LIF	95	59
364861	20233																	0	LIF	102	53
364862	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	LIF	245.5	50
364863	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	LIF	164.5	52
364864	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	LIF	167	73
364865	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	LIF	156	41
364866	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	LIF	174	57
364867	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	LIF	121	43
364868	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	LIF	75	33
364869	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	LIF	344	53
364870	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	LIF	332	94
364871	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	LIF	289	63
364872	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	LIF	325	61
364873	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	LIF	221	59
364874	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	LIF	306.5	62
364875	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	LIF	302	55
364876	20233																	0	LIF	91	50
364877	20233						RA2159	51112.0										3	LIF	85	72
364878	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	LIF	87	41
364879	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	LIF	154	59
364880	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	LIF	107.5	40
364881	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	LIF	80	51
364882	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	LIF	94.5	54
364883	20233						RA2159	51112.0										3	LIF	163	58
364884	20233						N2586	51107.0										3	LIF	176.5	42
364885	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	LIF	122	51
364886	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	LIF	103	53
364887	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	LIF	146	39
364888	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	LIF	109	51
364889	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	LIF	117	31
364890	20233						N2586	51107.0										3	LIF	138	46
364891	20233																	0	LIF	73	55
364892	20233						RA2159	51112.0								2	ug/mL	4	LIF	154	51
364893	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	LIF	209	65
364894	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	LIF	153	51
364895	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	LIF	143.5	58
364896	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	LIF	109	61
364897	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	LIF	109.5	58
364898	20233						N2586	51107.0								2	ug/mL	4	LIF	269	65
364899	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	LIF	220	57
364900	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	LIF	154	58
364901	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	LIF	250	45
364902	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	LIF	166.5	92
364903	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	LIF	110	43
364904	20233						RA2159	51112.0										4	LIF		0
364905	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	LIF		0
364906	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	LIF		0
364907	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	LIF		0
364908	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	LIF		0
364909	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	LIF		0
364910	20233						RA2159	51112.0										4	LIF		0
364911	20233						N2586	51107.0										4	LIF		0
364912	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	LIF		0
364913	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	LIF		0
364914	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	LIF		0
364915	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	LIF		0
364916	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	LIF		0
364917	20233						N2586	51107.0										4	LIF		0
364918	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	LIF	98	43
364919	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	LIF	88	37
364920	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	LIF	109	53
364921	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	LIF	131	59
364922	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	LIF	123.5	54
364923	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	LIF	149.5	50
364924	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	LIF	168.5	72
364925	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	LIF	129	56
364926	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	LIF	141	60
364927	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	LIF	136	59
364928	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	LIF	127	75
364929	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	LIF	118	67
364930	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	LIF	92	36
364931	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	LIF	89	57
364932	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	LIF	104	63
364933	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	LIF	112	50
364934	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	LIF	305.5	62
364935	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	LIF	84	44
364936	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	LIF	134	54
364937	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	LIF	128.5	42
364938	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	LIF	100	46
364939	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	LIF	138	42
364940	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	LIF	142	52
364941	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	LIF	178	39
364942	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	LIF	122	97
364943	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	LIF	155	57
364944	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	LIF	123	50
364945	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	LIF	135	57
364946	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	LIF	116	57
364947	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	LIF	115.5	72
364948	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	LIF	176	45
364949	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	LIF	153.5	54
364950	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	LIF	168	55
364951	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	LIF	136	62
364952	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	LIF	173.5	58
364953	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	LIF	128	80
364954	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	LIF	91	73
364955	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	LIF	89	68
364956	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	LIF	140	61
364957	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	LIF	83	56
364958	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	LIF	91	61
364959	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	LIF	81	59
364960	20233						RA2159	51112.0										4	LIF	91	66
364961	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	LIF	140	63
364962	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	LIF	191.5	50
364963	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	LIF	146.5	52
364964	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	LIF	155	55
364965	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	LIF	152	43
364966	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	LIF	109.5	68
364967	20233						N2586	51107.0										4	LIF	123	51
364968	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	LIF	183.5	64
364969	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	LIF	86	55
364970	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	LIF	76	55
364971	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	LIF	76	55
364972	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	LIF	102.5	52
364973	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	LIF	153	68
364974	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	LIF	195	55
364975	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	LIF	196.5	50
364976	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	LIF	118.5	64
364977	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	LIF	287	39
364978	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	LIF	121	39
364979	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	LIF	102.5	56
364980	20233						RA2159	51112.0										4	LIF	127.5	82
364981	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	LIF	111	41
364982	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	LIF	87	43
364983	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	LIF	82	53
364984	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	LIF	94	39
364985	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	LIF	90.5	14
364986	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	LIF	106	11
364987	20233						N2586	51107.0										4	LIF	133	7
364988	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	LIF	242.5	14
364989	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	LIF	108.5	50
364990	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	LIF	138	38
364991	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	LIF	133	43
364992	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	LIF	110	66
364993	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	LIF	197	42
364994	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	LIF	83	67
364995	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	LIF	94	53
364996	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	LIF	85	59
364997	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	LIF	156.5	66
364998	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	LIF	98	69
364999	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	LIF	88	49
365000	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	LIF	83	21
365001	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	LIF	137.5	50
365002	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	LIF	136	53
365003	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	LIF	191	49
365004	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	LIF	161	41
365005	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	LIF	100.5	54
365006	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	LIF	94	53
365007	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	LIF	97.5	44
365008	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	LIF	226.5	50
365009	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	LIF	98	67
365010	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	LIF	64.5	44
365011	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	LIF	82.5	58
365012	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	LIF	81	50
365013	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	LIF	72	51
365014	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	LIF	75	47
365015	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	LIF	106	50
365016	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	LIF	149	45
365017	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	LIF	160	30
365018	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	LIF	128.5	58
365019	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	LIF	130	37
365020	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	LIF	82	53
365021	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	LIF	177	55
365022	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	LIF	351	69
365023	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	LIF	233.5	54
365024	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	LIF	540	60
365025	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	LIF	254	47
365026	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	LIF	255.5	50
365027	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	LIF	343	64
365028	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	LIF	80	54
365029	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	LIF	613	46
365030	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	LIF	496	45
365031	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	LIF	469	55
365032	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	LIF	680	56
365033	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	LIF	283	46
365034	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	LIF	179	68
365035	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	LIF	140	54
365036	20233																	0	LIF	100	65
365037	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	LIF	184	47
365038	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	LIF	194	48
365039	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	LIF	173	61
365040	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	LIF	175	56
365041	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	LIF	145	41
365042	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	LIF	141	49
365043	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	LIF	64.5	48
365044	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	LIF	410	47
365045	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	LIF	365	50
365046	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	LIF	334.5	58
365047	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	LIF	473.5	30
365048	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	LIF	316	31
365049	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	LIF	111	45
365050	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	LIF	147	43
365051	20233																	0	LIF	63	41
365052	20233						RA2159	51112.0										4	LIF	75	59
365053	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	LIF	81	53
365054	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	LIF	79.5	80
365055	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	LIF	80	61
365056	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	LIF	87	50
365057	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	LIF	76	86
365058	20233						RA2159	51112.0										4	LIF	90	62
365059	20233						N2586	51107.0										4	LIF	128	53
365060	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	LIF	147	53
365061	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	LIF	143	43
365062	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	LIF	114	56
365063	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	LIF	107	45
365064	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	LIF	96	48
365065	20233						N2586	51107.0										4	LIF	189	39
365066	20233								TNF-a	201285.0						100	ng/mL	0	LIF	85	64
365067	20233								IL-1 alpha	201286.0						100	ng/mL	0	LIF	161	60
365068	20233								IL-6	201287.0						100	ug/mL	0	LIF	111	51
365069	20233								IL-17A	201288.0						100	ng/mL	0	LIF	103	65
365070	20233								EGF	201289.0						100	ng/mL	0	LIF	280	66
365071	20233								IGF-I	201290.0						100	ug/mL	0	LIF	86	49
365072	20233								Adiponectin	201291.0						5	ng/mL	0	LIF	300	56
365073	20233								Leptin	201292.0						1	ng/mL	0	LIF	102	48
365074	20233								Visfatin	201293.0						1	ng/mL	0	LIF	92	43
365075	20233															2	ug/mL	0	LIF	89	71
365076	20233								TNF-a	201285.0						100	ng/mL	0	LIF	95	49
365077	20233								IL-1 alpha	201286.0						100	ng/mL	0	LIF	165.5	54
365078	20233								IL-6	201287.0						100	ug/mL	0	LIF	80.5	60
365079	20233								IL-17A	201288.0						100	ng/mL	0	LIF	95	48
365080	20233								EGF	201289.0						100	ng/mL	0	LIF	100.5	56
365081	20233								IGF-I	201290.0						100	ug/mL	0	LIF	108.5	44
365082	20233								Adiponectin	201291.0						5	ng/mL	0	LIF	333.5	46
365083	20233								Leptin	201292.0						1	ng/mL	0	LIF	92.5	50
365084	20233								Visfatin	201293.0						1	ng/mL	0	LIF	89	58
365085	20233															2	ug/mL	0	LIF	87	56
365086	20233								TNF-a	201285.0						100	ng/mL	0	LIF	93	58
365087	20233								IL-1 alpha	201286.0						100	ng/mL	0	LIF	137	56
365088	20233								IL-6	201287.0						100	ug/mL	0	LIF	98.5	64
365089	20233								IL-17A	201288.0						100	ng/mL	0	LIF	85	50
365090	20233								EGF	201289.0						100	ng/mL	0	LIF	84.5	56
365091	20233								IGF-I	201290.0						100	ug/mL	0	LIF	85	55
365092	20233								Adiponectin	201291.0						5	ng/mL	0	LIF	242	49
365093	20233								Leptin	201292.0						1	ng/mL	0	LIF	62	49
365094	20233								Visfatin	201293.0						1	ng/mL	0	LIF	89	41
365095	20233															2	ug/mL	0	LIF	111.5	56
365096	20233								TNF-a	201285.0						100	ng/mL	0	LIF	102.5	46
365097	20233								IL-1 alpha	201286.0						100	ng/mL	0	LIF	131	71
365098	20233								IL-6	201287.0						100	ug/mL	0	LIF	199	58
365099	20233								IL-17A	201288.0						100	ng/mL	0	LIF	76	67
365100	20233								EGF	201289.0						100	ng/mL	0	LIF	71	71
365101	20233								IGF-I	201290.0						100	ug/mL	0	LIF	69	51
365102	20233								Adiponectin	201291.0						5	ng/mL	0	LIF	339	38
365103	20233								Leptin	201292.0						1	ng/mL	0	LIF	222	45
365104	20233								Visfatin	201293.0						1	ng/mL	0	LIF	133	41
365105	20233															2	ug/mL	0	LIF	81	44
365106	20233																	0	TNFb	53	60
365107	20233						RA2159	51112.0										1	TNFb	37	67
365108	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	TNFb	43.5	64
365109	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	TNFb	52.5	50
365110	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	TNFb	41	52
365111	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	TNFb	53	62
365112	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	TNFb	53.5	58
365113	20233						RA2159	51112.0										1	TNFb	50	70
365114	20233						N2586	51107.0										1	TNFb	70	61
365115	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	TNFb	52	54
365116	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	TNFb	46	67
365117	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	TNFb	50	55
365118	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	TNFb	62	61
365119	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	TNFb	45	39
365120	20233						N2586	51107.0										1	TNFb	47	35
365121	20233																	0	TNFb	79	51
365122	20233																	0	TNFb	43	38
365123	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	TNFb	49	50
365124	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	TNFb	56	77
365125	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TNFb	45	70
365126	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TNFb	41	50
365127	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TNFb	57	43
365128	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	TNFb	55	45
365129	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	TNFb	64	50
365130	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	TNFb	64	49
365131	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	TNFb	88	47
365132	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TNFb	43	33
365133	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TNFb	60	64
365134	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TNFb	74	53
365135	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	TNFb	50	35
365136	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	TNFb	49	70
365137	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	TNFb	91	52
365138	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	TNFb	85	64
365139	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TNFb	61	45
365140	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TNFb	79	57
365141	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TNFb	57	50
365142	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	TNFb	63	59
365143	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	TNFb	43.5	38
365144	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	TNFb	72.5	62
365145	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	TNFb	66	56
365146	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TNFb	68.5	50
365147	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TNFb	76	51
365148	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TNFb	72	45
365149	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	TNFb	62.5	52
365150	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	TNFb	48	37
365151	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	TNFb	62	56
365152	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	TNFb	51	65
365153	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TNFb	49.5	48
365154	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TNFb	49	59
365155	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TNFb	47	66
365156	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	TNFb	36	39
365157	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	TNFb	41.5	50
365158	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	TNFb	50.5	56
365159	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	TNFb	45.5	52
365160	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TNFb	38	60
365161	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TNFb	42.5	34
365162	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TNFb	49	38
365163	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	TNFb	52	51
365164	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	TNFb	47	44
365165	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	TNFb	50	62
365166	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	TNFb	44	66
365167	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TNFb	37	52
365168	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TNFb	36	63
365169	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TNFb	37	60
365170	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	TNFb	49	70
365171	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	TNFb	51	37
365172	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	TNFb	51	37
365173	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TNFb	94	28
365174	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TNFb	55	31
365175	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TNFb	44	35
365176	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	TNFb	56.5	60
365177	20233						RA2159	51112.0										1	TNFb	44	55
365178	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	TNFb	104	69
365179	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	TNFb	59	51
365180	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	TNFb	45	60
365181	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	TNFb	43	57
365182	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	TNFb	40	50
365183	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	TNFb	44	43
365184	20233						N2586	51107.0										1	TNFb	38	63
365185	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	TNFb	44	54
365186	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	TNFb	62	48
365187	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	TNFb	52	66
365188	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	TNFb	45.5	54
365189	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	TNFb	39	60
365190	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	TNFb	38	44
365191	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	TNFb	62	50
365192	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	TNFb	40	57
365193	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TNFb	44	70
365194	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TNFb	48.5	66
365195	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TNFb	66	53
365196	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	TNFb	42	67
365197	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	TNFb	33	55
365198	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	TNFb	35	60
365199	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	TNFb	63	72
365200	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TNFb	41	58
365201	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TNFb	50	61
365202	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TNFb	58	56
365203	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	TNFb	40.5	64
365204	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	TNFb	51.5	54
365205	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	TNFb	68	73
365206	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	TNFb	64	69
365207	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TNFb	98	54
365208	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TNFb	61	52
365209	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TNFb	66	55
365210	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	TNFb	52	51
365211	20233						RA2159	51112.0										1	TNFb	43	50
365212	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	TNFb	67.5	48
365213	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	TNFb	46.5	68
365214	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TNFb	50	55
365215	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TNFb	47	45
365216	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TNFb	48	21
365217	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	TNFb	55	51
365218	20233						N2586	51107.0										1	TNFb	39	33
365219	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	TNFb	84	54
365220	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	TNFb	79.5	60
365221	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TNFb	94.5	52
365222	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TNFb	81	62
365223	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TNFb	98	60
365224	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	TNFb	92.5	54
365225	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	TNFb	80	60
365226	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	TNFb	85	59
365227	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TNFb	82	43
365228	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TNFb	67.5	42
365229	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TNFb	110	50
365230	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	TNFb	58	45
365231	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	TNFb	46	51
365232	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	TNFb	35.5	46
365233	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TNFb	40	44
365234	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TNFb	64	58
365235	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TNFb	41	36
365236	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	TNFb	51	33
365237	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	TNFb	45	27
365238	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	TNFb	69	53
365239	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TNFb	35	43
365240	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TNFb	43	33
365241	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TNFb	41	43
365242	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	TNFb	52	38
365243	20233						RA2159	51112.0										1	TNFb		0
365244	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	TNFb		0
365245	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	TNFb		0
365246	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	TNFb		0
365247	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	TNFb		0
365248	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	TNFb		0
365249	20233						RA2159	51112.0										1	TNFb		0
365250	20233						N2586	51107.0										1	TNFb		0
365251	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	TNFb		0
365252	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	TNFb		0
365253	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	TNFb		0
365254	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	TNFb		0
365255	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	TNFb		0
365256	20233						N2586	51107.0										1	TNFb		0
365257	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	TNFb	52	51
365258	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	TNFb	88	61
365259	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TNFb	34	71
365260	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TNFb	41	50
365261	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TNFb	38	53
365262	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	TNFb	41	51
365263	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	TNFb	39.5	44
365264	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	TNFb	68	37
365265	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TNFb	98	45
365266	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TNFb	44	55
365267	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TNFb	56	28
365268	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	TNFb	46	28
365269	20233																	0	TNFb	36	62
365270	20233						RA2159	51112.0								2	ug/mL	1	TNFb	62	42
365271	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	TNFb	50.5	42
365272	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	TNFb	38.5	34
365273	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	TNFb	47	63
365274	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	TNFb	37.5	68
365275	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	TNFb	52	61
365276	20233						N2586	51107.0								2	ug/mL	1	TNFb	43	55
365277	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	TNFb	41	33
365278	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	TNFb	69	43
365279	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	TNFb	65	47
365280	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	TNFb	41	40
365281	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	TNFb	45	31
365282	20233																	0	TNFb	47	45
365283	20233						RA2159	51112.0										2	TNFb	43	59
365284	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	TNFb	56.5	46
365285	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	TNFb	38.5	48
365286	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	TNFb	51.5	50
365287	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	TNFb	52	50
365288	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	TNFb	63	53
365289	20233						RA2159	51112.0										2	TNFb	53	50
365290	20233						N2586	51107.0										2	TNFb	56	43
365291	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	TNFb	44	47
365292	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	TNFb	45	61
365293	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	TNFb	75.5	56
365294	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	TNFb	39.5	50
365295	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	TNFb	61	31
365296	20233						N2586	51107.0										2	TNFb	54	50
365297	20233																	0	TNFb	45	63
365298	20233																	0	TNFb	67	59
365299	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	TNFb	43	63
365300	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	TNFb	45	52
365301	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	TNFb	55.5	54
365302	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	TNFb	52.5	60
365303	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	TNFb	44	55
365304	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	TNFb	72	56
365305	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	TNFb	49	56
365306	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	TNFb	60	66
365307	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	TNFb	39	59
365308	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	TNFb	40	63
365309	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	TNFb	76	43
365310	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	TNFb	76.5	46
365311	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	TNFb	61	34
365312	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	TNFb	54	52
365313	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	TNFb	77	64
365314	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	TNFb	74	51
365315	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	TNFb	62	61
365316	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	TNFb	88	59
365317	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	TNFb	64	62
365318	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	TNFb	66	60
365319	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	TNFb	39	68
365320	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	TNFb	81	64
365321	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	TNFb	77	57
365322	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	TNFb	59	62
365323	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	TNFb	64.5	42
365324	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	TNFb	70	45
365325	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	TNFb	53.5	52
365326	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	TNFb	51	63
365327	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	TNFb	103	50
365328	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	TNFb	37	59
365329	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	TNFb	86	66
365330	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	TNFb	51	50
365331	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	TNFb	44.5	46
365332	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	TNFb	58	47
365333	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	TNFb	56.5	60
365334	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	TNFb	49	49
365335	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	TNFb	69	63
365336	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	TNFb	55	58
365337	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	TNFb	46	65
365338	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	TNFb	39	43
365339	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	TNFb	44.5	54
365340	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	TNFb	61.5	54
365341	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	TNFb	49	64
365342	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	TNFb	45	59
365343	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	TNFb	45.5	54
365344	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	TNFb	58	75
365345	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	TNFb	41	65
365346	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	TNFb	35	23
365347	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	TNFb	37.5	34
365348	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	TNFb	46	40
365349	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	TNFb	79	71
365350	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	TNFb	44.5	12
365351	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	TNFb	56	29
365352	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	TNFb	55.5	40
365353	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	TNFb	80	59
365354	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	TNFb	61	57
365355	20233						RA2159	51112.0										2	TNFb	34	61
365356	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	TNFb	46	49
365357	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	TNFb	50	42
365358	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	TNFb	44	33
365359	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	TNFb	42.5	50
365360	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	TNFb	39	54
365361	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	TNFb	86	50
365362	20233						N2586	51107.0										2	TNFb	42	55
365363	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	TNFb	67	53
365364	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	TNFb	56	55
365365	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	TNFb	50	59
365366	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	TNFb	48	50
365367	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	TNFb	40.5	54
365368	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	TNFb	52	67
365369	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	TNFb	61	65
365370	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	TNFb	44	59
365371	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	TNFb	37.5	48
365372	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	TNFb	47	64
365373	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	TNFb	32	53
365374	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	TNFb	38	55
365375	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	TNFb	70	53
365376	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	TNFb	49	45
365377	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	TNFb	56	50
365378	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	TNFb	56	64
365379	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	TNFb	58	60
365380	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	TNFb	68	57
365381	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	TNFb	73	66
365382	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	TNFb	37	71
365383	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	TNFb	44.5	50
365384	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	TNFb	83	51
365385	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	TNFb	42	50
365386	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	TNFb	45.5	56
365387	20233						RA2159	51112.0										2	TNFb	42	51
365388	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	TNFb	46.5	44
365389	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	TNFb	76	56
365390	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	TNFb	47	50
365391	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	TNFb	39.5	36
365392	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	TNFb	44	81
365393	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	TNFb	43	57
365394	20233						N2586	51107.0										2	TNFb	50	51
365395	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	TNFb	68	61
365396	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	TNFb	65.5	72
365397	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	TNFb	90	33
365398	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	TNFb	74	45
365399	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	TNFb	72	66
365400	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	TNFb	72	65
365401	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	TNFb	86	61
365402	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	TNFb	79	53
365403	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	TNFb	90.5	48
365404	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	TNFb	91	24
365405	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	TNFb	81	37
365406	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	TNFb	81	65
365407	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	TNFb	38	65
365408	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	TNFb	44.5	56
365409	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	TNFb	43	57
365410	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	TNFb	39	60
365411	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	TNFb	42	64
365412	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	TNFb	51	69
365413	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	TNFb	51	70
365414	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	TNFb	59.5	64
365415	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	TNFb	48	61
365416	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	TNFb	37	54
365417	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	TNFb	42	51
365418	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	TNFb	44	61
365419	20233						RA2159	51112.0										2	TNFb		0
365420	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	TNFb		0
365421	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	TNFb		0
365422	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	TNFb		0
365423	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	TNFb		0
365424	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	TNFb		0
365425	20233						RA2159	51112.0										2	TNFb		0
365426	20233						N2586	51107.0										2	TNFb		0
365427	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	TNFb		0
365428	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	TNFb		0
365429	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	TNFb		0
365430	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	TNFb		0
365431	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	TNFb		0
365432	20233						N2586	51107.0										2	TNFb		0
365433	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	TNFb	49	39
365434	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	TNFb	49	85
365435	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	TNFb	53.5	60
365436	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	TNFb	56	50
365437	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	TNFb	41	54
365438	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	TNFb	40.5	66
365439	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	TNFb	50.5	76
365440	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	TNFb	52	64
365441	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	TNFb	32.5	60
365442	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	TNFb	34	49
365443	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	TNFb	42	55
365444	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	TNFb	38	30
365445	20233																	0	TNFb	39	82
365446	20233						RA2159	51112.0								2	ug/mL	2	TNFb	59	50
365447	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	TNFb	53.5	36
365448	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	TNFb	60	41
365449	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	TNFb	37	58
365450	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	TNFb	47	63
365451	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	TNFb	50	55
365452	20233						N2586	51107.0								2	ug/mL	2	TNFb	53	58
365453	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	TNFb	46.5	42
365454	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	TNFb	44	40
365455	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	TNFb	45	37
365456	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	TNFb	38	31
365457	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	TNFb	40	45
365458	20233																	0	TNFb	42.5	56
365459	20233						RA2159	51112.0								2	ug/mL	3	TNFb	40.5	62
365460	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	TNFb	56.5	62
365461	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	TNFb	48	60
365462	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	TNFb	57	73
365463	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	TNFb	48	79
365464	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	TNFb	50	71
365465	20233						N2586	51107.0								2	ug/mL	3	TNFb	53.5	52
365466	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	TNFb	132	58
365467	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	TNFb	58	71
365468	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	TNFb	33.5	52
365469	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	TNFb	39	40
365470	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	TNFb	57	49
365471	20233						RA2159	51112.0										3	TNFb		0
365472	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	TNFb		0
365473	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	TNFb		0
365474	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	TNFb		0
365475	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	TNFb		0
365476	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	TNFb		0
365477	20233						RA2159	51112.0										3	TNFb		0
365478	20233						N2586	51107.0										3	TNFb		0
365479	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	TNFb		0
365480	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	TNFb		0
365481	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	TNFb		0
365482	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	TNFb		0
365483	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	TNFb		0
365484	20233						N2586	51107.0										3	TNFb		0
365485	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	TNFb	97.5	50
365486	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	TNFb	64	64
365487	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TNFb	47	57
365488	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TNFb	40	51
365489	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TNFb	38	61
365490	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	TNFb	37	56
365491	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	TNFb	47.5	66
365492	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	TNFb	38	59
365493	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TNFb	29	50
365494	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TNFb	38.5	50
365495	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TNFb	49.5	50
365496	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	TNFb	43	64
365497	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	TNFb	54.5	58
365498	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	TNFb	30.5	66
365499	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TNFb	36	63
365500	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TNFb	34.5	50
365501	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TNFb	43	50
365502	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	TNFb	39	64
365503	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	TNFb	38.5	52
365504	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	TNFb	53	67
365505	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TNFb	40	52
365506	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TNFb	42.5	48
365507	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TNFb	34	61
365508	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	TNFb	38	53
365509	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	TNFb	75.5	60
365510	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	TNFb	69	56
365511	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TNFb	104	50
365512	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TNFb	70	60
365513	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TNFb	84.5	56
365514	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	TNFb	88	49
365515	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	TNFb	77.5	50
365516	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	TNFb	71	61
365517	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TNFb	72	50
365518	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TNFb	72	47
365519	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TNFb	65.5	44
365520	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	TNFb	85	67
365521	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	TNFb	50	56
365522	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	TNFb	58	56
365523	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TNFb	66	63
365524	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TNFb	43	57
365525	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TNFb	39	52
365526	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	TNFb	37.5	52
365527	20233						RA2159	51112.0										3	TNFb	38	56
365528	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	TNFb	46	61
365529	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	TNFb	53	80
365530	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TNFb	31	55
365531	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TNFb	336	57
365532	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TNFb	39	63
365533	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	TNFb	39	53
365534	20233						N2586	51107.0										3	TNFb	56	58
365535	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	TNFb	44	50
365536	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	TNFb	38.5	52
365537	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TNFb	80	58
365538	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TNFb	67	52
365539	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TNFb	47	48
365540	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	TNFb	28.5	56
365541	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	TNFb	72	69
365542	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	TNFb	46	51
365543	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	TNFb	46.5	58
365544	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TNFb	61	61
365545	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TNFb	99	53
365546	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TNFb	56	53
365547	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	TNFb	50	50
365548	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	TNFb	30	58
365549	20233						RA2159	51112.0										3	TNFb	47	57
365550	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	TNFb	39	55
365551	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	TNFb	29	50
365552	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	TNFb	39.5	50
365553	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	TNFb	44	51
365554	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	TNFb	57	42
365555	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	TNFb	45.5	50
365556	20233						N2586	51107.0										3	TNFb	35	51
365557	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	TNFb	52	50
365558	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	TNFb	29	58
365559	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	TNFb	164	60
365560	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	TNFb	66	63
365561	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	TNFb	39	54
365562	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	TNFb	39	55
365563	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	TNFb	56	73
365564	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	TNFb	44	76
365565	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TNFb	44	59
365566	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TNFb	37.5	72
365567	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TNFb	33	49
365568	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	TNFb	37	49
365569	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	TNFb	45	66
365570	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	TNFb	37.5	52
365571	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TNFb	37	53
365572	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TNFb	121	46
365573	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TNFb	40	68
365574	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	TNFb	34	42
365575	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	TNFb	37	52
365576	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	TNFb	40.5	78
365577	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TNFb	37	43
365578	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TNFb	25	55
365579	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TNFb	35	47
365580	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	TNFb	36	46
365581	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	TNFb	44	61
365582	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	TNFb	89	70
365583	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	TNFb	29.5	46
365584	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TNFb	29	41
365585	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TNFb	33	60
365586	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TNFb	37.5	50
365587	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	TNFb	35.5	82
365588	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	TNFb	43.5	56
365589	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	TNFb	51	50
365590	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	TNFb	57	60
365591	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TNFb	57	50
365592	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TNFb	76	51
365593	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TNFb	65	56
365594	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	TNFb	60.5	46
365595	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	TNFb	39	68
365596	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	TNFb	86	63
365597	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	TNFb	54.5	50
365598	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TNFb	48	55
365599	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TNFb	61.5	56
365600	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TNFb	56.5	48
365601	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	TNFb	49	61
365602	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	TNFb	31.5	50
365603	20233																	0	TNFb	57	63
365604	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	TNFb	318.5	54
365605	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	TNFb	58	55
365606	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TNFb	48	66
365607	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TNFb	30.5	46
365608	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TNFb	46	56
365609	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	TNFb	51	40
365610	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	TNFb	41	35
365611	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	TNFb	33.5	52
365612	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	TNFb	80	87
365613	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TNFb	36	50
365614	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TNFb	35.5	66
365615	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TNFb	83	69
365616	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	TNFb	39	50
365617	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	TNFb	122	39
365618	20233																	0	TNFb	51	55
365619	20233						RA2159	51112.0										3	TNFb	44	53
365620	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	TNFb	46	52
365621	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	TNFb	84	41
365622	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	TNFb	52.5	42
365623	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	TNFb	36	62
365624	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	TNFb	46	43
365625	20233						RA2159	51112.0										3	TNFb	87.5	68
365626	20233						N2586	51107.0										3	TNFb	57	47
365627	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	TNFb	34	41
365628	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	TNFb	33	45
365629	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	TNFb	48.5	58
365630	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	TNFb	38	51
365631	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	TNFb	47	23
365632	20233						N2586	51107.0										3	TNFb	54	59
365633	20233																	0	TNFb	38	51
365634	20233						RA2159	51112.0								2	ug/mL	4	TNFb	112.5	50
365635	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	TNFb	103	58
365636	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	TNFb	76	61
365637	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	TNFb	58	59
365638	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	TNFb	51.5	68
365639	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	TNFb	43	62
365640	20233						N2586	51107.0								2	ug/mL	4	TNFb	54	59
365641	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	TNFb	54.5	52
365642	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	TNFb	37.5	48
365643	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	TNFb	71	41
365644	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	TNFb	39	65
365645	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	TNFb	36	49
365646	20233						RA2159	51112.0										4	TNFb		0
365647	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	TNFb		0
365648	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	TNFb		0
365649	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	TNFb		0
365650	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	TNFb		0
365651	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	TNFb		0
365652	20233						RA2159	51112.0										4	TNFb		0
365653	20233						N2586	51107.0										4	TNFb		0
365654	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	TNFb		0
365655	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	TNFb		0
365656	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	TNFb		0
365657	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	TNFb		0
365658	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	TNFb		0
365659	20233						N2586	51107.0										4	TNFb		0
365660	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	TNFb	53	37
365661	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	TNFb	37	36
365662	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	TNFb	55	61
365663	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	TNFb	68	61
365664	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	TNFb	72	55
365665	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	TNFb	69	73
365666	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	TNFb	56	52
365667	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	TNFb	38	60
365668	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	TNFb	51	48
365669	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	TNFb	49	50
365670	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	TNFb	33	66
365671	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	TNFb	44	57
365672	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	TNFb	46	38
365673	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	TNFb	39	49
365674	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	TNFb	59	71
365675	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	TNFb	55	58
365676	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	TNFb	160	77
365677	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	TNFb	41	41
365678	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	TNFb	33.5	60
365679	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	TNFb	35	40
365680	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	TNFb	35	49
365681	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	TNFb	40	60
365682	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	TNFb	55.5	40
365683	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	TNFb	84	49
365684	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	TNFb	70	90
365685	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	TNFb	89	53
365686	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	TNFb	73	85
365687	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	TNFb	87	47
365688	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	TNFb	76	61
365689	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	TNFb	68	73
365690	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	TNFb	68.5	62
365691	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	TNFb	59.5	56
365692	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	TNFb	79	60
365693	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	TNFb	62	69
365694	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	TNFb	81	65
365695	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	TNFb	63	57
365696	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	TNFb	43	51
365697	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	TNFb	35	49
365698	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	TNFb	63	65
365699	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	TNFb	36	57
365700	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	TNFb	42	63
365701	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	TNFb	35	50
365702	20233						RA2159	51112.0										4	TNFb	45.5	52
365703	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	TNFb	46	58
365704	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	TNFb	72	51
365705	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	TNFb	52.5	54
365706	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	TNFb	44.5	42
365707	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	TNFb	54.5	46
365708	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	TNFb	39.5	60
365709	20233						N2586	51107.0										4	TNFb	39.5	68
365710	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	TNFb	72	67
365711	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	TNFb	34.5	64
365712	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	TNFb	31	67
365713	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	TNFb	33	66
365714	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	TNFb	51	69
365715	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	TNFb	68.5	62
365716	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	TNFb	46	46
365717	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	TNFb	72	70
365718	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	TNFb	31	71
365719	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	TNFb	80	49
365720	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	TNFb	38	47
365721	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	TNFb	35	63
365722	20233						RA2159	51112.0										4	TNFb	77	76
365723	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	TNFb	48	46
365724	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	TNFb	35	45
365725	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	TNFb	32	68
365726	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	TNFb	41	31
365727	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	TNFb	47.5	14
365728	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	TNFb	48	14
365729	20233						N2586	51107.0										4	TNFb	46	8
365730	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	TNFb	70	10
365731	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	TNFb	44	49
365732	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	TNFb	66	49
365733	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	TNFb	47	49
365734	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	TNFb	51	40
365735	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	TNFb	63	65
365736	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	TNFb	36	71
365737	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	TNFb	44	50
365738	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	TNFb	41.5	60
365739	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	TNFb	75	47
365740	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	TNFb	46	55
365741	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	TNFb	44	49
365742	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	TNFb	41	31
365743	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	TNFb	32	46
365744	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	TNFb	37.5	50
365745	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	TNFb	66	51
365746	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	TNFb	41	55
365747	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	TNFb	31	47
365748	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	TNFb	33	51
365749	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	TNFb	44	45
365750	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	TNFb	101	65
365751	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	TNFb	59	63
365752	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	TNFb	30.5	56
365753	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	TNFb	37	64
365754	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	TNFb	31.5	46
365755	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	TNFb	29	44
365756	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	TNFb	38	55
365757	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	TNFb	26	54
365758	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	TNFb	61	60
365759	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	TNFb	74.5	38
365760	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	TNFb	40	52
365761	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	TNFb	36	50
365762	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	TNFb	30	46
365763	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	TNFb	49.5	46
365764	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	TNFb	73	74
365765	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	TNFb	50.5	50
365766	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	TNFb	151	69
365767	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	TNFb	56	60
365768	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	TNFb	66	33
365769	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	TNFb	96	39
365770	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	TNFb	39	71
365771	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	TNFb	60	39
365772	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	TNFb	52	64
365773	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	TNFb	64	49
365774	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	TNFb	97	65
365775	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	TNFb	50	53
365776	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	TNFb	74.5	62
365777	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	TNFb	43	41
365778	20233																	0	TNFb	62	52
365779	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	TNFb	55.5	48
365780	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	TNFb	52	48
365781	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	TNFb	39	41
365782	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	TNFb	36	60
365783	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	TNFb	37	55
365784	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	TNFb	43	67
365785	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	TNFb	33	35
365786	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	TNFb	39	59
365787	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	TNFb	41	69
365788	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	TNFb	45.5	50
365789	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	TNFb	48	43
365790	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	TNFb	43	40
365791	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	TNFb	52	31
365792	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	TNFb	42	62
365793	20233																	0	TNFb	32	49
365794	20233						RA2159	51112.0										4	TNFb	38	62
365795	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	TNFb	42.5	54
365796	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	TNFb	36.5	66
365797	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	TNFb	29.5	58
365798	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	TNFb	43.5	72
365799	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	TNFb	29.5	50
365800	20233						RA2159	51112.0										4	TNFb	43.5	64
365801	20233						N2586	51107.0										4	TNFb	35	60
365802	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	TNFb	45	48
365803	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	TNFb	52.5	40
365804	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	TNFb	27	51
365805	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	TNFb	33	42
365806	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	TNFb	41	45
365807	20233						N2586	51107.0										4	TNFb	68	47
365808	20233								TNF-a	201285.0						100	ng/mL	0	TNFb	47	49
365809	20233								IL-1 alpha	201286.0						100	ng/mL	0	TNFb	85	69
365810	20233								IL-6	201287.0						100	ug/mL	0	TNFb	67	37
365811	20233								IL-17A	201288.0						100	ng/mL	0	TNFb	55	46
365812	20233								EGF	201289.0						100	ng/mL	0	TNFb	163	69
365813	20233								IGF-I	201290.0						100	ug/mL	0	TNFb	47	44
365814	20233								Adiponectin	201291.0						5	ng/mL	0	TNFb	270	50
365815	20233								Leptin	201292.0						1	ng/mL	0	TNFb	67.5	54
365816	20233								Visfatin	201293.0						1	ng/mL	0	TNFb	54	49
365817	20233															2	ug/mL	0	TNFb	47	57
365818	20233								TNF-a	201285.0						100	ng/mL	0	TNFb	59	40
365819	20233								IL-1 alpha	201286.0						100	ng/mL	0	TNFb	68.5	46
365820	20233								IL-6	201287.0						100	ug/mL	0	TNFb	42	50
365821	20233								IL-17A	201288.0						100	ng/mL	0	TNFb	60	41
365822	20233								EGF	201289.0						100	ng/mL	0	TNFb	64	47
365823	20233								IGF-I	201290.0						100	ug/mL	0	TNFb	84	59
365824	20233								Adiponectin	201291.0						5	ng/mL	0	TNFb	263.5	52
365825	20233								Leptin	201292.0						1	ng/mL	0	TNFb	55	65
365826	20233								Visfatin	201293.0						1	ng/mL	0	TNFb	61	52
365827	20233															2	ug/mL	0	TNFb	53	43
365828	20233								TNF-a	201285.0						100	ng/mL	0	TNFb	49.5	50
365829	20233								IL-1 alpha	201286.0						100	ng/mL	0	TNFb	59.5	52
365830	20233								IL-6	201287.0						100	ug/mL	0	TNFb	47.5	50
365831	20233								IL-17A	201288.0						100	ng/mL	0	TNFb	47	72
365832	20233								EGF	201289.0						100	ng/mL	0	TNFb	42.5	50
365833	20233								IGF-I	201290.0						100	ug/mL	0	TNFb	51	45
365834	20233								Adiponectin	201291.0						5	ng/mL	0	TNFb	235.5	56
365835	20233								Leptin	201292.0						1	ng/mL	0	TNFb	32	43
365836	20233								Visfatin	201293.0						1	ng/mL	0	TNFb	52	68
365837	20233															2	ug/mL	0	TNFb	54	60
365838	20233								TNF-a	201285.0						100	ng/mL	0	TNFb	56	47
365839	20233								IL-1 alpha	201286.0						100	ng/mL	0	TNFb	66.5	52
365840	20233								IL-6	201287.0						100	ug/mL	0	TNFb	94	57
365841	20233								IL-17A	201288.0						100	ng/mL	0	TNFb	39.5	52
365842	20233								EGF	201289.0						100	ng/mL	0	TNFb	42	68
365843	20233								IGF-I	201290.0						100	ug/mL	0	TNFb	36	53
365844	20233								Adiponectin	201291.0						5	ng/mL	0	TNFb	284	48
365845	20233								Leptin	201292.0						1	ng/mL	0	TNFb	102	45
365846	20233								Visfatin	201293.0						1	ng/mL	0	TNFb	84.5	56
365847	20233															2	ug/mL	0	TNFb	35.5	34
365848	20233																	0	MIF	12	52
365849	20233						RA2159	51112.0										1	MIF	21.5	58
365850	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MIF	23	69
365851	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MIF	20	78
365852	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MIF	22	57
365853	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MIF	18.5	46
365854	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MIF	23	59
365855	20233						RA2159	51112.0										1	MIF	22	68
365856	20233						N2586	51107.0										1	MIF	49	75
365857	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MIF	50	61
365858	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MIF	39	55
365859	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MIF	46	49
365860	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MIF	48.5	36
365861	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MIF	45	45
365862	20233						N2586	51107.0										1	MIF	43	51
365863	20233																	0	MIF	14	49
365864	20233																	0	MIF	12	36
365865	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	MIF	55.5	62
365866	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	MIF	64	56
365867	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIF	89.5	76
365868	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIF	66	60
365869	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIF	61	59
365870	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	MIF	36.5	52
365871	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	MIF	21.5	62
365872	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	MIF	214	53
365873	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	MIF	175	34
365874	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIF	175	37
365875	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIF	220	59
365876	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	MIF	209	73
365877	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	MIF	202	29
365878	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	MIF	50	49
365879	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	MIF	38.5	60
365880	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	MIF	40	65
365881	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIF	53.5	56
365882	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIF	36	54
365883	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIF	33.5	60
365884	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	MIF	24	56
365885	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	MIF	21.5	32
365886	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	MIF	121	45
365887	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	MIF	125	59
365888	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIF	184	57
365889	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIF	150	71
365890	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	MIF	150.5	66
365891	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	MIF	88	41
365892	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	MIF	36	44
365893	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	MIF	20	58
365894	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	MIF	20	65
365895	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIF	20	48
365896	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIF	18	64
365897	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIF	20	68
365898	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	MIF	17	57
365899	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	MIF	22	57
365900	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	MIF	48	57
365901	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	MIF	46.5	52
365902	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIF	45.5	56
365903	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIF	47	44
365904	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	MIF	43	49
365905	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	MIF	46	50
365906	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	MIF	61	59
365907	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	MIF	18	71
365908	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	MIF	21	73
365909	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIF	21.5	56
365910	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIF	17	78
365911	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIF	21.5	48
365912	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	MIF	21	50
365913	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	MIF	68	41
365914	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	MIF	57	43
365915	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIF	59	38
365916	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIF	56	37
365917	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	MIF	46.5	48
365918	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	MIF	51.5	40
365919	20233						RA2159	51112.0										1	MIF	18.5	36
365920	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MIF	23	53
365921	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MIF	24	55
365922	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MIF	20	65
365923	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MIF	24.5	58
365924	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MIF	21	57
365925	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	MIF	17.5	40
365926	20233						N2586	51107.0										1	MIF	48	49
365927	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MIF	46	59
365928	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MIF	47	52
365929	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MIF	52	53
365930	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MIF	49	47
365931	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MIF	37	63
365932	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	MIF	41	35
365933	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	MIF	20	63
365934	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	MIF	20.5	66
365935	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIF	19	69
365936	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIF	18	62
365937	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIF	21.5	54
365938	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	MIF	19	69
365939	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	MIF	21	49
365940	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	MIF	61.5	60
365941	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	MIF	54	53
365942	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIF	34	61
365943	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIF	60	64
365944	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	MIF	68	51
365945	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	MIF	50	56
365946	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	MIF	48	45
365947	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	MIF	18	67
365948	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	MIF	20	59
365949	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIF	18	74
365950	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIF	19	41
365951	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIF	18	48
365952	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	MIF	21	63
365953	20233						RA2159	51112.0										1	MIF	21	69
365954	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	MIF	49	47
365955	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	MIF	58	61
365956	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIF	43	45
365957	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIF	51.5	46
365958	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	MIF	58	46
365959	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	MIF	54	35
365960	20233						N2586	51107.0										1	MIF	38	37
365961	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	MIF	68	50
365962	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	MIF	75	59
365963	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIF	90	71
365964	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIF	66	65
365965	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIF	89.5	80
365966	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	MIF	98.5	50
365967	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	MIF	88	77
365968	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	MIF	79	51
365969	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIF	81	39
365970	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIF	82.5	58
365971	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	MIF	100	53
365972	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	MIF	77	54
365973	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	MIF	20	69
365974	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	MIF	18	60
365975	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIF	21	59
365976	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIF	19	59
365977	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIF	16.5	46
365978	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	MIF	16	46
365979	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	MIF	40	37
365980	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	MIF	46.5	48
365981	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIF	38	59
365982	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIF	50	39
365983	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	MIF	40.5	32
365984	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	MIF	37	54
365985	20233						RA2159	51112.0										1	MIF		0
365986	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	MIF		0
365987	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	MIF		0
365988	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	MIF		0
365989	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	MIF		0
365990	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	MIF		0
365991	20233						RA2159	51112.0										1	MIF		0
365992	20233						N2586	51107.0										1	MIF		0
365993	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	MIF		0
365994	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	MIF		0
365995	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	MIF		0
365996	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	MIF		0
365997	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	MIF		0
365998	20233						N2586	51107.0										1	MIF		0
365999	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	MIF	14	50
366000	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	MIF	17	49
366001	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIF	17	55
366002	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIF	18	62
366003	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIF	17	49
366004	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	MIF	22	47
366005	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	MIF	46	39
366006	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	MIF	67	37
366007	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIF	39	49
366008	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIF	44	54
366009	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	MIF	41	33
366010	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	MIF	42.5	44
366011	20233																	0	MIF	9.5	62
366012	20233						RA2159	51112.0								2	ug/mL	1	MIF	24	51
366013	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	MIF	26	48
366014	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MIF	28	50
366015	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MIF	29.5	56
366016	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	MIF	20.5	56
366017	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	MIF	18	65
366018	20233						N2586	51107.0								2	ug/mL	1	MIF	70.5	52
366019	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	MIF	71	35
366020	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MIF	58	40
366021	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MIF	74	38
366022	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	MIF	70	36
366023	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	MIF	60	30
366024	20233																	0	MIF	13	64
366025	20233						RA2159	51112.0										2	MIF	20	76
366026	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MIF	19	48
366027	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MIF	19	54
366028	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MIF	20.5	64
366029	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MIF	21	73
366030	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MIF	20	55
366031	20233						RA2159	51112.0										2	MIF	21	67
366032	20233						N2586	51107.0										2	MIF	42	65
366033	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MIF	46	52
366034	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MIF	40	59
366035	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MIF	48	53
366036	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MIF	38	64
366037	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MIF	43	47
366038	20233						N2586	51107.0										2	MIF	50	53
366039	20233																	0	MIF	13	55
366040	20233																	0	MIF	13	50
366041	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	MIF	69.5	66
366042	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	MIF	59	50
366043	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	MIF	62	66
366044	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIF	63.5	58
366045	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIF	50	59
366046	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	MIF	40	69
366047	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	MIF	21	65
366048	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	MIF	183	55
366049	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	MIF	143	67
366050	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	MIF	165	53
366051	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIF	184	54
366052	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	MIF	108.5	58
366053	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	MIF	134	51
366054	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	MIF	46	51
366055	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	MIF	35	61
366056	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	MIF	79	55
366057	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	MIF	43	59
366058	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIF	50	71
366059	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIF	34	59
366060	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	MIF	39	58
366061	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	MIF	21	69
366062	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	MIF	145	69
366063	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	MIF	240	64
366064	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	MIF	137	51
366065	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIF	208	53
366066	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	MIF	90	58
366067	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	MIF	127	47
366068	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	MIF	36.5	50
366069	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	MIF	23	63
366070	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	MIF	16	56
366071	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	MIF	21	67
366072	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIF	23	52
366073	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIF	21.5	74
366074	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	MIF	18	40
366075	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	MIF	23	73
366076	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	MIF	47.5	54
366077	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	MIF	42	72
366078	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	MIF	44	50
366079	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIF	59	61
366080	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	MIF	39	55
366081	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	MIF	39.5	48
366082	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	MIF	45	65
366083	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	MIF	22	50
366084	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	MIF	22	60
366085	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	MIF	28	73
366086	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIF	26	51
366087	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIF	22	45
366088	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	MIF	21.5	36
366089	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	MIF	25	29
366090	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	MIF	59	49
366091	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	MIF	62	65
366092	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	MIF	46	13
366093	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIF	61	15
366094	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	MIF	38	51
366095	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	MIF	42.5	54
366096	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	MIF	40	70
366097	20233						RA2159	51112.0										2	MIF	20.5	50
366098	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MIF	22	57
366099	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MIF	20	54
366100	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MIF	23	43
366101	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MIF	19	54
366102	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MIF	19.5	50
366103	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	MIF	25	65
366104	20233						N2586	51107.0										2	MIF	52	53
366105	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MIF	48	51
366106	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MIF	43	46
366107	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MIF	65.5	56
366108	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MIF	40.5	40
366109	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MIF	41.5	54
366110	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	MIF	37	63
366111	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	MIF	16	66
366112	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	MIF	24	72
366113	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	MIF	18	51
366114	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	MIF	17	53
366115	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	MIF	18	36
366116	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	MIF	20	63
366117	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	MIF	47.5	56
366118	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	MIF	57.5	38
366119	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	MIF	44	57
366120	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	MIF	63.5	74
366121	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	MIF	38.5	60
366122	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	MIF	48	67
366123	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	MIF	18.5	50
366124	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	MIF	17	72
366125	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	MIF	17	63
366126	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIF	22	72
366127	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIF	20.5	54
366128	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	MIF	22	35
366129	20233						RA2159	51112.0										2	MIF	22	41
366130	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	MIF	48	64
366131	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	MIF	55	51
366132	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	MIF	40	66
366133	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIF	57	47
366134	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	MIF	41	66
366135	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	MIF	39	52
366136	20233						N2586	51107.0										2	MIF	41	53
366137	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	MIF	53.5	50
366138	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	MIF	52.5	64
366139	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	MIF	56	75
366140	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIF	63	52
366141	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIF	55	65
366142	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	MIF	61	53
366143	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	MIF	96	55
366144	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	MIF	90	61
366145	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	MIF	111	50
366146	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIF	108	43
366147	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	MIF	98	58
366148	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	MIF	98	77
366149	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	MIF	18	50
366150	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	MIF	19	65
366151	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	MIF	17	53
366152	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIF	17	65
366153	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIF	17	63
366154	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	MIF	21	57
366155	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	MIF	40	78
366156	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	MIF	40	60
366157	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	MIF	36.5	74
366158	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIF	48	36
366159	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	MIF	32.5	44
366160	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	MIF	36	61
366161	20233						RA2159	51112.0										2	MIF		0
366162	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	MIF		0
366163	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	MIF		0
366164	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	MIF		0
366165	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	MIF		0
366166	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	MIF		0
366167	20233						RA2159	51112.0										2	MIF		0
366168	20233						N2586	51107.0										2	MIF		0
366169	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	MIF		0
366170	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	MIF		0
366171	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	MIF		0
366172	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	MIF		0
366173	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	MIF		0
366174	20233						N2586	51107.0										2	MIF		0
366175	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	MIF	17	49
366176	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	MIF	20	87
366177	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	MIF	17	51
366178	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIF	21.5	62
366179	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIF	18	50
366180	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	MIF	18.5	62
366181	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	MIF	41	59
366182	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	MIF	47.5	52
366183	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	MIF	36.5	50
366184	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIF	50	45
366185	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	MIF	35	59
366186	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	MIF	40	43
366187	20233																	0	MIF	14	74
366188	20233						RA2159	51112.0								2	ug/mL	2	MIF	23	53
366189	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	MIF	29.5	48
366190	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	MIF	23	54
366191	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	MIF	27	65
366192	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	MIF	23.5	60
366193	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	MIF	19	53
366194	20233						N2586	51107.0								2	ug/mL	2	MIF	76	55
366195	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	MIF	91	41
366196	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	MIF	72.5	38
366197	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	MIF	86	47
366198	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	MIF	51.5	48
366199	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	MIF	53	48
366200	20233																	0	MIF	12	61
366201	20233						RA2159	51112.0								2	ug/mL	3	MIF	30	57
366202	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	MIF	33.5	62
366203	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MIF	28.5	58
366204	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MIF	30	76
366205	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	MIF	24	50
366206	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	MIF	27	53
366207	20233						N2586	51107.0								2	ug/mL	3	MIF	84	60
366208	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	MIF	185	63
366209	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MIF	83.5	58
366210	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MIF	111.5	62
366211	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	MIF	84	51
366212	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	MIF	74	51
366213	20233						RA2159	51112.0										3	MIF		0
366214	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MIF		0
366215	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MIF		0
366216	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MIF		0
366217	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MIF		0
366218	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MIF		0
366219	20233						RA2159	51112.0										3	MIF		0
366220	20233						N2586	51107.0										3	MIF		0
366221	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MIF		0
366222	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MIF		0
366223	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MIF		0
366224	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MIF		0
366225	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MIF		0
366226	20233						N2586	51107.0										3	MIF		0
366227	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	MIF	24	50
366228	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	MIF	20	57
366229	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIF	18.5	58
366230	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIF	20	56
366231	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIF	22	53
366232	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	MIF	21	67
366233	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	MIF	56.5	52
366234	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	MIF	52	70
366235	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIF	39.5	66
366236	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIF	55.5	66
366237	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	MIF	52.5	58
366238	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	MIF	47	65
366239	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	MIF	19	57
366240	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	MIF	21	58
366241	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIF	18.5	60
366242	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIF	16	60
366243	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIF	18	65
366244	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	MIF	25	59
366245	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	MIF	57	63
366246	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	MIF	61	64
366247	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIF	46.5	50
366248	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIF	53	79
366249	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	MIF	49	50
366250	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	MIF	50	70
366251	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	MIF	58	55
366252	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	MIF	57	67
366253	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIF	58	57
366254	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIF	54.5	50
366255	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIF	57	65
366256	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	MIF	62	65
366257	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	MIF	109.5	72
366258	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	MIF	97	70
366259	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIF	93	69
366260	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIF	89	50
366261	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	MIF	92	53
366262	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	MIF	95	73
366263	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	MIF	16.5	54
366264	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	MIF	20	63
366265	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIF	19	50
366266	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIF	21	53
366267	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIF	19.5	44
366268	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	MIF	23	62
366269	20233						RA2159	51112.0										3	MIF	23	65
366270	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	MIF	70	61
366271	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	MIF	66	76
366272	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIF	42	63
366273	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIF	66	70
366274	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	MIF	55	70
366275	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	MIF	43	59
366276	20233						N2586	51107.0										3	MIF	56	61
366277	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	MIF	21	66
366278	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	MIF	19	57
366279	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIF	19.5	50
366280	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIF	21	46
366281	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIF	23.5	78
366282	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	MIF	23	64
366283	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	MIF	20	63
366284	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	MIF	66	59
366285	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	MIF	75	71
366286	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIF	55	76
366287	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIF	81	61
366288	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	MIF	56	63
366289	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	MIF	46.5	64
366290	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	MIF	29	55
366291	20233						RA2159	51112.0										3	MIF	21	66
366292	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MIF	18	55
366293	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MIF	17	61
366294	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MIF	20	64
366295	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MIF	19	65
366296	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MIF	20.5	64
366297	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	MIF	17	69
366298	20233						N2586	51107.0										3	MIF	56	72
366299	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MIF	73.5	54
366300	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MIF	48	70
366301	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MIF	72	65
366302	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MIF	60	71
366303	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MIF	44	57
366304	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	MIF	42	52
366305	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	MIF	16.5	68
366306	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	MIF	17	64
366307	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIF	22	61
366308	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIF	20.5	54
366309	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIF	20	57
366310	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	MIF	18	59
366311	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	MIF	63	50
366312	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	MIF	63.5	58
366313	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIF	47	75
366314	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIF	92	76
366315	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	MIF	49	51
366316	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	MIF	45	53
366317	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	MIF	18.5	68
366318	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	MIF	21	64
366319	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIF	21	52
366320	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIF	22	50
366321	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIF	18	66
366322	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	MIF	20	54
366323	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	MIF	23	62
366324	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	MIF	58	57
366325	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	MIF	62	55
366326	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIF	43	66
366327	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIF	52	50
366328	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	MIF	51	55
366329	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	MIF	42	54
366330	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	MIF	46	51
366331	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	MIF	41	53
366332	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	MIF	43	61
366333	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIF	55	63
366334	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIF	51	39
366335	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIF	45	67
366336	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	MIF	25	58
366337	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	MIF	23	55
366338	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	MIF	150.5	50
366339	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	MIF	233.5	64
366340	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIF	171	59
366341	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIF	203	45
366342	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	MIF	82	52
366343	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	MIF	70	74
366344	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	MIF	35.5	64
366345	20233																	0	MIF	11	58
366346	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	MIF	90.5	50
366347	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	MIF	72	58
366348	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIF	104.5	50
366349	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIF	88	43
366350	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIF	63	63
366351	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	MIF	48	49
366352	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	MIF	18.5	26
366353	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	MIF	191	52
366354	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	MIF	195.5	50
366355	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIF	189	61
366356	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIF	197	71
366357	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	MIF	94.5	52
366358	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	MIF	137	58
366359	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	MIF	60	58
366360	20233																	0	MIF	11	47
366361	20233						RA2159	51112.0										3	MIF	16.5	48
366362	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	MIF	24.5	42
366363	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	MIF	23	39
366364	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	MIF	21.5	52
366365	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	MIF	20	65
366366	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	MIF	20.5	46
366367	20233						RA2159	51112.0										3	MIF	20	63
366368	20233						N2586	51107.0										3	MIF	57	49
366369	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	MIF	41	52
366370	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	MIF	37	40
366371	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	MIF	49	63
366372	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	MIF	44	62
366373	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	MIF	39.5	30
366374	20233						N2586	51107.0										3	MIF	39.5	40
366375	20233																	0	MIF	11	51
366376	20233						RA2159	51112.0								2	ug/mL	4	MIF	43	53
366377	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	MIF	34	58
366378	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	MIF	31	55
366379	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	MIF	36	54
366380	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	MIF	37	50
366381	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	MIF	25	58
366382	20233						N2586	51107.0								2	ug/mL	4	MIF	101.5	50
366383	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	MIF	122	56
366384	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	MIF	75	39
366385	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	MIF	108	50
366386	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	MIF	74	71
366387	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	MIF	39	47
366388	20233						RA2159	51112.0										4	MIF		0
366389	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MIF		0
366390	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MIF		0
366391	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MIF		0
366392	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MIF		0
366393	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MIF		0
366394	20233						RA2159	51112.0										4	MIF		0
366395	20233						N2586	51107.0										4	MIF		0
366396	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MIF		0
366397	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MIF		0
366398	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MIF		0
366399	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MIF		0
366400	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MIF		0
366401	20233						N2586	51107.0										4	MIF		0
366402	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	MIF	20	53
366403	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	MIF	25	41
366404	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	MIF	27	64
366405	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIF	25	69
366406	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIF	21	61
366407	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	MIF	23	73
366408	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	MIF	56	59
366409	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	MIF	49.5	46
366410	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	MIF	39.5	52
366411	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIF	52	57
366412	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	MIF	51.5	84
366413	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	MIF	42	46
366414	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	MIF	25	33
366415	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	MIF	22	43
366416	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	MIF	25	65
366417	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIF	23	53
366418	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIF	30	62
366419	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	MIF	21	63
366420	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	MIF	58.5	50
366421	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	MIF	53	47
366422	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	MIF	42	39
366423	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIF	54	59
366424	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	MIF	54	49
366425	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	MIF	44.5	64
366426	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	MIF	69	86
366427	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	MIF	63	63
366428	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	MIF	63	64
366429	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIF	56	67
366430	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIF	64	77
366431	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	MIF	52	59
366432	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	MIF	86.5	54
366433	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	MIF	93	59
366434	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	MIF	93	69
366435	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIF	85.5	50
366436	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	MIF	100.5	62
366437	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	MIF	61.5	60
366438	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	MIF	22.5	60
366439	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	MIF	27	60
366440	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	MIF	27	60
366441	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIF	24.5	54
366442	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIF	26.5	56
366443	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	MIF	20	62
366444	20233						RA2159	51112.0										4	MIF	25	57
366445	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	MIF	58	65
366446	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	MIF	65	68
366447	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	MIF	54.5	56
366448	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIF	55	57
366449	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	MIF	62	52
366450	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	MIF	35	79
366451	20233						N2586	51107.0										4	MIF	51	64
366452	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	MIF	26.5	50
366453	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	MIF	25	50
366454	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	MIF	23	65
366455	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	MIF	22	54
366456	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	MIF	21	59
366457	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	MIF	23	50
366458	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	MIF	85.5	52
366459	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	MIF	67	69
366460	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	MIF	49	81
366461	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	MIF	99.5	48
366462	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	MIF	58	53
366463	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	MIF	38	67
366464	20233						RA2159	51112.0										4	MIF	23	82
366465	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MIF	28	35
366466	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MIF	24.5	44
366467	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MIF	22	58
366468	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MIF	26	33
366469	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MIF	25	19
366470	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	MIF	21	11
366471	20233						N2586	51107.0										4	MIF		6
366472	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MIF	67	15
366473	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MIF	46.5	62
366474	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MIF	57	37
366475	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MIF	51	44
366476	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MIF	37	67
366477	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	MIF	57	52
366478	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	MIF	19	52
366479	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	MIF	26	60
366480	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	MIF	20	68
366481	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIF	23	51
366482	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIF	23	63
366483	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	MIF	20.5	44
366484	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	MIF	22	31
366485	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	MIF	65	58
366486	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	MIF	72	55
366487	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	MIF	71	53
366488	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIF	59	59
366489	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	MIF	116	73
366490	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	MIF	39	69
366491	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	MIF	82	46
366492	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	MIF	21	69
366493	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	MIF	21.5	58
366494	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	MIF	20	44
366495	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIF	23	73
366496	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIF	22	45
366497	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	MIF	21.5	48
366498	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	MIF	18.5	44
366499	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	MIF	48	48
366500	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	MIF	61	55
366501	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	MIF	50	39
366502	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIF	55	51
366503	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	MIF	49	47
366504	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	MIF	40	51
366505	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	MIF	61	61
366506	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	MIF	66	65
366507	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	MIF	76	67
366508	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	MIF	71	68
366509	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIF	56	55
366510	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIF	42	47
366511	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	MIF	46	52
366512	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	MIF	17.5	66
366513	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	MIF	158	56
366514	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	MIF	214	75
366515	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	MIF	198.5	52
366516	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIF	205	64
366517	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	MIF	103	45
366518	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	MIF	47.5	58
366519	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	MIF	41.5	50
366520	20233																	0	MIF	11	59
366521	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	MIF	78	57
366522	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	MIF	79	52
366523	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	MIF	76	51
366524	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIF	71	58
366525	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIF	61.5	48
366526	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	MIF	41.5	58
366527	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	MIF	20	45
366528	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	MIF	232	65
366529	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	MIF	210	65
366530	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	MIF	224	53
366531	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIF	289	39
366532	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	MIF	184	47
366533	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	MIF	89.5	54
366534	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	MIF	64.5	46
366535	20233																	0	MIF	9	43
366536	20233						RA2159	51112.0										4	MIF	21	61
366537	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	MIF	21	56
366538	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	MIF	17	63
366539	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	MIF	19.5	68
366540	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	MIF	23	61
366541	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	MIF	17	67
366542	20233						RA2159	51112.0										4	MIF	21	63
366543	20233						N2586	51107.0										4	MIF	54	69
366544	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	MIF	55	35
366545	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	MIF	47	56
366546	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	MIF	56	50
366547	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	MIF	48	47
366548	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	MIF	40	45
366549	20233						N2586	51107.0										4	MIF	53	53
366550	20233								TNF-a	201285.0						100	ng/mL	0	MIF	13	64
366551	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIF	13.5	54
366552	20233								IL-6	201287.0						100	ug/mL	0	MIF	11	34
366553	20233								IL-17A	201288.0						100	ng/mL	0	MIF	12	65
366554	20233								EGF	201289.0						100	ng/mL	0	MIF	14	45
366555	20233								IGF-I	201290.0						100	ug/mL	0	MIF	10	51
366556	20233								Adiponectin	201291.0						5	ng/mL	0	MIF	455	63
366557	20233								Leptin	201292.0						1	ng/mL	0	MIF	11	46
366558	20233								Visfatin	201293.0						1	ng/mL	0	MIF	10	55
366559	20233															2	ug/mL	0	MIF	11	58
366560	20233								TNF-a	201285.0						100	ng/mL	0	MIF	11	45
366561	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIF	16.5	50
366562	20233								IL-6	201287.0						100	ug/mL	0	MIF	10	54
366563	20233								IL-17A	201288.0						100	ng/mL	0	MIF	13	53
366564	20233								EGF	201289.0						100	ng/mL	0	MIF	14	63
366565	20233								IGF-I	201290.0						100	ug/mL	0	MIF	14	58
366566	20233								Adiponectin	201291.0						5	ng/mL	0	MIF	378	63
366567	20233								Leptin	201292.0						1	ng/mL	0	MIF	12	53
366568	20233								Visfatin	201293.0						1	ng/mL	0	MIF	12.5	62
366569	20233															2	ug/mL	0	MIF	9.5	48
366570	20233								TNF-a	201285.0						100	ng/mL	0	MIF	10	55
366571	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIF	11	53
366572	20233								IL-6	201287.0						100	ug/mL	0	MIF	17	59
366573	20233								IL-17A	201288.0						100	ng/mL	0	MIF	11	59
366574	20233								EGF	201289.0						100	ng/mL	0	MIF	12	46
366575	20233								IGF-I	201290.0						100	ug/mL	0	MIF	11	50
366576	20233								Adiponectin	201291.0						5	ng/mL	0	MIF	279	51
366577	20233								Leptin	201292.0						1	ng/mL	0	MIF	12.5	46
366578	20233								Visfatin	201293.0						1	ng/mL	0	MIF	13	62
366579	20233															2	ug/mL	0	MIF	11	74
366580	20233								TNF-a	201285.0						100	ng/mL	0	MIF	12	35
366581	20233								IL-1 alpha	201286.0						100	ng/mL	0	MIF	16	52
366582	20233								IL-6	201287.0						100	ug/mL	0	MIF	13	60
366583	20233								IL-17A	201288.0						100	ng/mL	0	MIF	8	50
366584	20233								EGF	201289.0						100	ng/mL	0	MIF	11	60
366585	20233								IGF-I	201290.0						100	ug/mL	0	MIF	11	41
366586	20233								Adiponectin	201291.0						5	ng/mL	0	MIF	430	70
366587	20233								Leptin	201292.0						1	ng/mL	0	MIF	11	48
366588	20233								Visfatin	201293.0						1	ng/mL	0	MIF	13	45
366589	20233															2	ug/mL	0	MIF	13	44
366590	20233																	0	IL18	14	69
366591	20233						RA2159	51112.0										1	IL18	17	69
366592	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL18	22	91
366593	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL18	20.5	72
366594	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL18	18	87
366595	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL18	18	69
366596	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL18	19.5	86
366597	20233						RA2159	51112.0										1	IL18	23	86
366598	20233						N2586	51107.0										1	IL18	46	92
366599	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL18	50	75
366600	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL18	44	107
366601	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL18	52.5	60
366602	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL18	50	59
366603	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL18	42	58
366604	20233						N2586	51107.0										1	IL18	42	42
366605	20233																	0	IL18	12	67
366606	20233																	0	IL18	12	54
366607	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL18	75	83
366608	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL18	66	81
366609	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL18	104.5	64
366610	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL18	71.5	64
366611	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL18	78	86
366612	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL18	36	61
366613	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL18	18.5	76
366614	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL18	248.5	56
366615	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL18	215.5	58
366616	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL18	194.5	60
366617	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL18	230.5	64
366618	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL18	241	71
366619	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL18	222	35
366620	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL18	54	81
366621	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL18	42	76
366622	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL18	41.5	88
366623	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL18	58	61
366624	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL18	45	66
366625	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL18	41.5	56
366626	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL18	19.5	70
366627	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL18	18	60
366628	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL18	136	66
366629	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL18	159	66
366630	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL18	214	59
366631	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL18	186	56
366632	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL18	175	81
366633	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL18	90	56
366634	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL18	39	63
366635	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL18	18	64
366636	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL18	19	70
366637	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL18	14	55
366638	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL18	16	73
366639	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL18	18	80
366640	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL18	17	80
366641	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL18	21	73
366642	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL18	64	53
366643	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL18	47	75
366644	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL18	45	95
366645	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL18	47	47
366646	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL18	41	63
366647	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL18	45.5	58
366648	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL18	63.5	72
366649	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL18	17	75
366650	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL18	17	76
366651	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL18	17	65
366652	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL18	19	84
366653	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL18	22	79
366654	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL18	20	65
366655	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL18	74	43
366656	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL18	66.5	46
366657	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL18	74.5	44
366658	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL18	54.5	54
366659	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL18	55.5	52
366660	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL18	54	69
366661	20233						RA2159	51112.0										1	IL18	17	62
366662	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL18	28	92
366663	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL18	18	71
366664	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL18	19	79
366665	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL18	17	85
366666	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL18	19	84
366667	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL18	19	68
366668	20233						N2586	51107.0										1	IL18	54.5	68
366669	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL18	53	65
366670	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL18	50.5	66
366671	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL18	48	67
366672	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL18	63	66
366673	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL18	39	60
366674	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL18	39	54
366675	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL18	17	77
366676	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL18	18	85
366677	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL18	18	68
366678	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL18	21	73
366679	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL18	22	67
366680	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL18	19	97
366681	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL18	19.5	76
366682	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL18	62	85
366683	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL18	60	71
366684	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL18	40	70
366685	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL18	64	87
366686	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL18	70	77
366687	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL18	48	73
366688	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL18	46	67
366689	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL18	21	64
366690	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL18	20	73
366691	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL18	16	83
366692	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL18	15	65
366693	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL18	19	80
366694	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL18	21	81
366695	20233						RA2159	51112.0										1	IL18	16	75
366696	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL18	57	67
366697	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL18	62	83
366698	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL18	39	53
366699	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL18	64	53
366700	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL18	57.5	38
366701	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL18	62.5	52
366702	20233						N2586	51107.0										1	IL18	43.5	50
366703	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL18	63	67
366704	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL18	67.5	68
366705	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL18	79.5	66
366706	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL18	67.5	72
366707	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL18	91.5	56
366708	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL18	90	74
366709	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL18	102	87
366710	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL18	89.5	84
366711	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL18	93	49
366712	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL18	92	58
366713	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL18	102	53
366714	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL18	75	66
366715	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL18	16.5	78
366716	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL18	15	65
366717	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL18	15	62
366718	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL18	16	75
366719	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL18	15	33
366720	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL18	16	50
366721	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL18	47.5	38
366722	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL18	42.5	46
366723	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL18	36	68
366724	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL18	46.5	38
366725	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL18	38.5	42
366726	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL18	38.5	64
366727	20233						RA2159	51112.0										1	IL18		0
366728	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL18		0
366729	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL18		0
366730	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL18		0
366731	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL18		0
366732	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL18		0
366733	20233						RA2159	51112.0										1	IL18		0
366734	20233						N2586	51107.0										1	IL18		0
366735	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL18		0
366736	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL18		0
366737	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL18		0
366738	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL18		0
366739	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL18		0
366740	20233						N2586	51107.0										1	IL18		0
366741	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL18	22	67
366742	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL18	16.5	66
366743	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL18	14	86
366744	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL18	16	69
366745	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL18	13	53
366746	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL18	19	59
366747	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL18	40	52
366748	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL18	59.5	48
366749	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL18	47	61
366750	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL18	54	68
366751	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL18	59.5	36
366752	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL18	36	36
366753	20233																	0	IL18	10	62
366754	20233						RA2159	51112.0								2	ug/mL	1	IL18	29	70
366755	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL18	30.5	70
366756	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL18	20	61
366757	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL18	24	70
366758	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL18	20	73
366759	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL18	12	72
366760	20233						N2586	51107.0								2	ug/mL	1	IL18	73.5	64
366761	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL18	77	45
366762	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL18	68	53
366763	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL18	84.5	40
366764	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL18	79	55
366765	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL18	73	37
366766	20233																	0	IL18	13	67
366767	20233						RA2159	51112.0										2	IL18	20	80
366768	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL18	20	83
366769	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL18	18.5	84
366770	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL18	18	88
366771	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL18	21	83
366772	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL18	21	81
366773	20233						RA2159	51112.0										2	IL18	19	57
366774	20233						N2586	51107.0										2	IL18	48.5	74
366775	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL18	50.5	66
366776	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL18	50	72
366777	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL18	58.5	64
366778	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL18	46	76
366779	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL18	42.5	48
366780	20233						N2586	51107.0										2	IL18	49	70
366781	20233																	0	IL18	14	85
366782	20233																	0	IL18	11	82
366783	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL18	79.5	80
366784	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL18	67	65
366785	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL18	69.5	76
366786	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL18	64	85
366787	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL18	50	69
366788	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL18	45	59
366789	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL18	21	81
366790	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL18	204	63
366791	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL18	169	72
366792	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL18	155	58
366793	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL18	239	43
366794	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL18	131	72
366795	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL18	157	51
366796	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL18	50	73
366797	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL18	43	81
366798	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL18	75	83
366799	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL18	43	59
366800	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL18	60	73
366801	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL18	33	68
366802	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL18	49.5	72
366803	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL18	18	65
366804	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL18	157	91
366805	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL18	283	70
366806	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL18	153.5	74
366807	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL18	224	55
366808	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL18	90	57
366809	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL18	145	69
366810	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL18	40.5	94
366811	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL18	26	83
366812	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL18	14	76
366813	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL18	22.5	74
366814	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL18	21	75
366815	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL18	15	75
366816	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL18	15	53
366817	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL18	22	85
366818	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL18	55	72
366819	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL18	56	70
366820	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL18	50	82
366821	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL18	55	53
366822	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL18	34.5	76
366823	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL18	42	64
366824	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL18	49	67
366825	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL18	18	73
366826	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL18	26.5	68
366827	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL18	23	82
366828	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL18	23	65
366829	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL18	19	72
366830	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL18	18	50
366831	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL18	23	44
366832	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL18	71	69
366833	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL18	75	68
366834	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL18	46	17
366835	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL18	74	29
366836	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL18	41	52
366837	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL18	47	68
366838	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL18	43	85
366839	20233						RA2159	51112.0										2	IL18	20	66
366840	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL18	23	60
366841	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL18	18	68
366842	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL18	22	65
366843	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL18	16	92
366844	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL18	18	77
366845	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL18	21	94
366846	20233						N2586	51107.0										2	IL18	62	78
366847	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL18	56	67
366848	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL18	46	84
366849	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL18	75	73
366850	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL18	34.5	66
366851	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL18	46	52
366852	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL18	40	67
366853	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL18	17	91
366854	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL18	20	79
366855	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL18	16	61
366856	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL18	19	64
366857	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL18	16	57
366858	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL18	19.5	62
366859	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL18	60	67
366860	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL18	74	59
366861	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL18	40	70
366862	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL18	73	67
366863	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL18	42	95
366864	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL18	50.5	72
366865	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL18	13	76
366866	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL18	21	95
366867	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL18	16.5	66
366868	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL18	20	85
366869	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL18	16	63
366870	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL18	16	50
366871	20233						RA2159	51112.0										2	IL18	17	71
366872	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL18	54	51
366873	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL18	60	77
366874	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL18	43.5	80
366875	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL18	66	61
366876	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL18	34	85
366877	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL18	40	76
366878	20233						N2586	51107.0										2	IL18	45.5	74
366879	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL18	60	65
366880	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL18	64	83
366881	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL18	54	76
366882	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL18	62.5	54
366883	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL18	58.5	78
366884	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL18	55.5	80
366885	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL18	94	79
366886	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL18	91.5	72
366887	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL18	100	54
366888	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL18	111.5	66
366889	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL18	85	66
366890	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL18	84	85
366891	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL18	16	71
366892	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL18	17	73
366893	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL18	20	82
366894	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL18	18.5	72
366895	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL18	13.5	58
366896	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL18	16	72
366897	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL18	39.5	74
366898	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL18	37	70
366899	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL18	34	86
366900	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL18	53	73
366901	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL18	33	80
366902	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL18	38	78
366903	20233						RA2159	51112.0										2	IL18		0
366904	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL18		0
366905	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL18		0
366906	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL18		0
366907	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL18		0
366908	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL18		0
366909	20233						RA2159	51112.0										2	IL18		0
366910	20233						N2586	51107.0										2	IL18		0
366911	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL18		0
366912	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL18		0
366913	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL18		0
366914	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL18		0
366915	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL18		0
366916	20233						N2586	51107.0										2	IL18		0
366917	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL18	16.5	60
366918	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL18	19	97
366919	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL18	15	67
366920	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL18	18	66
366921	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL18	12	69
366922	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL18	15	91
366923	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL18	47	79
366924	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL18	53	69
366925	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL18	40	77
366926	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL18	58	67
366927	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL18	35	81
366928	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL18	42	49
366929	20233																	0	IL18	12	87
366930	20233						RA2159	51112.0								2	ug/mL	2	IL18	27.5	72
366931	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL18	34.5	60
366932	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL18	19.5	56
366933	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL18	26	57
366934	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL18	19	61
366935	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL18	20	57
366936	20233						N2586	51107.0								2	ug/mL	2	IL18	75	68
366937	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL18	91	42
366938	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL18	81.5	60
366939	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL18	95	46
366940	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL18	44	57
366941	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL18	69	68
366942	20233																	0	IL18	11	63
366943	20233						RA2159	51112.0								2	ug/mL	3	IL18	29	82
366944	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL18	36.5	72
366945	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL18	23	79
366946	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL18	32	78
366947	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL18	27	92
366948	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL18	23	64
366949	20233						N2586	51107.0								2	ug/mL	3	IL18	99	63
366950	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL18	215	73
366951	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL18	89	76
366952	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL18	140	75
366953	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL18	54	48
366954	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL18	84	65
366955	20233						RA2159	51112.0										3	IL18		0
366956	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL18		0
366957	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL18		0
366958	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL18		0
366959	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL18		0
366960	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL18		0
366961	20233						RA2159	51112.0										3	IL18		0
366962	20233						N2586	51107.0										3	IL18		0
366963	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL18		0
366964	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL18		0
366965	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL18		0
366966	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL18		0
366967	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL18		0
366968	20233						N2586	51107.0										3	IL18		0
366969	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL18	25.5	56
366970	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL18	17	85
366971	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL18	20	73
366972	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL18	19	51
366973	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL18	18.5	72
366974	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL18	19.5	70
366975	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL18	58.5	80
366976	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL18	64.5	72
366977	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL18	46	73
366978	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL18	63	68
366979	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL18	56	79
366980	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL18	45	78
366981	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL18	18	87
366982	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL18	19.5	80
366983	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL18	17	81
366984	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL18	19	66
366985	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL18	16.5	80
366986	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL18	21	61
366987	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL18	58	71
366988	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL18	62	94
366989	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL18	51	71
366990	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL18	62.5	82
366991	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL18	43	97
366992	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL18	52	70
366993	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL18	66	65
366994	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL18	57	83
366995	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL18	64	81
366996	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL18	67.5	88
366997	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL18	60.5	58
366998	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL18	58	86
366999	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL18	107	86
367000	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL18	111.5	74
367001	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL18	95.5	62
367002	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL18	106	61
367003	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL18	93	55
367004	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL18	101	83
367005	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL18	15	90
367006	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL18	19	79
367007	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL18	16	64
367008	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL18	18	81
367009	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL18	21	66
367010	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL18	19	74
367011	20233						RA2159	51112.0										3	IL18	19	85
367012	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL18	74	85
367013	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL18	79.5	64
367014	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL18	51	75
367015	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL18	82.5	72
367016	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL18	41	69
367017	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL18	42.5	50
367018	20233						N2586	51107.0										3	IL18	71.5	80
367019	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL18	19	65
367020	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL18	23	72
367021	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL18	18	67
367022	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL18	21.5	68
367023	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL18	23	78
367024	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL18	19	85
367025	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL18	22	69
367026	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL18	81	79
367027	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL18	87	89
367028	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL18	63	91
367029	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL18	109.5	72
367030	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL18	43.5	74
367031	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL18	48	84
367032	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL18	35	74
367033	20233						RA2159	51112.0										3	IL18	19	77
367034	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL18	15	61
367035	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL18	15.5	78
367036	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL18	18	61
367037	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL18	16	79
367038	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL18	19	55
367039	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL18	17.5	88
367040	20233						N2586	51107.0										3	IL18	68	74
367041	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL18	76.5	76
367042	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL18	49	74
367043	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL18	98.5	76
367044	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL18	55	72
367045	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL18	49	53
367046	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL18	52	64
367047	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL18	19	75
367048	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL18	20.5	78
367049	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL18	17	77
367050	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL18	21.5	68
367051	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL18	18	87
367052	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL18	20	83
367053	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL18	70	72
367054	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL18	72	75
367055	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL18	50	58
367056	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL18	123	69
367057	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL18	48.5	70
367058	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL18	46	68
367059	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL18	19	80
367060	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL18	18	71
367061	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL18	14	95
367062	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL18	20	72
367063	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL18	16	63
367064	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL18	17	54
367065	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL18	20	94
367066	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL18	75	68
367067	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL18	56	83
367068	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL18	41	62
367069	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL18	60	69
367070	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL18	41	78
367071	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL18	37	72
367072	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL18	46.5	74
367073	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL18	45.5	84
367074	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL18	54	75
367075	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL18	58	100
367076	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL18	60	65
367077	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL18	48	87
367078	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL18	24	79
367079	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL18	18	82
367080	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL18	168	74
367081	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL18	266	76
367082	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL18	226.5	86
367083	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL18	252	73
367084	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL18	57	70
367085	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL18	79	89
367086	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL18	43	83
367087	20233																	0	IL18	12.5	80
367088	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL18	139	65
367089	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL18	86.5	62
367090	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL18	105	97
367091	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL18	95	52
367092	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL18	86	63
367093	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL18	40	68
367094	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL18	18	48
367095	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL18	217	71
367096	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL18	206	101
367097	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL18	206	84
367098	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL18	238	79
367099	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL18	75	73
367100	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL18	170	74
367101	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL18	64.5	88
367102	20233																	0	IL18	10	59
367103	20233						RA2159	51112.0										3	IL18	20	84
367104	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL18	19	59
367105	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL18	22	79
367106	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL18	19	55
367107	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL18	16	69
367108	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL18	16	54
367109	20233						RA2159	51112.0										3	IL18	19	76
367110	20233						N2586	51107.0										3	IL18	70	55
367111	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL18	60	61
367112	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL18	40	69
367113	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL18	62	76
367114	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL18	53	72
367115	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL18	50	57
367116	20233						N2586	51107.0										3	IL18	57	65
367117	20233																	0	IL18	14	73
367118	20233						RA2159	51112.0								2	ug/mL	4	IL18	64	66
367119	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL18	41	67
367120	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL18	33	73
367121	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL18	34	78
367122	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL18	29	101
367123	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL18	25.5	60
367124	20233						N2586	51107.0								2	ug/mL	4	IL18	115.5	76
367125	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL18	117.5	70
367126	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL18	94	75
367127	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL18	131.5	64
367128	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL18	82	81
367129	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL18	42	52
367130	20233						RA2159	51112.0										4	IL18		0
367131	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL18		0
367132	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL18		0
367133	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL18		0
367134	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL18		0
367135	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL18		0
367136	20233						RA2159	51112.0										4	IL18		0
367137	20233						N2586	51107.0										4	IL18		0
367138	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL18		0
367139	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL18		0
367140	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL18		0
367141	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL18		0
367142	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL18		0
367143	20233						N2586	51107.0										4	IL18		0
367144	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL18	30	61
367145	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL18	26.5	54
367146	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL18	21	64
367147	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL18	23	95
367148	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL18	21	85
367149	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL18	23	80
367150	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL18	70	62
367151	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL18	53	71
367152	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL18	45.5	58
367153	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL18	55	82
367154	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL18	52.5	66
367155	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL18	41	69
367156	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL18	21.5	62
367157	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL18	18	73
367158	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL18	20	88
367159	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL18	24.5	56
367160	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL18	35	97
367161	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL18	18	61
367162	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL18	60	73
367163	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL18	50	60
367164	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL18	53	51
367165	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL18	56.5	64
367166	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL18	49.5	66
367167	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL18	48.5	58
367168	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL18	75	95
367169	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL18	63	79
367170	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL18	67	80
367171	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL18	61.5	82
367172	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL18	66.5	70
367173	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL18	60	94
367174	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL18	103	59
367175	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL18	105	69
367176	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL18	97	69
367177	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL18	98	82
367178	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL18	108	80
367179	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL18	72.5	74
367180	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL18	23.5	68
367181	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL18	24	96
367182	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL18	28	88
367183	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL18	25.5	76
367184	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL18	24.5	62
367185	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL18	19	75
367186	20233						RA2159	51112.0										4	IL18	20	79
367187	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL18	57.5	62
367188	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL18	79.5	100
367189	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL18	55.5	72
367190	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL18	68.5	62
367191	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL18	74	93
367192	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL18	42.5	88
367193	20233						N2586	51107.0										4	IL18	55	72
367194	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL18	29	83
367195	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL18	27	55
367196	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL18	21.5	84
367197	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL18	20	78
367198	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL18	25	70
367199	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL18	24	85
367200	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL18	97.5	56
367201	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL18	87	93
367202	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL18	55	88
367203	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL18	107.5	66
367204	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL18	66	69
367205	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL18	38	77
367206	20233						RA2159	51112.0										4	IL18	23	102
367207	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL18	25	67
367208	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL18	23	60
367209	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL18	24	83
367210	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL18	21	51
367211	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL18	15.5	24
367212	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL18	13.5	10
367213	20233						N2586	51107.0										4	IL18	61	9
367214	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL18	74	15
367215	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL18	44	76
367216	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL18	58.5	60
367217	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL18	56.5	44
367218	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL18	42.5	66
367219	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL18	54	55
367220	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL18	19	63
367221	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL18	30	72
367222	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL18	21	87
367223	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL18	24	85
367224	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL18	21	73
367225	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL18	19	78
367226	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL18	23	33
367227	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL18	73	61
367228	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL18	74.5	60
367229	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL18	78	61
367230	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL18	72	55
367231	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL18	57.5	68
367232	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL18	42	73
367233	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL18	31	65
367234	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL18	31	85
367235	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL18	25	77
367236	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL18	21	67
367237	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL18	23	79
367238	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL18	22	74
367239	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL18	19	62
367240	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL18	21	70
367241	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL18	62.5	50
367242	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL18	61.5	96
367243	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL18	48	41
367244	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL18	61	59
367245	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL18	54	52
367246	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL18	48	56
367247	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL18	81	77
367248	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL18	63	81
367249	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL18	91	74
367250	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL18	96	63
367251	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL18	60.5	80
367252	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL18	44	59
367253	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL18	71	54
367254	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL18	18.5	84
367255	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL18	182	63
367256	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL18	209	81
367257	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL18	219	67
367258	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL18	215.5	66
367259	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL18	120	57
367260	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL18	47	78
367261	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL18	46	69
367262	20233																	0	IL18	14.5	82
367263	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL18	88	66
367264	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL18	95.5	60
367265	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL18	94.5	62
367266	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL18	85	85
367267	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL18	70	65
367268	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL18	48	83
367269	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL18	18	76
367270	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL18	302	68
367271	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL18	261.5	74
367272	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL18	255.5	72
367273	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL18	361.5	56
367274	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL18	233.5	68
367275	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL18	41	55
367276	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL18	63	74
367277	20233																	0	IL18	8	67
367278	20233						RA2159	51112.0										4	IL18	18	67
367279	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL18	19	67
367280	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL18	20	74
367281	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL18	24	61
367282	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL18	22	99
367283	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL18	17.5	62
367284	20233						RA2159	51112.0										4	IL18	18.5	88
367285	20233						N2586	51107.0										4	IL18	61.5	50
367286	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL18	59	44
367287	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL18	51	62
367288	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL18	62	71
367289	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL18	49	54
367290	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL18	42	74
367291	20233						N2586	51107.0										4	IL18	57	53
367292	20233								TNF-a	201285.0						100	ng/mL	0	IL18	14	79
367293	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL18	12	67
367294	20233								IL-6	201287.0						100	ug/mL	0	IL18	15	65
367295	20233								IL-17A	201288.0						100	ng/mL	0	IL18	14	76
367296	20233								EGF	201289.0						100	ng/mL	0	IL18	15	86
367297	20233								IGF-I	201290.0						100	ug/mL	0	IL18	12	58
367298	20233								Adiponectin	201291.0						5	ng/mL	0	IL18	323	93
367299	20233								Leptin	201292.0						1	ng/mL	0	IL18	20	73
367300	20233								Visfatin	201293.0						1	ng/mL	0	IL18	14	77
367301	20233															2	ug/mL	0	IL18	13	73
367302	20233								TNF-a	201285.0						100	ng/mL	0	IL18	10	49
367303	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL18	13	71
367304	20233								IL-6	201287.0						100	ug/mL	0	IL18	12.5	74
367305	20233								IL-17A	201288.0						100	ng/mL	0	IL18	15	63
367306	20233								EGF	201289.0						100	ng/mL	0	IL18	13	63
367307	20233								IGF-I	201290.0						100	ug/mL	0	IL18	15	67
367308	20233								Adiponectin	201291.0						5	ng/mL	0	IL18	309	62
367309	20233								Leptin	201292.0						1	ng/mL	0	IL18	22	69
367310	20233								Visfatin	201293.0						1	ng/mL	0	IL18	14	50
367311	20233															2	ug/mL	0	IL18	12	58
367312	20233								TNF-a	201285.0						100	ng/mL	0	IL18	13	91
367313	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL18	13	70
367314	20233								IL-6	201287.0						100	ug/mL	0	IL18	13	64
367315	20233								IL-17A	201288.0						100	ng/mL	0	IL18	11.5	64
367316	20233								EGF	201289.0						100	ng/mL	0	IL18	10	64
367317	20233								IGF-I	201290.0						100	ug/mL	0	IL18	12	64
367318	20233								Adiponectin	201291.0						5	ng/mL	0	IL18	268	63
367319	20233								Leptin	201292.0						1	ng/mL	0	IL18	17	70
367320	20233								Visfatin	201293.0						1	ng/mL	0	IL18	14	65
367321	20233															2	ug/mL	0	IL18	12	92
367322	20233								TNF-a	201285.0						100	ng/mL	0	IL18	12	41
367323	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL18	12	77
367324	20233								IL-6	201287.0						100	ug/mL	0	IL18	19	72
367325	20233								IL-17A	201288.0						100	ng/mL	0	IL18	13	51
367326	20233								EGF	201289.0						100	ng/mL	0	IL18	12	84
367327	20233								IGF-I	201290.0						100	ug/mL	0	IL18	13	65
367328	20233								Adiponectin	201291.0						5	ng/mL	0	IL18	357	50
367329	20233								Leptin	201292.0						1	ng/mL	0	IL18	25	54
367330	20233								Visfatin	201293.0						1	ng/mL	0	IL18	12	57
367331	20233															2	ug/mL	0	IL18	10.5	52
367332	20233																	0	b-NGF	10	50
367333	20233						RA2159	51112.0										1	b-NGF	41	59
367334	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	b-NGF	53.5	68
367335	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	b-NGF	38	66
367336	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	b-NGF	49	57
367337	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	b-NGF	49.5	54
367338	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	b-NGF	40	53
367339	20233						RA2159	51112.0										1	b-NGF	49	82
367340	20233						N2586	51107.0										1	b-NGF	92	71
367341	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	b-NGF	113	71
367342	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	b-NGF	90	69
367343	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	b-NGF	114	55
367344	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	b-NGF	94.5	38
367345	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	b-NGF	72	41
367346	20233						N2586	51107.0										1	b-NGF	74	37
367347	20233																	0	b-NGF	8.5	58
367348	20233																	0	b-NGF	11	40
367349	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	b-NGF	168.5	58
367350	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	b-NGF	188	69
367351	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	b-NGF	126	75
367352	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	b-NGF	159	62
367353	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	b-NGF	201.5	56
367354	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	b-NGF	62	61
367355	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	b-NGF	46	44
367356	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	b-NGF	358	33
367357	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	b-NGF	229	40
367358	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	b-NGF	265	35
367359	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	b-NGF	320	50
367360	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	b-NGF	389	61
367361	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	b-NGF	239	47
367362	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	b-NGF	88	61
367363	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	b-NGF	155	57
367364	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	b-NGF	140	93
367365	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	b-NGF	103	60
367366	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	b-NGF	150	55
367367	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	b-NGF	110.5	62
367368	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	b-NGF	54	61
367369	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	b-NGF	49	48
367370	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	b-NGF	292	50
367371	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	b-NGF	302	53
367372	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	b-NGF	308	57
367373	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	b-NGF	279	59
367374	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	b-NGF	271	71
367375	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	b-NGF	125	38
367376	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	b-NGF	76	54
367377	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	b-NGF	45	71
367378	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	b-NGF	39	66
367379	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	b-NGF	37.5	46
367380	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	b-NGF	45	68
367381	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	b-NGF	43	63
367382	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	b-NGF	39	69
367383	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	b-NGF	55.5	74
367384	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	b-NGF	98	61
367385	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	b-NGF	107.5	48
367386	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	b-NGF	69	53
367387	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	b-NGF	93	41
367388	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	b-NGF	79	47
367389	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	b-NGF	71.5	56
367390	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	b-NGF	96	42
367391	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	b-NGF	48	69
367392	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	b-NGF	54	53
367393	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	b-NGF	40	57
367394	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	b-NGF	45	82
367395	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	b-NGF	61.5	62
367396	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	b-NGF	48	53
367397	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	b-NGF	112	42
367398	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	b-NGF	112	41
367399	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	b-NGF	101	31
367400	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	b-NGF	74.5	40
367401	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	b-NGF	84	40
367402	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	b-NGF	65	50
367403	20233						RA2159	51112.0										1	b-NGF	51	36
367404	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	b-NGF	49.5	60
367405	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	b-NGF	33.5	68
367406	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	b-NGF	43	87
367407	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	b-NGF	40	79
367408	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	b-NGF	38	63
367409	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	b-NGF	34.5	48
367410	20233						N2586	51107.0										1	b-NGF	81.5	44
367411	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	b-NGF	84	37
367412	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	b-NGF	57	46
367413	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	b-NGF	59	64
367414	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	b-NGF	72.5	56
367415	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	b-NGF	52	72
367416	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	b-NGF	57.5	40
367417	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	b-NGF	53	60
367418	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	b-NGF	51	60
367419	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	b-NGF	33	65
367420	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	b-NGF	54	57
367421	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	b-NGF	55	65
367422	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	b-NGF	39	68
367423	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	b-NGF	34	47
367424	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	b-NGF	94.5	72
367425	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	b-NGF	88	65
367426	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	b-NGF	66.5	54
367427	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	b-NGF	88	65
367428	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	b-NGF	90	65
367429	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	b-NGF	62.5	60
367430	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	b-NGF	49	53
367431	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	b-NGF	53	61
367432	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	b-NGF	37	75
367433	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	b-NGF	29	53
367434	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	b-NGF	37	43
367435	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	b-NGF	41	59
367436	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	b-NGF	38	53
367437	20233						RA2159	51112.0										1	b-NGF	35	56
367438	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	b-NGF	103	47
367439	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	b-NGF	95	76
367440	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	b-NGF	64.5	30
367441	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	b-NGF	82.5	56
367442	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	b-NGF	87.5	40
367443	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	b-NGF	77.5	38
367444	20233						N2586	51107.0										1	b-NGF	71	35
367445	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	b-NGF	94	61
367446	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	b-NGF	97	63
367447	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	b-NGF	101.5	72
367448	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	b-NGF	99.5	64
367449	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	b-NGF	131	63
367450	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	b-NGF	117	78
367451	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	b-NGF	132.5	52
367452	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	b-NGF	113	54
367453	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	b-NGF	106	51
367454	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	b-NGF	114	41
367455	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	b-NGF	122	47
367456	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	b-NGF	96	59
367457	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	b-NGF	41	52
367458	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	b-NGF	37	55
367459	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	b-NGF	29	50
367460	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	b-NGF	44.5	62
367461	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	b-NGF	39	31
367462	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	b-NGF	35.5	36
367463	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	b-NGF	75	28
367464	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	b-NGF	85.5	40
367465	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	b-NGF	53	41
367466	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	b-NGF	72	25
367467	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	b-NGF	63	44
367468	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	b-NGF	61	53
367469	20233						RA2159	51112.0										1	b-NGF		0
367470	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	b-NGF		0
367471	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	b-NGF		0
367472	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	b-NGF		0
367473	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	b-NGF		0
367474	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	b-NGF		0
367475	20233						RA2159	51112.0										1	b-NGF		0
367476	20233						N2586	51107.0										1	b-NGF		0
367477	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	b-NGF		0
367478	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	b-NGF		0
367479	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	b-NGF		0
367480	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	b-NGF		0
367481	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	b-NGF		0
367482	20233						N2586	51107.0										1	b-NGF		0
367483	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	b-NGF	64	53
367484	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	b-NGF	57	67
367485	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	b-NGF	52	61
367486	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	b-NGF	55.5	60
367487	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	b-NGF	54	54
367488	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	b-NGF	43	54
367489	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	b-NGF	73	43
367490	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	b-NGF	83	35
367491	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	b-NGF	64	63
367492	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	b-NGF	83	57
367493	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	b-NGF	71	30
367494	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	b-NGF	69	39
367495	20233																	0	b-NGF	9.5	58
367496	20233						RA2159	51112.0								2	ug/mL	1	b-NGF	59	42
367497	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	b-NGF	74	60
367498	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	b-NGF	47	29
367499	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	b-NGF	67	73
367500	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	b-NGF	58	58
367501	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	b-NGF	31	77
367502	20233						N2586	51107.0								2	ug/mL	1	b-NGF	149	52
367503	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	b-NGF	177	31
367504	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	b-NGF	89	46
367505	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	b-NGF	117	46
367506	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	b-NGF	131.5	54
367507	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	b-NGF	99	43
367508	20233																	0	b-NGF	8	50
367509	20233						RA2159	51112.0										2	b-NGF	57	70
367510	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	b-NGF	45	51
367511	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	b-NGF	47	62
367512	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	b-NGF	56	73
367513	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	b-NGF	52	71
367514	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	b-NGF	55	56
367515	20233						RA2159	51112.0										2	b-NGF	46	56
367516	20233						N2586	51107.0										2	b-NGF	84.5	56
367517	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	b-NGF	86	55
367518	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	b-NGF	85	61
367519	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	b-NGF	103	47
367520	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	b-NGF	68	85
367521	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	b-NGF	83	37
367522	20233						N2586	51107.0										2	b-NGF	125	69
367523	20233																	0	b-NGF	7	56
367524	20233																	0	b-NGF	8	78
367525	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	b-NGF	176.5	78
367526	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	b-NGF	126	57
367527	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	b-NGF	158	67
367528	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	b-NGF	194	71
367529	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	b-NGF	143.5	50
367530	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	b-NGF	106	51
367531	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	b-NGF	56	58
367532	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	b-NGF	408	46
367533	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	b-NGF	254	67
367534	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	b-NGF	311.5	70
367535	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	b-NGF	376	47
367536	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	b-NGF	288.5	48
367537	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	b-NGF	289	39
367538	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	b-NGF	115	59
367539	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	b-NGF	147	67
367540	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	b-NGF	119.5	62
367541	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	b-NGF	129.5	62
367542	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	b-NGF	219	55
367543	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	b-NGF	152	68
367544	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	b-NGF	113.5	54
367545	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	b-NGF	36	54
367546	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	b-NGF	346	59
367547	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	b-NGF	301	51
367548	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	b-NGF	310.5	46
367549	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	b-NGF	439.5	62
367550	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	b-NGF	354.5	48
367551	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	b-NGF	273	45
367552	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	b-NGF	82	57
367553	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	b-NGF	52	66
367554	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	b-NGF	38.5	66
367555	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	b-NGF	46.5	50
367556	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	b-NGF	45	65
367557	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	b-NGF	38	53
367558	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	b-NGF	47	33
367559	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	b-NGF	53	51
367560	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	b-NGF	109	55
367561	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	b-NGF	83	87
367562	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	b-NGF	85	70
367563	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	b-NGF	83	75
367564	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	b-NGF	71	53
367565	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	b-NGF	64	57
367566	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	b-NGF	80	52
367567	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	b-NGF	52	56
367568	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	b-NGF	43	67
367569	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	b-NGF	52	53
367570	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	b-NGF	50.5	64
367571	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	b-NGF	46.5	48
367572	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	b-NGF	45.5	30
367573	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	b-NGF	54.5	40
367574	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	b-NGF	119	39
367575	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	b-NGF	111	70
367576	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	b-NGF	91	21
367577	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	b-NGF	135	25
367578	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	b-NGF	77	39
367579	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	b-NGF	78	56
367580	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	b-NGF	75	79
367581	20233						RA2159	51112.0										2	b-NGF	37	67
367582	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	b-NGF	29	57
367583	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	b-NGF	28	57
367584	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	b-NGF	37	43
367585	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	b-NGF	31	47
367586	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	b-NGF	37.5	60
367587	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	b-NGF	32	73
367588	20233						N2586	51107.0										2	b-NGF	87	60
367589	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	b-NGF	70	59
367590	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	b-NGF	85	77
367591	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	b-NGF	103.5	68
367592	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	b-NGF	56	47
367593	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	b-NGF	76	55
367594	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	b-NGF	63	68
367595	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	b-NGF	40.5	62
367596	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	b-NGF	36	79
367597	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	b-NGF	33	57
367598	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	b-NGF	40	51
367599	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	b-NGF	37	64
367600	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	b-NGF	42	64
367601	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	b-NGF	79	57
367602	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	b-NGF	98.5	26
367603	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	b-NGF	62	55
367604	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	b-NGF	91.5	62
367605	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	b-NGF	69.5	68
367606	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	b-NGF	76	69
367607	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	b-NGF	43	57
367608	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	b-NGF	34	68
367609	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	b-NGF	30.5	62
367610	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	b-NGF	39.5	76
367611	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	b-NGF	40	53
367612	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	b-NGF	46	51
367613	20233						RA2159	51112.0										2	b-NGF	48.5	38
367614	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	b-NGF	85	43
367615	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	b-NGF	93	72
367616	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	b-NGF	78.5	74
367617	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	b-NGF	99.5	52
367618	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	b-NGF	57.5	68
367619	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	b-NGF	53	59
367620	20233						N2586	51107.0										2	b-NGF	94	59
367621	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	b-NGF	86	58
367622	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	b-NGF	81	47
367623	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	b-NGF	82	61
367624	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	b-NGF	83	62
367625	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	b-NGF	79.5	66
367626	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	b-NGF	84.5	64
367627	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	b-NGF	125	65
367628	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	b-NGF	116	59
367629	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	b-NGF	158	50
367630	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	b-NGF	172.5	36
367631	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	b-NGF	115.5	44
367632	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	b-NGF	111.5	54
367633	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	b-NGF	47	55
367634	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	b-NGF	35	64
367635	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	b-NGF	38	56
367636	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	b-NGF	40	53
367637	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	b-NGF	29	68
367638	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	b-NGF	42	49
367639	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	b-NGF	75	67
367640	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	b-NGF	66.5	50
367641	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	b-NGF	65	65
367642	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	b-NGF	88	48
367643	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	b-NGF	51.5	60
367644	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	b-NGF	64.5	48
367645	20233						RA2159	51112.0										2	b-NGF		0
367646	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	b-NGF		0
367647	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	b-NGF		0
367648	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	b-NGF		0
367649	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	b-NGF		0
367650	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	b-NGF		0
367651	20233						RA2159	51112.0										2	b-NGF		0
367652	20233						N2586	51107.0										2	b-NGF		0
367653	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	b-NGF		0
367654	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	b-NGF		0
367655	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	b-NGF		0
367656	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	b-NGF		0
367657	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	b-NGF		0
367658	20233						N2586	51107.0										2	b-NGF		0
367659	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	b-NGF	64.5	46
367660	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	b-NGF	46	83
367661	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	b-NGF	47.5	50
367662	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	b-NGF	57	51
367663	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	b-NGF	41	39
367664	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	b-NGF	38	72
367665	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	b-NGF	92.5	62
367666	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	b-NGF	83	52
367667	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	b-NGF	94	58
367668	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	b-NGF	97	42
367669	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	b-NGF	67	59
367670	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	b-NGF	84	39
367671	20233																	0	b-NGF	7.5	66
367672	20233						RA2159	51112.0								2	ug/mL	2	b-NGF	117.5	74
367673	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	b-NGF	51	42
367674	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	b-NGF	82.5	58
367675	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	b-NGF	97	60
367676	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	b-NGF	77	57
367677	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	b-NGF	65	57
367678	20233						N2586	51107.0								2	ug/mL	2	b-NGF	150	63
367679	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	b-NGF	147	35
367680	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	b-NGF	201	39
367681	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	b-NGF	156	54
367682	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	b-NGF	102	45
367683	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	b-NGF	104	57
367684	20233																	0	b-NGF	9	58
367685	20233						RA2159	51112.0								2	ug/mL	3	b-NGF	70	61
367686	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	b-NGF	68	51
367687	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	b-NGF	52	70
367688	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	b-NGF	66	35
367689	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	b-NGF	77	65
367690	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	b-NGF	39	57
367691	20233						N2586	51107.0								2	ug/mL	3	b-NGF	172	59
367692	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	b-NGF	201	57
367693	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	b-NGF	134	59
367694	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	b-NGF	151	54
367695	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	b-NGF	67.5	58
367696	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	b-NGF	93	61
367697	20233						RA2159	51112.0										3	b-NGF		0
367698	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	b-NGF		0
367699	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	b-NGF		0
367700	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	b-NGF		0
367701	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	b-NGF		0
367702	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	b-NGF		0
367703	20233						RA2159	51112.0										3	b-NGF		0
367704	20233						N2586	51107.0										3	b-NGF		0
367705	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	b-NGF		0
367706	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	b-NGF		0
367707	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	b-NGF		0
367708	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	b-NGF		0
367709	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	b-NGF		0
367710	20233						N2586	51107.0										3	b-NGF		0
367711	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	b-NGF	54	54
367712	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	b-NGF	41	63
367713	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	b-NGF	35	57
367714	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	b-NGF	37	43
367715	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	b-NGF	40	73
367716	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	b-NGF	29	61
367717	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	b-NGF	88	68
367718	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	b-NGF	89	79
367719	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	b-NGF	59	65
367720	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	b-NGF	77	66
367721	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	b-NGF	70	57
367722	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	b-NGF	59	56
367723	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	b-NGF	25	67
367724	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	b-NGF	23	67
367725	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	b-NGF	21.5	50
367726	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	b-NGF	24	71
367727	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	b-NGF	21	53
367728	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	b-NGF	29	50
367729	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	b-NGF	75	62
367730	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	b-NGF	72	75
367731	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	b-NGF	61	73
367732	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	b-NGF	75	57
367733	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	b-NGF	53	62
367734	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	b-NGF	62	65
367735	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	b-NGF	76	52
367736	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	b-NGF	65	70
367737	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	b-NGF	63	82
367738	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	b-NGF	76	59
367739	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	b-NGF	72	63
367740	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	b-NGF	69.5	64
367741	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	b-NGF	138	69
367742	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	b-NGF	132	69
367743	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	b-NGF	103	62
367744	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	b-NGF	121	48
367745	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	b-NGF	114	41
367746	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	b-NGF	113	66
367747	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	b-NGF	25	59
367748	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	b-NGF	28	61
367749	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	b-NGF	27	64
367750	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	b-NGF	28	49
367751	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	b-NGF	33	66
367752	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	b-NGF	32	47
367753	20233						RA2159	51112.0										3	b-NGF	33	65
367754	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	b-NGF	97.5	52
367755	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	b-NGF	84	61
367756	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	b-NGF	59	57
367757	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	b-NGF	80	75
367758	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	b-NGF	44.5	58
367759	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	b-NGF	58.5	52
367760	20233						N2586	51107.0										3	b-NGF	71.5	54
367761	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	b-NGF	30	62
367762	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	b-NGF	32	66
367763	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	b-NGF	31	68
367764	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	b-NGF	37	41
367765	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	b-NGF	45	55
367766	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	b-NGF	30	61
367767	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	b-NGF	28	66
367768	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	b-NGF	96	69
367769	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	b-NGF	87	73
367770	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	b-NGF	71	50
367771	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	b-NGF	110.5	66
367772	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	b-NGF	45.5	62
367773	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	b-NGF	54	69
367774	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	b-NGF	46	69
367775	20233						RA2159	51112.0										3	b-NGF	28	64
367776	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	b-NGF	21	52
367777	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	b-NGF	25	65
367778	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	b-NGF	34	51
367779	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	b-NGF	26	56
367780	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	b-NGF	23.5	34
367781	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	b-NGF	25	67
367782	20233						N2586	51107.0										3	b-NGF	78	72
367783	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	b-NGF	76	59
367784	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	b-NGF	58	50
367785	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	b-NGF	96.5	50
367786	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	b-NGF	49	60
367787	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	b-NGF	46	69
367788	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	b-NGF	53.5	60
367789	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	b-NGF	25	71
367790	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	b-NGF	27	59
367791	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	b-NGF	30	64
367792	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	b-NGF	28	70
367793	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	b-NGF	34	72
367794	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	b-NGF	28	63
367795	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	b-NGF	92.5	64
367796	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	b-NGF	80	54
367797	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	b-NGF	58	80
367798	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	b-NGF	113.5	50
367799	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	b-NGF	51	66
367800	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	b-NGF	57	46
367801	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	b-NGF	23	57
367802	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	b-NGF	28	61
367803	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	b-NGF	26.5	50
367804	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	b-NGF	30	66
367805	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	b-NGF	26	68
367806	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	b-NGF	30.5	48
367807	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	b-NGF	33	61
367808	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	b-NGF	87	67
367809	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	b-NGF	64	57
367810	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	b-NGF	51	61
367811	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	b-NGF	69	56
367812	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	b-NGF	48	58
367813	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	b-NGF	52	64
367814	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	b-NGF	66	55
367815	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	b-NGF	75	68
367816	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	b-NGF	83.5	58
367817	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	b-NGF	80	77
367818	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	b-NGF	109	75
367819	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	b-NGF	109.5	48
367820	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	b-NGF	34.5	60
367821	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	b-NGF	33	43
367822	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	b-NGF	237	66
367823	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	b-NGF	293.5	40
367824	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	b-NGF	255.5	54
367825	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	b-NGF	315	64
367826	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	b-NGF	61	63
367827	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	b-NGF	100.5	60
367828	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	b-NGF	50	65
367829	20233																	0	b-NGF	7	56
367830	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	b-NGF	191	55
367831	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	b-NGF	127	53
367832	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	b-NGF	107	80
367833	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	b-NGF	120	39
367834	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	b-NGF	106	74
367835	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	b-NGF	58	60
367836	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	b-NGF	29	41
367837	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	b-NGF	298.5	50
367838	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	b-NGF	224.5	74
367839	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	b-NGF	222	70
367840	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	b-NGF	259	53
367841	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	b-NGF	82	51
367842	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	b-NGF	206	65
367843	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	b-NGF	70	53
367844	20233																	0	b-NGF	8	48
367845	20233						RA2159	51112.0										3	b-NGF	33	71
367846	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	b-NGF	34	44
367847	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	b-NGF	34	56
367848	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	b-NGF	29.5	40
367849	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	b-NGF	32	57
367850	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	b-NGF	28	47
367851	20233						RA2159	51112.0										3	b-NGF	31	69
367852	20233						N2586	51107.0										3	b-NGF	73	67
367853	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	b-NGF	62.5	66
367854	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	b-NGF	54	44
367855	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	b-NGF	68	49
367856	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	b-NGF	59	51
367857	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	b-NGF	54	35
367858	20233						N2586	51107.0										3	b-NGF	66.5	42
367859	20233																	0	b-NGF	9	60
367860	20233						RA2159	51112.0								2	ug/mL	4	b-NGF	124	61
367861	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	b-NGF	85	63
367862	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	b-NGF	116	65
367863	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	b-NGF	108	35
367864	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	b-NGF	124	51
367865	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	b-NGF	71.5	62
367866	20233						N2586	51107.0								2	ug/mL	4	b-NGF	194	69
367867	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	b-NGF	223.5	56
367868	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	b-NGF	123.5	44
367869	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	b-NGF	177	34
367870	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	b-NGF	117.5	70
367871	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	b-NGF	96.5	34
367872	20233						RA2159	51112.0										4	b-NGF		0
367873	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	b-NGF		0
367874	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	b-NGF		0
367875	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	b-NGF		0
367876	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	b-NGF		0
367877	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	b-NGF		0
367878	20233						RA2159	51112.0										4	b-NGF		0
367879	20233						N2586	51107.0										4	b-NGF		0
367880	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	b-NGF		0
367881	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	b-NGF		0
367882	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	b-NGF		0
367883	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	b-NGF		0
367884	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	b-NGF		0
367885	20233						N2586	51107.0										4	b-NGF		0
367886	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	b-NGF	94	47
367887	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	b-NGF	71.5	40
367888	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	b-NGF	84	60
367889	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	b-NGF	67	50
367890	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	b-NGF	60.5	76
367891	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	b-NGF	58	74
367892	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	b-NGF	127	50
367893	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	b-NGF	115	63
367894	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	b-NGF	80	59
367895	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	b-NGF	99	52
367896	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	b-NGF	93	71
367897	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	b-NGF	86	56
367898	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	b-NGF	72	50
367899	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	b-NGF	56	51
367900	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	b-NGF	64	71
367901	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	b-NGF	56	61
367902	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	b-NGF	64.5	68
367903	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	b-NGF	46.5	56
367904	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	b-NGF	104	53
367905	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	b-NGF	93	51
367906	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	b-NGF	70	46
367907	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	b-NGF	101.5	44
367908	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	b-NGF	76	51
367909	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	b-NGF	80	45
367910	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	b-NGF	107	82
367911	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	b-NGF	87	50
367912	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	b-NGF	93	75
367913	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	b-NGF	94	69
367914	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	b-NGF	87	60
367915	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	b-NGF	86	86
367916	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	b-NGF	146	59
367917	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	b-NGF	150.5	52
367918	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	b-NGF	131	43
367919	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	b-NGF	133	50
367920	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	b-NGF	144	48
367921	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	b-NGF	112	50
367922	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	b-NGF	70	57
367923	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	b-NGF	42	77
367924	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	b-NGF	54	53
367925	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	b-NGF	58	61
367926	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	b-NGF	49	65
367927	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	b-NGF	48	56
367928	20233						RA2159	51112.0										4	b-NGF	48.5	72
367929	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	b-NGF	86.5	56
367930	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	b-NGF	108	76
367931	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	b-NGF	68.5	70
367932	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	b-NGF	99	45
367933	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	b-NGF	84	73
367934	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	b-NGF	73	64
367935	20233						N2586	51107.0										4	b-NGF	98.5	50
367936	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	b-NGF	56	65
367937	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	b-NGF	33.5	56
367938	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	b-NGF	34	67
367939	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	b-NGF	44	57
367940	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	b-NGF	43	55
367941	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	b-NGF	40.5	74
367942	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	b-NGF	133	58
367943	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	b-NGF	116.5	62
367944	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	b-NGF	72.5	62
367945	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	b-NGF	121.5	44
367946	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	b-NGF	69	54
367947	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	b-NGF	55.5	56
367948	20233						RA2159	51112.0										4	b-NGF	41.5	74
367949	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	b-NGF	34	65
367950	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	b-NGF	33	42
367951	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	b-NGF	41	69
367952	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	b-NGF	44.5	36
367953	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	b-NGF	37.5	16
367954	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	b-NGF	38	12
367955	20233						N2586	51107.0										4	b-NGF		6
367956	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	b-NGF	124	10
367957	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	b-NGF	55	65
367958	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	b-NGF	84	48
367959	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	b-NGF	67	43
367960	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	b-NGF	66	57
367961	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	b-NGF	62	62
367962	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	b-NGF	44.5	50
367963	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	b-NGF	45	62
367964	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	b-NGF	45	71
367965	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	b-NGF	45.5	72
367966	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	b-NGF	49	70
367967	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	b-NGF	36	45
367968	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	b-NGF	47.5	28
367969	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	b-NGF	128	41
367970	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	b-NGF	137	62
367971	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	b-NGF	95.5	40
367972	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	b-NGF	100.5	46
367973	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	b-NGF	79.5	58
367974	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	b-NGF	72	66
367975	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	b-NGF	49.5	50
367976	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	b-NGF	60	71
367977	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	b-NGF	34	82
367978	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	b-NGF	40.5	56
367979	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	b-NGF	46	62
367980	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	b-NGF	33	53
367981	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	b-NGF	40	70
367982	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	b-NGF	44.5	46
367983	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	b-NGF	98	57
367984	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	b-NGF	111	62
367985	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	b-NGF	76	45
367986	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	b-NGF	95.5	60
367987	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	b-NGF	73.5	54
367988	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	b-NGF	78.5	50
367989	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	b-NGF	123	45
367990	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	b-NGF	174	65
367991	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	b-NGF	139	60
367992	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	b-NGF	201.5	68
367993	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	b-NGF	168	63
367994	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	b-NGF	133	42
367995	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	b-NGF	116.5	48
367996	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	b-NGF	37	73
367997	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	b-NGF	325	66
367998	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	b-NGF	331.5	46
367999	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	b-NGF	284	48
368000	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	b-NGF	325	44
368001	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	b-NGF	154.5	46
368002	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	b-NGF	89	57
368003	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	b-NGF	76	56
368004	20233																	0	b-NGF	9	56
368005	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	b-NGF	211.5	60
368006	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	b-NGF	133	53
368007	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	b-NGF	190	51
368008	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	b-NGF	187	70
368009	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	b-NGF	174	55
368010	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	b-NGF	109.5	56
368011	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	b-NGF	57	35
368012	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	b-NGF	503.5	56
368013	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	b-NGF	418	67
368014	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	b-NGF	342	56
368015	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	b-NGF	459	49
368016	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	b-NGF	262.5	34
368017	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	b-NGF	82	47
368018	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	b-NGF	101	53
368019	20233																	0	b-NGF	9	42
368020	20233						RA2159	51112.0										4	b-NGF	57.5	48
368021	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	b-NGF	43	55
368022	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	b-NGF	56	63
368023	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	b-NGF	50.5	68
368024	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	b-NGF	51.5	54
368025	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	b-NGF	51	69
368026	20233						RA2159	51112.0										4	b-NGF	61	54
368027	20233						N2586	51107.0										4	b-NGF	110	63
368028	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	b-NGF	114.5	46
368029	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	b-NGF	94	43
368030	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	b-NGF	92.5	68
368031	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	b-NGF	75.5	48
368032	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	b-NGF	88	51
368033	20233						N2586	51107.0										4	b-NGF	106	49
368034	20233								TNF-a	201285.0						100	ng/mL	0	b-NGF	10	72
368035	20233								IL-1 alpha	201286.0						100	ng/mL	0	b-NGF	12.5	64
368036	20233								IL-6	201287.0						100	ug/mL	0	b-NGF	11	37
368037	20233								IL-17A	201288.0						100	ng/mL	0	b-NGF	10	57
368038	20233								EGF	201289.0						100	ng/mL	0	b-NGF	11	68
368039	20233								IGF-I	201290.0						100	ug/mL	0	b-NGF	8	61
368040	20233								Adiponectin	201291.0						5	ng/mL	0	b-NGF	449	64
368041	20233								Leptin	201292.0						1	ng/mL	0	b-NGF	11.5	62
368042	20233								Visfatin	201293.0						1	ng/mL	0	b-NGF	49.5	54
368043	20233															2	ug/mL	0	b-NGF	9	49
368044	20233								TNF-a	201285.0						100	ng/mL	0	b-NGF	7	44
368045	20233								IL-1 alpha	201286.0						100	ng/mL	0	b-NGF	12	61
368046	20233								IL-6	201287.0						100	ug/mL	0	b-NGF	9	75
368047	20233								IL-17A	201288.0						100	ng/mL	0	b-NGF	7	45
368048	20233								EGF	201289.0						100	ng/mL	0	b-NGF	10	53
368049	20233								IGF-I	201290.0						100	ug/mL	0	b-NGF	8	45
368050	20233								Adiponectin	201291.0						5	ng/mL	0	b-NGF	364	57
368051	20233								Leptin	201292.0						1	ng/mL	0	b-NGF	9	47
368052	20233								Visfatin	201293.0						1	ng/mL	0	b-NGF	52	54
368053	20233															2	ug/mL	0	b-NGF	7	43
368054	20233								TNF-a	201285.0						100	ng/mL	0	b-NGF	9	64
368055	20233								IL-1 alpha	201286.0						100	ng/mL	0	b-NGF	14	53
368056	20233								IL-6	201287.0						100	ug/mL	0	b-NGF	10	62
368057	20233								IL-17A	201288.0						100	ng/mL	0	b-NGF	12	57
368058	20233								EGF	201289.0						100	ng/mL	0	b-NGF	7	60
368059	20233								IGF-I	201290.0						100	ug/mL	0	b-NGF	9	59
368060	20233								Adiponectin	201291.0						5	ng/mL	0	b-NGF	321	43
368061	20233								Leptin	201292.0						1	ng/mL	0	b-NGF	12.5	40
368062	20233								Visfatin	201293.0						1	ng/mL	0	b-NGF	36	57
368063	20233															2	ug/mL	0	b-NGF	10	71
368064	20233								TNF-a	201285.0						100	ng/mL	0	b-NGF	9	35
368065	20233								IL-1 alpha	201286.0						100	ng/mL	0	b-NGF	12	67
368066	20233								IL-6	201287.0						100	ug/mL	0	b-NGF	9	64
368067	20233								IL-17A	201288.0						100	ng/mL	0	b-NGF	6	58
368068	20233								EGF	201289.0						100	ng/mL	0	b-NGF	8	61
368069	20233								IGF-I	201290.0						100	ug/mL	0	b-NGF	10	55
368070	20233								Adiponectin	201291.0						5	ng/mL	0	b-NGF	499	61
368071	20233								Leptin	201292.0						1	ng/mL	0	b-NGF	9	36
368072	20233								Visfatin	201293.0						1	ng/mL	0	b-NGF	53	49
368073	20233															2	ug/mL	0	b-NGF	8	50
368074	20233																	0	GRO-a	57	83
368075	20233						RA2159	51112.0										1	GRO-a	4471	50
368076	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	GRO-a	2286	57
368077	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	GRO-a	2338	57
368078	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	GRO-a	3430.5	74
368079	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	GRO-a	4227	71
368080	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	GRO-a	3240	57
368081	20233						RA2159	51112.0										1	GRO-a	4631	79
368082	20233						N2586	51107.0										1	GRO-a	6427	83
368083	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	GRO-a	7401	59
368084	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	GRO-a	5917	60
368085	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	GRO-a	8113	56
368086	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	GRO-a	7968	41
368087	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	GRO-a	6118	45
368088	20233						N2586	51107.0										1	GRO-a	7777.5	34
368089	20233																	0	GRO-a	70.5	52
368090	20233																	0	GRO-a	39	42
368091	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	GRO-a	14217	51
368092	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	GRO-a	12548	73
368093	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	GRO-a	11199	76
368094	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	GRO-a	12818.5	64
368095	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	GRO-a	13637	54
368096	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	GRO-a	6013	63
368097	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	GRO-a	5053.5	58
368098	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	GRO-a	16881	43
368099	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	GRO-a	15283	34
368100	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	GRO-a	12261	48
368101	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	GRO-a	16003	57
368102	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	GRO-a	17245	71
368103	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	GRO-a	15632	39
368104	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	GRO-a	5433	48
368105	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	GRO-a	19189.5	62
368106	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	GRO-a	19531	90
368107	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	GRO-a	18097.5	58
368108	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	GRO-a	18450	57
368109	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	GRO-a	18757.5	66
368110	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	GRO-a	6546	55
368111	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	GRO-a	5702	58
368112	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	GRO-a	19758.5	56
368113	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	GRO-a	19872	60
368114	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	GRO-a	20361	51
368115	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	GRO-a	19884	72
368116	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	GRO-a	19519.5	64
368117	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	GRO-a	18177	53
368118	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	GRO-a	6616	47
368119	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	GRO-a	3304	72
368120	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	GRO-a	2067	66
368121	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	GRO-a	2404	63
368122	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	GRO-a	4025	66
368123	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	GRO-a	3999.5	50
368124	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	GRO-a	2723	67
368125	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	GRO-a	5086	56
368126	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	GRO-a	9237	46
368127	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	GRO-a	6270	55
368128	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	GRO-a	5139	44
368129	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	GRO-a	7502	52
368130	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	GRO-a	7116	49
368131	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	GRO-a	5852	54
368132	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	GRO-a	10293.5	64
368133	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	GRO-a	11825	61
368134	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	GRO-a	7062	67
368135	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	GRO-a	15310.5	50
368136	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	GRO-a	11159	49
368137	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	GRO-a	14818.5	54
368138	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	GRO-a	4650	76
368139	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	GRO-a	17631	39
368140	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	GRO-a	15045	38
368141	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	GRO-a	18428	29
368142	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	GRO-a	14434	50
368143	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	GRO-a	14774	38
368144	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	GRO-a	12507	49
368145	20233						RA2159	51112.0										1	GRO-a	4596	41
368146	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	GRO-a	3661	57
368147	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	GRO-a	3132	77
368148	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	GRO-a	5332	70
368149	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	GRO-a	4479	65
368150	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	GRO-a	2443	70
368151	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	GRO-a	1786	43
368152	20233						N2586	51107.0										1	GRO-a	5624	53
368153	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	GRO-a	6466	64
368154	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	GRO-a	8673	56
368155	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	GRO-a	6971	67
368156	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	GRO-a	7537	57
368157	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	GRO-a	5921.5	52
368158	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	GRO-a	3178	41
368159	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	GRO-a	5449	61
368160	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	GRO-a	3419	75
368161	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	GRO-a	4005	67
368162	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	GRO-a	4946	70
368163	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	GRO-a	6692	49
368164	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	GRO-a	3026	59
368165	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	GRO-a	4356.5	70
368166	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	GRO-a	8909	69
368167	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	GRO-a	9212.5	64
368168	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	GRO-a	7745	67
368169	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	GRO-a	9792.5	68
368170	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	GRO-a	9426.5	58
368171	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	GRO-a	6754.5	54
368172	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	GRO-a	5785	57
368173	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	GRO-a	4898	67
368174	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	GRO-a	1576	61
368175	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	GRO-a	2327	52
368176	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	GRO-a	3749	53
368177	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	GRO-a	3912	60
368178	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	GRO-a	3010	53
368179	20233						RA2159	51112.0										1	GRO-a	4705	68
368180	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	GRO-a	6665	63
368181	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	GRO-a	7109	66
368182	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	GRO-a	5643.5	48
368183	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	GRO-a	6076	65
368184	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	GRO-a	6444	38
368185	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	GRO-a	5399	39
368186	20233						N2586	51107.0										1	GRO-a	6660	41
368187	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	GRO-a	3078.5	66
368188	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	GRO-a	1673.5	64
368189	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	GRO-a	1955	63
368190	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	GRO-a	3305	57
368191	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	GRO-a	3909.5	64
368192	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	GRO-a	2036	66
368193	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	GRO-a	7162	55
368194	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	GRO-a	6965.5	66
368195	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	GRO-a	6497.5	34
368196	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	GRO-a	8397	50
368197	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	GRO-a	7466	59
368198	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	GRO-a	5665	59
368199	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	GRO-a	3547	58
368200	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	GRO-a	1330	52
368201	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	GRO-a	1932	60
368202	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	GRO-a	2840.5	66
368203	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	GRO-a	2753	37
368204	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	GRO-a	1906.5	40
368205	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	GRO-a	7872	32
368206	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	GRO-a	7606	53
368207	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	GRO-a	5438	53
368208	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	GRO-a	6234	45
368209	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	GRO-a	7194	55
368210	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	GRO-a	5296	42
368211	20233						RA2159	51112.0										1	GRO-a		0
368212	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	GRO-a		0
368213	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	GRO-a		0
368214	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	GRO-a		0
368215	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	GRO-a		0
368216	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	GRO-a		0
368217	20233						RA2159	51112.0										1	GRO-a		0
368218	20233						N2586	51107.0										1	GRO-a		0
368219	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	GRO-a		0
368220	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	GRO-a		0
368221	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	GRO-a		0
368222	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	GRO-a		0
368223	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	GRO-a		0
368224	20233						N2586	51107.0										1	GRO-a		0
368225	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	GRO-a	3077	55
368226	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	GRO-a	2271	56
368227	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	GRO-a	2638	69
368228	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	GRO-a	4073.5	56
368229	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	GRO-a	4197.5	62
368230	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	GRO-a	2129.5	44
368231	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	GRO-a	6435	33
368232	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	GRO-a	7782	52
368233	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	GRO-a	5790	61
368234	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	GRO-a	6727	49
368235	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	GRO-a	5758	35
368236	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	GRO-a	4678.5	34
368237	20233																	0	GRO-a	33	73
368238	20233						RA2159	51112.0								2	ug/mL	1	GRO-a	14213	55
368239	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	GRO-a	11638	51
368240	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	GRO-a	6362	54
368241	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	GRO-a	12273	73
368242	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	GRO-a	12175	56
368243	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	GRO-a	5034	73
368244	20233						N2586	51107.0								2	ug/mL	1	GRO-a	16285	54
368245	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	GRO-a	14862	32
368246	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	GRO-a	9031	40
368247	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	GRO-a	14236	39
368248	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	GRO-a	15681	42
368249	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	GRO-a	14387	34
368250	20233																	0	GRO-a	45.5	48
368251	20233						RA2159	51112.0										2	GRO-a	5007	68
368252	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	GRO-a	4663.5	50
368253	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	GRO-a	3493	53
368254	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	GRO-a	5267	69
368255	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	GRO-a	1663	55
368256	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	GRO-a	4586	62
368257	20233						RA2159	51112.0										2	GRO-a	5754	68
368258	20233						N2586	51107.0										2	GRO-a	7090.5	68
368259	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	GRO-a	5192.5	58
368260	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	GRO-a	7624	62
368261	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	GRO-a	7401	46
368262	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	GRO-a	4169	69
368263	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	GRO-a	6507.5	44
368264	20233						N2586	51107.0										2	GRO-a	8189.5	60
368265	20233																	0	GRO-a	43.5	70
368266	20233																	0	GRO-a	53	71
368267	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	GRO-a	14382	86
368268	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	GRO-a	12700	74
368269	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	GRO-a	12961	56
368270	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	GRO-a	13768	59
368271	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	GRO-a	8736.5	52
368272	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	GRO-a	12507	55
368273	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	GRO-a	4736	65
368274	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	GRO-a	16289	51
368275	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	GRO-a	11869.5	54
368276	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	GRO-a	15369	53
368277	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	GRO-a	16064.5	46
368278	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	GRO-a	12805	58
368279	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	GRO-a	14976	49
368280	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	GRO-a	8002	46
368281	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	GRO-a	18120.5	72
368282	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	GRO-a	18314	53
368283	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	GRO-a	19838	62
368284	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	GRO-a	19349	56
368285	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	GRO-a	19565.5	50
368286	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	GRO-a	20350	50
368287	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	GRO-a	4040	50
368288	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	GRO-a	19940.5	70
368289	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	GRO-a	18404.5	64
368290	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	GRO-a	19986	60
368291	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	GRO-a	19429	57
368292	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	GRO-a	20361	61
368293	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	GRO-a	19599	74
368294	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	GRO-a	6168	65
368295	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	GRO-a	5330	67
368296	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	GRO-a	4709	57
368297	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	GRO-a	6086	64
368298	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	GRO-a	5840	69
368299	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	GRO-a	1736.5	58
368300	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	GRO-a	6092.5	42
368301	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	GRO-a	6355.5	56
368302	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	GRO-a	8440	70
368303	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	GRO-a	5842.5	76
368304	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	GRO-a	7062	59
368305	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	GRO-a	7014	71
368306	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	GRO-a	3226	46
368307	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	GRO-a	5620.5	52
368308	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	GRO-a	7311	62
368309	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	GRO-a	13177	73
368310	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	GRO-a	12575.5	62
368311	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	GRO-a	12674	67
368312	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	GRO-a	14413	70
368313	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	GRO-a	4841	72
368314	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	GRO-a	12180	39
368315	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	GRO-a	6960.5	28
368316	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	GRO-a	15582	50
368317	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	GRO-a	11637	63
368318	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	GRO-a	13555.5	16
368319	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	GRO-a	17722	27
368320	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	GRO-a	9749	53
368321	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	GRO-a	13129	62
368322	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	GRO-a	6664	75
368323	20233						RA2159	51112.0										2	GRO-a	4992	59
368324	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	GRO-a	4738	55
368325	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	GRO-a	3595	56
368326	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	GRO-a	5662	49
368327	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	GRO-a	1393	74
368328	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	GRO-a	5422	65
368329	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	GRO-a	3107.5	78
368330	20233						N2586	51107.0										2	GRO-a	8559	57
368331	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	GRO-a	5498	67
368332	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	GRO-a	7951	69
368333	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	GRO-a	7684	58
368334	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	GRO-a	2964	45
368335	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	GRO-a	5854.5	62
368336	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	GRO-a	5060	59
368337	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	GRO-a	6310	77
368338	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	GRO-a	6794	71
368339	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	GRO-a	5042.5	66
368340	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	GRO-a	6388.5	84
368341	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	GRO-a	2054	73
368342	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	GRO-a	6765	55
368343	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	GRO-a	10284.5	60
368344	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	GRO-a	8935	44
368345	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	GRO-a	8661	69
368346	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	GRO-a	8975	64
368347	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	GRO-a	4328	57
368348	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	GRO-a	6941	59
368349	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	GRO-a	3920	56
368350	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	GRO-a	4956	71
368351	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	GRO-a	3782	51
368352	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	GRO-a	6045	83
368353	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	GRO-a	1523	55
368354	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	GRO-a	4996	43
368355	20233						RA2159	51112.0										2	GRO-a	4544	38
368356	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	GRO-a	7971	40
368357	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	GRO-a	5121	51
368358	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	GRO-a	6515	75
368359	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	GRO-a	6365.5	44
368360	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	GRO-a	2417	70
368361	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	GRO-a	4782.5	56
368362	20233						N2586	51107.0										2	GRO-a	7984	65
368363	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	GRO-a	3680	87
368364	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	GRO-a	3956	56
368365	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	GRO-a	3502	68
368366	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	GRO-a	3777	63
368367	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	GRO-a	1484	68
368368	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	GRO-a	4917.5	66
368369	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	GRO-a	7355.5	50
368370	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	GRO-a	4597	55
368371	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	GRO-a	7066	47
368372	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	GRO-a	6662	41
368373	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	GRO-a	2827	50
368374	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	GRO-a	5884.5	82
368375	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	GRO-a	5075	65
368376	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	GRO-a	3896	68
368377	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	GRO-a	4746	75
368378	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	GRO-a	6261	56
368379	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	GRO-a	1010.5	50
368380	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	GRO-a	4961	75
368381	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	GRO-a	6484	64
368382	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	GRO-a	4399	74
368383	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	GRO-a	5572.5	48
368384	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	GRO-a	5616	71
368385	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	GRO-a	2796	55
368386	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	GRO-a	5293	57
368387	20233						RA2159	51112.0										2	GRO-a		0
368388	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	GRO-a		0
368389	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	GRO-a		0
368390	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	GRO-a		0
368391	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	GRO-a		0
368392	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	GRO-a		0
368393	20233						RA2159	51112.0										2	GRO-a		0
368394	20233						N2586	51107.0										2	GRO-a		0
368395	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	GRO-a		0
368396	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	GRO-a		0
368397	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	GRO-a		0
368398	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	GRO-a		0
368399	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	GRO-a		0
368400	20233						N2586	51107.0										2	GRO-a		0
368401	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	GRO-a	6599	47
368402	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	GRO-a	4804	78
368403	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	GRO-a	4159	63
368404	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	GRO-a	4990	59
368405	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	GRO-a	1241	61
368406	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	GRO-a	4069	60
368407	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	GRO-a	7918	61
368408	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	GRO-a	5294.5	66
368409	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	GRO-a	6775	59
368410	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	GRO-a	6669	53
368411	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	GRO-a	3097.5	68
368412	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	GRO-a	5839	31
368413	20233																	0	GRO-a	34.5	72
368414	20233						RA2159	51112.0								2	ug/mL	2	GRO-a	16003.5	68
368415	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	GRO-a	12548	53
368416	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	GRO-a	11051	34
368417	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	GRO-a	13058	50
368418	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	GRO-a	5854	72
368419	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	GRO-a	14016	59
368420	20233						N2586	51107.0								2	ug/mL	2	GRO-a	16608	63
368421	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	GRO-a	14609	49
368422	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	GRO-a	16926	51
368423	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	GRO-a	16224	44
368424	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	GRO-a	11216.5	56
368425	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	GRO-a	13281	64
368426	20233																	0	GRO-a	46	79
368427	20233						RA2159	51112.0								2	ug/mL	3	GRO-a	14826	51
368428	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	GRO-a	13655	83
368429	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	GRO-a	8069	73
368430	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	GRO-a	14674	55
368431	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	GRO-a	13095	76
368432	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	GRO-a	6488.5	58
368433	20233						N2586	51107.0								2	ug/mL	3	GRO-a	17826	74
368434	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	GRO-a	18864	77
368435	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	GRO-a	18134	50
368436	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	GRO-a	19571	53
368437	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	GRO-a	3759	49
368438	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	GRO-a	15497	53
368439	20233						RA2159	51112.0										3	GRO-a		0
368440	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	GRO-a		0
368441	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	GRO-a		0
368442	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	GRO-a		0
368443	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	GRO-a		0
368444	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	GRO-a		0
368445	20233						RA2159	51112.0										3	GRO-a		0
368446	20233						N2586	51107.0										3	GRO-a		0
368447	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	GRO-a		0
368448	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	GRO-a		0
368449	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	GRO-a		0
368450	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	GRO-a		0
368451	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	GRO-a		0
368452	20233						N2586	51107.0										3	GRO-a		0
368453	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	GRO-a	6393	78
368454	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	GRO-a	2647	63
368455	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	GRO-a	4111	63
368456	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	GRO-a	4709	43
368457	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	GRO-a	5030	54
368458	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	GRO-a	2144	54
368459	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	GRO-a	8033.5	64
368460	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	GRO-a	6470	59
368461	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	GRO-a	7366	68
368462	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	GRO-a	7691	59
368463	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	GRO-a	3514.5	62
368464	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	GRO-a	5462	59
368465	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	GRO-a	4747.5	68
368466	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	GRO-a	2260	63
368467	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	GRO-a	2730.5	64
368468	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	GRO-a	4704.5	64
368469	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	GRO-a	3601.5	42
368470	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	GRO-a	2409	59
368471	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	GRO-a	9108	54
368472	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	GRO-a	7073	87
368473	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	GRO-a	6784	70
368474	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	GRO-a	6823	63
368475	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	GRO-a	3063	69
368476	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	GRO-a	4578	50
368477	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	GRO-a	3474	61
368478	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	GRO-a	1970.5	70
368479	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	GRO-a	3324	71
368480	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	GRO-a	3986	82
368481	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	GRO-a	4171.5	62
368482	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	GRO-a	1999	62
368483	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	GRO-a	8740	69
368484	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	GRO-a	6317	61
368485	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	GRO-a	5856	59
368486	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	GRO-a	7833	64
368487	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	GRO-a	2492.5	44
368488	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	GRO-a	4221	70
368489	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	GRO-a	4280	61
368490	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	GRO-a	2731.5	52
368491	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	GRO-a	3219	67
368492	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	GRO-a	5052	53
368493	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	GRO-a	5779	61
368494	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	GRO-a	3035	57
368495	20233						RA2159	51112.0										3	GRO-a	5747.5	74
368496	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	GRO-a	10304	59
368497	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	GRO-a	8217.5	62
368498	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	GRO-a	7403.5	68
368499	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	GRO-a	8766	71
368500	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	GRO-a	2270.5	62
368501	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	GRO-a	4455	62
368502	20233						N2586	51107.0										3	GRO-a	10104	55
368503	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	GRO-a	6112	69
368504	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	GRO-a	3950	60
368505	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	GRO-a	6384.5	80
368506	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	GRO-a	6539	54
368507	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	GRO-a	7553.5	68
368508	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	GRO-a	2965	64
368509	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	GRO-a	4072.5	62
368510	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	GRO-a	11421.5	68
368511	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	GRO-a	9054	55
368512	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	GRO-a	8546	63
368513	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	GRO-a	12156	50
368514	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	GRO-a	3660	68
368515	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	GRO-a	5466	70
368516	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	GRO-a	1697.5	56
368517	20233						RA2159	51112.0										3	GRO-a	5926	63
368518	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	GRO-a	2746	53
368519	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	GRO-a	3635	53
368520	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	GRO-a	6284	61
368521	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	GRO-a	5864	55
368522	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	GRO-a	2876.5	66
368523	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	GRO-a	1653	72
368524	20233						N2586	51107.0										3	GRO-a	9790.5	70
368525	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	GRO-a	7110	63
368526	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	GRO-a	6641	71
368527	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	GRO-a	9516	69
368528	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	GRO-a	2905	59
368529	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	GRO-a	4049	61
368530	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	GRO-a	6615	69
368531	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	GRO-a	13140.5	64
368532	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	GRO-a	7726	71
368533	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	GRO-a	16443	67
368534	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	GRO-a	14747	61
368535	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	GRO-a	14614	72
368536	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	GRO-a	4728.5	98
368537	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	GRO-a	16708	72
368538	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	GRO-a	12751	69
368539	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	GRO-a	13423	74
368540	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	GRO-a	19491.5	66
368541	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	GRO-a	13861.5	62
368542	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	GRO-a	12185	57
368543	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	GRO-a	4461	59
368544	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	GRO-a	2896	71
368545	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	GRO-a	2962	67
368546	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	GRO-a	4212.5	68
368547	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	GRO-a	4642	73
368548	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	GRO-a	2585.5	48
368549	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	GRO-a	7215	69
368550	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	GRO-a	7984	54
368551	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	GRO-a	6148	61
368552	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	GRO-a	6150	54
368553	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	GRO-a	8017.5	62
368554	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	GRO-a	2038	75
368555	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	GRO-a	4879	60
368556	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	GRO-a	8827.5	66
368557	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	GRO-a	19548	77
368558	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	GRO-a	19434	47
368559	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	GRO-a	18909.5	80
368560	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	GRO-a	18043	69
368561	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	GRO-a	19845	84
368562	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	GRO-a	7082	69
368563	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	GRO-a	6065.5	84
368564	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	GRO-a	20768.5	82
368565	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	GRO-a	18385	73
368566	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	GRO-a	20198	50
368567	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	GRO-a	19514	64
368568	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	GRO-a	15511	59
368569	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	GRO-a	18122.5	74
368570	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	GRO-a	6818.5	64
368571	20233																	0	GRO-a	65	68
368572	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	GRO-a	15052	59
368573	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	GRO-a	14310	69
368574	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	GRO-a	11612	69
368575	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	GRO-a	14832	46
368576	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	GRO-a	14140	51
368577	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	GRO-a	7681	63
368578	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	GRO-a	5954.5	28
368579	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	GRO-a	16537	63
368580	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	GRO-a	14768	69
368581	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	GRO-a	16474	78
368582	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	GRO-a	16362	75
368583	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	GRO-a	5268.5	64
368584	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	GRO-a	14876.5	78
368585	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	GRO-a	9337.5	68
368586	20233																	0	GRO-a	55	67
368587	20233						RA2159	51112.0										3	GRO-a	3707	61
368588	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	GRO-a	3268	55
368589	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	GRO-a	4031	65
368590	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	GRO-a	5081	47
368591	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	GRO-a	5046	62
368592	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	GRO-a	2184	47
368593	20233						RA2159	51112.0										3	GRO-a	5373.5	72
368594	20233						N2586	51107.0										3	GRO-a	8084.5	58
368595	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	GRO-a	5624	51
368596	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	GRO-a	6221	57
368597	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	GRO-a	7656	59
368598	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	GRO-a	5006	44
368599	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	GRO-a	5321	45
368600	20233						N2586	51107.0										3	GRO-a	8400	60
368601	20233																	0	GRO-a	40	43
368602	20233						RA2159	51112.0								2	ug/mL	4	GRO-a	18054	70
368603	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	GRO-a	16138	56
368604	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	GRO-a	17256	74
368605	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	GRO-a	16788.5	62
368606	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	GRO-a	8179.5	64
368607	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	GRO-a	14813	71
368608	20233						N2586	51107.0								2	ug/mL	4	GRO-a	18955	72
368609	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	GRO-a	18145.5	56
368610	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	GRO-a	12286	43
368611	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	GRO-a	18750	35
368612	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	GRO-a	13246.5	50
368613	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	GRO-a	1569	53
368614	20233						RA2159	51112.0										4	GRO-a		0
368615	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	GRO-a		0
368616	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	GRO-a		0
368617	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	GRO-a		0
368618	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	GRO-a		0
368619	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	GRO-a		0
368620	20233						RA2159	51112.0										4	GRO-a		0
368621	20233						N2586	51107.0										4	GRO-a		0
368622	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	GRO-a		0
368623	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	GRO-a		0
368624	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	GRO-a		0
368625	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	GRO-a		0
368626	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	GRO-a		0
368627	20233						N2586	51107.0										4	GRO-a		0
368628	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	GRO-a	7381	43
368629	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	GRO-a	6681	49
368630	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	GRO-a	6999	51
368631	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	GRO-a	6684	77
368632	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	GRO-a	3016	61
368633	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	GRO-a	7422	71
368634	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	GRO-a	8295.5	56
368635	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	GRO-a	7569	84
368636	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	GRO-a	7973	74
368637	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	GRO-a	7377	61
368638	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	GRO-a	6761.5	84
368639	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	GRO-a	1526.5	68
368640	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	GRO-a	7467	67
368641	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	GRO-a	5621.5	60
368642	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	GRO-a	7786	65
368643	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	GRO-a	8061	65
368644	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	GRO-a	3263.5	76
368645	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	GRO-a	7033.5	58
368646	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	GRO-a	8766	67
368647	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	GRO-a	7531	47
368648	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	GRO-a	6053	39
368649	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	GRO-a	8138.5	70
368650	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	GRO-a	6858	55
368651	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	GRO-a	1779.5	46
368652	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	GRO-a	6784	97
368653	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	GRO-a	6175	63
368654	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	GRO-a	6317	79
368655	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	GRO-a	6560	67
368656	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	GRO-a	3445	61
368657	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	GRO-a	7151.5	68
368658	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	GRO-a	8239	47
368659	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	GRO-a	7172	64
368660	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	GRO-a	6642.5	76
368661	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	GRO-a	7335	73
368662	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	GRO-a	5915	57
368663	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	GRO-a	1317.5	66
368664	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	GRO-a	8734.5	66
368665	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	GRO-a	7252	72
368666	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	GRO-a	7350.5	58
368667	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	GRO-a	8675.5	68
368668	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	GRO-a	3223	53
368669	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	GRO-a	7360	65
368670	20233						RA2159	51112.0										4	GRO-a	6908	50
368671	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	GRO-a	8476	77
368672	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	GRO-a	7476.5	72
368673	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	GRO-a	8157	64
368674	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	GRO-a	8811	45
368675	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	GRO-a	7117.5	68
368676	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	GRO-a	2229	70
368677	20233						N2586	51107.0										4	GRO-a	9208	76
368678	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	GRO-a	9024.5	74
368679	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	GRO-a	7384	88
368680	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	GRO-a	7054.5	66
368681	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	GRO-a	7435	69
368682	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	GRO-a	3365	69
368683	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	GRO-a	7413	96
368684	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	GRO-a	13108	47
368685	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	GRO-a	9434	85
368686	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	GRO-a	10141.5	78
368687	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	GRO-a	11559	59
368688	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	GRO-a	7462	61
368689	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	GRO-a	1923	75
368690	20233						RA2159	51112.0										4	GRO-a	7686	81
368691	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	GRO-a	5788	49
368692	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	GRO-a	6096.5	50
368693	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	GRO-a	7013	67
368694	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	GRO-a	3031	43
368695	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	GRO-a	8356.5	14
368696	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	GRO-a	5645	15
368697	20233						N2586	51107.0										4	GRO-a	8912	10
368698	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	GRO-a	8755	13
368699	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	GRO-a	8223	48
368700	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	GRO-a	9781	59
368701	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	GRO-a	6589.5	32
368702	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	GRO-a	1951	65
368703	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	GRO-a	4841	48
368704	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	GRO-a	10532	57
368705	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	GRO-a	12655	55
368706	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	GRO-a	13105.5	68
368707	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	GRO-a	13000	65
368708	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	GRO-a	6480	63
368709	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	GRO-a	12748	57
368710	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	GRO-a	7474.5	26
368711	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	GRO-a	17518	53
368712	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	GRO-a	17176	61
368713	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	GRO-a	18818	41
368714	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	GRO-a	16492	57
368715	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	GRO-a	12132	61
368716	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	GRO-a	2177	43
368717	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	GRO-a	1442.5	42
368718	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	GRO-a	6741.5	68
368719	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	GRO-a	5263.5	66
368720	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	GRO-a	5664	55
368721	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	GRO-a	6341	80
368722	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	GRO-a	2846	43
368723	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	GRO-a	7260.5	52
368724	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	GRO-a	7003	51
368725	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	GRO-a	9285	55
368726	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	GRO-a	9224	54
368727	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	GRO-a	7912	32
368728	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	GRO-a	8811	61
368729	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	GRO-a	7028	59
368730	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	GRO-a	2063	41
368731	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	GRO-a	9552	47
368732	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	GRO-a	20266.5	58
368733	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	GRO-a	18248	59
368734	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	GRO-a	22616.5	70
368735	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	GRO-a	19901.5	66
368736	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	GRO-a	18476	54
368737	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	GRO-a	20974	60
368738	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	GRO-a	4449	68
368739	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	GRO-a	17940	60
368740	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	GRO-a	20666	77
368741	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	GRO-a	20255.5	52
368742	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	GRO-a	20506	63
368743	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	GRO-a	18727	58
368744	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	GRO-a	2121	77
368745	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	GRO-a	8408	43
368746	20233																	0	GRO-a	53	60
368747	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	GRO-a	15219	59
368748	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	GRO-a	14244	69
368749	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	GRO-a	15549.5	54
368750	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	GRO-a	15419	51
368751	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	GRO-a	10261	50
368752	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	GRO-a	13867	74
368753	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	GRO-a	5551.5	66
368754	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	GRO-a	17700.5	52
368755	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	GRO-a	16890.5	72
368756	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	GRO-a	15284	53
368757	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	GRO-a	17575.5	46
368758	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	GRO-a	14525.5	52
368759	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	GRO-a	1771	40
368760	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	GRO-a	6818	52
368761	20233																	0	GRO-a	26	59
368762	20233						RA2159	51112.0										4	GRO-a	4761	52
368763	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	GRO-a	5165.5	60
368764	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	GRO-a	4854	57
368765	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	GRO-a	5772	59
368766	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	GRO-a	2934	75
368767	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	GRO-a	5118	71
368768	20233						RA2159	51112.0										4	GRO-a	6386	59
368769	20233						N2586	51107.0										4	GRO-a	9037.5	74
368770	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	GRO-a	7496.5	38
368771	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	GRO-a	6719.5	64
368772	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	GRO-a	8194	63
368773	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	GRO-a	6180	58
368774	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	GRO-a	3950.5	50
368775	20233						N2586	51107.0										4	GRO-a	10129	37
368776	20233								TNF-a	201285.0						100	ng/mL	0	GRO-a	44	73
368777	20233								IL-1 alpha	201286.0						100	ng/mL	0	GRO-a	69	63
368778	20233								IL-6	201287.0						100	ug/mL	0	GRO-a	53	49
368779	20233								IL-17A	201288.0						100	ng/mL	0	GRO-a	51	51
368780	20233								EGF	201289.0						100	ng/mL	0	GRO-a	138	48
368781	20233								IGF-I	201290.0						100	ug/mL	0	GRO-a	43	55
368782	20233								Adiponectin	201291.0						5	ng/mL	0	GRO-a	275	65
368783	20233								Leptin	201292.0						1	ng/mL	0	GRO-a	64.5	46
368784	20233								Visfatin	201293.0						1	ng/mL	0	GRO-a	56	55
368785	20233															2	ug/mL	0	GRO-a	51	59
368786	20233								TNF-a	201285.0						100	ng/mL	0	GRO-a	56.5	44
368787	20233								IL-1 alpha	201286.0						100	ng/mL	0	GRO-a	65	55
368788	20233								IL-6	201287.0						100	ug/mL	0	GRO-a	36	58
368789	20233								IL-17A	201288.0						100	ng/mL	0	GRO-a	55	62
368790	20233								EGF	201289.0						100	ng/mL	0	GRO-a	61	54
368791	20233								IGF-I	201290.0						100	ug/mL	0	GRO-a	68	55
368792	20233								Adiponectin	201291.0						5	ng/mL	0	GRO-a	306	58
368793	20233								Leptin	201292.0						1	ng/mL	0	GRO-a	50	71
368794	20233								Visfatin	201293.0						1	ng/mL	0	GRO-a	60.5	50
368795	20233															2	ug/mL	0	GRO-a	49	63
368796	20233								TNF-a	201285.0						100	ng/mL	0	GRO-a	53	76
368797	20233								IL-1 alpha	201286.0						100	ng/mL	0	GRO-a	57	63
368798	20233								IL-6	201287.0						100	ug/mL	0	GRO-a	48	61
368799	20233								IL-17A	201288.0						100	ng/mL	0	GRO-a	61	72
368800	20233								EGF	201289.0						100	ng/mL	0	GRO-a	45	60
368801	20233								IGF-I	201290.0						100	ug/mL	0	GRO-a	50	77
368802	20233								Adiponectin	201291.0						5	ng/mL	0	GRO-a	279	51
368803	20233								Leptin	201292.0						1	ng/mL	0	GRO-a	37	53
368804	20233								Visfatin	201293.0						1	ng/mL	0	GRO-a	44	58
368805	20233															2	ug/mL	0	GRO-a	63	76
368806	20233								TNF-a	201285.0						100	ng/mL	0	GRO-a	52	45
368807	20233								IL-1 alpha	201286.0						100	ng/mL	0	GRO-a	54.5	66
368808	20233								IL-6	201287.0						100	ug/mL	0	GRO-a	99	83
368809	20233								IL-17A	201288.0						100	ng/mL	0	GRO-a	46	61
368810	20233								EGF	201289.0						100	ng/mL	0	GRO-a	40	91
368811	20233								IGF-I	201290.0						100	ug/mL	0	GRO-a	37	43
368812	20233								Adiponectin	201291.0						5	ng/mL	0	GRO-a	324	45
368813	20233								Leptin	201292.0						1	ng/mL	0	GRO-a	93	51
368814	20233								Visfatin	201293.0						1	ng/mL	0	GRO-a	110	41
368815	20233															2	ug/mL	0	GRO-a	42	48
368816	20233																	0	HGF	22	59
368817	20233						RA2159	51112.0										1	HGF	49	64
368818	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	HGF	52.5	78
368819	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	HGF	32	83
368820	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	HGF	43	84
368821	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	HGF	45.5	68
368822	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	HGF	41	73
368823	20233						RA2159	51112.0										1	HGF	62	59
368824	20233						N2586	51107.0										1	HGF	53	79
368825	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	HGF	52.5	72
368826	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	HGF	46	75
368827	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	HGF	54	51
368828	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	HGF	46	43
368829	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	HGF	45	43
368830	20233						N2586	51107.0										1	HGF	46.5	42
368831	20233																	0	HGF	20.5	80
368832	20233																	0	HGF	17	30
368833	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	HGF	84	69
368834	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	HGF	77	81
368835	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	HGF	83.5	72
368836	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	HGF	83	61
368837	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	HGF	90	58
368838	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	HGF	50	70
368839	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	HGF	50	73
368840	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	HGF	147	54
368841	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	HGF	147	49
368842	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	HGF	136	39
368843	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	HGF	171.5	56
368844	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	HGF	165	72
368845	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	HGF	148	35
368846	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	HGF	55	69
368847	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	HGF	81	67
368848	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	HGF	59	72
368849	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	HGF	65	48
368850	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	HGF	67.5	64
368851	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	HGF	68	75
368852	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	HGF	40.5	58
368853	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	HGF	61	59
368854	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	HGF	111	55
368855	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	HGF	101	48
368856	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	HGF	152.5	54
368857	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	HGF	132	63
368858	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	HGF	140.5	62
368859	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	HGF	85	47
368860	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	HGF	43.5	36
368861	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	HGF	54	64
368862	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	HGF	48	65
368863	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	HGF	40	53
368864	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	HGF	41	59
368865	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	HGF	43	74
368866	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	HGF	36	66
368867	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	HGF	40	79
368868	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	HGF	51	54
368869	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	HGF	48	70
368870	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	HGF	38.5	50
368871	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	HGF	45.5	46
368872	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	HGF	46	57
368873	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	HGF	52	45
368874	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	HGF	59	58
368875	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	HGF	47	66
368876	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	HGF	53	63
368877	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	HGF	29	68
368878	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	HGF	40	81
368879	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	HGF	36	61
368880	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	HGF	38	67
368881	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	HGF	61	41
368882	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	HGF	58	43
368883	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	HGF	58	32
368884	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	HGF	56	41
368885	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	HGF	47	47
368886	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	HGF	53	61
368887	20233						RA2159	51112.0										1	HGF	42	47
368888	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	HGF	56	75
368889	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	HGF	32.5	54
368890	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	HGF	37	79
368891	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	HGF	37.5	80
368892	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	HGF	33	63
368893	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	HGF	41	56
368894	20233						N2586	51107.0										1	HGF	55	63
368895	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	HGF	45.5	58
368896	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	HGF	44	52
368897	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	HGF	42	63
368898	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	HGF	47	61
368899	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	HGF	40	54
368900	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	HGF	40	55
368901	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	HGF	48	68
368902	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	HGF	38	81
368903	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	HGF	29	69
368904	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	HGF	41	64
368905	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	HGF	38	63
368906	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	HGF	38	86
368907	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	HGF	44	65
368908	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	HGF	58	59
368909	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	HGF	55	67
368910	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	HGF	41	80
368911	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	HGF	57	72
368912	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	HGF	63	70
368913	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	HGF	45.5	72
368914	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	HGF	46	53
368915	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	HGF	59	59
368916	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	HGF	44	69
368917	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	HGF	29	58
368918	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	HGF	36	50
368919	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	HGF	44	72
368920	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	HGF	39.5	50
368921	20233						RA2159	51112.0										1	HGF	49	61
368922	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	HGF	50	61
368923	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	HGF	54	72
368924	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	HGF	42.5	48
368925	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	HGF	54.5	60
368926	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	HGF	50	33
368927	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	HGF	58	46
368928	20233						N2586	51107.0										1	HGF	43	52
368929	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	HGF	83	57
368930	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	HGF	73	65
368931	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	HGF	66.5	62
368932	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	HGF	63	53
368933	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	HGF	75	66
368934	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	HGF	75	56
368935	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	HGF	79	73
368936	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	HGF	68	66
368937	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	HGF	71	50
368938	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	HGF	67	67
368939	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	HGF	73.5	46
368940	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	HGF	62	75
368941	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	HGF	51	73
368942	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	HGF	43	65
368943	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	HGF	48	69
368944	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	HGF	36	70
368945	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	HGF	40	40
368946	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	HGF	37	41
368947	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	HGF	54	35
368948	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	HGF	51.5	46
368949	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	HGF	41	54
368950	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	HGF	55	38
368951	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	HGF	57	36
368952	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	HGF	52.5	46
368953	20233						RA2159	51112.0										1	HGF		0
368954	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	HGF		0
368955	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	HGF		0
368956	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	HGF		0
368957	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	HGF		0
368958	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	HGF		0
368959	20233						RA2159	51112.0										1	HGF		0
368960	20233						N2586	51107.0										1	HGF		0
368961	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	HGF		0
368962	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	HGF		0
368963	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	HGF		0
368964	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	HGF		0
368965	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	HGF		0
368966	20233						N2586	51107.0										1	HGF		0
368967	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	HGF	53	57
368968	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	HGF	56	87
368969	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	HGF	38	74
368970	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	HGF	43	61
368971	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	HGF	41	63
368972	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	HGF	39	48
368973	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	HGF	50.5	50
368974	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	HGF	49	48
368975	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	HGF	49	52
368976	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	HGF	49.5	48
368977	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	HGF	54	46
368978	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	HGF	49	29
368979	20233																	0	HGF	17	59
368980	20233						RA2159	51112.0								2	ug/mL	1	HGF	50.5	62
368981	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	HGF	62.5	52
368982	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	HGF	51	56
368983	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	HGF	58	63
368984	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	HGF	52	64
368985	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	HGF	39.5	86
368986	20233						N2586	51107.0								2	ug/mL	1	HGF	71	46
368987	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	HGF	75.5	34
368988	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	HGF	56	51
368989	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	HGF	76.5	60
368990	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	HGF	65	44
368991	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	HGF	65	50
368992	20233																	0	HGF	17.5	44
368993	20233						RA2159	51112.0										2	HGF	60.5	70
368994	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	HGF	47	61
368995	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	HGF	50	45
368996	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	HGF	48	74
368997	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	HGF	56	83
368998	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	HGF	48	62
368999	20233						RA2159	51112.0										2	HGF	53	61
369000	20233						N2586	51107.0										2	HGF	51	70
369001	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	HGF	49	59
369002	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	HGF	44.5	74
369003	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	HGF	50	67
369004	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	HGF	41	70
369005	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	HGF	43.5	46
369006	20233						N2586	51107.0										2	HGF	51.5	62
369007	20233																	0	HGF	20.5	52
369008	20233																	0	HGF	18	64
369009	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	HGF	89.5	66
369010	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	HGF	80	80
369011	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	HGF	72	72
369012	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	HGF	72	99
369013	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	HGF	60	57
369014	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	HGF	61	63
369015	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	HGF	50	63
369016	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	HGF	145	67
369017	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	HGF	124	56
369018	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	HGF	106	53
369019	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	HGF	127.5	48
369020	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	HGF	96	51
369021	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	HGF	119	33
369022	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	HGF	51.5	54
369023	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	HGF	72	71
369024	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	HGF	83	59
369025	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	HGF	63	71
369026	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	HGF	81.5	66
369027	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	HGF	88	71
369028	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	HGF	64	57
369029	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	HGF	38	73
369030	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	HGF	120	63
369031	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	HGF	198	65
369032	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	HGF	117	69
369033	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	HGF	160.5	50
369034	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	HGF	80	56
369035	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	HGF	119.5	58
369036	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	HGF	42	78
369037	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	HGF	45	75
369038	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	HGF	36	71
369039	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	HGF	40	69
369040	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	HGF	36	70
369041	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	HGF	38	70
369042	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	HGF	41	41
369043	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	HGF	41	59
369044	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	HGF	54	55
369045	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	HGF	50	75
369046	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	HGF	44	67
369047	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	HGF	51.5	56
369048	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	HGF	40	59
369049	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	HGF	43	42
369050	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	HGF	46	41
369051	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	HGF	42	75
369052	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	HGF	39	63
369053	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	HGF	36.5	62
369054	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	HGF	39.5	76
369055	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	HGF	40.5	52
369056	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	HGF	42.5	42
369057	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	HGF	49	45
369058	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	HGF	55.5	52
369059	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	HGF	60.5	86
369060	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	HGF	51	23
369061	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	HGF	63.5	32
369062	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	HGF	44.5	42
369063	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	HGF	45	69
369064	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	HGF	43.5	82
369065	20233						RA2159	51112.0										2	HGF	37	83
369066	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	HGF	38	71
369067	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	HGF	28	58
369068	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	HGF	30	47
369069	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	HGF	38	57
369070	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	HGF	42.5	60
369071	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	HGF	35.5	64
369072	20233						N2586	51107.0										2	HGF	49.5	58
369073	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	HGF	54	81
369074	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	HGF	46	77
369075	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	HGF	63	63
369076	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	HGF	41	55
369077	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	HGF	45	52
369078	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	HGF	47	77
369079	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	HGF	36	66
369080	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	HGF	38	89
369081	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	HGF	35	63
369082	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	HGF	32	64
369083	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	HGF	41.5	78
369084	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	HGF	57	72
369085	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	HGF	50	65
369086	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	HGF	54	41
369087	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	HGF	46	68
369088	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	HGF	55.5	68
369089	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	HGF	47	68
369090	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	HGF	46	73
369091	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	HGF	38	64
369092	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	HGF	32	72
369093	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	HGF	37	70
369094	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	HGF	36	75
369095	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	HGF	39	58
369096	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	HGF	41	49
369097	20233						RA2159	51112.0										2	HGF	44.5	50
369098	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	HGF	44	53
369099	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	HGF	53	61
369100	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	HGF	47.5	68
369101	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	HGF	49	49
369102	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	HGF	37	81
369103	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	HGF	41	73
369104	20233						N2586	51107.0										2	HGF	48	56
369105	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	HGF	64	77
369106	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	HGF	51	58
369107	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	HGF	59.5	42
369108	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	HGF	56	59
369109	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	HGF	52	55
369110	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	HGF	64	64
369111	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	HGF	69	51
369112	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	HGF	70	56
369113	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	HGF	78.5	52
369114	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	HGF	91	44
369115	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	HGF	69	51
369116	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	HGF	64	71
369117	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	HGF	43.5	56
369118	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	HGF	35	73
369119	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	HGF	41	71
369120	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	HGF	41	62
369121	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	HGF	36	66
369122	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	HGF	47.5	58
369123	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	HGF	37	71
369124	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	HGF	42	78
369125	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	HGF	39	75
369126	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	HGF	45	54
369127	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	HGF	35	82
369128	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	HGF	42	59
369129	20233						RA2159	51112.0										2	HGF		0
369130	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	HGF		0
369131	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	HGF		0
369132	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	HGF		0
369133	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	HGF		0
369134	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	HGF		0
369135	20233						RA2159	51112.0										2	HGF		0
369136	20233						N2586	51107.0										2	HGF		0
369137	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	HGF		0
369138	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	HGF		0
369139	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	HGF		0
369140	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	HGF		0
369141	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	HGF		0
369142	20233						N2586	51107.0										2	HGF		0
369143	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	HGF	51	61
369144	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	HGF	41.5	96
369145	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	HGF	40.5	64
369146	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	HGF	37	78
369147	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	HGF	44	71
369148	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	HGF	45	77
369149	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	HGF	47.5	72
369150	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	HGF	51.5	56
369151	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	HGF	43	61
369152	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	HGF	46	46
369153	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	HGF	37	70
369154	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	HGF	39	51
369155	20233																	0	HGF	18	72
369156	20233						RA2159	51112.0								2	ug/mL	2	HGF	54.5	72
369157	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	HGF	52.5	60
369158	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	HGF	55	56
369159	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	HGF	50	67
369160	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	HGF	51.5	68
369161	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	HGF	57	68
369162	20233						N2586	51107.0								2	ug/mL	2	HGF	65	71
369163	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	HGF	63	51
369164	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	HGF	68	42
369165	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	HGF	78	53
369166	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	HGF	52	56
369167	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	HGF	63	61
369168	20233																	0	HGF	17	75
369169	20233						RA2159	51112.0								2	ug/mL	3	HGF	53.5	58
369170	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	HGF	53	59
369171	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	HGF	39.5	56
369172	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	HGF	54	77
369173	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	HGF	57	72
369174	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	HGF	56	56
369175	20233						N2586	51107.0								2	ug/mL	3	HGF	86	65
369176	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	HGF	152	67
369177	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	HGF	76.5	64
369178	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	HGF	91.5	76
369179	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	HGF	47	45
369180	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	HGF	72	58
369181	20233						RA2159	51112.0										3	HGF		0
369182	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	HGF		0
369183	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	HGF		0
369184	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	HGF		0
369185	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	HGF		0
369186	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	HGF		0
369187	20233						RA2159	51112.0										3	HGF		0
369188	20233						N2586	51107.0										3	HGF		0
369189	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	HGF		0
369190	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	HGF		0
369191	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	HGF		0
369192	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	HGF		0
369193	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	HGF		0
369194	20233						N2586	51107.0										3	HGF		0
369195	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	HGF	61	63
369196	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	HGF	44	71
369197	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	HGF	37.5	68
369198	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	HGF	40	63
369199	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	HGF	43	75
369200	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	HGF	39	83
369201	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	HGF	53.5	82
369202	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	HGF	56	75
369203	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	HGF	48.5	62
369204	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	HGF	60	60
369205	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	HGF	51	62
369206	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	HGF	42	61
369207	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	HGF	35	78
369208	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	HGF	42	59
369209	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	HGF	32.5	66
369210	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	HGF	42	82
369211	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	HGF	39.5	82
369212	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	HGF	35.5	64
369213	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	HGF	52.5	64
369214	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	HGF	57.5	84
369215	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	HGF	46	63
369216	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	HGF	49.5	60
369217	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	HGF	45	67
369218	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	HGF	50	54
369219	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	HGF	73	57
369220	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	HGF	59	86
369221	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	HGF	48	60
369222	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	HGF	55	72
369223	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	HGF	55	53
369224	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	HGF	55	77
369225	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	HGF	78	59
369226	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	HGF	75	66
369227	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	HGF	67	61
369228	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	HGF	71	80
369229	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	HGF	70	45
369230	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	HGF	65	74
369231	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	HGF	58.5	82
369232	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	HGF	42	70
369233	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	HGF	35	63
369234	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	HGF	39.5	64
369235	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	HGF	46	67
369236	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	HGF	36.5	50
369237	20233						RA2159	51112.0										3	HGF	47	67
369238	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	HGF	63.5	76
369239	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	HGF	65	63
369240	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	HGF	52	71
369241	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	HGF	66	67
369242	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	HGF	41	57
369243	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	HGF	48	50
369244	20233						N2586	51107.0										3	HGF	55	61
369245	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	HGF	46	62
369246	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	HGF	42	57
369247	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	HGF	26	66
369248	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	HGF	46	72
369249	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	HGF	41.5	72
369250	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	HGF	40	87
369251	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	HGF	35	58
369252	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	HGF	62	84
369253	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	HGF	62	79
369254	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	HGF	53	76
369255	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	HGF	77	59
369256	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	HGF	47	68
369257	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	HGF	50.5	92
369258	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	HGF	33	76
369259	20233						RA2159	51112.0										3	HGF	44.5	86
369260	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	HGF	35	73
369261	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	HGF	29	63
369262	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	HGF	38	70
369263	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	HGF	35	65
369264	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	HGF	34.5	48
369265	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	HGF	36	84
369266	20233						N2586	51107.0										3	HGF	55	51
369267	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	HGF	60	92
369268	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	HGF	45	85
369269	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	HGF	73.5	68
369270	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	HGF	54	57
369271	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	HGF	42	73
369272	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	HGF	43.5	50
369273	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	HGF	41	75
369274	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	HGF	40.5	62
369275	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	HGF	32.5	68
369276	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	HGF	41	59
369277	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	HGF	40	73
369278	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	HGF	38	56
369279	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	HGF	57	65
369280	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	HGF	67.5	60
369281	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	HGF	48	80
369282	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	HGF	88.5	82
369283	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	HGF	44.5	68
369284	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	HGF	45	55
369285	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	HGF	50	63
369286	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	HGF	39	53
369287	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	HGF	29.5	70
369288	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	HGF	33.5	62
369289	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	HGF	38	81
369290	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	HGF	44	48
369291	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	HGF	39.5	78
369292	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	HGF	59	80
369293	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	HGF	56	49
369294	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	HGF	44	74
369295	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	HGF	61.5	70
369296	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	HGF	39	58
369297	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	HGF	40	67
369298	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	HGF	58	57
369299	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	HGF	74	80
369300	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	HGF	62.5	60
369301	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	HGF	63	88
369302	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	HGF	84	72
369303	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	HGF	78	67
369304	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	HGF	44	66
369305	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	HGF	36	67
369306	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	HGF	129	71
369307	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	HGF	185	80
369308	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	HGF	141	61
369309	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	HGF	166	50
369310	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	HGF	63	59
369311	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	HGF	64.5	74
369312	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	HGF	40	74
369313	20233																	0	HGF	18	69
369314	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	HGF	93	53
369315	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	HGF	78.5	62
369316	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	HGF	79	62
369317	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	HGF	88	44
369318	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	HGF	85.5	50
369319	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	HGF	46.5	62
369320	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	HGF	33.5	40
369321	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	HGF	136	65
369322	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	HGF	143	90
369323	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	HGF	127	81
369324	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	HGF	150	56
369325	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	HGF	72	50
369326	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	HGF	105.5	68
369327	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	HGF	61	70
369328	20233																	0	HGF	20	44
369329	20233						RA2159	51112.0										3	HGF	53	69
369330	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	HGF	45	53
369331	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	HGF	40	67
369332	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	HGF	42	46
369333	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	HGF	46	67
369334	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	HGF	46	57
369335	20233						RA2159	51112.0										3	HGF	47	65
369336	20233						N2586	51107.0										3	HGF	59	55
369337	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	HGF	49	71
369338	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	HGF	38	70
369339	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	HGF	55.5	86
369340	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	HGF	47	61
369341	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	HGF	41	38
369342	20233						N2586	51107.0										3	HGF	49	58
369343	20233																	0	HGF	17	53
369344	20233						RA2159	51112.0								2	ug/mL	4	HGF	61	70
369345	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	HGF	60	66
369346	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	HGF	57.5	82
369347	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	HGF	58	49
369348	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	HGF	53	68
369349	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	HGF	61	60
369350	20233						N2586	51107.0								2	ug/mL	4	HGF	85.5	62
369351	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	HGF	94	77
369352	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	HGF	70	55
369353	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	HGF	96	46
369354	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	HGF	71	76
369355	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	HGF	43	48
369356	20233						RA2159	51112.0										4	HGF		0
369357	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	HGF		0
369358	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	HGF		0
369359	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	HGF		0
369360	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	HGF		0
369361	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	HGF		0
369362	20233						RA2159	51112.0										4	HGF		0
369363	20233						N2586	51107.0										4	HGF		0
369364	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	HGF		0
369365	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	HGF		0
369366	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	HGF		0
369367	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	HGF		0
369368	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	HGF		0
369369	20233						N2586	51107.0										4	HGF		0
369370	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	HGF	50	50
369371	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	HGF	41	61
369372	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	HGF	46	54
369373	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	HGF	38	73
369374	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	HGF	42	55
369375	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	HGF	52	78
369376	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	HGF	61	62
369377	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	HGF	53	71
369378	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	HGF	41	67
369379	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	HGF	56	67
369380	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	HGF	50	82
369381	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	HGF	41	81
369382	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	HGF	43.5	54
369383	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	HGF	38.5	58
369384	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	HGF	39	71
369385	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	HGF	42	69
369386	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	HGF	52.5	70
369387	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	HGF	54	51
369388	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	HGF	64.5	64
369389	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	HGF	51.5	58
369390	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	HGF	40.5	54
369391	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	HGF	54	58
369392	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	HGF	49	65
369393	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	HGF	42	58
369394	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	HGF	71.5	92
369395	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	HGF	52	61
369396	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	HGF	51	73
369397	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	HGF	46.5	72
369398	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	HGF	55	61
369399	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	HGF	56	94
369400	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	HGF	76	65
369401	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	HGF	71	62
369402	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	HGF	63	75
369403	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	HGF	71	71
369404	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	HGF	72	65
369405	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	HGF	53.5	64
369406	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	HGF	43	67
369407	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	HGF	37	63
369408	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	HGF	32	61
369409	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	HGF	36	61
369410	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	HGF	35	72
369411	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	HGF	57	51
369412	20233						RA2159	51112.0										4	HGF	45	55
369413	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	HGF	56	74
369414	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	HGF	60	77
369415	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	HGF	44	59
369416	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	HGF	54.5	52
369417	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	HGF	57	77
369418	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	HGF	40	79
369419	20233						N2586	51107.0										4	HGF	55	64
369420	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	HGF	46	83
369421	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	HGF	35.5	56
369422	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	HGF	33	70
369423	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	HGF	31.5	66
369424	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	HGF	35	73
369425	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	HGF	56	91
369426	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	HGF	69	55
369427	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	HGF	65	67
369428	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	HGF	44	75
369429	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	HGF	86	54
369430	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	HGF	50	69
369431	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	HGF	38	61
369432	20233						RA2159	51112.0										4	HGF	35	85
369433	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	HGF	34.5	64
369434	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	HGF	31	49
369435	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	HGF	33	74
369436	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	HGF	37	39
369437	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	HGF	48	17
369438	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	HGF		5
369439	20233						N2586	51107.0										4	HGF	45	7
369440	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	HGF	72	10
369441	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	HGF	40	65
369442	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	HGF	61	44
369443	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	HGF	50	53
369444	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	HGF	40.5	58
369445	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	HGF	53	50
369446	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	HGF	45	71
369447	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	HGF	40	69
369448	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	HGF	37	53
369449	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	HGF	36	65
369450	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	HGF	36	55
369451	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	HGF	43.5	56
369452	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	HGF	49	39
369453	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	HGF	61	65
369454	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	HGF	61	55
369455	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	HGF	67	54
369456	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	HGF	53.5	56
369457	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	HGF	55.5	62
369458	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	HGF	40	71
369459	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	HGF	34	61
369460	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	HGF	49.5	72
369461	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	HGF	36.5	74
369462	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	HGF	27	47
369463	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	HGF	35	61
369464	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	HGF	34.5	52
369465	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	HGF	52	60
369466	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	HGF	41	63
369467	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	HGF	56	49
369468	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	HGF	56	71
369469	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	HGF	43	33
369470	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	HGF	50	50
369471	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	HGF	47	57
369472	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	HGF	43	45
369473	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	HGF	58.5	52
369474	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	HGF	81	64
369475	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	HGF	92	66
369476	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	HGF	95.5	80
369477	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	HGF	65	71
369478	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	HGF	61	71
369479	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	HGF	89	57
369480	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	HGF	37	67
369481	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	HGF	130.5	58
369482	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	HGF	150.5	58
369483	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	HGF	180	57
369484	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	HGF	158	57
369485	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	HGF	84	55
369486	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	HGF	43	57
369487	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	HGF	41	43
369488	20233																	0	HGF	18	59
369489	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	HGF	91	44
369490	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	HGF	81	42
369491	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	HGF	88	54
369492	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	HGF	77	71
369493	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	HGF	77	55
369494	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	HGF	59	67
369495	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	HGF	46.5	54
369496	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	HGF	187	57
369497	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	HGF	190	74
369498	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	HGF	153.5	64
369499	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	HGF	220	33
369500	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	HGF	143	49
369501	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	HGF	41	48
369502	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	HGF	53	67
369503	20233																	0	HGF	16	41
369504	20233						RA2159	51112.0										4	HGF	52	67
369505	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	HGF	37	79
369506	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	HGF	40	56
369507	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	HGF	43.5	64
369508	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	HGF	43	72
369509	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	HGF	43	71
369510	20233						RA2159	51112.0										4	HGF	47	63
369511	20233						N2586	51107.0										4	HGF	52	83
369512	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	HGF	52.5	50
369513	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	HGF	46.5	54
369514	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	HGF	54	55
369515	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	HGF	45.5	58
369516	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	HGF	41	55
369517	20233						N2586	51107.0										4	HGF	52.5	66
369518	20233								TNF-a	201285.0						100	ng/mL	0	HGF	19.5	54
369519	20233								IL-1 alpha	201286.0						100	ng/mL	0	HGF	25	61
369520	20233								IL-6	201287.0						100	ug/mL	0	HGF	21	47
369521	20233								IL-17A	201288.0						100	ng/mL	0	HGF	22	55
369522	20233								EGF	201289.0						100	ng/mL	0	HGF	25	67
369523	20233								IGF-I	201290.0						100	ug/mL	0	HGF	22	58
369524	20233								Adiponectin	201291.0						5	ng/mL	0	HGF	189	59
369525	20233								Leptin	201292.0						1	ng/mL	0	HGF	20	55
369526	20233								Visfatin	201293.0						1	ng/mL	0	HGF	20	59
369527	20233															2	ug/mL	0	HGF	17	62
369528	20233								TNF-a	201285.0						100	ng/mL	0	HGF	18	62
369529	20233								IL-1 alpha	201286.0						100	ng/mL	0	HGF	25	66
369530	20233								IL-6	201287.0						100	ug/mL	0	HGF	18	53
369531	20233								IL-17A	201288.0						100	ng/mL	0	HGF	20	61
369532	20233								EGF	201289.0						100	ng/mL	0	HGF	19	74
369533	20233								IGF-I	201290.0						100	ug/mL	0	HGF	19	59
369534	20233								Adiponectin	201291.0						5	ng/mL	0	HGF	188	65
369535	20233								Leptin	201292.0						1	ng/mL	0	HGF	21	71
369536	20233								Visfatin	201293.0						1	ng/mL	0	HGF	19	63
369537	20233															2	ug/mL	0	HGF	16	61
369538	20233								TNF-a	201285.0						100	ng/mL	0	HGF	17	61
369539	20233								IL-1 alpha	201286.0						100	ng/mL	0	HGF	21	91
369540	20233								IL-6	201287.0						100	ug/mL	0	HGF	22	71
369541	20233								IL-17A	201288.0						100	ng/mL	0	HGF	14	71
369542	20233								EGF	201289.0						100	ng/mL	0	HGF	19	61
369543	20233								IGF-I	201290.0						100	ug/mL	0	HGF	17	70
369544	20233								Adiponectin	201291.0						5	ng/mL	0	HGF	124.5	70
369545	20233								Leptin	201292.0						1	ng/mL	0	HGF	17.5	46
369546	20233								Visfatin	201293.0						1	ng/mL	0	HGF	17	64
369547	20233															2	ug/mL	0	HGF	19	67
369548	20233								TNF-a	201285.0						100	ng/mL	0	HGF	15	38
369549	20233								IL-1 alpha	201286.0						100	ng/mL	0	HGF	26	70
369550	20233								IL-6	201287.0						100	ug/mL	0	HGF	22	68
369551	20233								IL-17A	201288.0						100	ng/mL	0	HGF	16	58
369552	20233								EGF	201289.0						100	ng/mL	0	HGF	17	70
369553	20233								IGF-I	201290.0						100	ug/mL	0	HGF	18	54
369554	20233								Adiponectin	201291.0						5	ng/mL	0	HGF	187	49
369555	20233								Leptin	201292.0						1	ng/mL	0	HGF	23.5	54
369556	20233								Visfatin	201293.0						1	ng/mL	0	HGF	17.5	46
369557	20233															2	ug/mL	0	HGF	18	45
369558	20233																	0	IL1-a	75	65
369559	20233						RA2159	51112.0										1	IL1-a	55	58
369560	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL1-a	50	50
369561	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL1-a	67	54
369562	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL1-a	64	72
369563	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL1-a	71.5	62
369564	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL1-a	65	54
369565	20233						RA2159	51112.0										1	IL1-a	62	66
369566	20233						N2586	51107.0										1	IL1-a	85	50
369567	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL1-a	79	67
369568	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL1-a	80.5	60
369569	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL1-a	69	54
369570	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL1-a	92.5	44
369571	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL1-a	69	35
369572	20233						N2586	51107.0										1	IL1-a	103	39
369573	20233																	0	IL1-a	88	46
369574	20233																	0	IL1-a	61	35
369575	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL1-a	61.5	72
369576	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL1-a	70	63
369577	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL1-a	69	76
369578	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL1-a	58.5	60
369579	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL1-a	83	52
369580	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL1-a	75.5	56
369581	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL1-a	83	71
369582	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL1-a	83	35
369583	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL1-a	92	47
369584	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL1-a	58	37
369585	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL1-a	76	58
369586	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL1-a	104	60
369587	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL1-a	76	35
369588	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL1-a	59.5	72
369589	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL1-a	24707	55
369590	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL1-a	25093	67
369591	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL1-a	27027	51
369592	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL1-a	21794.5	48
369593	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL1-a	19451	75
369594	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL1-a	24047	57
369595	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL1-a	73.5	52
369596	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL1-a	27141	43
369597	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL1-a	25298	59
369598	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL1-a	27892	55
369599	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL1-a	27141	58
369600	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL1-a	26515	56
369601	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL1-a	25491.5	46
369602	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL1-a	72.5	40
369603	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL1-a	72	59
369604	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL1-a	73	61
369605	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL1-a	62	51
369606	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL1-a	69	60
369607	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL1-a	66	63
369608	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL1-a	72	57
369609	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL1-a	52	58
369610	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL1-a	71	53
369611	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL1-a	70	61
369612	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL1-a	51.5	40
369613	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL1-a	59	37
369614	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL1-a	64	53
369615	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL1-a	62.5	70
369616	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL1-a	74	60
369617	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL1-a	81	62
369618	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL1-a	56	57
369619	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL1-a	51.5	50
369620	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL1-a	58	85
369621	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL1-a	55.5	60
369622	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL1-a	57	55
369623	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL1-a	65	29
369624	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL1-a	55	39
369625	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL1-a	103	29
369626	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL1-a	85	29
369627	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL1-a	56.5	32
369628	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL1-a	73	41
369629	20233						RA2159	51112.0										1	IL1-a	62	45
369630	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL1-a	251	72
369631	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL1-a	82	73
369632	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL1-a	55	85
369633	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL1-a	57	81
369634	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL1-a	53	58
369635	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL1-a	68	42
369636	20233						N2586	51107.0										1	IL1-a	67	44
369637	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL1-a	64	49
369638	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL1-a	74	47
369639	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL1-a	58	65
369640	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL1-a	65	57
369641	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL1-a	56	49
369642	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL1-a	60	44
369643	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL1-a	79.5	60
369644	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL1-a	57	67
369645	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL1-a	49	57
369646	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL1-a	68	61
369647	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL1-a	90.5	48
369648	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL1-a	63.5	56
369649	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL1-a	51	57
369650	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL1-a	50.5	64
369651	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL1-a	91	72
369652	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL1-a	55.5	76
369653	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL1-a	69	50
369654	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL1-a	70	56
369655	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL1-a	58.5	50
369656	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL1-a	68	41
369657	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL1-a	74	61
369658	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL1-a	85.5	62
369659	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL1-a	118	55
369660	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL1-a	78	45
369661	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL1-a	83.5	50
369662	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL1-a	73	59
369663	20233						RA2159	51112.0										1	IL1-a	56	65
369664	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL1-a	88	36
369665	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL1-a	74	67
369666	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL1-a	64	44
369667	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL1-a	80	65
369668	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL1-a	65.5	36
369669	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL1-a	84	35
369670	20233						N2586	51107.0										1	IL1-a	54	43
369671	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL1-a	85	64
369672	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL1-a	99	53
369673	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL1-a	92.5	42
369674	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL1-a	104	76
369675	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL1-a	106.5	64
369676	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL1-a	104	57
369677	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL1-a	85.5	58
369678	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL1-a	87	61
369679	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL1-a	89	29
369680	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL1-a	74.5	50
369681	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL1-a	107	44
369682	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL1-a	77	60
369683	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL1-a	55	55
369684	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL1-a	48.5	50
369685	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL1-a	57.5	44
369686	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL1-a	79	54
369687	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL1-a	56	36
369688	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL1-a	68.5	38
369689	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL1-a	61.5	38
369690	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL1-a	79.5	40
369691	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL1-a	58	59
369692	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL1-a	67	27
369693	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL1-a	61.5	38
369694	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL1-a	66	36
369695	20233						RA2159	51112.0										1	IL1-a		0
369696	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL1-a		0
369697	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL1-a		0
369698	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL1-a		0
369699	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL1-a		0
369700	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL1-a		0
369701	20233						RA2159	51112.0										1	IL1-a		0
369702	20233						N2586	51107.0										1	IL1-a		0
369703	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL1-a		0
369704	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL1-a		0
369705	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL1-a		0
369706	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL1-a		0
369707	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL1-a		0
369708	20233						N2586	51107.0										1	IL1-a		0
369709	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL1-a	71	63
369710	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL1-a	101	56
369711	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL1-a	48	55
369712	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL1-a	51	54
369713	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL1-a	58	43
369714	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL1-a	65	43
369715	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL1-a	75	45
369716	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL1-a	126	34
369717	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL1-a	215	65
369718	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL1-a	59	40
369719	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL1-a	82	39
369720	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL1-a	50.5	28
369721	20233																	0	IL1-a	50	67
369722	20233						RA2159	51112.0								2	ug/mL	1	IL1-a	69.5	44
369723	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL1-a	79	50
369724	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL1-a	50	48
369725	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL1-a	119.5	80
369726	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL1-a	50	62
369727	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL1-a	65.5	70
369728	20233						N2586	51107.0								2	ug/mL	1	IL1-a	54	61
369729	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL1-a	47	35
369730	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL1-a	86	36
369731	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL1-a	70	31
369732	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL1-a	48	48
369733	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL1-a	65.5	30
369734	20233																	0	IL1-a	63.5	56
369735	20233						RA2159	51112.0										2	IL1-a	85	65
369736	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL1-a	72.5	52
369737	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL1-a	62	58
369738	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL1-a	70	62
369739	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL1-a	64	77
369740	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL1-a	91	78
369741	20233						RA2159	51112.0										2	IL1-a	83	65
369742	20233						N2586	51107.0										2	IL1-a	76	59
369743	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL1-a	63	51
369744	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL1-a	64.5	76
369745	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL1-a	86.5	62
369746	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL1-a	59	73
369747	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL1-a	92	47
369748	20233						N2586	51107.0										2	IL1-a	74	86
369749	20233																	0	IL1-a	58	64
369750	20233																	0	IL1-a	67.5	54
369751	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL1-a	53	73
369752	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL1-a	67	69
369753	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL1-a	70	60
369754	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL1-a	61	62
369755	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL1-a	57	53
369756	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL1-a	93	65
369757	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL1-a	204	63
369758	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL1-a	81	71
369759	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL1-a	53	55
369760	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL1-a	68.5	56
369761	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL1-a	79.5	42
369762	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL1-a	97	58
369763	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL1-a	77.5	40
369764	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL1-a	71.5	42
369765	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL1-a	25457	65
369766	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL1-a	25298	57
369767	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL1-a	26322	69
369768	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL1-a	26106	60
369769	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL1-a	26390	67
369770	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL1-a	20475	61
369771	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL1-a	56	57
369772	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL1-a	19156	63
369773	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL1-a	23432.5	58
369774	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL1-a	16401	45
369775	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL1-a	17108	53
369776	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL1-a	18996	54
369777	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL1-a	18086	47
369778	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL1-a	76	57
369779	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL1-a	232.5	74
369780	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL1-a	52	61
369781	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL1-a	151	61
369782	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL1-a	62	61
369783	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL1-a	62	57
369784	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL1-a	80	37
369785	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL1-a	62	57
369786	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL1-a	64	70
369787	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL1-a	76	69
369788	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL1-a	77	56
369789	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL1-a	64	57
369790	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL1-a	58	52
369791	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL1-a	56	57
369792	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL1-a	70.5	34
369793	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL1-a	165	59
369794	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL1-a	76	56
369795	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL1-a	73	57
369796	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL1-a	89	55
369797	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL1-a	54	55
369798	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL1-a	53	28
369799	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL1-a	53	45
369800	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL1-a	53	51
369801	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL1-a	93.5	74
369802	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL1-a	69.5	16
369803	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL1-a	70	19
369804	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL1-a	78	41
369805	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL1-a	152.5	68
369806	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL1-a	76	83
369807	20233						RA2159	51112.0										2	IL1-a	58	61
369808	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL1-a	61	47
369809	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL1-a	67.5	60
369810	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL1-a	57	46
369811	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL1-a	66.5	72
369812	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL1-a	55.5	62
369813	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL1-a	174	73
369814	20233						N2586	51107.0										2	IL1-a	64.5	56
369815	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL1-a	85	61
369816	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL1-a	74	55
369817	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL1-a	79	59
369818	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL1-a	63	46
369819	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL1-a	57	63
369820	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL1-a	152	67
369821	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL1-a	79	63
369822	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL1-a	53.5	74
369823	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL1-a	63	61
369824	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL1-a	62.5	72
369825	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL1-a	52	46
369826	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL1-a	61	75
369827	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL1-a	475	47
369828	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL1-a	75	42
369829	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL1-a	60	65
369830	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL1-a	74.5	72
369831	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL1-a	84	79
369832	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL1-a	102.5	70
369833	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL1-a	93	79
369834	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL1-a	53	85
369835	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL1-a	59	55
369836	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL1-a	106.5	64
369837	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL1-a	55	57
369838	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL1-a	63	35
369839	20233						RA2159	51112.0										2	IL1-a	74	41
369840	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL1-a	63.5	40
369841	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL1-a	86	65
369842	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL1-a	52	76
369843	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL1-a	98	49
369844	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL1-a	77	50
369845	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL1-a	79.5	72
369846	20233						N2586	51107.0										2	IL1-a	70.5	58
369847	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL1-a	86	67
369848	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL1-a	91	63
369849	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL1-a	90	50
369850	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL1-a	87	66
369851	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL1-a	118	63
369852	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL1-a	93	53
369853	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL1-a	82	72
369854	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL1-a	84	53
369855	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL1-a	106	39
369856	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL1-a	101	36
369857	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL1-a	113	61
369858	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL1-a	88.5	60
369859	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL1-a	56	62
369860	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL1-a	60	50
369861	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL1-a	57	58
369862	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL1-a	51	55
369863	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL1-a	53	50
369864	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL1-a	60.5	56
369865	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL1-a	71	73
369866	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL1-a	77	57
369867	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL1-a	79	59
369868	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL1-a	53	41
369869	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL1-a	70	45
369870	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL1-a	64	69
369871	20233						RA2159	51112.0										2	IL1-a		0
369872	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL1-a		0
369873	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL1-a		0
369874	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL1-a		0
369875	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL1-a		0
369876	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL1-a		0
369877	20233						RA2159	51112.0										2	IL1-a		0
369878	20233						N2586	51107.0										2	IL1-a		0
369879	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL1-a		0
369880	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL1-a		0
369881	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL1-a		0
369882	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL1-a		0
369883	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL1-a		0
369884	20233						N2586	51107.0										2	IL1-a		0
369885	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL1-a	65.5	44
369886	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL1-a	84	101
369887	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL1-a	69	56
369888	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL1-a	77	65
369889	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL1-a	77	63
369890	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL1-a	81.5	58
369891	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL1-a	75.5	54
369892	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL1-a	68	57
369893	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL1-a	57	52
369894	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL1-a	54	46
369895	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL1-a	64	55
369896	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL1-a	61.5	32
369897	20233																	0	IL1-a	78.5	74
369898	20233						RA2159	51112.0								2	ug/mL	2	IL1-a	226.5	64
369899	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL1-a	88.5	38
369900	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL1-a	94	48
369901	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL1-a	59	57
369902	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL1-a	73.5	52
369903	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL1-a	94	74
369904	20233						N2586	51107.0								2	ug/mL	2	IL1-a	74	55
369905	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL1-a	125	48
369906	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL1-a	73	40
369907	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL1-a	79	55
369908	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL1-a	57.5	30
369909	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL1-a	61	41
369910	20233																	0	IL1-a	62	68
369911	20233						RA2159	51112.0								2	ug/mL	3	IL1-a	62	50
369912	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL1-a	98	75
369913	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL1-a	62	58
369914	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL1-a	98	65
369915	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL1-a	72	61
369916	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL1-a	72	50
369917	20233						N2586	51107.0								2	ug/mL	3	IL1-a	69	55
369918	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL1-a	442	42
369919	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL1-a	114.5	50
369920	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL1-a	65	49
369921	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL1-a	67	49
369922	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL1-a	80	57
369923	20233						RA2159	51112.0										3	IL1-a		0
369924	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL1-a		0
369925	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL1-a		0
369926	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL1-a		0
369927	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL1-a		0
369928	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL1-a		0
369929	20233						RA2159	51112.0										3	IL1-a		0
369930	20233						N2586	51107.0										3	IL1-a		0
369931	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL1-a		0
369932	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL1-a		0
369933	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL1-a		0
369934	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL1-a		0
369935	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL1-a		0
369936	20233						N2586	51107.0										3	IL1-a		0
369937	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL1-a	300.5	54
369938	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL1-a	133	74
369939	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL1-a	68	52
369940	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL1-a	58.5	52
369941	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL1-a	63	65
369942	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL1-a	61	57
369943	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL1-a	67.5	50
369944	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL1-a	57	61
369945	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL1-a	48	61
369946	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL1-a	53	59
369947	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL1-a	80.5	50
369948	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL1-a	69	59
369949	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL1-a	80.5	66
369950	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL1-a	51	65
369951	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL1-a	55.5	58
369952	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL1-a	46.5	62
369953	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL1-a	68	71
369954	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL1-a	67.5	68
369955	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL1-a	64	56
369956	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL1-a	81	74
369957	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL1-a	52	55
369958	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL1-a	59	73
369959	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL1-a	64	58
369960	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL1-a	55	52
369961	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL1-a	82.5	56
369962	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL1-a	95	70
369963	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL1-a	132.5	76
369964	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL1-a	84	75
369965	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL1-a	96	67
369966	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL1-a	108	67
369967	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL1-a	93	67
369968	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL1-a	118.5	50
369969	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL1-a	302	64
369970	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL1-a	80	53
369971	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL1-a	84	44
369972	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL1-a	120.5	74
369973	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL1-a	77.5	50
369974	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL1-a	85	71
369975	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL1-a	94	61
369976	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL1-a	59	58
369977	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL1-a	52.5	58
369978	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL1-a	90	49
369979	20233						RA2159	51112.0										3	IL1-a	68	58
369980	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL1-a	64	52
369981	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL1-a	84	50
369982	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL1-a	62	47
369983	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL1-a	536	67
369984	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL1-a	81	67
369985	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL1-a	68	52
369986	20233						N2586	51107.0										3	IL1-a	356	58
369987	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL1-a	77	75
369988	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL1-a	63.5	54
369989	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL1-a	113	63
369990	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL1-a	174	62
369991	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL1-a	83.5	72
369992	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL1-a	62	79
369993	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL1-a	104	64
369994	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL1-a	71	92
369995	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL1-a	72	72
369996	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL1-a	148.5	56
369997	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL1-a	282.5	58
369998	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL1-a	75	65
369999	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL1-a	70	52
370000	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL1-a	56	63
370001	20233						RA2159	51112.0										3	IL1-a	66	75
370002	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL1-a	61.5	56
370003	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL1-a	45	65
370004	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL1-a	61	67
370005	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL1-a	78.5	58
370006	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL1-a	82	43
370007	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL1-a	70.5	66
370008	20233						N2586	51107.0										3	IL1-a	53	59
370009	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL1-a	85	69
370010	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL1-a	56	50
370011	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL1-a	293	59
370012	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL1-a	245	65
370013	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL1-a	69.5	50
370014	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL1-a	72	60
370015	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL1-a	87	57
370016	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL1-a	72	84
370017	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL1-a	72	66
370018	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL1-a	62.5	62
370019	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL1-a	52	75
370020	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL1-a	52	64
370021	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL1-a	67	66
370022	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL1-a	60	69
370023	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL1-a	56	86
370024	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL1-a	349	67
370025	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL1-a	55	70
370026	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL1-a	61	55
370027	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL1-a	61	65
370028	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL1-a	54.5	74
370029	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL1-a	55	64
370030	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL1-a	45	53
370031	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL1-a	60.5	62
370032	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL1-a	53	65
370033	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL1-a	85.5	78
370034	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL1-a	198.5	50
370035	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL1-a	51.5	60
370036	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL1-a	47.5	58
370037	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL1-a	71	67
370038	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL1-a	55	66
370039	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL1-a	59.5	60
370040	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL1-a	74	51
370041	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL1-a	26973	58
370042	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL1-a	22787	59
370043	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL1-a	27030	87
370044	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL1-a	21510	72
370045	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL1-a	21236	70
370046	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL1-a	22719	67
370047	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL1-a	74.5	56
370048	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL1-a	24327	66
370049	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL1-a	24087	75
370050	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL1-a	18156.5	58
370051	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL1-a	22627.5	48
370052	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL1-a	23916.5	72
370053	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL1-a	15323	71
370054	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL1-a	50	59
370055	20233																	0	IL1-a	89	58
370056	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL1-a	472	57
370057	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL1-a	64	53
370058	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL1-a	82	69
370059	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL1-a	75.5	38
370060	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL1-a	66.5	76
370061	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL1-a	67.5	62
370062	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL1-a	69.5	44
370063	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL1-a	53	61
370064	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL1-a	101	87
370065	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL1-a	58	62
370066	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL1-a	57.5	66
370067	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL1-a	107	64
370068	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL1-a	60.5	62
370069	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL1-a	484	53
370070	20233																	0	IL1-a	84	69
370071	20233						RA2159	51112.0										3	IL1-a	66	57
370072	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL1-a	68.5	70
370073	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL1-a	225	61
370074	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL1-a	111	42
370075	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL1-a	139	50
370076	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL1-a	91	37
370077	20233						RA2159	51112.0										3	IL1-a	216.5	56
370078	20233						N2586	51107.0										3	IL1-a	84	44
370079	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL1-a	48	63
370080	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL1-a	48.5	54
370081	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL1-a	78	50
370082	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL1-a	67	44
370083	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL1-a	67	49
370084	20233						N2586	51107.0										3	IL1-a	76	57
370085	20233																	0	IL1-a	62	47
370086	20233						RA2159	51112.0								2	ug/mL	4	IL1-a	96	64
370087	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL1-a	131.5	76
370088	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL1-a	101	41
370089	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL1-a	75	71
370090	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL1-a	74	51
370091	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL1-a	63	58
370092	20233						N2586	51107.0								2	ug/mL	4	IL1-a	90.5	70
370093	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL1-a	75	81
370094	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL1-a	49	47
370095	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL1-a	115	58
370096	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL1-a	59	64
370097	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL1-a	63.5	38
370098	20233						RA2159	51112.0										4	IL1-a		0
370099	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL1-a		0
370100	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL1-a		0
370101	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL1-a		0
370102	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL1-a		0
370103	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL1-a		0
370104	20233						RA2159	51112.0										4	IL1-a		0
370105	20233						N2586	51107.0										4	IL1-a		0
370106	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL1-a		0
370107	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL1-a		0
370108	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL1-a		0
370109	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL1-a		0
370110	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL1-a		0
370111	20233						N2586	51107.0										4	IL1-a		0
370112	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL1-a	63	48
370113	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL1-a	75	46
370114	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL1-a	132	50
370115	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL1-a	98	76
370116	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL1-a	102	50
370117	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL1-a	183	69
370118	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL1-a	79	56
370119	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL1-a	81.5	52
370120	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL1-a	86	64
370121	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL1-a	68	59
370122	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL1-a	59	70
370123	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL1-a	66	53
370124	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL1-a	82	51
370125	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL1-a	54	54
370126	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL1-a	82.5	50
370127	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL1-a	93	54
370128	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL1-a	581	82
370129	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL1-a	51	51
370130	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL1-a	54	67
370131	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL1-a	81	59
370132	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL1-a	56	56
370133	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL1-a	72	60
370134	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL1-a	77	54
370135	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL1-a	171	50
370136	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL1-a	88	81
370137	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL1-a	115	53
370138	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL1-a	97.5	76
370139	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL1-a	108.5	56
370140	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL1-a	90	50
370141	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL1-a	96	63
370142	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL1-a	88	55
370143	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL1-a	82	51
370144	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL1-a	100	56
370145	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL1-a	73.5	52
370146	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL1-a	98	55
370147	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL1-a	88.5	56
370148	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL1-a	66	55
370149	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL1-a	59	78
370150	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL1-a	118	65
370151	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL1-a	57	59
370152	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL1-a	75.5	54
370153	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL1-a	62	60
370154	20233						RA2159	51112.0										4	IL1-a	61.5	56
370155	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL1-a	71	54
370156	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL1-a	132	77
370157	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL1-a	125	50
370158	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL1-a	61	39
370159	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL1-a	76	58
370160	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL1-a	74	73
370161	20233						N2586	51107.0										4	IL1-a	50.5	56
370162	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL1-a	201	60
370163	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL1-a	54	52
370164	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL1-a	52	55
370165	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL1-a	48	50
370166	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL1-a	79	38
370167	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL1-a	214	73
370168	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL1-a	80	53
370169	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL1-a	166.5	94
370170	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL1-a	46	50
370171	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL1-a	289	55
370172	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL1-a	57	59
370173	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL1-a	56	54
370174	20233						RA2159	51112.0										4	IL1-a	88	81
370175	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL1-a	69	59
370176	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL1-a	51	45
370177	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL1-a	55.5	50
370178	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL1-a	53	35
370179	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL1-a	56.5	16
370180	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL1-a		6
370181	20233						N2586	51107.0										4	IL1-a		4
370182	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL1-a	130	10
370183	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL1-a	63	51
370184	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL1-a	80	45
370185	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL1-a	60	37
370186	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL1-a	67	53
370187	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL1-a	160	49
370188	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL1-a	57	55
370189	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL1-a	63	61
370190	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL1-a	66	62
370191	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL1-a	104	70
370192	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL1-a	65	57
370193	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL1-a	60	73
370194	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL1-a	49.5	20
370195	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL1-a	49	47
370196	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL1-a	58	50
370197	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL1-a	88	50
370198	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL1-a	57	43
370199	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL1-a	65	65
370200	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL1-a	51	73
370201	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL1-a	75.5	32
370202	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL1-a	392	66
370203	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL1-a	76	50
370204	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL1-a	48	56
370205	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL1-a	57	54
370206	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL1-a	44	46
370207	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL1-a	50	41
370208	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL1-a	61	59
370209	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL1-a	47	45
370210	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL1-a	82	66
370211	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL1-a	92	41
370212	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL1-a	65	47
370213	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL1-a	55	50
370214	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL1-a	48.5	64
370215	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL1-a	72.5	46
370216	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL1-a	26939	75
370217	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL1-a	26744.5	60
370218	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL1-a	27897	63
370219	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL1-a	27577	64
370220	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL1-a	26232	67
370221	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL1-a	26288.5	60
370222	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL1-a	65.5	50
370223	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL1-a	25091	54
370224	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL1-a	24658	53
370225	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL1-a	27315	52
370226	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL1-a	27463	63
370227	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL1-a	23221	39
370228	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL1-a	23095	66
370229	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL1-a	73	49
370230	20233																	0	IL1-a	83	64
370231	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL1-a	74	62
370232	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL1-a	75	52
370233	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL1-a	56	50
370234	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL1-a	67.5	60
370235	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL1-a	64	51
370236	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL1-a	60	65
370237	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL1-a	48.5	30
370238	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL1-a	62	53
370239	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL1-a	63	67
370240	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL1-a	68	59
370241	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL1-a	73	59
370242	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL1-a	66	39
370243	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL1-a	61.5	48
370244	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL1-a	75	53
370245	20233																	0	IL1-a	56.5	48
370246	20233						RA2159	51112.0										4	IL1-a	62	73
370247	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL1-a	61	62
370248	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL1-a	61	61
370249	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL1-a	47.5	54
370250	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL1-a	61.5	102
370251	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL1-a	50	75
370252	20233						RA2159	51112.0										4	IL1-a	60.5	58
370253	20233						N2586	51107.0										4	IL1-a	107.5	50
370254	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL1-a	70	42
370255	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL1-a	117.5	36
370256	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL1-a	49	52
370257	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL1-a	49	53
370258	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL1-a	57	51
370259	20233						N2586	51107.0										4	IL1-a	195	37
370260	20233								TNF-a	201285.0						100	ng/mL	0	IL1-a	70	66
370261	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL1-a	28506	45
370262	20233								IL-6	201287.0						100	ug/mL	0	IL1-a	96	35
370263	20233								IL-17A	201288.0						100	ng/mL	0	IL1-a	71	66
370264	20233								EGF	201289.0						100	ng/mL	0	IL1-a	353	54
370265	20233								IGF-I	201290.0						100	ug/mL	0	IL1-a	66.5	60
370266	20233								Adiponectin	201291.0						5	ng/mL	0	IL1-a	238	50
370267	20233								Leptin	201292.0						1	ng/mL	0	IL1-a	79	45
370268	20233								Visfatin	201293.0						1	ng/mL	0	IL1-a	68	40
370269	20233															2	ug/mL	0	IL1-a	64	49
370270	20233								TNF-a	201285.0						100	ng/mL	0	IL1-a	84	32
370271	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL1-a	27732	45
370272	20233								IL-6	201287.0						100	ug/mL	0	IL1-a	60.5	64
370273	20233								IL-17A	201288.0						100	ng/mL	0	IL1-a	76.5	58
370274	20233								EGF	201289.0						100	ng/mL	0	IL1-a	67	49
370275	20233								IGF-I	201290.0						100	ug/mL	0	IL1-a	85.5	34
370276	20233								Adiponectin	201291.0						5	ng/mL	0	IL1-a	258	71
370277	20233								Leptin	201292.0						1	ng/mL	0	IL1-a	79	82
370278	20233								Visfatin	201293.0						1	ng/mL	0	IL1-a	79.5	56
370279	20233															2	ug/mL	0	IL1-a	72	46
370280	20233								TNF-a	201285.0						100	ng/mL	0	IL1-a	79	63
370281	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL1-a	26950	64
370282	20233								IL-6	201287.0						100	ug/mL	0	IL1-a	81.5	54
370283	20233								IL-17A	201288.0						100	ng/mL	0	IL1-a	84	55
370284	20233								EGF	201289.0						100	ng/mL	0	IL1-a	68	54
370285	20233								IGF-I	201290.0						100	ug/mL	0	IL1-a	74.5	56
370286	20233								Adiponectin	201291.0						5	ng/mL	0	IL1-a	200.5	58
370287	20233								Leptin	201292.0						1	ng/mL	0	IL1-a	55.5	62
370288	20233								Visfatin	201293.0						1	ng/mL	0	IL1-a	72.5	52
370289	20233															2	ug/mL	0	IL1-a	74.5	70
370290	20233								TNF-a	201285.0						100	ng/mL	0	IL1-a	97	37
370291	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL1-a	27418	52
370292	20233								IL-6	201287.0						100	ug/mL	0	IL1-a	313	67
370293	20233								IL-17A	201288.0						100	ng/mL	0	IL1-a	80	59
370294	20233								EGF	201289.0						100	ng/mL	0	IL1-a	65	76
370295	20233								IGF-I	201290.0						100	ug/mL	0	IL1-a	66	65
370296	20233								Adiponectin	201291.0						5	ng/mL	0	IL1-a	259	43
370297	20233								Leptin	201292.0						1	ng/mL	0	IL1-a	383.5	36
370298	20233								Visfatin	201293.0						1	ng/mL	0	IL1-a	125	49
370299	20233															2	ug/mL	0	IL1-a	64	47
370300	20233																	0	IL3	47	78
370301	20233						RA2159	51112.0										1	IL3	49	66
370302	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL3	48	62
370303	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL3	42	81
370304	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL3	46.5	90
370305	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL3	46.5	90
370306	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL3	45	68
370307	20233						RA2159	51112.0										1	IL3	55.5	78
370308	20233						N2586	51107.0										1	IL3	50	84
370309	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL3	50.5	78
370310	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL3	51.5	80
370311	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL3	48	82
370312	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL3	49	61
370313	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL3	40	50
370314	20233						N2586	51107.0										1	IL3	45.5	44
370315	20233																	0	IL3	57	67
370316	20233																	0	IL3	42	52
370317	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	IL3	41	59
370318	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL3	40	83
370319	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL3	51.5	90
370320	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL3	46	75
370321	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL3	62.5	70
370322	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL3	41.5	64
370323	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	IL3	45	71
370324	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	IL3	59	57
370325	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	IL3	52	47
370326	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL3	46.5	42
370327	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL3	46	75
370328	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	IL3	52.5	80
370329	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	IL3	50	46
370330	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	IL3	46	57
370331	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	IL3	52	65
370332	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL3	47	78
370333	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL3	55.5	70
370334	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL3	53	50
370335	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL3	49.5	54
370336	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL3	50.5	70
370337	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	IL3	54	70
370338	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	IL3	51	61
370339	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	IL3	54.5	64
370340	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL3	58	63
370341	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL3	53	75
370342	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	IL3	61	44
370343	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	IL3	57	40
370344	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	IL3	40	55
370345	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	IL3	48	50
370346	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL3	46	67
370347	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL3	44	49
370348	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL3	44	72
370349	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL3	45	85
370350	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL3	45	64
370351	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	IL3	46	84
370352	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	IL3	49.5	74
370353	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	IL3	40	45
370354	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL3	46	55
370355	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL3	44.5	52
370356	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	IL3	50	57
370357	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	IL3	38.5	56
370358	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	IL3	68.5	56
370359	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	IL3	41	84
370360	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL3	41	72
370361	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL3	37	79
370362	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL3	47.5	84
370363	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL3	44.5	70
370364	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL3	41	75
370365	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	IL3	59	38
370366	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	IL3	44.5	36
370367	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL3	39	39
370368	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL3	51	52
370369	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	IL3	37.5	46
370370	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	IL3	47	58
370371	20233						RA2159	51112.0										1	IL3	48	55
370372	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL3	96	64
370373	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL3	47	69
370374	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL3	43	85
370375	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL3	43	78
370376	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL3	46	69
370377	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	IL3	41.5	64
370378	20233						N2586	51107.0										1	IL3	49	53
370379	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL3	50	62
370380	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL3	37.5	54
370381	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL3	41	73
370382	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL3	48	63
370383	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL3	44	61
370384	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	IL3	48.5	46
370385	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	IL3	45.5	72
370386	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL3	39	78
370387	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL3	49.5	72
370388	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL3	42.5	68
370389	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL3	45	71
370390	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	IL3	40	72
370391	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	IL3	45	81
370392	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	IL3	41	67
370393	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	IL3	57.5	60
370394	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL3	48.5	74
370395	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL3	40	87
370396	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	IL3	44.5	58
370397	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	IL3	44	56
370398	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	IL3	34	45
370399	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	IL3	42.5	60
370400	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL3	41	77
370401	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL3	48	67
370402	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL3	54	66
370403	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL3	49	63
370404	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL3	55	59
370405	20233						RA2159	51112.0										1	IL3	41.5	82
370406	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	IL3	46	54
370407	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	IL3	46	94
370408	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL3	46	46
370409	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL3	49	59
370410	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	IL3	49	49
370411	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	IL3	53.5	44
370412	20233						N2586	51107.0										1	IL3	36	47
370413	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	IL3	112.5	74
370414	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL3	123	82
370415	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL3	124	73
370416	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL3	116.5	74
370417	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL3	135	85
370418	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL3	133.5	74
370419	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	IL3	97.5	76
370420	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	IL3	98	78
370421	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL3	104	47
370422	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL3	93	55
370423	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	IL3	109	49
370424	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	IL3	93.5	72
370425	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	IL3	45	85
370426	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL3	40	78
370427	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL3	42.5	52
370428	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL3	47	69
370429	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL3	49.5	50
370430	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL3	41	43
370431	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	IL3	40.5	34
370432	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	IL3	49	57
370433	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL3	42	71
370434	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL3	36.5	30
370435	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	IL3	40.5	40
370436	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	IL3	41	63
370437	20233						RA2159	51112.0										1	IL3		0
370438	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	IL3		0
370439	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	IL3		0
370440	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	IL3		0
370441	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	IL3		0
370442	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	IL3		0
370443	20233						RA2159	51112.0										1	IL3		0
370444	20233						N2586	51107.0										1	IL3		0
370445	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	IL3		0
370446	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	IL3		0
370447	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	IL3		0
370448	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	IL3		0
370449	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	IL3		0
370450	20233						N2586	51107.0										1	IL3		0
370451	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	IL3	42.5	56
370452	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL3	43.5	88
370453	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL3	40	77
370454	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL3	38	75
370455	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL3	43	59
370456	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL3	39	49
370457	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	IL3	50.5	40
370458	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	IL3	71	41
370459	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL3	94.5	52
370460	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL3	43	54
370461	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	IL3	63	37
370462	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	IL3	32.5	42
370463	20233																	0	IL3	47	64
370464	20233						RA2159	51112.0								2	ug/mL	1	IL3	50	43
370465	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	IL3	44	65
370466	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL3	41	47
370467	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL3	45	79
370468	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	IL3	33	72
370469	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	IL3	34.5	84
370470	20233						N2586	51107.0								2	ug/mL	1	IL3	42	68
370471	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	IL3	45.5	28
370472	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL3	50	36
370473	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL3	51	39
370474	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	IL3	38.5	56
370475	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	IL3	42	34
370476	20233																	0	IL3	51	66
370477	20233						RA2159	51112.0										2	IL3	41	69
370478	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL3	52.5	56
370479	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL3	45	55
370480	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL3	51.5	76
370481	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL3	43	83
370482	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL3	54	61
370483	20233						RA2159	51112.0										2	IL3	49	69
370484	20233						N2586	51107.0										2	IL3	49	72
370485	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL3	50	56
370486	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL3	45	59
370487	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL3	60	53
370488	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL3	42	69
370489	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL3	53	35
370490	20233						N2586	51107.0										2	IL3	53	71
370491	20233																	0	IL3	44.5	62
370492	20233																	0	IL3	47	63
370493	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	IL3	49	81
370494	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL3	49.5	72
370495	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL3	54	65
370496	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL3	46	67
370497	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL3	45.5	68
370498	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL3	45	65
370499	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	IL3	45	57
370500	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	IL3	63.5	52
370501	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	IL3	47.5	70
370502	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	IL3	44	56
370503	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL3	55	52
370504	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	IL3	41	73
370505	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	IL3	41	61
370506	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	IL3	49	54
370507	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	IL3	52	75
370508	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL3	43	73
370509	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL3	45	73
370510	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL3	53	75
370511	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL3	56.5	68
370512	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL3	49.5	62
370513	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	IL3	39	77
370514	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	IL3	54	79
370515	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	IL3	58	75
370516	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	IL3	55	61
370517	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL3	59	71
370518	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	IL3	58	56
370519	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	IL3	50	55
370520	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	IL3	47.5	82
370521	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	IL3	97	69
370522	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL3	36	60
370523	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL3	67	63
370524	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL3	39.5	68
370525	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL3	44.5	64
370526	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL3	45.5	36
370527	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	IL3	51	70
370528	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	IL3	48	71
370529	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	IL3	44	72
370530	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	IL3	45	67
370531	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL3	42.5	72
370532	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	IL3	43	60
370533	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	IL3	38	61
370534	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	IL3	46	70
370535	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	IL3	55.5	60
370536	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL3	49	61
370537	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL3	51.5	72
370538	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL3	66	61
370539	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL3	40	69
370540	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL3	40.5	52
370541	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	IL3	42	38
370542	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	IL3	43	52
370543	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	IL3	49	70
370544	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	IL3	52	11
370545	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL3	47	29
370546	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	IL3	51	53
370547	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	IL3	63	78
370548	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	IL3	52	76
370549	20233						RA2159	51112.0										2	IL3	42	78
370550	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL3	40.5	62
370551	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL3	55	47
370552	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL3	46	73
370553	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL3	47	61
370554	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL3	43.5	64
370555	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	IL3	97.5	86
370556	20233						N2586	51107.0										2	IL3	50	65
370557	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL3	45	62
370558	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL3	40	77
370559	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL3	58	69
370560	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL3	53	59
370561	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL3	46.5	64
370562	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	IL3	43.5	70
370563	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	IL3	42	75
370564	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	IL3	41	84
370565	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL3	46	67
370566	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL3	46.5	54
370567	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	IL3	46	71
370568	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL3	40	65
370569	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	IL3	52	76
370570	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	IL3	44	56
370571	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	IL3	47	70
370572	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL3	49	83
370573	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	IL3	50	79
370574	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	IL3	45	67
370575	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	IL3	47	82
370576	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL3	42.5	68
370577	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL3	43	68
370578	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL3	51	73
370579	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL3	44.5	64
370580	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL3	44	52
370581	20233						RA2159	51112.0										2	IL3	45	53
370582	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	IL3	43	46
370583	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	IL3	53	79
370584	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	IL3	44	90
370585	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL3	44	52
370586	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	IL3	42	99
370587	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	IL3	37	75
370588	20233						N2586	51107.0										2	IL3	55	81
370589	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	IL3	100	85
370590	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL3	96	77
370591	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL3	123	55
370592	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL3	103	71
370593	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL3	102	66
370594	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL3	95	80
370595	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	IL3	110	61
370596	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	IL3	102	93
370597	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	IL3	119.5	54
370598	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL3	123	54
370599	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	IL3	109	65
370600	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	IL3	114	69
370601	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	IL3	42	76
370602	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL3	37	59
370603	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL3	51.5	64
370604	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL3	40	78
370605	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL3	46.5	66
370606	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL3	42	75
370607	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	IL3	39	89
370608	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	IL3	45	73
370609	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	IL3	49	87
370610	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL3	40	70
370611	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	IL3	49	57
370612	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	IL3	44	61
370613	20233						RA2159	51112.0										2	IL3		0
370614	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	IL3		0
370615	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	IL3		0
370616	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	IL3		0
370617	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	IL3		0
370618	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	IL3		0
370619	20233						RA2159	51112.0										2	IL3		0
370620	20233						N2586	51107.0										2	IL3		0
370621	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	IL3		0
370622	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	IL3		0
370623	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	IL3		0
370624	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	IL3		0
370625	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	IL3		0
370626	20233						N2586	51107.0										2	IL3		0
370627	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	IL3	42	61
370628	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL3	45	104
370629	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL3	47.5	64
370630	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL3	50	52
370631	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL3	46.5	70
370632	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL3	39	84
370633	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	IL3	44	75
370634	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	IL3	45	74
370635	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	IL3	38	65
370636	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL3	41	55
370637	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	IL3	47	68
370638	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	IL3	42	60
370639	20233																	0	IL3	44	89
370640	20233						RA2159	51112.0								2	ug/mL	2	IL3	46	65
370641	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	IL3	47	42
370642	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	IL3	44.5	68
370643	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	IL3	33.5	78
370644	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	IL3	40	53
370645	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	IL3	41	66
370646	20233						N2586	51107.0								2	ug/mL	2	IL3	41	65
370647	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	IL3	37	50
370648	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	IL3	38	48
370649	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	IL3	39	57
370650	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	IL3	36	54
370651	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	IL3	39	80
370652	20233																	0	IL3	44.5	60
370653	20233						RA2159	51112.0								2	ug/mL	3	IL3	40	72
370654	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	IL3	47.5	64
370655	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL3	44	67
370656	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL3	48	81
370657	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	IL3	36	61
370658	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	IL3	39	73
370659	20233						N2586	51107.0								2	ug/mL	3	IL3	42	69
370660	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	IL3	163	77
370661	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL3	45.5	68
370662	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL3	36.5	54
370663	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	IL3	40	73
370664	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	IL3	48	57
370665	20233						RA2159	51112.0										3	IL3		0
370666	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL3		0
370667	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL3		0
370668	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL3		0
370669	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL3		0
370670	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL3		0
370671	20233						RA2159	51112.0										3	IL3		0
370672	20233						N2586	51107.0										3	IL3		0
370673	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL3		0
370674	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL3		0
370675	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL3		0
370676	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL3		0
370677	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL3		0
370678	20233						N2586	51107.0										3	IL3		0
370679	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	IL3	100	69
370680	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL3	59.5	80
370681	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL3	37	59
370682	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL3	51.5	72
370683	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL3	42.5	78
370684	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL3	47.5	64
370685	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	IL3	45	70
370686	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	IL3	42.5	92
370687	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL3	37	87
370688	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL3	45	65
370689	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	IL3	46	78
370690	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	IL3	40	79
370691	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	IL3	39	72
370692	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL3	40	53
370693	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL3	46	67
370694	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL3	39.5	70
370695	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL3	41.5	72
370696	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL3	39	87
370697	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	IL3	40	92
370698	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	IL3	46	98
370699	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL3	47	69
370700	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL3	43	74
370701	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	IL3	47.5	66
370702	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	IL3	36.5	64
370703	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	IL3	135	77
370704	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL3	107	85
370705	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL3	110	73
370706	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL3	109	90
370707	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL3	109	60
370708	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL3	109.5	72
370709	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	IL3	105	81
370710	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	IL3	116	84
370711	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL3	115.5	80
370712	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL3	96	69
370713	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	IL3	110	60
370714	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	IL3	110	78
370715	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	IL3	40	72
370716	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL3	46	90
370717	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL3	46.5	64
370718	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL3	41	65
370719	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL3	37	67
370720	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL3	45	63
370721	20233						RA2159	51112.0										3	IL3	40	73
370722	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	IL3	46.5	60
370723	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	IL3	49	60
370724	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL3	40	72
370725	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL3	47.5	56
370726	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	IL3	49.5	78
370727	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	IL3	34	65
370728	20233						N2586	51107.0										3	IL3	54	75
370729	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	IL3	39.5	66
370730	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL3	44.5	84
370731	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL3	42	77
370732	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL3	85	65
370733	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL3	47	74
370734	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	IL3	38.5	70
370735	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	IL3	43	72
370736	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	IL3	42	89
370737	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	IL3	43	79
370738	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL3	69.5	70
370739	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL3	113	75
370740	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	IL3	48	75
370741	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	IL3	40	74
370742	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	IL3	34.5	66
370743	20233						RA2159	51112.0										3	IL3	42.5	94
370744	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL3	41	69
370745	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL3	40	82
370746	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL3	41	63
370747	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL3	40.5	68
370748	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL3	48	59
370749	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	IL3	42	81
370750	20233						N2586	51107.0										3	IL3	40	56
370751	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL3	40	83
370752	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL3	43	77
370753	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL3	131.5	80
370754	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL3	115	79
370755	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL3	36.5	68
370756	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	IL3	42	63
370757	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	IL3	41	83
370758	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL3	38	79
370759	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL3	45	80
370760	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL3	43	61
370761	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL3	43	81
370762	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL3	33	65
370763	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	IL3	51	62
370764	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	IL3	44	86
370765	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL3	47	75
370766	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL3	125	77
370767	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	IL3	35	73
370768	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	IL3	40	59
370769	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	IL3	39.5	82
370770	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL3	45	59
370771	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL3	47	77
370772	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL3	39	88
370773	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL3	43	63
370774	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL3	45	55
370775	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	IL3	48	83
370776	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	IL3	103	78
370777	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	IL3	42	56
370778	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL3	37	66
370779	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL3	41	61
370780	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	IL3	41	79
370781	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	IL3	36	63
370782	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	IL3	43	73
370783	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	IL3	43.5	64
370784	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL3	52.5	74
370785	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL3	46.5	88
370786	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL3	59	58
370787	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL3	47.5	84
370788	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL3	43	61
370789	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	IL3	48	77
370790	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	IL3	48	67
370791	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	IL3	49	77
370792	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL3	45.5	74
370793	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL3	58	69
370794	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	IL3	46	72
370795	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	IL3	41.5	76
370796	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	IL3	39	72
370797	20233																	0	IL3	48.5	68
370798	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	IL3	73	65
370799	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL3	39	86
370800	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL3	49	86
370801	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL3	42	47
370802	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL3	51	62
370803	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL3	39.5	82
370804	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	IL3	39	46
370805	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	IL3	45	73
370806	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	IL3	47	106
370807	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL3	39	69
370808	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL3	45	70
370809	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	IL3	57	73
370810	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	IL3	45	73
370811	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	IL3	193	65
370812	20233																	0	IL3	47.5	54
370813	20233						RA2159	51112.0										3	IL3	42	88
370814	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	IL3	38	65
370815	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	IL3	86	69
370816	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	IL3	40.5	58
370817	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	IL3	52	83
370818	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	IL3	47	64
370819	20233						RA2159	51112.0										3	IL3	78	67
370820	20233						N2586	51107.0										3	IL3	40	62
370821	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	IL3	46	67
370822	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	IL3	44	56
370823	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	IL3	44.5	78
370824	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	IL3	45	70
370825	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	IL3	36	41
370826	20233						N2586	51107.0										3	IL3	39.5	66
370827	20233																	0	IL3	46.5	52
370828	20233						RA2159	51112.0								2	ug/mL	4	IL3	42	73
370829	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	IL3	44	66
370830	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	IL3	38	79
370831	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	IL3	39.5	70
370832	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	IL3	40	63
370833	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	IL3	35	73
370834	20233						N2586	51107.0								2	ug/mL	4	IL3	45.5	80
370835	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	IL3	43	65
370836	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	IL3	37	72
370837	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	IL3	34.5	56
370838	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	IL3	43	68
370839	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	IL3	34.5	48
370840	20233						RA2159	51112.0										4	IL3		0
370841	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL3		0
370842	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL3		0
370843	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL3		0
370844	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL3		0
370845	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL3		0
370846	20233						RA2159	51112.0										4	IL3		0
370847	20233						N2586	51107.0										4	IL3		0
370848	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL3		0
370849	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL3		0
370850	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL3		0
370851	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL3		0
370852	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL3		0
370853	20233						N2586	51107.0										4	IL3		0
370854	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	IL3	41	61
370855	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL3	42.5	50
370856	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL3	46	64
370857	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL3	49	79
370858	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL3	46	77
370859	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL3	66	73
370860	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	IL3	40	53
370861	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	IL3	39.5	70
370862	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	IL3	41	61
370863	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL3	38	67
370864	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	IL3	39	82
370865	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	IL3	39	68
370866	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	IL3	44.5	64
370867	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL3	41	58
370868	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL3	45	71
370869	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL3	45.5	52
370870	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL3	221	73
370871	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL3	39	54
370872	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	IL3	43.5	90
370873	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	IL3	48	66
370874	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	IL3	39.5	54
370875	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL3	41	62
370876	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	IL3	42	47
370877	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	IL3	76	67
370878	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	IL3	111.5	98
370879	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL3	100	73
370880	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL3	113.5	80
370881	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL3	110	65
370882	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL3	105	80
370883	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL3	95	75
370884	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	IL3	118	76
370885	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	IL3	112	63
370886	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	IL3	109	77
370887	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL3	104	69
370888	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	IL3	112	69
370889	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	IL3	94	57
370890	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	IL3	38	72
370891	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL3	38	62
370892	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL3	53.5	62
370893	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL3	39	72
370894	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL3	36	77
370895	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL3	34	83
370896	20233						RA2159	51112.0										4	IL3	46	75
370897	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	IL3	42	68
370898	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	IL3	56	75
370899	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	IL3	64	50
370900	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL3	41	45
370901	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	IL3	43.5	66
370902	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	IL3	41	84
370903	20233						N2586	51107.0										4	IL3	37.5	82
370904	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	IL3	92	84
370905	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	IL3	44	62
370906	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL3	43	73
370907	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL3	41.5	66
370908	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	IL3	44	57
370909	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL3	119	57
370910	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	IL3	49	59
370911	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	IL3	86.5	76
370912	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	IL3	39.5	74
370913	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL3	127.5	62
370914	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	IL3	40	59
370915	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	IL3	41	66
370916	20233						RA2159	51112.0										4	IL3	41	79
370917	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL3	42	62
370918	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL3	44	57
370919	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL3	38	59
370920	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL3	39	45
370921	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL3	40	29
370922	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	IL3	44	10
370923	20233						N2586	51107.0										4	IL3		2
370924	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL3	48	11
370925	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL3	40	61
370926	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL3	38	44
370927	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL3	41	49
370928	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL3	40	79
370929	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	IL3	59	59
370930	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	IL3	37	70
370931	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL3	39	81
370932	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL3	39	59
370933	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL3	45	68
370934	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL3	43	72
370935	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL3	46	52
370936	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	IL3	34	34
370937	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	IL3	40	61
370938	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	IL3	41	58
370939	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	IL3	43.5	50
370940	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL3	39	56
370941	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	IL3	38	73
370942	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	IL3	34	69
370943	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	IL3	38	54
370944	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	IL3	180.5	80
370945	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL3	38	89
370946	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL3	41	66
370947	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL3	37.5	66
370948	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL3	37	64
370949	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL3	40	65
370950	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	IL3	31	72
370951	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	IL3	37	59
370952	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	IL3	52	50
370953	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	IL3	40	52
370954	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL3	43	58
370955	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	IL3	37	63
370956	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	IL3	36	63
370957	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	IL3	39	80
370958	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	IL3	56	77
370959	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL3	45	87
370960	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL3	184.5	64
370961	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL3	49	78
370962	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL3	41.5	54
370963	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL3	87	77
370964	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	IL3	40	83
370965	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	IL3	49	77
370966	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	IL3	49	77
370967	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	IL3	50	55
370968	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL3	70	53
370969	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	IL3	43	44
370970	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	IL3	49	65
370971	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	IL3	40	63
370972	20233																	0	IL3	50	70
370973	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	IL3	48	45
370974	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL3	38	60
370975	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL3	45.5	60
370976	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL3	38	65
370977	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL3	39	61
370978	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL3	38	81
370979	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	IL3	39.5	70
370980	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	IL3	54	65
370981	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	IL3	49	79
370982	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	IL3	52	65
370983	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL3	48.5	48
370984	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	IL3	39	50
370985	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	IL3	41	51
370986	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	IL3	39	67
370987	20233																	0	IL3	45.5	64
370988	20233						RA2159	51112.0										4	IL3	39	57
370989	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	IL3	37.5	78
370990	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	IL3	42.5	62
370991	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	IL3	37	71
370992	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	IL3	43	75
370993	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	IL3	38	67
370994	20233						RA2159	51112.0										4	IL3	40	84
370995	20233						N2586	51107.0										4	IL3	38	86
370996	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	IL3	45	47
370997	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	IL3	57	57
370998	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	IL3	40	59
370999	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	IL3	37	69
371000	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	IL3	41	65
371001	20233						N2586	51107.0										4	IL3	87	59
371002	20233								TNF-a	201285.0						100	ng/mL	0	IL3	49	99
371003	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL3	55	70
371004	20233								IL-6	201287.0						100	ug/mL	0	IL3	63	49
371005	20233								IL-17A	201288.0						100	ng/mL	0	IL3	41.5	68
371006	20233								EGF	201289.0						100	ng/mL	0	IL3	106.5	58
371007	20233								IGF-I	201290.0						100	ug/mL	0	IL3	44	58
371008	20233								Adiponectin	201291.0						5	ng/mL	0	IL3	330.5	66
371009	20233								Leptin	201292.0						1	ng/mL	0	IL3	46	56
371010	20233								Visfatin	201293.0						1	ng/mL	0	IL3	54	68
371011	20233															2	ug/mL	0	IL3	50	63
371012	20233								TNF-a	201285.0						100	ng/mL	0	IL3	52	49
371013	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL3	56	59
371014	20233								IL-6	201287.0						100	ug/mL	0	IL3	53.5	78
371015	20233								IL-17A	201288.0						100	ng/mL	0	IL3	49	58
371016	20233								EGF	201289.0						100	ng/mL	0	IL3	63	80
371017	20233								IGF-I	201290.0						100	ug/mL	0	IL3	55.5	58
371018	20233								Adiponectin	201291.0						5	ng/mL	0	IL3	345	53
371019	20233								Leptin	201292.0						1	ng/mL	0	IL3	46	80
371020	20233								Visfatin	201293.0						1	ng/mL	0	IL3	53	61
371021	20233															2	ug/mL	0	IL3	51	56
371022	20233								TNF-a	201285.0						100	ng/mL	0	IL3	38.5	74
371023	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL3	46.5	64
371024	20233								IL-6	201287.0						100	ug/mL	0	IL3	55.5	64
371025	20233								IL-17A	201288.0						100	ng/mL	0	IL3	47	69
371026	20233								EGF	201289.0						100	ng/mL	0	IL3	39	72
371027	20233								IGF-I	201290.0						100	ug/mL	0	IL3	43.5	54
371028	20233								Adiponectin	201291.0						5	ng/mL	0	IL3	319	65
371029	20233								Leptin	201292.0						1	ng/mL	0	IL3	37	62
371030	20233								Visfatin	201293.0						1	ng/mL	0	IL3	51	58
371031	20233															2	ug/mL	0	IL3	56	78
371032	20233								TNF-a	201285.0						100	ng/mL	0	IL3	51	47
371033	20233								IL-1 alpha	201286.0						100	ng/mL	0	IL3	52	73
371034	20233								IL-6	201287.0						100	ug/mL	0	IL3	110.5	66
371035	20233								IL-17A	201288.0						100	ng/mL	0	IL3	44	81
371036	20233								EGF	201289.0						100	ng/mL	0	IL3	44	82
371037	20233								IGF-I	201290.0						100	ug/mL	0	IL3	45.5	50
371038	20233								Adiponectin	201291.0						5	ng/mL	0	IL3	374	51
371039	20233								Leptin	201292.0						1	ng/mL	0	IL3	151	57
371040	20233								Visfatin	201293.0						1	ng/mL	0	IL3	43	51
371041	20233															2	ug/mL	0	IL3	39	52
371042	20233																	0	SCF	25	78
371043	20233						RA2159	51112.0										1	SCF	46	61
371044	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	SCF	48	83
371045	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	SCF	44	72
371046	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	SCF	43	77
371047	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	SCF	46	66
371048	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	SCF	48	50
371049	20233						RA2159	51112.0										1	SCF	48	70
371050	20233						N2586	51107.0										1	SCF	63	81
371051	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	SCF	68	88
371052	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	SCF	66	75
371053	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	SCF	63.5	68
371054	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	SCF	63	57
371055	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	SCF	61	56
371056	20233						N2586	51107.0										1	SCF	56	49
371057	20233																	0	SCF	26.5	68
371058	20233																	0	SCF	25.5	50
371059	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	SCF	94.5	64
371060	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	SCF	86	74
371061	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SCF	108	72
371062	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SCF	98	64
371063	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SCF	99	69
371064	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	SCF	56	69
371065	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	SCF	44.5	88
371066	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	SCF	194	65
371067	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	SCF	149	44
371068	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SCF	153	47
371069	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SCF	181	75
371070	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SCF	201	49
371071	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	SCF	185	57
371072	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	SCF	62	70
371073	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	SCF	75	72
371074	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	SCF	64	87
371075	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SCF	77	60
371076	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SCF	66	69
371077	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SCF	66	70
371078	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	SCF	48.5	60
371079	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	SCF	48	64
371080	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	SCF	128	52
371081	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	SCF	137.5	60
371082	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SCF	172	63
371083	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SCF	166	81
371084	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SCF	147	57
371085	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	SCF	92	35
371086	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	SCF	49	39
371087	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	SCF	41	67
371088	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	SCF	47	72
371089	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SCF	37	50
371090	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SCF	35	62
371091	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SCF	43	71
371092	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	SCF	37	64
371093	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	SCF	45	75
371094	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	SCF	64.5	60
371095	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	SCF	58	61
371096	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SCF	58	63
371097	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SCF	65	49
371098	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SCF	51	57
371099	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	SCF	56	46
371100	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	SCF	76	67
371101	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	SCF	41.5	60
371102	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	SCF	33	65
371103	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SCF	34	73
371104	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SCF	39	80
371105	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SCF	45	69
371106	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	SCF	47	61
371107	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	SCF	84	47
371108	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	SCF	70	49
371109	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SCF	75	46
371110	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SCF	64	41
371111	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SCF	44.5	30
371112	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	SCF	67	53
371113	20233						RA2159	51112.0										1	SCF	42	55
371114	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	SCF	53	78
371115	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	SCF	38.5	82
371116	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	SCF	40	73
371117	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	SCF	37	68
371118	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	SCF	37	71
371119	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	SCF	38	51
371120	20233						N2586	51107.0										1	SCF	65	63
371121	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	SCF	64	52
371122	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	SCF	59.5	68
371123	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	SCF	63	70
371124	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	SCF	56	62
371125	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	SCF	56	50
371126	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	SCF	60	29
371127	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	SCF	49	53
371128	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	SCF	40	69
371129	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SCF	38	60
371130	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SCF	43	62
371131	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SCF	44.5	74
371132	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	SCF	39	85
371133	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	SCF	38	93
371134	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	SCF	73	73
371135	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	SCF	72	81
371136	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SCF	51	51
371137	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SCF	73.5	86
371138	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SCF	74	68
371139	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	SCF	62	67
371140	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	SCF	52.5	58
371141	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	SCF	44	68
371142	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	SCF	38	74
371143	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SCF	33	73
371144	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SCF	42	65
371145	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SCF	40	53
371146	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	SCF	39	75
371147	20233						RA2159	51112.0										1	SCF	40	68
371148	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	SCF	69	47
371149	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	SCF	64	85
371150	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SCF	59	55
371151	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SCF	72	61
371152	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SCF	69	33
371153	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	SCF	69	50
371154	20233						N2586	51107.0										1	SCF	56	60
371155	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	SCF	73	69
371156	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	SCF	77	60
371157	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SCF	74.5	74
371158	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SCF	72	50
371159	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SCF	87	70
371160	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	SCF	84	81
371161	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	SCF	98	77
371162	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	SCF	84	69
371163	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SCF	90	37
371164	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SCF	86.5	64
371165	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SCF	89	65
371166	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	SCF	71	66
371167	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	SCF	34	63
371168	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	SCF	32	53
371169	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SCF	29	50
371170	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SCF	33.5	70
371171	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SCF	29	36
371172	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	SCF	33	38
371173	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	SCF	64	33
371174	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	SCF	52	59
371175	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SCF	51	55
371176	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SCF	53	36
371177	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SCF	53	64
371178	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	SCF	53	41
371179	20233						RA2159	51112.0										1	SCF		0
371180	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	SCF		0
371181	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	SCF		0
371182	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	SCF		0
371183	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	SCF		0
371184	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	SCF		0
371185	20233						RA2159	51112.0										1	SCF		0
371186	20233						N2586	51107.0										1	SCF		0
371187	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	SCF		0
371188	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	SCF		0
371189	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	SCF		0
371190	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	SCF		0
371191	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	SCF		0
371192	20233						N2586	51107.0										1	SCF		0
371193	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	SCF	43	60
371194	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	SCF	36	59
371195	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SCF	34.5	78
371196	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SCF	36	60
371197	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SCF	38	59
371198	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	SCF	35	53
371199	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	SCF	56	57
371200	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	SCF	65	45
371201	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SCF	63	66
371202	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SCF	62.5	54
371203	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SCF	68.5	48
371204	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	SCF	50	37
371205	20233																	0	SCF	20	61
371206	20233						RA2159	51112.0								2	ug/mL	1	SCF	45	49
371207	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	SCF	50	69
371208	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	SCF	37	58
371209	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	SCF	48	53
371210	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	SCF	45	81
371211	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	SCF	32	87
371212	20233						N2586	51107.0								2	ug/mL	1	SCF	79.5	58
371213	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	SCF	83.5	46
371214	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	SCF	63	45
371215	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	SCF	87	55
371216	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	SCF	73	39
371217	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	SCF	74.5	36
371218	20233																	0	SCF	27	63
371219	20233						RA2159	51112.0										2	SCF	39	61
371220	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	SCF	43	72
371221	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	SCF	44	67
371222	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	SCF	44	82
371223	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	SCF	44	76
371224	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	SCF	46.5	72
371225	20233						RA2159	51112.0										2	SCF	43	75
371226	20233						N2586	51107.0										2	SCF	65.5	60
371227	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	SCF	64	53
371228	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	SCF	63	67
371229	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	SCF	68	58
371230	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	SCF	57	66
371231	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	SCF	61	44
371232	20233						N2586	51107.0										2	SCF	75	73
371233	20233																	0	SCF	23.5	70
371234	20233																	0	SCF	21.5	52
371235	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	SCF	93	90
371236	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	SCF	78	83
371237	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	SCF	81	75
371238	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	SCF	80.5	72
371239	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	SCF	67	62
371240	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	SCF	64	68
371241	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	SCF	44	60
371242	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	SCF	179	58
371243	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	SCF	154	65
371244	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	SCF	150	61
371245	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	SCF	166	49
371246	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	SCF	115	55
371247	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	SCF	138	55
371248	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	SCF	65	57
371249	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	SCF	66	55
371250	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	SCF	80	82
371251	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	SCF	70	57
371252	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	SCF	87	77
371253	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	SCF	61	84
371254	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	SCF	71	53
371255	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	SCF	39	71
371256	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	SCF	156	75
371257	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	SCF	221	77
371258	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	SCF	148	55
371259	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	SCF	204	55
371260	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	SCF	104	49
371261	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	SCF	137	74
371262	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	SCF	56	61
371263	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	SCF	50	52
371264	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	SCF	39	59
371265	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	SCF	47	83
371266	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	SCF	43	65
371267	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	SCF	38.5	84
371268	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	SCF	40.5	38
371269	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	SCF	43	59
371270	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	SCF	61	83
371271	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	SCF	62	64
371272	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	SCF	63	66
371273	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	SCF	62.5	84
371274	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	SCF	49	63
371275	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	SCF	51	69
371276	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	SCF	55	63
371277	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	SCF	43	82
371278	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	SCF	46.5	66
371279	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	SCF	43	78
371280	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	SCF	46	81
371281	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	SCF	38	59
371282	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	SCF	40	35
371283	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	SCF	47	29
371284	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	SCF	81.5	38
371285	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	SCF	79	75
371286	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	SCF	62.5	16
371287	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	SCF	78	30
371288	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	SCF	50.5	52
371289	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	SCF	60	74
371290	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	SCF	54.5	98
371291	20233						RA2159	51112.0										2	SCF	41.5	74
371292	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	SCF	43	69
371293	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	SCF	37	51
371294	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	SCF	39	71
371295	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	SCF	40	68
371296	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	SCF	39	65
371297	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	SCF	42	91
371298	20233						N2586	51107.0										2	SCF	65	50
371299	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	SCF	64	75
371300	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	SCF	54	79
371301	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	SCF	77	75
371302	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	SCF	48	61
371303	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	SCF	55	50
371304	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	SCF	50.5	50
371305	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	SCF	36.5	76
371306	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	SCF	45	95
371307	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	SCF	42	71
371308	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	SCF	40	68
371309	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	SCF	37.5	86
371310	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	SCF	37.5	70
371311	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	SCF	67	90
371312	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	SCF	76.5	48
371313	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	SCF	53	76
371314	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	SCF	75	80
371315	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	SCF	55	80
371316	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	SCF	64	72
371317	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	SCF	40.5	66
371318	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	SCF	34	88
371319	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	SCF	35.5	66
371320	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	SCF	42	92
371321	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	SCF	34	61
371322	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	SCF	40	44
371323	20233						RA2159	51112.0										2	SCF	36	61
371324	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	SCF	64	49
371325	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	SCF	62.5	68
371326	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	SCF	58	85
371327	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	SCF	64	55
371328	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	SCF	46	85
371329	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	SCF	43	66
371330	20233						N2586	51107.0										2	SCF	60	61
371331	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	SCF	60	84
371332	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	SCF	58	69
371333	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	SCF	60.5	60
371334	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	SCF	64	58
371335	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	SCF	55	69
371336	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	SCF	59	87
371337	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	SCF	95	51
371338	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	SCF	87	66
371339	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	SCF	93	55
371340	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	SCF	106.5	42
371341	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	SCF	83	64
371342	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	SCF	79	64
371343	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	SCF	34	82
371344	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	SCF	32	65
371345	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	SCF	36	63
371346	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	SCF	30	64
371347	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	SCF	32	70
371348	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	SCF	37	66
371349	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	SCF	54	93
371350	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	SCF	49	64
371351	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	SCF	45	89
371352	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	SCF	57	54
371353	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	SCF	46	60
371354	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	SCF	45	67
371355	20233						RA2159	51112.0										2	SCF		0
371356	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	SCF		0
371357	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	SCF		0
371358	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	SCF		0
371359	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	SCF		0
371360	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	SCF		0
371361	20233						RA2159	51112.0										2	SCF		0
371362	20233						N2586	51107.0										2	SCF		0
371363	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	SCF		0
371364	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	SCF		0
371365	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	SCF		0
371366	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	SCF		0
371367	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	SCF		0
371368	20233						N2586	51107.0										2	SCF		0
371369	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	SCF	40	69
371370	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	SCF	34	92
371371	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	SCF	36	67
371372	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	SCF	36	61
371373	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	SCF	32.5	70
371374	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	SCF	37	64
371375	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	SCF	53.5	76
371376	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	SCF	58	63
371377	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	SCF	53	73
371378	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	SCF	68	65
371379	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	SCF	43	64
371380	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	SCF	49	45
371381	20233																	0	SCF	17	81
371382	20233						RA2159	51112.0								2	ug/mL	2	SCF	51.5	62
371383	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	SCF	48	54
371384	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	SCF	44	62
371385	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	SCF	40	62
371386	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	SCF	38.5	54
371387	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	SCF	39.5	76
371388	20233						N2586	51107.0								2	ug/mL	2	SCF	81	69
371389	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	SCF	92	49
371390	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	SCF	77	51
371391	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	SCF	84	59
371392	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	SCF	58	53
371393	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	SCF	68.5	58
371394	20233																	0	SCF	22	66
371395	20233						RA2159	51112.0								2	ug/mL	3	SCF	49.5	56
371396	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	SCF	57	77
371397	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	SCF	40	81
371398	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	SCF	50.5	86
371399	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	SCF	49	77
371400	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	SCF	43	63
371401	20233						N2586	51107.0								2	ug/mL	3	SCF	103	81
371402	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	SCF	168	69
371403	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	SCF	86.5	72
371404	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	SCF	123.5	60
371405	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	SCF	69	62
371406	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	SCF	85	68
371407	20233						RA2159	51112.0										3	SCF		0
371408	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	SCF		0
371409	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	SCF		0
371410	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	SCF		0
371411	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	SCF		0
371412	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	SCF		0
371413	20233						RA2159	51112.0										3	SCF		0
371414	20233						N2586	51107.0										3	SCF		0
371415	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	SCF		0
371416	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	SCF		0
371417	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	SCF		0
371418	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	SCF		0
371419	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	SCF		0
371420	20233						N2586	51107.0										3	SCF		0
371421	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	SCF	49	63
371422	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	SCF	37	60
371423	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SCF	38	66
371424	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SCF	37.5	70
371425	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SCF	38	75
371426	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	SCF	37	90
371427	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	SCF	66	81
371428	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	SCF	67	71
371429	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SCF	54	71
371430	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SCF	72.5	60
371431	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SCF	59.5	78
371432	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	SCF	59	89
371433	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	SCF	40	59
371434	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	SCF	36	77
371435	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SCF	35	71
371436	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SCF	35	69
371437	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SCF	32.5	74
371438	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	SCF	41	75
371439	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	SCF	71	55
371440	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	SCF	72.5	100
371441	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SCF	57	71
371442	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SCF	70	63
371443	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SCF	57.5	76
371444	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	SCF	62	85
371445	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	SCF	65.5	72
371446	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	SCF	56	73
371447	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SCF	56	82
371448	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SCF	56	68
371449	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SCF	62	65
371450	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	SCF	60	76
371451	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	SCF	97.5	68
371452	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	SCF	96.5	68
371453	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SCF	84.5	62
371454	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SCF	98	57
371455	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SCF	83	49
371456	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	SCF	84	90
371457	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	SCF	36	70
371458	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	SCF	36	69
371459	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SCF	33	74
371460	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SCF	34	73
371461	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SCF	39.5	68
371462	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	SCF	38	73
371463	20233						RA2159	51112.0										3	SCF	37	81
371464	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	SCF	85	73
371465	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	SCF	80.5	66
371466	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SCF	59	82
371467	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SCF	77	73
371468	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SCF	53	75
371469	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	SCF	49.5	68
371470	20233						N2586	51107.0										3	SCF	75	78
371471	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	SCF	39	81
371472	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	SCF	39	69
371473	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SCF	31	79
371474	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SCF	47	65
371475	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SCF	41	82
371476	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	SCF	40	79
371477	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	SCF	37	73
371478	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	SCF	83	82
371479	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	SCF	83	63
371480	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SCF	66	69
371481	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SCF	91	66
371482	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SCF	53	70
371483	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	SCF	56	60
371484	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	SCF	41	57
371485	20233						RA2159	51112.0										3	SCF	36	91
371486	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	SCF	31	67
371487	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	SCF	30	61
371488	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	SCF	39	73
371489	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	SCF	34	65
371490	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	SCF	34	51
371491	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	SCF	34	84
371492	20233						N2586	51107.0										3	SCF	65.5	62
371493	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	SCF	72	65
371494	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	SCF	57	79
371495	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	SCF	96	73
371496	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	SCF	70	75
371497	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	SCF	53	60
371498	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	SCF	50.5	58
371499	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	SCF	40	93
371500	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	SCF	34	78
371501	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SCF	36.5	68
371502	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SCF	34	61
371503	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SCF	36	69
371504	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	SCF	34	76
371505	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	SCF	70.5	76
371506	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	SCF	78	87
371507	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SCF	60.5	66
371508	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SCF	122	69
371509	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SCF	51	72
371510	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	SCF	50	78
371511	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	SCF	30	60
371512	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	SCF	34	63
371513	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SCF	31	79
371514	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SCF	31	65
371515	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SCF	35	68
371516	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	SCF	36	72
371517	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	SCF	39	73
371518	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	SCF	72	73
371519	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	SCF	61.5	62
371520	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SCF	52	56
371521	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SCF	64	57
371522	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SCF	46	60
371523	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	SCF	50	76
371524	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	SCF	61	72
371525	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	SCF	62.5	72
371526	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	SCF	63	65
371527	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SCF	74.5	78
371528	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SCF	81	72
371529	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SCF	68	54
371530	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	SCF	44	74
371531	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	SCF	36	76
371532	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	SCF	158	82
371533	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	SCF	212	61
371534	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SCF	161	70
371535	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SCF	205	59
371536	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SCF	63	57
371537	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	SCF	75	89
371538	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	SCF	49	73
371539	20233																	0	SCF	20	75
371540	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	SCF	198.5	66
371541	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	SCF	97	74
371542	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SCF	97	82
371543	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SCF	87.5	54
371544	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SCF	95.5	78
371545	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	SCF	53	75
371546	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	SCF	39	51
371547	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	SCF	178	62
371548	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	SCF	181.5	86
371549	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SCF	180.5	62
371550	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SCF	185	84
371551	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SCF	81	52
371552	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	SCF	135	80
371553	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	SCF	80	76
371554	20233																	0	SCF	17	51
371555	20233						RA2159	51112.0										3	SCF	39	81
371556	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	SCF	42.5	58
371557	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	SCF	44	60
371558	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	SCF	37	55
371559	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	SCF	37	85
371560	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	SCF	39	43
371561	20233						RA2159	51112.0										3	SCF	41	58
371562	20233						N2586	51107.0										3	SCF	60	56
371563	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	SCF	56	55
371564	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	SCF	51.5	50
371565	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	SCF	64.5	72
371566	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	SCF	56.5	60
371567	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	SCF	57	33
371568	20233						N2586	51107.0										3	SCF	56	67
371569	20233																	0	SCF	20	52
371570	20233						RA2159	51112.0								2	ug/mL	4	SCF	71	73
371571	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	SCF	60.5	62
371572	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	SCF	52	59
371573	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	SCF	58.5	72
371574	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	SCF	53	70
371575	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	SCF	47.5	64
371576	20233						N2586	51107.0								2	ug/mL	4	SCF	106	65
371577	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	SCF	107	53
371578	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	SCF	86	62
371579	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	SCF	107.5	62
371580	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	SCF	86.5	64
371581	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	SCF	54	50
371582	20233						RA2159	51112.0										4	SCF		0
371583	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	SCF		0
371584	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	SCF		0
371585	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	SCF		0
371586	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	SCF		0
371587	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	SCF		0
371588	20233						RA2159	51112.0										4	SCF		0
371589	20233						N2586	51107.0										4	SCF		0
371590	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	SCF		0
371591	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	SCF		0
371592	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	SCF		0
371593	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	SCF		0
371594	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	SCF		0
371595	20233						N2586	51107.0										4	SCF		0
371596	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	SCF	46.5	56
371597	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	SCF	45	49
371598	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	SCF	44	60
371599	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	SCF	45	77
371600	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	SCF	40	76
371601	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	SCF	47	75
371602	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	SCF	77	52
371603	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	SCF	65	75
371604	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	SCF	58	65
371605	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	SCF	63	69
371606	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	SCF	68	78
371607	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	SCF	49.5	60
371608	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	SCF	43	47
371609	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	SCF	40	57
371610	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	SCF	38.5	74
371611	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	SCF	42	63
371612	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	SCF	64	61
371613	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	SCF	43	65
371614	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	SCF	66.5	66
371615	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	SCF	65	72
371616	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	SCF	54	63
371617	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	SCF	63	55
371618	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	SCF	60.5	66
371619	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	SCF	54.5	48
371620	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	SCF	74	96
371621	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	SCF	64.5	76
371622	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	SCF	65	72
371623	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	SCF	63	58
371624	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	SCF	59.5	62
371625	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	SCF	63	95
371626	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	SCF	85	59
371627	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	SCF	89	67
371628	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	SCF	89.5	76
371629	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	SCF	91	71
371630	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	SCF	91	79
371631	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	SCF	66	81
371632	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	SCF	42.5	64
371633	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	SCF	47.5	54
371634	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	SCF	43	72
371635	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	SCF	40	89
371636	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	SCF	40	60
371637	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	SCF	39	76
371638	20233						RA2159	51112.0										4	SCF	41	59
371639	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	SCF	66.5	66
371640	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	SCF	70.5	88
371641	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	SCF	56	64
371642	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	SCF	75	48
371643	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	SCF	80	73
371644	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	SCF	50	96
371645	20233						N2586	51107.0										4	SCF	59	68
371646	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	SCF	56	77
371647	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	SCF	45	77
371648	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	SCF	39	63
371649	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	SCF	38	55
371650	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	SCF	39.5	50
371651	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	SCF	46	93
371652	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	SCF	90	59
371653	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	SCF	84.5	88
371654	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	SCF	57	68
371655	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	SCF	105	66
371656	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	SCF	64	77
371657	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	SCF	47	81
371658	20233						RA2159	51112.0										4	SCF	41.5	98
371659	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	SCF	40.5	54
371660	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	SCF	40	60
371661	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	SCF	44.5	60
371662	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	SCF	43	41
371663	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	SCF	36	19
371664	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	SCF	47.5	10
371665	20233						N2586	51107.0										4	SCF	67	10
371666	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	SCF	93.5	10
371667	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	SCF	55	65
371668	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	SCF	71	56
371669	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	SCF	60.5	52
371670	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	SCF	46	47
371671	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	SCF	62.5	62
371672	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	SCF	37	65
371673	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	SCF	40.5	84
371674	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	SCF	38.5	64
371675	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	SCF	40	67
371676	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	SCF	42	80
371677	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	SCF	38	63
371678	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	SCF	33	32
371679	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	SCF	72	62
371680	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	SCF	82.5	56
371681	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	SCF	84	54
371682	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	SCF	65	49
371683	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	SCF	63	66
371684	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	SCF	46	76
371685	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	SCF	44	60
371686	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	SCF	55	79
371687	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	SCF	41	101
371688	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	SCF	35	55
371689	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	SCF	41	77
371690	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	SCF	37	63
371691	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	SCF	34.5	66
371692	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	SCF	42	59
371693	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	SCF	61.5	68
371694	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	SCF	63	67
371695	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	SCF	45.5	42
371696	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	SCF	60.5	64
371697	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	SCF	55	60
371698	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	SCF	53	65
371699	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	SCF	72	65
371700	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	SCF	78.5	82
371701	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	SCF	98	87
371702	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	SCF	109	85
371703	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	SCF	73	68
371704	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	SCF	56	50
371705	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	SCF	82	65
371706	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	SCF	31.5	70
371707	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	SCF	166.5	48
371708	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	SCF	159	73
371709	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	SCF	166	57
371710	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	SCF	207	65
371711	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	SCF	101	50
371712	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	SCF	53	85
371713	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	SCF	49	62
371714	20233																	0	SCF	22.5	66
371715	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	SCF	91	56
371716	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	SCF	93	65
371717	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	SCF	96	45
371718	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	SCF	86	66
371719	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	SCF	71.5	56
371720	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	SCF	63.5	60
371721	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	SCF	40	62
371722	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	SCF	229.5	74
371723	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	SCF	215	76
371724	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	SCF	204.5	70
371725	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	SCF	266	49
371726	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	SCF	174	60
371727	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	SCF	44	51
371728	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	SCF	66	59
371729	20233																	0	SCF	18	49
371730	20233						RA2159	51112.0										4	SCF	39.5	76
371731	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	SCF	39	72
371732	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	SCF	34.5	64
371733	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	SCF	35	61
371734	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	SCF	42	77
371735	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	SCF	35	75
371736	20233						RA2159	51112.0										4	SCF	38	60
371737	20233						N2586	51107.0										4	SCF	66	71
371738	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	SCF	61	52
371739	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	SCF	56	61
371740	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	SCF	68	55
371741	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	SCF	51	55
371742	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	SCF	54	49
371743	20233						N2586	51107.0										4	SCF	67.5	60
371744	20233								TNF-a	201285.0						100	ng/mL	0	SCF	27.5	84
371745	20233								IL-1 alpha	201286.0						100	ng/mL	0	SCF	25	61
371746	20233								IL-6	201287.0						100	ug/mL	0	SCF	27	49
371747	20233								IL-17A	201288.0						100	ng/mL	0	SCF	23.5	62
371748	20233								EGF	201289.0						100	ng/mL	0	SCF	35	70
371749	20233								IGF-I	201290.0						100	ug/mL	0	SCF	25	56
371750	20233								Adiponectin	201291.0						5	ng/mL	0	SCF	274	69
371751	20233								Leptin	201292.0						1	ng/mL	0	SCF	24	39
371752	20233								Visfatin	201293.0						1	ng/mL	0	SCF	24	63
371753	20233															2	ug/mL	0	SCF	23	65
371754	20233								TNF-a	201285.0						100	ng/mL	0	SCF	22	47
371755	20233								IL-1 alpha	201286.0						100	ng/mL	0	SCF	27	85
371756	20233								IL-6	201287.0						100	ug/mL	0	SCF	29	63
371757	20233								IL-17A	201288.0						100	ng/mL	0	SCF	26.5	62
371758	20233								EGF	201289.0						100	ng/mL	0	SCF	23	67
371759	20233								IGF-I	201290.0						100	ug/mL	0	SCF	22	49
371760	20233								Adiponectin	201291.0						5	ng/mL	0	SCF	237	55
371761	20233								Leptin	201292.0						1	ng/mL	0	SCF	25	70
371762	20233								Visfatin	201293.0						1	ng/mL	0	SCF	23	75
371763	20233															2	ug/mL	0	SCF	22	60
371764	20233								TNF-a	201285.0						100	ng/mL	0	SCF	22	61
371765	20233								IL-1 alpha	201286.0						100	ng/mL	0	SCF	23	68
371766	20233								IL-6	201287.0						100	ug/mL	0	SCF	22.5	76
371767	20233								IL-17A	201288.0						100	ng/mL	0	SCF	21	67
371768	20233								EGF	201289.0						100	ng/mL	0	SCF	22	61
371769	20233								IGF-I	201290.0						100	ug/mL	0	SCF	19	62
371770	20233								Adiponectin	201291.0						5	ng/mL	0	SCF	192.5	76
371771	20233								Leptin	201292.0						1	ng/mL	0	SCF	17	49
371772	20233								Visfatin	201293.0						1	ng/mL	0	SCF	16	61
371773	20233															2	ug/mL	0	SCF	20	68
371774	20233								TNF-a	201285.0						100	ng/mL	0	SCF	22.5	60
371775	20233								IL-1 alpha	201286.0						100	ng/mL	0	SCF	22	81
371776	20233								IL-6	201287.0						100	ug/mL	0	SCF	34	64
371777	20233								IL-17A	201288.0						100	ng/mL	0	SCF	21.5	74
371778	20233								EGF	201289.0						100	ng/mL	0	SCF	19	78
371779	20233								IGF-I	201290.0						100	ug/mL	0	SCF	20	42
371780	20233								Adiponectin	201291.0						5	ng/mL	0	SCF	274.5	54
371781	20233								Leptin	201292.0						1	ng/mL	0	SCF	28	49
371782	20233								Visfatin	201293.0						1	ng/mL	0	SCF	20	51
371783	20233															2	ug/mL	0	SCF	17.5	50
371784	20233																	0	TRAIL	26	69
371785	20233						RA2159	51112.0										1	TRAIL	26	63
371786	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	TRAIL	29	75
371787	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	TRAIL	23.5	72
371788	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	TRAIL	29	67
371789	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	TRAIL	29	77
371790	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	TRAIL	31	56
371791	20233						RA2159	51112.0										1	TRAIL	30	59
371792	20233						N2586	51107.0										1	TRAIL	40.5	78
371793	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	TRAIL	47.5	64
371794	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	TRAIL	43	76
371795	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	TRAIL	39.5	56
371796	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	TRAIL	41	55
371797	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	TRAIL	41	49
371798	20233						N2586	51107.0										1	TRAIL	30	33
371799	20233																	0	TRAIL	27	59
371800	20233																	0	TRAIL	21	37
371801	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	TRAIL	54	58
371802	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	TRAIL	52.5	62
371803	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TRAIL	66	74
371804	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TRAIL	52	71
371805	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TRAIL	57	59
371806	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	TRAIL	39	60
371807	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	TRAIL	28	61
371808	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	TRAIL	122	51
371809	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	TRAIL	98	43
371810	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TRAIL	91	33
371811	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TRAIL	126	71
371812	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	TRAIL	115	71
371813	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	TRAIL	103	51
371814	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	TRAIL	38	71
371815	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	TRAIL	46.5	50
371816	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	TRAIL	44	75
371817	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TRAIL	52.5	62
371818	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TRAIL	43.5	52
371819	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TRAIL	40	57
371820	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	TRAIL	33	53
371821	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	TRAIL	27	71
371822	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	TRAIL	91	60
371823	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	TRAIL	91	65
371824	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TRAIL	120.5	66
371825	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TRAIL	101.5	70
371826	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	TRAIL	95	73
371827	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	TRAIL	69	49
371828	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	TRAIL	39	53
371829	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	TRAIL	26	64
371830	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	TRAIL	26.5	62
371831	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TRAIL	25	56
371832	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TRAIL	28	67
371833	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TRAIL	29	62
371834	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	TRAIL	25	46
371835	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	TRAIL	28	78
371836	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	TRAIL	44	58
371837	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	TRAIL	41	60
371838	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TRAIL	36	65
371839	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TRAIL	41	50
371840	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	TRAIL	37.5	58
371841	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	TRAIL	40	48
371842	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	TRAIL	50.5	52
371843	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	TRAIL	31	67
371844	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	TRAIL	26	73
371845	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TRAIL	27	63
371846	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TRAIL	27	85
371847	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TRAIL	30	53
371848	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	TRAIL	31	73
371849	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	TRAIL	51.5	38
371850	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	TRAIL	42	41
371851	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TRAIL	48	35
371852	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TRAIL	43	47
371853	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	TRAIL	34.5	48
371854	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	TRAIL	47	57
371855	20233						RA2159	51112.0										1	TRAIL	25.5	38
371856	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	TRAIL	37	90
371857	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	TRAIL	30	54
371858	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	TRAIL	24	65
371859	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	TRAIL	27.5	78
371860	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	TRAIL	29	60
371861	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	TRAIL	30	56
371862	20233						N2586	51107.0										1	TRAIL	44	49
371863	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	TRAIL	43	47
371864	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	TRAIL	39	53
371865	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	TRAIL	43.5	60
371866	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	TRAIL	44	47
371867	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	TRAIL	43.5	42
371868	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	TRAIL	34	40
371869	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	TRAIL	30.5	58
371870	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	TRAIL	27	58
371871	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TRAIL	25	67
371872	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TRAIL	28	63
371873	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TRAIL	28	58
371874	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	TRAIL	28	68
371875	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	TRAIL	25	65
371876	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	TRAIL	50	61
371877	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	TRAIL	44	73
371878	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TRAIL	36.5	52
371879	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TRAIL	46	73
371880	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	TRAIL	45.5	54
371881	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	TRAIL	41	50
371882	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	TRAIL	43.5	54
371883	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	TRAIL	30	56
371884	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	TRAIL	27	68
371885	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TRAIL	26	69
371886	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TRAIL	24	71
371887	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TRAIL	27	53
371888	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	TRAIL	27.5	62
371889	20233						RA2159	51112.0										1	TRAIL	26.5	62
371890	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	TRAIL	49	61
371891	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	TRAIL	48.5	56
371892	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TRAIL	38	67
371893	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TRAIL	44	69
371894	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	TRAIL	46	39
371895	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	TRAIL	45	35
371896	20233						N2586	51107.0										1	TRAIL	34	49
371897	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	TRAIL	33	60
371898	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	TRAIL	39	65
371899	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TRAIL	38	51
371900	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TRAIL	36	71
371901	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TRAIL	40	79
371902	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	TRAIL	36	67
371903	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	TRAIL	54	89
371904	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	TRAIL	47	53
371905	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TRAIL	50	46
371906	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TRAIL	44	59
371907	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	TRAIL	51	47
371908	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	TRAIL	44	76
371909	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	TRAIL	26	73
371910	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	TRAIL	25	54
371911	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TRAIL	21.5	46
371912	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TRAIL	24	58
371913	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TRAIL	27.5	42
371914	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	TRAIL	27	25
371915	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	TRAIL	35	39
371916	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	TRAIL	39.5	38
371917	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TRAIL	40	46
371918	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TRAIL	38	35
371919	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	TRAIL	41	35
371920	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	TRAIL	34	57
371921	20233						RA2159	51112.0										1	TRAIL		0
371922	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	TRAIL		0
371923	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	TRAIL		0
371924	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	TRAIL		0
371925	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	TRAIL		0
371926	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	TRAIL		0
371927	20233						RA2159	51112.0										1	TRAIL		0
371928	20233						N2586	51107.0										1	TRAIL		0
371929	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	TRAIL		0
371930	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	TRAIL		0
371931	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	TRAIL		0
371932	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	TRAIL		0
371933	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	TRAIL		0
371934	20233						N2586	51107.0										1	TRAIL		0
371935	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	TRAIL	26	60
371936	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	TRAIL	25	75
371937	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TRAIL	23	67
371938	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TRAIL	22	55
371939	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TRAIL	27	57
371940	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	TRAIL	28	54
371941	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	TRAIL	35	51
371942	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	TRAIL	41	51
371943	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TRAIL	44	61
371944	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TRAIL	37.5	64
371945	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	TRAIL	38	36
371946	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	TRAIL	33	37
371947	20233																	0	TRAIL	23.5	68
371948	20233						RA2159	51112.0								2	ug/mL	1	TRAIL	27	55
371949	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	TRAIL	30.5	64
371950	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	TRAIL	24.5	42
371951	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	TRAIL	32	74
371952	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	TRAIL	26	66
371953	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	TRAIL	26	64
371954	20233						N2586	51107.0								2	ug/mL	1	TRAIL	52.5	38
371955	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	TRAIL	53	35
371956	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	TRAIL	49	51
371957	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	TRAIL	49.5	50
371958	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	TRAIL	46	45
371959	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	TRAIL	51	31
371960	20233																	0	TRAIL	23	55
371961	20233						RA2159	51112.0										2	TRAIL	25	83
371962	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	TRAIL	26	53
371963	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	TRAIL	27	68
371964	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	TRAIL	31	75
371965	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	TRAIL	29	79
371966	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	TRAIL	30	78
371967	20233						RA2159	51112.0										2	TRAIL	27	63
371968	20233						N2586	51107.0										2	TRAIL	43	63
371969	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	TRAIL	35.5	58
371970	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	TRAIL	39.5	82
371971	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	TRAIL	48	57
371972	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	TRAIL	35	61
371973	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	TRAIL	37	44
371974	20233						N2586	51107.0										2	TRAIL	42	55
371975	20233																	0	TRAIL	23	58
371976	20233																	0	TRAIL	23.5	66
371977	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	TRAIL	47	64
371978	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	TRAIL	52	68
371979	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	TRAIL	48	57
371980	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	TRAIL	50	69
371981	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	TRAIL	40	64
371982	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	TRAIL	35.5	50
371983	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	TRAIL	31	56
371984	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	TRAIL	98	55
371985	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	TRAIL	83	69
371986	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	TRAIL	91.5	54
371987	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	TRAIL	111	45
371988	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	TRAIL	67.5	54
371989	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	TRAIL	88	46
371990	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	TRAIL	42	54
371991	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	TRAIL	42	72
371992	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	TRAIL	57	73
371993	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	TRAIL	52	54
371994	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	TRAIL	55	55
371995	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	TRAIL	38	75
371996	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	TRAIL	44	71
371997	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	TRAIL	26	57
371998	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	TRAIL	87	44
371999	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	TRAIL	146.5	62
372000	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	TRAIL	104.5	68
372001	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	TRAIL	138.5	36
372002	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	TRAIL	70	69
372003	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	TRAIL	80	68
372004	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	TRAIL	36	63
372005	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	TRAIL	30	71
372006	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	TRAIL	23	67
372007	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	TRAIL	26	85
372008	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	TRAIL	26	67
372009	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	TRAIL	24.5	70
372010	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	TRAIL	25.5	50
372011	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	TRAIL	26.5	52
372012	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	TRAIL	38	60
372013	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	TRAIL	43	86
372014	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	TRAIL	38	65
372015	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	TRAIL	40	59
372016	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	TRAIL	33.5	60
372017	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	TRAIL	35	57
372018	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	TRAIL	40	51
372019	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	TRAIL	28	81
372020	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	TRAIL	32.5	68
372021	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	TRAIL	29	66
372022	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	TRAIL	30	72
372023	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	TRAIL	23	55
372024	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	TRAIL	25	40
372025	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	TRAIL	27	33
372026	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	TRAIL	46.5	48
372027	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	TRAIL	55	48
372028	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	TRAIL	37	11
372029	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	TRAIL	52	20
372030	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	TRAIL	36	50
372031	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	TRAIL	41	67
372032	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	TRAIL	40.5	82
372033	20233						RA2159	51112.0										2	TRAIL	29	92
372034	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	TRAIL	28.5	84
372035	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	TRAIL	24	66
372036	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	TRAIL	26	51
372037	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	TRAIL	23.5	66
372038	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	TRAIL	20	56
372039	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	TRAIL	33	63
372040	20233						N2586	51107.0										2	TRAIL	40	53
372041	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	TRAIL	47	77
372042	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	TRAIL	41	71
372043	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	TRAIL	49	65
372044	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	TRAIL	37	64
372045	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	TRAIL	38	62
372046	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	TRAIL	37	72
372047	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	TRAIL	28	67
372048	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	TRAIL	24.5	72
372049	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	TRAIL	26	59
372050	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	TRAIL	25	63
372051	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	TRAIL	27.5	74
372052	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	TRAIL	26	68
372053	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	TRAIL	43	71
372054	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	TRAIL	43.5	56
372055	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	TRAIL	41	62
372056	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	TRAIL	44	67
372057	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	TRAIL	41	61
372058	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	TRAIL	40	87
372059	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	TRAIL	26	60
372060	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	TRAIL	24	69
372061	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	TRAIL	28	59
372062	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	TRAIL	25	71
372063	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	TRAIL	24	61
372064	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	TRAIL	26	64
372065	20233						RA2159	51112.0										2	TRAIL	25	62
372066	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	TRAIL	40	44
372067	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	TRAIL	46	73
372068	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	TRAIL	39.5	92
372069	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	TRAIL	45	58
372070	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	TRAIL	33	76
372071	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	TRAIL	31	55
372072	20233						N2586	51107.0										2	TRAIL	39.5	70
372073	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	TRAIL	30	79
372074	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	TRAIL	33.5	72
372075	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	TRAIL	34.5	52
372076	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	TRAIL	28	55
372077	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	TRAIL	31	61
372078	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	TRAIL	33	65
372079	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	TRAIL	44	57
372080	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	TRAIL	53	61
372081	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	TRAIL	48	66
372082	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	TRAIL	55.5	46
372083	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	TRAIL	43	61
372084	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	TRAIL	49	66
372085	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	TRAIL	22	69
372086	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	TRAIL	25	66
372087	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	TRAIL	27	67
372088	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	TRAIL	24	63
372089	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	TRAIL	21	41
372090	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	TRAIL	25	74
372091	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	TRAIL	39	69
372092	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	TRAIL	35	47
372093	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	TRAIL	38	76
372094	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	TRAIL	40.5	48
372095	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	TRAIL	31.5	60
372096	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	TRAIL	30	52
372097	20233						RA2159	51112.0										2	TRAIL		0
372098	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	TRAIL		0
372099	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	TRAIL		0
372100	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	TRAIL		0
372101	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	TRAIL		0
372102	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	TRAIL		0
372103	20233						RA2159	51112.0										2	TRAIL		0
372104	20233						N2586	51107.0										2	TRAIL		0
372105	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	TRAIL		0
372106	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	TRAIL		0
372107	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	TRAIL		0
372108	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	TRAIL		0
372109	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	TRAIL		0
372110	20233						N2586	51107.0										2	TRAIL		0
372111	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	TRAIL	30	41
372112	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	TRAIL	26	91
372113	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	TRAIL	23	57
372114	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	TRAIL	28	62
372115	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	TRAIL	23	60
372116	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	TRAIL	25	67
372117	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	TRAIL	36	77
372118	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	TRAIL	44	61
372119	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	TRAIL	35	65
372120	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	TRAIL	39	53
372121	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	TRAIL	30.5	72
372122	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	TRAIL	35	51
372123	20233																	0	TRAIL	22	63
372124	20233						RA2159	51112.0								2	ug/mL	2	TRAIL	33	77
372125	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	TRAIL	35	45
372126	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	TRAIL	27	53
372127	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	TRAIL	28	53
372128	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	TRAIL	26.5	54
372129	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	TRAIL	25	67
372130	20233						N2586	51107.0								2	ug/mL	2	TRAIL	45	70
372131	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	TRAIL	55.5	46
372132	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	TRAIL	50	47
372133	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	TRAIL	55.5	50
372134	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	TRAIL	41	43
372135	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	TRAIL	40	58
372136	20233																	0	TRAIL	20	69
372137	20233						RA2159	51112.0								2	ug/mL	3	TRAIL	30	74
372138	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	TRAIL	37	50
372139	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	TRAIL	26	79
372140	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	TRAIL	30	59
372141	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	TRAIL	32	66
372142	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	TRAIL	28	61
372143	20233						N2586	51107.0								2	ug/mL	3	TRAIL	72	69
372144	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	TRAIL	115	82
372145	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	TRAIL	69.5	58
372146	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	TRAIL	76	81
372147	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	TRAIL	46.5	58
372148	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	TRAIL	55	61
372149	20233						RA2159	51112.0										3	TRAIL		0
372150	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	TRAIL		0
372151	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	TRAIL		0
372152	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	TRAIL		0
372153	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	TRAIL		0
372154	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	TRAIL		0
372155	20233						RA2159	51112.0										3	TRAIL		0
372156	20233						N2586	51107.0										3	TRAIL		0
372157	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	TRAIL		0
372158	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	TRAIL		0
372159	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	TRAIL		0
372160	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	TRAIL		0
372161	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	TRAIL		0
372162	20233						N2586	51107.0										3	TRAIL		0
372163	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	TRAIL	32	64
372164	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	TRAIL	27	81
372165	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TRAIL	25	74
372166	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TRAIL	26	61
372167	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TRAIL	26	67
372168	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	TRAIL	25.5	60
372169	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	TRAIL	44	50
372170	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	TRAIL	45	67
372171	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TRAIL	44.5	58
372172	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TRAIL	44	69
372173	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	TRAIL	44	69
372174	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	TRAIL	40	94
372175	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	TRAIL	26	59
372176	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	TRAIL	23	55
372177	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TRAIL	24.5	64
372178	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TRAIL	28	70
372179	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TRAIL	26	71
372180	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	TRAIL	29	61
372181	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	TRAIL	45	77
372182	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	TRAIL	45.5	84
372183	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TRAIL	42	61
372184	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TRAIL	49	61
372185	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	TRAIL	40.5	56
372186	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	TRAIL	41.5	72
372187	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	TRAIL	33.5	56
372188	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	TRAIL	32	86
372189	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TRAIL	34	62
372190	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TRAIL	29	67
372191	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TRAIL	34	56
372192	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	TRAIL	33	76
372193	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	TRAIL	57.5	82
372194	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	TRAIL	56	54
372195	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TRAIL	48.5	54
372196	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TRAIL	53	67
372197	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	TRAIL	48	57
372198	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	TRAIL	46	74
372199	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	TRAIL	25	75
372200	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	TRAIL	26.5	82
372201	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TRAIL	24	58
372202	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TRAIL	23	57
372203	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TRAIL	24	63
372204	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	TRAIL	25	64
372205	20233						RA2159	51112.0										3	TRAIL	28	65
372206	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	TRAIL	55	68
372207	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	TRAIL	56.5	72
372208	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TRAIL	40	59
372209	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TRAIL	60	79
372210	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	TRAIL	36	75
372211	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	TRAIL	37	63
372212	20233						N2586	51107.0										3	TRAIL	48	70
372213	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	TRAIL	25	67
372214	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	TRAIL	27.5	66
372215	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TRAIL	26.5	68
372216	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TRAIL	29	68
372217	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TRAIL	27	67
372218	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	TRAIL	27	58
372219	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	TRAIL	28	71
372220	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	TRAIL	53	84
372221	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	TRAIL	55	67
372222	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TRAIL	51	65
372223	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TRAIL	68	55
372224	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	TRAIL	44.5	66
372225	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	TRAIL	41	70
372226	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	TRAIL	32.5	74
372227	20233						RA2159	51112.0										3	TRAIL	26	69
372228	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	TRAIL	24	61
372229	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	TRAIL	24	66
372230	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	TRAIL	24	53
372231	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	TRAIL	24	71
372232	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	TRAIL	29.5	56
372233	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	TRAIL	26.5	72
372234	20233						N2586	51107.0										3	TRAIL	51	57
372235	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	TRAIL	53	73
372236	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	TRAIL	40	57
372237	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	TRAIL	67	63
372238	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	TRAIL	48	69
372239	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	TRAIL	40	66
372240	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	TRAIL	41	58
372241	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	TRAIL	27	61
372242	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	TRAIL	25	68
372243	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TRAIL	28	69
372244	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TRAIL	25	61
372245	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TRAIL	24.5	78
372246	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	TRAIL	23	79
372247	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	TRAIL	47	65
372248	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	TRAIL	50	62
372249	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TRAIL	37	76
372250	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TRAIL	76.5	64
372251	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	TRAIL	43	67
372252	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	TRAIL	40	60
372253	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	TRAIL	25	69
372254	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	TRAIL	23.5	72
372255	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TRAIL	23	67
372256	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TRAIL	22	69
372257	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TRAIL	22	77
372258	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	TRAIL	30	79
372259	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	TRAIL	28	87
372260	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	TRAIL	53	71
372261	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	TRAIL	42	58
372262	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TRAIL	37	63
372263	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TRAIL	42	74
372264	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	TRAIL	33.5	52
372265	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	TRAIL	37.5	82
372266	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	TRAIL	46	65
372267	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	TRAIL	45	68
372268	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	TRAIL	45	65
372269	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TRAIL	51.5	76
372270	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TRAIL	50	53
372271	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TRAIL	41	71
372272	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	TRAIL	34	61
372273	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	TRAIL	26.5	62
372274	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	TRAIL	105	72
372275	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	TRAIL	147	67
372276	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TRAIL	116	67
372277	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TRAIL	143	65
372278	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	TRAIL	50	60
372279	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	TRAIL	53	63
372280	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	TRAIL	39	61
372281	20233																	0	TRAIL	21.5	54
372282	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	TRAIL	72	53
372283	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	TRAIL	66	76
372284	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TRAIL	63	87
372285	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TRAIL	60	51
372286	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TRAIL	60	68
372287	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	TRAIL	37	64
372288	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	TRAIL	27	46
372289	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	TRAIL	104	61
372290	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	TRAIL	117	80
372291	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TRAIL	105.5	70
372292	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TRAIL	123	68
372293	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	TRAIL	54	55
372294	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	TRAIL	86	70
372295	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	TRAIL	59.5	66
372296	20233																	0	TRAIL	21.5	42
372297	20233						RA2159	51112.0										3	TRAIL	26	71
372298	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	TRAIL	27	62
372299	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	TRAIL	30	55
372300	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	TRAIL	24	54
372301	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	TRAIL	27	58
372302	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	TRAIL	26	65
372303	20233						RA2159	51112.0										3	TRAIL	27	61
372304	20233						N2586	51107.0										3	TRAIL	42	66
372305	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	TRAIL	43	44
372306	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	TRAIL	35	42
372307	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	TRAIL	45.5	70
372308	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	TRAIL	39	62
372309	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	TRAIL	36.5	36
372310	20233						N2586	51107.0										3	TRAIL	37	57
372311	20233																	0	TRAIL	23	57
372312	20233						RA2159	51112.0								2	ug/mL	4	TRAIL	41	61
372313	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	TRAIL	41	63
372314	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	TRAIL	35	59
372315	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	TRAIL	34.5	62
372316	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	TRAIL	33	60
372317	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	TRAIL	33	63
372318	20233						N2586	51107.0								2	ug/mL	4	TRAIL	66	67
372319	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	TRAIL	68.5	54
372320	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	TRAIL	59	67
372321	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	TRAIL	71.5	54
372322	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	TRAIL	49	69
372323	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	TRAIL	38	59
372324	20233						RA2159	51112.0										4	TRAIL		0
372325	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	TRAIL		0
372326	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	TRAIL		0
372327	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	TRAIL		0
372328	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	TRAIL		0
372329	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	TRAIL		0
372330	20233						RA2159	51112.0										4	TRAIL		0
372331	20233						N2586	51107.0										4	TRAIL		0
372332	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	TRAIL		0
372333	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	TRAIL		0
372334	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	TRAIL		0
372335	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	TRAIL		0
372336	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	TRAIL		0
372337	20233						N2586	51107.0										4	TRAIL		0
372338	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	TRAIL	31	42
372339	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	TRAIL	29	54
372340	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	TRAIL	28	72
372341	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	TRAIL	30	67
372342	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	TRAIL	27	73
372343	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	TRAIL	32	71
372344	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	TRAIL	47	58
372345	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	TRAIL	46.5	68
372346	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	TRAIL	36	68
372347	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	TRAIL	51	61
372348	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	TRAIL	47.5	90
372349	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	TRAIL	35	65
372350	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	TRAIL	28	65
372351	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	TRAIL	28	59
372352	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	TRAIL	30	61
372353	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	TRAIL	28.5	72
372354	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	TRAIL	47	66
372355	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	TRAIL	27	57
372356	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	TRAIL	48	61
372357	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	TRAIL	43	79
372358	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	TRAIL	35.5	62
372359	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	TRAIL	53	60
372360	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	TRAIL	42	54
372361	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	TRAIL	44	64
372362	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	TRAIL	39	83
372363	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	TRAIL	34	75
372364	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	TRAIL	37	74
372365	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	TRAIL	34	82
372366	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	TRAIL	33	76
372367	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	TRAIL	30	91
372368	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	TRAIL	54	71
372369	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	TRAIL	53.5	62
372370	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	TRAIL	49	61
372371	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	TRAIL	47	62
372372	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	TRAIL	51	72
372373	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	TRAIL	41.5	60
372374	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	TRAIL	28	71
372375	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	TRAIL	27	71
372376	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	TRAIL	30	51
372377	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	TRAIL	26	73
372378	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	TRAIL	27	55
372379	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	TRAIL	28	57
372380	20233						RA2159	51112.0										4	TRAIL	28	74
372381	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	TRAIL	48	68
372382	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	TRAIL	52	74
372383	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	TRAIL	41.5	60
372384	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	TRAIL	48	52
372385	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	TRAIL	50	72
372386	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	TRAIL	37	83
372387	20233						N2586	51107.0										4	TRAIL	45.5	74
372388	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	TRAIL	33	57
372389	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	TRAIL	32	60
372390	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	TRAIL	26	78
372391	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	TRAIL	26	78
372392	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	TRAIL	26	60
372393	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	TRAIL	33	69
372394	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	TRAIL	60.5	52
372395	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	TRAIL	56	79
372396	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	TRAIL	42	75
372397	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	TRAIL	74.5	54
372398	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	TRAIL	41.5	50
372399	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	TRAIL	34	82
372400	20233						RA2159	51112.0										4	TRAIL	29	82
372401	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	TRAIL	31	45
372402	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	TRAIL	28.5	50
372403	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	TRAIL	33	61
372404	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	TRAIL	26	39
372405	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	TRAIL	29	21
372406	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	TRAIL	22.5	12
372407	20233						N2586	51107.0										4	TRAIL	31.5	8
372408	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	TRAIL	58	7
372409	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	TRAIL	39	74
372410	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	TRAIL	47	59
372411	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	TRAIL	41	55
372412	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	TRAIL	35	72
372413	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	TRAIL	44.5	52
372414	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	TRAIL	25	63
372415	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	TRAIL	30	59
372416	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	TRAIL	29.5	74
372417	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	TRAIL	23.5	60
372418	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	TRAIL	29	73
372419	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	TRAIL	28	69
372420	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	TRAIL	26	33
372421	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	TRAIL	53	62
372422	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	TRAIL	60	55
372423	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	TRAIL	46	67
372424	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	TRAIL	51	43
372425	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	TRAIL	100	66
372426	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	TRAIL	32	55
372427	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	TRAIL	32	49
372428	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	TRAIL	45	74
372429	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	TRAIL	26	59
372430	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	TRAIL	28	58
372431	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	TRAIL	30.5	78
372432	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	TRAIL	28	58
372433	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	TRAIL	23	61
372434	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	TRAIL	28	54
372435	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	TRAIL	44	35
372436	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	TRAIL	46	58
372437	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	TRAIL	42	46
372438	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	TRAIL	44	53
372439	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	TRAIL	41	59
372440	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	TRAIL	33	54
372441	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	TRAIL	45	57
372442	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	TRAIL	49	69
372443	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	TRAIL	63.5	64
372444	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	TRAIL	79	60
372445	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	TRAIL	48	60
372446	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	TRAIL	47.5	54
372447	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	TRAIL	58	52
372448	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	TRAIL	23	66
372449	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	TRAIL	95	53
372450	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	TRAIL	115.5	76
372451	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	TRAIL	125	35
372452	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	TRAIL	105.5	58
372453	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	TRAIL	63	39
372454	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	TRAIL	44.5	72
372455	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	TRAIL	39	47
372456	20233																	0	TRAIL	21.5	58
372457	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	TRAIL	57	48
372458	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	TRAIL	58	57
372459	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	TRAIL	54	61
372460	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	TRAIL	58	72
372461	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	TRAIL	49	48
372462	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	TRAIL	40	76
372463	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	TRAIL	26	43
372464	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	TRAIL	134	62
372465	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	TRAIL	129	76
372466	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	TRAIL	118	57
372467	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	TRAIL	151	59
372468	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	TRAIL	103	62
372469	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	TRAIL	35	58
372470	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	TRAIL	43	59
372471	20233																	0	TRAIL	18.5	64
372472	20233						RA2159	51112.0										4	TRAIL	26	56
372473	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	TRAIL	28	67
372474	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	TRAIL	25.5	48
372475	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	TRAIL	25	61
372476	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	TRAIL	28	90
372477	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	TRAIL	28	57
372478	20233						RA2159	51112.0										4	TRAIL	25	64
372479	20233						N2586	51107.0										4	TRAIL	44	66
372480	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	TRAIL	47.5	48
372481	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	TRAIL	45	60
372482	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	TRAIL	45.5	60
372483	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	TRAIL	37	59
372484	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	TRAIL	36	56
372485	20233						N2586	51107.0										4	TRAIL	49	54
372486	20233								TNF-a	201285.0						100	ng/mL	0	TRAIL	24	71
372487	20233								IL-1 alpha	201286.0						100	ng/mL	0	TRAIL	32	77
372488	20233								IL-6	201287.0						100	ug/mL	0	TRAIL	22	47
372489	20233								IL-17A	201288.0						100	ng/mL	0	TRAIL	25	65
372490	20233								EGF	201289.0						100	ng/mL	0	TRAIL	29.5	58
372491	20233								IGF-I	201290.0						100	ug/mL	0	TRAIL	24	51
372492	20233								Adiponectin	201291.0						5	ng/mL	0	TRAIL	96.5	78
372493	20233								Leptin	201292.0						1	ng/mL	0	TRAIL	23.5	56
372494	20233								Visfatin	201293.0						1	ng/mL	0	TRAIL	25.5	62
372495	20233															2	ug/mL	0	TRAIL	24	59
372496	20233								TNF-a	201285.0						100	ng/mL	0	TRAIL	23.5	46
372497	20233								IL-1 alpha	201286.0						100	ng/mL	0	TRAIL	30.5	70
372498	20233								IL-6	201287.0						100	ug/mL	0	TRAIL	25	67
372499	20233								IL-17A	201288.0						100	ng/mL	0	TRAIL	23	80
372500	20233								EGF	201289.0						100	ng/mL	0	TRAIL	23	61
372501	20233								IGF-I	201290.0						100	ug/mL	0	TRAIL	25	47
372502	20233								Adiponectin	201291.0						5	ng/mL	0	TRAIL	95	69
372503	20233								Leptin	201292.0						1	ng/mL	0	TRAIL	25	77
372504	20233								Visfatin	201293.0						1	ng/mL	0	TRAIL	24	61
372505	20233															2	ug/mL	0	TRAIL	22	52
372506	20233								TNF-a	201285.0						100	ng/mL	0	TRAIL	20	56
372507	20233								IL-1 alpha	201286.0						100	ng/mL	0	TRAIL	27	68
372508	20233								IL-6	201287.0						100	ug/mL	0	TRAIL	24	66
372509	20233								IL-17A	201288.0						100	ng/mL	0	TRAIL	21	73
372510	20233								EGF	201289.0						100	ng/mL	0	TRAIL	22	63
372511	20233								IGF-I	201290.0						100	ug/mL	0	TRAIL	19	65
372512	20233								Adiponectin	201291.0						5	ng/mL	0	TRAIL	61	59
372513	20233								Leptin	201292.0						1	ng/mL	0	TRAIL	20.5	40
372514	20233								Visfatin	201293.0						1	ng/mL	0	TRAIL	20	53
372515	20233															2	ug/mL	0	TRAIL	20	75
372516	20233								TNF-a	201285.0						100	ng/mL	0	TRAIL	18	45
372517	20233								IL-1 alpha	201286.0						100	ng/mL	0	TRAIL	27	90
372518	20233								IL-6	201287.0						100	ug/mL	0	TRAIL	30	79
372519	20233								IL-17A	201288.0						100	ng/mL	0	TRAIL	22	59
372520	20233								EGF	201289.0						100	ng/mL	0	TRAIL	23	72
372521	20233								IGF-I	201290.0						100	ug/mL	0	TRAIL	21	65
372522	20233								Adiponectin	201291.0						5	ng/mL	0	TRAIL	87	54
372523	20233								Leptin	201292.0						1	ng/mL	0	TRAIL	28	55
372524	20233								Visfatin	201293.0						1	ng/mL	0	TRAIL	18	61
372525	20233															2	ug/mL	0	TRAIL	21.5	46
372526	20233																	0	M-CSF	92.5	76
372527	20233						RA2159	51112.0										1	M-CSF	144	79
372528	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	M-CSF	136	73
372529	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	M-CSF	121.5	62
372530	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	M-CSF	134	73
372531	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	M-CSF	168	82
372532	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	M-CSF	121	67
372533	20233						RA2159	51112.0										1	M-CSF	158	81
372534	20233						N2586	51107.0										1	M-CSF	223	83
372535	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	M-CSF	188	49
372536	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	M-CSF	165.5	82
372537	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	M-CSF	189	70
372538	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	M-CSF	190	36
372539	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	M-CSF	161	45
372540	20233						N2586	51107.0										1	M-CSF	173	43
372541	20233																	0	M-CSF	106	55
372542	20233																	0	M-CSF	60	41
372543	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	M-CSF	288	51
372544	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	M-CSF	258.5	70
372545	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	M-CSF	323.5	64
372546	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	M-CSF	320.5	68
372547	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	M-CSF	357	68
372548	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	M-CSF	189.5	74
372549	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	M-CSF	171	68
372550	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	M-CSF	455	51
372551	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	M-CSF	463.5	34
372552	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	M-CSF	416.5	36
372553	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	M-CSF	497.5	70
372554	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	M-CSF	451	67
372555	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	M-CSF	319	48
372556	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	M-CSF	168	67
372557	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	M-CSF	344.5	54
372558	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	M-CSF	266	69
372559	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	M-CSF	317	63
372560	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	M-CSF	374	61
372561	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	M-CSF	310	63
372562	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	M-CSF	129	53
372563	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	M-CSF	156	62
372564	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	M-CSF	437	52
372565	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	M-CSF	373	51
372566	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	M-CSF	495	59
372567	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	M-CSF	513.5	68
372568	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	M-CSF	524.5	78
372569	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	M-CSF	236	50
372570	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	M-CSF	159	44
372571	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	M-CSF	140	55
372572	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	M-CSF	142	60
372573	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	M-CSF	112	55
372574	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	M-CSF	137.5	68
372575	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	M-CSF	134	67
372576	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	M-CSF	136	68
372577	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	M-CSF	137	94
372578	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	M-CSF	202.5	70
372579	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	M-CSF	204	72
372580	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	M-CSF	158	61
372581	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	M-CSF	162.5	44
372582	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	M-CSF	179.5	58
372583	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	M-CSF	159.5	54
372584	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	M-CSF	169	63
372585	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	M-CSF	131	84
372586	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	M-CSF	127	67
372587	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	M-CSF	127	77
372588	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	M-CSF	135	81
372589	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	M-CSF	143	55
372590	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	M-CSF	124.5	58
372591	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	M-CSF	275.5	40
372592	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	M-CSF	218	30
372593	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	M-CSF	276.5	32
372594	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	M-CSF	241.5	46
372595	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	M-CSF	184	38
372596	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	M-CSF	203	59
372597	20233						RA2159	51112.0										1	M-CSF	131	45
372598	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	M-CSF	209	77
372599	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	M-CSF	113	69
372600	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	M-CSF	131	75
372601	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	M-CSF	135	50
372602	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	M-CSF	130	77
372603	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	M-CSF	119	45
372604	20233						N2586	51107.0										1	M-CSF	201	59
372605	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	M-CSF	192	53
372606	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	M-CSF	181.5	48
372607	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	M-CSF	181	50
372608	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	M-CSF	199	61
372609	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	M-CSF	150	63
372610	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	M-CSF	140	57
372611	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	M-CSF	162	69
372612	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	M-CSF	116.5	62
372613	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	M-CSF	91.5	62
372614	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	M-CSF	132	74
372615	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	M-CSF	171	55
372616	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	M-CSF	108	63
372617	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	M-CSF	109	75
372618	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	M-CSF	197	68
372619	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	M-CSF	199	63
372620	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	M-CSF	147	67
372621	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	M-CSF	194.5	60
372622	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	M-CSF	227.5	68
372623	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	M-CSF	160	54
372624	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	M-CSF	139.5	42
372625	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	M-CSF	177	70
372626	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	M-CSF	171.5	70
372627	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	M-CSF	195.5	72
372628	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	M-CSF	160	61
372629	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	M-CSF	158	49
372630	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	M-CSF	153.5	56
372631	20233						RA2159	51112.0										1	M-CSF	129	66
372632	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	M-CSF	213.5	62
372633	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	M-CSF	196	81
372634	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	M-CSF	189	49
372635	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	M-CSF	212	65
372636	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	M-CSF	189	46
372637	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	M-CSF	207	32
372638	20233						N2586	51107.0										1	M-CSF	127	46
372639	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	M-CSF	128.5	50
372640	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	M-CSF	139.5	54
372641	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	M-CSF	142	61
372642	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	M-CSF	134.5	72
372643	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	M-CSF	168	57
372644	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	M-CSF	170	68
372645	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	M-CSF	167	75
372646	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	M-CSF	166	71
372647	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	M-CSF	156	49
372648	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	M-CSF	166	53
372649	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	M-CSF	214	57
372650	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	M-CSF	143	70
372651	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	M-CSF	117.5	82
372652	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	M-CSF	97	55
372653	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	M-CSF	91	63
372654	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	M-CSF	155.5	62
372655	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	M-CSF	126	49
372656	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	M-CSF	121.5	40
372657	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	M-CSF	204	29
372658	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	M-CSF	203	75
372659	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	M-CSF	143.5	56
372660	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	M-CSF	211	33
372661	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	M-CSF	165.5	42
372662	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	M-CSF	174	53
372663	20233						RA2159	51112.0										1	M-CSF		0
372664	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	M-CSF		0
372665	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	M-CSF		0
372666	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	M-CSF		0
372667	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	M-CSF		0
372668	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	M-CSF		0
372669	20233						RA2159	51112.0										1	M-CSF		0
372670	20233						N2586	51107.0										1	M-CSF		0
372671	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	M-CSF		0
372672	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	M-CSF		0
372673	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	M-CSF		0
372674	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	M-CSF		0
372675	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	M-CSF		0
372676	20233						N2586	51107.0										1	M-CSF		0
372677	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	M-CSF	120	68
372678	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	M-CSF	170.5	68
372679	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	M-CSF	96.5	70
372680	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	M-CSF	121	63
372681	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	M-CSF	123	61
372682	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	M-CSF	118	49
372683	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	M-CSF	154	49
372684	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	M-CSF	223.5	30
372685	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	M-CSF	246	57
372686	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	M-CSF	177.5	54
372687	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	M-CSF	205	36
372688	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	M-CSF	162	52
372689	20233																	0	M-CSF	62.5	64
372690	20233						RA2159	51112.0								2	ug/mL	1	M-CSF	166	65
372691	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	M-CSF	204	58
372692	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	M-CSF	109.5	48
372693	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	M-CSF	201	53
372694	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	M-CSF	155.5	58
372695	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	M-CSF	134	86
372696	20233						N2586	51107.0								2	ug/mL	1	M-CSF	260.5	48
372697	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	M-CSF	241	36
372698	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	M-CSF	204	43
372699	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	M-CSF	262.5	46
372700	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	M-CSF	223	45
372701	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	M-CSF	198	35
372702	20233																	0	M-CSF	64	51
372703	20233						RA2159	51112.0										2	M-CSF	111	59
372704	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	M-CSF	145.5	58
372705	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	M-CSF	113	62
372706	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	M-CSF	141	73
372707	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	M-CSF	130.5	80
372708	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	M-CSF	163.5	64
372709	20233						RA2159	51112.0										2	M-CSF	157	63
372710	20233						N2586	51107.0										2	M-CSF	202	61
372711	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	M-CSF	173	51
372712	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	M-CSF	176	68
372713	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	M-CSF	218	41
372714	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	M-CSF	148	76
372715	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	M-CSF	182	37
372716	20233						N2586	51107.0										2	M-CSF	216.5	56
372717	20233																	0	M-CSF	78	69
372718	20233																	0	M-CSF	106	71
372719	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	M-CSF	288	82
372720	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	M-CSF	377	59
372721	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	M-CSF	320	55
372722	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	M-CSF	269	57
372723	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	M-CSF	217	55
372724	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	M-CSF	292	61
372725	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	M-CSF	158	57
372726	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	M-CSF	494	64
372727	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	M-CSF	456	74
372728	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	M-CSF	401	63
372729	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	M-CSF	419	54
372730	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	M-CSF	291.5	52
372731	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	M-CSF	355	49
372732	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	M-CSF	170	41
372733	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	M-CSF	359	71
372734	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	M-CSF	370	75
372735	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	M-CSF	290	65
372736	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	M-CSF	366	65
372737	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	M-CSF	267	67
372738	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	M-CSF	318	65
372739	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	M-CSF	120	58
372740	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	M-CSF	490	77
372741	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	M-CSF	537	50
372742	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	M-CSF	463	82
372743	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	M-CSF	480	53
372744	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	M-CSF	403	63
372745	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	M-CSF	382	56
372746	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	M-CSF	152.5	76
372747	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	M-CSF	203	72
372748	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	M-CSF	130	68
372749	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	M-CSF	192	77
372750	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	M-CSF	140	63
372751	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	M-CSF	120	73
372752	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	M-CSF	130.5	38
372753	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	M-CSF	150.5	58
372754	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	M-CSF	190.5	74
372755	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	M-CSF	224.5	66
372756	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	M-CSF	182	83
372757	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	M-CSF	184	81
372758	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	M-CSF	143	72
372759	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	M-CSF	139	59
372760	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	M-CSF	201	51
372761	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	M-CSF	169	59
372762	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	M-CSF	164.5	66
372763	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	M-CSF	136	59
372764	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	M-CSF	166	72
372765	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	M-CSF	130	51
372766	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	M-CSF	138	26
372767	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	M-CSF	149.5	32
372768	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	M-CSF	229	33
372769	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	M-CSF	240.5	72
372770	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	M-CSF	183.5	12
372771	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	M-CSF	217.5	22
372772	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	M-CSF	178.5	68
372773	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	M-CSF	197.5	86
372774	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	M-CSF	190	89
372775	20233						RA2159	51112.0										2	M-CSF	130	66
372776	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	M-CSF	133.5	68
372777	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	M-CSF	137	52
372778	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	M-CSF	124	41
372779	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	M-CSF	124.5	88
372780	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	M-CSF	137	61
372781	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	M-CSF	201.5	80
372782	20233						N2586	51107.0										2	M-CSF	214	50
372783	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	M-CSF	217	54
372784	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	M-CSF	187.5	66
372785	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	M-CSF	205.5	72
372786	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	M-CSF	154	55
372787	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	M-CSF	149	57
372788	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	M-CSF	169	65
372789	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	M-CSF	148	64
372790	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	M-CSF	133	87
372791	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	M-CSF	136	77
372792	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	M-CSF	132.5	70
372793	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	M-CSF	113.5	62
372794	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	M-CSF	123.5	58
372795	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	M-CSF	221	57
372796	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	M-CSF	220	41
372797	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	M-CSF	165	77
372798	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	M-CSF	173	71
372799	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	M-CSF	202	71
372800	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	M-CSF	198	61
372801	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	M-CSF	167	55
372802	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	M-CSF	129	65
372803	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	M-CSF	123.5	74
372804	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	M-CSF	194	50
372805	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	M-CSF	114	54
372806	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	M-CSF	135	45
372807	20233						RA2159	51112.0										2	M-CSF	125.5	48
372808	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	M-CSF	183	59
372809	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	M-CSF	231	57
372810	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	M-CSF	164	76
372811	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	M-CSF	157	45
372812	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	M-CSF	148	65
372813	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	M-CSF	137.5	72
372814	20233						N2586	51107.0										2	M-CSF	175.5	56
372815	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	M-CSF	134.5	76
372816	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	M-CSF	134	67
372817	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	M-CSF	159	54
372818	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	M-CSF	144	61
372819	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	M-CSF	127	76
372820	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	M-CSF	127	66
372821	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	M-CSF	163	55
372822	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	M-CSF	169	61
372823	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	M-CSF	156	61
372824	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	M-CSF	162.5	38
372825	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	M-CSF	152	62
372826	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	M-CSF	170	57
372827	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	M-CSF	120	63
372828	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	M-CSF	157	75
372829	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	M-CSF	128	70
372830	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	M-CSF	121	73
372831	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	M-CSF	104	74
372832	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	M-CSF	130	79
372833	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	M-CSF	173	65
372834	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	M-CSF	200	59
372835	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	M-CSF	150.5	84
372836	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	M-CSF	163	57
372837	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	M-CSF	142	59
372838	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	M-CSF	154	77
372839	20233						RA2159	51112.0										2	M-CSF		0
372840	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	M-CSF		0
372841	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	M-CSF		0
372842	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	M-CSF		0
372843	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	M-CSF		0
372844	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	M-CSF		0
372845	20233						RA2159	51112.0										2	M-CSF		0
372846	20233						N2586	51107.0										2	M-CSF		0
372847	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	M-CSF		0
372848	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	M-CSF		0
372849	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	M-CSF		0
372850	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	M-CSF		0
372851	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	M-CSF		0
372852	20233						N2586	51107.0										2	M-CSF		0
372853	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	M-CSF	116	52
372854	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	M-CSF	151.5	72
372855	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	M-CSF	130	76
372856	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	M-CSF	141	69
372857	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	M-CSF	102	65
372858	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	M-CSF	113.5	70
372859	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	M-CSF	182	71
372860	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	M-CSF	169	61
372861	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	M-CSF	152	62
372862	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	M-CSF	158	44
372863	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	M-CSF	130	70
372864	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	M-CSF	142	44
372865	20233																	0	M-CSF	59	67
372866	20233						RA2159	51112.0								2	ug/mL	2	M-CSF	237	89
372867	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	M-CSF	180	51
372868	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	M-CSF	210	57
372869	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	M-CSF	143	53
372870	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	M-CSF	116	56
372871	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	M-CSF	156	76
372872	20233						N2586	51107.0								2	ug/mL	2	M-CSF	249	76
372873	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	M-CSF	252.5	36
372874	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	M-CSF	217	45
372875	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	M-CSF	223	62
372876	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	M-CSF	148	63
372877	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	M-CSF	188	67
372878	20233																	0	M-CSF	57	58
372879	20233						RA2159	51112.0								2	ug/mL	3	M-CSF	168	50
372880	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	M-CSF	204	73
372881	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	M-CSF	125	60
372882	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	M-CSF	206	55
372883	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	M-CSF	199	72
372884	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	M-CSF	157	61
372885	20233						N2586	51107.0								2	ug/mL	3	M-CSF	282	53
372886	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	M-CSF	450	67
372887	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	M-CSF	246.5	68
372888	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	M-CSF	259	70
372889	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	M-CSF	196	63
372890	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	M-CSF	199.5	64
372891	20233						RA2159	51112.0										3	M-CSF		0
372892	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	M-CSF		0
372893	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	M-CSF		0
372894	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	M-CSF		0
372895	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	M-CSF		0
372896	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	M-CSF		0
372897	20233						RA2159	51112.0										3	M-CSF		0
372898	20233						N2586	51107.0										3	M-CSF		0
372899	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	M-CSF		0
372900	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	M-CSF		0
372901	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	M-CSF		0
372902	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	M-CSF		0
372903	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	M-CSF		0
372904	20233						N2586	51107.0										3	M-CSF		0
372905	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	M-CSF	196	74
372906	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	M-CSF	142	83
372907	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	M-CSF	101	71
372908	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	M-CSF	125	55
372909	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	M-CSF	121.5	68
372910	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	M-CSF	116	63
372911	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	M-CSF	168	79
372912	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	M-CSF	159	75
372913	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	M-CSF	133	70
372914	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	M-CSF	150.5	62
372915	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	M-CSF	155	64
372916	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	M-CSF	146	59
372917	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	M-CSF	113	71
372918	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	M-CSF	95.5	68
372919	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	M-CSF	89	67
372920	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	M-CSF	114	65
372921	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	M-CSF	113	72
372922	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	M-CSF	109	61
372923	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	M-CSF	170	73
372924	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	M-CSF	184	98
372925	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	M-CSF	140	60
372926	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	M-CSF	160	60
372927	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	M-CSF	149	64
372928	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	M-CSF	130.5	40
372929	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	M-CSF	114.5	74
372930	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	M-CSF	125	67
372931	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	M-CSF	141.5	74
372932	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	M-CSF	131	77
372933	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	M-CSF	137.5	56
372934	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	M-CSF	146	75
372935	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	M-CSF	153	59
372936	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	M-CSF	153	88
372937	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	M-CSF	148	72
372938	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	M-CSF	153	51
372939	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	M-CSF	140	49
372940	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	M-CSF	151.5	88
372941	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	M-CSF	117.5	66
372942	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	M-CSF	134.5	72
372943	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	M-CSF	120.5	60
372944	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	M-CSF	117	57
372945	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	M-CSF	103	65
372946	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	M-CSF	103.5	72
372947	20233						RA2159	51112.0										3	M-CSF	114	65
372948	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	M-CSF	165	68
372949	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	M-CSF	180	79
372950	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	M-CSF	140	61
372951	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	M-CSF	645.5	70
372952	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	M-CSF	158.5	76
372953	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	M-CSF	127	66
372954	20233						N2586	51107.0										3	M-CSF	179	76
372955	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	M-CSF	100.5	82
372956	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	M-CSF	96.5	76
372957	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	M-CSF	133	73
372958	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	M-CSF	148	75
372959	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	M-CSF	122	77
372960	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	M-CSF	105.5	60
372961	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	M-CSF	132	81
372962	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	M-CSF	183	82
372963	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	M-CSF	173.5	64
372964	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	M-CSF	172.5	60
372965	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	M-CSF	238	65
372966	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	M-CSF	181	62
372967	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	M-CSF	144	67
372968	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	M-CSF	89	61
372969	20233						RA2159	51112.0										3	M-CSF	99	81
372970	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	M-CSF	85	55
372971	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	M-CSF	83	59
372972	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	M-CSF	120.5	66
372973	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	M-CSF	127	51
372974	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	M-CSF	119	54
372975	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	M-CSF	104.5	88
372976	20233						N2586	51107.0										3	M-CSF	156	83
372977	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	M-CSF	186	62
372978	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	M-CSF	127.5	58
372979	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	M-CSF	319	57
372980	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	M-CSF	204	63
372981	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	M-CSF	116.5	60
372982	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	M-CSF	131	52
372983	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	M-CSF	118	69
372984	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	M-CSF	102.5	68
372985	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	M-CSF	119	68
372986	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	M-CSF	136	55
372987	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	M-CSF	107	89
372988	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	M-CSF	86	52
372989	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	M-CSF	190	73
372990	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	M-CSF	180.5	76
372991	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	M-CSF	137.5	60
372992	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	M-CSF	295	77
372993	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	M-CSF	130.5	64
372994	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	M-CSF	128	65
372995	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	M-CSF	87	53
372996	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	M-CSF	97	70
372997	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	M-CSF	82.5	74
372998	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	M-CSF	101.5	58
372999	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	M-CSF	100	80
373000	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	M-CSF	79	71
373001	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	M-CSF	115	59
373002	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	M-CSF	224	77
373003	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	M-CSF	153	55
373004	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	M-CSF	126	54
373005	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	M-CSF	150	61
373006	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	M-CSF	140	75
373007	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	M-CSF	126	63
373008	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	M-CSF	154	65
373009	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	M-CSF	233	80
373010	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	M-CSF	185	70
373011	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	M-CSF	229	69
373012	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	M-CSF	307	65
373013	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	M-CSF	293	70
373014	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	M-CSF	119	56
373015	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	M-CSF	112	66
373016	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	M-CSF	390	77
373017	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	M-CSF	398	75
373018	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	M-CSF	355	69
373019	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	M-CSF	433	69
373020	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	M-CSF	221	57
373021	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	M-CSF	209	85
373022	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	M-CSF	108	73
373023	20233																	0	M-CSF	79	69
373024	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	M-CSF	465	61
373025	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	M-CSF	185	58
373026	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	M-CSF	262	63
373027	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	M-CSF	251	53
373028	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	M-CSF	276	51
373029	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	M-CSF	146.5	66
373030	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	M-CSF	103	40
373031	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	M-CSF	325	56
373032	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	M-CSF	407.5	76
373033	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	M-CSF	349	69
373034	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	M-CSF	323	67
373035	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	M-CSF	282	73
373036	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	M-CSF	245	78
373037	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	M-CSF	242	63
373038	20233																	0	M-CSF	68	46
373039	20233						RA2159	51112.0										3	M-CSF	91	63
373040	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	M-CSF	96	51
373041	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	M-CSF	119.5	58
373042	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	M-CSF	112	49
373043	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	M-CSF	106	53
373044	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	M-CSF	105	55
373045	20233						RA2159	51112.0										3	M-CSF	172	72
373046	20233						N2586	51107.0										3	M-CSF	182	64
373047	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	M-CSF	127	55
373048	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	M-CSF	118.5	46
373049	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	M-CSF	147	73
373050	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	M-CSF	122	48
373051	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	M-CSF	120.5	40
373052	20233						N2586	51107.0										3	M-CSF	151	59
373053	20233																	0	M-CSF	53.5	58
373054	20233						RA2159	51112.0								2	ug/mL	4	M-CSF	185	73
373055	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	M-CSF	236.5	68
373056	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	M-CSF	199	61
373057	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	M-CSF	189	64
373058	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	M-CSF	145	53
373059	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	M-CSF	157	65
373060	20233						N2586	51107.0								2	ug/mL	4	M-CSF	265	72
373061	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	M-CSF	258	51
373062	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	M-CSF	160.5	34
373063	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	M-CSF	303	44
373064	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	M-CSF	146.5	76
373065	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	M-CSF	93	43
373066	20233						RA2159	51112.0										4	M-CSF		0
373067	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	M-CSF		0
373068	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	M-CSF		0
373069	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	M-CSF		0
373070	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	M-CSF		0
373071	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	M-CSF		0
373072	20233						RA2159	51112.0										4	M-CSF		0
373073	20233						N2586	51107.0										4	M-CSF		0
373074	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	M-CSF		0
373075	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	M-CSF		0
373076	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	M-CSF		0
373077	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	M-CSF		0
373078	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	M-CSF		0
373079	20233						N2586	51107.0										4	M-CSF		0
373080	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	M-CSF	112	48
373081	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	M-CSF	104	51
373082	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	M-CSF	130	69
373083	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	M-CSF	143.5	62
373084	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	M-CSF	164	65
373085	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	M-CSF	161	64
373086	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	M-CSF	170.5	56
373087	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	M-CSF	138	68
373088	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	M-CSF	154	60
373089	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	M-CSF	171	71
373090	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	M-CSF	134	71
373091	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	M-CSF	104	61
373092	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	M-CSF	127	69
373093	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	M-CSF	111	45
373094	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	M-CSF	138	87
373095	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	M-CSF	134.5	54
373096	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	M-CSF	244	73
373097	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	M-CSF	109	47
373098	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	M-CSF	152	69
373099	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	M-CSF	144	67
373100	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	M-CSF	110.5	44
373101	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	M-CSF	166	55
373102	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	M-CSF	142	55
373103	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	M-CSF	167	47
373104	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	M-CSF	127	96
373105	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	M-CSF	160	64
373106	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	M-CSF	141	70
373107	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	M-CSF	142	90
373108	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	M-CSF	130	61
373109	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	M-CSF	140	74
373110	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	M-CSF	146	67
373111	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	M-CSF	136	71
373112	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	M-CSF	147	45
373113	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	M-CSF	142	70
373114	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	M-CSF	146	61
373115	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	M-CSF	119.5	52
373116	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	M-CSF	119	73
373117	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	M-CSF	114.5	74
373118	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	M-CSF	159	57
373119	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	M-CSF	116	67
373120	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	M-CSF	105	70
373121	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	M-CSF	114	71
373122	20233						RA2159	51112.0										4	M-CSF	128.5	70
373123	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	M-CSF	153	63
373124	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	M-CSF	195	80
373125	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	M-CSF	150	64
373126	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	M-CSF	163.5	44
373127	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	M-CSF	146	61
373128	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	M-CSF	101.5	80
373129	20233						N2586	51107.0										4	M-CSF	134	65
373130	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	M-CSF	153.5	52
373131	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	M-CSF	110	79
373132	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	M-CSF	92	73
373133	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	M-CSF	109	71
373134	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	M-CSF	123	61
373135	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	M-CSF	166	81
373136	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	M-CSF	180	47
373137	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	M-CSF	221.5	78
373138	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	M-CSF	112.5	84
373139	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	M-CSF	249	57
373140	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	M-CSF	121.5	64
373141	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	M-CSF	94	53
373142	20233						RA2159	51112.0										4	M-CSF	131.5	84
373143	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	M-CSF	129	66
373144	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	M-CSF	109	38
373145	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	M-CSF	109	69
373146	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	M-CSF	92	47
373147	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	M-CSF	118	23
373148	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	M-CSF	117	14
373149	20233						N2586	51107.0										4	M-CSF		5
373150	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	M-CSF	181	11
373151	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	M-CSF	130	56
373152	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	M-CSF	177	45
373153	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	M-CSF	127.5	50
373154	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	M-CSF	102	66
373155	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	M-CSF	141	58
373156	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	M-CSF	110	60
373157	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	M-CSF	134	73
373158	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	M-CSF	117	80
373159	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	M-CSF	174	70
373160	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	M-CSF	115	65
373161	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	M-CSF	114.5	66
373162	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	M-CSF	104	28
373163	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	M-CSF	164	63
373164	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	M-CSF	142	63
373165	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	M-CSF	194	62
373166	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	M-CSF	172.5	52
373167	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	M-CSF	105	57
373168	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	M-CSF	83	57
373169	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	M-CSF	171	57
373170	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	M-CSF	204	73
373171	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	M-CSF	121	75
373172	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	M-CSF	110.5	52
373173	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	M-CSF	104.5	64
373174	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	M-CSF	93	37
373175	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	M-CSF	113	59
373176	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	M-CSF	114	57
373177	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	M-CSF	123	57
373178	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	M-CSF	157	63
373179	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	M-CSF	157.5	44
373180	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	M-CSF	155.5	62
373181	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	M-CSF	125	57
373182	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	M-CSF	82	46
373183	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	M-CSF	146	67
373184	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	M-CSF	303	79
373185	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	M-CSF	278	73
373186	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	M-CSF	417.5	56
373187	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	M-CSF	248	62
373188	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	M-CSF	242	64
373189	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	M-CSF	317.5	54
373190	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	M-CSF	100.5	72
373191	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	M-CSF	346.5	62
373192	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	M-CSF	303.5	70
373193	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	M-CSF	390.5	60
373194	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	M-CSF	438	65
373195	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	M-CSF	178.5	54
373196	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	M-CSF	111.5	58
373197	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	M-CSF	126	64
373198	20233																	0	M-CSF	74	51
373199	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	M-CSF	230	65
373200	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	M-CSF	247.5	50
373201	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	M-CSF	243	49
373202	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	M-CSF	245	65
373203	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	M-CSF	184.5	50
373204	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	M-CSF	196.5	64
373205	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	M-CSF	93	61
373206	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	M-CSF	398	55
373207	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	M-CSF	336.5	68
373208	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	M-CSF	341.5	62
373209	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	M-CSF	391.5	46
373210	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	M-CSF	222.5	52
373211	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	M-CSF	189	38
373212	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	M-CSF	140	54
373213	20233																	0	M-CSF	46	50
373214	20233						RA2159	51112.0										4	M-CSF	106.5	70
373215	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	M-CSF	104	67
373216	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	M-CSF	89	49
373217	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	M-CSF	94	77
373218	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	M-CSF	111	57
373219	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	M-CSF	104.5	70
373220	20233						RA2159	51112.0										4	M-CSF	113	75
373221	20233						N2586	51107.0										4	M-CSF	125	71
373222	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	M-CSF	138.5	44
373223	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	M-CSF	125	74
373224	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	M-CSF	134	70
373225	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	M-CSF	100.5	48
373226	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	M-CSF	104	52
373227	20233						N2586	51107.0										4	M-CSF	167.5	52
373228	20233								TNF-a	201285.0						100	ng/mL	0	M-CSF	74	73
373229	20233								IL-1 alpha	201286.0						100	ng/mL	0	M-CSF	86	77
373230	20233								IL-6	201287.0						100	ug/mL	0	M-CSF	86.5	50
373231	20233								IL-17A	201288.0						100	ng/mL	0	M-CSF	89	67
373232	20233								EGF	201289.0						100	ng/mL	0	M-CSF	205	69
373233	20233								IGF-I	201290.0						100	ug/mL	0	M-CSF	74	60
373234	20233								Adiponectin	201291.0						5	ng/mL	0	M-CSF	297	52
373235	20233								Leptin	201292.0						1	ng/mL	0	M-CSF	91	51
373236	20233								Visfatin	201293.0						1	ng/mL	0	M-CSF	95.5	66
373237	20233															2	ug/mL	0	M-CSF	79	53
373238	20233								TNF-a	201285.0						100	ng/mL	0	M-CSF	93	51
373239	20233								IL-1 alpha	201286.0						100	ng/mL	0	M-CSF	102	55
373240	20233								IL-6	201287.0						100	ug/mL	0	M-CSF	66	70
373241	20233								IL-17A	201288.0						100	ng/mL	0	M-CSF	77	61
373242	20233								EGF	201289.0						100	ng/mL	0	M-CSF	97.5	74
373243	20233								IGF-I	201290.0						100	ug/mL	0	M-CSF	113	49
373244	20233								Adiponectin	201291.0						5	ng/mL	0	M-CSF	320	71
373245	20233								Leptin	201292.0						1	ng/mL	0	M-CSF	76	62
373246	20233								Visfatin	201293.0						1	ng/mL	0	M-CSF	119	61
373247	20233															2	ug/mL	0	M-CSF	85.5	60
373248	20233								TNF-a	201285.0						100	ng/mL	0	M-CSF	68.5	72
373249	20233								IL-1 alpha	201286.0						100	ng/mL	0	M-CSF	59	76
373250	20233								IL-6	201287.0						100	ug/mL	0	M-CSF	79	78
373251	20233								IL-17A	201288.0						100	ng/mL	0	M-CSF	72	85
373252	20233								EGF	201289.0						100	ng/mL	0	M-CSF	61	67
373253	20233								IGF-I	201290.0						100	ug/mL	0	M-CSF	74	51
373254	20233								Adiponectin	201291.0						5	ng/mL	0	M-CSF	308	49
373255	20233								Leptin	201292.0						1	ng/mL	0	M-CSF	49	50
373256	20233								Visfatin	201293.0						1	ng/mL	0	M-CSF	70	58
373257	20233															2	ug/mL	0	M-CSF	82	69
373258	20233								TNF-a	201285.0						100	ng/mL	0	M-CSF	69	46
373259	20233								IL-1 alpha	201286.0						100	ng/mL	0	M-CSF	63.5	58
373260	20233								IL-6	201287.0						100	ug/mL	0	M-CSF	142	64
373261	20233								IL-17A	201288.0						100	ng/mL	0	M-CSF	69	57
373262	20233								EGF	201289.0						100	ng/mL	0	M-CSF	59	73
373263	20233								IGF-I	201290.0						100	ug/mL	0	M-CSF	52	59
373264	20233								Adiponectin	201291.0						5	ng/mL	0	M-CSF	352	47
373265	20233								Leptin	201292.0						1	ng/mL	0	M-CSF	150	58
373266	20233								Visfatin	201293.0						1	ng/mL	0	M-CSF	140.5	46
373267	20233															2	ug/mL	0	M-CSF	53.5	44
373268	20233																	0	CTACK	18	70
373269	20233						RA2159	51112.0										1	CTACK	17	63
373270	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	CTACK	19	75
373271	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	CTACK	18	91
373272	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	CTACK	17.5	62
373273	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	CTACK	18	63
373274	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	CTACK	18	65
373275	20233						RA2159	51112.0										1	CTACK	19	56
373276	20233						N2586	51107.0										1	CTACK	26	81
373277	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	CTACK	19	55
373278	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	CTACK	22	79
373279	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	CTACK	19.5	50
373280	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	CTACK	20	47
373281	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	CTACK	18	63
373282	20233						N2586	51107.0										1	CTACK	22.5	40
373283	20233																	0	CTACK	24	55
373284	20233																	0	CTACK	15	49
373285	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	CTACK	19	57
373286	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	CTACK	25	90
373287	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	CTACK	18	71
373288	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	CTACK	21	68
373289	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	CTACK	22	67
373290	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	CTACK	21.5	52
373291	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	CTACK	22	77
373292	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	CTACK	26.5	46
373293	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	CTACK	23	39
373294	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	CTACK	20	37
373295	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	CTACK	26	71
373296	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	CTACK	23	54
373297	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	CTACK	26	33
373298	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	CTACK	17	56
373299	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	CTACK	24	75
373300	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	CTACK	27	89
373301	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	CTACK	22.5	54
373302	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	CTACK	22.5	60
373303	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	CTACK	22	63
373304	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	CTACK	17.5	58
373305	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	CTACK	23	58
373306	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	CTACK	29	45
373307	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	CTACK	25.5	54
373308	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	CTACK	27	60
373309	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	CTACK	28.5	72
373310	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	CTACK	26	62
373311	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	CTACK	20	55
373312	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	CTACK	16	49
373313	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	CTACK	18	56
373314	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	CTACK	19	63
373315	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	CTACK	19	52
373316	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	CTACK	18	59
373317	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	CTACK	19	72
373318	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	CTACK	17.5	62
373319	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	CTACK	16	82
373320	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	CTACK	22	63
373321	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	CTACK	20	57
373322	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	CTACK	20	53
373323	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	CTACK	17.5	46
373324	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	CTACK	21	51
373325	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	CTACK	22.5	42
373326	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	CTACK	20	45
373327	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	CTACK	17	69
373328	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	CTACK	17	65
373329	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	CTACK	15.5	62
373330	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	CTACK	18	81
373331	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	CTACK	19	72
373332	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	CTACK	18	61
373333	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	CTACK	23	39
373334	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	CTACK	19	36
373335	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	CTACK	26	28
373336	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	CTACK	21.5	42
373337	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	CTACK	19	42
373338	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	CTACK	18	56
373339	20233						RA2159	51112.0										1	CTACK	19	33
373340	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	CTACK	29	82
373341	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	CTACK	20	63
373342	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	CTACK	14	89
373343	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	CTACK	18	63
373344	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	CTACK	19	77
373345	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	CTACK	16	52
373346	20233						N2586	51107.0										1	CTACK	20	57
373347	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	CTACK	17	65
373348	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	CTACK	21	49
373349	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	CTACK	18	58
373350	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	CTACK	18	73
373351	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	CTACK	17.5	60
373352	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	CTACK	18	47
373353	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	CTACK	23	70
373354	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	CTACK	17	55
373355	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	CTACK	18	64
373356	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	CTACK	16	63
373357	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	CTACK	24	62
373358	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	CTACK	16	62
373359	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	CTACK	17.5	62
373360	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	CTACK	16	67
373361	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	CTACK	19	74
373362	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	CTACK	17.5	56
373363	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	CTACK	20	79
373364	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	CTACK	20	55
373365	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	CTACK	21	53
373366	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	CTACK	18.5	58
373367	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	CTACK	20.5	62
373368	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	CTACK	23	59
373369	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	CTACK	27	66
373370	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	CTACK	20.5	68
373371	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	CTACK	19.5	78
373372	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	CTACK	16	60
373373	20233						RA2159	51112.0										1	CTACK	19	76
373374	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	CTACK	19	68
373375	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	CTACK	21	66
373376	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	CTACK	18	58
373377	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	CTACK	19	58
373378	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	CTACK	21.5	36
373379	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	CTACK	23	39
373380	20233						N2586	51107.0										1	CTACK	17	48
373381	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	CTACK	70	60
373382	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	CTACK	84.5	76
373383	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	CTACK	90	59
373384	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	CTACK	70.5	58
373385	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	CTACK	101	75
373386	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	CTACK	91.5	56
373387	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	CTACK	67	66
373388	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	CTACK	61.5	60
373389	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	CTACK	64	46
373390	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	CTACK	53	53
373391	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	CTACK	56	49
373392	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	CTACK	54	56
373393	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	CTACK	17	62
373394	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	CTACK	18	61
373395	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	CTACK	17	53
373396	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	CTACK	16.5	56
373397	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	CTACK	13	45
373398	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	CTACK	20	40
373399	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	CTACK	16	28
373400	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	CTACK	20	45
373401	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	CTACK	17.5	40
373402	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	CTACK	25	39
373403	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	CTACK	15	31
373404	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	CTACK	17	35
373405	20233						RA2159	51112.0										1	CTACK		0
373406	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	CTACK		0
373407	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	CTACK		0
373408	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	CTACK		0
373409	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	CTACK		0
373410	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	CTACK		0
373411	20233						RA2159	51112.0										1	CTACK		0
373412	20233						N2586	51107.0										1	CTACK		0
373413	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	CTACK		0
373414	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	CTACK		0
373415	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	CTACK		0
373416	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	CTACK		0
373417	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	CTACK		0
373418	20233						N2586	51107.0										1	CTACK		0
373419	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	CTACK	19.5	60
373420	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	CTACK	21	68
373421	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	CTACK	17	67
373422	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	CTACK	15	55
373423	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	CTACK	20	50
373424	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	CTACK	18	43
373425	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	CTACK	16	50
373426	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	CTACK	29	35
373427	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	CTACK	30	49
373428	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	CTACK	20	50
373429	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	CTACK	20	35
373430	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	CTACK	17	55
373431	20233																	0	CTACK	18	55
373432	20233						RA2159	51112.0								2	ug/mL	1	CTACK	14.5	42
373433	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	CTACK	16.5	60
373434	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	CTACK	16	45
373435	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	CTACK	19.5	66
373436	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	CTACK	15	71
373437	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	CTACK	17	80
373438	20233						N2586	51107.0								2	ug/mL	1	CTACK	20	49
373439	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	CTACK	19	31
373440	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	CTACK	22	42
373441	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	CTACK	23	43
373442	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	CTACK	17.5	44
373443	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	CTACK	18	29
373444	20233																	0	CTACK	18	60
373445	20233						RA2159	51112.0										2	CTACK	21	67
373446	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	CTACK	17	61
373447	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	CTACK	19	61
373448	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	CTACK	20	80
373449	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	CTACK	18	71
373450	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	CTACK	22	67
373451	20233						RA2159	51112.0										2	CTACK	22	59
373452	20233						N2586	51107.0										2	CTACK	20.5	50
373453	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	CTACK	21.5	54
373454	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	CTACK	17	81
373455	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	CTACK	23	49
373456	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	CTACK	19	59
373457	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	CTACK	20.5	44
373458	20233						N2586	51107.0										2	CTACK	22	71
373459	20233																	0	CTACK	20	61
373460	20233																	0	CTACK	22	64
373461	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	CTACK	19	67
373462	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	CTACK	20	67
373463	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	CTACK	21.5	54
373464	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	CTACK	19	67
373465	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	CTACK	19	65
373466	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	CTACK	21	52
373467	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	CTACK	22	55
373468	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	CTACK	26	49
373469	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	CTACK	21	60
373470	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	CTACK	20	53
373471	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	CTACK	29	39
373472	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	CTACK	27	72
373473	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	CTACK	24	36
373474	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	CTACK	21.5	62
373475	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	CTACK	20	74
373476	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	CTACK	21	69
373477	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	CTACK	23	71
373478	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	CTACK	26	65
373479	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	CTACK	20	54
373480	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	CTACK	22	77
373481	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	CTACK	19	66
373482	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	CTACK	26	57
373483	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	CTACK	27	89
373484	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	CTACK	24	65
373485	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	CTACK	28	50
373486	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	CTACK	28	63
373487	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	CTACK	24	43
373488	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	CTACK	16.5	66
373489	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	CTACK	31.5	72
373490	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	CTACK	17	61
373491	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	CTACK	25.5	52
373492	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	CTACK	18	74
373493	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	CTACK	16	59
373494	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	CTACK	19	47
373495	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	CTACK	19.5	68
373496	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	CTACK	22	69
373497	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	CTACK	21	63
373498	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	CTACK	19	63
373499	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	CTACK	20	55
373500	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	CTACK	19	65
373501	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	CTACK	16	47
373502	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	CTACK	15.5	68
373503	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	CTACK	25	77
373504	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	CTACK	18	65
373505	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	CTACK	19	75
373506	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	CTACK	21.5	70
373507	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	CTACK	15	60
373508	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	CTACK	18	32
373509	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	CTACK	17.5	38
373510	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	CTACK	18	41
373511	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	CTACK	22	69
373512	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	CTACK	15.5	14
373513	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	CTACK	23	24
373514	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	CTACK	17.5	44
373515	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	CTACK	22	65
373516	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	CTACK	23	83
373517	20233						RA2159	51112.0										2	CTACK	16	62
373518	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	CTACK	14	51
373519	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	CTACK	15	51
373520	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	CTACK	17.5	48
373521	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	CTACK	17	62
373522	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	CTACK	13	53
373523	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	CTACK	29	94
373524	20233						N2586	51107.0										2	CTACK	19	71
373525	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	CTACK	22	69
373526	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	CTACK	24	73
373527	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	CTACK	21	78
373528	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	CTACK	18	54
373529	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	CTACK	19	62
373530	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	CTACK	19	72
373531	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	CTACK	21	67
373532	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	CTACK	16	84
373533	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	CTACK	16.5	68
373534	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	CTACK	20	57
373535	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	CTACK	18	60
373536	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	CTACK	17	82
373537	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	CTACK	21.5	54
373538	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	CTACK	21	39
373539	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	CTACK	17	66
373540	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	CTACK	19	72
373541	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	CTACK	22	65
373542	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	CTACK	19	65
373543	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	CTACK	23	76
373544	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	CTACK	17	60
373545	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	CTACK	20	62
373546	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	CTACK	25	83
373547	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	CTACK	18	50
373548	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	CTACK	18	41
373549	20233						RA2159	51112.0										2	CTACK	21	49
373550	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	CTACK	18.5	36
373551	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	CTACK	24	59
373552	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	CTACK	22.5	56
373553	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	CTACK	16	48
373554	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	CTACK	18	73
373555	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	CTACK	17	66
373556	20233						N2586	51107.0										2	CTACK	24	68
373557	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	CTACK	60.5	60
373558	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	CTACK	48	51
373559	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	CTACK	69	73
373560	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	CTACK	61	49
373561	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	CTACK	62	69
373562	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	CTACK	61	77
373563	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	CTACK	69	55
373564	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	CTACK	65	57
373565	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	CTACK	79	62
373566	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	CTACK	81	39
373567	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	CTACK	78	70
373568	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	CTACK	76	71
373569	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	CTACK	16	55
373570	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	CTACK	18	63
373571	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	CTACK	20.5	66
373572	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	CTACK	17.5	60
373573	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	CTACK	15	78
373574	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	CTACK	16	61
373575	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	CTACK	18	85
373576	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	CTACK	20	64
373577	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	CTACK	17	59
373578	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	CTACK	19	55
373579	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	CTACK	20	53
373580	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	CTACK	19	63
373581	20233						RA2159	51112.0										2	CTACK		0
373582	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	CTACK		0
373583	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	CTACK		0
373584	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	CTACK		0
373585	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	CTACK		0
373586	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	CTACK		0
373587	20233						RA2159	51112.0										2	CTACK		0
373588	20233						N2586	51107.0										2	CTACK		0
373589	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	CTACK		0
373590	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	CTACK		0
373591	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	CTACK		0
373592	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	CTACK		0
373593	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	CTACK		0
373594	20233						N2586	51107.0										2	CTACK		0
373595	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	CTACK	18.5	52
373596	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	CTACK	19	83
373597	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	CTACK	17	72
373598	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	CTACK	19	69
373599	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	CTACK	17.5	58
373600	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	CTACK	13	61
373601	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	CTACK	17	65
373602	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	CTACK	17	47
373603	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	CTACK	16.5	52
373604	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	CTACK	18	55
373605	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	CTACK	18	60
373606	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	CTACK	17	48
373607	20233																	0	CTACK	17	68
373608	20233						RA2159	51112.0								2	ug/mL	2	CTACK	19.5	78
373609	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	CTACK	31	44
373610	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	CTACK	17.5	38
373611	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	CTACK	16	63
373612	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	CTACK	19	62
373613	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	CTACK	14	61
373614	20233						N2586	51107.0								2	ug/mL	2	CTACK	19	71
373615	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	CTACK	21.5	36
373616	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	CTACK	18	59
373617	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	CTACK	15	41
373618	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	CTACK	17	59
373619	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	CTACK	19	49
373620	20233																	0	CTACK	16	71
373621	20233						RA2159	51112.0								2	ug/mL	3	CTACK	15.5	68
373622	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	CTACK	18	57
373623	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	CTACK	19	61
373624	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	CTACK	16.5	72
373625	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	CTACK	16	89
373626	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	CTACK	15	71
373627	20233						N2586	51107.0								2	ug/mL	3	CTACK	18	62
373628	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	CTACK	38	61
373629	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	CTACK	18	49
373630	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	CTACK	18	68
373631	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	CTACK	15	59
373632	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	CTACK	23	51
373633	20233						RA2159	51112.0										3	CTACK		0
373634	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	CTACK		0
373635	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	CTACK		0
373636	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	CTACK		0
373637	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	CTACK		0
373638	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	CTACK		0
373639	20233						RA2159	51112.0										3	CTACK		0
373640	20233						N2586	51107.0										3	CTACK		0
373641	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	CTACK		0
373642	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	CTACK		0
373643	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	CTACK		0
373644	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	CTACK		0
373645	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	CTACK		0
373646	20233						N2586	51107.0										3	CTACK		0
373647	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	CTACK	34	75
373648	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	CTACK	18	69
373649	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	CTACK	17	56
373650	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	CTACK	17	58
373651	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	CTACK	17.5	62
373652	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	CTACK	17	58
373653	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	CTACK	20	58
373654	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	CTACK	15.5	68
373655	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	CTACK	15	71
373656	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	CTACK	17	69
373657	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	CTACK	16	73
373658	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	CTACK	17	73
373659	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	CTACK	17	61
373660	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	CTACK	15	67
373661	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	CTACK	15	63
373662	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	CTACK	13.5	66
373663	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	CTACK	17	56
373664	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	CTACK	17	55
373665	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	CTACK	16	69
373666	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	CTACK	20	73
373667	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	CTACK	16	69
373668	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	CTACK	18	73
373669	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	CTACK	18	59
373670	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	CTACK	15	64
373671	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	CTACK	63	72
373672	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	CTACK	52	65
373673	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	CTACK	63.5	62
373674	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	CTACK	57	63
373675	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	CTACK	59	56
373676	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	CTACK	58	72
373677	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	CTACK	59	95
373678	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	CTACK	65.5	72
373679	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	CTACK	55	53
373680	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	CTACK	59	46
373681	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	CTACK	73	45
373682	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	CTACK	69	89
373683	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	CTACK	19	89
373684	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	CTACK	18.5	64
373685	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	CTACK	21	80
373686	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	CTACK	17.5	48
373687	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	CTACK	16	75
373688	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	CTACK	13	66
373689	20233						RA2159	51112.0										3	CTACK	16	59
373690	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	CTACK	18	59
373691	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	CTACK	20	84
373692	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	CTACK	16	83
373693	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	CTACK	55	80
373694	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	CTACK	17	69
373695	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	CTACK	16	59
373696	20233						N2586	51107.0										3	CTACK	22	58
373697	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	CTACK	18.5	60
373698	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	CTACK	16	65
373699	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	CTACK	20.5	64
373700	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	CTACK	23	48
373701	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	CTACK	17	74
373702	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	CTACK	16	51
373703	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	CTACK	22.5	74
373704	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	CTACK	18	83
373705	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	CTACK	18	72
373706	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	CTACK	18.5	74
373707	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	CTACK	25.5	74
373708	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	CTACK	17	63
373709	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	CTACK	19.5	66
373710	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	CTACK	16	69
373711	20233						RA2159	51112.0										3	CTACK	17	64
373712	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	CTACK	15.5	64
373713	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	CTACK	15	66
373714	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	CTACK	17.5	74
373715	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	CTACK	18	56
373716	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	CTACK	19.5	52
373717	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	CTACK	17	80
373718	20233						N2586	51107.0										3	CTACK	16.5	56
373719	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	CTACK	20	52
373720	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	CTACK	15	86
373721	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	CTACK	33	62
373722	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	CTACK	24.5	70
373723	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	CTACK	18.5	60
373724	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	CTACK	16.5	54
373725	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	CTACK	18	94
373726	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	CTACK	15	89
373727	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	CTACK	18	53
373728	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	CTACK	17	71
373729	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	CTACK	17	64
373730	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	CTACK	17	55
373731	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	CTACK	18	70
373732	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	CTACK	18	60
373733	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	CTACK	15	70
373734	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	CTACK	29	51
373735	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	CTACK	16	72
373736	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	CTACK	15	57
373737	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	CTACK	16	61
373738	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	CTACK	18	53
373739	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	CTACK	16	69
373740	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	CTACK	14	58
373741	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	CTACK	15.5	74
373742	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	CTACK	14	63
373743	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	CTACK	15	67
373744	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	CTACK	25	69
373745	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	CTACK	19	54
373746	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	CTACK	19	63
373747	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	CTACK	17	59
373748	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	CTACK	16	61
373749	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	CTACK	14	61
373750	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	CTACK	19	70
373751	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	CTACK	19	87
373752	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	CTACK	17.5	76
373753	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	CTACK	19.5	66
373754	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	CTACK	21.5	66
373755	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	CTACK	23	75
373756	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	CTACK	20.5	66
373757	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	CTACK	15	59
373758	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	CTACK	25	67
373759	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	CTACK	22	75
373760	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	CTACK	20	55
373761	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	CTACK	27	52
373762	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	CTACK	19	77
373763	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	CTACK	19	83
373764	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	CTACK	15	68
373765	20233																	0	CTACK	18	60
373766	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	CTACK	20	53
373767	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	CTACK	17.5	56
373768	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	CTACK	19	75
373769	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	CTACK	17	40
373770	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	CTACK	15	50
373771	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	CTACK	17	69
373772	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	CTACK	14	44
373773	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	CTACK	16	59
373774	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	CTACK	24	74
373775	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	CTACK	14	54
373776	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	CTACK	20	75
373777	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	CTACK	22	67
373778	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	CTACK	17	96
373779	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	CTACK	34	61
373780	20233																	0	CTACK	19	61
373781	20233						RA2159	51112.0										3	CTACK	19	73
373782	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	CTACK	18.5	48
373783	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	CTACK	24	61
373784	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	CTACK	18	33
373785	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	CTACK	13	59
373786	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	CTACK	20.5	68
373787	20233						RA2159	51112.0										3	CTACK	24.5	60
373788	20233						N2586	51107.0										3	CTACK	17	35
373789	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	CTACK	14	48
373790	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	CTACK	16.5	46
373791	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	CTACK	16	79
373792	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	CTACK	15	63
373793	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	CTACK	15	44
373794	20233						N2586	51107.0										3	CTACK	19	64
373795	20233																	0	CTACK	15	55
373796	20233						RA2159	51112.0								2	ug/mL	4	CTACK	19	76
373797	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	CTACK	25.5	64
373798	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	CTACK	19.5	68
373799	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	CTACK	19	49
373800	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	CTACK	18.5	76
373801	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	CTACK	22	64
373802	20233						N2586	51107.0								2	ug/mL	4	CTACK	21	63
373803	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	CTACK	22.5	66
373804	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	CTACK	17	71
373805	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	CTACK	29.5	48
373806	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	CTACK	20	61
373807	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	CTACK	18.5	54
373808	20233						RA2159	51112.0										4	CTACK		0
373809	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	CTACK		0
373810	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	CTACK		0
373811	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	CTACK		0
373812	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	CTACK		0
373813	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	CTACK		0
373814	20233						RA2159	51112.0										4	CTACK		0
373815	20233						N2586	51107.0										4	CTACK		0
373816	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	CTACK		0
373817	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	CTACK		0
373818	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	CTACK		0
373819	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	CTACK		0
373820	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	CTACK		0
373821	20233						N2586	51107.0										4	CTACK		0
373822	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	CTACK	18	61
373823	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	CTACK	18	62
373824	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	CTACK	19	66
373825	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	CTACK	21	61
373826	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	CTACK	25	80
373827	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	CTACK	21	81
373828	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	CTACK	18	61
373829	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	CTACK	20	57
373830	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	CTACK	19	49
373831	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	CTACK	18	71
373832	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	CTACK	17	82
373833	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	CTACK	17	62
373834	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	CTACK	19	54
373835	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	CTACK	14	61
373836	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	CTACK	17.5	72
373837	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	CTACK	16	57
373838	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	CTACK	40	73
373839	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	CTACK	15	53
373840	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	CTACK	17	64
373841	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	CTACK	17	49
373842	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	CTACK	15	45
373843	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	CTACK	17	58
373844	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	CTACK	19	51
373845	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	CTACK	24.5	50
373846	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	CTACK	65.5	90
373847	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	CTACK	50	53
373848	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	CTACK	58	63
373849	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	CTACK	51.5	76
373850	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	CTACK	58	62
373851	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	CTACK	55	59
373852	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	CTACK	57.5	72
373853	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	CTACK	61	57
373854	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	CTACK	58.5	72
373855	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	CTACK	56	63
373856	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	CTACK	65.5	62
373857	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	CTACK	46	67
373858	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	CTACK	19	67
373859	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	CTACK	17	73
373860	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	CTACK	20	67
373861	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	CTACK	16	69
373862	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	CTACK	16	70
373863	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	CTACK	16.5	58
373864	20233						RA2159	51112.0										4	CTACK	16	71
373865	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	CTACK	18	63
373866	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	CTACK	20	61
373867	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	CTACK	19	51
373868	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	CTACK	18	39
373869	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	CTACK	19	66
373870	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	CTACK	18	73
373871	20233						N2586	51107.0										4	CTACK	17	81
373872	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	CTACK	24	73
373873	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	CTACK	15	67
373874	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	CTACK	13	71
373875	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	CTACK	16	53
373876	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	CTACK	19	69
373877	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	CTACK	23	91
373878	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	CTACK	21	45
373879	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	CTACK	23	79
373880	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	CTACK	16	68
373881	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	CTACK	27.5	52
373882	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	CTACK	18.5	42
373883	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	CTACK	18	57
373884	20233						RA2159	51112.0										4	CTACK	17	74
373885	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	CTACK	15	49
373886	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	CTACK	15	46
373887	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	CTACK	16	68
373888	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	CTACK	16	35
373889	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	CTACK	18	19
373890	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	CTACK	22	9
373891	20233						N2586	51107.0										4	CTACK	19.5	12
373892	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	CTACK		6
373893	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	CTACK	18	60
373894	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	CTACK	15.5	48
373895	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	CTACK	17	59
373896	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	CTACK	17	55
373897	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	CTACK	20	49
373898	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	CTACK	16.5	50
373899	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	CTACK	17	68
373900	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	CTACK	16	77
373901	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	CTACK	25	61
373902	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	CTACK	14.5	82
373903	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	CTACK	17	49
373904	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	CTACK	15	35
373905	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	CTACK	17	51
373906	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	CTACK	16.5	70
373907	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	CTACK	21	71
373908	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	CTACK	17	61
373909	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	CTACK	18	72
373910	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	CTACK	16	62
373911	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	CTACK	20	59
373912	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	CTACK	30	79
373913	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	CTACK	13.5	60
373914	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	CTACK	16	48
373915	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	CTACK	14.5	52
373916	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	CTACK	14.5	60
373917	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	CTACK	13.5	70
373918	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	CTACK	15	63
373919	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	CTACK	17	52
373920	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	CTACK	23.5	60
373921	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	CTACK	24.5	44
373922	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	CTACK	17	58
373923	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	CTACK	16	52
373924	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	CTACK	16	54
373925	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	CTACK	23	48
373926	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	CTACK	21	67
373927	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	CTACK	22	76
373928	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	CTACK	43	55
373929	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	CTACK	21	77
373930	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	CTACK	21	55
373931	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	CTACK	24	61
373932	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	CTACK	16	64
373933	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	CTACK	21	55
373934	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	CTACK	24	73
373935	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	CTACK	24.5	58
373936	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	CTACK	31	61
373937	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	CTACK	18	42
373938	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	CTACK	18	58
373939	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	CTACK	15.5	48
373940	20233																	0	CTACK	20	68
373941	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	CTACK	19	48
373942	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	CTACK	15	44
373943	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	CTACK	16	51
373944	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	CTACK	18	63
373945	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	CTACK	17	48
373946	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	CTACK	16	71
373947	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	CTACK	12.5	60
373948	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	CTACK	26	49
373949	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	CTACK	25	63
373950	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	CTACK	22	52
373951	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	CTACK	23.5	46
373952	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	CTACK	20	57
373953	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	CTACK	16	45
373954	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	CTACK	19	65
373955	20233																	0	CTACK	16	49
373956	20233						RA2159	51112.0										4	CTACK	16	67
373957	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	CTACK	16	61
373958	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	CTACK	15	68
373959	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	CTACK	15	50
373960	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	CTACK	16	81
373961	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	CTACK	16	61
373962	20233						RA2159	51112.0										4	CTACK	17	62
373963	20233						N2586	51107.0										4	CTACK	16.5	66
373964	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	CTACK	19	49
373965	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	CTACK	24	50
373966	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	CTACK	15	67
373967	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	CTACK	18	62
373968	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	CTACK	14	66
373969	20233						N2586	51107.0										4	CTACK	25	43
373970	20233								TNF-a	201285.0						100	ng/mL	0	CTACK	22	65
373971	20233								IL-1 alpha	201286.0						100	ng/mL	0	CTACK	22.5	68
373972	20233								IL-6	201287.0						100	ug/mL	0	CTACK	20	43
373973	20233								IL-17A	201288.0						100	ng/mL	0	CTACK	18.5	66
373974	20233								EGF	201289.0						100	ng/mL	0	CTACK	38	53
373975	20233								IGF-I	201290.0						100	ug/mL	0	CTACK	19	50
373976	20233								Adiponectin	201291.0						5	ng/mL	0	CTACK	361	67
373977	20233								Leptin	201292.0						1	ng/mL	0	CTACK	19	55
373978	20233								Visfatin	201293.0						1	ng/mL	0	CTACK	17	71
373979	20233															2	ug/mL	0	CTACK	18	57
373980	20233								TNF-a	201285.0						100	ng/mL	0	CTACK	18	40
373981	20233								IL-1 alpha	201286.0						100	ng/mL	0	CTACK	23	63
373982	20233								IL-6	201287.0						100	ug/mL	0	CTACK	22	63
373983	20233								IL-17A	201288.0						100	ng/mL	0	CTACK	21	46
373984	20233								EGF	201289.0						100	ng/mL	0	CTACK	21.5	60
373985	20233								IGF-I	201290.0						100	ug/mL	0	CTACK	22	59
373986	20233								Adiponectin	201291.0						5	ng/mL	0	CTACK	385	60
373987	20233								Leptin	201292.0						1	ng/mL	0	CTACK	21	62
373988	20233								Visfatin	201293.0						1	ng/mL	0	CTACK	20	58
373989	20233															2	ug/mL	0	CTACK	21	50
373990	20233								TNF-a	201285.0						100	ng/mL	0	CTACK	18	67
373991	20233								IL-1 alpha	201286.0						100	ng/mL	0	CTACK	18	65
373992	20233								IL-6	201287.0						100	ug/mL	0	CTACK	17	82
373993	20233								IL-17A	201288.0						100	ng/mL	0	CTACK	15	71
373994	20233								EGF	201289.0						100	ng/mL	0	CTACK	17	57
373995	20233								IGF-I	201290.0						100	ug/mL	0	CTACK	16	60
373996	20233								Adiponectin	201291.0						5	ng/mL	0	CTACK	267.5	58
373997	20233								Leptin	201292.0						1	ng/mL	0	CTACK	14	42
373998	20233								Visfatin	201293.0						1	ng/mL	0	CTACK	17.5	58
373999	20233															2	ug/mL	0	CTACK	21	55
374000	20233								TNF-a	201285.0						100	ng/mL	0	CTACK	18	44
374001	20233								IL-1 alpha	201286.0						100	ng/mL	0	CTACK	22	75
374002	20233								IL-6	201287.0						100	ug/mL	0	CTACK	32.5	66
374003	20233								IL-17A	201288.0						100	ng/mL	0	CTACK	12	49
374004	20233								EGF	201289.0						100	ng/mL	0	CTACK	16	71
374005	20233								IGF-I	201290.0						100	ug/mL	0	CTACK	14	49
374006	20233								Adiponectin	201291.0						5	ng/mL	0	CTACK	393	63
374007	20233								Leptin	201292.0						1	ng/mL	0	CTACK	28.5	46
374008	20233								Visfatin	201293.0						1	ng/mL	0	CTACK	21.5	56
374009	20233															2	ug/mL	0	CTACK	12	37
374010	20233																	0	SCGF-b	48	65
374011	20233						RA2159	51112.0										1	SCGF-b	70.5	68
374012	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	SCGF-b	76	61
374013	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	SCGF-b	80	78
374014	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	SCGF-b	73	53
374015	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	SCGF-b	83	61
374016	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	SCGF-b	93	50
374017	20233						RA2159	51112.0										1	SCGF-b	73	45
374018	20233						N2586	51107.0										1	SCGF-b	92	66
374019	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	SCGF-b	75	51
374020	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	SCGF-b	77	77
374021	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	SCGF-b	75	55
374022	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	SCGF-b	91	22
374023	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	SCGF-b	70	56
374024	20233						N2586	51107.0										1	SCGF-b	77.5	30
374025	20233																	0	SCGF-b	49	52
374026	20233																	0	SCGF-b	42.5	42
374027	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	1	SCGF-b	70	59
374028	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	SCGF-b	72	54
374029	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SCGF-b	66	55
374030	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SCGF-b	64	60
374031	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SCGF-b	74	65
374032	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	1	SCGF-b	69	54
374033	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			1	SCGF-b	86	60
374034	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	1	SCGF-b	73	53
374035	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	1	SCGF-b	68	47
374036	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SCGF-b	67.5	36
374037	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SCGF-b	72	61
374038	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	1	SCGF-b	72	73
374039	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	1	SCGF-b	64	34
374040	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			1	SCGF-b	79	68
374041	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	1	SCGF-b	78	51
374042	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	SCGF-b	83	67
374043	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SCGF-b	64	44
374044	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SCGF-b	90.5	46
374045	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SCGF-b	58	47
374046	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	SCGF-b	67	57
374047	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			1	SCGF-b	72	45
374048	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	1	SCGF-b	67.5	56
374049	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	1	SCGF-b	78	37
374050	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SCGF-b	82.5	56
374051	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SCGF-b	74	50
374052	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	1	SCGF-b	70	57
374053	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	1	SCGF-b	63	46
374054	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			1	SCGF-b	77	43
374055	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	1	SCGF-b	76	58
374056	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	SCGF-b	70.5	58
374057	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SCGF-b	74.5	52
374058	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SCGF-b	71	46
374059	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SCGF-b	64	55
374060	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	1	SCGF-b	67.5	48
374061	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			1	SCGF-b	64.5	78
374062	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	1	SCGF-b	74	44
374063	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	1	SCGF-b	65.5	56
374064	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SCGF-b	59	49
374065	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SCGF-b	66	45
374066	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	1	SCGF-b	65	45
374067	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	1	SCGF-b	63.5	54
374068	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			1	SCGF-b	76	49
374069	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	1	SCGF-b	67.5	56
374070	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	SCGF-b	65	64
374071	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SCGF-b	66	63
374072	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SCGF-b	68	54
374073	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SCGF-b	73	37
374074	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	1	SCGF-b	65.5	50
374075	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	1	SCGF-b	71	25
374076	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	1	SCGF-b	63.5	30
374077	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SCGF-b	86	31
374078	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SCGF-b	65.5	42
374079	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	1	SCGF-b	59	45
374080	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	1	SCGF-b	78.5	48
374081	20233						RA2159	51112.0										1	SCGF-b	77.5	32
374082	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	SCGF-b	71	60
374083	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	SCGF-b	63	66
374084	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	SCGF-b	61	50
374085	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	SCGF-b	58	74
374086	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	SCGF-b	62	68
374087	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			1	SCGF-b	64	47
374088	20233						N2586	51107.0										1	SCGF-b	63	45
374089	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	SCGF-b	62	47
374090	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	SCGF-b	64	47
374091	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	SCGF-b	64	50
374092	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	SCGF-b	60	57
374093	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	SCGF-b	65	47
374094	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			1	SCGF-b	66	33
374095	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	1	SCGF-b	84	61
374096	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	1	SCGF-b	67.5	60
374097	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SCGF-b	75	54
374098	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SCGF-b	63	57
374099	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SCGF-b	82.5	48
374100	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	1	SCGF-b	66	81
374101	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			1	SCGF-b	60	49
374102	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	1	SCGF-b	57	54
374103	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	1	SCGF-b	76	52
374104	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SCGF-b	65	74
374105	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SCGF-b	64	71
374106	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	1	SCGF-b	72	51
374107	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	1	SCGF-b	60	49
374108	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			1	SCGF-b	66	43
374109	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	1	SCGF-b	89	67
374110	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	SCGF-b	81	68
374111	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SCGF-b	84	59
374112	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SCGF-b	74	51
374113	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SCGF-b	87	67
374114	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	1	SCGF-b	68	50
374115	20233						RA2159	51112.0										1	SCGF-b	69	73
374116	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	1	SCGF-b	62.5	46
374117	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	1	SCGF-b	74	61
374118	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SCGF-b	60.5	40
374119	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SCGF-b	79.5	54
374120	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	1	SCGF-b	72	36
374121	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	1	SCGF-b	81	47
374122	20233						N2586	51107.0										1	SCGF-b	61	35
374123	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	1	SCGF-b	141	70
374124	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	SCGF-b	153	75
374125	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SCGF-b	147	49
374126	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SCGF-b	140	57
374127	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SCGF-b	211	50
374128	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	SCGF-b	157	79
374129	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	1	SCGF-b	120.5	54
374130	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	1	SCGF-b	117	55
374131	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SCGF-b	109	35
374132	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SCGF-b	100	55
374133	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	1	SCGF-b	133	51
374134	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	1	SCGF-b	99	52
374135	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	1	SCGF-b	76	45
374136	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	SCGF-b	56	46
374137	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SCGF-b	68.5	46
374138	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SCGF-b	68	65
374139	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SCGF-b	64	30
374140	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	1	SCGF-b	70	41
374141	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	1	SCGF-b	55	38
374142	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	1	SCGF-b	74	47
374143	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SCGF-b	59	35
374144	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SCGF-b	67.5	30
374145	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	1	SCGF-b	61	39
374146	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	1	SCGF-b	69.5	40
374147	20233						RA2159	51112.0										1	SCGF-b		0
374148	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			1	SCGF-b		0
374149	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			1	SCGF-b		0
374150	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			1	SCGF-b		0
374151	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			1	SCGF-b		0
374152	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			1	SCGF-b		0
374153	20233						RA2159	51112.0										1	SCGF-b		0
374154	20233						N2586	51107.0										1	SCGF-b		0
374155	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			1	SCGF-b		0
374156	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			1	SCGF-b		0
374157	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			1	SCGF-b		0
374158	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			1	SCGF-b		0
374159	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			1	SCGF-b		0
374160	20233						N2586	51107.0										1	SCGF-b		0
374161	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	1	SCGF-b	67	67
374162	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	SCGF-b	90	71
374163	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SCGF-b	60	55
374164	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SCGF-b	64	63
374165	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SCGF-b	63.5	54
374166	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	1	SCGF-b	62	36
374167	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	1	SCGF-b	68	39
374168	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	1	SCGF-b	75	42
374169	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SCGF-b	78.5	50
374170	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SCGF-b	59	48
374171	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	1	SCGF-b	64	27
374172	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	1	SCGF-b	70	37
374173	20233																	0	SCGF-b	39	78
374174	20233						RA2159	51112.0								2	ug/mL	1	SCGF-b	71	51
374175	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	1	SCGF-b	95.5	48
374176	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	SCGF-b	77	45
374177	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	SCGF-b	89	61
374178	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	1	SCGF-b	76	64
374179	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	1	SCGF-b	63	65
374180	20233						N2586	51107.0								2	ug/mL	1	SCGF-b	62	49
374181	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	1	SCGF-b	62	24
374182	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	1	SCGF-b	65.5	38
374183	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	SCGF-b	87	33
374184	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	1	SCGF-b	57	33
374185	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	1	SCGF-b	73	37
374186	20233																	0	SCGF-b	43	51
374187	20233						RA2159	51112.0										2	SCGF-b	77	50
374188	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	SCGF-b	80	35
374189	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	SCGF-b	77	52
374190	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	SCGF-b	81	79
374191	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	SCGF-b	79	65
374192	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	SCGF-b	79	62
374193	20233						RA2159	51112.0										2	SCGF-b	78.5	50
374194	20233						N2586	51107.0										2	SCGF-b	76	53
374195	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	SCGF-b	76	65
374196	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	SCGF-b	83	57
374197	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	SCGF-b	72.5	42
374198	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	SCGF-b	66	61
374199	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	SCGF-b	84	35
374200	20233						N2586	51107.0										2	SCGF-b	88	62
374201	20233																	0	SCGF-b	45	45
374202	20233																	0	SCGF-b	51	56
374203	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	2	SCGF-b	74	53
374204	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	2	SCGF-b	71	69
374205	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	SCGF-b	65	57
374206	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	SCGF-b	65.5	64
374207	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	2	SCGF-b	61.5	56
374208	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	SCGF-b	81	54
374209	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			2	SCGF-b	70.5	52
374210	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	2	SCGF-b	70	56
374211	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	2	SCGF-b	58	59
374212	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	2	SCGF-b	71.5	46
374213	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	SCGF-b	79	45
374214	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	2	SCGF-b	82	46
374215	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	2	SCGF-b	80	32
374216	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			2	SCGF-b	103	53
374217	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	2	SCGF-b	69	59
374218	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	SCGF-b	70	51
374219	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	SCGF-b	67	51
374220	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	SCGF-b	78	50
374221	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	SCGF-b	74	59
374222	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	SCGF-b	70.5	58
374223	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			2	SCGF-b	72	54
374224	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	2	SCGF-b	71	62
374225	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	2	SCGF-b	74	51
374226	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	2	SCGF-b	72	46
374227	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	SCGF-b	79	50
374228	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	2	SCGF-b	87.5	48
374229	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	2	SCGF-b	76	54
374230	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			2	SCGF-b	82	54
374231	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	2	SCGF-b	97.5	64
374232	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	2	SCGF-b	67	53
374233	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	SCGF-b	77	71
374234	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	SCGF-b	66	46
374235	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	2	SCGF-b	63	45
374236	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	SCGF-b	86	30
374237	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			2	SCGF-b	74	53
374238	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	2	SCGF-b	62	53
374239	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	2	SCGF-b	74	61
374240	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	2	SCGF-b	72	58
374241	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	SCGF-b	69.5	50
374242	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	2	SCGF-b	82	50
374243	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	2	SCGF-b	78	49
374244	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			2	SCGF-b	79	54
374245	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	2	SCGF-b	70	61
374246	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	2	SCGF-b	66	58
374247	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	SCGF-b	65	63
374248	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	SCGF-b	68	55
374249	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	2	SCGF-b	49	44
374250	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	SCGF-b	74	31
374251	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			2	SCGF-b	65	37
374252	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	2	SCGF-b	68	35
374253	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	2	SCGF-b	87	54
374254	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	2	SCGF-b	61	16
374255	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	SCGF-b	77	20
374256	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	2	SCGF-b	73	31
374257	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	2	SCGF-b	72	53
374258	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			2	SCGF-b	83	78
374259	20233						RA2159	51112.0										2	SCGF-b	67	64
374260	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	SCGF-b	65	69
374261	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	SCGF-b	59	41
374262	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	SCGF-b	75	35
374263	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	SCGF-b	60	53
374264	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	SCGF-b	71	64
374265	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			2	SCGF-b	72.5	64
374266	20233						N2586	51107.0										2	SCGF-b	63	63
374267	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	SCGF-b	72	59
374268	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	SCGF-b	71	63
374269	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	SCGF-b	66	63
374270	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	SCGF-b	60.5	48
374271	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	SCGF-b	76	53
374272	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			2	SCGF-b	80	59
374273	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	2	SCGF-b	72.5	50
374274	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	2	SCGF-b	74	66
374275	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	2	SCGF-b	52.5	54
374276	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	SCGF-b	61	55
374277	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	2	SCGF-b	59	49
374278	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	2	SCGF-b	59	53
374279	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	2	SCGF-b	66	71
374280	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	2	SCGF-b	63	33
374281	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	2	SCGF-b	71.5	50
374282	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	SCGF-b	58.5	50
374283	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	2	SCGF-b	83	50
374284	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	2	SCGF-b	71.5	70
374285	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	2	SCGF-b	79	61
374286	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	2	SCGF-b	63	70
374287	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	SCGF-b	69.5	50
374288	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	SCGF-b	70.5	68
374289	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	2	SCGF-b	66	44
374290	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	SCGF-b	66	44
374291	20233						RA2159	51112.0										2	SCGF-b	63	54
374292	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	2	SCGF-b	69.5	40
374293	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	2	SCGF-b	95	63
374294	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	2	SCGF-b	67	61
374295	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	SCGF-b	66.5	40
374296	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	2	SCGF-b	68	79
374297	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	2	SCGF-b	70	57
374298	20233						N2586	51107.0										2	SCGF-b	91.5	62
374299	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	2	SCGF-b	130	63
374300	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	SCGF-b	96	40
374301	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	SCGF-b	120	47
374302	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	SCGF-b	118	48
374303	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	SCGF-b	114	55
374304	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	SCGF-b	117	44
374305	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	2	SCGF-b	126	53
374306	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	2	SCGF-b	124	51
374307	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	2	SCGF-b	166	41
374308	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	SCGF-b	148.5	36
374309	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	2	SCGF-b	143.5	48
374310	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	2	SCGF-b	166	70
374311	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	2	SCGF-b	67.5	58
374312	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	2	SCGF-b	67.5	60
374313	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	SCGF-b	59.5	44
374314	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	SCGF-b	63	51
374315	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	2	SCGF-b	63	52
374316	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	SCGF-b	53	59
374317	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	2	SCGF-b	71	47
374318	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	2	SCGF-b	72	59
374319	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	2	SCGF-b	66	63
374320	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	SCGF-b	75	53
374321	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	2	SCGF-b	73	51
374322	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	2	SCGF-b	67	54
374323	20233						RA2159	51112.0										2	SCGF-b		0
374324	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			2	SCGF-b		0
374325	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			2	SCGF-b		0
374326	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			2	SCGF-b		0
374327	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			2	SCGF-b		0
374328	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			2	SCGF-b		0
374329	20233						RA2159	51112.0										2	SCGF-b		0
374330	20233						N2586	51107.0										2	SCGF-b		0
374331	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			2	SCGF-b		0
374332	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			2	SCGF-b		0
374333	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			2	SCGF-b		0
374334	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			2	SCGF-b		0
374335	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			2	SCGF-b		0
374336	20233						N2586	51107.0										2	SCGF-b		0
374337	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	2	SCGF-b	76	37
374338	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	2	SCGF-b	73	75
374339	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	SCGF-b	65	53
374340	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	SCGF-b	65	62
374341	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	2	SCGF-b	66	61
374342	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	SCGF-b	64.5	64
374343	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	2	SCGF-b	70	70
374344	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	2	SCGF-b	69	49
374345	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	2	SCGF-b	66	50
374346	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	SCGF-b	71	57
374347	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	2	SCGF-b	65	53
374348	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	2	SCGF-b	68	41
374349	20233																	0	SCGF-b	35.5	56
374350	20233						RA2159	51112.0								2	ug/mL	2	SCGF-b	84	68
374351	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	2	SCGF-b	93	35
374352	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	2	SCGF-b	95.5	38
374353	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	2	SCGF-b	66.5	50
374354	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	2	SCGF-b	65	49
374355	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	2	SCGF-b	83.5	58
374356	20233						N2586	51107.0								2	ug/mL	2	SCGF-b	70	61
374357	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	2	SCGF-b	81	57
374358	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	2	SCGF-b	65.5	36
374359	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	2	SCGF-b	63	46
374360	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	2	SCGF-b	51.5	42
374361	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	2	SCGF-b	69	59
374362	20233																	0	SCGF-b	44	50
374363	20233						RA2159	51112.0								2	ug/mL	3	SCGF-b	73.5	56
374364	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM	2	ug/mL	3	SCGF-b	75	67
374365	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	SCGF-b	75	73
374366	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	SCGF-b	89	59
374367	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM	2	ug/mL	3	SCGF-b	77	57
374368	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM	2	ug/mL	3	SCGF-b	59	52
374369	20233						N2586	51107.0								2	ug/mL	3	SCGF-b	65	57
374370	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM	2	ug/mL	3	SCGF-b	91	63
374371	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM	2	ug/mL	3	SCGF-b	66.5	50
374372	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	SCGF-b	66.5	56
374373	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM	2	ug/mL	3	SCGF-b	67	56
374374	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM	2	ug/mL	3	SCGF-b	80.5	62
374375	20233						RA2159	51112.0										3	SCGF-b		0
374376	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	SCGF-b		0
374377	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	SCGF-b		0
374378	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	SCGF-b		0
374379	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	SCGF-b		0
374380	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	SCGF-b		0
374381	20233						RA2159	51112.0										3	SCGF-b		0
374382	20233						N2586	51107.0										3	SCGF-b		0
374383	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	SCGF-b		0
374384	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	SCGF-b		0
374385	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	SCGF-b		0
374386	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	SCGF-b		0
374387	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	SCGF-b		0
374388	20233						N2586	51107.0										3	SCGF-b		0
374389	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	3	SCGF-b	101	63
374390	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	SCGF-b	67	47
374391	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SCGF-b	82.5	66
374392	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SCGF-b	55	53
374393	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SCGF-b	71	60
374394	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Visfatin	201293.0				2	uM	1	ng/mL	3	SCGF-b	70.5	52
374395	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	3	SCGF-b	72	51
374396	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	3	SCGF-b	71.5	80
374397	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SCGF-b	64.5	70
374398	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SCGF-b	68	69
374399	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	3	SCGF-b	67	52
374400	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Visfatin	201293.0				2	uM	1	ng/mL	3	SCGF-b	83.5	50
374401	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	3	SCGF-b	72	66
374402	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	SCGF-b	78	75
374403	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SCGF-b	74	61
374404	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SCGF-b	68	59
374405	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SCGF-b	70	61
374406	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Leptin	201292.0				2	uM	1	ng/mL	3	SCGF-b	70.5	50
374407	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	3	SCGF-b	68	62
374408	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	3	SCGF-b	71.5	78
374409	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SCGF-b	68.5	74
374410	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SCGF-b	66	47
374411	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	3	SCGF-b	71	61
374412	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Leptin	201292.0				2	uM	1	ng/mL	3	SCGF-b	60	76
374413	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	3	SCGF-b	130.5	58
374414	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	SCGF-b	117.5	62
374415	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SCGF-b	136.5	58
374416	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SCGF-b	114.5	62
374417	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SCGF-b	118	50
374418	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	SCGF-b	111	61
374419	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	3	SCGF-b	130	59
374420	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	3	SCGF-b	139	61
374421	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SCGF-b	121.5	62
374422	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SCGF-b	128	57
374423	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	3	SCGF-b	124	43
374424	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	Adiponectin	201291.0				2	uM	5	ng/mL	3	SCGF-b	145	59
374425	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	3	SCGF-b	74.5	58
374426	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	SCGF-b	72	69
374427	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SCGF-b	83	54
374428	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SCGF-b	65	51
374429	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SCGF-b	70	57
374430	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IGF-I	201290.0				2	uM	100	ug/mL	3	SCGF-b	59	53
374431	20233						RA2159	51112.0										3	SCGF-b	67.5	66
374432	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	3	SCGF-b	75	51
374433	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	3	SCGF-b	88	59
374434	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SCGF-b	76	72
374435	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SCGF-b	182	71
374436	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	3	SCGF-b	60	55
374437	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IGF-I	201290.0				2	uM	100	ug/mL	3	SCGF-b	60.5	52
374438	20233						N2586	51107.0										3	SCGF-b	84	78
374439	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	3	SCGF-b	71.5	50
374440	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	3	SCGF-b	67	55
374441	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SCGF-b	79.5	54
374442	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SCGF-b	64	65
374443	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SCGF-b	72	71
374444	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	EGF	201289.0				2	uM	100	ng/mL	3	SCGF-b	58.5	52
374445	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			3	SCGF-b	79	63
374446	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	3	SCGF-b	68.5	62
374447	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	3	SCGF-b	62	57
374448	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SCGF-b	60.5	52
374449	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SCGF-b	82	54
374450	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	3	SCGF-b	73.5	60
374451	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	EGF	201289.0				2	uM	100	ng/mL	3	SCGF-b	57	63
374452	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			3	SCGF-b	66	65
374453	20233						RA2159	51112.0										3	SCGF-b	68	60
374454	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	SCGF-b	60.5	58
374455	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	SCGF-b	60	57
374456	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	SCGF-b	57	52
374457	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	SCGF-b	70	63
374458	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	SCGF-b	75	43
374459	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			3	SCGF-b	65	74
374460	20233						N2586	51107.0										3	SCGF-b	62	50
374461	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	SCGF-b	77.5	74
374462	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	SCGF-b	60	55
374463	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	SCGF-b	87	50
374464	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	SCGF-b	71	55
374465	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	SCGF-b	64	64
374466	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			3	SCGF-b	70	59
374467	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	3	SCGF-b	73	67
374468	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	SCGF-b	62	50
374469	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SCGF-b	75	62
374470	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SCGF-b	71	61
374471	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SCGF-b	62.5	64
374472	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-17A	201288.0				2	uM	100	ng/mL	3	SCGF-b	65	66
374473	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	3	SCGF-b	62	55
374474	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	3	SCGF-b	69	51
374475	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SCGF-b	63	67
374476	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SCGF-b	91	61
374477	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	3	SCGF-b	59	51
374478	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-17A	201288.0				2	uM	100	ng/mL	3	SCGF-b	72.5	44
374479	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	3	SCGF-b	77	53
374480	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	SCGF-b	90.5	64
374481	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SCGF-b	64	53
374482	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SCGF-b	59.5	54
374483	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SCGF-b	68	55
374484	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-6	201287.0				2	uM	100	ug/mL	3	SCGF-b	70.5	48
374485	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			3	SCGF-b	63.5	60
374486	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	3	SCGF-b	81.5	52
374487	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	3	SCGF-b	58.5	54
374488	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SCGF-b	63	40
374489	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SCGF-b	59.5	68
374490	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	3	SCGF-b	73.5	56
374491	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-6	201287.0				2	uM	100	ug/mL	3	SCGF-b	72	60
374492	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			3	SCGF-b	90	50
374493	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	3	SCGF-b	66	64
374494	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	SCGF-b	68.5	42
374495	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SCGF-b	79	83
374496	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SCGF-b	77	73
374497	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SCGF-b	71.5	68
374498	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	SCGF-b	64.5	48
374499	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			3	SCGF-b	58.5	56
374500	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	3	SCGF-b	68.5	54
374501	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	3	SCGF-b	57.5	64
374502	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SCGF-b	60	69
374503	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SCGF-b	77.5	48
374504	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	3	SCGF-b	76	53
374505	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	IL-1 alpha	201286.0				2	uM	100	ng/mL	3	SCGF-b	67.5	50
374506	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			3	SCGF-b	69	55
374507	20233																	0	SCGF-b	45.5	58
374508	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	3	SCGF-b	97	51
374509	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	SCGF-b	76	61
374510	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SCGF-b	72	74
374511	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SCGF-b	68	42
374512	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SCGF-b	74.5	56
374513	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0	TNF-a	201285.0				2	uM	100	ng/mL	3	SCGF-b	83	53
374514	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			3	SCGF-b	60.5	32
374515	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	3	SCGF-b	61	55
374516	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	3	SCGF-b	73	79
374517	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SCGF-b	60	60
374518	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SCGF-b	61.5	66
374519	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	3	SCGF-b	86	57
374520	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0	TNF-a	201285.0				2	uM	100	ng/mL	3	SCGF-b	71	70
374521	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			3	SCGF-b	95	61
374522	20233																	0	SCGF-b	43	43
374523	20233						RA2159	51112.0										3	SCGF-b	86	55
374524	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			3	SCGF-b	76.5	60
374525	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			3	SCGF-b	80.5	54
374526	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			3	SCGF-b	75.5	32
374527	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			3	SCGF-b	83.5	56
374528	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			3	SCGF-b	72	47
374529	20233						RA2159	51112.0										3	SCGF-b	85	51
374530	20233						N2586	51107.0										3	SCGF-b	102	51
374531	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			3	SCGF-b	64.5	44
374532	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			3	SCGF-b	59.5	50
374533	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			3	SCGF-b	78.5	56
374534	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			3	SCGF-b	63	61
374535	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			3	SCGF-b	88	31
374536	20233						N2586	51107.0										3	SCGF-b	74	43
374537	20233																	0	SCGF-b	48	49
374538	20233						RA2159	51112.0								2	ug/mL	4	SCGF-b	77.5	50
374539	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM	2	ug/mL	4	SCGF-b	105	61
374540	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM	2	ug/mL	4	SCGF-b	80.5	58
374541	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM	2	ug/mL	4	SCGF-b	74	46
374542	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM	2	ug/mL	4	SCGF-b	68.5	54
374543	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM	2	ug/mL	4	SCGF-b	76	51
374544	20233						N2586	51107.0								2	ug/mL	4	SCGF-b	78	50
374545	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM	2	ug/mL	4	SCGF-b	66	55
374546	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM	2	ug/mL	4	SCGF-b	60	53
374547	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM	2	ug/mL	4	SCGF-b	67	32
374548	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM	2	ug/mL	4	SCGF-b	80	55
374549	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM	2	ug/mL	4	SCGF-b	65	55
374550	20233						RA2159	51112.0										4	SCGF-b		0
374551	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	SCGF-b		0
374552	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	SCGF-b		0
374553	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	SCGF-b		0
374554	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	SCGF-b		0
374555	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	SCGF-b		0
374556	20233						RA2159	51112.0										4	SCGF-b		0
374557	20233						N2586	51107.0										4	SCGF-b		0
374558	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	SCGF-b		0
374559	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	SCGF-b		0
374560	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	SCGF-b		0
374561	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	SCGF-b		0
374562	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	SCGF-b		0
374563	20233						N2586	51107.0										4	SCGF-b		0
374564	20233						RA2159	51112.0	Visfatin	201293.0						1	ng/mL	4	SCGF-b	83	37
374565	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Visfatin	201293.0				1	uM	1	ng/mL	4	SCGF-b	74.5	46
374566	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	SCGF-b	89.5	50
374567	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	SCGF-b	75	63
374568	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Visfatin	201293.0				3	uM	1	ng/mL	4	SCGF-b	81.5	50
374569	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	SCGF-b	82	59
374570	20233						N2586	51107.0	Visfatin	201293.0						1	ng/mL	4	SCGF-b	77	42
374571	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Visfatin	201293.0				1	uM	1	ng/mL	4	SCGF-b	70	68
374572	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Visfatin	201293.0				0.1	uM	1	ng/mL	4	SCGF-b	67.5	66
374573	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	SCGF-b	76	57
374574	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Visfatin	201293.0				3	uM	1	ng/mL	4	SCGF-b	68	77
374575	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Visfatin	201293.0				0.3	uM	1	ng/mL	4	SCGF-b	73.5	48
374576	20233						RA2159	51112.0	Leptin	201292.0						1	ng/mL	4	SCGF-b	76.5	52
374577	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Leptin	201292.0				1	uM	1	ng/mL	4	SCGF-b	63	47
374578	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	SCGF-b	68	53
374579	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	SCGF-b	68	68
374580	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Leptin	201292.0				3	uM	1	ng/mL	4	SCGF-b	106	50
374581	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	SCGF-b	68.5	40
374582	20233						N2586	51107.0	Leptin	201292.0						1	ng/mL	4	SCGF-b	77.5	66
374583	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Leptin	201292.0				1	uM	1	ng/mL	4	SCGF-b	63	59
374584	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Leptin	201292.0				0.1	uM	1	ng/mL	4	SCGF-b	52	33
374585	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	SCGF-b	63	58
374586	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Leptin	201292.0				3	uM	1	ng/mL	4	SCGF-b	70	42
374587	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Leptin	201292.0				0.3	uM	1	ng/mL	4	SCGF-b	86	36
374588	20233						RA2159	51112.0	Adiponectin	201291.0						5	ng/mL	4	SCGF-b	126	50
374589	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	SCGF-b	116	56
374590	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	SCGF-b	122	60
374591	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	SCGF-b	113	59
374592	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	SCGF-b	124.5	54
374593	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	SCGF-b	122	50
374594	20233						N2586	51107.0	Adiponectin	201291.0						5	ng/mL	4	SCGF-b	108	62
374595	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	Adiponectin	201291.0				1	uM	5	ng/mL	4	SCGF-b	103	61
374596	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	Adiponectin	201291.0				0.1	uM	5	ng/mL	4	SCGF-b	117.5	66
374597	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	SCGF-b	105	50
374598	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	Adiponectin	201291.0				3	uM	5	ng/mL	4	SCGF-b	124	68
374599	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	Adiponectin	201291.0				0.3	uM	5	ng/mL	4	SCGF-b	91	51
374600	20233						RA2159	51112.0	IGF-I	201290.0						100	ug/mL	4	SCGF-b	75	67
374601	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IGF-I	201290.0				1	uM	100	ug/mL	4	SCGF-b	71	64
374602	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	SCGF-b	75.5	56
374603	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	SCGF-b	72.5	60
374604	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IGF-I	201290.0				3	uM	100	ug/mL	4	SCGF-b	74	59
374605	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	SCGF-b	65.5	54
374606	20233						RA2159	51112.0										4	SCGF-b	76	61
374607	20233						N2586	51107.0	IGF-I	201290.0						100	ug/mL	4	SCGF-b	72	55
374608	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IGF-I	201290.0				1	uM	100	ug/mL	4	SCGF-b	74	57
374609	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IGF-I	201290.0				0.1	uM	100	ug/mL	4	SCGF-b	67	52
374610	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	SCGF-b	77.5	34
374611	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IGF-I	201290.0				3	uM	100	ug/mL	4	SCGF-b	73	57
374612	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IGF-I	201290.0				0.3	uM	100	ug/mL	4	SCGF-b	60.5	50
374613	20233						N2586	51107.0										4	SCGF-b	80	58
374614	20233						RA2159	51112.0	EGF	201289.0						100	ng/mL	4	SCGF-b	77	80
374615	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	EGF	201289.0				1	uM	100	ng/mL	4	SCGF-b	58	65
374616	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	EGF	201289.0				0.1	uM	100	ng/mL	4	SCGF-b	61	50
374617	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	SCGF-b	58	53
374618	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	EGF	201289.0				3	uM	100	ng/mL	4	SCGF-b	85	43
374619	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	EGF	201289.0				0.3	uM	100	ng/mL	4	SCGF-b	84	55
374620	20233						N2586	51107.0	EGF	201289.0						100	ng/mL	4	SCGF-b	67	51
374621	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	EGF	201289.0				1	uM	100	ng/mL	4	SCGF-b	70.5	60
374622	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	EGF	201289.0				0.1	uM	100	ng/mL	4	SCGF-b	53.5	64
374623	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	SCGF-b	69	54
374624	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	EGF	201289.0				3	uM	100	ng/mL	4	SCGF-b	70	48
374625	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	EGF	201289.0				0.3	uM	100	ng/mL	4	SCGF-b	61.5	54
374626	20233						RA2159	51112.0										4	SCGF-b	80	50
374627	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	SCGF-b	65	53
374628	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	SCGF-b	68	51
374629	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	SCGF-b	62	65
374630	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	SCGF-b	62.5	46
374631	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	SCGF-b	65.5	22
374632	20233	10228.0	102.0	3.0	LSM-2309	IKK16	RA2159	51112.0						2	uM			4	SCGF-b	54	11
374633	20233						N2586	51107.0										4	SCGF-b		2
374634	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	SCGF-b	58	13
374635	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	SCGF-b	62	65
374636	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	SCGF-b	71	35
374637	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	SCGF-b	62.5	62
374638	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	SCGF-b	65	55
374639	20233	10228.0	102.0	3.0	LSM-2309	IKK16	N2586	51107.0						2	uM			4	SCGF-b	87.5	38
374640	20233						RA2159	51112.0	IL-17A	201288.0						100	ng/mL	4	SCGF-b	63	54
374641	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-17A	201288.0				1	uM	100	ng/mL	4	SCGF-b	57	55
374642	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	SCGF-b	59	63
374643	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	SCGF-b	73.5	56
374644	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-17A	201288.0				3	uM	100	ng/mL	4	SCGF-b	60	63
374645	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	SCGF-b	75	53
374646	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	RA2159	51112.0						0.3	uM			4	SCGF-b	62	31
374647	20233						N2586	51107.0	IL-17A	201288.0						100	ng/mL	4	SCGF-b	63	51
374648	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-17A	201288.0				1	uM	100	ng/mL	4	SCGF-b	74	55
374649	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-17A	201288.0				0.1	uM	100	ng/mL	4	SCGF-b	71.5	54
374650	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	SCGF-b	62	62
374651	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-17A	201288.0				3	uM	100	ng/mL	4	SCGF-b	48.5	58
374652	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-17A	201288.0				0.3	uM	100	ng/mL	4	SCGF-b	61.5	56
374653	20233	10226.0	101.0	2.0	LSM-1227	Tofacitinib	N2586	51107.0						0.3	uM			4	SCGF-b	67	35
374654	20233						RA2159	51112.0	IL-6	201287.0						100	ug/mL	4	SCGF-b	83.5	64
374655	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-6	201287.0				1	uM	100	ug/mL	4	SCGF-b	59	69
374656	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	SCGF-b	65.5	48
374657	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	SCGF-b	61	55
374658	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-6	201287.0				3	uM	100	ug/mL	4	SCGF-b	63.5	32
374659	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	SCGF-b	72.5	60
374660	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	RA2159	51112.0						0.3	uM			4	SCGF-b	62.5	70
374661	20233						N2586	51107.0	IL-6	201287.0						100	ug/mL	4	SCGF-b	72	49
374662	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-6	201287.0				1	uM	100	ug/mL	4	SCGF-b	68	61
374663	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-6	201287.0				0.1	uM	100	ug/mL	4	SCGF-b	73	39
374664	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	SCGF-b	68	47
374665	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-6	201287.0				3	uM	100	ug/mL	4	SCGF-b	64	63
374666	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-6	201287.0				0.3	uM	100	ug/mL	4	SCGF-b	56	51
374667	20233	10138.0	101.0	5.0	LSM-1139	Ruxolitinib	N2586	51107.0						0.3	uM			4	SCGF-b	85	41
374668	20233						RA2159	51112.0	IL-1 alpha	201286.0						100	ng/mL	4	SCGF-b	78	49
374669	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	SCGF-b	59	50
374670	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	SCGF-b	83	50
374671	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	SCGF-b	64	53
374672	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	SCGF-b	71	57
374673	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	SCGF-b	83.5	72
374674	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	RA2159	51112.0						0.3	uM			4	SCGF-b	62.5	68
374675	20233						N2586	51107.0	IL-1 alpha	201286.0						100	ng/mL	4	SCGF-b	67	63
374676	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	IL-1 alpha	201286.0				1	uM	100	ng/mL	4	SCGF-b	63	68
374677	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	IL-1 alpha	201286.0				0.1	uM	100	ng/mL	4	SCGF-b	71	41
374678	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	SCGF-b	64	60
374679	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	IL-1 alpha	201286.0				3	uM	100	ng/mL	4	SCGF-b	62	43
374680	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	IL-1 alpha	201286.0				0.3	uM	100	ng/mL	4	SCGF-b	74	49
374681	20233	10230.0	101.0	3.0	LSM-1231	Lestaurtinib	N2586	51107.0						0.3	uM			4	SCGF-b	60.5	42
374682	20233																	0	SCGF-b	44	54
374683	20233						RA2159	51112.0	TNF-a	201285.0						100	ng/mL	4	SCGF-b	66	53
374684	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0	TNF-a	201285.0				1	uM	100	ng/mL	4	SCGF-b	66.5	46
374685	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	SCGF-b	70	52
374686	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	SCGF-b	72	53
374687	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0	TNF-a	201285.0				3	uM	100	ng/mL	4	SCGF-b	60	40
374688	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	SCGF-b	77.5	56
374689	20233	10048.0	101.0	5.0	LSM-1048	PD184352	RA2159	51112.0						0.1	uM			4	SCGF-b	66	44
374690	20233						N2586	51107.0	TNF-a	201285.0						100	ng/mL	4	SCGF-b	82	65
374691	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0	TNF-a	201285.0				1	uM	100	ng/mL	4	SCGF-b	68.5	50
374692	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0	TNF-a	201285.0				0.1	uM	100	ng/mL	4	SCGF-b	70.5	56
374693	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	SCGF-b	60.5	40
374694	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0	TNF-a	201285.0				3	uM	100	ng/mL	4	SCGF-b	78.5	44
374695	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0	TNF-a	201285.0				0.3	uM	100	ng/mL	4	SCGF-b	72	33
374696	20233	10048.0	101.0	5.0	LSM-1048	PD184352	N2586	51107.0						0.1	uM			4	SCGF-b	80	55
374697	20233																	0	SCGF-b	38	33
374698	20233						RA2159	51112.0										4	SCGF-b	89	60
374699	20233	10227.0	101.0	2.0	LSM-1228	EO1428	RA2159	51112.0						1	uM			4	SCGF-b	72	52
374700	20233	10126.0	102.0	5.0	LSM-1126	PI103	RA2159	51112.0						0.1	uM			4	SCGF-b	78	53
374701	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	RA2159	51112.0						3	uM			4	SCGF-b	79	64
374702	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	RA2159	51112.0						3	uM			4	SCGF-b	86	65
374703	20233	10477.0	101.0	1.0		JNK-IN-11	RA2159	51112.0						0.3	uM			4	SCGF-b	70	61
374704	20233						RA2159	51112.0										4	SCGF-b	76	53
374705	20233						N2586	51107.0										4	SCGF-b	78	67
374706	20233	10227.0	101.0	2.0	LSM-1228	EO1428	N2586	51107.0						1	uM			4	SCGF-b	75.5	44
374707	20233	10126.0	102.0	5.0	LSM-1126	PI103	N2586	51107.0						0.1	uM			4	SCGF-b	69	44
374708	20233	10035.0	109.0	4.0	LSM-1035	Sigma A6730	N2586	51107.0						3	uM			4	SCGF-b	75	56
374709	20233	10363.0	101.0	2.0	LSM-36360	JNK-IN-8	N2586	51107.0						3	uM			4	SCGF-b	70	55
374710	20233	10477.0	101.0	1.0		JNK-IN-11	N2586	51107.0						0.3	uM			4	SCGF-b	76.5	40
374711	20233						N2586	51107.0										4	SCGF-b	72	46
374712	20233								TNF-a	201285.0						100	ng/mL	0	SCGF-b	52	71
374713	20233								IL-1 alpha	201286.0						100	ng/mL	0	SCGF-b	51	61
374714	20233								IL-6	201287.0						100	ug/mL	0	SCGF-b	50.5	30
374715	20233								IL-17A	201288.0						100	ng/mL	0	SCGF-b	47	65
374716	20233								EGF	201289.0						100	ng/mL	0	SCGF-b	68.5	48
374717	20233								IGF-I	201290.0						100	ug/mL	0	SCGF-b	50	48
374718	20233								Adiponectin	201291.0						5	ng/mL	0	SCGF-b	465	41
374719	20233								Leptin	201292.0						1	ng/mL	0	SCGF-b	48	62
374720	20233								Visfatin	201293.0						1	ng/mL	0	SCGF-b	56.5	46
374721	20233															2	ug/mL	0	SCGF-b	41	51
374722	20233								TNF-a	201285.0						100	ng/mL	0	SCGF-b	48	41
374723	20233								IL-1 alpha	201286.0						100	ng/mL	0	SCGF-b	54	55
374724	20233								IL-6	201287.0						100	ug/mL	0	SCGF-b	39.5	52
374725	20233								IL-17A	201288.0						100	ng/mL	0	SCGF-b	44	77
374726	20233								EGF	201289.0						100	ng/mL	0	SCGF-b	51	60
374727	20233								IGF-I	201290.0						100	ug/mL	0	SCGF-b	52	39
374728	20233								Adiponectin	201291.0						5	ng/mL	0	SCGF-b	434	52
374729	20233								Leptin	201292.0						1	ng/mL	0	SCGF-b	40	67
374730	20233								Visfatin	201293.0						1	ng/mL	0	SCGF-b	49	50
374731	20233															2	ug/mL	0	SCGF-b	43	39
374732	20233								TNF-a	201285.0						100	ng/mL	0	SCGF-b	43	62
374733	20233								IL-1 alpha	201286.0						100	ng/mL	0	SCGF-b	41	53
374734	20233								IL-6	201287.0						100	ug/mL	0	SCGF-b	40	74
374735	20233								IL-17A	201288.0						100	ng/mL	0	SCGF-b	39	53
374736	20233								EGF	201289.0						100	ng/mL	0	SCGF-b	43	35
374737	20233								IGF-I	201290.0						100	ug/mL	0	SCGF-b	39	59
374738	20233								Adiponectin	201291.0						5	ng/mL	0	SCGF-b	307.5	54
374739	20233								Leptin	201292.0						1	ng/mL	0	SCGF-b	33	37
374740	20233								Visfatin	201293.0						1	ng/mL	0	SCGF-b	38	48
374741	20233															2	ug/mL	0	SCGF-b	48	67
374742	20233								TNF-a	201285.0						100	ng/mL	0	SCGF-b	45.5	38
374743	20233								IL-1 alpha	201286.0						100	ng/mL	0	SCGF-b	46.5	62
374744	20233								IL-6	201287.0						100	ug/mL	0	SCGF-b	53.5	64
374745	20233								IL-17A	201288.0						100	ng/mL	0	SCGF-b	42	59
374746	20233								EGF	201289.0						100	ng/mL	0	SCGF-b	42	83
374747	20233								IGF-I	201290.0						100	ug/mL	0	SCGF-b	34.5	34
374748	20233								Adiponectin	201291.0						5	ng/mL	0	SCGF-b	492	50
374749	20233								Leptin	201292.0						1	ng/mL	0	SCGF-b	57	45
374750	20233								Visfatin	201293.0						1	ng/mL	0	SCGF-b	53	41
374751	20233															2	ug/mL	0	SCGF-b	34	45
